# EDGAR Filing Document

**Accession Number:** 0000810016
**File Stem:** 0001206774-23-000348
**Filing Date:** 2023-3
**Character Count:** 1366194
**Document Hash:** 7ffa497b9bba59d56ab20a865363767c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001206774-23-000348.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0001206774-23-000348

**CONFORMED SUBMISSION TYPE**: N-CSR

**PUBLIC DOCUMENT COUNT**: 48

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**EFFECTIVENESS DATE**: 20230310

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ivy Variable Insurance Portfolios
- **CENTRAL INDEX KEY:** 0000810016
- **IRS NUMBER:** 481146010
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-CSR
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-05017
- **FILM NUMBER:** 23722957

**BUSINESS ADDRESS:**
- **STREET 1:** 6300 LAMAR AVENUE
- **CITY:** OVERLAND PARK
- **STATE:** KS
- **ZIP:** 66202
- **BUSINESS PHONE:** 9132362000

**MAIL ADDRESS:**
- **STREET 1:** P O BOX 29217
- **CITY:** SHAWNEE MISSION
- **STATE:** KS
- **ZIP:** 66201-9217

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ivy Funds Variable Insurance Portfolios
- **DATE OF NAME CHANGE:** 20100301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ivy Funds Variable Insurance Portfolios, Inc.
- **DATE OF NAME CHANGE:** 20080819

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** W&R TARGET FUNDS INC
- **DATE OF NAME CHANGE:** 20001026

## Series and Classes Contracts Data

### Delaware Ivy VIP Asset Strategy (Series ID: S000006224)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017158 | Class II     |  |
| C000190645 | Class I      |  |

### Delaware Ivy VIP International Core Equity (Series ID: S000006225)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017159 | Class II     |  |

### Delaware Ivy VIP Mid Cap Growth (Series ID: S000006228)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017162 | Class II     |  |
| C000190647 | Class I      |  |

### Delaware VIP Real Estate Securities (Series ID: S000006231)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017165 | Class II     |  |

### Delaware Ivy VIP Science and Technology (Series ID: S000006232)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017166 | Class II     |  |
| C000190648 | Class I      |  |

### Delaware Ivy VIP Small Cap Growth (Series ID: S000006233)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017167 | Class II     |  |
| C000203521 | Class I      |  |

### Delaware Ivy VIP Smid Cap Core (Series ID: S000006234)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017168 | Class II     |  |

### Delaware Ivy VIP Balanced (Series ID: S000006235)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017169 | Class II     |  |

### Delaware Ivy VIP Value (Series ID: S000006236)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017170 | Class II     |  |

### Delaware Ivy VIP Corporate Bond (Series ID: S000006237)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017171 | Class II     |  |

### Delaware Ivy VIP Core Equity (Series ID: S000006238)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017172 | Class II     |  |

### Delaware Ivy VIP Global Value Equity (Series ID: S000006239)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017173 | Class II     |  |

### Delaware Ivy VIP Natural Resources (Series ID: S000006240)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017174 | Class II     |  |

### Delaware Ivy VIP Growth (Series ID: S000006241)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017175 | Class II     |  |

### Delaware Ivy VIP High Income (Series ID: S000006242)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017176 | Class II     |  |
| C000190649 | Class I      |  |

### Delaware Ivy VIP Global Growth (Series ID: S000006243)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000017177 | Class II     |  |

### Delaware Ivy VIP Energy (Series ID: S000011749)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000032174 | Class II     |  |
| C000190650 | Class I      |  |

### Delaware Ivy VIP Pathfinder Aggressive (Series ID: S000020588)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000057543 | Class II     |  |

### Delaware Ivy VIP Pathfinder Moderately Aggressive (Series ID: S000020589)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000057544 | Class II     |  |

### Delaware Ivy VIP Pathfinder Moderate (Series ID: S000020590)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000057545 | Class II     |  |

### Delaware Ivy VIP Pathfinder Moderately Conservative (Series ID: S000020591)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000057546 | Class II     |  |

### Delaware Ivy VIP Pathfinder Conservative (Series ID: S000020592)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000057547 | Class II     |  |

### Delaware Ivy VIP Limited-Term Bond (Series ID: S000029766)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000091476 | Class II     |  |

### Delaware Ivy VIP Pathfinder Moderate - Managed Volatility (Series ID: S000041732)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000129560 | Class II     |  |

### Delaware Ivy VIP Pathfinder Moderately Aggressive - Managed Volatility (Series ID: S000041733)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000129561 | Class II     |  |

### Delaware Ivy VIP Pathfinder Moderately Conservative - Managed Volatility (Series ID: S000041734)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000129562 | Class II     |  |

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM N-CSR**

**CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT <br> INVESTMENT COMPANIES**

---

| | |
|:---|:---|
| &nbsp;&nbsp;Investment Company Act file number: | &nbsp;&nbsp;811-5017 |
| &nbsp;&nbsp;Exact name of registrant as specified in charter: | &nbsp;&nbsp;Ivy Variable Insurance Portfolios |
| &nbsp;&nbsp;Address of principal executive offices: | &nbsp;&nbsp;610 Market Street<br> Philadelphia, PA 19106 |
| &nbsp;&nbsp;Name and address of agent for service: | &nbsp;&nbsp;David F. Connor, Esq.<br> 610 Market Street<br> Philadelphia, PA 19106 |
| &nbsp;&nbsp;Registrant's telephone number, including area code: | &nbsp;&nbsp;(800) 523-1918 |
| &nbsp;&nbsp;Date of fiscal year end: | &nbsp;&nbsp;December 31 |
| &nbsp;&nbsp;Date of reporting period: | &nbsp;&nbsp;December 31, 2022 |

---

Item 1. Reports to Stockholders

---

| | |
|:---|:---|
| ![](mimivip4167561_ncsrx1x1.jpg) | ![](mimivip4167561_ncsrx1x2.jpg) |

---

**Annual report**

**Ivy Variable Insurance Portfolios**

Delaware Ivy VIP Asset Strategy

Delaware Ivy VIP Balanced

Delaware Ivy VIP Energy

Delaware Ivy VIP Growth

Delaware Ivy VIP High Income

Delaware Ivy VIP International Core Equity

Delaware Ivy VIP Mid Cap Growth

Delaware Ivy VIP Natural Resources

Delaware Ivy VIP Science and Technology

Delaware Ivy VIP Small Cap Growth

Delaware Ivy VIP Smid Cap Core

December 31, 2022 <br>

[**Table of Contents**](#toc1)

**Table of contents**

---

| | |
|:---|:---|
| **[Portfolio management reviews](#a001)** | **[1](#a001)** |
| **[Performance summaries](#a002)** | **[23](#a002)** |
| **[Disclosure of Portfolio expenses](#a003)** | **[46](#a003)** |
| **[Security type / sector / country allocations and top 10 equity holdings](#a004)** | **[49](#a004)** |
| **[Schedules of investments](#a005)** | **[60](#a005)** |
| **[Statements of assets and liabilities](#a006)** | **[97](#a006)** |
| **[Statements of operations](#a007)** | **[103](#a007)** |
| **[Statements of changes in net assets](#a008)** | **[106](#a008)** |
| **[Financial highlights](#a009)** | **[112](#a009)** |
| **[Notes to financial statements](#a010)** | **[129](#a010)** |
| **[Report of independent registered public accounting firm.](#a011)** | **[163](#a011)** |
| **[Other Portfolio information](#a012)** | **[164](#a012)** |
| **[Board of trustees / directors and officers addendum](#a013)** | **[170](#a013)** |

---

Macquarie Asset Management (MAM) is the asset management division of Macquarie Group. MAM is a full-service asset manager offering a diverse range of products across public and private markets including fixed income, equities, multi-asset solutions, private credit, infrastructure, renewables, natural assets, real estate, and asset finance. The Public Investments business is a part of MAM and includes the following investment advisers: Macquarie Investment Management Business Trust (MIMBT), Macquarie Funds Management Hong Kong Limited, Macquarie Investment Management Austria Kapitalanlage AG, Macquarie Investment Management Global Limited, Macquarie Investment Management Europe Limited, and Macquarie Investment Management Europe S.A.

**Other than Macquarie Bank Limited ABN 46 008 583 542 ("Macquarie Bank"), any Macquarie Group entity noted in this document is not an authorized deposit-taking institution for the purposes of the Banking Act 1959 (Commonwealth of Australia). The obligations of these other Macquarie Group entities do not represent deposits or other liabilities of Macquarie Bank. Macquarie Bank does not guarantee or otherwise provide assurance in respect of the obligations of these other Macquarie Group entities. In addition, if this document relates to an investment, (a) the investor is subject to investment risk including possible delays in repayment and loss of income and principal invested and (b) none of Macquarie Bank or any other Macquarie Group entity guarantees any particular rate of return on or the performance of the investment, nor do they guarantee repayment of capital in respect of the investment.**

The Portfolios are governed by US laws and regulations.

Unless otherwise noted, views expressed herein are current as of December 31, 2022, and subject to change for events occurring after such date.

The Portfolios are not FDIC insured and are not guaranteed. It is possible to lose the principal amount invested.

Advisory services provided by Delaware Management Company, a series of MIMBT, a US registered investment advisor.

The Portfolios are distributed by **Delaware Distributors, L.P.** (DDLP), an affiliate of MIMBT and Macquarie Group Limited.

All third-party marks cited are the property of their respective owners.© 2023 Macquarie Management Holdings, Inc. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Asset Strategy

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide total return.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Asset Strategy experienced a negative return but outperformed its benchmark, the MSCI All Country World Index. The Portfolio's Class I shares declined 14.54% and its Class II shares declined 14.71%. Returns reflect reinvestment of all distributions. During the same period, the benchmark declined 18.36% (net). For complete, annualized performance of Delaware Ivy VIP Asset Strategy, please see the table on page 23.

**Market review**

The year 2022 may mark one of the greatest paradigm shifts for global markets and economies in recent history. A confluence of events, including fallout from pandemic spending and loose monetary policy, catalyzed what had been years in the making.

Tighter central-bank policies, inflation, global supply-chain disruptions, the end of cheap Russian energy for Europe, and labor shortages created broad-based asset-price declines with few exceptions. Equities fell along with bond markets, which typically provide protection, as investors scrambled to face what we believe will be a new reality.

Years of lower interest rates and quantitative easing finally came to an end and manifested in the form of inflation. Perpetuating inflationary pressure, the war in Ukraine drove increases to energy and food prices, particularly in Europe. Responding to the invasion, western nations implemented sanctions against Russia, effectively preventing Russia from supplying its natural gas, oil, wheat, and other commodities to most of the world. In addition, home prices and wage growth became concerning. Home affordability was historically low, and labor shortages along with demographic shifts created a challenging economic scenario for central banks to navigate.

In response, the US Federal Reserve initiated a series of interest rate hikes. Other central banks quickly followed. The US increased rates 4.25 percentage points and the European Central Bank (ECB) increased rates 2.5 percentage points, abandoning negative rate policy. With higher rates, market valuations quickly declined. Extremely high multiples, afforded by longer-duration growth companies through the low-rate environment over the past decade, were hit particularly hard.

China maintained its zero-COVID policy throughout most of the year before finally opening up in December as the pressure from its population and weakening economy became too great. We believe that this should enable growth to resume in China and ease supply-chain disruptions globally.

There were few places for investors to seek refuge during the fiscal year. From an equity sector perspective, energy was the only area of the market in positive territory. Years of underinvestment and supply shortages became a challenge for the world when Russian commodities were cut off. Investment in traditional energy became a focus with the acknowledgment that it will be many years before alternative energy sources replace fossil fuels to a significant degree.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

Stock selection in the communication services and consumer discretionary sectors were the leading contributors to the Portfolio's performance while stock selection in the consumer staples and information technology sectors detracted. At a country level, the US and Canada contributed the most while Germany was the biggest drag on relative performance.

On an individual stock basis, **ConocoPhillips**, a US-based integrated energy company, and **Canadian Natural Resources Ltd**., a Canadian energy company primarily focused on exploration and production, were the largest contributors. Both companies had significant growth resulting from higher energy prices. While we are valuation sensitive and have trimmed energy positions as these stocks rallied, we remain overweight the sector.

The largest detractors from Portfolio performance were **HelloFresh SE**, a German food-delivery service popular in the US and overseas, and **Intuit Inc**., a US-based software company with a focus on accounting and financial-management software solutions.

HelloFresh had benefited from the pandemic as more people opted for food delivery, but despite continued sales growth, the company had to spend more on customer acquisition and marketing expenses. While we believe HelloFresh may be able to convert new customers into future sales growth, we felt there are better opportunities in companies with similar growth profiles. We exited the position. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Asset Strategy

Intuit has been a strong multi-year performer, and from a sales and profitability standpoint continues to do well. However, the valuation for the stock compressed significantly during the measurement period as overall market multiples declined, and investors grew concerned about Intuit's exposure to small- and medium-sized businesses, which are at greater risk from both inflation and recession. That said, the company has performed well, it has a stable core business with tax software, and it has some growth optionality with new segments like payments. We believe that earnings expectations are too low and that there is upside potential to Intuit. Accordingly, we have maintained the Portfolio's position.

The Portfolio's use of futures and foreign exchange (FX) currency positions had a limited effect during the fiscal year. Overall, derivatives were immaterial to the Portfolio's performance during the fiscal year. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Balanced

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek provide total return through a combination of capital appreciation and current income.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Balanced declined, outperforming its equity benchmark, the S&P 500<sup>®</sup> Index, which also declined, but underperforming its fixed-income benchmark, Bloomberg US Aggregate Bond Index, which likewise declined. The Portfolio's Class II shares declined 16.11%. Returns reflect reinvestment of all distributions. During the same period, the Portfolio's equity benchmark fell 18.11% while its fixed-income benchmark fell 13.01%. The performance of the Portfolio reflects the mix of returns in the underlying assets during the reporting period as well as allocation weightings. For complete, annualized performance of Delaware Ivy VIP Balanced, please see the table on page 25.

**Market review**

In January 2022, at the beginning of the Portfolio's fiscal year ending December 31, 2022, the US Federal Reserve was engaged in frequent and serious discussions about raising interest rates. Investors reacted by selling bonds, pushing yields higher and equity prices lower. Further downward pressure on equities resulted as Russia built up troops along the Ukraine border. The following month, Russia invaded Ukraine, prompting unprecedented sanctions including a freeze on Russian central bank reserves, an oil embargo, and a trading ban on Russian financial stocks. Equities sold off globally while commodity prices soared. Government bonds were briefly in demand as a short-term haven, but quickly resumed their downward trend.

Tighter central bank monetary policy characterized the rest of the fiscal year, with the Fed leading the way. Beginning in March, in an effort to bring inflation under control, the Fed raised the federal funds rate five times, including three 0.75-percentage-point increases at the June, July, and September meetings of the Federal Open Market Committee (FOMC). As a result, the target short-term interest rate rose from a range of zero to 0.25% in January 2022 to a range of 4.25% to 4.50% by the end of the fiscal year.

Other central banks, including the Bank of England and the European Central Bank (ECB), also took repeated steps to tighten monetary policy in their jurisdictions. Meanwhile, equities and bonds posted historically poor performance throughout the period in the face of brutal headwinds and unrelenting negative news. The challenges confronting investors included soaring inflation, consequent aggressive monetary tightening, ongoing supply-chain problems, China's zero-COVID-policy-related lockdowns, the Russia-Ukraine war, and soaring energy prices. Higher energy prices and oil and gas supply disruptions hit Europe hardest as Russia cut off gas to several European Union (EU) countries. In turn, the Group of Seven (G7) nations and later the EU implemented an oil embargo.

Among major central banks, only the Bank of Japan maintained ultra-loose monetary policy as it attempted to keep Japanese yields stable by buying bonds. However, that led to a weakening of the Japanese yen, which fell to a 20-year low.

Markets rallied briefly in July 2022 when a near-term turnaround in inflation seemed possible. Despite investors' concern about economic growth slowing, stocks appreciated along with other risk-asset classes, including corporate, high yield, convertible, and emerging market bonds. A key reason for this appreciation was the decline in yields on US and euro-zone government bonds, leading to significant price gains. However, the tide turned again in mid-August and the bear market returned for most asset classes as hope for an inflation slowdown was dashed. Central banks reaffirmed their intentions to continue aggressive tightening of monetary policy. Recession fears mounted and the energy crisis worsened as Russia announced it was shutting down a gas pipeline for maintenance. German yields rose sharply, and the euro fell below parity with the US dollar for the first time in 20 years.

The picture worsened further in September 2022, with heavy losses among virtually all asset classes. Energy prices continued to fall while the European inflation rate reached double-digit levels and central banks planned further interest rate hikes. In November, the markets staged a brief recovery. An anticipated interest rate hike of 0.75 percentage points at the beginning of the month was followed by poorer economic data and slightly declining inflation rates, fueling hope that rate hikes would soon slow down. Against this backdrop, both equities and bonds rose strongly. Thanks to sharply falling risk premiums, investment grade corporate and emerging market government bonds performed particularly well. The US dollar weakened, and the price of oil fell due to weaker demand. China relaxed its zero-COVID policy somewhat, but record-high infections led to new restrictions, resulting in protests and somewhat deteriorating market sentiment toward the end of the month.

Instead of a much hoped for year-end rally, equities and bonds suffered significant losses in December. Global inflation rates fell slightly and, as expected, the major central banks raised key interest rates, albeit by smaller amounts than before (the Fed and the ECB each raised rates by 0.50 percentage points). However, the ECB indicated that significantly higher interest rates were still needed, causing yields to rise sharply and <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Balanced

prices to fall. In Europe, bonds lost much more than stocks, while the reverse occurred in the US, as tech stocks slipped again. China surprised many by ending its zero-COVID policy, and Japan slightly tightened its monetary policy, which helped firm up the yen. Meanwhile, the US dollar lost some ground.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

A combination of interest rates rising as well as risk assets selling off put pressure across capital markets broadly during the Portfolio's fiscal year affecting its performance. The Portfolio's performance benefitted from an underweight allocation to fixed-income securities, which enabled the team to invest in other asset classes that performed better than fixed income during the fiscal year. The fixed-income portion of the Portfolio also outperformed its fixed-income benchmark on a relative basis.

Security selection within US equities during the reporting period added to performance while from an asset allocation standpoint, an overweight to US equities detracted from performance. Within the equity portion of the Portfolio, sector allocation drove essentially all the positive relative performance. Lower-than-market exposure to consumer discretionary and communication services stocks helped returns. The Portfolio's relative underweight to the energy sector detracted from performance.

The Portfolio's use of futures positions had a limited effect during the fiscal year. Overall, derivatives were immaterial to the Portfolio's performance during the fiscal year. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Energy

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide capital growth and appreciation.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Energy advanced, although it underperformed its benchmark, the S&P 1500 Energy Sector Index. The Portfolio's Class I shares advanced 50.85% and its Class II shares advanced 50.42%. Returns reflect reinvestment of all distributions. During the same period, the benchmark advanced 63.77%. For complete, annualized performance of Delaware Ivy VIP Energy, please see the table on page 27.

**Market review**

Global markets fell sharply in 2022 in a year marked by an unprovoked war, a European energy crisis, restrictive zero-COVID policies, supply chain crises, and pernicious inflation. Energy markets experienced wild swings during the year, as supply constraints and curtailments, influenced by the Russia-Ukraine war, pushed up natural gas, crude oil, and refined product prices. During the first half of the year, inflation proved stickier, and it became clear the US Federal Reserve would raise rates aggressively. After extensive monetary tightening campaigns by global central banks during 2022, inflation showed signs of abating by the end of the year. However, this tightening also affected global economic activity and commodity demand, which weighed on commodity prices. The S&P 500<sup>®</sup> Index fell 18.11%, while the S&P 1500 Energy Sector Index fared much better, rising 63.77% for the year.

The European energy crisis sent European natural gas and refined product prices soaring to start the year. This stabilized in the fourth quarter as a flotilla of liquefied natural gas (LNG) carriers arrived in Europe. European natural gas inventories filled, providing a buffer through winter. After reaching all-time highs midyear, European natural gas prices fell more than 50% by year end, finishing almost flat. Crude oil prices also climbed through $100 during the year, before falling back in the fourth quarter to finish largely flat. Energy prices remain elevated, which continues to strain economic conditions.

Inflation, and the Fed's plan to raise rates and normalize monetary policy to combat inflation, remained among the biggest market concerns during the year. Rhetoric from the Fed and aggressive rate hikes suggest the end of tight monetary conditions is far off. However, investors remain hyper focused on the significance of each economic indicator that might signal the end of the tightening cycle. We are currently in a market where good economic news is bad news, as it indicates the Fed's aggressive policy stance will likely continue. Meanwhile, China's major shift away from the country's zero-COVID policy late in the year boosted economic sentiment.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

While we remain bullish on natural resources in the long term, we don't expect this structural bull market to trend in a straight line. We are quite cognizant that the currently deteriorating global economic conditions will affect demand for oil, natural gas, and refined products. We do hold the view that this could prove to be an odd recession where oil prices remain resilient despite deteriorating demand given a challenged supply outlook. Pressures related to environmental, social, and governance (ESG) investing continue to plague long-term supply. Access to capital, geology, geography, and regulation all continue to limit growth. Any additional volatility in energy prices will likely further limit growth by curtailing capital programs. When economic conditions inevitably improve, we expect that supply will remain constrained while demand surges. We anticipate that this will cause even greater upside for energy and energy equities as the cycle turns.

**Chevron Corp.,** one of the largest integrated oil companies in the world, was the Portfolio's largest contributor to performance during the year. After a decade of subpar returns and poor capital allocation decisions, the major energy companies adopted a more capital disciplined framework targeting returns on capital and returns of capital to shareholders. Historically, energy companies composed 10% of the S&P 500 Index weighting. After falling to around 2% of the Index weighting in the depths of the 2020 negative oil price environment, energy companies clawed their way back. The new business model focusing on capital discipline and shareholder returns led to much improved profitability and yield metrics. Capital rushed back into the sector during 2022, primarily targeting the safest and most liquid names, the US listed major integrated oils, including Chevron. After substantial outperformance during the year, we elected to exit our Chevron position and replaced it with what we viewed as a more favorably valued European integrated oil company.

**Occidental Petroleum Corp.** was the Portfolio's second-largest contributor to performance for the year. In 2019, Occidental Petroleum consummated one of the worst-timed acquisitions in the energy space by outbidding Chevron for Anadarko Petroleum. Occidental Petroleum levered up to win the bidding war with Chevron, which almost immediately sent the company into distress as oil and gas prices faltered in 2020. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Energy

Part of the financing for this transaction came from Berkshire Hathaway in the form of preferred stock with warrants. After teetering in the depths of the 2020 energy crisis, Occidental Petroleum carefully navigated its way out of its debt spiral. As commodity prices improved, the company used its significant free cash flow generation to reduce leverage. Investors began focusing on the quality of the company's assets versus its questionable balance sheet. One investor who took notice was Berkshire Hathaway's Warren Buffett, who aggressively bought shares over the course of 2022. This further supported the share price. Occidental Petroleum has now largely cleaned up its balance sheet and boasts attractive assets and opportunities in the carbon capture, utilization, and storage (CCUS) space. We believe 2023 could lead to enhanced shareholder returns and have maintained the Portfolio's position.

The Portfolio's largest detractor from performance was also a long-term portfolio holding, **Parex Resources Inc.** Parex Resources is a Colombian-focused exploration and production company with 2022 estimated production of approximately 50,000 barrels per day, no debt, and net cash on its balance sheet. Parex Resources was an early adopter of a more capital-disciplined model targeting modest growth and higher shareholder returns. To wit, the company has bought back 10% of its stock in each of the past four years and recently announced approval to commence the full buyback this year. This is in addition to a dividend that currently yields approximately 5%. In 2022, Colombia elected a new president who immediately implemented a new tax regime. Investors grew skittish and sold Colombian-focused energy companies. At year end, Parex Resources traded at a heavily discounted valuation, which we believe is onerously pricing in these risks, and, as a result, have maintained the Portfolio's position.

The second-largest detractor from the Portfolio's performance for the fiscal year was also a long-term portfolio holding, **Denbury Inc.** Denbury is a leader in enhanced oil recovery (EOR), which uses carbon dioxide (CO2) in oil reservoirs to increase production. Naturally, due to the legacy EOR business, Denbury boasts significant CO2 pipeline infrastructure in and around the industrialized Gulf Coast. Denbury is applying its expertise in CO2 sequestration and existing infrastructure to compete in the emerging CCUS industry. The company has meaningfully enhanced its CCUS business over the past few years by securing leasehold and entering into agreements with numerous industrial emitters. During the third quarter of 2022, Bloomberg reported that Denbury was working with advisors to explore a potential sale, which led to a substantial increase in the company's share price. This announcement did not come to fruition by the end of the fourth quarter, leading to a retracement in the share price. Irrespective of the potential for a sale, we believe the CCUS and EOR businesses within Denbury are underappreciated, and we continue to maintain the position.

The Portfolio's use of foreign exchange (FX) currency positions had a limited effect during the fiscal year. Overall, derivatives were immaterial to the Portfolio's performance during the fiscal year.

At the end of the Portfolio's fiscal year, volatility remains. The Fed continues its aggressive policy stance to defeat inflation. Forward economic indicators are clearly changing, most notably in housing. Robust employment numbers remain which gives the Fed additional room to remain aggressive, in our view. We think this will have negative economic consequences, which we expect to filter through to demand for more economically sensitive commodities, including oil and natural gas. That said, oil has historically been what we consider an ideal inflation hedge.

We think the major tailwind for the energy sector is on the supply side, where we see underinvestment and the world remaining structurally short energy. Despite elevated oil prices, the traditional capital expenditure (capex) cycle never took place as companies rewarded shareholders at the expense of chasing production growth. Geopolitical uncertainty, both domestically and internationally, has curtailed additional investment in anything other than short-lead-time energy projects. Investment in oil and gas also remains modest due to environmental, social, and governance concerns and managements continuing to practice capital discipline.

Meanwhile, demand for energy continues to grow and has arguably become less elastic. Europe remains decidedly short energy and has resorted to burning coal to meet energy needs despite the continent's climate goals. Oil and refined product demand has continued to rebound from COVID-19 lows. The incredibly commodity-intensive energy transition continues unabated. Restricted supply against less elastic demand gives us confidence in "higher for longer," with resilience continuing despite anticipated weakness. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Growth

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide growth of capital.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Growth experienced a negative return but outperformed its benchmark, the Russell 1000<sup>®</sup> Growth Index. The Portfolio's Class II shares declined 27.24%. Returns reflect reinvestment of all distributions. During the same period, the benchmark declined 29.14%. For complete, annualized performance of Delaware Ivy VIP Growth, please see the table on page 29.

**Market review**

After solid gains of 38.5% and 27.6%, respectively for 2020 and 2021, the Russell 1000 Growth Index posted a sizeable drawdown of 29.1% for calendar year 2022. Despite this decline, it is important to keep things in perspective. Excluding a slight drop of 1.5% in 2018, this marks the first year of a significant negative return for the Portfolio's benchmark since the recession of 2008-2009. Furthermore, over the past five years the Russell 1000 Growth Index gained 68%, strong performance considering the recent drawdown, and over the past 10 years the index rose 274%.

While value styles shined during 2022, there were also moments of clarity wherein investors were drawn back to business quality – profitability, cash flow, and competitive advantage – as a necessary consideration. The market's hunt for the next "thematic" trade, whether it was a peak in interest rates, lower inflation, or a US Federal Reserve policy pivot, was not a sustainable and repeatable investment strategy. It is not surprising that in a period when the relative growth of many "hyper-growth" companies disappointed, investors returned to a theme with lasting power – business quality. The gains realized during 2020 and early 2021 in many low-quality, hyper growth companies were based on unsustainable growth-rate expectations, which led to disappointment during 2022.

There were some key events that occurred in 2022 that will shape the outlook for the coming year. Particularly notable was the aggressive increase of interest rates. The Fed raised rates 4.25%, starting at near zero in March 2022 and ending the year at 4.375%. Additionally, starting in June 2022 the Fed initiated quantitative tightening by reducing its balance sheet by $80 to $90 billion per month. The inversion of the yield curve provided support for those arguing a recession is on the horizon.

This aggressive policy response was necessary as inflation hit a four-decade high. While a portion of the sharp move higher in inflation was attributable to unique circumstances associated with the pandemic, such as supply disruptions and continued China COVID-19 lockdowns, the services component continued to remain elevated. Exiting the year, the Fed made it clear that it wants to address the "stable prices" portion of its dual mandate and that it, too, believes some amount of economic pain is required to get there.

Labor markets remained strong throughout the year. The unemployment rate remained at a 50-year low despite the Fed's tightening and clear signals of economic slowing. One clear signal of slowing was the move lower in manufacturing data with headline data hovering around contraction territory. Housing data weakened as activity was directly affected by the higher rates, which more than doubled from their lows, cratering affordability. The ripple effects from a slowdown in housing can easily turn into waves given its importance to the overall economy.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

Our strategy is anchored in our beliefs that business quality is more persistent than growth, that the market structurally undervalues quality businesses, and that growth companies with attractive risk-reward profiles are the soundest vehicles for long-term compounding of wealth. As such, we continue to populate the Portfolio with high-quality, wide-moat companies supported by secular growth tailwinds and reasonable valuations.

From a sector perspective, strong stock selection in the consumer discretionary, information technology (IT) and communication services sectors were the largest contributors to outperformance. Stock selection in the industrials and financials sectors, along with underweight positions in the energy and healthcare sectors, were the largest detractors.

The consumer discretionary sector was the largest contributor to the Portfolio's outperformance. Lack of exposure to Tesla Inc. accounted for most of the Portfolio's consumer discretionary contribution. We remain convicted in our view that economics in the auto industry will be competed away over time and Tesla is overpriced relative to its realizable future earnings. Additional contributors, but of lesser magnitude, included **LVMH Moet Hennessy Louis Vuitton SE Unsponsored ADR** and **Ferrari NV**. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Growth

Positive relative performance in IT was helped by outperformance from the Portfolio's overweight positions in **Motorola Solutions Inc., Visa Inc.**, and **VeriSign Inc.** Each of these names provide critical components or services to their customers such that their businesses should be able to outperform in periods of economic weakness. These contributions were able to overwhelm negative stock contributions from **PayPal Holdings Inc.**, **salesforce.com Inc.**, and **NVIDIA Corp**.

Within communications services relative outperformance was driven by **Electronic Arts Inc.** In addition to benefiting from the pandemic, Electronic Arts has been able to sustain growth because of its subscription-like video game franchises. Lack of exposure to Netflix Inc. (no longer a Portfolio holding) and an underweight exposure to **Meta Platforms Inc.** (no longer a Portfolio holding) also drove outperformance.

The relative underperformance within the industrials sector was driven by weakness in **TransUnion** and **Stanley, Black & Decker Inc.**, along with a lack of exposure to a machinery stocks. TransUnion's weakness was related to the company's exposure to both mortgage activity and to fintech health. Stanley, Black & Decker (no longer a Portfolio holding) struggled to forecast end-market demand and was also hit with input prices. Machinery stocks, such as Caterpillar Inc. (not owned), saw strong relative performance as investors favored relative value. Notable positive offsets to this industrials' headwind were relative strength from the Portfolio's overweight positions in **CoStar Group Inc.** and **J.B. Hunt Transport Services Inc.**

The energy sector was a negative contributor during the year as the Portfolio lacked exposure. Energy was driven by rising commodity prices related to unfortunate geopolitical events. We remain comfortable with our lack of exposure to these transitory trends.

We are full of optimism that the current environment, while volatile, is extremely ripe for active stock picking to generate significant value. It is unlikely that we will return to a zero-rate environment and with that regime change comes a different set of standards. Higher valuation levels and access to capital will have to be earned through consistent growth, strong cash generation, strong profitability, and disciplined capital management. The days of free money and an "everyone wins" mentality is likely behind us.

We believe this regime change will highlight the importance of high-quality stock selection and the minimization, through a disciplined process, of behavioral mistakes. The likelihood of false positives, or mistakes, has already dramatically increased in the post-pandemic reopening euphoria and we believe this will likely continue to increase over the coming years. The tendency to favor growth as a way to validate quality will be exposed as a poor investment strategy resulting in a high degree of what we call "growth flame-outs" that can be associated with material disappointment.

Inflationary pressures are cooling, but they may prove to be more resilient. This is important because the persistence of inflation could keep the Fed involved longer, which has negative ramifications on economic activity both for 2023 and likely for 2024. Risk assets (cyclicals and high growth) will periodically react positively to the concept of a "Fed Pivot" wherein the central bank would slow or pause its rate hikes, thereby creating a bullish narrative. We believe these "risk-on" events will be difficult to sustain until expectations are reset materially lower and overly optimistic outlooks are extinguished.

Investors should favor these high-quality stocks through cycles, and especially in periods of downside volatility, as we believe quality-first investing is a superior long-term strategy for durable compounding. If downside volatility does not surface, we believe our portfolio of high-quality growth stocks will likewise shine as their "growthy" attributes will prove to be more sustainable, remain underappreciated and allow for strong upside participation.

Our conviction is high as we believe business quality is more persistent than growth, and through-the-cycle outperformance can be achieved through a disciplined stock selection process that prioritizes high-quality business models first and growth second. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP High Income

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide total return through a combination of high current income and capital appreciation.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP High Income experienced a negative return but outperformed its benchmark, the ICE BofA US High Yield Constrained Index. The Portfolio's Class I shares declined 10.91% and its Class II shares declined 11.12%\*. Returns reflect reinvestment of all distributions. During the same period, the benchmark declined 11.21%. For complete, annualized performance of the Delaware Ivy VIP High Income, please see the table on page 31.

\*Total return for the report period presented differs from the return in "Financial highlights." The total return presented above is calculated based on the net asset value (NAV) at which shareholder transactions were processed. The total return presented in "Financial highlights" is calculated in the same manner but also takes into account certain adjustments that are necessary under US generally accepted accounting principles required in the annual report.

**Market review**

High yield bond prices were buffeted by a trifecta of negative forces in 2022, with soaring inflation, rising interest rates, and recessionary fears combining to cause the sub-investment grade sector to post one of its weakest performances in recent memory.

As the fiscal year began, there was widespread concern that the US Federal Reserve had fallen significantly behind the inflationary curve and that a series of rate hikes — some of them unusually large — would be necessary to catch up. That view was subsequently confirmed when the Fed hiked rates seven times between March and December for a total increase of nearly 4.5 percentage points. Three of those increases were by 0.75 percentage points each, helping to push the benchmark federal funds rate to its highest level in 15 years.

Not surprisingly, the steep rise in borrowing costs triggered fears of recession, with the odds of a so-called soft economic landing seeming to recede with each discouraging print of the Consumer Price Index (CPI) which measures changes in the prices paid by consumers for a basket of goods and services. At its peak in June, year-over-year headline inflation in the US exceeded 9%, the highest level since 1981. Gloomy sentiment regarding inflation and the economy was amplified in February by Russia's invasion of Ukraine, which exerted further upward pressure on food and energy prices. Meanwhile, a lingering and not-yet-fully understood shortage of workers in the late-COVID era —particularly among aging Baby Boomers — compounded the difficulty of the Fed's inflation fight by keeping wages elevated.

The June inflation report nearly coincided with an initial bottom for high yield bond prices. This eventually stabilized during the late summer and early fall and then rallied through most of the fourth quarter on the back of falling energy costs, dragging the headline CPI lower as well. Meanwhile, still-healthy household and corporate balance sheets and a booming labor market appeared to lower the risk of a severe recession, allowing the Fed to continue its tightening campaign as the year drew to a close.

Among industry groups, energy was the leading performer supported by an oil price that topped $100 a barrel before falling back. The metals and mining also outperformed, particularly late in the year as the Chinese government's abrupt abandonment of its zero-COVID policy unleashed a sharp rally in copper, the metal that China consumes in prodigious amounts. Conversely, weakness was especially pronounced in retail (consumers pulling back), automotive (rising interest rates), broadcasters (weak advertising market), and cable and telecommunications (duration sensitivity).

Overall, credit spreads widened from 3.11 percentage points to 4.81 percentage points over the fiscal year while the yield on the Portfolio's benchmark spiked from 4.33% to 8.98%.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

We managed the Portfolio during its fiscal year with the view that a recession was on the way, but that any downturn would likely be short and shallow. Notably, market liquidity began drying up early in 2022, making large-scale portfolio adjustments potentially costly and inefficient. However, over the second half of the fiscal period, we incrementally added risk and income to the Portfolio in businesses in which we continued to hold strong fundamental conviction, and that appeared to offer what we viewed as compelling longer-term value.

For example, we viewed the bonds of two major players in the cruise line industry — **Royal Caribbean** and **Carnival** — as well-positioned to strongly outperform as the economy rebounded and COVID-related concerns receded further. In both instances, we recognized that the bonds <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP High Income

could lag the benchmark over the near term, which they did. However, we were willing to accept short-term underperformance and elevated volatility to own bonds that could have the potential to benefit disproportionately when a sustained rally in credit and risk assets got underway.

The Portfolio's positions in **Digicell Ltd., Mitel** (no longer a Portfolio holding)**,** and **Ligado Networks** also lagged the benchmark through a combination of business-specific factors (Ligado's low-orbit satellite service, for example, was thought to interfere with 911 service), and due to debt restructuring issues.

Conversely, companies that had already emerged from restructuring generally did well, or at least better. Among that group, the Portfolio's position in **Studio City** strongly outperformed, with most of the gains coming after the Chinese government abruptly abandoned its zero-COVID policy in late November. This was an unexpected move that offered a ray of hope for Macau's moribund casino industry. We also added to our weighting within the energy sector, which contributed to relative returns through security selection. Specifically, our stakes in the oil field services companies **PBF Holdings** (no longer a Portfolio holding)**, USA Compression**, and **Weatherford International** outperformed the benchmark.

The Portfolio's use of foreign exchange (FX) currency positions had a limited effect during the fiscal year. Overall, derivatives were immaterial to the Portfolio's performance during the fiscal year.

We construct the Delaware Ivy VIP High Income portfolio on a bottom-up, bond-by-bond basis while seeking a high level of income. As such, the portfolio maintains an overweight to the B-rated and CCC-rated rating buckets of the ICE BofA US High Yield Constrained benchmark.

While there is no consensus regarding potential default rates within high yield bonds in 2023, we anticipate that defaults will exceed the historical average of around 3%. Given the unusually murky outlook for monetary policy and economic growth, we think it remains likely that all asset markets will pass through bouts of heightened volatility as the various storylines play out. In that highly uncertain environment, we believe our disciplined, research-driven process is well suited to potentially delivering income and solid risk-adjusted returns to our valued shareholders.

Please know that we appreciate the confidence that you have shown in us, and we pledge to always keep your financial objectives foremost in our minds as we move forward. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP International Core Equity

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide capital growth and appreciation.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP International Core Equity declined, although it outperformed its benchmark, the MSCI ACWI ex USA Index. The Portfolio's Class II shares declined 14.32%\*. Returns reflect reinvestment of all distributions. During the same period, the benchmark declined 16.00% (net). For complete, annualized performance of Delaware Ivy VIP International Core Equity, please see the table on page 33.

\*Total return for the report period presented differs from the return in "Financial highlights." The total return presented above is calculated based on the net asset value (NAV) at which shareholder transactions were processed. The total return presented in "Financial highlights" is calculated in the same manner but also takes into account certain adjustments that are necessary under US generally accepted accounting principles required in the annual report.

**Market review**

The year 2022 may mark one of the greatest paradigm shifts for global markets and economies in recent history. A confluence of events, including fallout from pandemic spending and loose monetary policy, catalyzed what had been years in the making.

Major central bank policy shifts, inflation, changes to global supply chains, the end of cheap Russian energy for Europe, and labor shortages created broad-based asset price declines with few exceptions. Equities fell along with bond markets, which typically provide protection, as investors scrambled to face, what we believe will be, a new reality.

Years of lower interest rates and quantitative easing finally came to an end and manifested in the form of inflation. Perpetuating inflationary pressure, the war in Ukraine drove increases to energy and food prices, particularly in Europe. Responding to the invasion, western nations implemented sanctions against Russia, effectively preventing Russia from supplying its natural gas, oil, wheat, and other commodities to most of the world. In addition, home prices and wage growth became concerning. Home affordability was historically low and labor shortages along with demographic shifts created a challenging economic scenario for central banks to navigate.

In response, the US Federal Reserve initiated a series of interest rate hikes. Other central banks quickly followed. The US increased rates 4.25 percentage points and the European Central Bank (ECB) increased rates 2.5 percentage points, abandoning negative rate policy. With higher rates, market valuations quickly declined. Extremely high multiples, afforded by longer-duration growth companies through the low-rate environment for the past decade, were hit particularly hard.

China maintained its zero-COVID policy throughout most of the year before opening up in December as the pressure from China's population and its weakening economy became too great. We believe that this should enable growth to resume in China and ease supply-chain disruptions globally.

There were few places for investors to seek refuge during the fiscal year. From an equity sector perspective, energy was the only area of the market in positive territory. Years of underinvestment and supply shortages became a challenge for the world when Russian commodities were cut off. Investment in traditional energy became a focus with the acknowledgment that it will be many years before alternative energy sources replace fossil fuels to a significant degree.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

Stock selection and an overweight position in energy relative to the benchmark were the leading contributors to the Portfolio's performance. Stock selection in the consumer staples sector detracted from performance. At a country level, Canada, Japan, and China contributed most while Germany was the biggest drag.

On an individual stock basis, **Suncor Energy Inc.**, a Canadian integrated energy company, and **Schlumberger**, a US-based oil services company, were the strongest contributors. Suncor benefited from higher oil and gas prices as revenue and cash flow grew substantially, and the company increased its dividend. Schlumberger also rallied with the broader energy complex. Higher demand for onshore and offshore services <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP International Core Equity

drove growth, particularly in its international business, which accounts for more than 80% of sales. While we trimmed the Portfolio's energy exposure during the final quarter of the year, we continue to believe both these companies can potentially generate substantial cash flow that they will return to shareholders.

**HelloFresh SE,** a German food delivery service popular in the US and overseas, and **Canada Goose Holdings**, a Canadian apparel company, were the largest detractors from Portfolio performance. HelloFresh had benefited from the pandemic as more people opted for food delivery. However, despite continued sales growth, it has had to spend more on customer acquisition and marketing expenses. Also, as interest rates climbed, higher growth and higher valuation stocks, including HelloFresh, pulled back more than the market. We continue to own HelloFresh within the Portfolio, however. We think that HelloFresh will convert customers into its subscription model and return to positive cash flow. Also, the current valuation is near multi-year lows for the business which we consider to be advantageous. The valuation for Canada Goose compressed despite continued sales growth. While we believe it is a great brand with promising growth potential, we are not confident that we have a differentiated enough view to justify owning the stock. As a result, we decided to sell our shares and exit the position within the Portfolio.

The Portfolio's use of foreign exchange (FX) currency positions had a limited effect during the fiscal year. Overall, derivatives were immaterial to the Portfolio's performance during the fiscal year. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Mid Cap Growth

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide growth of capital.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Mid Cap Growth had a negative return and underperformed its benchmark, Russell Midcap<sup>®</sup> Growth Index, which also declined. The Portfolio's Class I shares declined 30.62% and its Class II shares declined 30.78%. Returns reflect reinvestment of all distributions. During the same period, the Portfolio's benchmark declined 26.72%. For complete annualized performance of Delaware Ivy VIP Mid Cap Growth, please see the table on page 35.

**Market review**

The Russell Midcap Growth Index declined 26.72% for the year, with all sectors within the index except energy and utilities turning in negative performance. The Russell Midcap Growth Index underperformed the Russell Midcap<sup>®</sup> Value Index for the second year in a row as the risk-off trade held serve while the market continued to struggle with the US Federal Reserve's aggressive response to rising inflation.

Though the overwhelming trend was to the downside, there was significant volatility throughout the year as the markets tried to understand and price peak inflation and assess the corresponding aggressive Fed moves against stubborn employment, and wage and manufacturing data that had yet to show a change. Continued strength in these measures led the Fed to reiterate its higher-and-hold interest rate policy instead of pivoting to a more dovish stance. As labor markets remained tight, the talk of peak inflation continued to be offset by the growing concern of a hard landing due to the stress of tighter financial conditions. The US Treasury yield curve remained inverted at a level not seen in this century. As rates continued to move higher, housing affordability sank precipitously, as mortgage rates more than doubled off their lows. The final leg to the downdraft emerged as focus began to shift from the macro concerns to corporate earnings degradation and the ultimate impact on how earnings and earnings growth should be appropriately priced, given higher interest rates.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

Sector allocation was the primary driver of underperformance, led significantly by the Portfolio's continued lack of exposure to the dramatically outperforming energy sector for the year. Though the energy sector is a small allocation within the benchmark, and we continue to have no exposure to it, the sector returned 59.15% for 2022, which detracted from the Portfolio's relative returns. We remain wary of the energy sector, where companies have tended to spend with reckless, cyclical abandon, and not for the longer-term viability and profile of their businesses. Recently, however, there has been an interesting change in that dynamic, as shareholders have spoken, and managements have listened to the desire for more capital discipline. We continue to research potential names for the Portfolio but have yet to enter any positions of note.

The strongest contribution to relative outperformance where the Portfolio had exposure was in the healthcare sector, followed by communication services, consumer discretionary, and consumer staples. The Portfolio's lack of exposure to the real estate sector contributed to relative performance, as did our cash position for the year. The leading detractors from relative performance where the Portfolio had exposure were information technology (IT), industrials, financials, and materials. The lack of exposure to utilities also detracted from relative performance.

The IT sector remained the largest allocation within the Portfolio for the reporting period and was the largest overall detractor from relative performance, while healthcare, the largest overweight sector relative to the benchmark, added the most significant outperformance during the year. The largest relative detractors in IT were **Marvell Technology Inc.**, **DocuSign Inc.**, and **Coherent Corp.**, and the largest relative contributors within the healthcare sector were **ABIOMED Inc.**, **Genmab**, and **Horizon Therapeutics**. ABIOMED and Horizon Therapeutics are no longer Portfolio holdings.

Equity options detracted from performance by way of exposure early in the reporting period to portfolio insurance in lieu of raising excess cash. As the year unfolded, we began to deploy excess cash as we viewed corporate valuations as more and more attractive and our outlook for an earnings recession remained shallow and short-lived. The Portfolio's use of options had a limited effect on performance during the fiscal year.

The top five individual relative contributors to the Portfolio's performance for the reporting period were **CoStar Group Inc.**, ABIOMED Inc., Genmab, Horizon Therapeutics, and **DexCom Inc**.

The five largest individual relative detractors from Portfolio performance for the reporting period were **Trex Company Inc**., Marvell Technology Inc., DocuSign Inc., **Scotts Miracle-Gro Company** (no longer a Portfolio holding), and **Clarivate PLC**. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Mid Cap Growth

Given this backdrop, we are remaining measured in how we approach the management of the Portfolio. We believe that although the anticipated recessionary environment will not be severe, there is always a behavioral impact of investors on stock prices, and the current environment lends itself to a greater magnitude due to the number and significance of macroeconomic uncertainties. We are keenly aware that stock prices may not accurately reflect the true intrinsic value nor potential growth opportunity of companies for a full market cycle. In this environment, we have become less concerned with valuation risk and are more focused on earnings risk, and while there are still small pockets of valuation risk within the index, we are discovering more and more company-specific opportunities as we filter through the mid-cap growth universe with the lens of holding names for three to five years. The idea of reshoring is of particular interest to us now. The production problems of the pandemic only served to intensify an existing corporate trend to diversify supply chains. From an investment perspective, automation is the word that resonates with us, from manufacturing to transportation to delivery.

As growth managers, we continue to look for opportunities to invest in companies that we believe have sound capital structures and the ability to grow throughout business and economic cycles, not because of the cycle. These business models feature a product or service that appears durable to us, coupled with capital structure and a management team that is able to execute competitively in any market environment. We continue to seek opportunities in business and consumer technology, innovation in life sciences, the green energy revolution, and many other areas that we think should continue to grow, regardless of the economic cycle. Stock picking is always key to our process and performance, but it will be paramount in this environment as we seek to manage valuation risk in the Portfolio, while investing in durable, secular growth companies. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Natural Resources

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide capital growth and appreciation.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Natural Resources advanced, although it underperformed its benchmark, the S&P North American Natural Resources Sector Index. The Portfolio's Class II shares advanced 17.72%. Returns reflect reinvestment of all distributions. During the same period, the benchmark advanced 34.07%. For complete, annualized performance of Delaware Ivy VIP Natural Resources, please see the table on page 37.

**Market review**

Global markets fell sharply in 2022 in a year marked by an unprovoked war, a European energy crisis, restrictive zero-COVID policies, supply chain crises, and pernicious inflation. Commodity markets experienced wild swings during the year, as supply constraints and curtailments, influenced by the Russia-Ukraine war, pushed up a number of commodities, notably natural gas, crude oil, fertilizers, and agricultural products. During the first half of the year, inflation proved stickier, and it became clear the US Federal Reserve would raise rates aggressively. After extensive monetary tightening campaigns by global central banks during 2022, inflation showed signs of abating by the end of the year. However, this tightening also affected global economic activity and commodity demand, which weighed on commodity prices. The S&P 500<sup>®</sup> Index fell 18.11% for the year. The S&P Global Natural Resources Index (net) and S&P North American Natural Resources Sector Index fared much better, rising 9.59% and 34.07%, respectively.

The European energy crisis sent European natural gas and refined product prices soaring to start the year. This stabilized in the fourth quarter as a flotilla of liquefied natural gas (LNG) carriers arrived in Europe. European natural gas inventories filled, providing a buffer through winter. After reaching all-time highs midyear, European natural gas prices fell more than 50% by year end, finishing almost flat. Crude oil prices also climbed through $100 during the year, before falling back in the fourth quarter to finish largely flat. Energy prices remain elevated, which continues to strain economic conditions. Copper and aluminum prices followed a similar pattern, but declined 14% and 13%, respectively, during the year. Fertilizer prices followed the same pattern as many farmers skipped applications for potash, causing a disappointing demand and falling prices by year end.

Inflation, and the Fed's plan to raise rates and normalize monetary policy to combat inflation, remained among the biggest market concerns during the year. Rhetoric from the Fed and aggressive rate hikes suggest the end of tight monetary conditions is far off. However, investors remain hyper focused on the significance of each economic indicator that might signal the end of the tightening cycle. We are currently in a market where good economic news is bad news, as it indicates the Fed's aggressive policy stance will likely continue. Meanwhile, China's major shift away from the country's zero-COVID policy late in the year boosted economic sentiment.

On the back of relative Fed tightening and an energy-independent economy, the US dollar rallied strongly in the first three quarters of the year, before finally receding during the fourth quarter. Meanwhile, other central banks undertook more aggressive policy shifts, notably Japan. The relative easing of energy prices and the economic crisis in Europe also added to foreign currency strength. Gold and silver prices rallied into year end on the back of a weakening dollar to both finish roughly flat.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

While we remain bullish on natural resources in the long term, we don't expect this structural bull market to trend in a straight line. We are quite cognizant that the currently deteriorating global economic conditions will affect demand for several of our favorite economically sensitive commodities – oil, natural gas, refined products, copper, and aluminum. We do hold the view that this could prove to be an odd recession where commodity prices remain resilient despite deteriorating demand given challenged supply outlooks for commodities. Pressures related to environmental, social, and governance (ESG) investing continue to plague the long-term supply outlook. Access to capital, geology, geography, and regulation all continue to limit growth. Any additional volatility in commodity prices will likely further limit growth by curtailing capital programs. When economic conditions inevitably improve, we expect that supply will remain constrained while demand surges. We anticipate that this will cause even greater upside for commodities and natural resource equities as the cycle turns.

The Portfolio underperformed its benchmark due to subsector exposures. Approximately 65% of the S&P North American Natural Resources Sector Index is composed of companies in the energy sector, whereas the Portfolio held approximately 44%. As measured by the S&P 500<sup>®</sup> <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Natural Resources

Energy Index, the energy sector rose 65% during 2022, outperforming all other natural resource subsectors. Most notably, this outperformance came from integrated oil and gas, where the Portfolio was considerably underweight versus the benchmark.

**Valero Energy Corp.,** the largest independent refiner in the world, was the Portfolio's largest contributor to performance during the year. Valero Energy has a very underappreciated renewable fuels business, in our view. It benefited from the strong refining environment driven by globally tight product markets on the back of the European energy crisis. Moreover, during the year, Valero Energy brought online its latest renewable diesel plant, and it is now the largest producer of renewable diesel in the world. Importantly, through its joint venture with Darling Ingredients, Valero is also the lowest cost producer. Valero Energy's balance sheet is now pristine, and we think the company is situated to commence substantial returns of capital to shareholders. Although we expect refining margins to return to more normalized levels in the near term, we believe Valero Energy is well positioned and remains attractively valued.

**Chesapeake Energy Corp.,** one of the largest North American natural gas producers, was the Portfolio's second-largest contributor to performance during the year. Historically, Chesapeake Energy was known as a company with high quality and low-cost assets but was overlevered and had onerous midstream contracts that weighed on profitability. Through bankruptcy, Chesapeake Energy emerged in 2021 with a clean balance sheet, new management team, new strategy, and the same high-quality assets that were now unburdened. The current management team is rationalizing the portfolio down to core basins and adopting a strategy of modest growth and high shareholder returns. Although we are concerned about natural gas prices through 2025 when a new wave of LNG export facilities comes online, we continue to find Chesapeake Energy's valuation discount on a reduced natural gas price deck unwarranted.

The continued retracement in growth-oriented, long-cycle equities during the year hurt **LiCycle Holdings Corp.** LiCycle Holdings provides lithium-ion battery recycling solutions. Importantly, versus traditional battery recycling processes where the batteries are burned to recover the metals, creating significant greenhouse gas-intensive emissions, LiCycle Holdings uses a patented hydrometallurgical process. Several joint venture and direct investments in the company from notable entities, including LG Chem, Koch and Glencore have recently validated the process and platform. LiCycle Holdings' first hub facility in Rochester, N.Y., is scheduled to come online by year-end 2023. If the company can open this facility on time and on budget, we expect this to lead to a step change in profitability. We maintain a small position in LiCycle Holdings.

The Fed rapidly raising rates substantially affected the outlook for housing as the year progressed. This filtered through to names exposed to wood products and timber, which affected **Weyerhauser Co**. Although the outlook for wood products remains bleak, the longer-term trends for Weyerhauser remain favorable given its mill and timber positioning. Moreover, the company did an excellent job repairing its balance sheet since 2020 and now remains positioned to execute on countercyclical shareholder returns. The nascent carbon markets also provide additional upside for one of the largest carbon capturers in the world through its timber holdings. We continue to maintain the Portfolio's exposure to Weyerhauser given these company-specific fundamentals.

The Portfolio's use of foreign exchange (FX) currency positions had a limited effect during the fiscal year. Overall, derivatives were immaterial to the Portfolio's performance during the fiscal year.

At the end of the Portfolio's fiscal year, volatility remains. The Fed continues its aggressive policy stance to defeat inflation. Forward economic indicators are clearly changing, most notably in housing. Robust employment numbers remain which gives the Fed additional room to remain aggressive, in our view. We think this will have negative economic consequences, which we expect to filter through to demand for more economically sensitive commodities. We believe this backdrop should prove an ideal environment for gold and precious metals.

We think the major tailwind for the natural resources sector continues to be on the supply side. Despite elevated commodity prices, the traditional capital expenditure (capex) cycle never took place as companies rewarded shareholders at the expense of chasing growth. Geopolitical uncertainty has curtailed additional investment in several commodities, notably copper. Investment in oil and gas remains modest due to ESG concerns and managements continuing to remain capital disciplined.

Meanwhile, demand for commodities continues to grow and has arguably become less elastic. Europe remains decidedly short energy and has resorted to burning coal to meet energy needs despite the continent's climate goals. Oil and refined product demand has continued to rebound from COVID-19 lows. The incredibly commodity-intensive energy transition continues unabated. Restricted supply against less elastic demand gives us confidence in "higher for longer," with resilience continuing despite anticipated weakness. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Science and Technology

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide growth of capital.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Science and Technology experienced a negative return but outperformed its benchmark, the S&P North American Technology Sector Index. The Portfolio's Class I shares declined 31.67% and its Class II shares declined 31.83%. Returns reflect reinvestment of all distributions. During the same period, the benchmark declined 35.36%. For complete, annualized performance of Delaware Ivy VIP Science and Technology, please see the table on page 39.

**Market review**

Throughout 2022 the markets hung on every word of the US Federal Reserve. Rapidly rising inflation across the economy, accompanied by a 50-year low in unemployment, drove the Fed to begin raising interest rates in March and continue aggressively raising rates throughout the year. By the end of 2022, the federal funds rate had increased more than four percentage points to a rate of almost 4.5%. The Fed's aggressive tightening of monetary policy was not limited to interest rates; it began aggressively shrinking its balance sheet as well. By September, the Fed had reduced its balance sheet at a pace of $80-$90 billion per month.

Tighter monetary policy was not limited to the US. Globally, other central banks followed suit raising rates to battle similar inflationary challenges. The European Central Bank (ECB) and the Bank of England raised interest rates to the highest levels in more than a decade. Additionally, in December, the Bank of Japan surprised markets when it allowed 10-year yields to rise to the highest level in seven years.

These focused global efforts to tighten monetary policy were a direct result of the inflationary pressures driven by both robust demand and supply disruptions. Government stimulus during the pandemic and pent-up services demand led to healthy spending across the economy. Supply chains struggled to keep up, however, as economic disruptions caused by COVID-19, particularly in China, and the Russian-Ukrainian war persisted. Inflation rose to 40-year highs and housing pricing briefly accelerated before mortgage rates succumbed to higher interest rates. As the Fed's actions took hold during the course of the year, inventories increased meaningfully when demand slowed and supply chains recovered. Eventually, retailers went from empty shelves to heavily discounting certain products.

Politically, the US had a relatively "boring" year following the events of early 2021. Congress passed the Inflation Reduction Act, which set a 15% minimum corporate tax rate and a 1% tax on equity buybacks. Additionally, the bill addressed Medicare prescription-drug pricing and introduced several incentives for more efficient energy use and development. From investors' perspective, overall corporate taxes are set to increase approximately $100 billion as tax extenders expire and the Inflation Reduction Act takes effect.

Internationally, the Russian-Ukrainian war and China's continued aggressive COVID-19 lockdown policy dominated headlines. While the war was particularly disruptive to energy consumption in Europe, the early humanitarian crisis waned as the region adapted to what will likely be a drawn-out conflict. China's zero-COVID policy led to economic weakness and the country's weakest GDP growth on record. As a result, late in the fiscal period China's government undertook some fiscal and monetary easing. It now appears likely that China will re-open the economy and provide stimulus within the property market.

The return of higher interest rates and the threat of persistent inflation led to a challenging year in financial markets. Fundamentally, after a decade of easy monetary policy and extended periods of zero interest rates, the investors were reminded that capital has a cost. In this context, market multiples contracted meaningfully, especially for the most highly valued growth stocks.

During the fiscal year, information technology (IT) stocks came under significant pressure. Within IT, the semiconductor, Internet, and media subsectors were the weakest performers. While still negative on an absolute basis, the hardware, IT services, and software subsectors outperformed the broader sector. The healthcare sector broadly outperformed the technology universe.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

Relative outperformers in the Portfolio's IT exposure included **T-Mobile US Inc.**, **Amphenol Corp.**, and **Etsy Inc.** An underweight position in **Meta Platforms Inc.** (no longer a Portfolio holding) also contributed to relative performance. Positions in **Snap Inc.**, **Seagate Technology Holdings PLC**, and **Luminar Technologies Inc.** were significant detractors, while an underweight position in **Visa Inc.** also hurt relative performance. Snap and Visa are no longer Portfolio holdings. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Science and Technology

During the measurement period, the Portfolio's exposure to healthcare performed relatively in line with the Portfolio's all-technology benchmark. Since healthcare is not represented in the benchmark, the Portfolio's allocation to the sector is an important distinction when comparing performance metrics. Underperformance in the Portfolio's healthcare equipment subsector offset outperformance in its pharmaceutical exposure.

The Portfolio's use of foreign exchange (FX) currency positions had a limited effect during the fiscal year. Overall, derivatives were immaterial to the Portfolio's performance during the fiscal year.

The Portfolio maintained a mid-single digit average cash position during the fiscal year, which positively contributed to relative performance due to the market's overall decline.

As we entered fiscal 2022, we were concerned about the rising specter of inflation and tightening monetary policy. These concerns materialized with widespread pressure on higher multiple stocks within our universe. Given our market view and with our disciplined valuation approach to investing in innovation, we started the fiscal year with increased weightings in larger-capitalization companies and a healthy amount of cash. We anticipated opportunities over the course of the fiscal year to invest in what we considered to be attractive stocks at more compelling valuations. As the fiscal year progressed, we lowered our exposure to the "mega-cap" technology stocks and added a handful of these attractively valued stocks that offered compelling innovation opportunities.

The Portfolio had approximately 63.3% of its equity exposure in the IT sector as of December 31, 2022. The overall exposure in IT is more appropriately assessed by including the communication services sector, which includes many companies previously in the IT sector. The Portfolio had approximately 13.0% of its equity assets in the communication services sector at year end, for a total of 76.3% of assets exposed to the IT and communications services sectors.

At the end of the reporting period, 7.8% of the Portfolio's equity assets were in the healthcare sector. Our lower healthcare exposure compared to historical averages is primarily a result of reducing the Portfolio's biotechnology weighting. In developing markets, as the standard of living increases, we believe the demand for quality healthcare should increase. In our opinion, biotechnology, healthcare IT systems, and pharmaceuticals are among the leading innovators and early adopters of new science and technology, so we continue to focus on companies in those areas.

The Portfolio's "applied science and technology" holdings span several industries and sectors and, along with the consumer discretionary sector (largely **Amazon.com Inc.**), make up the remainder of the Portfolio's equity composition. At the end of the fiscal year, the Portfolio's cash position was 4.8% of net assets. We consistently have some cash on hand to take advantage of opportunities that may present themselves.

At the end of the Portfolio's fiscal year, volatility continues in the equity markets. And, while volatility creates near-term uncertainty, we use these times in the market to opportunistically add new companies or adjust weightings to take advantage of what we believe are great long-term stories. We view our long-term investment horizon and concentrated Portfolio as compelling advantages during these times of market uncertainty.

We see innovation in the changes brought about by the work from home trend, the early development of the metaverse, and the continued electrification of transportation as potentially driving new investment opportunities. Additionally, the persisting supply-chain shortages highlight the increasing value and integral role of semiconductors in the global economy.

As always, we will continue to carefully examine the macro factors underlying our investment universe, especially current issues like the regulatory risks facing big technology and China's restrictive technology policies. We have high conviction that our attention to bottom-up (stock by stock) research, coupled with the innovation happening across the globe should continue to provide the Portfolio with potentially attractive investment opportunities. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Small Cap Growth

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide growth of capital.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Small Cap Growth experienced a negative return, underperforming its benchmark, the Russell 2000<sup>®</sup> Growth Index. The Portfolio's Class I shares declined 26.61% and its Class II shares declined 26.83%. Returns reflect reinvestment of all distributions. During the same period, the benchmark declined 26.36%. For complete, annualized performance of Delaware Ivy VIP Small Cap Growth, please see the table on page 41.

**Market review**

For small-cap growth stocks, 2022 was the third-worst year of the past 25, eclipsed only by the global financial crisis of 2008-2009 and the 2002 "tech bubble." The double-whammy of rising interest rates, which hurt valuations, and the lingering pandemic-induced economic disruption, which dampened earnings estimates, was largely responsible. The 10-year Treasury yield, which had been in a downtrend since 2008, bottomed near zero and remained there for almost a year following the onset of the pandemic. In 2021, growth stocks thrived as the economy responded to significant fiscal and monetary stimulus. Earnings growth surged for most major sectors of the market. But that surprisingly strong growth led to significant shortages and supply-chain disruptions that fueled inflation and led to the conditions that stifled equity markets in 2022.

Small-cap growth stocks had been a major beneficiary of the low interest rate, healthy economic environment and were thus vulnerable to rising rates. During 2022, the 10-year Treasury yield rose from 1.5% to 3.9% and the yield curve inverted midway through the year. High yield spreads rose more than 250 basis points by midyear signaling increased concern about a potential recession (a basis point equals one-hundredth of a percentage point). The combination crushed small-cap growth stocks by the end of the second quarter. A brief attempt at a late summer rally was thwarted over the balance of the year. The Russell 2000 Growth Index declined more than 26% for the year and lagged the Russell 2000<sup>®</sup> Value Index, which declined 16%. High-valuation, non-earning growth stocks were punished the most during the year. Energy was the only sector to generate a positive return. The worst-performing sectors were communication services, consumer discretionary, real estate, and information technology (IT).

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

Throughout the fiscal year, the Portfolio consistently maintained its strategy of diversifying across sectors while emphasizing quality growth companies. The Portfolio performed ahead of the benchmark for most of the year before it succumbed to the relentless pressure on growth stocks. Those stocks that had outperformed most during the year were the last targets of the selloff. Energy stocks were a prime example. Although energy companies dramatically outperformed for the first 10 months of the year, beginning in mid-November, energy stocks sold off significantly in spite of a fundamental outlook that remains healthy. **BJ's Wholesale Club Holdings Inc.** was another example. A large position in the Portfolio, BJ's had been a strong performer throughout the year but fell under the pressure of the market selloff – again, despite consistently good sales and earnings results. The Portfolio's attribution for the year shows that stock selection contributed positively in all sectors of the portfolio except healthcare.

Sector allocation, or weighting, detracted from performance in the IT sector, which was consistently overweight the benchmark during the fiscal period. The Portfolio's small underweight in the energy sector also detracted from performance. The benchmark energy sector was up 41.9% for the year while the Portfolio gained 39.4%. A weighting of one percentage point below the benchmark was to blame.

The Portfolio's allocation to the healthcare sector detracted, primarily the result of poor stock selection. Several holdings that previously were strong performers drastically reversed course due to high valuations, underwhelming profitability, weakness in procedure volumes, and disappointing sales as potential customers were constrained by rising prices. The overall healthcare sector underperformed the broader index, a departure from typical down years. More specifically, small-cap healthcare did not perform like a defensive sector. The repercussions of COVID-19 on the healthcare system lasted well beyond expectations. Many companies with new products or services faced challenges getting in front of decision-makers, obtaining budget sign offs, or hiring personnel to accept, install, and implement new product platforms.

In many cases we felt the new product or service was superior and would gain traction in the marketplace, but that scenario was rarely realized.

For example, **Omnicell Inc.** has a best-in-class solution for medication management that has successfully gained share in past years but hit a <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Small Cap Growth

significant wall this period due to budget constraints and facilities' inability to implement new platforms while labor is scarce. As a result, previously consistent revenues and bookings dried up for several quarters and visibility was lost. Omnicell is no longer a Portfolio holding.

For the healthcare sector as a whole, we decided to maintain our positions in some companies where we felt sufficiently confident that competitive advantages remained compelling. In other instances, we exited our positions and moved on. We may renew those positions if and when sales visibility better matches our investment horizon. Through this environment, we maintained our long-term philosophy of owning names with novel offerings that make healthcare more efficient and value based.

The industrials sector contributed on both an absolute and relative basis during the period, benefiting from advantageous stock selection. Our neutral allocation also contributed slightly as the industrial sector outperformed the market as a whole. We had exposure to alternative energy, resource management, and electrification, which we think have plenty of demand and visibility going forward. Lesser exposure to housing-related names, such as building supplies, and areas only growing via cyclical inflation also aided performance. We maintained our process of searching for areas of the economy that have long-term growth potential rather than attempting to time cyclical stocks.

The consumer discretionary sector was the largest contributor for the year while IT was a modest drag. Stock selection led the way in the consumer discretionary sector. **Monarch Casino & Resort Inc.**, **Texas Roadhouse Inc.**, and **Visteon Corp.** were all significant contributors. Other relative contributors (declining less than the index) included **Churchill Downs Inc.** (no longer a Portfolio holding) and **Marriott Vacations Worldwide Corp.** Pent-up demand for experiences, both travel and dining, helped drive success for these companies.

The IT sector has historically been a large driver of outperformance for the Portfolio and we expect it will continue to be the most-favored sector from a fundamental growth perspective. That said, the sector corrected last year, reflecting the macro factors mentioned above. We reduced our large overweight versus the index throughout the year as we exited less-seasoned companies in favor of a higher quality, profitable group of stocks. The result was performance for the year that essentially matched the benchmark, with the drag from an overweight offset by modestly positive stock selection. The Portfolio also benefited from several take-outs as private equity firms took advantage of lower stock prices to make strategic acquisitions.

At the end of the Portfolio's fiscal year, we see no need to change its strategic positioning as we navigate through the headwind of interest rate hikes and their impact on the economy. Clearly a lot of damage has been done to small-cap stock valuations, obviating the need to be overly defensive. The Portfolio's emphasis on high-quality, sustainable-growth businesses across all major sectors of the market has worked well in the small-cap growth asset class and remains the focus of the Portfolio. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Smid Cap Core

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide capital appreciation.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Smid Cap Core experienced a negative return but outperformed its benchmark, the Russell 2500™ Index. The Portfolio's Class II shares declined 14.84%. Returns reflect reinvestment of all distributions. During the same period, the Portfolio's benchmark declined 18.37%. For complete, annualized performance of Delaware Ivy VIP Smid Cap Core, please see the table on page 43.

**Market review**

For the fiscal year ended December 31, 2022, the Russell 2500 Index, declined 18.37%. Smid-cap growth stocks underperformed smid-cap value stocks, the Russell 2500™ Growth Index declined 26.21% and the Russell 2500™ Value Index declined 13.08%. Small- and large-cap stocks underperformed, as the Russell 2000<sup>®</sup> Index declined 20.44% and the large-cap Russell 1000<sup>®</sup> Index declined 19.13% for the year.

Sector-level performance within the Russell 2500 Index was mostly negative with only one sector, energy, advancing and 15 declining. Companies in the utilities, capital goods, and consumer staples sectors declined the least for the year. The weakest sectors in the benchmark for the year were credit cyclicals, information technology, healthcare, and consumer discretionary.

The third-quarter 2022 US gross domestic product (GDP) annualized growth rate of 3.2% was above consensus and followed two consecutive quarters of declining GDP. The December Purchasing Manager's Index (PMI) registered 48.4%, which indicated the manufacturing sector contracted for the second consecutive month, following a 29-month period of growth. Readings below 50% indicate contraction. December's figure was the lowest since May 2020, when it fell to 43.5%.

With respect to labor, the US unemployment rate ended December 31, 2022, at 3.5%, its lowest rate for the year. For the 12 months ended December 31, 2022, the US Consumer Price Index (CPI) increased 6.5%, the smallest 12-month increase since the period ended October 31, 2021. The Conference Board Consumer Confidence Index<sup>®</sup> decreased during the fiscal year, from a December 2021 reading of 115.2 to 108.3 in December 2022. The National Federation of Independent Business (NFIB) Small Business Optimism Index declined during the fourth quarter to 89.8 in December, marking the 12th consecutive month below the 49-year average of 98.

Source: Bloomberg, unless otherwise noted.

**Within the Portfolio**

Strong stock selection in the IT, finance, and healthcare sectors contributed to outperformance for the year as the Portfolio's positions declined by less than those in the benchmark. Contribution was positive in 13 of 16 sectors over the year, as three sectors detracted. Stock selection detracted from performance in the consumer staples, capital goods, and real estate investment trust (REIT) sectors.

Energy was the strongest-performing sector in the benchmark and Portfolio for the fiscal year. Shares of **Diamondback Energy Inc.** outperformed as the company continued to improve its earnings and free cash flow profile. During the fiscal year, Diamondback increased its dividend and declared an additional variable cash dividend. Diamondback is committed to returning 75% of free cash flow to shareholders, using various methods including dividends and share repurchases, which it executed on as well during the year, repurchasing over five million shares. We maintained the Portfolio's position in Diamondback as the company is a leader in low-cost operations, has a high free cash flow yield, and management is committed to maximizing returns for shareholders.

Specialty contractor **Quanta Services Inc.** was a top contributor for the year as the company delivered financial strength across its electric power, renewable energy, and underground utility infrastructure solutions business segments. We maintained the Portfolio's position in Quanta Services as we believe that the company offers attractive opportunities for investors to gain exposure to long-term secular growth trends.

Stock selection contributed in the IT sector as the Portfolio's positions in companies in the systems industry outperformed. **ExlService Holdings Inc.**, a data analytics and digital operations and solutions company, outperformed during the Portfolio's fiscal year. ExlService benefited from the digitization of back office and customer-facing technology, serving clients in the insurance, healthcare, travel, transportation, and logistics industries. The company grew revenues and earnings. Additionally, its operational excellence led to operating income margin expansion. We maintained the Portfolio's position in ExlService as we believe the company is well positioned to expand its solutions to new and existing customers. <br>

[**Table of Contents**](#toc1)

Portfolio management reviews

Delaware Ivy VIP Smid Cap Core

In the software industry, shares of cyber-security analytics company **Rapid7 Inc.** underperformed during the fiscal year. Since we purchased Rapid7, it diversified its offerings to become a multi-pillar platform covering threat detection and response, cloud security, and vulnerability risk. Rapid7 delivered good financial results during the year. However, management noted its annualized recurring revenue (ARR) growth rate would slow below its historical level of about 20% on softening economic conditions. We maintained the Portfolio's position in Rapid7 as the company has multiple product drivers to help it reach its 2025 free cash flow and ARR financial goals.

In the medical products industry, shares of contract development and manufacturing company **Catalent Inc.** underperformed. Catalent's fiscal first quarter 2023 financial results were weaker than expected and the company reduced its financial guidance to reflect worsening economic conditions. We maintained the Portfolio's position in Catalent as it has an impressive suite of products, is trading at a discounted valuation, and we believe that management has taken steps to position the company for organic growth.

The Portfolio's position in multibrand specialty apparel retailer **American Eagle Outfitters Inc.** underperformed during the fiscal year. At the start of the period, we believed American Eagle would experience sales-growth pressure due to lapsing stimulus payments. At the same time, we believed management had established a competitive moat that would drive sustained growth longer term. The company reported weak results for its fiscal second quarter and indicated it expected continued weakness due to higher inventories and the need for more retail promotions. We exited the Portfolio's position before the end of the fiscal year.

The Portfolio ended the year with the largest Portfolio overweights in the transportation, consumer discretionary, business services, and healthcare sectors. The largest sector underweights were in utilities, REITs, IT, and capital goods.

We believe that the current market and economic environment should continue to support active management. In our opinion, we can take advantage of market conditions that have created valuation disconnects. We continue to maintain our strategy of investing in companies that we believe have strong balance sheets and cash flow, sustainable competitive advantages, and high-quality management teams with the potential to deliver value to shareholders. We appreciate your confidence and look forward to serving your investment needs in the next fiscal year. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Asset Strategy

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year | Lifetime |
| Class I shares (commenced operations on April 28, 2017) | -14.54% | +2.61% | +4.57% |  | +5.97% |
| Class II shares (commenced operations on May 1, 1995) | -14.71% | +2.37% | +4.32% | +4.46% |  |
| MSCI ACWI Index (net) | -18.36% | +4.00% | +5.23% | +7.98% |  |
| MSCI ACWI Index (gross) | -17.96% | +4.49% | +5.75% | +8.54% |  |

---

Returns reflect the reinvestment of all distributions. Please see page 24 for a description of the index.

As described in the Portfolio's most recent prospectus, the net expense ratios for Class I and Class II shares of the Portfolio were 0.62% and 0.87%, respectively, while total operating expenses for Class I and Class II shares were 0.75% and 1.00%, respectively. The management fee for Class I and Class II shares was 0.70%, and the annual distribution and service (12b-1) fee for Class II shares was 0.25% of average daily net assets. The expense ratios may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratios in the prospectus include acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Risk is increased in a concentrated portfolio since it holds a limited number of securities with each investment having a greater effect on overall performance.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

Fixed income securities and bond funds can lose value, and investors can lose principal as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Asset Strategy

The Portfolio may invest in derivatives, which may involve additional expenses and are subject to risk, including the risk that an underlying security or securities index moves in the opposite direction from what the portfolio manager anticipated. A derivatives transaction depends upon the counterparties' ability to fulfil their contractual obligations.

Exposure to the commodities markets may subject the Portfolio to greater volatility than investments in traditional securities.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx26x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x2.jpg) | MSCI ACWI Index (gross) | $10000 | $22686 |
| ![](mimivip4167561_ncsrx26x3.jpg) | MSCI ACWI Index (net) | $10000 | $21545 |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP Asset Strategy – Class II shares | $10000 | $15465 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Asset Strategy Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the MSCI ACWI Index for the period from December 31, 2012 through December 31, 2022.

The MSCI ACWI (All Country World Index) represents large- and mid-cap stocks across developed and emerging markets worldwide. The index covers approximately 85% of the global investable equity opportunity set. Index "net" return approximates the minimum possible dividend reinvestment, after deduction of withholding tax at the highest possible rate. Index "gross" return approximates the maximum possible dividend reinvestment.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Performance of Class I shares will vary due to different charges and expenses.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Balanced

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on May 3, 1994) | -16.11% | +3.55% | +5.57% | +7.05% |
| S&P 500 Index | -18.11% | +7.66% | +9.42% | +12.56% |
| Bloomberg US Aggregate Index | -13.01% | -2.71% | +0.02% | +1.06% |

---

Returns reflect the reinvestment of all distributions. Please see page 26 for a description of each index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.00%. The management fee was 0.70%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

Risk is increased in a concentrated portfolio since it holds a limited number of securities with each investment having a greater effect on the overall performance.

There is no guarantee that dividend paying stocks will continue to pay dividends.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Balanced

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx28x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x2.jpg) | S&P 500 Index | $10000 | $32654 |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP Balanced – Class II shares | $10000 | $19767 |
| ![](mimivip4167561_ncsrx26x3.jpg) | Bloomberg US Aggregate Index | $10000 | $11108 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Balanced Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the S&P 500 Index and the Bloomberg US Aggregate Index for the period from December 31, 2012 through December 31, 2022.

The S&P 500 Index measures the performance of 500 mostly large-cap stocks weighted by market value, and is often used to represent performance of the US stock market.

The Bloomberg US Aggregate Index is a broad-based benchmark that measures the investment grade, US dollar-denominated, fixed-rate taxable bond market.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Energy

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year | Lifetime |
| Class I shares (commenced operations on April 28, 2017) | +50.85% | +10.79% | -1.41% |  | -0.98% |
| Class II shares (commenced operations on May 1, 2006) | +50.42% | +10.50% | -1.66% | -0.39% |  |
| S&P 1500 Energy Sector Index | +63.77% | +18.92% | +8.35% | +5.16% |  |

---

Returns reflect the reinvestment of all distributions. Please see page 28 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class I and Class II shares were 0.97% and 1.22%, respectively. The management fee for Class I and Class II shares was 0.85%, and the annual distribution and service (12b-1) fee for Class II was 0.25% of average daily net assets. The expense ratios may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratios in the prospectus include acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Because the Portfolio invests more than 25% of its total assets in the energy related industry, the Portfolio may be more susceptible to a single economic, regulatory, or technological occurrence than a portfolio that does not concentrate its investments in this industry. Investing in companies involved in one specified sector may be more risky and volatile than an investment with greater diversification.

Risk is increased in a concentrated portfolio since it holds a limited number of securities with each investment having a greater effect on the overall performance.

Investing in the energy sector can be riskier than other types of investment activities because of a range of factors, including price fluctuation caused by real and perceived inflationary trends and political developments, and the cost assumed by energy companies in complying with environmental safety regulations.

The Portfolio may invest in initial public offerings (IPOs), which can have a significant positive impact on the Portfolio's performance that may not be replicated in the future. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Energy

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx30x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x2.jpg) | S&P 1500 Energy Sector Index | $10000 | $16533 |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP Energy — Class II shares | $10000 | $9615 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Energy Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the S&P 1500 Energy Sector Index for the period from December 31, 2012 through December 31, 2022.

The S&P 1500 Energy Sector Index comprises those companies included in the S&P Composite 1500<sup>®</sup> that are classified as members of the GICS<sup>®</sup> Energy sector.

The S&P 500 Index, mentioned on page 5, measures the performance of 500 mostly large-cap stocks weighted by market value and is often used to represent performance of the US stock market.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Performance of Class I shares will vary due to different charges and expenses.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Growth

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on July 31, 1987) | -27.24% | +7.29% | +11.53% | +13.96% |
| Russell 1000 Growth Index | -29.14% | +7.79% | +10.96% | +14.10% |

---

Returns reflect the reinvestment of all distributions. Please see page 30 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 0.99%. The management fee was 0.70%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

"Non-diversified" investments may allocate more of their net assets to investments in single securities than "diversified" investments. Resulting adverse effects may subject these investments to greater risks and volatility.

Risk is increased in a concentrated portfolio since it holds a limited number of securities with each investment having a greater effect on overall performance.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Growth

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx32x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x2.jpg) | Russell 1000 Growth Index | $10000 | $37397 |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP Growth — Class II shares | $10000 | $36940 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Growth Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the Russell 1000 Growth Index for the period from December 31, 2012 through December 31, 2022.

The Russell 1000 Growth Index measures the performance of the large-cap growth segment of the US equity universe. It includes those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP High Income

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year | Lifetime |
| Class I shares (commenced operations on April 28, 2017) | -10.91% | +0.23% | +1.96% |  | +2.33% |
| Class II shares (commenced operations on July 13, 1987) | -11.12%\* | -0.02% | +1.70% | +3.56% |  |
| ICE BofA US High Yield Constrained Index | -11.21% | -0.26% | +2.10% | +3.94% |  |

---

\*Total return for the report period presented in the table differs from the return in "Financial highlights." The total return presented in the above table is calculated based on the net asset value (NAV) at which shareholder transactions were processed. The total return presented in "Financial highlights" is calculated in the same manner but also takes into account certain adjustments that are necessary under US generally accepted accounting principles required in the annual report.

Returns reflect the reinvestment of all distributions. Please see page 32 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class I and Class II shares were 0.70% and 0.95%, respectively. The management fee for Class I and Class II shares was 0.61%, and the annual distribution and service (12b-1) fee for Class II was 0.25% of average daily net assets. The expense ratios may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratios in the prospectus include acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal, as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. The Fund may also be subject to prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity, at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

High yielding, noninvestment-grade bonds (junk bonds) involve higher risk than investment grade bonds. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP High Income

The high yield secondary market is particularly susceptible to liquidity problems when institutional investors, such as mutual funds and certain other financial institutions, temporarily stop buying bonds for regulatory, financial, or other reasons. In addition, a less liquid secondary market makes it more difficult to obtain precise valuations of the high yield securities.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx34x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x2.jpg) | ICE BofA US High Yield Constrained Index | $10000 | $14715 |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP High Income — Class II shares | $10000 | $14195 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP High Income Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the ICE BofA US High Yield Constrained Index for the period from December 31, 2012 through December 31, 2022.

The ICE BofA US High Yield Constrained Index tracks the performance of US dollar-denominated high yield corporate debt publicly issued in the US domestic market, but caps individual issuer exposure at 2% of the benchmark.

The US Consumer Price Index (CPI), mentioned on page 9, is a measure of inflation that is calculated by the US Department of Labor, representing changes in prices of all goods and services purchased for consumption by urban households.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Performance of Class I shares will vary due to different charges and expenses.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP International Core Equity

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on May 1, 1992) | -14.32%\* | +1.59% | +0.45% | +4.80% |
| MSCI ACWI ex USA Index (net) | -16.00% | +0.07% | +0.88% | +3.80% |

---

\*Total return for the report period presented in the table differs from the return in "Financial highlights." The total return presented in the above table is calculated based on the net asset value (NAV) at which shareholder transactions were processed. The total return presented in "Financial highlights" is calculated in the same manner but also takes into account certain adjustments that are necessary under US generally accepted accounting principles required in the annual report.

Returns reflect the reinvestment of all distributions. Please see page 34 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.16%. The management fee was 0.85%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus. Investments in variable products involve risk.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP International Core Equity

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx36x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP International Core Equity — Class II shares | $10000 | $15984 |
| ![](mimivip4167561_ncsrx26x2.jpg) | MSCI ACWI ex USA Index (gross) | $10000 | $15208 |
| ![](mimivip4167561_ncsrx26x3.jpg) | MSCI ACWI ex USA Index (net) | $10000 | $14520 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP International Core Equity Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the MSCI ACWI ex USA Index for the period from December 31, 2012 through December 31, 2022.

The MSCI ACWI (All Country World Index) ex USA Index represents large- and mid-cap stocks across developed and emerging markets worldwide, excluding the United States. The index covers approximately 85% of the global investable equity opportunity set outside the United States. Index "net" return approximates the minimum possible dividend reinvestment, after deduction of withholding tax at the highest possible rate. Index "gross" return approximates the maximum possible dividend reinvestment.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Mid Cap Growth

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year | Lifetime |
| Class I shares (commenced operations on April 28, 2017) | -30.62% | +6.53% | +10.87% |  | +12.49% |
| Class II shares (commenced operations on April 28, 2005) | -30.78% | +6.27% | +10.59% | +11.39% |  |
| Russell Midcap Growth Index | -26.72% | +3.85% | +7.64% | +11.41% |  |

---

Returns reflect the reinvestment of all distributions. Please see page 36 for a description of the index.

As described in the Portfolio's most recent prospectus, the net expense ratio for Class I and Class II shares of the Portfolio were 0.85% and 1.10%, respectively, while total operating expenses for Class I and Class II shares were 0.89 and 1.14%, respectively. The management fee for Class I and Class II shares was 0.85%, and the annual distribution and service (12b-1) fee for Class II was 0.25% of average daily net assets. The expense ratios may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratios in the prospectus include acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Investments in small and/or medium-sized companies typically exhibit greater risk and higher volatility than larger, more established companies.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Mid Cap Growth

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx38x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x2.jpg) | Russell Midcap Growth Index | $10000 | $29456 |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP Mid Cap Growth — Class II shares | $10000 | $29419 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Mid Cap Growth Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the Russell Midcap Growth Index for the period from December 31, 2012 through December 31, 2022.

The Russell Midcap Growth Index measures the performance of the mid-cap growth segment of the US equity universe. It includes those Russell Midcap Index companies with higher price-to-book ratios and higher forecasted growth values.

The Russell Midcap Value Index, mentioned on page 13, measures the performance of the mid-cap value segment of the US equity universe. It includes those Russell Midcap Index companies with lower price-to-book ratios and lower forecasted growth values.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company.

The Institute for Supply Management (ISM) Manufacturing and Non-Manufacturing New Orders Index, mentioned on page 14, monitors new order volume based on the ISM's surveys of manufacturing and non-manufacturing firms.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Performance of Class I shares will vary due to different charges and expenses.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Natural Resources

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on April 28, 2005) | +17.72% | +9.49% | +1.98% | +0.23% |
| S&P North American Natural Resources Sector Index | +34.07% | +14.97% | +7.13% | +4.05% |

---

Returns reflect the reinvestment of all distributions. Please see page 38 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.21%. The management fee was 0.85%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus. Investments in variable products involve risk.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

Because the Portfolio invests significantly in natural resources securities, there is the risk that the Portfolio will perform poorly during a downturn in the natural resource sector.

The Portfolio may invest in derivatives, which may involve additional expenses and are subject to risk, including the risk that an underlying security or securities index moves in the opposite direction from what the portfolio manager anticipated. A derivatives transaction depends upon the counterparties' ability to fulfil their contractual obligations.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Natural Resources

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx40x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x4.jpg) | S&P North American Natural Resources Sector Index | $10000 | $14878 |
| ![](mimivip4167561_ncsrx26x2.jpg) | Delaware Ivy VIP Natural Resources – Class II shares | $10000 | $10229 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Natural Resources Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the S&P North American Natural Resources Sector Index for the period from December 31, 2012 through December 31, 2022.

The S&P North American Natural Resources Sector Index provides investors with a benchmark that represents US traded securities that are classified under the GICS<sup>®</sup> energy and materials sector, excluding the chemicals industry and steel subindustry.

The S&P 500 Index, mentioned on page 15, measures the performance of 500 mostly large-cap stocks weighted by market value and is often used to represent performance of the US stock market.

The S&P 500 Energy Index, mentioned on page 15, comprises those companies in the S&P 500 Index that are classified as members of the GICS<sup>®</sup> energy sector.

The S&P Global Natural Resources Index, mentioned on page 15, includes 90 of the largest publicly traded companies in natural resources and commodities businesses that meet specific investability requirements, offering investors diversified and investable equity exposure across three primary commodity-related sectors: agribusiness, energy, and metals and mining. The "net total return" index reinvests regular cash dividends after the deduction of applicable withholding taxes.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Science and Technology

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year | Lifetime |
| Class I shares (commenced operations on April 28, 2017) | -31.67% | +2.30% | +8.80% |  | +10.77% |
| Class II shares (commenced operations on April 4, 1997) | -31.83% | +2.05% | +8.53% | +12.18% |  |
| S&P North American Technology Sector Index | -35.36% | +5.85% | +11.73% | +16.60% |  |

---

Returns reflect the reinvestment of all distributions. Please see page 40 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class I and Class II shares were 0.89% and 1.14%, respectively. The management fee for Class I and Class II shares was 0.85%, and the annual distribution and service (12b-1) fee for Class II was 0.25% of average daily net assets. The expense ratios may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratios in the prospectus include acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus. Investments in variable products involve risk.

Because the Fund invests more than 25% of its total assets in the science and technology industry, the Fund's performance may be more susceptible to a single economic, regulatory or technological occurrence than a fund that does not concentrate its investments in this industry.

"Non-diversified" investments may allocate more of their net assets to investments in single securities than "diversified" investments. Resulting adverse effects may subject these investments to greater risks and volatility.

Investment risks associated with investing in science and technology securities, in addition to other risks, include: operating in rapidly changing fields, abrupt or erratic market movements, limited product lines, markets or financial resources, management that is dependent on a limited number of people, short product cycles, aggressive pricing of products and services, new market entrants and obsolescence of existing technology.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Science and Technology

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx42x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x2.jpg) | S&P North American Technology Sector Index | $10000 | $46444 |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP Science and Technology — Class II shares | $10000 | $31566 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Science and Technology Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the S&P North American Technology Sector Index for the period from December 31, 2012 through December 31, 2022.

The S&P North American Technology Sector Index provides investors with a benchmark that represents US securities classified under the GICS<sup>®</sup> information technology sector as well as the internet and direct marketing retail, interactive home entertainment, and interactive media and services subindustries.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Performance of Class I shares will vary due to different charges and expenses.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Small Cap Growth

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year | Lifetime |
| Class I shares (commenced operations on November 2, 2018) | -26.61% | +1.83% |  |  | +3.33% |
| Class II shares (commenced operations on May 3, 1994) | -26.83% | +1.56% | +4.38% | +8.83% |  |
| Russell 2000 Growth Index | -26.36% | +0.65% | +3.51% | +9.20% |  |

---

Returns reflect the reinvestment of all distributions. Please see page 42 for a description of the index.

As described in the Portfolio's most recent prospectus, the net expense ratios for Class I and Class II shares of the Portfolio were 0.89% and 1.14%, respectively, while total operating expenses for Class I and Class II shares were 0.90% and 1.15%, respectively. The management fee for Class I and Class II shares was 0.85%, and the annual distribution and service (12b-1) fee for Class II was 0.25% of average daily net assets. The expense ratios may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratios in the prospectus include acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Investments in small and/or medium-sized companies typically exhibit greater risk and higher volatility than larger, more established companies.

The Portfolio may invest in initial public offerings (IPOs), which can have a significant positive impact on the Portfolio's performance that may not be replicated in the future.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Small Cap Growth

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx44x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x2.jpg) | Russell 2000 Growth Index | $10000 | $24112 |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP Small Cap Growth – Class II shares | $10000 | $23297 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Small Cap Growth Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the Russell 2000 Growth Index for the period from December 31, 2012 through December 31, 2022.

The Russell 2000 Growth Index measures the performance of the small-cap growth segment of the US equity universe. It includes those Russell 2000 companies with higher price-to-book ratios and higher forecasted growth values.

The Russell 2000 Value Index, mentioned on page 19, measures the performance of the small-cap value segment of the US equity universe. It includes those Russell 2000 companies with lower price-to-book ratios and lower forecasted growth values.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Performance of Class I shares will vary due to different charges and expenses.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Smid Cap Core

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on October 1, 1997) | -14.84% | +3.25% | +4.14% | +9.25% |
| Russell 2500 Index | -18.37% | +5.00% | +5.89% | +10.03% |

---

Returns reflect the reinvestment of all distributions. Please see page 44 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.17%. The management fee was 0.85%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Investments in small and/or medium-sized companies typically exhibit greater risk and higher volatility than larger, more established companies.

Risk is increased in a concentrated portfolio since it holds a limited number of securities with each investment having a greater effect on the overall performance.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc1)

Performance summaries (Unaudited)

Delaware Ivy VIP Smid Cap Core

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167561_ncsrx46x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167561_ncsrx26x2.jpg) | Russell 2500 Index | $10000 | $26003 |
| ![](mimivip4167561_ncsrx26x4.jpg) | Delaware Ivy VIP Smid Cap Core – Class II shares | $10000 | $24233 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Smid Cap Core Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the Russell 2500 Index for the period from December 31, 2012 through December 31, 2022.

The Russell 2500 Index measures the performance of the small- to mid-cap segment of the US equity universe. The Russell 2500 Index is a subset of the Russell 3000<sup>®</sup> Index, representing approximately 2,500 of the smallest securities based on a combination of their market cap and current index membership.

The Russell 2500 Growth Index, mentioned on page 21, measures the performance of the small- to mid-cap growth segment of the US equity universe. It includes those Russell 2500 companies with higher price-to-book ratios and higher forecasted growth values.

The Russell 2500 Value Index, mentioned on page 21, measures the performance of the small- to mid-cap value segment of the US equity universe. It includes those Russell 2500 companies with lower price-to-book ratios and lower forecasted growth values.

The Russell 2000 Index, mentioned on page 21, measures the performance of the small-cap segment of the US equity universe.

The Russell 1000 Index, mentioned on page 21, measures the performance of the large-cap segment of the US equity universe.

The Purchasing Managers' Index (PMI), mentioned on page 21, is an indicator of the economic health of the manufacturing sector. A PMI reading above 50% indicates that the manufacturing economy is generally expanding; below 50% indicates that it is generally contracting.

The US Consumer Price Index (CPI), mentioned on page 21, is a measure of inflation that is calculated by the US Department of Labor, representing changes in prices of all goods and services purchased for consumption by urban households.

The Conference Board Consumer Confidence Index, mentioned on page 21, is a barometer of the health of the US economy from the perspective of the consumer. The index is based on consumers' perceptions of current business and employment conditions, as well as their expectations for six months hence regarding business conditions, employment, and income. The resulting relative value is then used as an "index value" and compared against each respective monthly value for 1985. In that year, the result of the index was arbitrarily set at 100, representing it as the index benchmark.

The NFIB Small Business Optimism Index, mentioned on page 21, is a survey asking small business owners a battery of questions related to their expectations for the future and their plans to hire, build inventory, borrow, and expand. <br>

[**Table of Contents**](#toc1)

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc1)

Disclosure of Portfolio expenses

For the six-month period from July 1, 2022 to December 31, 2022 (Unaudited)

As a shareholder of the Portfolio, you incur ongoing costs, which may include management fees; distribution and service (12b-1) fees; and other Portfolio expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Portfolio and to compare these costs with the ongoing costs of investing in other mutual funds.

The examples are based on an investment of $1,000 invested at the beginning of the period and held for the entire six-month period from July 1, 2022 to December 31, 2022.

**Actual expenses**

The first section of the tables shown, "Actual Portfolio return," provides information about actual account values and actual expenses. You may use the information in this section of the table, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first section under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period.

**Hypothetical example for comparison purposes**

The second section of the tables shown, "Hypothetical 5% return," provides information about hypothetical account values and hypothetical expenses based on a Portfolio's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Portfolio's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in each Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the tables are meant to highlight your ongoing costs only. As a shareholder of the Portfolio, you do not incur any transaction costs, such as sales charges (loads), redemption fees or exchange fees, but shareholders of other funds may incur such costs. Also, the fees related to the variable annuity investment or the deferred sales charge that could apply have not been included. Therefore, the second section of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. The Portfolios' expenses shown in the tables reflect fee waivers in effect and assume reinvestment of all dividends and distributions.

**Delaware Ivy VIP Asset Strategy<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class I | $1000.00 | $1023.70 | 0.72% | $3.67 |
| Class II | 1000.00 | 1022.40 | 0.89% | 4.54 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class I | $1000.00 | $1021.58 | 0.72% | $3.67 |
| Class II | 1000.00 | 1020.72 | 0.89% | 4.53 |

---

**Delaware Ivy VIP Balanced<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class II | $1000.00 | $1012.90 | 1.11% | $5.63 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1019.61 | 1.11% | $5.65 |

---

[**Table of Contents**](#toc1)

**Delaware Ivy VIP Energy<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class I | $1000.00 | $1180.10 | 1.00% | $5.50 |
| Class II | 1000.00 | 1178.30 | 1.25% | 6.86 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class I | $1000.00 | $1020.16 | 1.00% | $5.09 |
| Class II | 1000.00 | 1018.90 | 1.25% | 6.36 |

---

**Delaware Ivy VIP Growth<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class II | $1000.00 | $997.70 | 1.00% | $5.04 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1020.16 | 1.00% | $5.09 |

---

**Delaware Ivy VIP High Income<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class I | $1000.00 | $1036.60 | 0.71% | $3.64 |
| Class II | 1000.00 | 1033.60 | 0.96% | 4.92 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class I | $1000.00 | $1021.63 | 0.71% | $3.62 |
| Class II | 1000.00 | 1020.37 | 0.96% | 4.89 |

---

**Delaware Ivy VIP International Core<br> Equity Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class II | $1000.00 | $1043.10 | 1.19% | $6.13 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1019.21 | 1.19% | $6.06 |

---

**Delaware Ivy VIP Mid Cap Growth<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class I | $1000.00 | $1033.70 | 0.85% | $4.36 |
| Class II | 1000.00 | 1032.40 | 1.10% | 5.64 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class I | $1000.00 | $1020.92 | 0.85% | $4.33 |
| Class II | 1000.00 | 1019.66 | 1.10% | 5.60 |

---

**Delaware Ivy VIP Natural Resources<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class II | $1000.00 | $1135.40 | 1.34% | $7.21 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1018.45 | 1.34% | $6.82 |

---

[**Table of Contents**](#toc1)

Disclosure of Portfolio expenses

**Delaware Ivy VIP Science and Technology<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class I | $1000.00 | $996.40 | 0.88% | $4.43 |
| Class II | 1000.00 | 995.10 | 1.13% | 5.68 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class I | $1000.00 | $1020.77 | 0.88% | $4.48 |
| Class II | 1000.00 | 1019.51 | 1.13% | 5.75 |

---

**Delaware Ivy VIP Small Cap Growth<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22<br> to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class I | $1000.00 | $1003.60 | 0.89% | $4.49 |
| Class II | 1000.00 | 1002.40 | 1.14% | 5.75 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class I | $1000.00 | $1020.72 | 0.89% | $4.53 |
| Class II | 1000.00 | 1019.46 | 1.14% | 5.80 |

---

**Delaware Ivy VIP Smid Cap Core<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** | **Actual Portfolio return<sup>†</sup>** |
| Class II | $1000.00 | $1061.80 | 1.25% | $6.50 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1018.90 | 1.25% | $6.36 |

---

\*"Expenses Paid During Period" are equal to the relevant Portfolio's annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period).

<sup>†</sup>Because actual returns reflect only the most recent six-month period, the returns shown may differ significantly from fiscal year returns.

In addition to the Portfolios' expenses reflected above and on the previous pages, each Portfolio also indirectly bears its portion of the fees and expenses of any investment companies (Underlying Funds), including exchange-traded funds in which it invests. The tables above and on the previous pages do not reflect the expenses of any applicable Underlying Funds. <br>

[**Table of Contents**](#toc1)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Asset Strategy As of

December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Agency Collateralized Mortgage Obligations** | **0.16%** |
| **Agency Commercial Mortgage-Backed Securities** | **0.82%** |
| **Agency Mortgage-Backed Securities** | **8.11%** |
| **Convertible Bonds** | **0.18%** |
| **Corporate Bonds** | **11.06%** |
| Banking | 2.74% |
| Basic Industry | 0.32% |
| Brokerage | 0.09% |
| Capital Goods | 0.47% |
| Communications | 1.66% |
| Consumer Cyclical | 0.77% |
| Consumer Non-Cyclical | 0.96% |
| Consumer Staples | 0.11% |
| Electric | 1.28% |
| Energy | 0.47% |
| Finance Companies | 0.62% |
| Insurance | 0.37% |
| Natural Gas | 0.11% |
| Real Estate Investment Trusts | 0.07% |
| Technology | 0.98% |
| Transportation | 0.04% |
| **Non-Agency Commercial Mortgage-Backed Security** | **0.00%** |
| **Sovereign Bonds** | **0.14%** |
| **US Treasury Obligations** | **13.86%** |
| **Common Stocks** | **56.65%** |
| Communication Services | 4.09% |
| Consumer Discretionary | 7.42% |
| Consumer Staples | 4.20% |
| Energy | 3.84% |
| Financials | 7.39% |
| Healthcare | 9.58% |
| Industrials | 6.62% |
| Information Technology | 11.66% |
| Materials | 0.50% |
| Utilities | 1.35% |
| **Exchange-Traded Funds** | **2.80%** |
| **Bullion** | **4.66%** |
| **Short-Term Investments** | **1.44%** |
| **Securities Lending Collateral** | **2.44%** |
| **Total Value of Securities** | **102.32%** |
| **Obligation to Return Securities Lending Collateral** | **(2.44** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **0.12%** |
| **Total Net Assets** | **100.00%** |

---

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Microsoft | 1.45% |
| UnitedHealth Group | 1.40% |
| Deutsche Telekom | 1.37% |
| ORIX | 1.35% |
| Mastercard Class A | 1.34% |
| ConocoPhillips | 1.32% |
| Canadian Natural Resources | 1.31% |
| Larsen & Toubro | 1.21% |
| Procter & Gamble | 1.20% |
| Genmab | 1.18% |

---

[**Table of Contents**](#toc1)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Balanced

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Agency Collateralized Mortgage Obligations** | **0.47%** |
| **Agency Mortgage-Backed Securities** | **8.43%** |
| **Convertible Bonds** | **0.05%** |
| **Corporate Bonds** | **11.27%** |
| Banking | 1.86% |
| Basic Industry | 0.15% |
| Brokerage | 0.52% |
| Capital Goods | 0.52% |
| Communications | 1.69% |
| Consumer Cyclical | 0.64% |
| Consumer Non-Cyclical | 1.09% |
| Electric | 1.19% |
| Energy | 0.50% |
| Finance Companies | 0.28% |
| Insurance | 0.57% |
| Natural Gas | 0.11% |
| Real Estate Investment Trusts | 0.29% |
| Technology | 1.67% |
| Transportation | 0.19% |
| **Non-Agency Commercial Mortgage-Backed Securities** | **2.87%** |
| **US Treasury Obligations** | **16.03%** |
| **Common Stocks** | **55.43%** |
| Communications | 2.73% |
| Consumer Discretionary | 3.63% |
| Consumer Staples | 2.40% |
| Energy | 2.20% |
| Financials | 10.39% |
| Healthcare | 8.81% |
| Industrials | 7.27% |
| Information Technology | 13.35% |
| Materials | 2.74% |
| Utilities | 1.91% |
| **Exchange-Traded Funds** | **3.03%** |
| **Short-Term Investments** | **2.55%** |
| **Securities Lending Collateral** | **0.72%** |
| **Total Value of Securities** | **100.85%** |
| **Obligation to Return Securities Lending Collateral** | **(0.72** **%)** |
| **Liabilities Net of Receivables and Other Assets** | **(0.13** **%)** |
| **Total Net Assets** | **100.00%** |

---

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Microsoft | 4.37% |
| UnitedHealth Group | 3.26% |
| NextEra Energy | 1.91% |
| United Rentals | 1.90% |
| Progressive | 1.71% |
| Apple | 1.64% |
| Linde | 1.64% |
| HCA Healthcare | 1.51% |
| TE Connectivity | 1.50% |
| Microchip Technology | 1.49% |

---

[**Table of Contents**](#toc1)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Energy

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Common Stocks** | **95.23%** |
| Consumer Discretionary | 0.49% |
| Consumer Staples | 2.12% |
| Energy\* | 88.87% |
| Financials | 0.50% |
| Industrials | 3.25% |
| **Master Limited Partnerships** | **2.02%** |
| **Short-Term Investments** | **2.71%** |
| **Securities Lending Collateral** | **1.86%** |
| **Total Value of Securities** | **101.82%** |
| **Obligation to Return Securities Lending Collateral** | **(1.86** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **0.04%** |
| **Total Net Assets** | **100.00%** |

---

\*To monitor compliance with the Portfolio's concentration guidelines as described in the Portfolio's Prospectus and Statement of Additional Information, the Energy sector (as disclosed herein for financial reporting purposes) is subdivided into a variety of "industries" (in accordance with the requirements of the Investment Company Act of 1940, as amended). The Energy sector consisted of Coal, Energy-Alternative Sources, Oil Component-Exploration & Production, Oil Company-Integrated, Oil Refining & Marketing, Oil & Gas Drilling, Oil- Field Services, Oil-US Royalty Trusts, and Pipelines. As of December 31, 2022, such amounts, as a percentage of total net assets, were 1.23%, 1.38%, 55.18%, 8.55%, 7.85%, 4.22%, 5.01%, 3.36%, and 2.09%, respectively. The percentage in any such single industry will comply with the Portfolio's concentration policy even if the percentages in the Energy sector for financial reporting purposes may exceed 25%.

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Shell | 6.90% |
| ConocoPhillips | 6.21% |
| Denbury | 6.16% |
| EOG Resources | 6.14% |
| Chord Energy | 6.04% |
| Chesapeake Energy | 5.61% |
| Schlumberger | 5.01% |
| Tourmaline Oil | 4.60% |
| Valero Energy | 4.40% |
| Occidental Petroleum | 4.39% |

---

[**Table of Contents**](#toc1)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Growth

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Common Stocks** | **99.61%** |
| Communication Services | 8.98% |
| Consumer Discretionary | 12.92% |
| Consumer Staples | 3.62% |
| Financials | 4.87% |
| Healthcare | 10.73% |
| Industrials | 10.30% |
| Information Technology\* | 48.19% |
| **Short-Term Investments** | **0.34%** |
| **Total Value of Securities** | **99.95%** |
| **Receivables and Other Assets Net of Liabilities** | **0.05%** |
| **Total Net Assets** | **100.00%** |

---

\*To monitor compliance with the Portfolio's concentration guidelines as described in the Portfolio's Prospectus and Statement of Additional Information, the Information Technology sector (as disclosed herein for financial reporting purposes) is subdivided into a variety of "industries" (in accordance with the requirements of the Investment Company Act of 1940, as amended). The Information Technology sector consisted of Commercial Services, Computers, Diversified Financial Services, Internet, Semiconductors, Software and Telecommunications. As of December 31, 2022, such amounts, as a percentage of total net assets, were 0.92%, 7.94%, 5.93%, 4.79%, 2.68%, 21.03% and 4.90%, respectively. The percentage in any such single industry will comply with the Portfolio's concentration policy even if the percentages in the Information Technology sector for financial reporting purposes may exceed 25%.

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Microsoft | 12.42% |
| Apple | 7.94% |
| Visa Class A | 5.93% |
| Alphabet Class A | 5.09% |
| Motorola Solutions | 4.90% |
| VeriSign | 4.79% |
| Amazon.com | 4.73% |
| UnitedHealth Group | 4.27% |
| CoStar Group | 4.25% |
| Coca-Cola | 3.38% |

---

[**Table of Contents**](#toc1)

Security type / sector allocations

Delaware Ivy VIP High Income

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Convertible Bonds** | **1.14%** |
| **Corporate Bonds** | **70.32%** |
| Automotive | 0.77% |
| Banking | 0.43% |
| Basic Industry | 2.92% |
| Capital Goods | 3.36% |
| Communications | 6.82% |
| Consumer Goods | 1.64% |
| Energy | 11.41% |
| Financial Services | 3.46% |
| Healthcare | 5.99% |
| Insurance | 3.23% |
| Leisure | 5.38% |
| Media | 9.00% |
| Retail | 3.31% |
| Services | 4.62% |
| Technology & Electronics | 3.11% |
| Transportation | 2.52% |
| Utilities | 2.35% |
| **Municipal Bonds** | **0.51%** |
| **Loan Agreements** | **10.42%** |
| **Common Stocks** | **2.06%** |
| Basic Industry | 0.39% |
| Consumer Goods | 0.00% |
| Energy | 0.23% |
| Leisure | 1.11% |
| Retail | 0.05% |
| Services | 0.28% |
| Utilities | 0.00% |
| **Preferred Stock** | **0.02%** |
| **Exchange-Traded Funds** | **4.00%** |
| **Warrants** | **0.01%** |
| **Short-Term Investments** | **9.55%** |
| **Securities Lending Collateral** | **4.82%** |
| **Total Value of Securities** | **102.85%** |
| **Obligation to Return Securities Lending Collateral** | **(4.82** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **1.97%** |
| **Total Net Assets** | **100.00%** |

---

[**Table of Contents**](#toc1)

Security type / country and sector allocations

Delaware Ivy VIP International Core Equity

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / country | Percentage<br> of net assets |
| **Common Stocks by Country** | **97.16%** |
| Australia | 1.46% |
| Austria | 1.01% |
| Brazil | 3.21% |
| Canada | 5.87% |
| China | 5.15% |
| China/Hong Kong | 6.67% |
| Denmark | 4.69% |
| France | 13.73% |
| Germany | 11.42% |
| Hong Kong | 1.82% |
| India | 3.59% |
| Japan | 10.12% |
| Netherlands | 4.98% |
| Norway | 1.02% |
| Republic of Korea | 3.70% |
| Spain | 1.78% |
| Switzerland | 1.90% |
| Taiwan | 1.88% |
| United Kingdom | 8.32% |
| United States | 4.84% |
| **Short-Term Investments** | **0.66%** |
| **Securities Lending Collateral** | **1.54%** |
| **Total Value of Securities** | **99.36%** |
| **Obligation to Return Securities Lending Collateral** | **(1.54** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **2.18%** |
| **Total Net Assets** | **100.00%** |

---

---

| | |
|:---|:---|
| Common stocks by sector | Percentage<br> of net assets |
| Communication Services | 4.09% |
| Consumer Discretionary | 16.07% |
| Consumer Staples | 9.04% |
| Energy | 10.36% |
| Financials | 17.82% |
| Healthcare | 10.08% |
| Industrials | 14.62% |
| Information Technology | 7.73% |
| Materials | 3.70% |
| Utilities | 3.65% |
| **Total** | **97.16%** |

---

[**Table of Contents**](#toc1)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Mid Cap Growth

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Common Stocks** | **97.95%** |
| Communication Services | 7.05% |
| Consumer Discretionary | 14.69% |
| Consumer Staples | 1.36% |
| Financials | 6.88% |
| Healthcare | 18.50% |
| Industrials | 16.13% |
| Information Technology\* | 32.49% |
| Materials | 0.85% |
| **Short-Term Investments** | **2.21%** |
| **Securities Lending Collateral** | **0.04%** |
| **Total Value of Securities** | **100.20%** |
| **Obligation to Return Securities Lending Collateral** | **(0.04** **%)** |
| **Liabilities Net of Receivables and Other Assets** | **(0.16** **%)** |
| **Total Net Assets** | **100.00%** |

---

\*To monitor compliance with the Portfolio's concentration guidelines as described in the Portfolio's Prospectus and Statement of Additional Information, the Information Technology sector (as disclosed herein for financial reporting purposes) is subdivided into a variety of "industries" (in accordance with the requirements of the Investment Company Act of 1940, as amended). The Information Technology sector consisted of Computers, Electrical Components & Equipment, Electronics, Office & Business Equipment, Semiconductors, Software, and Telecommunications. As of December 31, 2022, such amounts, as a percentage of total net assets, were 2.24%, 3.64%, 5.14%, 0.70%, 8.94%, 9.89%, and 1.94%, respectively. The percentage in any such single industry will comply with the Portfolio's concentration policy even if the percentages in the Information Technology sector for financial reporting purposes may exceed 25%.

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| CoStar Group | 4.72% |
| Dexcom | 3.92% |
| MarketAxess Holdings | 3.05% |
| Monolithic Power Systems | 2.76% |
| Pinterest Class A | 2.55% |
| Microchip Technology | 2.36% |
| BorgWarner | 2.31% |
| HEICO Class A | 2.23% |
| Keysight Technologies | 2.23% |
| Chipotle Mexican Grill | 2.22% |

---

[**Table of Contents**](#toc1)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Natural Resources

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Closed-Ended Trust** | **3.19%** |
| **Common Stocks** | **95.35%** |
| Basic Industry\* | 27.69% |
| Consumer Discretionary | 0.50% |
| Consumer Staples | 7.59% |
| Energy\* | 43.17% |
| Financials | 0.52% |
| Industrials | 5.46% |
| Materials | 8.39% |
| Real Estate Investment Trusts | 2.03% |
| **Short-Term Investments** | **1.45%** |
| **Securities Lending Collateral** | **3.52%** |
| **Total Value of Securities** | **103.51%** |
| **Obligation to Return Securities Lending Collateral** | **(3.52** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **0.01%** |
| **Total Net Assets** | **100.00%** |

---

\*To monitor compliance with the Portfolio's concentration guidelines as described in the Portfolio's Prospectus and Statement of Additional Information, the Basic Industry and Energy sectors (as disclosed herein for financial reporting purposes) are subdivided into a variety of "industries" (in accordance with the requirements of the Investment Company Act of 1940, as amended). The Basic Industry sector consisted of Agricultural Chemicals, Gold Mining, Metal-Copper, Platinum, and Precious Metals. As of December 31, 2022, such amounts, as a percentage of total net assets, were 6.06%, 5.56%, 8.65%, 3.56%, and 3.86%, respectively. The Energy sector consisted of Energy-Alternative Sources, Oil Component-Exploration & Production, Oil Company-Integrated, Oil Refining & Marketing, Oil & Gas Drilling, Oil- Field Services, and Oil-US Royalty Trusts. As of December 31, 2022, such amounts, as a percentage of total net assets, were 1.24%, 22.98%, 3.95%, 4.58%, 2.48%, 4.26%, and 3.68%, respectively. The percentage in any such single industry will comply with the Portfolio's concentration policy even if the percentages in the Basic Industry and Energy sectors for financial reporting purposes may exceed 25%.

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Valero Energy | 4.58% |
| Chesapeake Energy | 4.37% |
| Denbury | 4.29% |
| Schlumberger | 4.26% |
| Newmont | 4.09% |
| Shell | 3.95% |
| Wheaton Precious Metals | 3.87% |
| Freeport-McMoRan | 3.68% |
| Kimbell Royalty Partners | 3.68% |
| Anglo American | 3.56% |

---

[**Table of Contents**](#toc1)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Science and Technology

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Common Stocks** | **95.48%** |
| Communication Services | 13.12% |
| Consumer Discretionary | 9.13% |
| Healthcare | 7.74% |
| Industrials | 2.11% |
| Information Technology\* | 63.38% |
| **Short-Term Investments** | **4.60%** |
| **Securities Lending Collateral** | **0.15%** |
| **Total Value of Securities** | **100.23%** |
| **Obligation to Return Securities Lending Collateral** | **(0.15** **%)** |
| **Liabilities Net of Receivables and Other Assets** | **(0.08** **%)** |
| **Total Net Assets** | **100.00%** |

---

\*To monitor compliance with the Portfolio's concentration guidelines as described in the Portfolio's Prospectus and Statement of Additional Information, the Information Technology sector (as disclosed herein for financial reporting purposes) is subdivided into a variety of "industries" (in accordance with the requirements of the Investment Company Act of 1940, as amended). The Information Technology sector consisted of Commercial Services, Computers, Diversified Financial Services, Electronics, Internet, Office & Business Equipment, Semiconductors, and Software. As of December 31, 2022, such amounts, as a percentage of total net assets, were 2.79%, 8.76%, 2.60%, 4.64%, 3.76%, 2.39%, 23.70%, and 14.74%, respectively. The percentage in any such single industry will comply with the Portfolio's concentration policy even if the percentages in the Information Technology sector for financial reporting purposes may exceed 25%.

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Microsoft | 7.14% |
| ASML Holding | 4.49% |
| Amazon.com | 4.33% |
| T-Mobile US | 4.04% |
| Apple | 3.82% |
| Amphenol Class A | 3.44% |
| Pinterest Class A | 3.28% |
| VeriSign | 3.25% |
| Microchip Technology | 3.14% |
| Analog Devices | 3.10% |

---

[**Table of Contents**](#toc1)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Small Cap Growth

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Common Stocks** | **97.14%** |
| Communication Services | 1.55% |
| Consumer Discretionary | 13.92% |
| Consumer Staples | 5.48% |
| Energy | 5.85% |
| Financials | 4.49% |
| Healthcare | 21.32% |
| Industrials | 18.76% |
| Information Technology | 23.51% |
| Materials | 1.47% |
| Real Estate | 0.79% |
| **Short-Term Investments** | **3.01%** |
| **Securities Lending Collateral** | **0.09%** |
| **Total Value of Securities** | **100.24%** |
| **Obligation to Return Securities Lending Collateral** | **(0.09** **%)** |
| **Liabilities Net of Receivables and Other Assets** | **(0.15** **%)** |
| **Total Net Assets** | **100.00%** |

---

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| BJ's Wholesale Club Holdings | 2.85% |
| Allegro MicroSystems | 2.75% |
| Visteon | 2.34% |
| Red Rock Resorts Class A | 2.32% |
| Marriott Vacations Worldwide | 2.25% |
| Kinsale Capital Group | 2.13% |
| Cactus Class A | 2.12% |
| Paycor HCM | 2.00% |
| Inmode | 1.98% |
| Progyny | 1.97% |

---

[**Table of Contents**](#toc1)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Smid Cap Core

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Common Stocks** | **98.22%** |
| Basic Materials | 7.88% |
| Business Services | 5.44% |
| Capital Goods | 10.78% |
| Consumer Discretionary | 5.78% |
| Consumer Services | 2.21% |
| Consumer Staples | 3.19% |
| Credit Cyclicals | 3.11% |
| Energy | 5.33% |
| Financials | 15.52% |
| Healthcare | 13.05% |
| Media | 1.79% |
| Real Estate Investment Trusts | 6.39% |
| Technology | 12.77% |
| Transportation | 3.07% |
| Utilities | 1.91% |
| **Short-Term Investments** | **1.92%** |
| **Total Value of Securities** | **100.14%** |
| **Liabilities Net of Receivables and Other Assets** | **(0.14** **%)** |
| **Total Net Assets** | **100.00%** |

---

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Liberty Energy | 2.24% |
| Chesapeake Energy | 1.77% |
| Reliance Steel & Aluminum | 1.67% |
| WillScot Mobile Mini Holdings | 1.48% |
| ExlService Holdings | 1.46% |
| Quanta Services | 1.45% |
| Huntsman | 1.43% |
| Casey's General Stores | 1.38% |
| Primerica | 1.38% |
| Reinsurance Group of America | 1.36% |

---

[**Table of Contents**](#toc1)

Consolidated schedules of investments

Delaware Ivy VIP Asset Strategy December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Agency Collateralized Mortgage Obligations — 0.16%** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae REMI`Cs |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2015-18 NS 1.731%<br> (6.12% minus LIBOR01M,<br> Cap 6.12%) 4/25/45 Σ, • | 1076900 | $115261 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2015-37 SB 1.231%<br> (5.62% minus LIBOR01M,<br> Cap 5.62%) 6/25/45 Σ, • | 2271350 | 183012 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2016-48 US 1.711%<br> (6.10% minus LIBOR01M,<br> Cap 6.10%) 8/25/46 Σ, • | 2654113 | 198202 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2017-33 AI 4.50%<br> 5/25/47 Σ | 1082384 | 167218 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2019-13 IP 5.00%<br> 3/25/49 Σ | 730527 | 147829 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 4740 SB 1.832%<br> (6.15% minus LIBOR01M,<br> Cap 6.15%) 11/15/47 Σ, • | 1079533 | 111001 |
| &nbsp;&nbsp;**Total Agency Collateralized Mortgage Obligations**<br> (cost $1,550,808) |  | **922523** |
| &nbsp;&nbsp;**Agency Commercial Mortgage-Backed Securities — 0.82%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2017-M2 A2 2.759%<br> 2/25/27 • | 1449932 | 1364592 |
| &nbsp;&nbsp;&nbsp;&nbsp;Freddie Mac Multifamily<br> Structured Pass Through<br> Certificates |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series K103 X1 0.758%<br> 11/25/29 • | 2019727 | 71320 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series K115 X1 1.429%<br> 6/25/30 • | 1792693 | 136711 |
| &nbsp;&nbsp;&nbsp;&nbsp;FREMF Mortgage Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2016-K60 B 144A 3.543%<br> 12/25/49 #, • | 2751000 | 2517132 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2018-K73 B 144A 3.854%<br> 2/25/51 #, • | 600000 | 544263 |
| &nbsp;&nbsp;**Total Agency Commercial Mortgage-Backed Securities**<br> (cost $5,355,368) |  | **4634018** |
| &nbsp;&nbsp;**Agency Mortgage-Backed Securities — 8.11%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae S.F. 15 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 4/1/36 | 2128466 | 1953122 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae S.F. 30 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.00% 4/1/51 | 3938375 | 3215712 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.00% 10/1/51 | 3389123 | 2762107 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 7/1/50 | 3697392 | 3160296 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 8/1/50 | 754412 | 669588 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 12/1/51 | 1010060 | 892296 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 8/1/48 | 3960228 | 3676673 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae S.F. 30 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 3/1/47 | 1848842 | 1770957 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 9/1/52 | 1252353 | 1205924 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 6/1/52 | 934607 | 921682 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 9/1/52 | 1959222 | 1932128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 10/1/52 | 1425214 | 1430042 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 11/1/52 | 918427 | 929057 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 12/1/52 | 1028911 | 1031673 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.00% 12/1/52 | 1105886 | 1122545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae S.F. 30 yr TBA |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 1/1/53 | 1147000 | 1149829 |
| &nbsp;&nbsp;&nbsp;&nbsp;Freddie Mac S.F. 30 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.00% 3/1/52 | 1569553 | 1277996 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 1/1/51 | 1094902 | 939219 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 1/1/52 | 1530347 | 1299324 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 2/1/52 | 3075533 | 2700246 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 6/1/47 | 1531718 | 1420560 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 8/1/52 | 956907 | 902589 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 9/1/52 | 1564107 | 1506991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 7/1/52 | 1175687 | 1159428 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 9/1/52 | 1011087 | 1021094 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 11/1/52 | 1191418 | 1196686 |
| &nbsp;&nbsp;&nbsp;&nbsp;GNMA II S.F. 30 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 12/20/51 | 524714 | 468846 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 6/20/50 | 3795081 | 3521135 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 9/20/52 | 728082 | 721630 |
| &nbsp;&nbsp;**Total Agency Mortgage-Backed Securities**<br> (cost $49,427,989) |  | **45959375** |
| **Convertible Bonds — 0.18%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Liberty Broadband 144A 2.75%<br> exercise price $857.56,<br> maturity date 9/30/50 # | 38000 | 37105 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liberty Broadband 144A 1.25%<br> exercise price $900.01,<br> maturity date 9/30/50 # | 999000 | 969030 |
| **Total Convertible Bonds<br> (cost $989,126)** |  | **1006135** |
| &nbsp;&nbsp;**Corporate Bonds — 11.06%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Banking — 2.74% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bank of America |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.676% 6/19/41 µ | 290000 | 196127 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.375% 1/27/27 µ, Ψ | 45000 | 38224 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.015% 7/22/33 µ | 445000 | 423794 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.204% 11/10/28 µ | 290000 | 299938 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bank of New York Mellon |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.802% 10/25/28 µ | 179000 | 185417 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.834% 10/25/33 µ | 375000 | 389935 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Barclays 7.325% 11/2/26 µ | 200000 | 207379 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** | | |
| &nbsp;&nbsp;Banking (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Citigroup |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.122% 1/28/27 µ | 2500000 | $2181382 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.07% 2/24/28 µ | 115000 | 103840 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.61% 9/29/26 µ | 100000 | 100533 |
| &nbsp;&nbsp;&nbsp;&nbsp;Citizens Bank 6.064%<br> 10/24/25 µ | 750000 | 758993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Suisse Group 144A<br> 6.442% 8/11/28 #, µ | 655000 | 597467 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fifth Third Bancorp |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.337% 4/25/33 µ | 430000 | 394100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.361% 10/27/28 µ | 295000 | 304046 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fifth Third Bank 5.852%<br> 10/27/25 µ | 250000 | 252704 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.542% 9/10/27 µ | 570000 | 492415 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.102% 2/24/33 µ | 45000 | 36656 |
| &nbsp;&nbsp;&nbsp;&nbsp;Huntington National Bank |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.552% 5/17/28 µ | 255000 | 246442 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.65% 1/10/30 | 250000 | 252501 |
| &nbsp;&nbsp;&nbsp;&nbsp;JPMorgan Chase & Co. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.953% 2/4/32 µ | 165000 | 126593 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.851% 7/25/28 µ | 490000 | 478448 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KeyBank 5.85% 11/15/27 | 80000 | 82717 |
| &nbsp;&nbsp;&nbsp;&nbsp;KeyCorp 4.789% 6/1/33 \*, µ | 914000 | 865666 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.928% 4/28/32 µ | 625000 | 473039 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.484% 9/16/36 µ | 1500000 | 1091085 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.138% 10/16/26 µ | 135000 | 138027 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.296% 10/18/28 µ | 165000 | 170623 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.342% 10/18/33 µ | 110000 | 115610 |
| &nbsp;&nbsp;&nbsp;&nbsp;PNC Financial Services Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.671% 10/28/25 µ | 195000 | 197215 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.20% 9/15/27 µ, Ψ | 160000 | 156760 |
| &nbsp;&nbsp;&nbsp;&nbsp;State Street |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.203% 2/7/28 µ | 140000 | 125962 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.751% 11/4/26 µ | 45000 | 46113 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.82% 11/4/28 µ | 30000 | 31035 |
| &nbsp;&nbsp;&nbsp;&nbsp;SVB Financial Group 4.57%<br> 4/29/33 \*, µ | 520000 | 461503 |
| &nbsp;&nbsp;&nbsp;&nbsp;Toronto-Dominion Bank 4.108%<br> 6/8/27 \* | 495000 | 479290 |
| &nbsp;&nbsp;&nbsp;&nbsp;Truist Financial 6.123%<br> 10/28/33 \*, µ | 117000 | 123476 |
| &nbsp;&nbsp;&nbsp;&nbsp;UniCredit 144A 5.459%<br> 6/30/35 #, µ | 1000000 | 814409 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Bancorp |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.491% 11/3/36 µ | 1245000 | 950395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.727% 10/21/26 µ | 135000 | 137646 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo & Co. 4.808%<br> 7/25/28 µ | 995000 | 973452 |
|  |  | 15500957 |
| &nbsp;&nbsp;Basic Industry — 0.32% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Celanese US Holdings 6.05%<br> 3/15/25 | 400000 | 398782 |
| &nbsp;&nbsp;&nbsp;&nbsp;Newmont 2.60% 7/15/32 \* | 75000 | 59912 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sherwin-Williams 2.90% 3/15/52 | 710000 | 445140 |
| &nbsp;&nbsp;&nbsp;&nbsp;Suzano Austria 2.50% 9/15/28 | 600000 | 505686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Westlake 3.125% 8/15/51 | 690000 | 427620 |
|  |  | 1837140 |
| &nbsp;&nbsp;Brokerage — 0.09% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Jefferies Financial Group 2.625%<br> 10/15/31 | 630000 | 482098 |
|  |  | 482098 |
| &nbsp;&nbsp;Capital Goods — 0.47% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Aeropuerto Internacional de<br> Tocumen 144A 4.00%<br> 8/11/41 # | 500000 | 412716 |
| &nbsp;&nbsp;&nbsp;&nbsp;Boeing |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.875% 5/1/25 | 393000 | 390345 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.805% 5/1/50 | 429000 | 399944 |
| &nbsp;&nbsp;&nbsp;&nbsp;Eaton 4.15% 3/15/33 | 300000 | 279834 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lockheed Martin |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.90% 6/15/32 | 145000 | 137076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.15% 6/15/53 | 125000 | 106729 |
| &nbsp;&nbsp;&nbsp;&nbsp;Standard Industries 144A<br> 4.375% 7/15/30 # | 1173000 | 958352 |
|  |  | 2684996 |
| &nbsp;&nbsp;Communications — 1.66%<br> AT&T |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.25% 2/1/32 \* | 1500000 | 1179625 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.65% 6/1/51 | 2653000 | 1880529 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charter Communications<br> Operating 3.85% 4/1/61 | 1625000 | 945558 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comcast 1.50% 2/15/31 | 2000000 | 1562032 |
| &nbsp;&nbsp;&nbsp;&nbsp;Crown Castle |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.05% 7/15/26 | 490000 | 423960 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.10% 4/1/31 | 555000 | 438758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Empresa Nacional de<br> Telecomunicaciones 144A<br> 3.05% 9/14/32 # | 500000 | 398222 |
| &nbsp;&nbsp;&nbsp;&nbsp;Verizon Communications |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.50% 9/18/30 \* | 3000000 | 2339239 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.875% 11/20/50 | 135000 | 85220 |
| &nbsp;&nbsp;&nbsp;&nbsp;Warnermedia Holdings 144A<br> 5.141% 3/15/52 # | 175000 | 127895 |
|  |  | 9381038 |

---

[**Table of Contents**](#toc1)

Consolidated schedules of investments

Delaware Ivy VIP Asset Strategy

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** | | |
| &nbsp;&nbsp;Consumer Cyclical — 0.77% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Alibaba Group Holding 2.125%<br> 2/9/31 \* | 500000 | $399286 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amazon.com |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.50% 6/3/30 | 654000 | 527016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 6/3/50 | 753000 | 477991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.60% 4/13/32 | 170000 | 156074 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aptiv 3.10% 12/1/51 | 595000 | 353935 |
| &nbsp;&nbsp;&nbsp;&nbsp;Carnival 144A 4.00% 8/1/28 # | 550000 | 449548 |
| &nbsp;&nbsp;&nbsp;&nbsp;Home Depot 1.875% 9/15/31 | 1000000 | 801700 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sands China 2.80% 3/8/27 | 1000000 | 857790 |
| &nbsp;&nbsp;&nbsp;&nbsp;VICI Properties 4.95% 2/15/30 | 370000 | 352709 |
|  |  | 4376049 |
| &nbsp;&nbsp;Consumer Non-Cyclical — 0.96% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AbbVie 3.20% 11/21/29 | 2000000 | 1807503 |
| &nbsp;&nbsp;&nbsp;&nbsp;CVS Health |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.30% 8/21/27 | 2000000 | 1696373 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.70% 8/21/40 | 655000 | 454968 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.78% 3/25/38 | 215000 | 196709 |
| &nbsp;&nbsp;&nbsp;&nbsp;GE HealthCare Technologies |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.60% 11/15/25 # | 115000 | 115832 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.65% 11/15/27 # | 115000 | 116547 |
| &nbsp;&nbsp;&nbsp;&nbsp;JBS USA LUX 144A 3.00%<br> 2/2/29 # | 225000 | 186708 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nestle Holdings 144A 1.875%<br> 9/14/31 #, \* | 1000000 | 807453 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zoetis 5.40% 11/14/25 | 65000 | 66369 |
|  |  | 5448462 |
| &nbsp;&nbsp;Consumer Staples — 0.11% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;COTA Series D 144A 4.896%<br> 10/2/23 #, <<, = | 3642397 | 637419 |
|  |  | 637419 |
| &nbsp;&nbsp;Electric — 1.28% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Appalachian Power 4.50%<br> 8/1/32 | 540000 | 505092 |
| &nbsp;&nbsp;&nbsp;&nbsp;Berkshire Hathaway Energy<br> 2.85% 5/15/51 | 160000 | 105489 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comision Federal de Electricidad 144A<br> 3.875% 7/26/33 #, \* | 500000 | 380401 |
| &nbsp;&nbsp;&nbsp;&nbsp;Duke Energy Carolinas<br> 3.95% 11/15/28 | 795000 | 764431 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fells Point Funding Trust 144A<br> 3.046% 1/31/27 # | 115000 | 104824 |
| &nbsp;&nbsp;&nbsp;&nbsp;Indianapolis Power & Light 144A<br> 5.65% 12/1/32 # | 170000 | 174892 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nevada Power 5.90% 5/1/53 | 260000 | 278779 |
| &nbsp;&nbsp;&nbsp;&nbsp;NextEra Energy Capital Holdings<br> 3.00% 1/15/52 | 170000 | 111758 |
| &nbsp;&nbsp;&nbsp;&nbsp;NRG Energy<br> 144A 2.00% 12/2/25 # | 1100000 | 982275 |
| &nbsp;&nbsp;&nbsp;&nbsp;NRG Energy<br> 144A 2.45% 12/2/27 # | 110000 | 91312 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pacific Gas and Electric 3.00%<br> 6/15/28 | 1154000 | 999859 |
| &nbsp;&nbsp;&nbsp;&nbsp;PacifiCorp 5.35% 12/1/53 | 90000 | 89632 |
| &nbsp;&nbsp;&nbsp;&nbsp;Southern 5.70% 10/15/32 | 205000 | 210337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Virginia Electric and Power<br> 2.45% 12/15/50 | 2500000 | 1492599 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vistra Operations 144A 5.125%<br> 5/13/25 # | 1000000 | 979685 |
|  |  | 7271365 |
| Energy — 0.47% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BP Capital Markets America |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;2.721% 1/12/32 | 215000 | 179775 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.939% 6/4/51 | 555000 | 367965 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diamondback Energy 4.25%<br> 3/15/52 | 45000 | 33124 |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy Transfer 5.75% 2/15/33 | 90000 | 88226 |
| &nbsp;&nbsp;&nbsp;&nbsp;Enterprise Products Operating<br> 3.30% 2/15/53 | 670000 | 448698 |
| &nbsp;&nbsp;&nbsp;&nbsp;Galaxy Pipeline Assets Bidco<br> 144A 2.625% 3/31/36 # | 500000 | 404362 |
| &nbsp;&nbsp;&nbsp;&nbsp;Targa Resources Partners 5.00%<br> 1/15/28 | 700000 | 668912 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valero Energy 3.65% 12/1/51 | 645000 | 458321 |
|  |  | 2649383 |
| Finance Companies — 0.62% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AerCap Ireland Capital DAC<br> 2.45% 10/29/26 | 2500000 | 2189345 |
| Air Lease |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;2.875% 1/15/32 \* | 440000 | 350666 |
| &nbsp;&nbsp;&nbsp;&nbsp;4.125% 12/15/26 µ, y | 605000 | 415938 |
| &nbsp;&nbsp;&nbsp;&nbsp;5.85% 12/15/27 | 115000 | 115073 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aviation Capital Group 144A<br> 3.50% 11/1/27 # | 495000 | 433130 |
|  |  | 3504152 |
| Insurance — 0.37% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AIA Group 144A 3.375% 4/7/30 # | 540000 | 475706 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aon 5.00% 9/12/32 | 635000 | 629920 |
| &nbsp;&nbsp;&nbsp;&nbsp;Athene Holding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.45% 5/15/52 | 385000 | 237814 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.95% 5/25/51 | 175000 | 118791 |
| &nbsp;&nbsp;&nbsp;&nbsp;Berkshire Hathaway Finance<br> 3.85% 3/15/52 | 555000 | 445314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Humana |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.75% 3/1/28 | 125000 | 127862 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.875% 3/1/33 | 50000 | 51777 |
|  |  | 2087184 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** | | |
| &nbsp;&nbsp;Natural Gas — 0.11% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Atmos Energy |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.85% 2/15/52 | 150000 | $97756 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.75% 10/15/52 | 270000 | 283536 |
| &nbsp;&nbsp;&nbsp;&nbsp;Southern Co. Gas Capital 5.15%<br> 9/15/32 | 231000 | 227424 |
|  |  | 608716 |
| &nbsp;&nbsp;Real Estate Investment Trusts — 0.07% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Homes 4 Rent 3.625%<br> 4/15/32 | 85000 | 71726 |
| &nbsp;&nbsp;&nbsp;&nbsp;Digital Realty Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.45% 7/15/28 | 120000 | 113838 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.55% 1/15/28 | 210000 | 211767 |
|  |  | 397331 |
| &nbsp;&nbsp;Technology — 0.98% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.40% 8/20/50 | 878000 | 550126 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.65% 2/8/51 | 2000000 | 1328568 |
| &nbsp;&nbsp;&nbsp;&nbsp;Autodesk 2.40% 12/15/31 \* | 165000 | 132235 |
| &nbsp;&nbsp;&nbsp;&nbsp;Broadcom 144A 1.95% 2/15/28 # | 1500000 | 1269532 |
| &nbsp;&nbsp;&nbsp;&nbsp;CDW 3.276% 12/1/28 | 555000 | 476209 |
| &nbsp;&nbsp;&nbsp;&nbsp;Entegris Escrow 144A 4.75%<br> 4/15/29 # | 150000 | 137093 |
| &nbsp;&nbsp;&nbsp;&nbsp;Iron Mountain 144A 5.25%<br> 7/15/30 # | 290000 | 252664 |
| &nbsp;&nbsp;&nbsp;&nbsp;Iron Mountain Information |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Management Services 144A<br> 5.00% 7/15/32 # | 895000 | 744770 |
| &nbsp;&nbsp;&nbsp;&nbsp;Oracle |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;5.80% 11/10/25 \* | 45000 | 46058 |
| &nbsp;&nbsp;&nbsp;&nbsp;6.15% 11/9/29 | 95000 | 98832 |
| &nbsp;&nbsp;&nbsp;&nbsp;PayPal Holdings 3.90% 6/1/27 | 40000 | 38554 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workday |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;3.50% 4/1/27 | 20000 | 18722 |
| &nbsp;&nbsp;&nbsp;&nbsp;3.70% 4/1/29 | 45000 | 41379 |
| &nbsp;&nbsp;&nbsp;&nbsp;3.80% 4/1/32 | 465000 | 411772 |
|  |  | 5546514 |
| &nbsp;&nbsp;Transportation — 0.04% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Burlington Northern Santa Fe |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.875% 6/15/52 | 135000 | 90651 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.45% 1/15/53 | 145000 | 129643 |
|  |  | 220294 |
| &nbsp;&nbsp;**Total Corporate Bonds**<br> (cost $74,763,264) |  | **62633098** |
| **Non-Agency Commercial Mortgage-Backed Security — 0.00%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Merrill Lynch Mortgage Investors<br> Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 1998-C1 F 6.25%<br> 11/15/26 • | 13867 | 13860 |
| &nbsp;&nbsp;**Total Non-Agency Commercial Mortgage-<br> Backed Security <br> (cost $13,941)** |  | **13860** |
| **Sovereign Bonds — 0.14%Δ** |  |  |
| &nbsp;&nbsp;Mexico — 0.07% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mexico Government International<br> Bond |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 4/27/51 | 500000 | 407546 |
|  |  | 407546 |
| &nbsp;&nbsp;Peru — 0.07% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Peruvian Government<br> International Bond<br> 3.00% 1/15/34 | 500000 | 395452 |
|  |  | 395452 |
| &nbsp;&nbsp;**Total Sovereign Bonds**<br> (cost $1,078,165) |  | **802998** |
| &nbsp;&nbsp;**US Treasury Obligations — 13.86%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Bonds |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.25% 2/15/52 | 2460000 | 1711622 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.375% 2/15/42 | 5290000 | 4041581 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.875% 5/15/52 | 450000 | 360703 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 2/15/49 | 1235000 | 1017717 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 11/15/52 | 470000 | 470808 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.375% 2/15/38 | 2755000 | 2886723 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.75% 2/15/37 | 1055000 | 1153371 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Floating Rate Note<br> 4.60% (USBMMY3M + 0.14%)<br> 10/31/24 • | 22510000 | 22486851 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Notes |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.125% 4/30/23 | 9410000 | 9280760 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.875% 4/30/29 | 2910000 | 2725795 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.875% 11/30/27 \* | 205000 | 203911 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.875% 11/30/29 | 35000 | 34773 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 12/15/25 | 340000 | 337875 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 10/31/29 | 370000 | 370202 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.125% 10/31/27 | 6555000 | 6579581 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.125% 11/15/32 | 2110000 | 2153684 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.25% 10/15/25 | 9725000 | 9718922 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.375% 10/31/24 | 10985000 | 10954534 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 11/15/25 | 1995000 | 2007313 |
| **Total US Treasury Obligations**<br> (cost $80,659,937) |  | **78496726** |

---

[**Table of Contents**](#toc1)

Consolidated schedules of investments

Delaware Ivy VIP Asset Strategy

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 56.65%** | | |
| &nbsp;&nbsp;Communication Services — 4.09% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Alphabet Class A † | 64229 | $5666925 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deutsche Telekom | 389356 | 7768060 |
| &nbsp;&nbsp;&nbsp;&nbsp;Frontier Communications Parent † | 94176 | 2399604 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tencent Holdings | 93300 | 3992364 |
| &nbsp;&nbsp;&nbsp;&nbsp;T-Mobile US † | 24046 | 3366440 |
|  |  | 23193393 |
| &nbsp;&nbsp;Consumer Discretionary — 7.42% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amazon.com † | 28020 | 2353680 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aptiv † | 50880 | 4738454 |
| &nbsp;&nbsp;&nbsp;&nbsp;Burlington Stores † | 20920 | 4241739 |
| &nbsp;&nbsp;&nbsp;&nbsp;Darden Restaurants | 45896 | 6348794 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ferrari | 18958 | 4062777 |
| &nbsp;&nbsp;&nbsp;&nbsp;H World Group ADR | 101313 | 4297698 |
| &nbsp;&nbsp;&nbsp;&nbsp;JD.com ADR | 76331 | 4284459 |
| &nbsp;&nbsp;&nbsp;&nbsp;LVMH Moet Hennessy Louis Vuitton | 4246 | 3090234 |
| &nbsp;&nbsp;&nbsp;&nbsp;Media Group Holdings Series H <br> <<, =, † | 31963 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Media Group Holdings Series T <br> <<, =, † | 4006 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Skechers USA Class A † | 117737 | 4939067 |
| &nbsp;&nbsp;&nbsp;&nbsp;Subaru | 239331 | 3697376 |
|  |  | 42054278 |
| &nbsp;&nbsp;Consumer Staples — 4.20% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asahi Group Holdings \* | 52100 | 1635171 |
| &nbsp;&nbsp;&nbsp;&nbsp;Casey's General Stores | 13923 | 3123625 |
| &nbsp;&nbsp;&nbsp;&nbsp;China Mengniu Dairy † | 1336313 | 6060571 |
| &nbsp;&nbsp;&nbsp;&nbsp;COTA Series B <<, =, † | 26 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Procter & Gamble | 44895 | 6804286 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reckitt Benckiser Group | 88528 | 6158272 |
|  |  | 23781925 |
| &nbsp;&nbsp;Energy — 3.84% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Canadian Natural Resources | 133282 | 7401149 |
| &nbsp;&nbsp;&nbsp;&nbsp;ConocoPhillips | 63277 | 7466686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Schlumberger | 30591 | 1635395 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shell | 90620 | 2568671 |
| &nbsp;&nbsp;&nbsp;&nbsp;TotalEnergies \* | 42618 | 2675639 |
|  |  | 21747540 |
| &nbsp;&nbsp;Financials — 7.39% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AGNC Investment | 430186 | 4452425 |
| &nbsp;&nbsp;&nbsp;&nbsp;BNP Paribas | 90528 | 5160229 |
| &nbsp;&nbsp;&nbsp;&nbsp;First Republic Bank | 36302 | 4424851 |
| &nbsp;&nbsp;&nbsp;&nbsp;ICICI Bank | 326459 | 3515363 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intercontinental Exchange | 34768 | 3566849 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley | 52640 | 4475453 |
| &nbsp;&nbsp;&nbsp;&nbsp;ORIX | 472697 | 7630361 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prudential | 349601 | 4765380 |
| &nbsp;&nbsp;&nbsp;&nbsp;State Bank of India | 522483 | 3875835 |
|  |  | 41866746 |
| &nbsp;&nbsp;Healthcare — 9.58% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Abbott Laboratories | 39329 | 4317931 |
| &nbsp;&nbsp;&nbsp;&nbsp;AstraZeneca | 39780 | 5394964 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bayer | 84466 | 4369384 |
| &nbsp;&nbsp;&nbsp;&nbsp;Eli Lilly & Co. | 12490 | 4569342 |
| &nbsp;&nbsp;&nbsp;&nbsp;Genmab † | 15800 | 6689094 |
| &nbsp;&nbsp;&nbsp;&nbsp;Regeneron Pharmaceuticals † | 8299 | 5987645 |
| &nbsp;&nbsp;&nbsp;&nbsp;Thermo Fisher Scientific | 6798 | 3743591 |
| &nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group | 15013 | 7959592 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals † | 20592 | 5946558 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zimmer Biomet Holdings | 41286 | 5263965 |
|  |  | 54242066 |
| &nbsp;&nbsp;Industrials — 6.62% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Airbus | 53081 | 6308218 |
| &nbsp;&nbsp;&nbsp;&nbsp;Generac Holdings † | 5183 | 521721 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ingersoll Rand | 80393 | 4200534 |
| &nbsp;&nbsp;&nbsp;&nbsp;Larsen & Toubro | 270951 | 6831253 |
| &nbsp;&nbsp;&nbsp;&nbsp;Raytheon Technologies | 64352 | 6494404 |
| &nbsp;&nbsp;&nbsp;&nbsp;Thales | 34306 | 4381037 |
| &nbsp;&nbsp;&nbsp;&nbsp;Union Pacific | 23778 | 4923711 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vinci | 38600 | 3854684 |
|  |  | 37515562 |
| &nbsp;&nbsp;Information Technology — 11.66% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ambarella † | 56930 | 4681354 |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple | 39925 | 5187455 |
| &nbsp;&nbsp;&nbsp;&nbsp;Autodesk † | 19028 | 3555762 |
| &nbsp;&nbsp;&nbsp;&nbsp;Check Point Software<br> Technologies † | 47018 | 5931791 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intuit | 14283 | 5559229 |
| &nbsp;&nbsp;&nbsp;&nbsp;KLA | 7435 | 2803218 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mastercard Class A | 21873 | 7605898 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microchip Technology | 43139 | 3030515 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microsoft | 34279 | 8220790 |
| &nbsp;&nbsp;&nbsp;&nbsp;NVIDIA | 21288 | 3111028 |
| &nbsp;&nbsp;&nbsp;&nbsp;PayPal Holdings † | 47705 | 3397550 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seagate Technology Holdings | 45380 | 2387442 |
| &nbsp;&nbsp;&nbsp;&nbsp;Taiwan Semiconductor<br> Manufacturing | 362450 | 5288960 |
| &nbsp;&nbsp;&nbsp;&nbsp;VeriSign † | 25618 | 5262962 |
|  |  | 66023954 |
| Materials — 0.50% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Barrick Gold | 164020 | 2817863 |
|  |  | 2817863 |
| Utilities — 1.35% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;NTPC | 1598277 | 3215680 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks (continued)** | | |
| &nbsp;&nbsp;Utilities (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;RWE | 99129 | $4413225 |
|  |  | 7628905 |
| &nbsp;&nbsp;**Total Common Stocks**<br> (cost $343,192,957) |  | **320872232** |
| &nbsp;&nbsp;**Exchange-Traded Funds — 2.80%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;iShares 0-5 Year High Yield<br> Corporate Bond ETF \* | 205191 | 8390260 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vanguard Russell 2000 ETF \* | 105746 | 7441346 |
| **Total Exchange-Traded Funds**<br> (cost $16,635,596) |  | **15831606** |
|  | **Troy<br> Ounces** |  |
| &nbsp;&nbsp;**Bullion — 4.66%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gold | 14463 | 26371837 |
| &nbsp;&nbsp;**Total Bullion**<br> (cost $17,562,017) |  | **26371837** |
|  | **Number of<br> shares** |  |
| &nbsp;&nbsp;**Short-Term Investments — 1.44%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 1.44% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven- day effective yield 4.03%) | 2033971 | 2033971 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.06%) | 2033971 | 2033971 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven- day effective yield 4.23%) | 2033971 | 2033971 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.11%) | 2033971 | 2033971 |
| &nbsp;&nbsp;**Total Short-Term Investments<br> (cost $8,135,884)** |  | **8135884** |
| &nbsp;&nbsp;**Total Value of Securities Before<br> Securities Lending Collateral—99.88%**<br> (cost $599,365,052) |  | **565680292** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 2.44%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 2.44% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference<br> Government Money Market<br> Fund - Institutional Shares<br> (seven-day effective yield<br> 4.31%) | 13818320 | 13818320 |
| **Total Securities Lending Collateral**<br> (cost $13,818,320) |  | **13818320** |
| **Total Value of <br> Securities—102.32%**<br> (cost $613,183,372) |  | $**579,498,612■** |

---

---

| | |
|:---|:---|
| ° | Principal amount shown is stated in USD unless noted that the security is denominated in another currency. |
| <sup>Σ</sup> | Interest only security. An interest only security is the interest only portion of a fixed income security, which is separated and sold individually from the principal portion of the security. |
| • | Variable rate investment. Rates reset periodically. Rate shown reflects the rate in effect at December 31, 2022. For securities based on a published reference rate and spread, the reference rate and spread are indicated in their descriptions. The reference rate descriptions (i.e. LIBOR03M, LIBOR06M, etc.) used in this report are identical for different securities, but the underlying reference rates may differ due to the timing of the reset period. Certain variable rate securities are not based on a published reference rate and spread but are determined by the issuer or agent and are based on current market conditions, or for mortgage-backed securities, are impacted by the individual mortgages which are paying off over time. These securities do not indicate a reference rate and spread in their descriptions. |
| # | Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. At December 31, 2022, the aggregate value of Rule 144A securities was $16,120,744, which represents 2.85% of the Portfolio's net assets. See Note 13 in "Notes to financial statements." |
| <sup>µ</sup> | Fixed to variable rate investment. The rate shown reflects the fixed rate in effect at December 31, 2022. Rate will reset at a future date. |
| <sup>Ψ</sup> | Perpetual security. Maturity date represents next call date. |
| \* | Fully or partially on loan. |
| <sup><<</sup> | Affiliated company. See Note 2 in "Notes to financial statements." |
| = | The value of this security was determined using significant unobservable inputs and is reported as a Level 3 security in the disclosure table located in Note 3 in "Notes to financial statements." |
| <sup>Δ</sup> | Securities have been classified by country of risk. |
| † | Non-income producing security. |
| <sup>\*\*</sup> | See Note 12 in "Notes to financial statements" for additional information on securities lending collateral. |

---

[**Table of Contents**](#toc1)

Consolidated schedules of investments

Delaware Ivy VIP Asset Strategy

&nbsp;&nbsp;&nbsp;&nbsp;■ Includes $17,116,801 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $3,833,114.

The following futures contracts were outstanding at December 31, 2022:<sup>1</sup>

**Futures Contracts Exchange-Traded**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Contracts to Buy (Sell) | Contracts to Buy (Sell) | Notional<br> Amount | Notional<br> Cost<br> (Proceeds) | Expiration<br> Date | Value/<br> Unrealized<br> Appreciation | Value/<br> Unrealized<br> Depreciation | Variation<br> Margin<br> Due from<br> (Due to)<br> Brokers |
| 22 | US Treasury 5 yr Notes | $2374453 | $2374322 | 3/31/23 | $131 | $— | $(1891) |
|  | US Treasury 10 yr |  |  |  |  |  |  |
| 165 | Notes | 18528985 | 18580939 | 3/22/23 |  | (51954) | (23202) |
|  | US Treasury Ultra |  |  |  |  |  |  |
| 7 | Bonds | 940188 | 938053 | 3/22/23 | 2135 |  | (3500) |
| Total Futures Contracts | Total Futures Contracts |  | $21893314 |  | $2266 | $(51954) | $(28593) |

---

The use of futures contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The notional amounts presented above represent the Portfolio's total exposure in such contracts, whereas only the variation margin is reflected in the Portfolio's net assets.

<sup>1</sup>See Note 10 in "Notes to financial statements."

**Summary of abbreviations:**

ADR – American Depositary Receipt

DAC – Designated Activity Company

ETF – Exchange-Traded Fund

FREMF – Freddie Mac Multifamily

GNMA – Government National Mortgage Association

ICE – Intercontinental Exchange, Inc.

LIBOR – London Interbank Offered Rate

LIBOR01M – ICE LIBOR USD 1 Month

LIBOR03M – ICE LIBOR USD 3 Month

LIBOR06M – ICE LIBOR USD 6 Month

S.F. – Single Family

TBA – To be announced

USBMMY3M – US Treasury 3 Month Bill Money Market Yield

USD – US Dollar

yr – Year

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP Balanced

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Agency Collateralized Mortgage Obligations — 0.47%** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae REMICs |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2016-36 VB 3.50%<br> 6/25/29 | 329519 | $317838 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2016-71 NB 3.00%<br> 10/25/46 | 439925 | 400478 |
| &nbsp;&nbsp;&nbsp;&nbsp;Freddie Mac REMICs |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 4616 HW 3.00%<br> 6/15/45 | 277203 | 258118 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vendee Mortgage Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 1997-1 3A 8.293%<br> 12/15/26 | 12139 | 12412 |
| &nbsp;&nbsp;**Total Agency Collateralized Mortgage Obligations**<br> (cost $1,100,063) |  | **988846** |
| **Agency Mortgage-Backed Securities — 8.43%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae S.F. 15 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 8/1/35 | 189692 | 174057 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae S.F. 20 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.00% 5/1/41 | 235949 | 200942 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 9/1/42 | 349553 | 331161 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae S.F. 30 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.00% 4/1/51 | 821102 | 670436 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 1/1/52 | 513697 | 435726 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 4/1/52 | 238364 | 202143 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 12/1/51 | 619872 | 547601 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 2/1/52 | 781027 | 685475 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 1/1/48 | 70412 | 65293 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 8/1/50 | 61000 | 56559 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 8/1/51 | 461115 | 419957 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 1/1/52 | 586878 | 534121 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 4/1/52 | 1138000 | 1044788 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 11/1/43 | 216049 | 213293 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 10/1/44 | 77021 | 75662 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 5/1/49 | 197000 | 192304 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 6/1/52 | 355950 | 351028 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 9/1/52 | 750857 | 740473 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 10/1/52 | 546037 | 547888 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 11/1/52 | 294297 | 297704 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 12/1/52 | 326386 | 327262 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.50% 10/1/28 | 23019 | 23571 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.50% 2/1/29 | 11509 | 11729 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.50% 2/1/32 | 85267 | 89299 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.00% 7/1/31 | 18934 | 19787 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.00% 9/1/31 | 34050 | 35071 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.00% 2/1/32 | 37439 | 38502 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.00% 3/1/32 | 17941 | 18804 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.00% 7/1/32 | 36465 | 37438 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.50% 4/1/31 | 10431 | 10581 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae S.F. 30 yr TBA <br> 5.50% 1/1/53 | 242000 | 242597 |
| &nbsp;&nbsp;&nbsp;&nbsp;Freddie Mac S.F. 15 yr<br> 2.00% 12/1/35 | 267239 | 239036 |
| &nbsp;&nbsp;&nbsp;&nbsp;Freddie Mac S.F. 20 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.00% 3/1/41 | 862653 | 734656 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 2/1/42 | 359540 | 312660 |
| &nbsp;&nbsp;&nbsp;&nbsp;Freddie Mac S.F. 30 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.00% 3/1/52 | 232029 | 188928 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 7/1/50 | 393426 | 337865 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 1/1/52 | 1469948 | 1250850 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 8/1/51 | 35971 | 31803 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 12/1/51 | 1029753 | 904738 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 2/1/52 | 1037327 | 910748 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 6/1/47 | 670085 | 621456 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 4/1/52 | 552029 | 504038 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 8/1/52 | 765136 | 721704 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 9/1/52 | 684951 | 659939 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 7/1/52 | 375553 | 370359 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 9/1/52 | 324768 | 328275 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 11/1/52 | 429088 | 430851 |
| &nbsp;&nbsp;&nbsp;&nbsp;GNMA II S.F. 30 yr |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 12/20/51 | 177652 | 158737 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 9/20/52 | 232430 | 230370 |
| &nbsp;&nbsp;**Total Agency Mortgage-Backed Securities**<br> (cost $19,069,726) |  | **17578265** |
| &nbsp;&nbsp;**Convertible Bonds — 0.05%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Liberty Broadband 144A 2.75%<br> exercise price $857.56,<br> maturity date 9/30/50 # | 4000 | 3906 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liberty Broadband 144A 1.25%<br> exercise price $900.01,<br> maturity date 9/30/50 # | 113000 | 109610 |
| **Total Convertible Bonds**<br> (cost $111,597) |  | **113516** |
| &nbsp;&nbsp;**Corporate Bonds — 11.27%** |  |  |
| &nbsp;&nbsp;Banking — 1.86% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of America |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.482% 9/21/36 µ | 400000 | 294823 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.676% 6/19/41 µ | 110000 | 74393 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.375% 1/27/27 µ, y | 45000 | 38224 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.204% 11/10/28 µ | 75000 | 77570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of New York Mellon 5.802% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10/25/28 µ | 36000 | 37291 |
| &nbsp;&nbsp;&nbsp;&nbsp;Citigroup |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.61% 9/29/26 µ | 40000 | 40213 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.25% 8/15/26 µ, y | 648000 | 630180 |
| &nbsp;&nbsp;&nbsp;&nbsp;Citizens Bank 6.064% 10/24/25 µ | 250000 | 252998 |

---

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Balanced

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** | | |
| &nbsp;&nbsp;Banking (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fifth Third Bancorp |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.337% 4/25/33 µ | 24000 | $21996 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.361% 10/27/28 µ | 16000 | 16491 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.542% 9/10/27 µ | 25000 | 21597 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.102% 2/24/33 µ | 375000 | 305468 |
| &nbsp;&nbsp;&nbsp;&nbsp;Huntington National Bank 4.552%<br> 5/17/28 µ | 250000 | 241610 |
| &nbsp;&nbsp;&nbsp;&nbsp;JPMorgan Chase & Co. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.953% 2/4/32 µ | 60000 | 46034 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.851% 7/25/28 µ | 140000 | 136700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 8/1/24 µ, y | 337000 | 308542 |
| &nbsp;&nbsp;&nbsp;&nbsp;KeyBank 5.85% 11/15/27 | 280000 | 289511 |
| &nbsp;&nbsp;&nbsp;&nbsp;KeyCorp 4.789% 6/1/33 \*, µ | 42000 | 39779 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.484% 9/16/36 µ | 120000 | 87287 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.138% 10/16/26 µ | 50000 | 51121 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.296% 10/18/28 µ | 65000 | 67215 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.342% 10/18/33 µ | 40000 | 42040 |
| &nbsp;&nbsp;&nbsp;&nbsp;PNC Financial Services Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.671% 10/28/25 µ | 75000 | 75852 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.20% 9/15/27 µ, y | 60000 | 58785 |
| &nbsp;&nbsp;&nbsp;&nbsp;State Street |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.203% 2/7/28 µ | 50000 | 44986 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.751% 11/4/26 µ | 15000 | 15371 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.82% 11/4/28 µ | 10000 | 10345 |
| &nbsp;&nbsp;&nbsp;&nbsp;SVB Financial Group 4.57%<br> 4/29/33 \*, µ | 70000 | 62125 |
| &nbsp;&nbsp;&nbsp;&nbsp;Toronto-Dominion Bank 4.108%<br> 6/8/27 \* | 75000 | 72620 |
| &nbsp;&nbsp;&nbsp;&nbsp;Truist Financial 6.123%<br> 10/28/33 \*, µ | 46000 | 48546 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Bancorp 5.727% 10/21/26 µ | 50000 | 50980 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo & Co. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.572% 2/11/31 µ | 290000 | 240771 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.808% 7/25/28 µ | 75000 | 73376 |
|  |  | 3874840 |
| &nbsp;&nbsp;Basic Industry — 0.15% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Celanese US Holdings 6.05%<br> 3/15/25 | 155000 | 154528 |
| &nbsp;&nbsp;&nbsp;&nbsp;Newmont 2.60% 7/15/32 \* | 25000 | 19971 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sherwin-Williams 3.30% 5/15/50 | 205000 | 141037 |
|  |  | 315536 |
| &nbsp;&nbsp;Brokerage — 0.52% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Blackstone Holdings Finance<br> 144A 2.00% 1/30/32 # | 325000 | 239544 |
| &nbsp;&nbsp;&nbsp;&nbsp;KKR Group Finance VIII 144A<br> 3.50% 8/25/50 # | 350000 | 235463 |
| &nbsp;&nbsp;&nbsp;&nbsp;LSEGA Financing 144A 2.50%<br> 4/6/31 #, \* | 350000 | 290749 |
| &nbsp;&nbsp;&nbsp;&nbsp;National Securities Clearing 144A<br> 1.50% 4/23/25 # | 350000 | 324735 |
|  |  | 1090491 |
| &nbsp;&nbsp;Capital Goods — 0.52% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Boeing |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.25% 2/1/28 | 25000 | 22747 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.75% 2/1/50 | 265000 | 183050 |
| &nbsp;&nbsp;&nbsp;&nbsp;Eaton 4.15% 3/15/33 | 230000 | 214539 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lockheed Martin |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.90% 6/15/32 | 215000 | 203251 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.15% 6/15/53 | 45000 | 38422 |
| &nbsp;&nbsp;&nbsp;&nbsp;Raytheon Technologies 2.25%<br> 7/1/30 | 300000 | 250343 |
| &nbsp;&nbsp;&nbsp;&nbsp;Standard Industries 144A 4.375%<br> 7/15/30 # | 219000 | 178925 |
|  |  | 1091277 |
| &nbsp;&nbsp;Communications — 1.69% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AT&T 3.50% 9/15/53 | 520000 | 353306 |
| &nbsp;&nbsp;&nbsp;&nbsp;CCO Holdings 144A 4.25%<br> 1/15/34 # | 470000 | 347800 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charter Communications<br> Operating 3.85% 4/1/61 | 315000 | 183293 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comcast |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;3.45% 2/1/50 | 675000 | 492742 |
| &nbsp;&nbsp;&nbsp;&nbsp;4.25% 10/15/30 | 450000 | 431667 |
| &nbsp;&nbsp;&nbsp;&nbsp;Crown Castle |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;1.05% 7/15/26 | 110000 | 95175 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.10% 4/1/31 | 210000 | 166016 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sprint 7.875% 9/15/23 | 315000 | 320098 |
| &nbsp;&nbsp;&nbsp;&nbsp;T-Mobile USA 3.875% 4/15/30 | 290000 | 263366 |
| &nbsp;&nbsp;&nbsp;&nbsp;Verizon Communications |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;2.875% 11/20/50 | 50000 | 31563 |
| &nbsp;&nbsp;&nbsp;&nbsp;4.50% 8/10/33 | 500000 | 469457 |
| &nbsp;&nbsp;&nbsp;&nbsp;Walt Disney 2.75% 9/1/49 | 500000 | 333001 |
| &nbsp;&nbsp;&nbsp;&nbsp;Warnermedia Holdings 144A<br> 5.141% 3/15/52 # | 65000 | 47504 |
|  |  | 3534988 |
| &nbsp;&nbsp;Consumer Cyclical — 0.64% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amazon.com |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;2.50% 6/3/50 | 80000 | 50783 |
| &nbsp;&nbsp;&nbsp;&nbsp;3.60% 4/13/32 | 65000 | 59675 |
| &nbsp;&nbsp;&nbsp;&nbsp;Carnival 144A 4.00% 8/1/28 # | 105000 | 85823 |
| &nbsp;&nbsp;&nbsp;&nbsp;General Motors Financial 3.70%<br> 5/9/23 | 150000 | 149279 |
| &nbsp;&nbsp;&nbsp;&nbsp;Home Depot 3.35% 4/15/50 | 700000 | 517259 |
| &nbsp;&nbsp;&nbsp;&nbsp;PVH 4.625% 7/10/25 | 350000 | 338293 |
| &nbsp;&nbsp;&nbsp;&nbsp;VICI Properties 4.95% 2/15/30 \* | 140000 | 133457 |
|  |  | 1334569 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| **Corporate Bonds (continued)** | | |
| &nbsp;&nbsp;Consumer Non-Cyclical — 1.09% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Coca-Cola 2.25% 1/5/32 \* | 600000 | $504936 |
| &nbsp;&nbsp;&nbsp;&nbsp;CVS Health |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.78% 3/25/38 | 125000 | 114365 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.05% 3/25/48 | 180000 | 162474 |
| &nbsp;&nbsp;&nbsp;&nbsp;JBS USA LUX 144A 3.00%<br> 2/2/29 # | 80000 | 66385 |
| &nbsp;&nbsp;&nbsp;&nbsp;Johnson & Johnson 3.40%<br> 1/15/38 | 1000000 | 852780 |
| &nbsp;&nbsp;&nbsp;&nbsp;Merck & Co. 2.75% 12/10/51 | 250000 | 168258 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nestle Holdings 144A 4.00%<br> 9/24/48 # | 380000 | 321876 |
| &nbsp;&nbsp;&nbsp;&nbsp;Royalty Pharma 3.55% 9/2/50 | 79000 | 50796 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zoetis 5.40% 11/14/25 \* | 25000 | 25527 |
|  |  | 2267397 |
| &nbsp;&nbsp;Electric — 1.19% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Appalachian Power 4.50% 8/1/32 | 280000 | 261900 |
| &nbsp;&nbsp;&nbsp;&nbsp;Berkshire Hathaway Energy <br> 2.85% 5/15/51 | 260000 | 171420 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commonwealth Edison 2.20%<br> 3/1/30 | 350000 | 294210 |
| &nbsp;&nbsp;&nbsp;&nbsp;Duke Energy Carolinas 3.95%<br> 11/15/28 | 275000 | 264426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Entergy |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;2.80% 6/15/30 | 235000 | 199032 |
| &nbsp;&nbsp;&nbsp;&nbsp;3.75% 6/15/50 | 125000 | 92618 |
| &nbsp;&nbsp;&nbsp;&nbsp;Florida Power & Light 3.15%<br> 10/1/49 | 425000 | 308191 |
| &nbsp;&nbsp;&nbsp;&nbsp;Indianapolis Power & Light 144A <br> 5.65% 12/1/32 # | 65000 | 66870 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nevada Power 5.90% 5/1/53 | 100000 | 107223 |
| &nbsp;&nbsp;&nbsp;&nbsp;NextEra Energy Capital Holdings <br> 3.00% 1/15/52 | 65000 | 42731 |
| &nbsp;&nbsp;&nbsp;&nbsp;Oglethorpe Power 5.05% 10/1/48 | 185000 | 159061 |
| &nbsp;&nbsp;&nbsp;&nbsp;Oncor Electric Delivery 2.75%<br> 5/15/30 | 450000 | 392958 |
| &nbsp;&nbsp;&nbsp;&nbsp;PacifiCorp 5.35% 12/1/53 | 35000 | 34857 |
| &nbsp;&nbsp;&nbsp;&nbsp;Southern 5.70% 10/15/32 | 75000 | 76952 |
|  |  | 2472449 |
| Energy — 0.50% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BP Capital Markets America |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;2.721% 1/12/32 | 80000 | 66893 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cheniere Energy Partners 3.25%<br> 1/31/32 | 120000 | 95527 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diamondback Energy 4.25%<br> 3/15/52 | 15000 | 11041 |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy Transfer 5.75% 2/15/33 | 35000 | 34310 |
| &nbsp;&nbsp;&nbsp;&nbsp;EQT 6.125% 2/1/25 | 500000 | 501990 |
| &nbsp;&nbsp;&nbsp;&nbsp;Targa Resources Partners 5.00%<br> 1/15/28 | 170000 | 162450 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valero Energy 3.65% 12/1/51 | 245000 | 174091 |
|  |  | 1046302 |
| Finance Companies — 0.28% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AerCap Ireland Capital DAC <br> 6.50% 7/15/25 \* | 250000 | 253556 |
| &nbsp;&nbsp;&nbsp;&nbsp;Air Lease |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;2.875% 1/15/32 \* | 160000 | 127515 |
| &nbsp;&nbsp;&nbsp;&nbsp;5.85% 12/15/27 | 45000 | 45029 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aviation Capital Group 144A <br> 3.50% 11/1/27 # | 190000 | 166252 |
|  |  | 592352 |
| &nbsp;&nbsp;Insurance — 0.57% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Aon 5.00% 9/12/32 | 245000 | 243040 |
| &nbsp;&nbsp;&nbsp;&nbsp;Athene Holding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.45% 5/15/52 | 150000 | 92655 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.95% 5/25/51 | 65000 | 44122 |
| &nbsp;&nbsp;&nbsp;&nbsp;Berkshire Hathaway Finance<br> 3.85% 3/15/52 | 210000 | 168497 |
| &nbsp;&nbsp;&nbsp;&nbsp;Humana |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.75% 3/1/28 | 46000 | 47053 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.875% 3/1/33 | 20000 | 20711 |
| &nbsp;&nbsp;&nbsp;&nbsp;Northwestern Mutual Life <br> Insurance 144A 3.85%<br> 9/30/47 # | 500000 | 383791 |
| &nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group 3.05%<br> 5/15/41 | 250000 | 188887 |
|  |  | 1188756 |
| &nbsp;&nbsp;Natural Gas — 0.11% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Atmos Energy |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.85% 2/15/52 | 55000 | 35844 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.75% 10/15/52 | 105000 | 110264 |
| &nbsp;&nbsp;&nbsp;&nbsp;Southern Co. Gas Capital 5.15%<br> 9/15/32 \* | 91000 | 89591 |
|  |  | 235699 |
| &nbsp;&nbsp;Real Estate Investment Trusts — 0.29% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Homes 4 Rent 3.625%<br> 4/15/32 | 35000 | 29535 |
| &nbsp;&nbsp;&nbsp;&nbsp;Digital Realty Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.45% 7/15/28 | 45000 | 42689 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.55% 1/15/28 | 80000 | 80673 |
| &nbsp;&nbsp;&nbsp;&nbsp;Extra Space Storage 2.35%<br> 3/15/32 | 600000 | 455529 |
|  |  | 608426 |
| &nbsp;&nbsp;Technology — 1.67% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.65% 5/11/50 | 175000 | 116613 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.95% 9/11/49 | 500000 | 356422 |

---

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Balanced

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** |  |  |
| &nbsp;&nbsp;Technology (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Autodesk |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.40% 12/15/31 \* | 60000 | $48085 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.85% 1/15/30 | 500000 | 431013 |
| &nbsp;&nbsp;&nbsp;&nbsp;CDW 3.276% 12/1/28 | 35000 | 30031 |
| &nbsp;&nbsp;&nbsp;&nbsp;Entegris Escrow 144A 4.75%<br> 4/15/29 # | 55000 | 50267 |
| &nbsp;&nbsp;&nbsp;&nbsp;Infor 144A 1.75% 7/15/25 # | 125000 | 113051 |
| &nbsp;&nbsp;&nbsp;&nbsp;Iron Mountain 144A 5.25%<br> 7/15/30 # | 54000 | 47048 |
| &nbsp;&nbsp;&nbsp;&nbsp;Iron Mountain Information |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Management Services 144A<br> 5.00% 7/15/32 # | 165000 | 137304 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microsoft 3.45% 8/8/36 | 365000 | 324332 |
| &nbsp;&nbsp;&nbsp;&nbsp;Oracle |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;5.80% 11/10/25 \* | 15000 | 15352 |
| &nbsp;&nbsp;&nbsp;&nbsp;6.15% 11/9/29 | 35000 | 36412 |
| &nbsp;&nbsp;&nbsp;&nbsp;PayPal Holdings 3.90% 6/1/27 | 15000 | 14458 |
| &nbsp;&nbsp;&nbsp;&nbsp;ServiceNow 1.40% 9/1/30 | 435000 | 333762 |
| &nbsp;&nbsp;&nbsp;&nbsp;Thomson Reuters 3.35% 5/15/26 | 425000 | 402577 |
| &nbsp;&nbsp;&nbsp;&nbsp;TSMC Global 144A 1.75%<br> 4/23/28 # | 600000 | 508429 |
| &nbsp;&nbsp;&nbsp;&nbsp;Visa 2.70% 4/15/40 | 440000 | 335120 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workday |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 4/1/27 | 10000 | 9361 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.70% 4/1/29 | 15000 | 13793 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.80% 4/1/32 | 175000 | 154968 |
|  |  | 3478398 |
| &nbsp;&nbsp;Transportation — 0.19% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Burlington Northern Santa Fe |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.875% 6/15/52 | 50000 | 33575 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.45% 1/15/53 | 55000 | 49175 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kansas City Southern 2.875%<br> 11/15/29 | 350000 | 303112 |
|  |  | 385862 |
| **Total Corporate Bonds**<br> (cost $27,591,298) |  | **23517342** |
| **Non-Agency Commercial Mortgage-Backed Securities — 2.87%** |  |  |
| BANK |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2021-BN32 A5 2.643%<br> 4/15/54 | 730000 | 609008 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2021-BN36 A5 2.47%<br> 9/15/64 | 860000 | 701031 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-BNK39 A4<br> 2.928% 2/15/55 | 862000 | 727360 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-BNK39 B 3.239%<br> 2/15/55 • | 100000 | 74422 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-BNK39 C 3.27%<br> 2/15/55 • | 45000 | 30667 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BANK |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-BNK40 A4<br> 3.394% 3/15/64 • | 850000 | 746924 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-BNK40 B 3.394%<br> 3/15/64 • | 100000 | 75732 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Benchmark Mortgage Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-B32 A5 3.002%<br> 1/15/55 • | 1000000 | 845258 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-B32 B 3.202%<br> 1/15/55 • | 100000 | 72821 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-B32 C 3.454%<br> 1/15/55 • | 125000 | 85049 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-B33 A5 3.458%<br> 3/15/55 | 900000 | 796277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-B33 B 3.615%<br> 3/15/55 • | 50000 | 38754 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-B33 C 3.615%<br> 3/15/55 • | 50000 | 36046 |
| &nbsp;&nbsp;&nbsp;&nbsp;BMO Mortgage Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-C1 A5 3.374%<br> 2/17/55 • | 500000 | 433846 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo Commercial |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage Trust<br> Series 2021-C61 A4 2.658%<br> 11/15/54 | 865000 | 703968 |
| &nbsp;&nbsp;**Total Non-Agency Commercial Mortgage-<br> Backed Securities**<br> (cost $7,261,705) |  | **5977163** |
| &nbsp;&nbsp;**US Treasury Obligations — 16.03%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Bonds |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.375% 2/15/42 | 1470000 | 1123086 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.875% 5/15/52 | 75000 | 60117 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 8/15/52 | 835000 | 688223 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 11/15/52 | 775000 | 776332 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Floating Rate Note |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;4.60% (USBMMY3M + 0.14%)<br> 10/31/24 • | 1270000 | 1268694 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Notes |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.125% 4/30/23 | 9955400 | 9818670 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.125% 12/15/23 \* | 3195000 | 3060727 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.375% 4/15/24 | 4885000 | 4623195 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.50% 11/30/24 | 1700000 | 1608957 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.75% 8/15/32 | 825000 | 751395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.875% 11/30/27 \* | 360000 | 358087 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.875% 11/30/29 | 10000 | 9935 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.125% 10/31/27 | 875000 | 878281 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.125% 11/15/32 | 1765000 | 1801541 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.25% 10/15/25 | 5140000 | 5136787 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.375% 10/31/24 | 1140000 | 1136838 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**US Treasury Obligations (continued)** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Notes<br> 4.50% 11/30/24 \* | 340000 | $340040 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total US Treasury Obligations**<br> (cost $34,256,349) |  | **33440905** |
|  | **Number of<br> shares** |  |
| &nbsp;&nbsp;**Common Stocks — 55.43%** |  |  |
| &nbsp;&nbsp;Communications — 2.73% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Alphabet Class A † | 22921 | 2022320 |
| &nbsp;&nbsp;&nbsp;&nbsp;Alphabet Class C † | 19477 | 1728194 |
| &nbsp;&nbsp;&nbsp;&nbsp;Take-Two Interactive Software † | 18735 | 1950876 |
|  |  | 5701390 |
| Consumer Discretionary — 3.63% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amazon.com † | 25227 | 2119068 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aptiv † | 27101 | 2523916 |
| &nbsp;&nbsp;&nbsp;&nbsp;AutoZone † | 1189 | 2932288 |
|  |  | 7575272 |
| Consumer Staples — 2.40% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Costco Wholesale | 4452 | 2032338 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sysco | 38967 | 2979027 |
|  |  | 5011365 |
| Energy — 2.20% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ConocoPhillips | 25460 | 3004280 |
| &nbsp;&nbsp;&nbsp;&nbsp;Schlumberger | 29488 | 1576428 |
|  |  | 4580708 |
| Financials — 10.39% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Express | 10042 | 1483706 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aon Class A | 5939 | 1782531 |
| &nbsp;&nbsp;&nbsp;&nbsp;Artisan Partners Asset<br> Management Class A | 43937 | 1304929 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of America | 40772 | 1350369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Blackstone | 23154 | 1717795 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charles Schwab | 31009 | 2581809 |
| &nbsp;&nbsp;&nbsp;&nbsp;CME Group | 7453 | 1253297 |
| &nbsp;&nbsp;&nbsp;&nbsp;Discover Financial Services | 4833 | 472812 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intercontinental Exchange | 10897 | 1117923 |
| &nbsp;&nbsp;&nbsp;&nbsp;KKR & Co. | 46597 | 2163033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley | 33872 | 2879797 |
| &nbsp;&nbsp;&nbsp;&nbsp;Progressive | 27457 | 3561448 |
|  |  | 21669449 |
| Healthcare — 8.81% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Danaher | 11117 | 2950674 |
| &nbsp;&nbsp;&nbsp;&nbsp;Eli Lilly & Co. | 4077 | 1491530 |
| &nbsp;&nbsp;&nbsp;&nbsp;HCA Healthcare | 13134 | 3151634 |
| &nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group | 12822 | 6797968 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals † | 5308 | 1532844 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zoetis | 16774 | 2458230 |
|  |  | 18382880 |
| Industrials — 7.27% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Airbus ADR | 97297 | 2885829 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deere & Co. | 6166 | 2643734 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equifax | 12016 | 2335430 |
| &nbsp;&nbsp;&nbsp;&nbsp;Raytheon Technologies | 15701 | 1584545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Union Pacific | 8430 | 1745600 |
| &nbsp;&nbsp;&nbsp;&nbsp;United Rentals † | 11181 | 3973951 |
|  |  | 15169089 |
| Information Technology — 13.35% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple | 26378 | 3427293 |
| &nbsp;&nbsp;&nbsp;&nbsp;Applied Materials | 22342 | 2175664 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intuit | 5089 | 1980741 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mastercard Class A | 5986 | 2081512 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microchip Technology | 44276 | 3110389 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microsoft | 38016 | 9116997 |
| &nbsp;&nbsp;&nbsp;&nbsp;TE Connectivity | 27260 | 3129448 |
| &nbsp;&nbsp;&nbsp;&nbsp;VeriSign † | 11885 | 2441654 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zebra Technologies Class A † | 1543 | 395641 |
|  |  | 27859339 |
| Materials — 2.74% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Linde | 10505 | 3426521 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sherwin-Williams | 9654 | 2291184 |
|  |  | 5717705 |
| Utilities — 1.91% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;NextEra Energy | 47565 | 3976434 |
|  |  | 3976434 |
| **Total Common Stocks**<br> (cost $123,418,192) |  | **115643631** |
| **Exchange-Traded Funds — 3.03%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;iShares 0-5 Year Investment<br> Grade Corporate Bond ETF\* | 45886 | 2196104 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vanguard Russell 2000 ETF\* | 58566 | 4121290 |
| **Total Exchange-Traded Funds**<br> (cost $6,693,006) |  | **6317394** |
| **Short-Term Investments — 2.55%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 2.55% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund –<br> Institutional Shares (seven-day<br> effective yield 4.03%) | 1332244 | 1332244 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money<br> Market Government Portfolio –<br> Class I (seven-day effective<br> yield 4.06%) | 1332244 | 1332244 |

---

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Balanced

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Short-Term Investments (continued)** | | |
| &nbsp;&nbsp;Money Market Mutual Funds (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square<br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 1332244 | $1332244 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional<br> Liquidity Funds Government<br> Portfolio – Institutional Class<br> (seven-day effective yield 4.11%) | 1332244 | 1332244 |
| &nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $5,328,976) |  | **5328976** |
| &nbsp;&nbsp;**Total Value of Securities Before<br> Securities Lending Collateral—100.13%**<br> (cost $224,830,912) |  | **208906038** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 0.72%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 0.72% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference<br> Government Money Market<br> Fund - Institutional Shares<br> (seven-day effective yield<br> 4.31%) | 1496265 | 1496265 |
| &nbsp;&nbsp;**Total Securities Lending Collateral**<br> (cost $1,496,265) |  | **1496265** |
| &nbsp;&nbsp;**Total Value of Securities—100.85%**<br> (cost $226,327,177) |  | $**210,402,303■** |

---

---

| | |
|:---|:---|
| <sup>°</sup> | Principal amount shown is stated in USD unless noted that the security is denominated in another currency. |
| <sup>#</sup> | Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. At December 31, 2022, the aggregate value of Rule 144A securities was $3,725,332, which represents 1.79% of the Portfolio's net assets. See Note 13 in "Notes to financial statements." |
| <sup>µ</sup> | Fixed to variable rate investment. The rate shown reflects the fixed rate in effect at December 31, 2022. Rate will reset at a future date. |
| <sup>Ψ</sup> | Perpetual security. Maturity date represents next call date. |
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>•</sup> | Variable rate investment. Rates reset periodically. Rate shown reflects the rate in effect at December 31, 2022. For securities based on a published reference rate and spread, the reference rate and spread are indicated in their descriptions. The reference rate descriptions (i.e. LIBOR03M, LIBOR06M, etc.) used in this report are identical for different securities, but the underlying reference rates may differ due to the timing of the reset period. Certain variable rate securities are not based on a published reference rate and spread but are determined by the issuer or agent and are based on current market conditions, or for mortgage-backed securities, are impacted by the individual mortgages which are paying off over time. These securities do not indicate a reference rate and spread in their descriptions. |
| <sup>†</sup> | Non-income producing security. |
| <sup>\*\*</sup> | See Note 12 in "Notes to financial statements" for additional information on securities lending collateral. |
| ■ | Includes $6,998,190 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $5,675,598. |

---

[**Table of Contents**](#toc1)

The following futures contracts were outstanding at December 31, 2022:<sup>1</sup>

**Futures Contracts Exchange-Traded**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Contracts to Buy (Sell) | Contracts to Buy (Sell) | Notional<br> Amount | Notional<br> Cost<br> (Proceeds) | Expiration<br> Date | Value/<br> Unrealized<br> Appreciation | Value/<br> Unrealized<br> Depreciation | Variation<br> Margin<br> Due from<br> (Due to)<br> Brokers |
| 57 | US Treasury 5 yr Notes | $6151992 | $6151652 | 3/31/23 | $340 | $— | $(4899) |
|  | US Treasury 10 yr |  |  |  |  |  |  |
| 10 | Notes | 1122968 | 1126117 | 3/22/23 |  | (3149) | (1406) |
|  | US Treasury Ultra |  |  |  |  |  |  |
| 3 | Bonds | 402938 | 402023 | 3/22/23 | 915 |  | (1500) |
|  | US Treasury 10 yr Ultra |  |  |  |  |  |  |
| (18) | Notes | (2129062) | (2131971) | 3/22/23 | 2909 |  | 1125 |
| Total Futures Contracts | Total Futures Contracts |  | $5547821 |  | $4164 | $(3149) | $(6680) |

---

The use of futures contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The notional amounts presented above represent the Portfolio's total exposure in such contracts, whereas only the variation margin is reflected in the Portfolio's net assets.

<sup>1</sup>See Note 10 in "Notes to financial statements."

**Summary of abbreviations:**

ADR – American Depositary Receipt

DAC – Designated Activity Company

ETF – Exchange-Traded Fund

GNMA – Government National Mortgage Association

ICE – Intercontinental Exchange, Inc.

LIBOR – London Interbank Offered Rate

LIBOR03M – ICE LIBOR USD 3 Month

LIBOR06M – ICE LIBOR USD 6 Month

S.F. – Single Family

TBA – To be announced

USBMMY3M – US Treasury 3 Month Bill Money Market Yield

USD – US Dollar

yr – Year

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Energy

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 95.23% ♦** |  |  |
| &nbsp;&nbsp;Consumer Discretionary — 0.49% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Spruce Power Holding † | 654518 | $601568 |
|  |  | 601568 |
| &nbsp;&nbsp;Consumer Staples — 2.12% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Darling Ingredients † | 42109 | 2635602 |
|  |  | 2635602 |
| &nbsp;&nbsp;Energy — 88.87% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Chesapeake Energy \* | 73721 | 6957051 |
| &nbsp;&nbsp;&nbsp;&nbsp;Chord Energy | 54780 | 7494452 |
| &nbsp;&nbsp;&nbsp;&nbsp;ConocoPhillips | 65272 | 7702096 |
| &nbsp;&nbsp;&nbsp;&nbsp;Coterra Energy | 94889 | 2331423 |
| &nbsp;&nbsp;&nbsp;&nbsp;Denbury † | 87768 | 7637571 |
| &nbsp;&nbsp;&nbsp;&nbsp;Devon Energy | 83100 | 5111481 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diamondback Energy | 9273 | 1268361 |
| &nbsp;&nbsp;&nbsp;&nbsp;Enterprise Products Partners | 54728 | 1320039 |
| &nbsp;&nbsp;&nbsp;&nbsp;EOG Resources | 58811 | 7617201 |
| &nbsp;&nbsp;&nbsp;&nbsp;EQT | 98837 | 3343656 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equinor | 56887 | 2042794 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equitrans Midstream | 189063 | 1266722 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kimbell Royalty Partners | 249715 | 4170240 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marathon Petroleum | 36799 | 4283036 |
| &nbsp;&nbsp;&nbsp;&nbsp;Occidental Petroleum | 86535 | 5450840 |
| &nbsp;&nbsp;&nbsp;&nbsp;Parex Resources | 251182 | 3738048 |
| &nbsp;&nbsp;&nbsp;&nbsp;Peabody Energy \*, † | 57559 | 1520709 |
| &nbsp;&nbsp;&nbsp;&nbsp;Schlumberger | 116132 | 6208417 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shell | 304420 | 8560344 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sunrun † | 71470 | 1716709 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tourmaline Oil | 113176 | 5710623 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unit † | 70714 | 4091512 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valaris † | 77322 | 5228514 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valero Energy | 43030 | 5458786 |
|  |  | 110230625 |
| &nbsp;&nbsp;Financials — 0.50% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rice Acquisition Class A † | 61237 | 622780 |
|  |  | 622780 |
| &nbsp;&nbsp;Industrials — 3.25% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Generac Holdings † | 13597 | 1368674 |
| &nbsp;&nbsp;&nbsp;&nbsp;Li-Cycle Holdings \*, † | 263337 | 1253484 |
| &nbsp;&nbsp;&nbsp;&nbsp;NuScale Power \*, † | 137360 | 1409314 |
|  |  | 4031472 |
| &nbsp;&nbsp;**Total Common Stocks**<br> (cost $110,587,026) |  | **118122047** |
| &nbsp;&nbsp;**Master Limited Partnerships — 2.02%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Black Stone Minerals | 148782 | 2509952 |
| &nbsp;&nbsp;**Total Master Limited Partnerships**<br> (cost $2,060,899) |  | **2509952** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Short-Term Investments — 2.71%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 2.71% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day <br> effective yield 4.03%) | 839717 | 839717 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio – <br> Class I (seven-day effective <br> yield 4.06%) | 839717 | 839717 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square<br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 839717 | 839717 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 839717 | 839717 |
| &nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $3,358,868) |  | **3358868** |
| &nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral—99.96%**<br> (cost $116,006,793) |  | **123990867** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 1.86%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 1.86% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference <br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 2302463 | 2302463 |
| &nbsp;&nbsp;**Total Securities Lending Collateral**<br> (cost $2,302,463) |  | **2302463** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—101.82%**<br> (cost $118,309,256) |  | **$126,293,330■** |

---

---

| | |
|:---|:---|
| ♦ | Narrow industries are utilized for compliance purposes for concentration whereas broad sectors are used for financial reporting. |
| † | Non-income producing security. |
| \* | Fully or partially on loan. |
| <sup>\*\*</sup> | See Note 12 in "Notes to financial statements" for additional information on securities lending collateral. |
| **■** | Includes $10,672,836 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $8,696,894. |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP Growth

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 99.61% ♦** |  |  |
| &nbsp;&nbsp;Communication Services — 8.98% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Alphabet Class A † | 362636 | $31995374 |
| &nbsp;&nbsp;&nbsp;&nbsp;Alphabet Class C † | 55850 | 4955571 |
| &nbsp;&nbsp;&nbsp;&nbsp;Electronic Arts | 158952 | 19420755 |
|  |  | 56371700 |
| &nbsp;&nbsp;Consumer Discretionary — 12.92% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amazon.com † | 353473 | 29691732 |
| &nbsp;&nbsp;&nbsp;&nbsp;Booking Holdings † | 3850 | 7758828 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ferrari \* | 63024 | 13501001 |
| &nbsp;&nbsp;&nbsp;&nbsp;Home Depot | 26372 | 8329860 |
| &nbsp;&nbsp;&nbsp;&nbsp;LVMH Moet Hennessy Louis<br> Vuitton ADR | 69320 | 10042388 |
| &nbsp;&nbsp;&nbsp;&nbsp;NIKE Class B | 101255 | 11847848 |
|  |  | 81171657 |
| &nbsp;&nbsp;Consumer Staples — 3.62% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Coca-Cola | 333584 | 21219278 |
| &nbsp;&nbsp;&nbsp;&nbsp;Estee Lauder Class A | 6186 | 1534809 |
|  |  | 22754087 |
| &nbsp;&nbsp;Financials — 4.87% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Intercontinental Exchange | 144060 | 14779116 |
| &nbsp;&nbsp;&nbsp;&nbsp;S&P Global | 47261 | 15829599 |
|  |  | 30608715 |
| &nbsp;&nbsp;Healthcare — 10.73% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cooper | 38380 | 12691114 |
| &nbsp;&nbsp;&nbsp;&nbsp;Danaher | 36497 | 9687034 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intuitive Surgical † | 35759 | 9488651 |
| &nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group | 50587 | 26820216 |
| &nbsp;&nbsp;&nbsp;&nbsp;Veeva Systems Class A † | 15053 | 2429253 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zoetis | 42911 | 6288607 |
|  |  | 67404875 |
| &nbsp;&nbsp;Industrials — 10.30% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;CoStar Group † | 345916 | 26732389 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equifax | 18508 | 3597215 |
| &nbsp;&nbsp;&nbsp;&nbsp;JB Hunt Transport Services | 68458 | 11936337 |
| &nbsp;&nbsp;&nbsp;&nbsp;TransUnion | 209139 | 11868638 |
| &nbsp;&nbsp;&nbsp;&nbsp;Union Pacific | 24645 | 5103240 |
| &nbsp;&nbsp;&nbsp;&nbsp;Verisk Analytics | 30846 | 5441851 |
|  |  | 64679670 |
| &nbsp;&nbsp;Information Technology — 48.19% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adobe † | 35769 | 12037341 |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple | 383779 | 49864405 |
| &nbsp;&nbsp;&nbsp;&nbsp;Autodesk † | 40972 | 7656438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Broadridge Financial Solutions | 87192 | 11695063 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intuit | 37676 | 14664253 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microsoft | 325420 | 78042224 |
| &nbsp;&nbsp;&nbsp;&nbsp;Motorola Solutions | 119427 | 30777532 |
| &nbsp;&nbsp;&nbsp;&nbsp;NVIDIA | 115156 | 16828898 |
| &nbsp;&nbsp;&nbsp;&nbsp;PayPal Holdings † | 81586 | 5810555 |
| &nbsp;&nbsp;&nbsp;&nbsp;Salesforce † | 60577 | 8031904 |
| &nbsp;&nbsp;&nbsp;&nbsp;VeriSign † | 146520 | 30101069 |
| &nbsp;&nbsp;&nbsp;&nbsp;Visa Class A \* | 179272 | 37245551 |
|  |  | 302755233 |
| &nbsp;&nbsp;**Total Common Stocks**<br> (cost $492,560,530) |  | **625745937** |
| &nbsp;&nbsp;**Short-Term Investments — 0.34%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 0.34% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund –<br> Institutional Shares (seven-day <br> effective yield 4.03%) | 537483 | 537483 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio – <br> Class I (seven-day effective <br> yield 4.06%) | 537483 | 537483 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 537483 | 537483 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 537483 | 537483 |
| &nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $2,149,932) |  | **2149932** |
| &nbsp;&nbsp;**Total Value of Securities—99.95%**<br> (cost $494,710,462) |  | **$627,895,869■** |

---

---

| | |
|:---|:---|
| ♦ | Narrow industries are utilized for compliance purposes for concentration whereas broad sectors are used for financial reporting. |
| † | Non-income producing security. |
| \* | Fully or partially on loan. |
| **■** | Includes $40,780,181 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $41,710,267. |

---

**Summary of abbreviations:**

ADR – American Depositary Receipt

S&P – Standard & Poor's Financial Services LLC

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP High Income

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Convertible Bonds — 1.14%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;New Cotai 5.00% exercise price<br> $100.00, maturity date<br> 2/2/27 = | 3298686 | $7605540 |
| &nbsp;&nbsp;&nbsp;&nbsp;Spirit Airlines 1.00% exercise<br> price $49.07, maturity date<br> 5/15/26 | 1186000 | 960660 |
| &nbsp;&nbsp;**Total Convertible Bonds**<br> (cost $4,249,792) |  | **8566200** |
| &nbsp;&nbsp;**Corporate Bonds — 70.32%** |  |  |
| &nbsp;&nbsp;Automotive — 0.77% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ford Motor 4.75% 1/15/43 | 2660000 | 1915327 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodyear Tire & Rubber 5.25%<br> 7/15/31 | 4740000 | 3883198 |
|  |  | 5798525 |
| &nbsp;&nbsp;Banking — 0.43% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deutsche Bank 6.00%<br> 10/30/25 µ, ψ | 3800000 | 3241672 |
|  |  | 3241672 |
| &nbsp;&nbsp;Basic Industry — 2.92% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cerdia Finanz 144A 10.50%<br> 2/15/27 # | 3160000 | 2651364 |
| &nbsp;&nbsp;&nbsp;&nbsp;Chemours 144A 5.75%<br> 11/15/28 # | 4550000 | 4093180 |
| &nbsp;&nbsp;&nbsp;&nbsp;First Quantum Minerals 144A<br> 6.875% 10/15/27 # | 1941000 | 1825090 |
| &nbsp;&nbsp;&nbsp;&nbsp;FMG Resources August 2006 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.875% 4/15/30 # | 3340000 | 3116128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.125% 4/15/32 # | 1505000 | 1405738 |
| &nbsp;&nbsp;&nbsp;&nbsp;Novelis 144A 4.75% 1/30/30 # | 6240000 | 5546237 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vibrantz Technologies 144A<br> 9.00% 2/15/30 # | 4410000 | 3333786 |
|  |  | 21971523 |
| &nbsp;&nbsp;Capital Goods — 3.36% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ARD Finance 144A PIK 6.50%<br> 6/30/27 #, > | 1751144 | 1220744 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ardagh Metal Packaging Finance<br> USA 144A 3.25% 9/1/28 # | 614000 | 522339 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bombardier 144A 6.00%<br> 2/15/28 # | 2074000 | 1920400 |
| &nbsp;&nbsp;&nbsp;&nbsp;Clydesdale Acquisition Holdings<br> 144A 6.625% 4/15/29 # | 755000 | 718779 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mauser Packaging Solutions<br> Holding 144A 5.50% 4/15/24 # | 4390000 | 4277648 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sealed Air 144A 5.00% 4/15/29 # | 2175000 | 2047643 |
| &nbsp;&nbsp;&nbsp;&nbsp;TransDigm 5.50% 11/15/27 | 7030000 | 6615792 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wesco Aircraft Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 8.50% 11/15/24 # | 6782000 | 3357090 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 9.00% 11/15/26 #, \* | 6438000 | 4361745 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 13.125% 11/15/27 # | 858000 | 216645 |
|  |  | 25258825 |
| &nbsp;&nbsp;Communications — 6.82% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Altice Financing 144A 5.75%<br> 8/15/29 # | 5719000 | 4509076 |
| &nbsp;&nbsp;&nbsp;&nbsp;Altice France |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.125% 7/15/29 # | 2375000 | 1784880 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.50% 10/15/29 # | 1292000 | 987495 |
| &nbsp;&nbsp;&nbsp;&nbsp;Altice France Holding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.00% 2/15/28 # | 10750000 | 6368748 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 10.50% 5/15/27 # | 4453000 | 3404986 |
| &nbsp;&nbsp;&nbsp;&nbsp;Connect Finco 144A 6.75%<br> 10/1/26 # | 6220000 | 5777257 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consolidated Communications |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.00% 10/1/28 # | 1129000 | 834068 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.50% 10/1/28 # | 6113000 | 4765455 |
| &nbsp;&nbsp;&nbsp;&nbsp;Digicel International Finance |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 8.00% 12/31/26 # | 1158698 | 512330 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 8.75% 5/25/24 # | 4031000 | 3473029 |
| &nbsp;&nbsp;&nbsp;&nbsp;Frontier Communications<br> Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.00% 5/1/28 # | 745000 | 651137 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.875% 10/15/27 # | 3836000 | 3570434 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.875% 11/1/29 | 1011498 | 783887 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.00% 1/15/30 # | 805000 | 633433 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.75% 5/1/29 #, \* | 3287000 | 2723707 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 8.75% 5/15/30 # | 1080000 | 1100190 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ligado Networks 144A PIK <br> 15.50% 11/1/23 #, >> | 8927517 | 2911263 |
| &nbsp;&nbsp;&nbsp;&nbsp;Northwest Fiber 144A 4.75%<br> 4/30/27 # | 2743000 | 2416892 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sable International Finance 144A<br> 5.75% 9/7/27 # | 875000 | 808719 |
| &nbsp;&nbsp;&nbsp;&nbsp;Telesat Canada |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.625% 12/6/26 # | 6406000 | 2954914 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.50% 10/15/27 # | 1130000 | 328639 |
|  |  | 51300539 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Goods — 1.64% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Clydesdale Acquisition Holdings<br> 144A 8.75% 4/15/30 # | 2415000 | 2071699 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kronos Acquisition Holdings<br> 144A 5.00% 12/31/26 # | 2411000 | 2088529 |
| &nbsp;&nbsp;&nbsp;&nbsp;MajorDrive Holdings IV 144A<br> 6.375% 6/1/29 # | 6450000 | 4821317 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pilgrim's Pride 144A 4.25%<br> 4/15/31 # | 3775000 | 3216300 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** |  |  |
| &nbsp;&nbsp;Consumer Goods (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Scotts Miracle-Gro 4.00% 4/1/31 | 160000 | $122466 |
|  |  | 12320311 |
| &nbsp;&nbsp;Energy — 11.41% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ascent Resources Utica<br> Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.875% 6/30/29 # | 2401000 | 2143925 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 7.00% 11/1/26 # | 1898000 | 1844039 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bellatrix Exploration |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.50% 9/11/23 = | 1022000 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.50% 12/15/23 = | 1113000 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Callon Petroleum |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 7.50% 6/15/30 #, \* | 2445000 | 2240353 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 8.00% 8/1/28 # | 5090000 | 4858806 |
| &nbsp;&nbsp;&nbsp;&nbsp;CNX Midstream Partners 144A<br> 4.75% 4/15/30 # | 545000 | 447971 |
| &nbsp;&nbsp;&nbsp;&nbsp;CNX Resources 144A<br> 6.00% 1/15/29 # | 6420000 | 5916859 |
| &nbsp;&nbsp;&nbsp;&nbsp;Crestwood Midstream Partners |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.625% 5/1/27 # | 1636000 | 1524294 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.00% 2/1/29 # | 850000 | 781112 |
| &nbsp;&nbsp;&nbsp;&nbsp;EQM Midstream Partners 144A<br> 4.75% 1/15/31 # | 8299000 | 6800657 |
| &nbsp;&nbsp;&nbsp;&nbsp;Genesis Energy |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.75% 2/1/28 | 3335000 | 3075070 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.00% 1/15/27 | 5255000 | 4970284 |
| &nbsp;&nbsp;&nbsp;&nbsp;Hilcorp Energy I |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.00% 4/15/30 # | 5220000 | 4649564 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.00% 2/1/31 # | 705000 | 610748 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.25% 4/15/32 # | 2665000 | 2303588 |
| &nbsp;&nbsp;&nbsp;&nbsp;Laredo Petroleum 10.125%<br> 1/15/28 \* | 2876000 | 2809088 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mesquite Energy 144A 7.25%<br> 2/15/23 #, ‡ | 622000 | 10108 |
| &nbsp;&nbsp;&nbsp;&nbsp;Murphy Oil 6.375% 7/15/28 | 8268000 | 7970184 |
| &nbsp;&nbsp;&nbsp;&nbsp;NuStar Logistics |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.00% 6/1/26 | 4126000 | 3980052 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.375% 10/1/30 | 4170000 | 3863254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Occidental Petroleum |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.20% 3/15/48 | 255000 | 196259 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.40% 4/15/46 | 1008000 | 789057 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.40% 8/15/49 | 1985000 | 1552637 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 7/15/44 | 1030000 | 825140 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.45% 9/15/36 | 2225000 | 2274517 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.60% 3/15/46 | 1850000 | 1907803 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.625% 9/1/30 | 1680000 | 1739867 |
| &nbsp;&nbsp;&nbsp;&nbsp;Southwestern Energy |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.375% 2/1/29 | 760000 | 705664 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.375% 3/15/30 | 7590000 | 6936835 |
| &nbsp;&nbsp;&nbsp;&nbsp;USA Compression Partners |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.875% 4/1/26 | 665000 | 638995 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.875% 9/1/27 | 3885000 | 3638712 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weatherford International 144A<br> 8.625% 4/30/30 # | 3935000 | 3785837 |
|  |  | 85791279 |
| &nbsp;&nbsp;Financial Services — 3.46% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AerCap Holdings 5.875% <br> 10/10/79 \*, µ | 3802000 | 3467082 |
| &nbsp;&nbsp;&nbsp;&nbsp;Air Lease 4.65% 6/15/26 µ, ψ | 2028000 | 1699910 |
| &nbsp;&nbsp;&nbsp;&nbsp;Castlelake Aviation Finance DAC <br> 144A 5.00% 4/15/27 # | 4590000 | 3999904 |
| &nbsp;&nbsp;&nbsp;&nbsp;Compass Group Diversified <br> Holdings 144A 5.25% <br> 4/15/29 # | 2531000 | 2169297 |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Suisse Group 144A 9.75% <br> 6/23/27 #, µ, ψ | 4715000 | 4118870 |
| &nbsp;&nbsp;&nbsp;&nbsp;Highlands Holdings Bond Issuer <br> 144A PIK 7.625% <br> 10/15/25 #, > | 4059145 | 3797871 |
| &nbsp;&nbsp;&nbsp;&nbsp;Medline Borrower |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 3.875% 4/1/29 # | 4981000 | 4023378 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.25% 10/1/29 #, \* | 884000 | 703713 |
| &nbsp;&nbsp;&nbsp;&nbsp;Midcap Financial Issuer Trust <br> 144A 6.50% 5/1/28 # | 2340000 | 2015828 |
|  |  | 25995853 |
| &nbsp;&nbsp;Healthcare — 5.99% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Avantor Funding 144A 3.875% <br> 11/1/29 # | 9835000 | 8271481 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bausch Health 144A 6.125% <br> 2/1/27 # | 3140000 | 2169363 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cheplapharm Arzneimittel 144A <br> 5.50% 1/15/28 # | 4525000 | 3790954 |
| &nbsp;&nbsp;&nbsp;&nbsp;CHS |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.75% 2/15/31 # | 3000000 | 2183685 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.25% 5/15/30 # | 1600000 | 1209316 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consensus Cloud Solutions |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.00% 10/15/26 # | 1785000 | 1677018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.50% 10/15/28 # | 2477000 | 2281487 |
| &nbsp;&nbsp;&nbsp;&nbsp;Encompass Health |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.625% 4/1/31 | 1495000 | 1287377 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.75% 2/1/30 | 969000 | 852475 |
| &nbsp;&nbsp;&nbsp;&nbsp;Hadrian Merger Sub 144A 8.50% <br> 5/1/26 # | 509000 | 450569 |
| &nbsp;&nbsp;&nbsp;&nbsp;ModivCare Escrow Issuer 144A <br> 5.00% 10/1/29 # | 4672000 | 3945971 |
| &nbsp;&nbsp;&nbsp;&nbsp;Organon & Co. 144A 5.125% <br> 4/30/31 # | 6670000 | 5787127 |
| &nbsp;&nbsp;&nbsp;&nbsp;Par Pharmaceutical 144A 7.50%<br> 4/1/27 #, ‡ | 2936000 | 2237525 |

---

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP High Income

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** |  |  |
| &nbsp;&nbsp;Healthcare (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Tenet Healthcare |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.375% 1/15/30 # | 3810000 | $3304489 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.125% 10/1/28 # | 4170000 | 3742283 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Renal Care 144A 10.625% <br> 7/15/27 # | 8340000 | 1834800 |
|  |  | 45025920 |
| &nbsp;&nbsp;Insurance — 3.23% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ardonagh Midco 2 144A PIK <br> 11.50% 1/15/27 #, >> | 8039978 | 7678179 |
| &nbsp;&nbsp;&nbsp;&nbsp;HUB International 144A 5.625% <br> 12/1/29 # | 6605000 | 5777277 |
| &nbsp;&nbsp;&nbsp;&nbsp;Jones Deslauriers Insurance <br> Management 144A 10.50% <br> 12/15/30 # | 3385000 | 3338132 |
| &nbsp;&nbsp;&nbsp;&nbsp;NFP |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.875% 8/15/28 # | 6907000 | 5708490 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 7.50% 10/1/30 # | 1865000 | 1765360 |
|  |  | 24267438 |
| &nbsp;&nbsp;Leisure — 5.38% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Boyd Gaming |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.75% 12/1/27 \* | 4385000 | 4090503 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.75% 6/15/31 # | 3900000 | 3397602 |
| &nbsp;&nbsp;&nbsp;&nbsp;Carnival |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.75% 3/1/27 # | 5753000 | 4117825 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.00% 5/1/29 # | 7316000 | 4888968 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 7.625% 3/1/26 # | 4148000 | 3295025 |
| &nbsp;&nbsp;&nbsp;&nbsp;Royal Caribbean Cruises |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.375% 7/15/27 # | 6644000 | 5387958 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.50% 8/31/26 # | 480000 | 404400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.50% 4/1/28 # | 8914000 | 7129596 |
| &nbsp;&nbsp;&nbsp;&nbsp;Scientific Games Holdings 144A <br> 6.625% 3/1/30 # | 4515000 | 3819690 |
| &nbsp;&nbsp;&nbsp;&nbsp;Scientific Games International <br> 144A 7.25% 11/15/29 # | 4065000 | 3909717 |
|  |  | 40441284 |
| &nbsp;&nbsp;Media — 9.00% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Advantage Sales & Marketing <br> 144A 6.50% 11/15/28 # | 5940000 | 4538041 |
| &nbsp;&nbsp;&nbsp;&nbsp;AMC Networks 4.25% 2/15/29 | 4609000 | 2878632 |
| &nbsp;&nbsp;&nbsp;&nbsp;Arches Buyer 144A 6.125% <br> 12/1/28 # | 3964000 | 3186442 |
| &nbsp;&nbsp;&nbsp;&nbsp;CCO Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.50% 8/15/30 # | 2924000 | 2422271 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.75% 2/1/32 # | 3290000 | 2673931 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.375% 9/1/29 # | 6850000 | 6450405 |
| &nbsp;&nbsp;&nbsp;&nbsp;CMG Media 144A 8.875% <br> 12/15/27 # | 4286000 | 3232844 |
| &nbsp;&nbsp;&nbsp;&nbsp;CSC Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.50% 11/15/31 # | 1754000 | 1220238 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.625% 12/1/30 # | 7234000 | 4013706 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.00% 11/15/31 # | 2381000 | 1333360 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.75% 1/15/30 # | 1372000 | 776820 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cumulus Media New Holdings <br> 144A 6.75% 7/1/26 # | 4075000 | 3429438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Directv Financing 144A 5.875% <br> 8/15/27 # | 6662000 | 5972883 |
| &nbsp;&nbsp;&nbsp;&nbsp;DISH DBS 144A 5.75% <br> 12/1/28 # | 4555000 | 3644000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gray Escrow II 144A 5.375% <br> 11/15/31 # | 495000 | 357605 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gray Television 144A 4.75% <br> 10/15/30 # | 2215000 | 1605875 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nexstar Media 144A 4.75% <br> 11/1/28 # | 4400000 | 3812644 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sirius XM Radio 144A 4.125% <br> 7/1/30 # | 9080000 | 7513382 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stagwell Global 144A 5.625% <br> 8/15/29 # | 4022000 | 3324002 |
| &nbsp;&nbsp;&nbsp;&nbsp;VTR Comunicaciones 144A <br> 4.375% 4/15/29 # | 3166000 | 1858933 |
| &nbsp;&nbsp;&nbsp;&nbsp;VTR Finance 144A 6.375% <br> 7/15/28 # | 2826000 | 1095911 |
| &nbsp;&nbsp;&nbsp;&nbsp;VZ Secured Financing 144A <br> 5.00% 1/15/32 # | 2805000 | 2284480 |
|  |  | 67625843 |
| &nbsp;&nbsp;Retail — 3.31% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbury Automotive Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 3/1/28 | 2576930 | 2271989 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.625% 11/15/29 # | 85000 | 71725 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.75% 3/1/30 | 4450930 | 3728529 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.00% 2/15/32 # | 85000 | 70040 |
| &nbsp;&nbsp;&nbsp;&nbsp;CP Atlas Buyer 144A 7.00% <br> 12/1/28 # | 1146000 | 852629 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lithia Motors |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 3.875% 6/1/29 # | 1666000 | 1372043 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.375% 1/15/31 # | 1271000 | 1036348 |
| &nbsp;&nbsp;&nbsp;&nbsp;LSF9 Atlantis Holdings 144A <br> 7.75% 2/15/26 # | 6302000 | 5585526 |
| &nbsp;&nbsp;&nbsp;&nbsp;Michaels |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.25% 5/1/28 # | 2801000 | 2256866 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 7.875% 5/1/29 # | 2518000 | 1686930 |
| &nbsp;&nbsp;&nbsp;&nbsp;PetSmart 144A 7.75% 2/15/29 # | 6288000 | 5917432 |
|  |  | 24850057 |
| &nbsp;&nbsp;Services — 4.62% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adtalem Global Education 144A <br> 5.50% 3/1/28 # | 4951000 | 4499073 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** |  |  |
| &nbsp;&nbsp;Services (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ahern Rentals 144A 7.375% <br> 5/15/23 # | 3231000 | $3231000 |
| &nbsp;&nbsp;&nbsp;&nbsp;CDW 3.569% 12/1/31 | 6715000 | 5545994 |
| &nbsp;&nbsp;&nbsp;&nbsp;NESCO Holdings II 144A 5.50% <br> 4/15/29 # | 4712000 | 4129125 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sabre GLBL |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 7.375% 9/1/25 # | 313000 | 301323 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 9.25% 4/15/25 # | 756000 | 754395 |
| &nbsp;&nbsp;&nbsp;&nbsp;Staples |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 7.50% 4/15/26 # | 4599000 | 3967741 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 10.75% 4/15/27 # | 7660000 | 5528069 |
| &nbsp;&nbsp;&nbsp;&nbsp;United Rentals North America <br> 144A 6.00% 12/15/29 # | 2915000 | 2902393 |
| &nbsp;&nbsp;&nbsp;&nbsp;White Cap Buyer 144A 6.875% <br> 10/15/28 # | 4435000 | 3843565 |
| &nbsp;&nbsp;&nbsp;&nbsp;White Cap Parent 144A PIK <br> 8.25% 3/15/26 #, « | 36000 | 31167 |
|  |  | 34733845 |
| &nbsp;&nbsp;Technology & Electronics — 3.11% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AthenaHealth Group 144A 6.50% <br> 2/15/30 # | 2060000 | 1521943 |
| &nbsp;&nbsp;&nbsp;&nbsp;CommScope Technologies 144A <br> 6.00% 6/15/25 # | 2480000 | 2261909 |
| &nbsp;&nbsp;&nbsp;&nbsp;Entegris Escrow |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.75% 4/15/29 # | 2121000 | 1938493 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.95% 6/15/30 # | 5825000 | 5379387 |
| &nbsp;&nbsp;&nbsp;&nbsp;NCR |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.00% 10/1/28 # | 2287000 | 1953474 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.125% 4/15/29 # | 6521000 | 5465303 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.25% 10/1/30 # | 782000 | 646429 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.125% 9/1/29 # | 983000 | 920737 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sensata Technologies 144A <br> 4.00% 4/15/29 # | 3805000 | 3286949 |
|  |  | 23374624 |
| &nbsp;&nbsp;Transportation — 2.52% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Air Canada 144A 3.875% <br> 8/15/26 # | 8105000 | 7192642 |
| &nbsp;&nbsp;&nbsp;&nbsp;American Airlines 144A 5.75% <br> 4/20/29 # | 2801832 | 2565808 |
| &nbsp;&nbsp;&nbsp;&nbsp;Grupo Aeromexico 144A 8.50% <br> 3/17/27 # | 4490000 | 3971367 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seaspan 144A 5.50% 8/1/29 # | 6910000 | 5245589 |
|  |  | 18975406 |
| &nbsp;&nbsp;Utilities — 2.35% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Calpine |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.625% 2/1/29 # | 3295000 | 2832576 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.00% 2/1/31 # | 370000 | 310988 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.125% 3/15/28 #, \* | 5470000 | 4891973 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vistra |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 7.00% 12/15/26 #, µ, Ψ | 6710000 | 6115348 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 8.00% 10/15/26 #, µ, Ψ | 3650000 | 3493312 |
|  |  | 17644197 |
| &nbsp;&nbsp;**Total Corporate Bonds**<br> (cost $623,406,153) |  | **528617141** |
| &nbsp;&nbsp;**Municipal Bonds — 0.51%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commonwealth of Puerto Rico |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series A1 2.986% 7/1/24^ | 47686 | 44216 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series A-1 4.00% 7/1/35 | 104086 | 87845 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series A-1 4.00% 7/1/37 | 110562 | 90729 |
| &nbsp;&nbsp;&nbsp;&nbsp;GDB Debt Recovery Authority of <br> Puerto Rico <br> 7.50% 8/20/40 | 4300407 | 3601591 |
| &nbsp;&nbsp;**Total Municipal Bonds**<br> (cost $4,347,275) |  | **3824381** |
| &nbsp;&nbsp;**Loan Agreements — 10.42%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Advantage Sales & Marketing <br> Tranche B-1 8.284% <br> (LIBOR03M + 4.50%) <br> 10/28/27 • | 4480499 | 3727914 |
| &nbsp;&nbsp;&nbsp;&nbsp;Air Canada 8.13% (LIBOR03M + <br> 3.50%) 8/11/28 • | 1895238 | 1877865 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amynta Agency Borrower <br> Tranche B 1st Lien 8.884% <br> (LIBOR01M + 4.50%) <br> 2/28/25 • | 8581647 | 8152565 |
| &nbsp;&nbsp;&nbsp;&nbsp;Applied Systems 2nd Lien <br> 11.33% (SOFR03M + 5.75%) <br> 5/9/28 • | 4121112 | 4110809 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ascent Resources Utica <br> Holdings 2nd Lien 12.941% <br> (LIBOR03M + 9.00%) <br> 11/1/25 • | 1233000 | 1305953 |
| &nbsp;&nbsp;&nbsp;&nbsp;Clydesdale Acquisition Holdings <br> Tranche B 8.598% (SOFR01M <br> + 3.25%) 4/13/29 • | 698845 | 667632 |
| &nbsp;&nbsp;&nbsp;&nbsp;CNT Holdings I 2nd Lien <br> 10.489% (SOFR03M + 6.75%) <br> 11/6/28 • | 2060000 | 1953566 |
| &nbsp;&nbsp;&nbsp;&nbsp;CP Atlas Buyer Tranche B <br> 7.884% (LIBOR01M + 3.50%) <br> 11/23/27 • | 4374564 | 3846883 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foresight Energy 12.73% <br> (LIBOR03M + 8.00%) <br> 6/30/27 • | 1263869 | 1251231 |
| &nbsp;&nbsp;&nbsp;&nbsp;Form Technologies Tranche B <br> 9.199% (LIBOR03M+ 4.75%) <br> 7/22/25 • | 11882723 | 10357777 |

---

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP High Income

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Loan Agreements (continued)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Heartland Dental 9.323% <br> (SOFR01M + 5.00%) <br> 4/30/25 • | 3905375 | $3690579 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hexion Holdings 1st Lien 8.934% <br> (SOFR03M + 4.50%) 3/3/30 • | 900475 | 776209 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hexion Holdings 2nd Lien <br> 11.859% (SOFR01M + 7.54%) <br> 3/15/30 • | 3665000 | 2913675 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hunter Douglas Holding BV <br> Tranche B-1 7.859% <br> (SOFR03M + 3.50%) <br> 2/26/29 • | 2068679 | 1831557 |
| &nbsp;&nbsp;&nbsp;&nbsp;Jones DesLauriers Insurance <br> Management 1st Lien 8.812% <br> (CDOR03M + 4.25%) <br> 3/27/28 • | 5051637 | 3469736 |
| &nbsp;&nbsp;&nbsp;&nbsp;Jones DesLauriers Insurance <br> Management 1st Lien 8.812% <br> (CDOR03M + 4.25%) <br> 3/27/28 • | 1150602 | 790295 |
| &nbsp;&nbsp;&nbsp;&nbsp;MLN US HoldCo |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.154% (SOFR03M + 6.7%) <br> 10/18/27 • | 8256075 | 6687421 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.704% (SOFR03M + <br> 9.25%)Tranche B 10/18/27 • | 2336000 | 1810400 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pre Paid Legal Services 2nd Lien <br> 11.384% (LIBOR01M + <br> 7.00%) 12/14/29 • | 2245000 | 2062594 |
| &nbsp;&nbsp;&nbsp;&nbsp;SPX Flow 8.923% (SOFR01M + <br> 4.60%) 4/5/29 • | 4673288 | 4360761 |
| &nbsp;&nbsp;&nbsp;&nbsp;Swf Holdings I 8.753% <br> (LIBOR03M + 4.00%) <br> 10/6/28 • | 4229987 | 3477049 |
| &nbsp;&nbsp;&nbsp;&nbsp;UKG 2nd Lien 8.998% <br> (LIBOR03M + 5.25%) 5/3/27 • | 5615000 | 5186856 |
| &nbsp;&nbsp;&nbsp;&nbsp;United PF Holdings 1st Lien <br> 13.23% (LIBOR03M + 8.50%) <br> 12/30/26 • | 663863 | 597477 |
| &nbsp;&nbsp;&nbsp;&nbsp;West Corporation Tranche B <br> 8.415% (LIBOR03M + 4.00%) <br> 10/10/24 • | 3687613 | 3395676 |
| &nbsp;&nbsp;**Total Loan Agreements** <br> (cost $85,949,109) |  | **78302480** |
|  | **Number of<br> shares** |  |
| &nbsp;&nbsp;**Common Stocks — 2.06%** |  |  |
| &nbsp;&nbsp;Basic Industry — 0.39% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BIS Industries Holdings =, † | 1604602 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foresight Energy = | 185516 | 2851374 |
| &nbsp;&nbsp;&nbsp;&nbsp;Westmoreland Coal =, † | 28632 | 49819 |
|  |  | 2901193 |
| &nbsp;&nbsp;Consumer Goods — 0.00% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; ASG Warrant =, † | 1200 | 0 |
|  |  | 0 |
| &nbsp;&nbsp;Energy — 0.23% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;KCA Deutag International =, † | 26774 | 1722460 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sabine Oil & Gas Holdings =, † | 263 | 326 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vantage Drilling International † | 452 | 6554 |
|  |  | 1729340 |
| &nbsp;&nbsp;Leisure — 1.11% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;New Cotai =, † | 3072567 | 2833678 |
| &nbsp;&nbsp;&nbsp;&nbsp;Studio City International Holdings <br> ADR † | 924584 | 5510521 |
|  |  | 8344199 |
| &nbsp;&nbsp;Retail — 0.05% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;True Religion Apparel =, † | 23 | 388989 |
|  |  | 388989 |
| &nbsp;&nbsp;Services — 0.28% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Laureate Education | 217638 | 2093678 |
|  |  | 2093678 |
| &nbsp;&nbsp;Utilities — 0.00% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Larchmont Resources =, † | 1007 | 38772 |
|  |  | 38772 |
| &nbsp;&nbsp;**Total Common Stocks** <br> (cost $45,720,743) |  | **15496171** |
| &nbsp;&nbsp;**Preferred Stock — 0.02%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;True Religion Apparel <br> 6.25% =, ω | 24 | 119120 |
| &nbsp;&nbsp;**Total Preferred Stock**<br> (cost $392,061) |  | **119120** |
| &nbsp;&nbsp;**Exchange-Traded Funds — 4.00%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Invesco Senior Loan ETF\* | 424157 | 8707943 |
| &nbsp;&nbsp;&nbsp;&nbsp;iShares iBoxx High Yield <br> Corporate Bond ETF\* | 290000 | 21352700 |
| &nbsp;&nbsp;**Total Exchange-Traded Funds** <br> (cost $33,375,159) |  | **30060643** |
| &nbsp;&nbsp;**Warrants — 0.01%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;California Resources † | 7744 | 97575 |
| &nbsp;&nbsp;**Total Warrants**<br> (cost $673,784) |  | **97575** |
| &nbsp;&nbsp;**Short-Term Investments — 9.55%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 9.55% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund –<br> Institutional Shares (seven- <br> day effective yield 4.03%) | 17952264 | 17952264 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Short-Term Investments (continued)** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio <br> – Class I (seven-day effective <br> yield 4.06%) | 17952264 | $17952264 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial <br> Square Government Fund – <br> Institutional Shares (seven- <br> day effective yield 4.23%) | 17952264 | 17952264 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 17952264 | 17952264 |
| &nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $71,809,056) |  | **71809056** |
| &nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral—98.03%** <br> (cost $869,923,132) |  | **736892767** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 4.82%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 4.82% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference<br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 36258877 | 36258877 |
| &nbsp;&nbsp;**Total Securities Lending Collateral** <br> (cost $36,258,877) |  | **36258877** |
| &nbsp;&nbsp;**Total Value of <br> Securities—102.85%**<br> (cost $906,182,009) |  | $**773,151,644■** |

---

---

| | |
|:---|:---|
| ° | Principal amount shown is stated in USD unless noted that the security is denominated in another currency. |
| <sup>=</sup> | The value of this security was determined using significant unobservable inputs and is reported as a Level 3 security in the disclosure table located in Note 3 in "Notes to financial statements." |
| <sup>µ</sup> | Fixed to variable rate investment. The rate shown reflects the fixed rate in effect at December 31, 2022. Rate will reset at a future date. |
| <sup>Ψ</sup> | Perpetual security. Maturity date represents next call date. |
| # | Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. At December 31, 2022, the aggregate value of Rule 144A securities was $438,358,890, which represents 58.31% of the Portfolio's net assets. See Note 13 in "Notes to financial statements." |
| > | PIK. 100% of the income received was in the form of cash. |
| \* | Fully or partially on loan. |
| <sup>>></sup> | PIK. 100% of the income received was in the form of principal. |
| ‡ | Non-income producing security. Security is currently in default. |
| « | PIK. The first payment of cash and/or principal will be made after December 31, 2022. |
| ^ | Zero-coupon security. The rate shown is the effective yield at the time of purchase. |
| • | Variable rate investment. Rates reset periodically. Rate shown reflects the rate in effect at December 31, 2022. For securities based on a published reference rate and spread, the reference rate and spread are indicated in their descriptions. The reference rate descriptions (i.e. LIBOR03M, LIBOR06M, etc.) used in this report are identical for different securities, but the underlying reference rates may differ due to the timing of the reset period. Certain variable rate securities are not based on a published reference rate and spread but are determined by the issuer or agent and are based on current market conditions, or for mortgage-backed securities, are impacted by the individual mortgages which are paying off over time. These securities do not indicate a reference rate and spread in their descriptions. |
| † | Non-income producing security. |
| <sup>ω</sup> | Perpetual security with no stated maturity date. |
| \*\* | See Note 12 in "Notes to financial statements" for additional information on securities lending collateral. |
| ■ | Includes $38,792,042 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $3,636,615. |

---

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP High Income

The following foreign currency exchange contracts were outstanding at

December 31, 2022:<sup>1</sup>

**Foreign Currency Exchange Contracts**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Counterparty | Currency to<br> Receive (Deliver) | In Exchange For | In Exchange For | Settlement<br> Date | Unrealized Appreciation |
| TD CAD | (6430000) | USD | 4833565 | 1/20/23 | $84180 |

---

The use of foreign currency exchange contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The foreign currency exchange contract presented above represent the Portfolio's total exposure in such contracts, whereas only the net unrealized appreciation (depreciation) is reflected in the Portfolio's net assets.

<sup>1</sup>See Note 10 in "Notes to financial statements."

**Summary of abbreviations:**

ADR – American Depositary Receipt

CDOR03M – 3 Month Canadian Dollar Offered Rate

DAC – Designated Activity Company

ETF – Exchange-Traded Fund

ICE – Intercontinental Exchange, Inc.

LIBOR – London Interbank Offered Rate

LIBOR01M – ICE LIBOR USD 1 Month

LIBOR03M – ICE LIBOR USD 3 Month

LIBOR06M – ICE LIBOR USD 6 Month

PIK – Payment-in-kind

SOFR – Secured Overnight Financing Rate

SOFR01M – Secured Overnight Financing Rate 1 Month

SOFR03M – Secured Overnight Financing Rate 3 Month

TD – TD Bank

**Summary of currencies:**

CAD – Canadian Dollar

USD – US Dollar

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP International Core Equity

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks – 97.16%Δ** |  |  |
| &nbsp;&nbsp;Australia — 1.46% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Newcrest Mining | 504226 | $7085759 |
|  |  | 7085759 |
| &nbsp;&nbsp;Austria — 1.01% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mondi | 285809 | 4870228 |
|  |  | 4870228 |
| &nbsp;&nbsp;Brazil — 3.21% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Banco do Brasil | 1252618 | 8239675 |
| &nbsp;&nbsp;&nbsp;&nbsp;MercadoLibre † | 8652 | 7321668 |
|  |  | 15561343 |
| &nbsp;&nbsp;Canada — 5.87% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Canadian Pacific Railway | 125812 | 9380149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dollarama | 168255 | 9840556 |
| &nbsp;&nbsp;&nbsp;&nbsp;Suncor Energy | 289091 | 9170206 |
|  |  | 28390911 |
| &nbsp;&nbsp;China — 5.15% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;H World Group ADR | 256268 | 10870889 |
| &nbsp;&nbsp;&nbsp;&nbsp;JD.com ADR | 119442 | 6704280 |
| &nbsp;&nbsp;&nbsp;&nbsp;SITC International Holdings | 1292000 | 2873520 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tencent Holdings | 104700 | 4480177 |
|  |  | 24928866 |
| &nbsp;&nbsp;China/Hong Kong — 6.67% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;China Mengniu Dairy † | 1945000 | 8821144 |
| &nbsp;&nbsp;&nbsp;&nbsp;Li Ning | 958500 | 8319620 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prosus | 94751 | 6536919 |
| &nbsp;&nbsp;&nbsp;&nbsp;ZTO Express Cayman ADR \* | 320383 | 8608691 |
|  |  | 32286374 |
| &nbsp;&nbsp;Denmark — 4.69% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ambu Class B \*, † | 277330 | 3553056 |
| &nbsp;&nbsp;&nbsp;&nbsp;AP Moller - Maersk Class A | 1147 | 2537772 |
| &nbsp;&nbsp;&nbsp;&nbsp;AP Moller - Maersk Class B | 1968 | 4425082 |
| &nbsp;&nbsp;&nbsp;&nbsp;Genmab † | 28766 | 12178385 |
|  |  | 22694295 |
| &nbsp;&nbsp;France — 13.73% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Airbus | 85460 | 10156183 |
| &nbsp;&nbsp;&nbsp;&nbsp;BNP Paribas | 155141 | 8843264 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capgemini | 26973 | 4502783 |
| &nbsp;&nbsp;&nbsp;&nbsp;L'Oreal | 6974 | 2490430 |
| &nbsp;&nbsp;&nbsp;&nbsp;LVMH Moet Hennessy Louis <br> Vuitton | 13561 | 9869682 |
| &nbsp;&nbsp;&nbsp;&nbsp;Thales | 72674 | 9280810 |
| &nbsp;&nbsp;&nbsp;&nbsp;TotalEnergies \* | 193417 | 12143085 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vinci | 92000 | 9187330 |
|  |  | 66473567 |
| &nbsp;&nbsp;Germany — 11.42% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;adidas AG | 35778 | 4881534 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bayer | 171930 | 8893852 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deutsche Telekom | 538485 | 10743340 |
| &nbsp;&nbsp;&nbsp;&nbsp;HeidelbergCement | 104574 | 5964229 |
| &nbsp;&nbsp;&nbsp;&nbsp;HelloFresh † | 174736 | 3840057 |
| &nbsp;&nbsp;&nbsp;&nbsp;RWE | 237498 | 10573415 |
| &nbsp;&nbsp;&nbsp;&nbsp;SAP | 44795 | 4621978 |
| &nbsp;&nbsp;&nbsp;&nbsp;Siemens | 41371 | 5741184 |
|  |  | 55259589 |
| &nbsp;&nbsp;Hong Kong — 1.82% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prudential | 647659 | 8828182 |
|  |  | 8828182 |
| &nbsp;&nbsp;India — 3.59% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Axis Bank | 910797 | 10279907 |
| &nbsp;&nbsp;&nbsp;&nbsp;NTPC | 3538845 | 7120038 |
|  |  | 17399945 |
| &nbsp;&nbsp;Japan — 10.12% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asahi Group Holdings | 155100 | 4867852 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inpex \* | 696400 | 7407608 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nippon Telegraph & Telephone | 158500 | 4543409 |
| &nbsp;&nbsp;&nbsp;&nbsp;ORIX | 396151 | 6394742 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seven & i Holdings | 206100 | 8888494 |
| &nbsp;&nbsp;&nbsp;&nbsp;Subaru | 374023 | 5778205 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tokio Marine Holdings | 515322 | 11102354 |
|  |  | 48982664 |
| &nbsp;&nbsp;Netherlands — 4.98% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ASML Holding | 8838 | 4766269 |
| &nbsp;&nbsp;&nbsp;&nbsp;ING Groep | 710031 | 8655480 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shell | 377344 | 10696010 |
|  |  | 24117759 |
| &nbsp;&nbsp;Norway — 1.02% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;DNB Bank | 248437 | 4931057 |
|  |  | 4931057 |
| &nbsp;&nbsp;Republic of Korea — 3.70% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;LG | 137342 | 8504236 |
| &nbsp;&nbsp;&nbsp;&nbsp;Samsung Electronics | 213801 | 9384419 |
|  |  | 17888655 |
| &nbsp;&nbsp;Spain — 1.78% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Banco Bilbao Vizcaya Argentaria | 1428495 | 8615132 |
|  |  | 8615132 |
| &nbsp;&nbsp;Switzerland — 1.90% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Alcon | 109353 | 7496148 |
| &nbsp;&nbsp;&nbsp;&nbsp;Roche Holding | 5439 | 1708787 |
|  |  | 9204935 |

---

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP International Core Equity

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common StocksΔ (continued)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Taiwan — 1.88% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taiwan Semiconductor Manufacturing | 622000 | $9076377 |
|  |  | 9076377 |
| &nbsp;&nbsp;United Kingdom — 8.32% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AstraZeneca | 41041 | 5565981 |
| &nbsp;&nbsp;&nbsp;&nbsp;AstraZeneca ADR | 138835 | 9413013 |
| &nbsp;&nbsp;&nbsp;&nbsp;Haleon † | 1400861 | 5543905 |
| &nbsp;&nbsp;&nbsp;&nbsp;HSBC Holdings | 1674196 | 10437867 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reckitt Benckiser Group | 133997 | 9321231 |
|  |  | 40281997 |
| &nbsp;&nbsp;United States — 4.84% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Schlumberger | 200000 | 10692000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seagate Technology Holdings | 95998 | 5050455 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stellantis | 539909 | 7669338 |
|  |  | 23411793 |
| &nbsp;&nbsp;**Total Common Stocks** <br> (cost $496,208,224) |  | **470289428** |
| &nbsp;&nbsp;**Short-Term Investments – 0.66%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds – 0.66% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day <br> effective yield 4.03%) | 797897 | 797897 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio – <br> Class I (seven-day effective <br> yield 4.06%) | 797897 | 797897 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 797897 | 797897 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 797897 | 797897 |
| &nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $3,191,588) |  | **3191588** |
| &nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral—97.82%** <br> (cost $499,399,812) |  | **473481016** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* – 1.54%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 1.54% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference <br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 7445419 | 7445419 |
| &nbsp;&nbsp;**Total Securities Lending Collateral** <br> (cost $7,445,419) |  | **7445419** |
| &nbsp;&nbsp;**Total Value of Securities—99.36%** <br> (cost $506,845,231) |  | $**480,926,435■** |

---

---

| | |
|:---|:---|
| <sup>Δ</sup> | Securities have been classified by country of risk. |
| <sup>†</sup> | Non-income producing security. |
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>\*\*</sup> | See Note 12 in "Notes to financial statements" for additional information on securities lending collateral. |
| ■ | Includes $25,427,392 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $19,180,768. |

---

[**Table of Contents**](#toc1)

The following foreign currency exchange contracts were outstanding at December 31, 2022:<sup>1</sup>

**Foreign Currency Exchange Contracts**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Counterparty | Currency to <br> Receive (Deliver) | Currency to <br> Receive (Deliver) | In Exchange For | In Exchange For | Settlement<br> Date | Unrealized <br> Appreciation | Unrealized <br> Depreciation |
| BNYM | CHF | (1548856) | USD | 1678837 | 1/3/23 | $3045 | $— |
| BNYM | CHF | (1541520) | USD | 1666729 | 1/4/23 |  | (311) |
| BNYM | KRW | (2147483648) | USD | 2867236 | 1/3/23 |  | (18540) |
| Total Foreign Currency Exchange Contracts | Total Foreign Currency Exchange Contracts | Total Foreign Currency Exchange Contracts |  |  |  | $3045 | $(18851) |

---

The use of foreign currency exchange contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The foreign currency exchange contract presented above represent the Portfolio's total exposure in such contracts, whereas only the net unrealized appreciation (depreciation) is reflected in the Portfolio's net assets.

<sup>1</sup>See Note 10 in "Notes to financial statements."

**Summary of abbreviations:**

ADR – American Depositary Receipt

AG – Aktiengesellschaft

BNYM – Bank of New York Mellon

**Summary of currencies:**

CHF – Swiss Franc

KRW – South Korean Won

USD – US Dollar

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Mid Cap Growth December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 97.95% ⧫** |  |  |
| &nbsp;&nbsp;Communication Services — 7.05% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Electronic Arts | 45187 | $5520948 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pinterest Class A † | 484348 | 11759946 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shutterstock | 86019 | 4534922 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade Desk Class A † | 137438 | 6161345 |
| &nbsp;&nbsp;&nbsp;&nbsp;ZoomInfo Technologies † | 147817 | 4450770 |
|  |  | 32427931 |
| &nbsp;&nbsp;Consumer Discretionary — 14.69% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BorgWarner | 263672 | 10612798 |
| &nbsp;&nbsp;&nbsp;&nbsp;Chipotle Mexican Grill † | 7358 | 10209152 |
| &nbsp;&nbsp;&nbsp;&nbsp;Floor & Decor Holdings Class A † | 71789 | 4998668 |
| &nbsp;&nbsp;&nbsp;&nbsp;Levi Strauss & Co. Class A \* | 342774 | 5319853 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lululemon Athletica † | 21501 | 6888490 |
| &nbsp;&nbsp;&nbsp;&nbsp;National Vision Holdings \*, † | 175636 | 6807651 |
| &nbsp;&nbsp;&nbsp;&nbsp;On Holding Class A † | 250103 | 4291768 |
| &nbsp;&nbsp;&nbsp;&nbsp;Petco Health & Wellness † | 310930 | 2947616 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pool | 24596 | 7436109 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vail Resorts | 33935 | 8088407 |
|  |  | 67600512 |
| &nbsp;&nbsp;Consumer Staples — 1.36% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Brown-Forman Class B | 94998 | 6239469 |
|  |  | 6239469 |
| &nbsp;&nbsp;Financials — 6.88% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;First Republic Bank | 63210 | 7704667 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kinsale Capital Group | 18053 | 4721220 |
| &nbsp;&nbsp;&nbsp;&nbsp;MarketAxess Holdings | 50324 | 14034860 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pinnacle Financial Partners | 70694 | 5188940 |
|  |  | 31649687 |
| &nbsp;&nbsp;Healthcare — 18.50% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Agilent Technologies | 52667 | 7881617 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bio-Techne | 92716 | 7684302 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dexcom ~, † | 159158 | 18023052 |
| &nbsp;&nbsp;&nbsp;&nbsp;Edwards Lifesciences † | 80757 | 6025280 |
| &nbsp;&nbsp;&nbsp;&nbsp;Envista Holdings † | 228811 | 7704066 |
| &nbsp;&nbsp;&nbsp;&nbsp;Genmab ADR \*, † | 199716 | 8463964 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intuitive Surgical † | 34195 | 9073643 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repligen † | 51697 | 8752819 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seagen † | 54285 | 6976165 |
| &nbsp;&nbsp;&nbsp;&nbsp;West Pharmaceutical Services | 19363 | 4557082 |
|  |  | 85141990 |
| &nbsp;&nbsp;Industrials — 16.13% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;A O Smith | 109755 | 6282376 |
| &nbsp;&nbsp;&nbsp;&nbsp;Clarivate † | 372163 | 3103839 |
| &nbsp;&nbsp;&nbsp;&nbsp;Copart † | 83228 | 5067753 |
| &nbsp;&nbsp;&nbsp;&nbsp;CoStar Group ~, † | 281278 | 21737164 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fastenal ~ | 145696 | 6894335 |
| &nbsp;&nbsp;&nbsp;&nbsp;Generac Holdings † | 45338 | 4563723 |
| &nbsp;&nbsp;&nbsp;&nbsp;HEICO Class A | 85518 | 10249332 |
| &nbsp;&nbsp;&nbsp;&nbsp;IDEX | 29720 | 6785968 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Lincoln Electric Holdings | 19236 | 2779410 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trex † | 159631 | 6757180 |
|  |  | 74221080 |
| &nbsp;&nbsp;Information Technology — 32.49% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Arista Networks † | 73492 | 8918254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Coherent \*, † | 199984 | 7019438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Crowdstrike Holdings Class A † | 54644 | 5753467 |
| &nbsp;&nbsp;&nbsp;&nbsp;DocuSign † | 125431 | 6951386 |
| &nbsp;&nbsp;&nbsp;&nbsp;EngageSmart \*, † | 124213 | 2186149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Five9 † | 79901 | 5422082 |
| &nbsp;&nbsp;&nbsp;&nbsp;Genpact | 98484 | 4561779 |
| &nbsp;&nbsp;&nbsp;&nbsp;HubSpot † | 5806 | 1678689 |
| &nbsp;&nbsp;&nbsp;&nbsp;Keysight Technologies † | 59902 | 10247435 |
| &nbsp;&nbsp;&nbsp;&nbsp;Littelfuse | 22766 | 5013073 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marvell Technology | 211089 | 7818737 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microchip Technology | 154782 | 10873436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Monolithic Power Systems | 35984 | 12724302 |
| &nbsp;&nbsp;&nbsp;&nbsp;Novanta † | 41241 | 5603415 |
| &nbsp;&nbsp;&nbsp;&nbsp;Paycom Software † | 31905 | 9900441 |
| &nbsp;&nbsp;&nbsp;&nbsp;Teradyne \* | 111514 | 9740748 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trimble † | 126437 | 6392655 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tyler Technologies † | 27245 | 8784060 |
| &nbsp;&nbsp;&nbsp;&nbsp;Universal Display | 56537 | 6108257 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workday Class A † | 29304 | 4903438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workiva \*, † | 67855 | 5697784 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zebra Technologies Class A † | 12562 | 3221022 |
|  |  | 149520047 |
| &nbsp;&nbsp;Materials — 0.85% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Martin Marietta Materials | 11630 | 3930591 |
|  |  | 3930591 |
| &nbsp;&nbsp;**Total Common Stocks**<br> (cost $427,247,585) |  | **450731307** |
| &nbsp;&nbsp;**Short-Term Investments — 2.21%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 2.21% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day <br> effective yield 4.03%) | 2545258 | 2545258 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio –<br> Class I (seven-day effective <br> yield 4.06%) | 2545259 | 2545259 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 2545259 | 2545259 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Short-Term Investments (continued)** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 2545258 | $2545258 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $10,181,034) |  | **10181034** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral—100.16%** <br> (cost $437,428,619) |  | **460912341** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 0.04%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 0.04% |  |  |
| &nbsp;&nbsp;Dreyfus Institutional Preference <br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 195750 | 195750 |
| &nbsp;&nbsp;**Total Securities Lending Collateral** <br> (cost $195,750) |  | **195750** |
| &nbsp;&nbsp;**Total Value of Securities—100.20%** <br> (cost $437,624,369) |  | $**461,108,091■** |

---

---

| | |
|:---|:---|
| ⧫ | Narrow industries are utilized for compliance purposes for concentration whereas broad sectors are used for financial reporting. |
| † | Non-income producing security. |
| \* | Fully or partially on loan. |
| ~ | All or portion of the security has been pledged as collateral for potential options written. |
| <sup>\*\*</sup> | See Note 12 in "Notes to financial statements" for additional information on securities lending collateral. |
| ■ | Includes $16,635,152 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $16,762,042. |

---

**Summary of abbreviations:**

ADR – American Depositary Receipt

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Natural Resources

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Closed-Ended Trust — 3.19%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Sprott Physical Uranium Trust † | 299077 | $3496595 |
| &nbsp;&nbsp;**Total Closed-Ended Trust**<br> (cost $3,680,636) |  | **3496595** |
| &nbsp;&nbsp;**Common Stocks — 95.35%** |  |  |
| &nbsp;&nbsp;Basic Industry — 27.69% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Anglo American | 99622 | 3897976 |
| &nbsp;&nbsp;&nbsp;&nbsp;CF Industries Holdings | 41526 | 3538015 |
| &nbsp;&nbsp;&nbsp;&nbsp;ERO Copper † | 209026 | 2877581 |
| &nbsp;&nbsp;&nbsp;&nbsp;Freeport-McMoRan | 106122 | 4032636 |
| &nbsp;&nbsp;&nbsp;&nbsp;Hudbay Minerals | 505521 | 2562992 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kinross Gold \* | 394341 | 1612855 |
| &nbsp;&nbsp;&nbsp;&nbsp;Newmont | 94913 | 4479894 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nutrien | 42341 | 3092163 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wheaton Precious Metals \* | 108291 | 4232012 |
|  |  | 30326124 |
| &nbsp;&nbsp;Consumer Discretionary — 0.50% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Spruce Power Holding † | 588606 | 540988 |
|  |  | 540988 |
| &nbsp;&nbsp;Consumer Staples — 7.59% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Archer-Daniels-Midland | 29971 | 2782807 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bunge | 31753 | 3167997 |
| &nbsp;&nbsp;&nbsp;&nbsp;Darling Ingredients † | 37791 | 2365339 |
|  |  | 8316143 |
| &nbsp;&nbsp;Energy — 43.17% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Chesapeake Energy \* | 50751 | 4789372 |
| &nbsp;&nbsp;&nbsp;&nbsp;Chord Energy | 18951 | 2592686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Denbury † | 53979 | 4697253 |
| &nbsp;&nbsp;&nbsp;&nbsp;EOG Resources | 26970 | 3493154 |
| &nbsp;&nbsp;&nbsp;&nbsp;EQT | 74911 | 2534239 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kimbell Royalty Partners | 241447 | 4032165 |
| &nbsp;&nbsp;&nbsp;&nbsp;Occidental Petroleum | 41343 | 2604196 |
| &nbsp;&nbsp;&nbsp;&nbsp;Parex Resources | 76008 | 1131138 |
| &nbsp;&nbsp;&nbsp;&nbsp;Schlumberger | 87316 | 4667913 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shell | 153596 | 4319147 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sunrun † | 56734 | 1362751 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unit † | 57541 | 3329322 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valaris † | 40100 | 2711562 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valero Energy | 39545 | 5016679 |
|  |  | 47281577 |
| &nbsp;&nbsp;Financials — 0.52% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rice Acquisition Class A † | 55696 | 566428 |
|  |  | 566428 |
| &nbsp;&nbsp;Industrials — 5.46% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Arcosa | 65724 | 3571442 |
| &nbsp;&nbsp;&nbsp;&nbsp;China Metal Recycling Holdings = | 1900000 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Li-Cycle Holdings † | 215956 | 1027951 |
| &nbsp;&nbsp;&nbsp;&nbsp;NuScale Power \*, † | 134390 | 1378841 |
|  |  | 5978234 |
| &nbsp;&nbsp;Materials — 8.39% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Alcoa | 81649 | 3712580 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corteva | 18682 | 1098128 |
| &nbsp;&nbsp;&nbsp;&nbsp;Louisiana-Pacific | 27567 | 1631966 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pan American Silver | 101893 | 1663099 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sylvamo | 22299 | 1083508 |
|  |  | 9189281 |
| &nbsp;&nbsp;Real Estate Investment Trusts — 2.03% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weyerhaeuser | 71786 | 2225366 |
|  |  | 2225366 |
| &nbsp;&nbsp;**Total Common Stocks** <br> (cost $105,813,987) |  | **104424141** |
| &nbsp;&nbsp;**Short-Term Investments — 1.45%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 1.45% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day<br> effective yield 4.03%) | 397827 | 397827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio – <br> Class I (seven-day effective <br> yield 4.06%) | 397827 | 397827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 397827 | 397827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 397828 | 397828 |
| &nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $1,591,309) |  | **1591309** |
| &nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral—99.99%** <br> (cost $111,085,932) |  | **109512045** |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 3.52%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 3.52% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference <br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield 4.31%) | 3858940 | $3858940 |
| &nbsp;&nbsp;**Total Securities Lending Collateral** <br> (cost $3,858,940) |  | **3858940** |
| &nbsp;&nbsp;**Total Value of Securities—103.51%** <br> (cost $114,944,872) |  | $**113,370,985■** |

---

---

| | |
|:---|:---|
| <sup>†</sup> | Non-income producing security. |
| <sup>t</sup> | Narrow industries are utilized for compliance purposes for concentration whereas broad sectors are used for financial reporting. |
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>=</sup> | The value of this security was determined using significant unobservable inputs and is reported as a Level 3 security in the disclosure table located in Note 3 in "Notes to financial statements." |
| <sup>\*\*</sup> | See Note 12 in "Notes to financial statements" for additional information on securities lending collateral. |
| <sup>■</sup> | Includes $8,496,793 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $4,897,854. |

---

The following foreign currency exchange contracts were outstanding at December 31, 2022:<sup>1</sup>

**Foreign Currency Exchange Contracts**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Counterparty | Currency to <br> Receive (Deliver) | In Exchange For | In Exchange For | Settlement <br> Date | Unrealized <br> Depreciation |
| BNYM CAD | (144392) | USD | 106506 | 1/3/23 | $(137) |

---

The use of foreign currency exchange contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The foreign currency exchange contract presented above represent the Portfolio's total exposure in such contracts, whereas only the net unrealized appreciation (depreciation) is reflected in the Portfolio's net assets.

<sup>1</sup> See Note 10 in "Notes to financial statements."

**Summary of abbreviations:**

BNYM – Bank of New York Mellon

**Summary of currencies:**

CAD – Canadian Dollar

USD – US Dollar

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Science and Technology

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 95.48%** |  |  |
| &nbsp;&nbsp;Communication Services — 13.12% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Alphabet Class A † | 116875 | $10311881 |
| &nbsp;&nbsp;&nbsp;&nbsp;Netflix † | 36852 | 10866918 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pinterest Class A † | 611031 | 14835857 |
| &nbsp;&nbsp;&nbsp;&nbsp;Take-Two Interactive Software † | 48347 | 5034373 |
| &nbsp;&nbsp;&nbsp;&nbsp;T-Mobile US † | 130324 | 18245360 |
|  |  | 59294389 |
| &nbsp;&nbsp;Consumer Discretionary — 9.13% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amazon.com † | 232973 | 19569732 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aptiv † | 102005 | 9499726 |
| &nbsp;&nbsp;&nbsp;&nbsp;Etsy † | 74415 | 8913429 |
| &nbsp;&nbsp;&nbsp;&nbsp;Luminar Technologies \*, † | 663455 | 3284102 |
|  |  | 41266989 |
| &nbsp;&nbsp;Healthcare — 7.74% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Danaher | 43784 | 11621149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Edwards Lifesciences † | 61866 | 4615822 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intuitive Surgical † | 17432 | 4625581 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ionis Pharmaceuticals † | 125791 | 4751126 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals † | 24174 | 6980968 |
| &nbsp;&nbsp;&nbsp;&nbsp;West Pharmaceutical Services | 10074 | 2370916 |
|  |  | 34965562 |
| &nbsp;&nbsp;Industrials — 2.11% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Copart † | 44646 | 2718495 |
| &nbsp;&nbsp;&nbsp;&nbsp;L3Harris Technologies | 32830 | 6835534 |
|  |  | 9554029 |
| &nbsp;&nbsp;Information Technology — 63.38% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ambarella † | 120845 | 9937084 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amphenol Class A | 204284 | 15554184 |
| &nbsp;&nbsp;&nbsp;&nbsp;Analog Devices | 85317 | 13994547 |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple | 132728 | 17245349 |
| &nbsp;&nbsp;&nbsp;&nbsp;ASML Holding | 37093 | 20267615 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aspen Technology † | 22289 | 4578161 |
| &nbsp;&nbsp;&nbsp;&nbsp;Autodesk † | 48399 | 9044321 |
| &nbsp;&nbsp;&nbsp;&nbsp;Broadcom | 4477 | 2503225 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cadence Design Systems † | 57642 | 9259611 |
| &nbsp;&nbsp;&nbsp;&nbsp;CDW | 12719 | 2271359 |
| &nbsp;&nbsp;&nbsp;&nbsp;Flex † | 125485 | 2692908 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intuit | 29495 | 11480044 |
| &nbsp;&nbsp;&nbsp;&nbsp;Keysight Technologies † | 15952 | 2728909 |
| &nbsp;&nbsp;&nbsp;&nbsp;KLA | 32974 | 12432187 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mastercard Class A | 33807 | 11755708 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microchip Technology | 202040 | 14193310 |
| &nbsp;&nbsp;&nbsp;&nbsp;Micron Technology | 214925 | 10741951 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microsoft | 134546 | 32266822 |
| &nbsp;&nbsp;&nbsp;&nbsp;NVIDIA | 54605 | 7979975 |
| &nbsp;&nbsp;&nbsp;&nbsp;ON Semiconductor † | 190613 | 11888533 |
| &nbsp;&nbsp;&nbsp;&nbsp;PayPal Holdings † | 45903 | 3269212 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seagate Technology Holdings \* | 248318 | 13064010 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shift4 Payments Class A † | 166701 | 9323587 |
| &nbsp;&nbsp;&nbsp;&nbsp;Taiwan Semiconductor |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Manufacturing ADR | 42204 | 3143776 |
| &nbsp;&nbsp;&nbsp;&nbsp;VeriSign † | 71592 | 14707860 |
| &nbsp;&nbsp;&nbsp;&nbsp;WNS Holdings ADR † | 115730 | 9257243 |
| &nbsp;&nbsp;Zebra Technologies Class A † | 42210 | 10823066 |
|  |  | 286404557 |
| &nbsp;&nbsp;**Total Common Stocks** <br> (cost $437,548,312) |  | **431485526** |
| &nbsp;&nbsp;**Short-Term Investments — 4.60%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 4.60% |  |  |
| &nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day<br> effective yield 4.03%) | 5200068 | 5200068 |
| &nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio –<br> Class I (seven-day effective <br> yield 4.06%) | 5200068 | 5200068 |
| &nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – <br> Institutional Shares (seven-day<br> effective yield 4.23%) | 5200067 | 5200067 |
| &nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 5200068 | 5200068 |
| &nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $20,800,271) |  | **20800271** |
| &nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral—100.08%** <br> (cost $458,348,583) |  | **452285797** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 0.15%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 0.15% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference <br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 652255 | 652255 |
| &nbsp;&nbsp;**Total Securities Lending Collateral** <br> (cost $652,255) |  | **652255** |
| &nbsp;&nbsp;**Total Value of Securities—100.23%** <br> (cost $459,000,838) |  | $**452,938,052■** |

---

---

| | |
|:---|:---|
| <sup>t</sup> | Narrow industries are utilized for compliance purposes for concentration whereas broad sectors are used for financial reporting. |
| <sup>†</sup> | Non-income producing security. |
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>\*\*</sup> | See Note 12 in "Notes to financial statements" for additional information on securities lending collateral. |
| <sup>■</sup> | Includes $12,389,802 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $12,111,810. |

---

[**Table of Contents**](#toc1)

**Summary of abbreviations:**

ADR – American Depositary Receipt

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Small Cap Growth

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 97.14%** |  |  |
| &nbsp;&nbsp;Communication Services — 1.55% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Iridium Communications † | 40958 | $2105241 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nexstar Media Group | 5601 | 980343 |
|  |  | 3085584 |
| &nbsp;&nbsp;Consumer Discretionary — 13.92% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Boot Barn Holdings † | 32963 | 2060847 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fox Factory Holding † | 40347 | 3680857 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marriott Vacations Worldwide | 33241 | 4473906 |
| &nbsp;&nbsp;&nbsp;&nbsp;Monarch Casino & Resort † | 48741 | 3747696 |
| &nbsp;&nbsp;&nbsp;&nbsp;Red Rock Resorts Class A | 115396 | 4616994 |
| &nbsp;&nbsp;&nbsp;&nbsp;Texas Roadhouse | 42836 | 3895934 |
| &nbsp;&nbsp;&nbsp;&nbsp;Visteon † | 35587 | 4655847 |
| &nbsp;&nbsp;&nbsp;&nbsp;Xometry Class A \*, † | 17378 | 560093 |
|  |  | 27692174 |
| &nbsp;&nbsp;Consumer Staples — 5.48% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BJ's Wholesale Club Holdings † | 85545 | 5659657 |
| &nbsp;&nbsp;&nbsp;&nbsp;Duckhorn Portfolio † | 106372 | 1762584 |
| &nbsp;&nbsp;&nbsp;&nbsp;MGP Ingredients | 22817 | 2427273 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sovos Brands † | 73721 | 1059371 |
|  |  | 10908885 |
| &nbsp;&nbsp;Energy — 5.85% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cactus Class A | 84095 | 4226615 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liberty Energy | 114685 | 1836107 |
| &nbsp;&nbsp;&nbsp;&nbsp;Northern Oil and Gas \* | 45316 | 1396639 |
| &nbsp;&nbsp;&nbsp;&nbsp;SM Energy | 60995 | 2124456 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weatherford International † | 40205 | 2047238 |
|  |  | 11631055 |
| &nbsp;&nbsp;Financials — 4.49% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Focus Financial Partners |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class A † | 41371 | 1541897 |
| &nbsp;&nbsp;&nbsp;&nbsp;Houlihan Lokey | 16752 | 1460104 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kinsale Capital Group | 16200 | 4236624 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seacoast Banking | 54107 | 1687598 |
|  |  | 8926223 |
| &nbsp;&nbsp;Healthcare — 21.32% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AMN Healthcare Services † | 17987 | 1849423 |
| &nbsp;&nbsp;&nbsp;&nbsp;Axonics † | 33324 | 2083750 |
| &nbsp;&nbsp;&nbsp;&nbsp;CareDx † | 82870 | 945547 |
| &nbsp;&nbsp;&nbsp;&nbsp;CryoPort † | 136113 | 2361561 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cytek Biosciences † | 98835 | 1009105 |
| &nbsp;&nbsp;&nbsp;&nbsp;Evolent Health Class A † | 99386 | 2790759 |
| &nbsp;&nbsp;&nbsp;&nbsp;Harmony Biosciences Holdings \*, † | 65508 | 3609491 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inmode † | 110182 | 3933497 |
| &nbsp;&nbsp;&nbsp;&nbsp;Insmed † | 57685 | 1152546 |
| &nbsp;&nbsp;&nbsp;&nbsp;Option Care Health † | 81703 | 2458443 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pacira BioSciences \*, † | 82119 | 3170615 |
| &nbsp;&nbsp;&nbsp;&nbsp;Penumbra † | 17059 | 3794945 |
| &nbsp;&nbsp;&nbsp;&nbsp;Privia Health Group † | 119649 | 2717229 |
| &nbsp;&nbsp;&nbsp;&nbsp;Progyny † | 125727 | 3916396 |
| &nbsp;&nbsp;&nbsp;&nbsp;PTC Therapeutics † | 21338 | 814472 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tandem Diabetes Care † | 27495 | 1235900 |
| &nbsp;&nbsp;&nbsp;&nbsp;TransMedics Group † | 31370 | 1936156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vericel † | 100036 | 2634948 |
|  |  | 42414783 |
| &nbsp;&nbsp;Industrials — 18.76% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AAON | 20573 | 1549558 |
| &nbsp;&nbsp;&nbsp;&nbsp;Air Transport Services Group † | 102551 | 2664275 |
| &nbsp;&nbsp;&nbsp;&nbsp;Casella Waste Systems Class A † | 47067 | 3732884 |
| &nbsp;&nbsp;&nbsp;&nbsp;CBIZ † | 19113 | 895444 |
| &nbsp;&nbsp;&nbsp;&nbsp;Chart Industries † | 11594 | 1335977 |
| &nbsp;&nbsp;&nbsp;&nbsp;Clean Harbors † | 31640 | 3610757 |
| &nbsp;&nbsp;&nbsp;&nbsp;EnerSys | 47938 | 3539742 |
| &nbsp;&nbsp;&nbsp;&nbsp;Evoqua Water Technologies † | 66291 | 2625124 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kirby † | 47575 | 3061451 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kornit Digital † | 35262 | 809968 |
| &nbsp;&nbsp;&nbsp;&nbsp;Parsons † | 23333 | 1079151 |
| &nbsp;&nbsp;&nbsp;&nbsp;RBC Bearings \*, † | 14043 | 2939902 |
| &nbsp;&nbsp;&nbsp;&nbsp;Saia † | 13492 | 2829003 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shoals Technologies Group Class A † | 136896 | 3377224 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valmont Industries | 9867 | 3262721 |
|  |  | 37313181 |
| &nbsp;&nbsp;Information Technology — 23.51% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Allegro MicroSystems † | 181927 | 5461448 |
| &nbsp;&nbsp;&nbsp;&nbsp;Belden | 19206 | 1380911 |
| &nbsp;&nbsp;&nbsp;&nbsp;Box Class A † | 100243 | 3120565 |
| &nbsp;&nbsp;&nbsp;&nbsp;Calix † | 24634 | 1685705 |
| &nbsp;&nbsp;&nbsp;&nbsp;CyberArk Software † | 29649 | 3843993 |
| &nbsp;&nbsp;&nbsp;&nbsp;DoubleVerify Holdings † | 96822 | 2126211 |
| &nbsp;&nbsp;&nbsp;&nbsp;Five9 † | 28043 | 1902998 |
| &nbsp;&nbsp;&nbsp;&nbsp;Globant † | 19299 | 3245320 |
| &nbsp;&nbsp;&nbsp;&nbsp;Instructure Holdings † | 83813 | 1964577 |
| &nbsp;&nbsp;&nbsp;&nbsp;Jamf Holding \*, † | 63855 | 1360111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Onto Innovation † | 18800 | 1280092 |
| &nbsp;&nbsp;&nbsp;&nbsp;Paycor HCM † | 162750 | 3982492 |
| &nbsp;&nbsp;&nbsp;&nbsp;Power Integrations | 24157 | 1732540 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shift4 Payments Class A † | 53278 | 2979839 |
| &nbsp;&nbsp;&nbsp;&nbsp;Smartsheet Class A † | 75996 | 2991203 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sprout Social Class A † | 50903 | 2873983 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tenable Holdings † | 73190 | 2792198 |
| &nbsp;&nbsp;&nbsp;&nbsp;Viavi Solutions † | 193923 | 2038131 |
|  |  | 46762317 |
| &nbsp;&nbsp;Materials — 1.47% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ATI † | 97635 | 2915381 |
|  |  | 2915381 |
| &nbsp;&nbsp;Real Estate — 0.79% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ryman Hospitality Properties | 19312 | 1579335 |
|  |  | 1579335 |
| &nbsp;&nbsp;**Total Common Stocks** <br> (cost $223,230,740) |  | **193228918** |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Short-Term Investments — 3.01%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 3.01% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day <br> effective yield 4.03%) | 1497032 | $1497032 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio – <br> Class I (seven-day effective <br> yield 4.06%) | 1497032 | 1497032 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund –<br> Institutional Shares (seven-day <br> effective yield 4.23%) | 1497032 | 1497032 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 1497031 | 1497031 |
| &nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $5,988,127) |  | **5988127** |
| &nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral—100.15%** <br> (cost $229,218,867) |  | **199217045** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 0.09%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 0.09% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference <br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 168219 | 168219 |
| &nbsp;&nbsp;**Total Securities Lending Collateral** <br> (cost $168,219) |  | **168219** |
| &nbsp;&nbsp;**Total Value of Securities—100.24%** <br> (cost $229,387,086) |  | $**199,385,264■** |

---

---

| | |
|:---|:---|
| <sup>†</sup> | Non-income producing security. |
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>\*\*</sup> | See Note 12 in "Notes to financial statements" for additional information on securities lending collateral. |
| ■ | Includes $7,458,683 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $7,482,590. |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Smid Cap Core

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 98.22%** |  |  |
| &nbsp;&nbsp;Basic Materials — 7.88% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beacon Roofing Supply \*, † | 22730 | $1199917 |
| &nbsp;&nbsp;&nbsp;&nbsp;Boise Cascade | 18704 | 1284404 |
| &nbsp;&nbsp;&nbsp;&nbsp;Huntsman | 82504 | 2267210 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kaiser Aluminum | 13369 | 1015509 |
| &nbsp;&nbsp;&nbsp;&nbsp;Minerals Technologies | 26877 | 1631971 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reliance Steel & Aluminum | 13070 | 2645891 |
| &nbsp;&nbsp;&nbsp;&nbsp;Westrock | 28087 | 987539 |
| &nbsp;&nbsp;&nbsp;&nbsp;Worthington Industries | 28716 | 1427472 |
|  |  | 12459913 |
| &nbsp;&nbsp;Business Services — 5.44% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ABM Industries | 24682 | 1096374 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aramark | 47829 | 1977251 |
| &nbsp;&nbsp;&nbsp;&nbsp;ASGN † | 16796 | 1368538 |
| &nbsp;&nbsp;&nbsp;&nbsp;Casella Waste Systems Class A † | 10140 | 804203 |
| &nbsp;&nbsp;&nbsp;&nbsp;Clean Harbors † | 8913 | 1017152 |
| &nbsp;&nbsp;&nbsp;&nbsp;WillScot Mobile Mini Holdings † | 51877 | 2343284 |
|  |  | 8606802 |
| &nbsp;&nbsp;Capital Goods — 10.78% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ameresco Class A \*, † | 13156 | 751734 |
| &nbsp;&nbsp;&nbsp;&nbsp;Barnes Group | 9887 | 403884 |
| &nbsp;&nbsp;&nbsp;&nbsp;Carlisle | 4770 | 1124050 |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal Signal | 18389 | 854537 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gates Industrial † | 34066 | 388693 |
| &nbsp;&nbsp;&nbsp;&nbsp;Graco | 15379 | 1034392 |
| &nbsp;&nbsp;&nbsp;&nbsp;Jacobs Solutions | 6731 | 808191 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kadant | 3581 | 636093 |
| &nbsp;&nbsp;&nbsp;&nbsp;KBR | 21920 | 1157376 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lincoln Electric Holdings | 9786 | 1413979 |
| &nbsp;&nbsp;&nbsp;&nbsp;MasTec † | 14444 | 1232506 |
| &nbsp;&nbsp;&nbsp;&nbsp;Oshkosh | 12306 | 1085266 |
| &nbsp;&nbsp;&nbsp;&nbsp;Quanta Services | 16034 | 2284845 |
| &nbsp;&nbsp;&nbsp;&nbsp;Regal Rexnord | 6596 | 791388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tetra Tech | 6403 | 929652 |
| &nbsp;&nbsp;&nbsp;&nbsp;WESCO International † | 11414 | 1429033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zurn Elkay Water Solutions | 33946 | 717958 |
|  |  | 17043577 |
| &nbsp;&nbsp;Consumer Discretionary — 5.78% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BJ's Wholesale Club Holdings † | 18680 | 1235869 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dick's Sporting Goods | 16962 | 2040359 |
| &nbsp;&nbsp;&nbsp;&nbsp;Five Below † | 11711 | 2071324 |
| &nbsp;&nbsp;&nbsp;&nbsp;Malibu Boats Class A † | 21814 | 1162686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Steven Madden | 49033 | 1567095 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tractor Supply | 4711 | 1059834 |
|  |  | 9137167 |
| &nbsp;&nbsp;Consumer Services — 2.21% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Brinker International † | 22723 | 725091 |
| &nbsp;&nbsp;&nbsp;&nbsp;Jack in the Box | 7923 | 540586 |
| &nbsp;&nbsp;&nbsp;&nbsp;Texas Roadhouse | 12763 | 1160795 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wendy's | 46914 | 1061664 |
|  |  | 3488136 |
| &nbsp;&nbsp;Consumer Staples — 3.19% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Casey's General Stores | 9754 | 2188310 |
| &nbsp;&nbsp;&nbsp;&nbsp;Helen of Troy † | 3895 | 431994 |
| &nbsp;&nbsp;&nbsp;&nbsp;J & J Snack Foods | 8200 | 1227622 |
| &nbsp;&nbsp;&nbsp;&nbsp;YETI Holdings † | 29112 | 1202617 |
|  |  | 5050543 |
| &nbsp;&nbsp;Credit Cyclicals — 3.11% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BorgWarner | 30103 | 1211646 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dana | 37295 | 564273 |
| &nbsp;&nbsp;&nbsp;&nbsp;KB Home | 15626 | 497688 |
| &nbsp;&nbsp;&nbsp;&nbsp;La-Z-Boy | 25473 | 581294 |
| &nbsp;&nbsp;&nbsp;&nbsp;Taylor Morrison Home † | 22543 | 684180 |
| &nbsp;&nbsp;&nbsp;&nbsp;Toll Brothers | 27780 | 1386778 |
|  |  | 4925859 |
| &nbsp;&nbsp;Energy — 5.33% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Chesapeake Energy \* | 29584 | 2791842 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diamondback Energy | 15332 | 2097111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liberty Energy | 220698 | 3533375 |
|  |  | 8422328 |
| &nbsp;&nbsp;Financials — 15.52% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Axis Capital Holdings | 31804 | 1722823 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comerica | 18898 | 1263331 |
| &nbsp;&nbsp;&nbsp;&nbsp;East West Bancorp | 32072 | 2113545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Essent Group | 33688 | 1309789 |
| &nbsp;&nbsp;&nbsp;&nbsp;Hamilton Lane Class A | 13754 | 878606 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kemper | 26338 | 1295830 |
| &nbsp;&nbsp;&nbsp;&nbsp;NMI Holdings Class A † | 32945 | 688550 |
| &nbsp;&nbsp;&nbsp;&nbsp;Primerica | 15427 | 2187857 |
| &nbsp;&nbsp;&nbsp;&nbsp;Raymond James Financial | 13634 | 1456793 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinsurance Group of America | 15156 | 2153516 |
| &nbsp;&nbsp;&nbsp;&nbsp;SouthState | 17083 | 1304458 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stifel Financial | 29364 | 1713977 |
| &nbsp;&nbsp;&nbsp;&nbsp;Umpqua Holdings | 81053 | 1446796 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valley National Bancorp | 97680 | 1104761 |
| &nbsp;&nbsp;&nbsp;&nbsp;Webster Financial | 39124 | 1852130 |
| &nbsp;&nbsp;&nbsp;&nbsp;Western Alliance Bancorp | 15340 | 913650 |
| &nbsp;&nbsp;&nbsp;&nbsp;WSFS Financial | 25020 | 1134407 |
|  |  | 24540819 |
| &nbsp;&nbsp;Healthcare — 13.05% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amicus Therapeutics † | 60890 | 743467 |
| &nbsp;&nbsp;&nbsp;&nbsp;Azenta | 15195 | 884653 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bio-Techne | 16497 | 1367271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Blueprint Medicines † | 16466 | 721376 |
| &nbsp;&nbsp;&nbsp;&nbsp;Catalent † | 20307 | 914018 |
| &nbsp;&nbsp;&nbsp;&nbsp;Encompass Health | 22590 | 1351108 |
| &nbsp;&nbsp;&nbsp;&nbsp;Exact Sciences † | 12576 | 622638 |

---

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | **Number of <br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks (continued)** |  |  |
| &nbsp;&nbsp;Healthcare (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Halozyme Therapeutics † | 33740 | $1919806 |
| &nbsp;&nbsp;&nbsp;&nbsp;ICON † | 5826 | 1131701 |
| &nbsp;&nbsp;&nbsp;&nbsp;Insmed † | 34628 | 691867 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inspire Medical Systems † | 6463 | 1627900 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ligand Pharmaceuticals † | 10668 | 712622 |
| &nbsp;&nbsp;&nbsp;&nbsp;Natera † | 19790 | 794964 |
| &nbsp;&nbsp;&nbsp;&nbsp;Neurocrine Biosciences † | 14950 | 1785628 |
| &nbsp;&nbsp;&nbsp;&nbsp;OmniAb † | 52049 | 187376 |
| &nbsp;&nbsp;&nbsp;&nbsp;OmniAb 12.5 =, † | 3816 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;OmniAb 15 =, † | 3816 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;QuidelOrtho † | 8519 | 729823 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repligen † | 8065 | 1365485 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shockwave Medical † | 6644 | 1366073 |
| &nbsp;&nbsp;&nbsp;&nbsp;Supernus Pharmaceuticals † | 28492 | 1016310 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ultragenyx Pharmaceutical † | 15076 | 698471 |
|  |  | 20632557 |
| &nbsp;&nbsp;Media — 1.79% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;IMAX † | 41018 | 601324 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interpublic Group | 42097 | 1402251 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nexstar Media Group | 4719 | 825967 |
|  |  | 2829542 |
| &nbsp;&nbsp;Real Estate Investment Trusts — 6.39% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Brixmor Property Group | 71319 | 1616802 |
| &nbsp;&nbsp;&nbsp;&nbsp;Camden Property Trust | 12692 | 1419981 |
| &nbsp;&nbsp;&nbsp;&nbsp;DiamondRock Hospitality | 63439 | 519565 |
| &nbsp;&nbsp;&nbsp;&nbsp;First Industrial Realty Trust | 31518 | 1521059 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kite Realty Group Trust | 65593 | 1380733 |
| &nbsp;&nbsp;&nbsp;&nbsp;Life Storage | 14879 | 1465581 |
| &nbsp;&nbsp;&nbsp;&nbsp;LXP Industrial Trust | 67931 | 680668 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pebblebrook Hotel Trust | 45482 | 609004 |
| &nbsp;&nbsp;&nbsp;&nbsp;Physicians Realty Trust | 61306 | 887098 |
|  |  | 10100491 |
| &nbsp;&nbsp;Technology — 12.77% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Blackline † | 6003 | 403822 |
| &nbsp;&nbsp;&nbsp;&nbsp;Box Class A † | 15062 | 468880 |
| &nbsp;&nbsp;&nbsp;&nbsp;Coherent † | 25736 | 903334 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dynatrace † | 21210 | 812343 |
| &nbsp;&nbsp;&nbsp;&nbsp;ExlService Holdings † | 13582 | 2301198 |
| &nbsp;&nbsp;&nbsp;&nbsp;Guidewire Software † | 10366 | 648497 |
| &nbsp;&nbsp;&nbsp;&nbsp;MACOM Technology Solutions |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Holdings † | 17061 | 1074502 |
| &nbsp;&nbsp;&nbsp;&nbsp;MaxLinear † | 28220 | 958069 |
| &nbsp;&nbsp;&nbsp;&nbsp;ON Semiconductor † | 21029 | 1311579 |
| &nbsp;&nbsp;&nbsp;&nbsp;Paycom Software † | 1376 | 426987 |
| &nbsp;&nbsp;&nbsp;&nbsp;Procore Technologies † | 13548 | 639195 |
| &nbsp;&nbsp;&nbsp;&nbsp;PTC † | 15627 | 1875865 |
| &nbsp;&nbsp;&nbsp;&nbsp;Q2 Holdings † | 21312 | 572653 |
| &nbsp;&nbsp;&nbsp;&nbsp;Rapid7 † | 11793 | 400726 |
| &nbsp;&nbsp;&nbsp;&nbsp;Semtech † | 16199 | 464749 |
| &nbsp;&nbsp;&nbsp;&nbsp;Silicon Laboratories † | 6701 | 909125 |
| &nbsp;&nbsp;&nbsp;&nbsp;Smartsheet Class A † | 18482 | 727452 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sprout Social Class A † | 7548 | 426160 |
| &nbsp;&nbsp;&nbsp;&nbsp;SS&C Technologies Holdings | 9488 | 493945 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tyler Technologies † | 830 | 267600 |
| &nbsp;&nbsp;&nbsp;&nbsp;Varonis Systems † | 27113 | 649085 |
| &nbsp;&nbsp;&nbsp;&nbsp;WNS Holdings ADR † | 21977 | 1757940 |
| &nbsp;&nbsp;&nbsp;&nbsp;Yelp † | 24894 | 680602 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ziff Davis † | 12795 | 1012084 |
|  |  | 20186392 |
| &nbsp;&nbsp;Transportation — 3.07% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Allegiant Travel † | 7100 | 482729 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kirby † | 20886 | 1344014 |
| &nbsp;&nbsp;&nbsp;&nbsp;Knight-Swift Transportation |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Holdings | 29650 | 1553957 |
| &nbsp;&nbsp;&nbsp;&nbsp;Werner Enterprises \* | 36536 | 1470939 |
|  |  | 4851639 |
| &nbsp;&nbsp;Utilities — 1.91% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Black Hills \* | 22963 | 1615218 |
| &nbsp;&nbsp;&nbsp;&nbsp;Spire | 20478 | 1410115 |
|  |  | 3025333 |
| &nbsp;&nbsp;**Total Common Stocks**<br> (cost $170,787,860) |  | **155301098** |
| &nbsp;&nbsp;**Short-Term Investments — 1.92%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 1.92% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day <br> effective yield 4.03%) | 759433 | 759433 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio – <br> Class I (seven-day effective <br> yield 4.06%) | 759434 | 759434 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 759434 | 759434 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government Portfolio – <br> Institutional Class <br> (seven-day effective yield <br> 4.11%) | 759433 | 759433 |
| &nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $3,037,734) |  | **3037734** |
| &nbsp;&nbsp;**Total Value of <br> Securities—100.14%** <br> (cost $173,825,594) |  | $**158,338,832■** |

---

[**Table of Contents**](#toc1)

Schedules of investments

Delaware Ivy VIP Smid Cap Core

---

| | |
|:---|:---|
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>†</sup> | Non-income producing security. |
| <sup>=</sup> | The value of this security was determined using significant unobservable inputs and is reported as a Level 3 security in the disclosure table located in Note 3 in "Notes to financial statements." |
| ■ | Includes $6,570,947 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $6,781,009. |

---

**Summary of abbreviations:**

ADR – American Depositary Receipt

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Statements of assets and liabilities

December 31, 2022

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy <br> VIP Asset <br> Strategy<sup>Φ</sup> | Delaware Ivy <br> VIP Balanced | Delaware Ivy <br> VIP Energy | Delaware Ivy <br> VIP Growth |
| **Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments of unaffiliated issuers, at value\*,† | $538671036 | $208906038 | $123990867 | $627895869 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments of affiliated issuers, at value\*\* | 637419 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments held as collateral for loaned securities, at value<sup>=</sup> | 13818320 | 1496265 | 2302463 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash | 164546 | 33706 | 8922 | 3986 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash collateral due from broker on futures contracts | 485650 | 101090 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies, at value<sup>Δ</sup> | 73099 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bullion at value<sup>‡</sup> | 26371837 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable for securities sold | 1996282 |  | 206270 | 1174301 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend and interest receivable | 1634269 | 594698 | 87690 | 194368 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax reclaims receivable | 189155 | 9951 | 5749 | 6349 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable for portfolio shares sold | 4435 | 12913 | 191043 | 8086 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 1443 | 681 | 123 | 2256 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Assets | 584047491 | 211155342 | 126793127 | 629285215 |
| **Liabilities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligation to return securities lending collateral | 13818320 | 1496265 | 2302463 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for securities purchased | 2426413 | 486731 | 77203 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued capital gains taxes on appreciated securities | 477256 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | 322431 | 155336 | 79325 | 217228 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for portfolio shares redeemed | 216993 | 180115 | 199019 | 254405 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment management fees payable to affiliates | 197930 | 126866 | 89784 | 385535 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution fees payable to affiliates | 122012 | 45309 |  | 137691 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administration expenses payable to affiliates | 64652 | 30489 | 4325 | 79052 |
| &nbsp;&nbsp;&nbsp;&nbsp;Variation margin due to broker on future contracts | 28593 | 6680 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | 17674600 | 2527791 | 2752119 | 1073911 |
| **Total Net Assets** | $566372891 | $208627551 | $124041008 | $628211304 |
| **Net Assets Consist of:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | $606305142 | $226715237 | $132033018 | $424588516 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total distributable earnings (loss) | (39932251) | (18087686) | (7992010) | 203622788 |
| **Total Net Assets** | $566372891 | $208627551 | $124041008 | $628211304 |

---

[**Table of Contents**](#toc1)

Statements of assets and liabilities

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Delaware Ivy<br> VIP Asset <br> Strategy<sup>Φ</sup> | Delaware Ivy <br> VIP Balanced | Delaware Ivy <br> VIP Energy | Delaware Ivy <br> VIP Growth |
| **Net Asset Value** |  |  |  |  |
| **Class I:** |  |  |  |  |
| Net assets | $1010671 | $— | $446884 | $— |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 128698 |  | 88154 |  |
| Net asset value per share | $7.85 | $— | $5.07 | $— |
| **Class II:** |  |  |  |  |
| Net assets | $565362220 | $208627551 | $123594124 | $628211304 |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 71999326 | 44505316 | 24386469 | 78865666 |
| Net asset value per share | $7.85 | $4.69 | $5.07 | $7.97 |
| <sup>\*</sup>Investments of unaffiliated issuers, at cost | $548181173 | $224830912 | $116006793 | $494710462 |
| <sup>\*\*</sup>Investments of affiliated issuers, at cost | 33621862 |  |  |  |
| <sup>†</sup>Including securities on loan | 17116801 | 6998190 | 10672836 | 40780181 |
| <sup>=</sup>Short-term investments held as collateral for loaned securities, at cost | 13818320 | 1496265 | 2302463 |  |
| ‡Bullion, at cost | 17562017 |  |  |  |
| <sup>Δ</sup>Foreign currencies, at cost | 73014 |  |  |  |

---

<sup>Φ</sup>Consolidated statements of assets and liabilities

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP High<br> Income | Delaware Ivy<br> VIP<br> International<br> Core Equity | Delaware Ivy<br> VIP Mid Cap<br> Growth | Delaware Ivy<br> VIP Natural<br> Resources |
| **Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments, at value\*<sup>,†</sup> | $736892767 | $473481016 | $460912341 | $109512045 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments held as collateral for loaned securities, at value<sup>=</sup> | 36258877 | 7445419 | 195750 | 3858940 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash | 2319202 | 2701378 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies, at value<sup>Δ</sup> | 439333 | 5787213 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend and interest receivable | 12614953 | 663713 | 180027 | 44893 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable for securities sold | 1857597 | 6220948 | 990323 | 417518 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable for portfolio shares sold | 608034 | 1299 | 16616 | 7518 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized appreciation on foreign currency exchange contracts | 84180 | 3045 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax reclaims receivable | 7602 | 960428 |  | 19768 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses |  |  |  | 629 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reimbursement from affiliates |  | 20014 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 2348 |  | 1185 | 167 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Assets | 791084893 | 497284473 | 462296242 | 113861478 |
| **Liabilities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligation to return securities lending collateral | 36258877 | 7445419 | 195750 | 3858940 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for securities purchased | 1902516 | 4855791 | 1388727 | 205372 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment management fees payable to affiliates | 394598 | 352051 | 273276 | 80812 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for portfolio shares redeemed | 263398 | 229006 | 47246 | 87482 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash collateral due to brokers | 180000 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | 163124 | 203606 | 130180 | 99870 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution fees payable to affiliates | 156755 | 103544 | 3185 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Administration expenses payable to affiliates | 60290 | 56033 | 64316 | 6578 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized depreciation on foreign currency exchange contracts |  | 18851 |  | 137 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | 39379558 | 13264301 | 2102680 | 4339191 |
| **Total Net Assets** | $751705335 | $484020172 | $460193562 | $109522287 |
| **Net Assets Consist of:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | $973465651 | $509535554 | $380582110 | $148515814 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total distributable earnings (loss) | (221760316) | (25515382) | 79611452 | (38993527) |
| **Total Net Assets** | $751705335 | $484020172 | $460193562 | $109522287 |

---

[**Table of Contents**](#toc1)

Statements of assets and liabilities

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP High<br> Income | Delaware Ivy<br> VIP<br> International<br> Core Equity | Delaware Ivy<br> VIP Mid Cap<br> Growth | Delaware Ivy<br> VIP Natural<br> Resources |
| **Net Asset Value** |  |  |  |  |
| **Class I:** |  |  |  |  |
| Net assets | $15093433 | $— | $105163914 | $— |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 5344580 |  | 10954671 |  |
| Net asset value per share | $2.82 | $— | $9.60 | $— |
| **Class II:** |  |  |  |  |
| Net assets | $736611902 | $484020172 | $355029648 | $109522287 |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 261682475 | 34268020 | 37481007 | 22970884 |
| Net asset value per share | $2.81 | $14.12 | $9.47 | $4.77 |
| <sup>\*</sup>Investments, at cost | $869923132 | $499399812 | $437428619 | $111085932 |
| <sup>†</sup>Including securities on loan | 38792042 | 25427392 | 16635152 | 8496793 |
| <sup>=</sup>Short-term investments held as collateral for loaned securities, at cost | 36258877 | 7445419 | 195750 | 3858940 |
| <sup>Δ</sup>Foreign currencies, at cost | 438944 | 5845364 |  |  |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Science<br> and<br> Technology | Delaware Ivy<br> VIP Small Cap<br> Growth | Delaware Ivy<br> VIP Smid Cap<br> Core |
| **Assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments, at value\*<sup>,†</sup> | $452285797 | $199217045 | $158338832 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments held as collateral for loaned securities, at value<sup>=</sup> | 652255 | 168219 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash |  |  | 2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend and interest receivable | 361338 | 75517 | 136388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable for portfolio shares sold | 84682 | 47917 | 27062 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax reclaims receivable | 36270 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable for securities sold |  | 222111 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 1311 | 878 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Assets | 453421653 | 199731687 | 158504304 |
| **Liabilities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligation to return securities lending collateral | 652255 | 168219 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment management fees payable to affiliates | 337412 | 110185 | 116478 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for portfolio shares redeemed | 194116 | 59380 | 66240 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | 189888 | 146880 | 113568 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution fees payable to affiliates | 98944 | 39832 | 34258 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administration expenses payable to affiliates | 57558 | 37229 | 16295 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for securities purchased |  | 259693 | 46583 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | 1530173 | 821418 | 393422 |
| **Total Net Assets** | $451891480 | $198910269 | $158110882 |
| **Net Assets Consist of:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | $436154535 | $198738385 | $154641353 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total distributable earnings (loss) | 15736945 | 171884 | 3469529 |
| **Total Net Assets** | $451891480 | $198910269 | $158110882 |

---

[**Table of Contents**](#toc1)

Statements of assets and liabilities

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Science<br> and<br> Technology | Delaware Ivy<br> VIP Small Cap<br> Growth | Delaware Ivy<br> VIP Smid Cap<br> Core |
| **Net Asset Value** |  |  |  |
| **Class I :** |  |  |  |
| Net assets | $1331366 | $17453779 | $— |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 75196 | 2857471 |  |
| Net asset value per share | $17.71 | $6.11 | $— |
| **Class II:** |  |  |  |
| Net assets | $450560114 | $181456490 | $158110882 |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 25816693 | 30063320 | 14198406 |
| Net asset value per share | $17.45 | $6.04 | $11.14 |
| \*Investments, at cost | $458348583 | $229218867 | $173825594 |
| <sup>†</sup>Including securities on loan | 12389802 | 7458683 | 6570947 |
| <sup>=</sup>Short-term investments held as collateral for loaned securities, at cost | 652255 | 168219 |  |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Statements of operations

Year ended December 31, 2022

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Asset<br> Strategy<sup>φ</sup> | Delaware Ivy<br> VIP Balanced | Delaware Ivy<br> VIP Energy | Delaware Ivy<br> VIP Growth |
| **Investment Income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends | $6989271 | $1982023 | $4797708 | $5068437 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | 6147389 | 2105107 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest - affiliated | 153092 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities lending income | 46294 | 10491 | 268483 | 38330 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax withheld | (477861) | (8137) | (171147) | (45013) |
|  | 12858185 | 4089484 | 4895044 | 5061754 |
| **Expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment advisory fees | 4331264 | 1595597 | 1014989 | 5163240 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution expenses — Class II | 1544296 | 569856 | 297429 | 1844072 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounting and administration expenses | 145634 | 88898 | 49470 | 203053 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trustees' fees and expenses | 111760 | 64598 | 19136 | 49839 |
| &nbsp;&nbsp;&nbsp;&nbsp;Audit and tax fees | 49906 | 44863 | 31406 | 32076 |
| &nbsp;&nbsp;&nbsp;&nbsp;Custodian fees | 43434 | 20929 | 12825 | 14578 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reports and statements to shareholders servicing expenses | 21799 | 12746 | 16109 | 13930 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal fees | 3915 | 19776 | 10448 | 24404 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend disbursing and transfer agent fees and expenses | 202 | 300 | 5240 | 22361 |
| &nbsp;&nbsp;&nbsp;&nbsp;Registration fees | 7 | 7 | 7 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 23188 | 31047 | 12280 | 21419 |
|  | 6275405 | 2448617 | 1469339 | 7388979 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less expenses waived | (883022) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less expenses paid indirectly | (1) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 5392382 | 2448617 | 1469339 | 7388979 |
| **Net Investment Income (Loss)** | 7465803 | 1640867 | 3425705 | (2327225) |
| **Net Realized and Unrealized Gain (Loss):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments | 26411151 | (3563722) | 25614510 | 70668445 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies | (24579) |  | 95938 | (1544) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange contracts | (354355) |  | (66222) | 1640 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Futures contracts | (615677) | (69543) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Swap contracts |  | 7094 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 25416540 | (3626171) | 25644226 | 70668541 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments | (107115332) | (40892673) | 10282265 | (327274704) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliated investments | (32984443) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies | (28605) |  | 42 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Futures contracts | (49688) | 1015 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (140178068) | (40891658) | 10282307 | (327274704) |
| **Net Realized and Unrealized Gain (Loss)** | (114761528) | (44517829) | 35926533 | (256606163) |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | $(107295725) | $(42876962) | $39352238 | $(258933388) |

---

<sup>φ</sup>Consolidated statements of operations

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Statements of operations

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP High<br> Income | Delaware Ivy<br> VIP International<br> Core Equity | Delaware Ivy<br> VIP Mid Cap<br> Growth | Delaware Ivy<br> VIP Natural<br> Resources |
| **Investment Income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | $51947593 | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends | 3897313 | 15063915 | 2460720 | 3694325 |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities lending income | 1090139 | 92482 | 32665 | 336058 |
| &nbsp;&nbsp;&nbsp;&nbsp;Refund of previously paid foreign taxes |  | 2337777 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax withheld |  | (1718952) | (891) | (52783) |
|  | 56935045 | 15775222 | 2492494 | 3977600 |
| **Expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment advisory fees | 4954987 | 4337857 | 4385296 | 969717 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution expenses — Class II | 1971733 | 1275840 | 976163 | 285211 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounting and administration expenses | 135843 | 150871 | 168171 | 40308 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trustees' fees and expenses | 102232 | 55827 | 73898 | 34118 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal fees | 49149 | 14840 | 7380 | 13418 |
| &nbsp;&nbsp;&nbsp;&nbsp;Audit and tax fees | 45388 | 34455 | 31435 | 33589 |
| &nbsp;&nbsp;&nbsp;&nbsp;Custodian fees | 41880 | 76815 | 11113 | 19344 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reports and statements to shareholders servicing expenses | 22550 | 21664 | 19479 | 16610 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend disbursing and transfer agent fees and expenses | 20649 | 20726 | 18769 | 6098 |
| &nbsp;&nbsp;&nbsp;&nbsp;Registration fees | 7 | 6 | 7 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 35526 | 39651 | 14247 | 6157 |
|  | 7379944 | 6028552 | 5705958 | 1424577 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less expenses waived |  |  | (346147) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less expenses paid indirectly | (1) |  | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 7379943 | 6028552 | 5359810 | 1424577 |
| **Net Investment Income (Loss)** | 49555102 | 9746670 | (2867316) | 2553023 |
| **Net Realized and Unrealized Gain (Loss):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments | (35314361) | (7552485) | 56777928 | 13512786 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies | (281539) | (434170) |  | 96323 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange contracts | 285402 | 179734 |  | (136956) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options purchased |  |  | (181881) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options written |  |  | (378293) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | (35310498) | (7806921) | 56217754 | 13472153 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments | (139358170) | (91114545) | (271434455) | 275154 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliated investments | 24593161 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies | (746) | (52839) |  | 5171 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange contracts | 221233 | (15806) |  | (137) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options purchased |  |  | 68668 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options written |  |  | 524821 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (114544522) | (91183190) | (270840966) | 280188 |
| **Net Realized and Unrealized Gain (Loss)** | (149855020) | (98990111) | (214623212) | 13752341 |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | $(100299918) | $(89243441) | $(217490528) | $16305364 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Science<br> and<br> Technology | Delaware Ivy<br> VIP Small Cap<br> Growth | Delaware Ivy<br> VIP Smid Cap<br> Core |
| **Investment Income:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends | $3707359 | $1435484 | $2386450 |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities lending income | 81114 | 377888 | 12212 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax withheld | (92731) |  |  |
|  | 3695742 | 1813372 | 2398662 |
| **Expenses:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment advisory fees | 4501218 | 2731627 | 1396894 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution expenses — Class II | 1319841 | 749119 | 410851 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounting and administration expenses | 150933 | 111465 | 70206 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trustees' fees and expenses | 52099 | 50474 | 31014 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend disbursing and transfer agent fees and expenses | 38601 | 9368 | 12131 |
| &nbsp;&nbsp;&nbsp;&nbsp;Audit and tax fees | 31810 | 27681 | 31306 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reports and statements to shareholders servicing expenses | 19613 | 27022 | 13091 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal fees | 16354 | 11034 | 13373 |
| &nbsp;&nbsp;&nbsp;&nbsp;Custodian fees | 16279 | 18516 | 21923 |
| &nbsp;&nbsp;&nbsp;&nbsp;Registration fees | 7 | 7 | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 61223 | 12946 | 11426 |
|  | 6207978 | 3749259 | 2012221 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less expenses waived |  | (135551) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less expenses paid indirectly | (1) | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 6207977 | 3613707 | 2012221 |
| **Net Investment Income (Loss)** | (2512235) | (1800335) | 386441 |
| **Net Realized and Unrealized Gain (Loss):** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) on: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments | 24169592 | 24627627 | 18660935 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies | (1016) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange contracts | 196 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase from payment by affiliates<sup>1</sup> |  | 5772824 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 24168772 | 30400451 | 18660935 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments | (243220609) | (135463338) | (46656011) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies | (2306) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (243222915) | (135463338) | (46656011) |
| **Net Realized and Unrealized Gain (Loss)** | (219054143) | (105062887) | (27995076) |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | $(221566378) | $(106863222) | $(27608635) |

---

<sup>1</sup> See Note 2 in "Notes to financial statements."

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Statements of changes in net assets

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Asset<br> Strategy<sup>φ</sup> | Delaware Ivy<br> VIP Asset<br> Strategy<sup>φ</sup> | Delaware Ivy<br> VIP Balanced | Delaware Ivy<br> VIP Balanced |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $7465803 | $4820768 | $1640867 | $1753627 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 25416540 | 92334387 | (3626171) | 86905142 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (140178068) | (22017395) | (40891658) | (36223075) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (107295725) | 75137760 | (42876962) | 52435694 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (101290) | (123895) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (57229359) | (87212714) | (89099578) | (25006127) |
| &nbsp;&nbsp;&nbsp;&nbsp;Return of capital: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (813) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (485567) |  |  |  |
|  | (57817029) | (87336609) | (89099578) | (25006127) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 22114 | 930271 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 20319480 | 27512423 | 5054309 | 11704935 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 102103 | 123895 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 57714926 | 87212714 | 89099578 | 25006127 |
|  | 78158623 | 115779303 | 94153887 | 36711062 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (7197) | (228661) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (90741710) | (123849978) | (24816273) | (136600091) |
|  | (90748907) | (124078639) | (24816273) | (136600091) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | (12590284) | (8299336) | 69337614 | (99889029) |
| **Net Decrease in Net Assets** | (177703038) | (20498185) | (62638926) | (72459462) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 744075929 | 764574114 | 271266477 | 343725939 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $566372891 | $744075929 | $208627551 | $271266477 |

---

<sup>φ</sup> Consolidated statements of changes in net assets

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Energy | Delaware Ivy<br> VIP Energy | Delaware Ivy<br> VIP Growth | Delaware Ivy<br> VIP Growth |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $3425705 | $897768 | $(2327225) | $(4204182) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 25644226 | 10423212 | 70668541 | 184088806 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | 10282307 | 7865868 | (327274704) | 89386977 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | 39352238 | 19186848 | (258933388) | 269271601 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (14735) | (2647) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (3623499) | (1016972) | (179987618) | (98262055) |
|  | (3638234) | (1019619) | (179987618) | (98262055) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 849105 | 126637 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 92437878 | 50732309 | 47292019 | 103904201 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 14735 | 2647 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 3623499 | 1016972 | 179987618 | 98262055 |
|  | 96925217 | 51878565 | 227279637 | 202166256 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (681163) | (234664) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (82062558) | (39207540) | (182794509) | (246709528) |
|  | (82743721) | (39442204) | (182794509) | (246709528) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | 14181496 | 12436361 | 44485128 | (44543272) |
| **Net Increase (Decrease) in Net Assets** | 49895500 | 30603590 | (394435878) | 126466274 |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 74145508 | 43541918 | 1022647182 | 896180908 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $124041008 | $74145508 | $628211304 | $1022647182 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Statements of changes in net assets

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP High<br> Income | Delaware Ivy<br> VIP High<br> Income | Delaware Ivy<br> VIP International<br> Core Equity | Delaware Ivy<br> VIP International<br> Core Equity |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $49555102 | $53523791 | $9746670 | $9839024 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | (35310498) | (8915234) | (7806921) | 82070410 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (114544522) | 8375935 | (91183190) | (3179449) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (100299918) | 52984492 | (89243441) | 88729985 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (1120406) | (1264115) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (51556130) | (52760331) | (52574539) | (6911509) |
|  | (52676536) | (54024446) | (52574539) | (6911509) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 2138328 | 2988357 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 72956805 | 115230591 | 33398259 | 30336557 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 1120406 | 1264115 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 51556130 | 52760331 | 52574539 | 6911509 |
|  | 127771669 | 172243394 | 85972798 | 37248066 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (3926749) | (5598142) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (130609304) | (133627810) | (80660894) | (147978400) |
|  | (134536053) | (139225952) | (80660894) | (147978400) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | (6764384) | 33017442 | 5311904 | (110730334) |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital contributions<sup>1</sup> |  |  | 20014 |  |
| **Net Increase (Decrease) in Net Assets** | (159740838) | 31977488 | (136486062) | (28911858) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 911446173 | 879468685 | 620506234 | 649418092 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $751705335 | $911446173 | $484020172 | $620506234 |

---

<sup>1</sup> See Note 2 in "Notes to financial statements."

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Mid Cap<br> Growth | Delaware Ivy<br> VIP Mid Cap<br> Growth | Delaware Ivy<br> VIP Natural<br> Resources | Delaware Ivy<br> VIP Natural<br> Resources |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $(2867316) | $(4941349) | $2553023 | $1650874 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 56217754 | 115551436 | 13472153 | 16212480 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (270840966) | 167074 | 280188 | 2162426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (217490528) | 110777161 | 16305364 | 20025780 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (27030938) | (28371842) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (83204589) | (54305125) | (1937990) | (1377946) |
|  | (110235527) | (82676967) | (1937990) | (1377946) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 16860457 | 25638061 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 57945087 | 102814158 | 46421492 | 20233095 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 27030938 | 28371842 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 83204589 | 54305125 | 1937990 | 1377946 |
|  | 185041071 | 211129186 | 48359482 | 21611041 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (65638075) | (98590857) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (62327227) | (99353586) | (44058934) | (24226833) |
|  | (127965302) | (197944443) | (44058934) | (24226833) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | 57075769 | 13184743 | 4300548 | (2615792) |
| **Net Increase (Decrease) in Net Assets** | (270650286) | 41284937 | 18667922 | 16032042 |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 730843848 | 689558911 | 90854365 | 74822323 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $460193562 | $730843848 | $109522287 | $90854365 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Statements of changes in net assets

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Science<br> and<br> Technology | Delaware Ivy<br> VIP Science<br> and<br> Technology | Delaware Ivy<br> VIP Small Cap<br> Growth | Delaware Ivy<br> VIP Small Cap<br> Growth |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $(2512235) | $(5548436) | $(1800335) | $(3677140) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 24168772 | 264466265 | 24627627 | 79559037 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase from payment by affiliates |  |  | 5772824 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (243222915) | (159999164) | (135463338) | (55777763) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (221566378) | 98918665 | (106863222) | 20104134 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (204675) | (630025) | (4768113) | (6960521) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (66445227) | (201467757) | (71059344) | (51658903) |
|  | (66649902) | (202097782) | (75827457) | (58619424) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 530872 | 1857407 | 3175439 | 5805956 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 45016503 | 56146004 | 17370652 | 24884660 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | 204675 | 630024 | 4768113 | 6960521 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 66445227 | 201467759 | 71059344 | 51658903 |
|  | 112197277 | 260101194 | 96373548 | 89310040 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class I | (653015) | (2164748) | (22970280) | (20490747) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (80710910) | (123849716) | (129582097) | (57061025) |
|  | (81363925) | (126014464) | (152552377) | (77551772) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | 30833352 | 134086730 | (56178829) | 11758268 |
| **Net Increase (Decrease) in Net Assets** | (257382928) | 30907613 | (238869508) | (26757022) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 709274408 | 678366795 | 437779777 | 464536799 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $451891480 | $709274408 | $198910269 | $437779777 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

---

| | | |
|:---|:---|:---|
|  | Delaware Ivy<br> VIP Smid Cap<br> Core | Delaware Ivy<br> VIP Smid Cap<br> Core |
|  | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $386441 | $(200926) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 18660935 | 36031050 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (46656011) | 1327330 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (27608635) | 37157454 |
| **Dividends and Distributions to Shareholders from:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (34590065) |  |
|  | (34590065) |  |
| **Capital Share Transactions:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 29148495 | 18954835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 34590065 |  |
|  | 63738560 | 18954835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (25188039) | (57222880) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | 38550521 | (38268045) |
| **Net Decrease in Net Assets** | (23648179) | (1110591) |
| **Net Assets:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 181759061 | 182869652 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $158110882 | $181759061 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Financial highlights

Delaware Ivy VIP Asset Strategy Class I<sup>Φ</sup>

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
|  | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $10.20 | $10.45 | $9.50 | $8.29 | $9.37 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.12 | 0.08 | 0.17 | 0.20 | 0.18 |
| Net realized and unrealized gain (loss) | (1.60) | 1.01 | 1.16 | 1.63 | (0.67) |
| Total from investment operations | (1.48) | 1.09 | 1.33 | 1.83 | (0.49) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.16) | (0.20) | (0.22) | (0.23) | (0.20) |
| Net realized gain | (0.70) | (1.14) | (0.16) | (0.39) | (0.39) |
| Return of capital | (0.01) |  |  |  |  |
| Total dividends and distributions | (0.87) | (1.34) | (0.38) | (0.62) | (0.59) |
| **Net asset value, end of period** | $7.85 | $10.20 | $10.45 | $9.50 | $8.29 |
| **Total return<sup>2</sup>** | (14.54%)<sup>3</sup> | 10.72%<sup>3</sup> | 14.16% | 22.08%<sup>3</sup> | (5.20%)<sup>3</sup> |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $1011 | $1<sup>4</sup> | $—<sup>4,5</sup> | $1<sup>4</sup> | $—<sup>4,5</sup> |
| Ratio of expenses to average net assets<sup>6</sup> | 0.66% | 0.65% | 0.77% | 0.77% | 0.78% |
| Ratio of expenses to average net assets prior to fees waived<sup>6</sup> | 0.77% | 0.75% | 0.77% | 0.77% | 0.78% |
| Ratio of net investment income to average net assets | 1.42% | 0.76% | 1.83% | 2.19% | 1.91% |
| Ratio of net investment income to average net assets prior to fees waived | 1.31% | 0.66% | 1.83% | 2.19% | 1.91% |
| Portfolio turnover | 102% | 56% | 44% | 46% | 58% |

---

---

| | |
|:---|:---|
| <sup>Φ</sup> | Consolidated financial highlights. |
| <sup>1</sup> | Calculated using average shares outstanding. |
| <sup>2</sup> | Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle. |
| <sup>3</sup> | Total return during the period reflects waivers by the manager. Performance would have been lower had the waivers not been in effect. |
| <sup>4</sup> | Net assets reported in millions. |
| <sup>5</sup> | Rounds to less than $500 thousands. |
| <sup>6</sup> | Expense ratios do not include expenses of any investment companies in which the Portfolio invests. |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP Asset Strategy Class II<sup>Φ</sup>

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $10.19 | $10.44 | $9.50 | $8.29 | $9.37 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.10 | 0.07 | 0.15 | 0.18 | 0.16 |
| Net realized and unrealized gain (loss) | (1.59) | 1.00 | 1.15 | 1.62 | (0.67) |
| Total from investment operations | (1.49) | 1.07 | 1.30 | 1.80 | (0.51) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.14) | (0.18) | (0.20) | (0.20) | (0.18) |
| Net realized gain | (0.70) | (1.14) | (0.16) | (0.39) | (0.39) |
| Return of capital | (0.01) |  |  |  |  |
| Total dividends and distributions | (0.85) | (1.32) | (0.36) | (0.59) | (0.57) |
| **Net asset value, end of period** | $7.85 | $10.19 | $10.44 | $9.50 | $8.29 |
| **Total return<sup>2</sup>** | (14.71%)<sup>3</sup> | 10.44%<sup>3</sup> | 13.88% | 21.78% | (5.44%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $565362 | $743<sup>4</sup> | $764<sup>4</sup> | $772<sup>4</sup> | $753<sup>4</sup> |
| Ratio of expenses to average net assets<sup>5</sup> | 0.87% | 0.90% | 1.02% | 1.02% | 1.03% |
| Ratio of expenses to average net assets prior to fees waived<sup>5</sup> | 1.01% | 1.01% | 1.02% | 1.02% | 1.03% |
| Ratio of net investment income to average net assets | 1.21% | 0.64% | 1.60% | 1.94% | 1.65% |
| Ratio of net investment income to average net assets prior to fees waived | 1.07% | 0.53% | 1.60% | 1.94% | 1.65% |
| Portfolio turnover | 102% | 56% | 44% | 46% | 58% |

---

---

| | |
|:---|:---|
| <sup>Φ</sup> | Consolidated financial highlights. |
| <sup>1</sup> | Calculated using average shares outstanding. |
| <sup>2</sup> | Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle. |
| <sup>3</sup> | Total return during the period reflects waivers by the manager and/or distributor. Performance would have been lower had the waivers not been in effect. |
| <sup>4</sup> | Net assets reported in millions. |
| <sup>5</sup> | Expense ratios do not include expenses of any investment companies in which the Portfolio invests. |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Financial highlights

Delaware Ivy VIP Balanced Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $9.39 | $8.71 | $8.22 | $7.46 | $7.95 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.04 | 0.05 | 0.09 | 0.11 | 0.12 |
| Net realized and unrealized gain (loss) | (1.55) | 1.29 | 0.94 | 1.44 | (0.36) |
| Total from investment operations | (1.51) | 1.34 | 1.03 | 1.55 | (0.24) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.09) | (0.09) | (0.11) | (0.14) | (0.13) |
| Net realized gain | (3.10) | (0.57) | (0.43) | (0.65) | (0.12) |
| Total dividends and distributions | (3.19) | (0.66) | (0.54) | (0.79) | (0.25) |
| **Net asset value, end of period** | $4.69 | $9.39 | $8.71 | $8.22 | $7.46 |
| **Total return<sup>2</sup>** | (16.11%) | 15.97% | 14.11% | 22.09% | (3.24%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $208628 | $271<sup>3</sup> | $344<sup>3</sup> | $341<sup>3</sup> | $310<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 1.07% | 1.00% | 1.02% | 1.01% | 1.01% |
| Ratio of net investment income to average net assets | 0.72% | 0.51% | 1.13% | 1.38% | 1.55% |
| Portfolio turnover | 72% | 79% | 61% | 44% | 54% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP Energy Class I

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $3.48 | $2.48 | $4.02 | $3.88 | $5.87 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.15 | 0.04 | 0.04 | 0.03 | —<sup>2</sup> |
| Net realized and unrealized gain (loss) | 1.61 | 1.02 | (1.52) | 0.11 | (1.99) |
| Total from investment operations | 1.76 | 1.06 | (1.48) | 0.14 | (1.99) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.17) | (0.06) | (0.06) |  |  |
| Total dividends and distributions | (0.17) | (0.06) | (0.06) |  |  |
| **Net asset value, end of period** | $5.07 | $3.48 | $2.48 | $4.02 | $3.88 |
| **Total return<sup>3</sup>** | 50.85% | 42.33% | (36.67%)<sup>4</sup> | 3.74% | (33.96%)<sup>4</sup> |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $447 | $—<sup>5,6</sup> | $—<sup>5,6</sup> | $—<sup>5,6</sup> | $—<sup>5,6</sup> |
| Ratio of expenses to average net assets<sup>7</sup> | 0.98% | 0.97% | 1.06% | 1.04% | 0.94% |
| Ratio of expenses to average net assets prior to fees waived<sup>7</sup> | 0.98% | 0.97% | 1.12% | 1.04% | 0.94% |
| Ratio of net investment income (loss) to average net assets | 3.04% | 1.20% | 1.89% | 0.64% | (0.09%) |
| Ratio of net investment income (loss) to average net assets prior to fees waived | 3.04% | 1.20% | 1.83% | 0.64% | (0.09%) |
| Portfolio turnover | 85% | 119% | 54% | 21% | 37% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Amount is less than $0.005 per share.

<sup>3</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>4</sup> Total return during the period reflects waivers by the manager. Performance would have been lower had the waivers not been in effect.

<sup>5</sup> Net assets reported in millions.

<sup>6</sup> Rounds to less than $500 thousands.

<sup>7</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Financial highlights

Delaware Ivy VIP Energy Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $3.47 | $2.48 | $4.00 | $3.87 | $5.87 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income (loss)<sup>1</sup> | 0.14 | 0.04 | 0.04 | 0.02 | (0.02) |
| Net realized and unrealized gain (loss) | 1.61 | 1.00 | (1.52) | 0.11 | (1.98) |
| Total from investment operations | 1.75 | 1.04 | (1.48) | 0.13 | (2.00) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.15) | (0.05) | (0.04) |  |  |
| Total dividends and distributions | (0.15) | (0.05) | (0.04) |  |  |
| **Net asset value, end of period** | $5.07 | $3.47 | $2.48 | $4.00 | $3.87 |
| **Total return<sup>2</sup>** | 50.42% | 42.00% | (36.83%)<sup>3</sup> | 3.48% | (34.14%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $123594 | $74<sup>4</sup> | $44<sup>4</sup> | $42<sup>4</sup> | $39<sup>4</sup> |
| Ratio of expenses to average net assets<sup>5</sup> | 1.23% | 1.22% | 1.31% | 1.29% | 1.19% |
| Ratio of expenses to average net assets prior to fees waived<sup>5</sup> | 1.23% | 1.22% | 1.37% | 1.29% | 1.19% |
| Ratio of net investment income (loss) to average net assets | 2.87% | 1.41% | 1.62% | 0.42% | (0.41%) |
| Ratio of net investment income (loss) to average net assets prior |  |  |  |  |  |
| to fees waived | 2.87% | 1.41% | 1.56% | 0.42% | (0.41%) |
| Portfolio turnover | 85% | 119% | 54% | 21% | 37% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Total return during the period reflects waivers by the manager and/or distributor. Performance would have been lower had the waivers not been in effect.

<sup>4</sup> Net assets reported in millions.

<sup>5</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP Growth Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $14.85 | $12.70 | $11.33 | $11.02 | $12.09 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment loss<sup>1</sup> | (0.03) | (0.06) | (0.02) | (0.01) | —<sup>2</sup> |
| Net realized and unrealized gain (loss) | (3.97) | 3.57 | 3.03 | 3.58 | 0.36 |
| Total from investment operations | (4.00) | 3.51 | 3.01 | 3.57 | 0.36 |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income |  |  |  |  | —<sup>2</sup> |
| Net realized gain | (2.88) | (1.36) | (1.64) | (3.26) | (1.43) |
| Total dividends and distributions | (2.88) | (1.36) | (1.64) | (3.26) | (1.43) |
| **Net asset value, end of period** | $7.97 | $14.85 | $12.70 | $11.33 | $11.02 |
| **Total return<sup>3</sup>** | (27.24%) | 30.03% | 30.55% | 36.59% | 2.28% |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $628211 | $1023<sup>4</sup> | $896<sup>4</sup> | $791<sup>4</sup> | $669<sup>4</sup> |
| Ratio of expenses to average net assets<sup>5</sup> | 1.00% | 0.99% | 1.01% | 1.00% | 1.00% |
| Ratio of net investment loss to average net assets | (0.32%) | (0.42%) | (0.20%) | (0.05%) | (0.02%) |
| Portfolio turnover | 12% | 22% | 29% | 30% | 37% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Amount is less than $0.005 per share.

<sup>3</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>4</sup> Net assets reported in millions.

<sup>5</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Financial highlights

Delaware Ivy VIP High Income Class I

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $3.40 | $3.41 | $3.48 | $3.35 | $3.65 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.19 | 0.21 | 0.21 | 0.24 | 0.23 |
| Net realized and unrealized gain (loss) | (0.56) | (0.01) | (0.03) | 0.13 | (0.29) |
| Total from investment operations | (0.37) | 0.20 | 0.18 | 0.37 | (0.06) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.21) | (0.21) | (0.25) | (0.24) | (0.24) |
| Total dividends and distributions | (0.21) | (0.21) | (0.25) | (0.24) | (0.24) |
| **Net asset value, end of period** | $2.82 | $3.40 | $3.41 | $3.48 | $3.35 |
| **Total return<sup>2</sup>** | (10.91%) | 6.33% | 6.30% | 11.49% | (1.86%)<sup>3</sup> |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $15093 | $19<sup>4</sup> | $20<sup>4</sup> | $27<sup>4</sup> | $44<sup>4</sup> |
| Ratio of expenses to average net assets<sup>5</sup> | 0.67% | 0.67% | 0.69% | 0.67% | 0.66% |
| Ratio of expenses to average net assets prior to fees waived<sup>5</sup> | 0.67% | 0.67% | 0.69% | 0.67% | 0.66% |
| Ratio of net investment income to average net assets | 6.40% | 6.11% | 6.54% | 6.82% | 6.50% |
| Ratio of net investment income to average net assets prior to fees waived | 6.40% | 6.11% | 6.54% | 6.82% | 6.50% |
| Portfolio turnover | 61% | 54% | 52% | 35% | 42% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Total return during the period reflects waivers by the manager. Performance would have been lower had the waivers not been in effect.

<sup>4</sup> Net assets reported in millions.

<sup>5</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP High Income Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $3.39 | $3.40 | $3.47 | $3.34 | $3.64 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.18 | 0.20 | 0.20 | 0.23 | 0.22 |
| Net realized and unrealized gain (loss) | (0.56) | —<sup>2</sup> | (0.03) | 0.13 | (0.29) |
| Total from investment operations | (0.38) | 0.20 | 0.17 | 0.36 | (0.07) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.20) | (0.21) | (0.24) | (0.23) | (0.23) |
| Total dividends and distributions | (0.20) | (0.21) | (0.24) | (0.23) | (0.23) |
| **Net asset value, end of period** | $2.81 | $3.39 | $3.40 | $3.47 | $3.34 |
| **Total return<sup>3</sup>** | (11.28%) | 6.06% | 6.03% | 11.19% | (2.11%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $736612 | $892<sup>4</sup> | $859<sup>4</sup> | $859<sup>4</sup> | $803<sup>4</sup> |
| Ratio of expenses to average net assets<sup>5</sup> | 0.92% | 0.92% | 0.94% | 0.92% | 0.91% |
| Ratio of net investment income to average net assets | 6.15% | 5.85% | 6.28% | 6.57% | 6.27% |
| Portfolio turnover | 61% | 54% | 52% | 35% | 42% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Amount is less than $0.005 per share.

<sup>3</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>4</sup> Net assets reported in millions.

<sup>5</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Financial highlights

Delaware Ivy VIP International Core Equity Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $18.47 | $16.35 | $15.65 | $14.66 | $18.58 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.28 | 0.27 | 0.16 | 0.29 | 0.30 |
| Net realized and unrealized gain (loss) | (3.02) | 2.04 | 0.88 | 2.28 | (3.45) |
| Total from investment operations | (2.74) | 2.31 | 1.04 | 2.57 | (3.15) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.36) | (0.19) | (0.34) | (0.25) | (0.28) |
| Net realized gain | (1.25) |  | —<sup>2</sup> | (1.33) | (0.49) |
| Total dividends and distributions | (1.61) | (0.19) | (0.34) | (1.58) | (0.77) |
| Capital contributions | —<sup>2,3</sup> |  |  |  |  |
| **Net asset value, end of period** | $14.12 | $18.47 | $16.35 | $15.65 | $14.66 |
| **Total return<sup>4</sup>** | (14.72%)<sup>5,6</sup> | 14.18% | 7.19% | 18.69% | (17.81%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $484020 | $621<sup>7</sup> | $649<sup>7</sup> | $699<sup>7</sup> | $676<sup>7</sup> |
| Ratio of expenses to average net assets<sup>8</sup> | 1.18% | 1.16% | 1.17% | 1.16% | 1.16% |
| Ratio of net investment income to average net assets | 1.91% | 1.49% | 1.10% | 1.93% | 1.70% |
| Portfolio turnover | 63% | 81% | 82% | 69% | 51% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Amount is less than $0.005 per share.

<sup>3</sup> See Note 2 in "Notes to financial statements."

<sup>4</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>5</sup> Total return for the year ended December 31, 2022 includes the impact of the refund of previously paid foreign taxes. Total return would have been lower by 0.38% excluding refund of previously paid foreign taxes.

<sup>6</sup> Total return for the year ended December 31, 2022 includes the impact of the capital contribution, which was not material to the total return.

<sup>7</sup> Net assets reported in millions.

<sup>8</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP Mid Cap Growth Class I

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $17.99 | $17.60 | $12.77 | $11.10 | $11.63 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment loss<sup>1</sup> | (0.04) | (0.09) | (0.04) | (0.02) | (0.02) |
| Net realized and unrealized gain (loss) | (5.45) | 2.71 | 5.89 | 3.95 | 0.09 |
| Total from investment operations | (5.49) | 2.62 | 5.85 | 3.93 | 0.07 |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net realized gain | (2.90) | (2.23) | (1.02) | (2.26) | (0.60) |
| Total dividends and distributions | (2.90) | (2.23) | (1.02) | (2.26) | (0.60) |
| **Net asset value, end of period** | $9.60 | $17.99 | $17.60 | $12.77 | $11.10 |
| **Total return<sup>2</sup>** | (30.62%) | 16.65% | 49.37% | 38.28% | 0.20% |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $105164 | $212<sup>3</sup> | $246<sup>3</sup> | $233<sup>3</sup> | $184<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.85% | 0.85% | 0.85% | 0.85% | 0.85% |
| Ratio of expenses to average net assets prior to fees waived<sup>4</sup> | 0.92% | 0.89% | 0.90% | 0.90% | 0.90% |
| Ratio of net investment loss to average net assets | (0.38%) | (0.51%) | (0.27%) | (0.20%) | (0.14%) |
| Ratio of net investment loss to average net assets prior to fees waived | (0.45%) | (0.55%) | (0.32%) | (0.25%) | (0.19%) |
| Portfolio turnover | 29% | 27% | 25% | 20% | 53% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle. Total return during the period reflects waivers by the manager. Performance would have been lower had the waivers not been in effect.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Financial highlights

Delaware Ivy VIP Mid Cap Growth Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $17.84 | $17.48 | $12.69 | $11.07 | $11.61 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment loss<sup>1</sup> | (0.07) | (0.13) | (0.07) | (0.06) | (0.05) |
| Net realized and unrealized gain (loss) | (5.40) | 2.68 | 5.85 | 3.94 | 0.09 |
| Total from investment operations | (5.47) | 2.55 | 5.78 | 3.88 | 0.04 |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net realized gain | (2.90) | (2.19) | (0.99) | (2.26) | (0.58) |
| Total dividends and distributions | (2.90) | (2.19) | (0.99) | (2.26) | (0.58) |
| **Net asset value, end of period** | $9.47 | $17.84 | $17.48 | $12.69 | $11.07 |
| **Total return<sup>2</sup>** | (30.78%) | 16.36% | 49.00% | 37.94% | (0.06%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $355030 | $519<sup>3</sup> | $444<sup>3</sup> | $315<sup>3</sup> | $230<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% |
| Ratio of expenses to average net assets prior to fees waived<sup>4</sup> | 1.17% | 1.14% | 1.15% | 1.15% | 1.15% |
| Ratio of net investment loss to average net assets | (0.61%) | (0.76%) | (0.53%) | (0.45%) | (0.42%) |
| Ratio of net investment loss to average net assets prior to fees waived | (0.68%) | (0.80%) | (0.58%) | (0.50%) | (0.47%) |
| Portfolio turnover | 29% | 27% | 25% | 20% | 53% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle. Total return during the period reflects waivers by the manager and/or distributor. Performance would have been lower had the waivers not been in effect.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP Natural Resources Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $4.12 | $3.30 | $3.84 | $3.55 | $4.63 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.10 | 0.07 | 0.04 | 0.07 | 0.03 |
| Net realized and unrealized gain (loss) | 0.63 | 0.81 | (0.51) | 0.26 | (1.10) |
| Total from investment operations | 0.73 | 0.88 | (0.47) | 0.33 | (1.07) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.08) | (0.06) | (0.07) | (0.04) | (0.01) |
| Total dividends and distributions | (0.08) | (0.06) | (0.07) | (0.04) | (0.01) |
| **Net asset value, end of period** | $4.77 | $4.12 | $3.30 | $3.84 | $3.55 |
| **Total return<sup>2</sup>** | 17.72% | 26.68% | (11.99%) | 9.46% | (23.23%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $109522 | $91<sup>3</sup> | $75<sup>3</sup> | $88<sup>3</sup> | $88<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 1.25% | 1.21% | 1.31% | 1.24% | 1.21% |
| Ratio of net investment income to average net assets | 2.24% | 1.89% | 1.40% | 1.88% | 0.72% |
| Portfolio turnover | 65% | 121% | 71% | 36% | 33% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Financial highlights

Delaware Ivy VIP Science and Technology Class I

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $29.81 | $36.13 | $29.94 | $21.91 | $27.04 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment loss<sup>1</sup> | (0.05) | (0.22) | (0.14) | (0.06) | (0.03) |
| Net realized and unrealized gain (loss) | (9.20) | 5.56 | 10.31 | 10.95 | (1.24) |
| Total from investment operations | (9.25) | 5.34 | 10.17 | 10.89 | (1.27) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net realized gain | (2.85) | (11.66) | (3.98) | (2.86) | (3.86) |
| Total dividends and distributions | (2.85) | (11.66) | (3.98) | (2.86) | (3.86) |
| **Net asset value, end of period** | $17.71 | $29.81 | $36.13 | $29.94 | $21.91 |
| **Total return<sup>2</sup>** | (31.67%) | 15.45% | 35.70% | 49.86% | (5.00%)<sup>3</sup> |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $1331 | $2<sup>4</sup> | $2<sup>4</sup> | $1<sup>4</sup> | $1<sup>4</sup> |
| Ratio of expenses to average net assets<sup>5</sup> | 0.92% | 0.89% | 0.91% | 0.90% | 0.91% |
| Ratio of expenses to average net assets prior to fees waived<sup>5</sup> | 0.92% | 0.89% | 0.91% | 0.90% | 0.91% |
| Ratio of net investment loss to average net assets | (0.23%) | (0.57%) | (0.44%) | (0.23%) | (0.11%) |
| Ratio of net investment loss to average net assets prior to fees waived | (0.23%) | (0.57%) | (0.44%) | (0.23%) | (0.11%) |
| Portfolio turnover | 58% | 55% | 8% | 31% | 17% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Total return during the period reflects waivers by the manager. Performance would have been lower had the waivers not been in effect.

<sup>4</sup> Net assets reported in millions.

<sup>5</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP Science and Technology Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $29.51 | $35.87 | $29.82 | $21.84 | $27.04 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment loss<sup>1</sup> | (0.10) | (0.30) | (0.21) | (0.13) | (0.11) |
| Net realized and unrealized gain (loss) | (9.11) | 5.51 | 10.24 | 10.90 | (1.23) |
| Total from investment operations | (9.21) | 5.21 | 10.03 | 10.77 | (1.34) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net realized gain | (2.85) | (11.57) | (3.98) | (2.79) | (3.86) |
| Total dividends and distributions | (2.85) | (11.57) | (3.98) | (2.79) | (3.86) |
| **Net asset value, end of period** | $17.45 | $29.51 | $35.87 | $29.82 | $21.84 |
| **Total return<sup>2</sup>** | (31.83%) | 15.17% | 35.36% | 49.48% | (5.23%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $450560 | $707<sup>3</sup> | $676<sup>3</sup> | $579<sup>3</sup> | $429<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 1.17% | 1.14% | 1.16% | 1.15% | 1.16% |
| Ratio of net investment loss to average net assets | (0.48%) | (0.79%) | (0.67%) | (0.48%) | (0.38%) |
| Portfolio turnover | 58% | 55% | 8% | 31% | 17% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Financial highlights

Delaware Ivy VIP Small Cap Growth Class I

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **11/2/18 <br> to**<br>**12/31/181** |
| **Net asset value, beginning of period** | $11.01 | $12.15 | $8.80 | $7.69 | $8.76 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment loss<sup>2</sup> | (0.03) | (0.07) | (0.04) | (0.05) | —<sup>3</sup> |
| Net realized and unrealized gain (loss) | (2.97 | 0.55 | 3.39 | 1.85 | (1.07) |
| Total from investment operations | (3.00 | 0.48 | 3.35 | 1.80 | (1.07) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income |  | (0.14) |  |  |  |
| Net realized gain | (2.02 | (1.48) |  | (0.69) |  |
| Total dividends and distributions | (2.02 | (1.62) |  | (0.69) |  |
| Payment from affiliates | 0.124 |  |  |  |  |
| **Net asset value, end of period** | $6.11 | $11.01 | $12.15 | $8.80 | $7.69 |
| **Total return<sup>5</sup>** | (26.61) | 4.25% | 38.01% | 23.68% | (12.24%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $17454 | $47<sup>7</sup> | $59<sup>7</sup> | $58<sup>7</sup> | $52<sup>7</sup> |
| Ratio of expenses to average net assets<sup>8</sup> | 0.89% | 0.89% | 0.89% | 0.89% | 1.05%<sup>9</sup> |
| Ratio of expenses to average net assets prior to fees waived<sup>8</sup> | 0.93% | 0.90% | 0.92% | 0.91% | 1.07% |
| Ratio of net investment income (loss) to average net assets | (0.34% | (0.56%) | (0.46%) | (0.60%) | 0.15% |
| Ratio of net investment income (loss) to average net assets prior to fees waived | (0.38% | (0.57%) | (0.49%) | (0.62%) | 0.13% |
| Portfolio turnover | 100% | 48% | 50% | 41% | 52% |

---

<sup>1</sup> Date of commencement of operations; ratios have been annualized and total return and portfolio turnover have not been annualized.

<sup>2</sup> Calculated using average shares outstanding.

<sup>3</sup> Amount is less than $0.005 per share.

<sup>4</sup> See Note 2 in "Notes to Financial Statements."

<sup>5</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle. Total return during the period reflects waivers by the manager. Performance would have been lower had the waivers not been in effect.

<sup>6</sup> Total return for the year ended December 31, 2022 includes the impact of the payment from affiliates. Total return would have been lower by 1.09% excluding payment from affiliates.

<sup>7</sup> Net assets reported in millions.

<sup>8</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

<sup>9</sup> Expense ratio based on the period excluding reorganization expenses was 0.89%.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Delaware Ivy VIP Small Cap Growth Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $10.94 | $12.08 | $8.77 | $7.68 | $11.63 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment loss<sup>1</sup> | (0.04) | (0.10) | (0.06) | (0.07) | (0.06) |
| Net realized and unrealized gain (loss) | (2.98 | 0.56 | 3.37 | 1.85 | 0.03 |
| Total from investment operations | (3.02 | 0.46 | 3.31 | 1.78 | (0.03) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income |  | (0.12) |  |  | (0.05) |
| Net realized gain | (2.02 | (1.48) |  | (0.69) | (3.87) |
| Total dividends and distributions | (2.02 | (1.60) |  | (0.69) | (3.92) |
| Payment from affiliates | 0.142 |  |  |  |  |
| **Net asset value, end of period** | $6.04 | $10.94 | $12.08 | $8.77 | $7.68 |
| **Total return<sup>3</sup>** | (26.83) | 3.99% | 37.66% | 23.37% | (4.11%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $181456 | $391<sup>5</sup> | $406<sup>5</sup> | $331<sup>5</sup> | $300<sup>5</sup> |
| Ratio of expenses to average net assets<sup>6</sup> | 1.14% | 1.14% | 1.14% | 1.14% | 1.16%<sup>7</sup> |
| Ratio of expenses to average net assets prior to fees waived<sup>6</sup> | 1.18% | 1.15% | 1.17% | 1.17% | 1.18% |
| Ratio of net investment loss to average net assets | (0.58% | (0.80%) | (0.71%) | (0.84%) | (0.52%) |
| Ratio of net investment loss to average net assets prior to fees waived | (0.62% | (0.81%) | (0.74%) | (0.87%) | (0.54%) |
| Portfolio turnover | 100% | 48% | 50% | 41% | 52% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> See Note 2 in "Notes to Financial Statements."

<sup>3</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle. Total return during the period reflects waivers by the manager and/or distributor. Performance would have been lower had the waivers not been in effect.

<sup>4</sup> Total return for the year ended December 31, 2022 includes the impact of the payment from affiliates. Total return would have been lower by 1.28% excluding payment from affiliates.

<sup>5</sup> Net assets reported in millions.

<sup>6</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

<sup>7</sup> Expense ratio based on the period excluding reorganization expenses was 1.14%.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Financial highlights

Delaware Ivy VIP Smid Cap Core Class II

Selected data for each share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $16.73 | $13.85 | $13.71 | $13.51 | $18.32 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income (loss)<sup>1</sup> | 0.03 | (0.02) | (0.02) | —<sup>2</sup> | (0.06) |
| Net realized and unrealized gain (loss) | (2.57) | 2.90 | 0.80 | 3.12 | (1.37) |
| Total from investment operations | (2.54) | 2.88 | 0.78 | 3.12 | (1.43) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income |  |  |  |  | (0.02) |
| Net realized gain | (3.05) |  | (0.64) | (2.92) | (3.36) |
| Total dividends and distributions | (3.05) |  | (0.64) | (2.92) | (3.38) |
| **Net asset value, end of period** | $11.14 | $16.73 | $13.85 | $13.71 | $13.51 |
| **Total return<sup>3</sup>** | (14.84%) | 20.78% | 7.03% | 24.33% | (10.49%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $158111 | $182<sup>4</sup> | $183<sup>4</sup> | $188<sup>4</sup> | $175<sup>4</sup> |
| Ratio of expenses to average net assets<sup>5</sup> | 1.22% | 1.17% | 1.20% | 1.18% | 1.17% |
| Ratio of net investment income (loss) to average net assets | 0.24% | (0.10%) | (0.14%) | (0.05%) | (0.34%) |
| Portfolio turnover | 113% | 79% | 145% | 126% | 112% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Amount is less than $0.005 per share.

<sup>3</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>4</sup> Net assets reported in millions.

<sup>5</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

December 31, 2022

Ivy Variable Insurance Portfolios (Trust) is organized as a Delaware statutory trust and offers 26 portfolios. These financial statements and the related notes pertain to 11 portfolios: Delaware Ivy VIP Asset Strategy, Delaware Ivy VIP Balanced, Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, Delaware Ivy VIP High Income, Delaware Ivy VIP International Core Equity, Delaware Ivy VIP Mid Cap Growth, Delaware Ivy VIP Natural Resources, Delaware Ivy VIP Science and Technology, Delaware Ivy VIP Small Cap Growth, and Delaware Ivy VIP Smid Cap Core, (each, a Portfolio and collectively, the Portfolios). The Trust is an open-end investment company. Each of the Portfolios (other than Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, and Delaware Ivy VIP Science and Technology) are diversified as defined in the Investment Company Act of 1940, as amended (1940 Act). Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, and Delaware Ivy VIP Science and Technology are non-diversified as defined in the 1940 Act.

Each Portfolio offers Class II shares. Delaware Ivy VIP Asset Strategy, Delaware Ivy VIP Energy, Delaware Ivy VIP High Income, Delaware Ivy VIP Mid Cap Growth, Delaware Ivy VIP Science and Technology, and Delaware Ivy VIP Small Cap Growth also offer Class I shares. The Class I shares do not carry a distribution and service (12b-1) fee and the Class II shares carry a 12b-1 fee. The shares of the Portfolios are sold only to variable life insurance separate accounts and variable annuity separate accounts.

1. Significant Accounting Policies

Each Portfolio follows accounting and reporting guidance under Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946, Financial Services — Investment Companies. The following accounting policies are in accordance with US generally accepted accounting principles (US GAAP) and are consistently followed by the Portfolios.

**Security Valuation** — Equity securities and exchange-traded funds (ETFs), except those traded on the Nasdaq Stock Market LLC (Nasdaq), are valued at the last quoted sales price as of the time of the regular close of the New York Stock Exchange on the valuation date. Equity securities and ETFs traded on the Nasdaq are valued in accordance with the Nasdaq Official Closing Price, which may not be the last sales price. If, on a particular day, an equity security or ETF does not trade, the mean between the bid and the ask prices will be used, which approximates fair value. Equity securities listed on a foreign exchange are normally valued at the last quoted sales price on the valuation date. The fair value of bullion is at the last settlement price at the end of each day on the board of trade or exchange upon which they are traded. US government and agency securities are valued at the mean between the bid and the ask prices, which approximates fair value. Other debt securities are valued based upon valuations provided by an independent pricing service or broker and reviewed by management. To the extent current market prices are not available, the pricing service may take into account developments related to the specific security, as well as transactions in comparable securities. Valuations for fixed income securities utilize matrix systems, which reflect such factors as security prices, yields, maturities, and ratings, and are supplemented by dealer and exchange quotations. For asset-backed securities, collateralized mortgage obligations (CMOs), commercial mortgage securities, and US government agency mortgage securities, pricing vendors utilize matrix pricing which considers prepayment speed, attributes of the collateral, yield or price of bonds of comparable quality, coupon, maturity, and type as well as broker/dealer-supplied prices. Foreign currency exchange contracts and foreign cross currency exchange contracts are valued at the mean between the bid and the ask prices, which approximates fair value. Interpolated values are derived when the settlement date of the contract is an interim date for which quotations are not available. Futures contracts and options on futures contracts are valued at the daily quoted settlement prices. Exchange-traded options are valued at the last reported sale price or, if no sales are reported, at the mean between the last reported bid and the ask prices, which approximates fair value. Open-end investment companies, other than ETFs, are valued at their published net asset value (NAV). Generally, other securities and assets for which market quotations are not readily available are valued at fair value as determined in good faith by each Portfolio's valuation designee, Delaware Management Company (DMC). Subject to the oversight of each portfolio's Board of Trustees (Board), DMC, as valuation designee, has adopted policies and procedures to fair value securities for which market quotations are not readily available consistent with the requirements of Rule 2a-5 under the 1940 Act. In determining whether market quotations are readily available or fair valuation will be used, various factors will be taken into consideration, such as market closures or suspension of trading in a security. Restricted securities and private placements are valued at fair value.

**Federal and Foreign Income Taxes** — No provision for federal income taxes has been made as each Portfolio intends to continue to qualify for federal income tax purposes as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended, and make the requisite distributions to shareholders. Each Portfolio evaluates tax positions taken or expected to be taken in the course of preparing each Portfolio's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the "more-likely-than-not" threshold are recorded as a tax benefit or expense in the current year. Management has analyzed each Portfolio's tax positions taken or expected to be taken on each Portfolio's federal income tax returns through the year ended December 31, 2022, and for all open tax years (years ended December 31, 2019-December 31, 2021), and has concluded that <br>

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

1. Significant Accounting Policies (continued)

no provision for federal income tax is required in each Portfolio's financial statements. In regard to foreign taxes only, each Portfolio has open tax years in certain foreign countries in which it invests in that may date back to the inception of each Portfolio. If applicable, each Portfolio recognizes interest accrued on unrecognized tax benefits in interest expense and penalties in "Other" on the "Statements of operations." During the year ended December 31, 2022, the Portfolios did not incur any interest or tax penalties.

**Class Accounting** — Investment income, common expenses, and realized and unrealized gain (loss) on investments are allocated to the classes of each Portfolio on the basis of daily net assets of each class. Distribution expenses relating to a specific class are charged directly to that class.

**Foreign Currency Transactions** — Transactions denominated in foreign currencies are recorded at the prevailing exchange rates on the valuation date. The value of all assets and liabilities denominated in foreign currencies is translated daily into US dollars at the exchange rate of such currencies against the US dollar. Transaction gains or losses resulting from changes in exchange rates during the reporting period or upon settlement of the foreign currency transaction are reported in operations for the current period. The Portfolios generally bifurcate that portion of realized gains and losses on investments in debt securities which is due to changes in foreign exchange rates from that which is due to changes in market prices of debt securities. That portion of gains (losses), which is due to changes in foreign exchange rates, is included on the "Statements of operations" under "Net realized gain (loss) on foreign currencies." For foreign equity securities, the realized gains and losses are included on the "Statements of operations" under "Net realized gain (loss) on investments." The Portfolios report certain foreign currency related transactions as components of realized gains (losses) for financial reporting purposes, whereas such components are treated as ordinary income (loss) for federal income tax purposes.

**Derivative Financial Instruments** - The Portfolio may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other assets without owning or taking physical custody of securities, commodities and/ or other referenced assets or to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/or other risks.

Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction or illiquidity of the instrument. Pursuant to Rule 18f-4 under the 1940 Act, among other things, the Portfolio must either use derivative financial instruments with embedded leverage in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. The Portfolios' successful use of a derivative financial instrument depends on the investment adviser's ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the amount of appreciation the Portfolio can realize on an investment and/or may result in lower distributions paid to shareholders. The Portfolios' investments in these instruments, if any, are discussed in detail in the Notes to financial statements.

**Segregation and Collateralizations** - In certain cases, based on requirements and agreements with certain exchanges and third-party broker- dealers, the Portfolio may deliver or receive collateral in connection with certain investments (e.g., futures contracts, foreign currency exchange contracts, options written, securities with extended settlement periods, and swaps). Certain countries require that cash reserves be held while investing in companies incorporated in that country. These cash reserves and cash collateral that has been pledged/received to cover obligations of the Portfolio under derivative contracts, if any, will be reported separately on the "Statements of assets and liabilities" as cash collateral due to/from broker. Securities collateral pledged for the same purpose, if any, is noted on the "Schedules of investments."

**Use of Estimates** — The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the fair value of investments, the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and the differences could be material.

**Other** — Expenses directly attributable to a Portfolio are charged directly to that Portfolio. Other expenses common to various funds within the Delaware Funds by Macquarie<sup>®</sup> (Delaware Funds) are generally allocated among such funds on the basis of average net assets. Management fees and certain other expenses are paid monthly. Security transactions are recorded on the date the securities are purchased or sold (trade date) for financial reporting purposes. Costs used in calculating realized gains and losses on the sale of investment securities are those of the specific securities sold. Dividend income is recorded on the ex-dividend date and interest income is recorded on the accrual basis. Income and capital gain distributions from any investment companies (Underlying Funds) in which the Portfolio invests are recorded on the ex-dividend date. Discounts and premiums on debt securities are accreted or amortized to interest income, respectively, over the lives of the respective securities <br>

[**Table of Contents**](#toc1)

using the effective interest method. Premiums on callable debt securities are amortized to interest income to the earliest call date using the effective interest method. Realized gains (losses) on paydowns of asset- and mortgage-backed securities are classified as interest income. Distributions received from investments in real estate investment trusts (REITs) are recorded as dividend income on the ex-dividend date, subject to reclassification upon notice of the character of such distributions by the issuer, which are estimated. Foreign dividends are also recorded on the ex-dividend date or as soon after the ex-dividend date that the Portfolios are aware of such dividends, net of all tax withholdings, a portion of which may be reclaimable. Withholding taxes and reclaims on foreign dividends and interest have been recorded in accordance with the Portfolios' understanding of the applicable country's tax rules and rates. Each Portfolio may pay foreign capital gains taxes on certain foreign securities held, which are reported as components of realized losses for financial reporting purposes, whereas such components are treated as ordinary loss for federal income tax purposes. The Portfolios declare and pay dividends from net investment income and distributions from net realized gain on investments, if any, following the close of the fiscal year. The Portfolios may distribute more frequently, if necessary for tax purposes. Dividends and distributions, if any, are recorded on the ex-dividend date.

2. Investment Management, Administration Agreements, and Other Transactions with Affiliates

In accordance with the terms of its respective investment management agreement, each Portfolio pays DMC, a series of Macquarie Investment Management Business Trust and the investment manager, an annual fee which is calculated daily and paid monthly, based on each Portfolio's average daily net assets as follows:

---

| | |
|:---|:---|
| Portfolio | Management Fee (annual rate as a percentage of average daily net assets) |
| Delaware Ivy VIP Asset Strategy<sup>1</sup> | 0.70% of net assets up to $1 billion; |
|  | 0.65% of net assets over $1 billion and up to $2 billion; |
|  | 0.60% of net assets over $2 billion and up to $3 billion;<br> 0.55% of net assets over $3 billion. |
| Delaware Ivy VIP Balanced | 0.70% of net assets up to $1 billion; |
|  | 0.65% of net assets over $1 billion and up to $2 billion;<br> 0.60% of net assets over $2 billion and up to $3 billion;<br> 0.55% of net assets over $3 billion. |
| Delaware Ivy VIP Energy | 0.85% of net assets up to $1 billion; |
|  | 0.83% of net assets over $1 billion and up to $2 billion;<br> 0.80% of net assets over $2 billion and up to $3 billion;<br> 0.76% of net assets over $3 billion. |
| Delaware Ivy VIP Growth | 0.70% of net assets up to $1 billion; |
|  | 0.65% of net assets over $1 billion and up to $2 billion;<br> 0.60% of net assets over $2 billion and up to $3 billion;<br> 0.55% of net assets over $3 billion. |
| Delaware Ivy VIP High Income | 0.625% of net assets up to $500 million; |
|  | 0.60% of net assets over $500 million and up to $1 billion;<br> 0.55% of net assets over $1 billion and up to $1.5 billion;<br> 0.50% of net assets over $1.5 billion. |
| Delaware Ivy VIP International Core Equity | 0.85% of net assets up to $1 billion; |
|  | 0.83% of net assets over $1 billion and up to $2 billion;<br> 0.80% of net assets over $2 billion and up to $3 billion;<br> 0.76% of net assets over $3 billion. |
| Delaware Ivy VIP Mid Cap Growth | 0.85% of net assets up to $1 billion; |
|  | 0.83% of net assets over $1 billion and up to $2 billion;<br> 0.80% of net assets over $2 billion and up to $3 billion;<br> 0.76% of net assets over $3 billion. |

---

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

2. Investment Management, Administration Agreements, and Other Transactions with Affiliates (continued)

---

| | |
|:---|:---|
| Portfolio | Management Fee (annual rate as a percentage of average daily net assets) |
| Delaware Ivy VIP Natural Resources | 0.85% of net assets up to $1 billion; |
|  | 0.83% of net assets over $1 billion and up to $2 billion;<br> 0.80% of net assets over $2 billion and up to $3 billion;<br> 0.76% of net assets over $3 billion and up to $5 billion;<br> 0.73% of net assets over $5 billion and up to $10 billion;<br> 0.70% of net assets over $10 billion. |
| Delaware Ivy VIP Science and Technology | 0.85% of net assets up to $1 billion; |
|  | 0.83% of net assets over $1 billion and up to $2 billion;<br> 0.80% of net assets over $2 billion and up to $3 billion;<br> 0.76% of net assets over $3 billion. |
| Delaware Ivy VIP Small Cap Growth | 0.85% of net assets up to $1 billion; |
|  | 0.83% of net assets over $1 billion and up to $2 billion;<br> 0.80% of net assets over $2 billion and up to $3 billion;<br> 0.76% of net assets over $3 billion. |
| Delaware Ivy VIP Smid Cap Core | 0.85% of net assets up to $1 billion; |
|  | 0.83% of net assets over $1 billion and up to $2 billion;<br> 0.80% of net assets over $2 billion and up to $3 billion;<br> 0.76% of net assets over $3 billion. |

---

<sup>1</sup> DMC had contractually agreed to reduce the management fee paid by the Portfolio by an annual rate of 0.15% of average daily net assets through April 30, 2022.

DMC has entered into sub-advisory agreements with the following entities on behalf of the Portfolios:

Each of Macquarie Investment Management Austria Kapitalanlage AG (MIMAK), Macquarie Investment Management Europe Limited (MIMEL), Macquarie Investment Management Global Limited (MIMGL) and Macquarie Funds Management Hong Kong Limited (MFMHKL), are a part of Macquarie Asset Management (MAM) and an affiliate of DMC (the Affiliated Sub-Advisors). MAM is the marketing name for certain companies comprising the asset management division of Macquarie Group Limited. DMC and MIMAK are primarily responsible for the day-to-day management of the Delaware Ivy VIP Asset Strategy and Delaware Ivy VIP Balanced portfolios. In addition, the Manager may also seek fixed income investment advice and recommendations from MIMAK and DMC may also permit MIMAK to execute Portfolio security trades on behalf of DMC and exercise investment discretion for securities in certain markets where DMC believes it will be beneficial to utilize MIMAK's specialized market knowledge.

With respect to Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, Delaware Ivy VIP International Core Equity, Delaware Ivy VIP Mid Cap Growth, Delaware Ivy VIP Natural Resources, Delaware Ivy VIP Science and Technology, Delaware Ivy VIP Small Cap Growth and Delaware Ivy VIP Smid Cap Core, DMC has principal responsibility for the portfolio and may utilize MIMGL and MFMHKL to execute Portfolio security trades on behalf of DMC.

With respect to Delaware Ivy VIP High Income, DMC may seek investment advice and recommendations from MIMAK, MIMEL and MIMGL and may permit each to exercise investment discretion in certain markets where DMC believes it will be beneficial to utilize the specialized market knowledge of each of MIMAK, MIMEL and/or MIMGL.

Pursuant to the terms of the relevant sub-advisory agreement, an investment sub-advisory fee is paid by DMC to each Affiliated Sub-Advisor.

Prior to January 18, 2022 (for Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, Delaware Ivy VIP High Income, Delaware Ivy VIP Mid Cap Growth, Delaware Ivy VIP Natural Resources, Delaware Ivy VIP Science and Technology, and Delaware Ivy VIP Small Cap Growth), January 31, 2022 (for Delaware Ivy VIP Asset Strategy and Delaware Ivy VIP Balanced) and February 28, 2022 (for Delaware Ivy VIP

[**Table of Contents**](#toc1)

International Core Equity and Delaware Ivy VIP Smid Cap Core), the Portfolios had an Accounting Services Agreement with Waddell & Reed Services Company (WRSCO), doing business as WI Services Company (WISC). Under the agreement, WISC acted as the agent in providing bookkeeping and accounting services and assistance to each Portfolio, including maintenance of Portfolio records, pricing of Portfolio shares and preparation of certain shareholder reports. For these services, each Portfolio paid WISC a monthly fee of one-twelfth of the annual fee based on the average net asset levels shown in the following table:

---

| | |
|:---|:---|
| (M - Millions) | Annual Fee Rate |
| $0 to $10M | $0 |
| $10 to $25M | 11496 |
| $25 to $50M | 23100 |
| $50 to $100M | 35496 |
| $100 to $200M | 48396 |
| $200 to $350M | 63204 |
| $350 to $550M | 82500 |
| $550 to $750M | 96300 |
| $750 to $1,000M | 121596 |
| Over $1,000M | 148500 |

---

In addition, each Portfolio paid WISC a monthly administrative fee at the annual rate of 0.01%, or one basis point, for the first $1 billion of net assets with no fee charged for net assets in excess of $1 billion. This fee was voluntarily waived by WISC until each Portfolio's net assets were at least $10 million and is included in "Accounting and administration expenses" on the "Statements of operations."

Effective January 18, 2022 (for Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, Delaware Ivy VIP High Income, Delaware Ivy VIP Mid Cap Growth, Delaware Ivy VIP Natural Resources, Delaware Ivy VIP Science and Technology, and Delaware Ivy VIP Small Cap Growth),

January 31, 2022 (for Delaware Ivy VIP Asset Strategy and Delaware Ivy VIP Balanced) and February 28, 2022 (for Delaware Ivy VIP International Core Equity and Delaware Ivy VIP Smid Cap Core), Delaware Investments Fund Services Company (DIFSC), an affiliate of DMC, provides fund accounting and financial administrative oversight services to each Portfolio. For these services, DIFSC's fees are calculated daily and paid monthly, based on the aggregate daily net assets of all funds within the Delaware Funds at the following annual rates: 0.00475% of the first $35 billion; 0.0040% of the next $10 billion; 0.0025% of the next $45 billion; and 0.0015% of aggregate average daily net assets in excess of $90 billion (Total Fee). Each fund in the Delaware Funds pays a minimum of $4,000, which, in aggregate, is subtracted from the Total Fee.

Each fund then pays its portion of the remainder of the Total Fee on a relative NAV basis. These amounts are included on the "Statements of operations" under "Accounting and administration expenses." From the effective dates mentioned above to December 31, 2022, each Portfolio paid for these services as follows:

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Asset Strategy | $20954 |
| Delaware Ivy VIP Balanced | 11410 |
| Delaware Ivy VIP Energy | 6288 |
| Delaware Ivy VIP Growth | 20032 |
| Delaware Ivy VIP High Income | 26491 |
| Delaware Ivy VIP International Core Equity | 14006 |
| Delaware Ivy VIP Mid Cap Growth | 14620 |
| Delaware Ivy VIP Natural Resources | 6078 |
| Delaware Ivy VIP Science and Technology | 15401 |
| Delaware Ivy VIP Small Cap Growth | 10775 |
| Delaware Ivy VIP Smid Cap Core | 6315 |

---

Prior to June 27, 2022, under a Transfer Agency Agreement between the Trust and WISC, each Portfolio reimbursed WISC for certain out-of- pocket costs. Effective June 27, 2022, DIFSC is also the transfer agent and dividend disbursing agent of the Portfolios. For these services, DIFSC's fees are calculated daily and paid monthly, at the annual rate of 0.0075% of the Portfolios' average daily net assets. This amount is included on the "Statements of operations" under "Dividend disbursing and transfer agent fees and expenses." From June 27, 2022 through December 31, 2022, each Portfolio paid for these services as follows: <br>

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

2. Investment Management, Administration Agreements, and Other Transactions with Affiliates (continued)

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Asset Strategy | $18108 |
| Delaware Ivy VIP Balanced | 6783 |
| Delaware Ivy VIP Energy | 3925 |
| Delaware Ivy VIP Growth | 21265 |
| Delaware Ivy VIP High Income | 23830 |
| Delaware Ivy VIP International Core Equity | 14655 |
| Delaware Ivy VIP Mid Cap Growth | 15026 |
| Delaware Ivy VIP Natural Resources | 3635 |
| Delaware Ivy VIP Science and Technology | 15272 |
| Delaware Ivy VIP Small Cap Growth | 9550 |
| Delaware Ivy VIP Smid Cap Core | 4888 |

---

Pursuant to a sub-transfer agency agreement between DIFSC and BNY Mellon Investment Servicing (US) Inc. (BNYMIS), effective June 27, 2022, BNYMIS provides certain sub-transfer agency services to each Portfolio. Sub-transfer agency fees are paid by each Portfolio and are also included on the "Statements of operations" under "Dividend disbursing and transfer agent fees and expenses." The fees that are calculated daily and paid as invoices are received on a monthly or quarterly basis.

Pursuant to a distribution agreement and distribution plan, each Portfolio pays Delaware Distributors, L.P. (DDLP), the distributor and an affiliate of DMC, an annual 12b-1 fee of 0.25% of the average daily net assets of the Class II shares. The fees are calculated daily and paid monthly. Class I shares do not pay 12b-1 fees.

From January 1, 2022, (except as noted below) DMC (through April 29, 2023) and WRSCO (through June 27, 2022) have contractually agreed to waive all or a portion of its investment advisory fees and/or pay/reimburse expenses (excluding acquired fund fees and expenses, taxes, interest, short sale dividend and interest expenses, brokerage fees, certain insurance costs, and nonroutine expenses or costs, including, but not limited to, those relating to reorganizations, litigation, conducting shareholder meetings, and liquidations) as follows:

---

| | | |
|:---|:---|:---|
| Portfolio | Operating expense<br> limitation as a<br> percentage of average<br> daily net assets<br> Class I Shares | Operating expense<br> limitation as a<br> percentage of average<br> daily net assets<br> Class II Shares |
| Delaware Ivy VIP Asset Strategy | 0.62% | 0.87% |
| Delaware Ivy VIP Mid Cap Growth | 0.85% | 1.10% |
| Delaware Ivy VIP Small Cap Growth | 0.89%<sup>1</sup> | 1.14% |

---

<sup>1</sup> Effective April 29, 2022.

Through April 30, 2022, for each Portfolio that offered Class I Shares, the Portfolios' distributor and/or WISC had contractually agreed to reimburse sufficient fees to ensure that the total annual ordinary portfolio operating expenses of the Class I Shares were at all times equal to the total annual ordinary portfolio operating expenses of the Class II Shares less 0.25%, as calculated at the end of each month.

As provided in the investment management agreement, each Portfolio bears a portion of the cost of certain resources shared with DMC, including the cost of internal personnel of DMC and/or its affiliates that provide legal and regulatory reporting services to each Portfolio. These amounts are included on the "Statements of operations" under "Legal fees." For the year ended December 31, 2022, each Portfolio paid for internal legal and regulatory reporting services provided by DMC and/or its affiliates' employees as follows:

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Asset Strategy | $19360 |
| Delaware Ivy VIP Balanced | 6349 |
| Delaware Ivy VIP Energy | 3310 |
| Delaware Ivy VIP Growth | 22124 |
| Delaware Ivy VIP High Income | 32119 |

---

[**Table of Contents**](#toc1)

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP International Core Equity | $13786 |
| Delaware Ivy VIP Mid Cap Growth | 15383 |
| Delaware Ivy VIP Natural Resources | 3575 |
| Delaware Ivy VIP Science and Technology | 17164 |
| Delaware Ivy VIP Small Cap Growth | 9989 |
| Delaware Ivy VIP Smid Cap Core | 4532 |

---

Trustees' fees include expenses accrued by each Portfolio for each Trustee's retainer and meeting fees. Certain officers of DMC, DIFSC, and DDLP are officers and/or Trustees of the Trust. These officers and Trustees are paid no compensation by the Portfolios.

In addition to the management fees and other expenses of a Portfolio, a Portfolio indirectly bears the investment management fees and other expenses of any Underlying Funds including ETFs in which it invests. The amount of these fees and expenses incurred indirectly by a Portfolio will vary based upon the expense and fee levels of any Underlying Funds and the number of shares that are owned of any Underlying Funds at different times.

During the year ended December 31, 2022, DMC reimbursed the Delaware Ivy VIP Small Cap Growth $5,772,824 for losses related to a trade error. These amounts are included in "Net increase from payment by affiliates" in the Statements of Operations. The impact on total return is included in the annual returns for the year ended December 31, 2022.

Cross trades for the year ended December 31, 2022, were executed by the Portfolios pursuant to procedures adopted by the Board designed to ensure compliance with Rule 17a-7 under the 1940 Act. Cross trading is the buying or selling of portfolio securities between funds of investment companies, or between a fund of an investment company and another entity, that are or could be considered affiliates by virtue of having a common investment advisor (or affiliated investment advisors), common directors/trustees and/or common officers. At its regularly scheduled meetings, the Board reviews a report related to the Portfolios' compliance with the procedures adopted by the Board. Pursuant to these procedures, for the year ended December 31, 2022, the following Portfolios engaged in Rule 17a-7 securities purchases and securities sales, which resulted in net gains or losses as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Purchases | Sales | Net realized gain (loss) |
| Delaware Ivy VIP Asset Strategy | $1644406 | $— | $— |
| Delaware Ivy VIP Mid Cap Growth | 1373882 |  |  |
| Delaware Ivy VIP Smid Cap Core | 1566441 | 3585251 | (39304) |

---

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

2. Investment Management, Administration Agreements, and Other Transactions with Affiliates (continued)

A summary of the transactions in affiliated companies during the year ended December 31, 2022 was as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br>beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on<br> affiliated<br> securities | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br> on affiliated<br> securities | Value,<br> end of<br> period | Shares | Interest<br> Income |
| **Delaware Ivy VIP Asset Strategy** |  |  |  |  |  |  |  |  |
| **Corporate Bond—** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**0.11%** |  |  |  |  |  |  |  |  |
| COTA Series D |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;144A 4.896% |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;10/2/23<sup>#,=</sup> |  |  |  |  |  |  |  |  |
|  | $637419 | $— | $— | $— | $— | $637419 | 3642397 | $153092 |
| **Common Stocks—** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**0.00%** |  |  |  |  |  |  |  |  |
| COTA Series B<sup>=,†</sup> |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  | 26 |  |
| Media Group Holdings |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Series H<sup>=,†</sup> |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  | 31963 |  |
| Media Group Holdings |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Series T<sup>=,†</sup> |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  | 4006 |  |
|  | $— | $— | $— | $— | $— | $— |  | $— |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br> beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on<br> affiliated<br> securities | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br> on affiliated<br> securities | Value,<br> end of<br> period | Shares |
| **Delaware Ivy VIP High Income** |  |  |  |  |  |  |  |
| **Common Stocks—** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**0.00%** |  |  |  |  |  |  |  |
| Larchmont Resources<sup>\*,=,†</sup> |  |  |  |  |  |  |  |
|  | $92197 | $— | $(67778) | $— | $14353 | $— |  |
| New Cotai<sup>\*,=,†</sup> |  |  |  |  |  |  |  |
|  | 3929813 |  |  |  | (1096135) |  |  |
|  | $4022010 | $— | $(67778) | $— | $(1081782) | $— |  |
| **Loan** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**Agreements—** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**0.00%** |  |  |  |  |  |  |  |
| New Cotai LLC |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;(14.000% Cash |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;or 14.000% PIK) |  |  |  |  |  |  |  |
|  | $934937 | $24046 | $(984236) | $— | $25253 | $— |  |

---

<sup>#</sup> Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended.

<sup>=</sup> The value of this security was determined using significant unobservable inputs and is reported as a Level 3 security in the disclosure table located in Note 3 in "Notes to financial statements."

[**Table of Contents**](#toc1)

<sup>†</sup> Non-income producing security.

<sup>\*</sup> Issuer is not an affiliated investment of the Portfolio at December 31, 2022.

3. Investments

For the year ended December 31, 2022, each Portfolio made purchases and sales of investment securities other than short-term investments as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Portfolio | Purchases<br> other than <br>US government <br>securities | Purchases of<br> US government <br>securities | Sales<br> other than <br>US government <br>securities | Sales of <br>US government <br>securities |
| Delaware Ivy VIP Asset Strategy | $243407862 | $338229734 | $382602611 | $261916777 |
| Delaware Ivy VIP Balanced | 53360395 | 100692635 | 62797257 | 121350606 |
| Delaware Ivy VIP Energy | 110241740 |  | 97451224 |  |
| Delaware Ivy VIP Growth | 68935257 |  | 206857708 |  |
| Delaware Ivy VIP High Income | 435315717 |  | 450999877 |  |
| Delaware Ivy VIP International Core Equity | 319067509 |  | 359768924 |  |
| Delaware Ivy VIP Mid Cap Growth | 151322341 |  | 213493440 |  |
| Delaware Ivy VIP Natural Resources | 76528588 |  | 70475888 |  |
| Delaware Ivy VIP Science and Technology | 287136331 |  | 319765871 |  |
| Delaware Ivy VIP Small Cap Growth | 307616075 |  | 434217285 |  |
| Delaware Ivy VIP Smid Cap Core | 187056412 |  | 182839353 |  |

---

The tax cost of investments and derivatives includes adjustments to net unrealized appreciation (depreciation) which may not necessarily be the final tax cost basis adjustments but which approximate the tax basis unrealized gains and losses that may be realized and distributed to shareholders. At December 31, 2022, the cost and unrealized appreciation (depreciation) of investments and derivatives for federal income tax purposes for each Portfolio were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Portfolio | Cost of<br> investments<br> and derivatives | Aggregate<br> unrealized<br> appreciation<br> of investments<br> and derivatives | Aggregate<br> unrealized<br> depreciation<br> of investments<br> and derivatives | Net unrealized<br> appreciation<br> (depreciation)<br> of investments<br> and derivatives |
| Delaware Ivy VIP Asset Strategy | $643420379 | $57601700 | $(121364673) | $(63762973) |
| Delaware Ivy VIP Balanced | 227781565 | 8213255 | (24324754) | (16111499) |
| Delaware Ivy VIP Energy | 118434289 | 14090555 | (6231514) | 7859041 |
| Delaware Ivy VIP Growth | 494792318 | 161774732 | (28671181) | 133103551 |
| Delaware Ivy VIP High Income | 907844233 | 6350705 | (140495862) | (134145157) |
| Delaware Ivy VIP International Core Equity | 507886067 | 44645531 | (71620969) | (26975438) |
| Delaware Ivy VIP Mid Cap Growth | 437698363 | 94026359 | (70616631) | 23409728 |
| Delaware Ivy VIP Natural Resources | 115087075 | 10356931 | (12073158) | (1716227) |
| Delaware Ivy VIP Science and Technology | 459129131 | 56852656 | (63043735) | (6191079) |
| Delaware Ivy VIP Small Cap Growth | 231524501 | 6626044 | (38765281) | (32139237) |
| Delaware Ivy VIP Smid Cap Core | 174109957 | 7622785 | (23393910) | (15771125) |

---

US GAAP defines fair value as the price that each Portfolio would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. A three-level hierarchy for fair value measurements has been established based upon the transparency of inputs to the valuation of an asset or liability. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the reporting entity's own assumptions about the assumptions that market participants would use in pricing the

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

3. Investments (continued)

asset or liability based on the best information available under the circumstances. Each Portfolio's investment in its entirety is assigned a level based upon the observability of the inputs which are significant to the overall valuation. The three-level hierarchy of inputs is summarized as follows:

Level 1 - Inputs are quoted prices in active markets for identical investments. (Examples: equity securities, open-end investment companies, futures contracts, and exchange-traded options contracts)

---

| | |
|:---|:---|
| Level 2 - | Other observable inputs, including, but not limited to: quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks, and default rates) or other market-corroborated inputs. (Examples: debt securities, government securities, swap contracts, foreign currency exchange contracts, foreign securities utilizing international fair value pricing, broker-quoted securities, and fair valued securities) |

---

Level 3 - Significant unobservable inputs, including each Portfolio's own assumptions used to determine the fair value of investments. (Examples: broker-quoted securities and fair valued securities)

Level 3 investments are valued using significant unobservable inputs. Each Portfolio may also use an income-based valuation approach in which the anticipated future cash flows of the investment are discounted to calculate fair value. Discounts may also be applied due to the nature or duration of any restrictions on the disposition of the investments. Valuations may also be based upon current market prices of securities that are comparable in coupon, rating, maturity, and industry. The derived value of a Level 3 investment may not represent the value which is received upon disposition and this could impact the results of operations.

The following tables summarize the valuation of each Portfolio's investments by fair value hierarchy levels as of December 31, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP Asset Strategy | Delaware Ivy VIP Asset Strategy | Delaware Ivy VIP Asset Strategy | Delaware Ivy VIP Asset Strategy |
|  | Level 1 | Level 2 | Level 3 | Total |
| <u>Securities Assets:</u> |  |  |  |  |
| Agency Collateralized Mortgage |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Obligations | $— | $922523 | $— | $922523 |
| Agency Commercial Mortgage- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Backed Securities |  | 4634018 |  | 4634018 |
| Agency Mortgage-Backed |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Securities |  | 45959375 |  | 45959375 |
| Bullion |  | 26371837 |  | 26371837 |
| Common Stocks |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Communication Services | 23193393 |  |  | 23193393 |
| &nbsp;&nbsp;&nbsp;Consumer Discretionary | 42054278 |  | —1 | 42054278 |
| &nbsp;&nbsp;&nbsp;Consumer Staples | 23781925 |  | —1 | 23781925 |
| &nbsp;&nbsp;&nbsp;Energy | 21747540 |  |  | 21747540 |
| &nbsp;&nbsp;&nbsp;Financials | 41866746 |  |  | 41866746 |
| &nbsp;&nbsp;&nbsp;Healthcare | 54242066 |  |  | 54242066 |
| &nbsp;&nbsp;&nbsp;Industrials | 37515562 |  |  | 37515562 |
| &nbsp;&nbsp;&nbsp;Information Technology | 66023954 |  |  | 66023954 |
| &nbsp;&nbsp;&nbsp;Materials | 2817863 |  |  | 2817863 |

---

[**Table of Contents**](#toc1)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP Asset Strategy | Delaware Ivy VIP Asset Strategy | Delaware Ivy VIP Asset Strategy | Delaware Ivy VIP Asset Strategy |
|  | Level 1 | Level 2 | Level 3 | Total |
| Utilities | $7628905 | $— | $— | $7628905 |
| Convertible Bonds |  | 1006135 |  | 1006135 |
| Corporate Bonds<sup>2</sup> |  | 61995679 | 637419 | 62633098 |
| Exchange-Traded Funds | 15831606 |  |  | 15831606 |
| Non-Agency Commercial Mortgage-Backed Security |  | 13860 |  | 13860 |
| Sovereign Bonds |  | 802998 |  | 802998 |
| US Treasury Obligations |  | 78496726 |  | 78496726 |
| Short-Term Investments | 8135884 |  |  | 8135884 |
| Securities Lending Collateral | 13818320 |  |  | 13818320 |
| Total Value of Securities | $358658042 | $220203151 | $637419 | $579498612 |
| <u>Derivatives<sup>3</sup></u> |  |  |  |  |
| <u>Assets:</u> |  |  |  |  |
| Futures Contracts | $2266 | $— | $— | $2266 |
| <u>Liabilities:</u> |  |  |  |  |
| Futures Contracts | $(51954) | $— | $— | $(51954) |

---

<sup>1</sup> The security that has been valued at zero on the "Schedules of investments" is considered to be Level 3 investments in this table.

<sup>2</sup> Security type is valued across multiple levels. Level 1 investments represent exchange-traded investments, Level 2 investments represent investments with observable inputs or matrix-priced investments, and Level 3 investments represent investments without observable inputs. The amounts attributed to Level 1 investments, Level 2 investments, and Level 3 investments represent the following percentages of the total market value of these security types:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Level 1 | Level 2 | Level 3 | Total |
| Corporate Bonds | – | 98.98% | 1.02% | 100.00% |

---

<sup>3</sup> Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP Balanced | Delaware Ivy VIP Balanced | Delaware Ivy VIP Balanced |
|  | Level 1 | Level 2 | Total |
| <u>Securities</u> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Agency Collateralized Mortgage Obligations | $— | $988846 | $988846 |
| Agency Mortgage-Backed Securities |  | 17578265 | 17578265 |
| Common Stocks | 115643631 |  | 115643631 |
| Convertible Bonds |  | 113516 | 113516 |
| Corporate Bonds |  | 23517342 | 23517342 |
| Exchange-Traded Funds | 6317394 |  | 6317394 |
| Non-Agency Commercial Mortgage-Backed Securities |  | 5977163 | 5977163 |
| US Treasury Obligations |  | 33440905 | 33440905 |
| Short-Term Investments | 5328976 |  | 5328976 |
| Securities Lending Collateral | 1496265 |  | 1496265 |
| Total Value of Securities | $128786266 | $81616037 | $210402303 |

---

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

3. Investments (continued)

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP Balanced | Delaware Ivy VIP Balanced | Delaware Ivy VIP Balanced |
|  | Level 1 | Level 2 | Total |
| Derivatives<sup>1</sup> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Futures Contracts <u>Liabilities:</u> | $4164 | $— | $4164 |
| <u>Liabilities:</u> |  |  |  |
| Futures Contracts | $(3149) | $— | $(3149) |

---

<sup>1</sup> Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

---

| | |
|:---|:---|
|  | Delaware Ivy<br>VIP Energy |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Common Stocks | $118122047 |
| Master Limited Partnerships | 2509952 |
| Short-Term Investments | 3358868 |
| Securities Lending Collateral | 2302463 |
| Total Value of Securities | $126293330 |

---

---

| | |
|:---|:---|
|  | Delaware Ivy<br>VIP Energy |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Common Stocks | $625745937 |
| Short-Term Investments | 2149932 |
| Total Value of Securities | $627895869 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP High Income | Delaware Ivy VIP High Income | Delaware Ivy VIP High Income | Delaware Ivy VIP High Income |
|  | Level 1 | Level 2 | Level 3 | Total |
| <u>Securities</u> |  |  |  |  |
| <u>Assets:</u> |  |  |  |  |
| Common Stocks |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic Industry | $— | $— | $29011931 | $2901193 |
| &nbsp;&nbsp;&nbsp;Consumer Goods |  |  | —1 |  |
| &nbsp;&nbsp;&nbsp;Energy | 6554 |  | 1722786 | 1729340 |
| &nbsp;&nbsp;&nbsp;Leisure | 5510521 | —2833678 | 8344199 |  |
| &nbsp;&nbsp;&nbsp;Retail |  |  | 388989 | 388989 |
| &nbsp;&nbsp;&nbsp;Services | 2093678 |  |  | 2093678 |

---

[**Table of Contents**](#toc1)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP High Income | Delaware Ivy VIP High Income | Delaware Ivy VIP High Income | Delaware Ivy VIP High Income |
|  | Level 1 | Level 2 | Level 3 | Total |
| &nbsp;&nbsp;&nbsp;Utilities | $— | $— | $38772 | $38772 |
| Convertible Bonds<sup>2</sup> |  | 960660 | 7605540 | 8566200 |
| Corporate Bonds |  | 528617141 | —1 | 528617141 |
| Exchange-Traded Funds | 30060643 |  |  | 30060643 |
| Loan Agreements |  | 78302480 |  | 78302480 |
| Municipal Bonds |  | 3824381 |  | 3824381 |
| Preferred Stock |  |  | 119120 | 119120 |
| Warrants | 97575 |  |  | 97575 |
| Short-Term Investments | 71809056 |  |  | 71809056 |
| Securities Lending Collateral | 36258877 |  |  | 36258877 |
| Total Value of Securities | $145836904 | $611704662 | $15610078 | $773151644 |
| <u>Derivatives<sup>3</sup></u> |  |  |  |  |
| <u>Assets:</u> |  |  |  |  |
| Foreign Currency Exchange |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Contracts | $— | $84180 | $— | $84180 |

---

<sup>1</sup> The security that has been valued at zero on the "Schedules of investments" is considered to be Level 3 investments in this table.

<sup>2</sup> Security type is valued across multiple levels. Level 1 investments represent exchange-traded investments, Level 2 investments represent investments with observable inputs or matrix-priced investments, and Level 3 investments represent investments without observable inputs. The amounts attributed to Level 1 investments, Level 2 investments, and Level 3 investments represent the following percentages of the total market value of these security types:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Level 1 | Level 2 | Level 3 | Total |
| Convertible Bonds | – | 11.21% | 88.79% | 100.00% |

---

<sup>3</sup> Foreign currency exchange contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP International Core Equity | Delaware Ivy VIP International Core Equity | Delaware Ivy VIP International Core Equity |
|  | Level 1 | Level 2 | Total |
| <u>Securities</u> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Common Stocks |  |  |  |
| &nbsp;&nbsp;&nbsp;Australia | $7085759 | $— | $7085759 |
| &nbsp;&nbsp;&nbsp;Austria | 4870228 |  | 4870228 |
| &nbsp;&nbsp;&nbsp;Brazil | 15561343 |  | 15561343 |
| &nbsp;&nbsp;&nbsp;Canada | 28390911 |  | 28390911 |
| &nbsp;&nbsp;&nbsp;China | 24928866 |  | 24928866 |
| &nbsp;&nbsp;&nbsp;China/Hong Kong | 32286374 |  | 32286374 |
| &nbsp;&nbsp;&nbsp;Denmark | 22694295 |  | 22694295 |
| &nbsp;&nbsp;&nbsp;France | 66473567 |  | 66473567 |
| &nbsp;&nbsp;&nbsp;Germany | 55259589 |  | 55259589 |
| &nbsp;&nbsp;&nbsp;Hong Kong | 8828182 |  | 8828182 |
| &nbsp;&nbsp;&nbsp;India | 17399945 |  | 17399945 |
| &nbsp;&nbsp;&nbsp;Japan | 48982664 |  | 48982664 |
| &nbsp;&nbsp;&nbsp;Netherlands | 24117759 |  | 24117759 |
| &nbsp;&nbsp;&nbsp;Norway | 4931057 |  | 4931057 |
| &nbsp;&nbsp;&nbsp;Republic of Korea |  | 17888655 | 17888655 |

---

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**3. Investments (continued)**

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP International Core Equity | Delaware Ivy VIP International Core Equity | Delaware Ivy VIP International Core Equity |
|  | Level 1 | Level 2 | Total |
| &nbsp;&nbsp;&nbsp;Spain | $8615132 | $— | $8615132 |
| &nbsp;&nbsp;&nbsp;Switzerland | 9204935 |  | 9204935 |
| &nbsp;&nbsp;&nbsp;Taiwan | 9076377 |  | 9076377 |
| &nbsp;&nbsp;&nbsp;United Kingdom | 40281997 |  | 40281997 |
| &nbsp;&nbsp;&nbsp;United States | 23411793 |  | 23411793 |
| Short-Term Investments | 3191588 |  | 3191588 |
| Securities Lending Collateral | 7445419 |  | 7445419 |
| Total Value of Securities | $463037780 | $17888655 | $480926435 |
| <u>Derivatives<sup>1</sup></u> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Foreign Currency Exchange Contracts | $— | $3045 | $3045 |
| <u>Liabilities:</u> |  |  |  |
| Foreign Currency Exchange Contracts | $— | $(18851) | $(18851) |

---

<sup>1</sup>Foreign currency exchange contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

---

| | |
|:---|:---|
|  | Delaware Ivy<br>VIP Mid Cap<br>Growth |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Common Stocks | $450731307 |
| Short-Term Investments | 10181034 |
| Securities Lending Collateral | 195750 |
| Total Value of Securities | $461108091 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP Natural Resources | Delaware Ivy VIP Natural Resources | Delaware Ivy VIP Natural Resources | Delaware Ivy VIP Natural Resources |
|  | Level 1 | Level 2 | Level 3 | Total |
| <u>Securities</u> |  |  |  |  |
| <u>Assets:</u> |  |  |  |  |
| Closed-Ended Trust | $3496595 | $— | $— | $3496595 |
| Common Stocks |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic Industry | 30326124 |  |  | 30326124 |
| &nbsp;&nbsp;&nbsp;Consumer Discretionary | 540988 |  |  | 540988 |
| &nbsp;&nbsp;&nbsp;Consumer Staples | 8316143 |  |  | 8316143 |
| &nbsp;&nbsp;&nbsp;Energy | 47281577 |  |  | 47281577 |
| &nbsp;&nbsp;&nbsp;Financials | 566428 |  |  | 566428 |
| &nbsp;&nbsp;&nbsp;Industrials | 5978234 |  | —<sup>1</sup> | 5978234 |
| &nbsp;&nbsp;&nbsp;Materials | 9189281 |  |  | 9189281 |
| &nbsp;&nbsp;&nbsp;Real Estate Investment Trusts | 2225366 |  |  | 2225366 |
| Short-Term Investments | 1591309 |  |  | 1591309 |
| Securities Lending Collateral | 3858940 |  |  | 3858940 |

---

[**Table of Contents**](#toc1)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP Natural Resources | Delaware Ivy VIP Natural Resources | Delaware Ivy VIP Natural Resources | Delaware Ivy VIP Natural Resources |
|  | Level 1 | Level 2 | Level 3 | Total |
| Total Value of Securities | $113370985 | $— | $— | $113370985 |
| <u>Derivatives<sup>2</sup></u> |  |  |  |  |
| <u>Liabilities:</u> |  |  |  |  |
| Foreign Currency Exchange |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Contracts | $— | $(137) | $— | $(137) |

---

<sup>1</sup> The security that has been valued at zero on the "Schedules of investments" is considered to be Level 3 investments in this table.

<sup>2</sup> Foreign currency exchange contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

---

| | |
|:---|:---|
|  | Delaware Ivy<br>VIP Science<br>and Technology |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Common Stocks | $431485526 |
| Short-Term Investments | 20800271 |
| Securities Lending Collateral | 652255 |
| Total Value of Securities | $452938052 |

---

---

| | |
|:---|:---|
|  | Delaware Ivy<br>VIP Small Cap<br>Growth |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Common Stocks | $193228918 |
| Short-Term Investments | 5988127 |
| Securities Lending Collateral | 168219 |
| Total Value of Securities | $199385264 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP Smid Cap Core | Delaware Ivy VIP Smid Cap Core | Delaware Ivy VIP Smid Cap Core |
|  | Level 1 | Level 3 | Total |
| <u>Securities</u> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Common Stocks |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic Materials | $12459913 | $— | $12459913 |
| &nbsp;&nbsp;&nbsp;Business Services | 8606802 |  | 8606802 |
| &nbsp;&nbsp;&nbsp;Capital Goods | 17043577 |  | 17043577 |
| &nbsp;&nbsp;&nbsp;Consumer Discretionary | 9137167 |  | 9137167 |
| &nbsp;&nbsp;&nbsp;Consumer Services | 3488136 |  | 3488136 |
| &nbsp;&nbsp;&nbsp;Consumer Staples | 5050543 |  | 5050543 |
| &nbsp;&nbsp;&nbsp;Credit Cyclicals | 4925859 |  | 4925859 |

---

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**3. Investments (continued)**

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP Smid Cap Core | Delaware Ivy VIP Smid Cap Core | Delaware Ivy VIP Smid Cap Core |
|  | Level 1 | Level 3 | Total |
| &nbsp;&nbsp;&nbsp;Energy | $8422328 | $— | $8422328 |
| &nbsp;&nbsp;&nbsp;Financials | 24540819 |  | 24540819 |
| &nbsp;&nbsp;&nbsp;Healthcare | 20632557 | —<sup>1</sup> | 20632557 |
| &nbsp;&nbsp;&nbsp;Media | 2829542 |  | 2829542 |
| &nbsp;&nbsp;&nbsp;Real Estate Investment Trusts | 10100491 |  | 10100491 |
| &nbsp;&nbsp;&nbsp;Technology | 20186392 |  | 20186392 |
| &nbsp;&nbsp;&nbsp;Transportation | 4851639 |  | 4851639 |
| &nbsp;&nbsp;&nbsp;Utilities | 3025333 |  | 3025333 |
| Short-Term Investments | 3037734 |  | 3037734 |
| Total Value of Securities | $158338832 | $— | $158338832 |

---

<sup>1</sup>The security that has been valued at zero on the "Schedules of investments" is considered to be Level 3 investments in this table.

During the year ended December 31, 2022, there were no transfers into or out of Level 3 investments that had a significant impact to each Portfolio. Each Portfolio's policy is to recognize transfers into or out of Level 3 investments based on fair value at the beginning of the reporting period.

A reconciliation of Level 3 investments is presented when a Portfolio has a significant amount of Level 3 investments at the beginning or end of the period in relation to each Portfolio's net assets. Management has determined not to provide a reconciliation of Level 3 investments as the Level 3 investments were not considered significant to Delaware Ivy VIP Asset Strategy, Delaware Ivy VIP Natural Resources, and Delaware Ivy VIP Smid Cap Core net assets at the beginning or end of the period. Management has determined not to provide additional disclosure on Level 3 inputs since the Level 3 investments were not considered significant to each Portfolio's net assets at the end of the year. At December 31, 2022, Delaware Ivy VIP Balanced, Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, Delaware Ivy VIP International Core Equity, Delaware Ivy VIP Mid Cap Growth, Delaware Ivy VIP Science and Technology, and Delaware Ivy VIP Small Cap Growth had no Level 3 investments. <br>

[**Table of Contents**](#toc1)

The following is a reconciliation of investments in which significant unobservable inputs (Level 3) were used in determining fair value for the Portfolio:

**Delaware Ivy VIP High Income**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Common Stocks | Convertible Bonds | Preferred Stock | Loan<br> Agreements |
| Balance as of 12/31/21 | $8861471 | $— | $— | $31956907 |
| Amortization |  | 20134 |  | 23329 |
| Purchases |  | 3166425 |  |  |
| Sales |  |  |  | (9669558) |
| Net realized gain (loss) |  |  |  | (2475764) |
| Corporate actions | (67779) |  |  |  |
| Transfers in | 83825 |  | 392061 |  |
| Transfers out |  |  |  | (19598283) |
| Net change in unrealized appreciation (depreciation) | (992099) | 4418981 | (272941) | (236631) |
| Balance as of 12/31/22 | $7885418 | $7605540 | $119120 | $— |
| Net change in unrealized appreciation (depreciation) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;from Level 3 investments still held as of 12/31/22 | $(992099) | $4418981 | $(272941) | $— |

---

A significant change to the inputs may result in a significant change to the valuation. Quantitative information about Level 3 fair value measurements for the Portfolio is as follows:

**Delaware Ivy VIP High Income**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | | Valuation |  | Input |
| Assets | Value | Techniques | Unobservable Inputs | Value |
| Common Stocks | $326 | Liquidation approach | Net asset value | N/A |
| Common Stocks | 1722460 | Market approach | Broker quotes | N/A |
| Common Stocks | 2851374 | Market approach | Discount for lack of marketability | 30% |
| Common Stocks |  | Market approach | EV/EBITDA multiple | 5.67x |
| Common Stocks | 388989 | Market approach | EV/EBITDA multiple | 5.53x |
|  |  |  | EV/Revenue multiple | 0.49x |
| Common Stocks | 2922269 | Market approach | Financials | N/A |
| Convertible Bonds | 7605540 | Market approach | Financials | N/A |
| Preferred Stocks | 119120 | Market approach | EV/EBITDA multiple | 5.53x |
|  |  |  | EV/Revenue multiple | 0.49x |

---

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**4. Dividend and Distribution Information**

Income and long-term capital gain distributions are determined in accordance with federal income tax regulations, which may differ from US GAAP. Additionally, distributions from net gains on foreign currency transactions and net short-term gains on sales of investment securities are treated as ordinary income for federal income tax purposes. The tax character of dividends and distributions paid during the years ended December 31, 2022 and 2021 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |<br>Ordinary<br>income | Long-term<br>capital<br>gains |<br>Return of<br>capital |<br>Total |
| <u>Year ended December 31, 2022:</u> |  |  |  |  |
| Delaware Ivy VIP Asset Strategy | $12218054 | $45112595 | $486380 | $57817029 |
| Delaware Ivy VIP Balanced | 9102548 | 79997030 |  | 89099578 |
| Delaware Ivy VIP Energy | 3638234 |  |  | 3638234 |
| Delaware Ivy VIP Growth | 25682094 | 154305524 |  | 179987618 |
| Delaware Ivy VIP High Income | 52676536 |  |  | 52676536 |
| Delaware Ivy VIP International Core Equity | 52574539 |  |  | 52574539 |
| Delaware Ivy VIP Mid Cap Growth | 368739 | 109866788 |  | 110235527 |
| Delaware Ivy VIP Natural Resources | 1937990 |  |  | 1937990 |
| Delaware Ivy VIP Science and Technology | 566218 | 66083684 |  | 66649902 |
| Delaware Ivy VIP Small Cap Growth | 3135064 | 72692393 |  | 75827457 |
| Delaware Ivy VIP Smid Cap Core | 22361140 | 12228925 |  | 34590065 |
| <u>Year ended December 31, 2021:</u> |  |  |  |  |
| Delaware Ivy VIP Asset Strategy | 20615996 | 66720613 |  | 87336609 |
| Delaware Ivy VIP Balanced | 4023975 | 20982152 |  | 25006127 |
| Delaware Ivy VIP Energy | 1019619 |  |  | 1019619 |
| Delaware Ivy VIP Growth | 14994886 | 83267169 |  | 98262055 |
| Delaware Ivy VIP High Income | 54024446 |  |  | 54024446 |
| Delaware Ivy VIP International Core Equity | 6911509 |  |  | 6911509 |
| Delaware Ivy VIP Mid Cap Growth | 8454387 | 74222580 |  | 82676967 |
| Delaware Ivy VIP Natural Resources | 1377946 |  |  | 1377946 |
| Delaware Ivy VIP Science and Technology | 6940522 | 195157260 |  | 202097782 |
| Delaware Ivy VIP Small Cap Growth | 7137533 | 51481891 |  | 58619424 |
| Delaware Ivy VIP Smid Cap Core |  |  |  |  |

---

**5. Components of Net Assets on a Tax Basis**

As of December 31, 2022, the components of net assets on a tax basis were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy<br>VIP Asset<br>Strategy |<br>Delaware Ivy<br>VIP Balanced |<br>Delaware Ivy<br>VIP Energy |
| Shares of beneficial interest | $606305142 | $226715237 | $132033018 |
| Undistributed ordinary income |  | 1606530 | 77081 |
| Qualified late year loss deferrals | (561056) |  |  |
| Capital loss carryforwards |  | (3527238) | (15922908) |
| Deferred directors fees | (109319) | (55479) | (5272) |
| Unrealized appreciation (depreciation) of investments and foreign currencies | (39261876) | (16111499) | 7859089 |
| Net assets | $566372891 | $208627551 | $124041008 |

---

[**Table of Contents**](#toc1)

---

| | | | |
|:---|:---|:---|:---|
|  |<br>Delaware Ivy<br>VIP Growth |<br>Delaware Ivy<br>VIP High<br>Income | Delaware Ivy<br>VIP<br>International<br>Core Equity |
| Shares of beneficial interest | $424588516 | $973465651 | $509535554 |
| Undistributed ordinary income |  | 47877209 | 8440790 |
| Undistributed long-term capital gains | 70650593 |  |  |
| Capital loss carryforwards |  | (135448556) | (6823837) |
| Deferred directors fees | (131356) | (44201) | (65576) |
| Unrealized appreciation (depreciation) of investments and foreign currencies | 133103551 | (134144768) | (27066759) |
| Net assets | $628211304 | $751705335 | $484020172 |

---

---

| | | | |
|:---|:---|:---|:---|
|  |<br>Delaware Ivy<br>VIP Mid Cap<br>Growth |<br>Delaware Ivy<br>VIP Natural<br>Resources | Delaware Ivy<br>VIP Science<br>and<br>Technology |
| Shares of beneficial interest | $380582110 | $148515814 | $436154535 |
| Undistributed ordinary income |  | 2553282 |  |
| Undistributed long-term capital gains | 56224009 |  | 21977661 |
| Capital loss carryforwards |  | (39815139) |  |
| Deferred directors fees | (22285) | (14305) | (47348) |
| Unrealized appreciation (depreciation) of investments and foreign currencies | 23409728 | (1717365) | (6193368) |
| Net assets | $460193562 | $109522287 | $451891480 |

---

---

| | | |
|:---|:---|:---|
|  | Delaware Ivy<br>VIP Small Cap<br>Growth | Delaware Ivy<br>VIP Smid Cap<br>Core |
| Shares of beneficial interest | $198738385 | $154641353 |
| Undistributed ordinary income |  | 1924513 |
| Undistributed long-term capital gains | 32374394 | 17341005 |
| Deferred directors fees | (63273) | (24864) |
| Unrealized appreciation (depreciation) of investments and foreign currencies | (32139237) | (15771125) |
| Net assets | $198910269 | $158110882 |

---

\*A portion of the Portfolio's capital loss carryforward is subject to limitation under the Internal Revenue Code and related regulations.

Differences between components of net assets unrealized and tax cost unrealized may arise due to certain foreign currency transactions, foreign capital gains taxes, and amortization of callable bond premiums in accordance with ASU 2017-08.

The differences between book basis and tax basis components of net assets are primarily attributable to tax deferral of losses on wash sales, tax deferral of post-October losses, investments held within the wholly-owned subsidiary, tax treatments of debt restructurings, mark-to-market on foreign currency exchange contracts, mark-to-market on futures, and tax deferral on straddle losses.

For financial reporting purposes, capital accounts are adjusted to reflect the tax character of permanent book/tax differences. Reclassifications are primarily due to tax treatment of gain (loss) on foreign currency transactions, tax treatment of passive foreign investment companies (PFICS), tax treatment of paydown securities, and tax treatment of partnership securities. Results of operations and net assets were not affected by these reclassifications. For the year ended December 31, 2022, the Portfolios recorded the following reclassifications:

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy<br>VIP Balanced | Delaware Ivy<br>VIP Energy | Delaware Ivy<br>VIP Growth |
| Paid-in capital | $(216) | $(140) | $(2395101) |
| Total distributable earnings (loss) | 216 | 140 | 2395101 |

---

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**5. Components of Net Assets on a Tax Basis (continued)**

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy<br>VIP High<br>Income | Delaware Ivy<br>VIP Mid Cap<br>Growth | Delaware Ivy<br>VIP Natural<br>Resources |
| Paid-in capital | $(610) | $(2883416) | $(384) |
| Total distributable earnings (loss) | 610 | 2883416 | 384 |

---

---

| | | |
|:---|:---|:---|
|  | Delaware Ivy<br>VIP Science<br>and<br>Technology |<br>Delaware Ivy<br>VIP Small Cap<br>Growth |
| Paid-in capital | $(2540587) | $(1833935) |
| Total distributable earnings (loss) | 2540587 | 1833935 |

---

For federal income tax purposes, capital loss carryforwards may be carried forward and applied against future capital gains. At December 31, 2022, the Portfolio's utilized the following capital loss carryforwards:

---

| | |
|:---|:---|
| Delaware Ivy VIP Energy | $25688481 |
| Delaware Ivy VIP Natural Resources | 13461557 |

---

At December 31, 2022, capital loss carryforwards available to offset future realized capital gains are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Loss carryforward character | Loss carryforward character | Loss carryforward character |
|  | Short-term | Long-term | Total |
| Delaware Ivy VIP Balanced | $3527238 | $— | $3527238 |
| Delaware Ivy VIP Energy |  | 15922908 | 15922908 |
| Delaware Ivy VIP High Income | 13705995 | 121742561 | 135448556 |
| Delaware Ivy VIP International Core Equity | 6823837 |  | 6823837 |
| Delaware Ivy VIP Natural Resources |  | 39815139 | 39815139 |

---

[**Table of Contents**](#toc1)

**6. Capital Shares**

Transactions in capital shares were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Delaware Ivy | Delaware Ivy | | | | |
|  | VIP Asset | VIP Asset | Delaware Ivy | Delaware Ivy | Delaware Ivy | Delaware Ivy |
|  | Strategy | Strategy | VIP Balanced | VIP Balanced | VIP Energy | VIP Energy |
|  | Year ended | Year ended | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I | 2486 | 85603 |  |  | 167892 | 40171 |
| &nbsp;&nbsp;&nbsp;Class II | 2333217 | 2527289 | 831985 | 1285781 | 19735678 | 15999581 |
| Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I | 12694 | 12304 |  |  | 2955 | 784 |
| &nbsp;&nbsp;&nbsp;Class II | 7166681 | 8611365 | 18997778 | 2864489 | 726589 | 302277 |
|  | 9515078 | 11236561 | 19829763 | 4150270 | 20633114 | 16342813 |
| Shares redeemed: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I | (866) | (20424) |  |  | (130904) | (73355) |
| &nbsp;&nbsp;&nbsp;Class II | (10414827) | (11406014) | (4217111) | (14723694) | (17381020) | (12466804) |
|  | (10415693) | (11426438) | (4217111) | (14723694) | (17511924) | (12540159) |
| Net increase (decrease) | (900615) | (189877) | 15612652 | (10573424) | 3121190 | 3802654 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Growth | Delaware Ivy<br> VIP Growth | Delaware Ivy VIP High Income | Delaware Ivy VIP High Income | Delaware Ivy VIP International Core Equity | Delaware Ivy VIP International Core Equity |
|  | Year ended | Year ended | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I |  |  | 700806 | 870734 |  |  |
| &nbsp;&nbsp;&nbsp;Class II | 5246613 | 8071554 | 23969927 | 33527630 | 2382458 | 1662612 |
| Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: |  |  |
| &nbsp;&nbsp;&nbsp;Class I |  |  | 393125 | 376393 |  |  |
| &nbsp;&nbsp;&nbsp;Class II | 22330970 | 8105223 | 18153567 | 15740425 | 3768784 | 380829 |
|  | 27577583 | 16176777 | 43217425 | 50515182 | 6151242 | 2043441 |
| Shares redeemed: | Shares redeemed: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I |  |  | (1298839) | (1637633) |  |  |
| &nbsp;&nbsp;&nbsp;Class II | (17572568) | (17870523) | (43537541) | (39247512) | (5473984) | (8183115) |
|  | (17572568) | (17870523) | (44836380) | (40885145) | (5473984) | (8183115) |
| Net increase (decrease) | 10005015 | (1693746) | (1618955) | 9630037 | 677258 | (6139674) |

---

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**6. Capital Shares (continued)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | | | | Delaware Ivy | Delaware Ivy |
|  | Delaware Ivy | Delaware Ivy | Delaware Ivy | Delaware Ivy | VIP Science | VIP Science |
|  | VIP Mid Cap | VIP Mid Cap | VIP Natural | VIP Natural | and | and |
|  | Growth | Growth | Resources | Resources | Technology | Technology |
|  | Year ended | Year ended | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I | 1618195 | 1459307 |  |  | 24401 | 47856 |
| &nbsp;&nbsp;&nbsp;Class II | 4953182 | 5831186 | 9791609 | 5419205 | 2109519 | 1478206 |
| Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I | 2801133 | 1802886 |  |  | 10777 | 21351 |
| &nbsp;&nbsp;&nbsp;Class II | 8730807 | 3474127 | 410591 | 358187 | 3543762 | 6875144 |
|  | 18103317 | 12567506 | 10202200 | 5777392 | 5688459 | 8422557 |
| Shares redeemed: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I | (5242549) | (5429559) |  |  | (32133) | (55836) |
| &nbsp;&nbsp;&nbsp;Class II | (5289582) | (5616841) | (9308663) | (6370555) | (3802046) | (3239331) |
|  | (10532131) | (11046400) | (9308663) | (6370555) | (3834179) | (3295167) |
| Net increase (decrease) | 7571186 | 1521106 | 893537 | (593163) | 1854280 | 5127390 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy | Delaware Ivy | Delaware Ivy | Delaware Ivy |
|  | VIP Small Cap | VIP Small Cap | VIP Smid Cap | VIP Smid Cap |
|  | Growth | Growth | Core | Core |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I | 441146 | 478082 |  |  |
| &nbsp;&nbsp;&nbsp;Class II | 2259394 | 2086035 | 2177868 | 1199784 |
| Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I | 760465 | 641818 |  |  |
| &nbsp;&nbsp;&nbsp;Class II | 11461185 | 4789218 | 3164690 |  |
|  | 14922190 | 7995153 | 5342558 | 1199784 |
| Shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Class I | (2595852) | (1689541) |  |  |
| &nbsp;&nbsp;&nbsp;Class II | (19401535) | (4737495) | (2009932) | (3537932) |
|  | (21997387) | (6427036) | (2009932) | (3537932) |
| Net increase (decrease) | (7075197) | 1568117 | 3332626 | (2338148) |

---

**7. Basis of consolidation for Delaware Ivy VIP Asset Strategy**

Ivy VIP ASF II, Ltd. (the Subsidiary), a Cayman Islands exempted company, was incorporated as a wholly owned subsidiary acting as an investment vehicle for Delaware Ivy VIP Asset Strategy (referred to as the Portfolio in this subsection). Ivy VIP ASF III (SBP), LLC (the

[**Table of Contents**](#toc1)

Company), a Delaware limited liability company, was incorporated as a wholly owned company acting as an investment vehicle for the Portfolio. The Subsidiary and the Company act as investment vehicles for the Portfolio, in order to affect certain investments for the Portfolio consistent with the Portfolio's investment objectives and policies as specified in its prospectus and SAI.

The Portfolio's investment portfolio has been consolidated and includes the portfolio holdings of the Portfolio, its Subsidiary and the Company. The consolidated financial statements include the accounts of the Portfolio, its Subsidiary and the Company. All inter-company transactions and balances have been eliminated. A subscription agreement was entered into between the Portfolio and its Subsidiary and the Company comprising the entire issued share capital of the Subsidiary and the Company with the intent that the Portfolio will remain the sole shareholder and retain all rights. Under the Articles of Association, shares issued by the Subsidiary and the Company confer upon a shareholder the right to receive notice of, to attend and to vote at general meetings of the Subsidiary and the Company and shall confer upon the shareholder rights in a winding-up or repayment of capital and the right to participate in the profits or assets of the Subsidiary and the Company.

See the table below for details regarding the structure, incorporation and relationship as of December 31, 2022 of the Subsidiary and the Company to the Portfolio.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | <br>Date of<br>Incorporation | <br>Subscription<br>Agreement |<br>Portfolio<br>Net Assets |<br>Subsidiary/<br>company net assets | Percentage<br>of Portfolio net<br>assets |
| Ivy VIP ASF ll, Ltd. | 1-31-13 | 4-10-13 | $566372891 | $26564980 | 4.69% |
| Ivy VIP ASF lll |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;(SBP),LLC | 4-9-13 | 4-23-13 | 566372891 | 15288 | 0.00% |

---

**8. Line of Credit**

Each Portfolio, along with certain other funds in the Delaware Funds (Participants), was a participant in a $355,000,000 revolving line of credit (Agreement) intended to be used for temporary or emergency purposes as an additional source of liquidity to fund redemptions of investor shares. Under the Agreement, the Participants were charged an annual commitment fee of 0.15%, which was allocated across the Participants based on a weighted average of the respective net assets of each Participant. The Participants were permitted to borrow up to a maximum of one-third of their net assets under the Agreement. Each Participant was individually, and not jointly, liable for its particular advances, if any, under the line of credit. The line of credit available under the Agreement expired on October 31, 2022.

On October 31, 2022, each Portfolio, along with the other Participants, entered into an amendment to the Agreement for a $355,000,000 revolving line of credit to be used as described above. It operates in substantially the same manner as the original Agreement. Under the amendment to the Agreement, the Participants are charged an annual commitment fee of 0.15%, which is allocated across the Participants based on a weighted average of the respective net assets of each Participant. The line of credit available under the Agreement expires on October 30, 2023.

Each Portfolio had no amounts outstanding as of December 31, 2022, or at any time during the year then ended.

**9. Interfund Lending Program**

Pursuant to an exemptive order issued by the SEC (Order), the Ivy Funds and Ivy Variable Insurance Portfolios (collectively, the Funds only for purposes of this Note 9) have the ability to lend money to, and borrow money from, each other pursuant to a master interfund lending agreement (Interfund Lending Program). Under the Interfund Lending Program, the Funds may lend or borrow money for temporary purposes directly to or from one another (each, an Interfund Loan), subject to meeting the conditions of the Order. The interest rate to be charged on an Interfund Loan is the average of the overnight repurchase agreement rate and the short-term bank loan rate. This program is in existence but is not currently in use. The Funds made no Interfund Loans under the Interfund Lending Program during the year ended December 31, 2022.

**10. Derivatives**

US GAAP requires disclosures that enable investors to understand: (1) how and why an entity uses derivatives; (2) how they are accounted for; and (3) how they affect an entity's results of operations and financial position.

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**10. Derivatives (continued)**

**Foreign Currency Exchange Contracts** — Each Portfolio may enter into foreign currency exchange contracts and foreign cross currency exchange contracts as a way of managing foreign exchange rate risk. Each Portfolio may enter into these contracts to fix the US dollar value of a security that it has agreed to buy or sell for the period between the date the trade was entered into and the date the security is delivered and paid for. Each Portfolio may also enter into these contracts to hedge the US dollar value of securities it already owns that are denominated in foreign currencies. In addition, each Portfolio may enter into these contracts to facilitate or expedite the settlement of portfolio transactions. The change in value is recorded as an unrealized gain or loss. When the contract is closed, a realized gain or loss is recorded equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.

The use of foreign currency exchange contracts and foreign cross currency exchange contracts does not eliminate fluctuations in the underlying prices of the securities, but does establish a rate of exchange that can be achieved in the future. Although foreign currency exchange contracts and foreign cross currency exchange contracts limit the risk of loss due to an unfavorable change in the value of the hedged currency, they also limit any potential gain that might result should the value of the currency change favorably. In addition, each Portfolio could be exposed to risks if the counterparties to the contracts are unable to meet the terms of their contracts. Each Portfolio's maximum risk of loss from counterparty credit risk is the value of its currency exchanged with the counterparty. The risk is generally mitigated by having a netting arrangement between each Portfolio and the counterparty and by the posting of collateral by the counterparty to the Portfolios to cover each Portfolio's exposure to the counterparty. Open foreign currency exchange contracts, if any, are disclosed on the "Schedules of investments".

At December 31, 2022, Delaware Ivy VIP High Income received $180,000 in cash as collateral for open foreign currency exchange contracts, which is included in "Cash collateral due to brokers" on the "Statements of assets and liabilities." During the year ended December 31, 2022, Delaware Ivy VIP High Income and Delaware Ivy VIP Science and Technology used foreign currency exchange contracts to hedge the US dollar value of securities it already owns that are denominated in foreign currencies to increase/ decrease exposure to foreign currencies.

During the year ended December 31, 2022, Delaware Ivy VIP Asset Strategy, Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, Delaware Ivy VIP International Core Equity and Delaware Ivy VIP Natural Resources used foreign currency exchange contracts to facilitate or expedite the settlement of portfolio transactions.

**Futures Contracts** — A futures contract is an agreement in which the writer (or seller) of the contract agrees to deliver to the buyer an amount of cash or securities equal to a specific dollar amount times the difference between the value of a specific security or index at the close of the last trading day of the contract and the price at which the agreement is made. The Portfolios may use futures in the normal course of pursuing its investment objective. The Portfolios may invest in futures contracts to hedge its existing portfolio securities against fluctuations in fair value caused by changes in prevailing market interest rates. Upon entering into a futures contract, the Portfolios deposit cash or pledge US government securities to a broker, equal to the minimum "initial margin" requirements of the exchange on which the contract is traded. Subsequent payments are received from the broker or paid to the broker each day, based on the daily fluctuation in the market value of the contract. These receipts or payments are known as "variation margin" and are recorded daily by the Portfolios as unrealized gains or losses until the contracts are closed. When the contracts are closed, the Portfolios record a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Risks of entering into futures contracts include potential imperfect correlation between the futures contracts and the underlying securities and the possibility of an illiquid secondary market for these instruments. When investing in futures, there is reduced counterparty credit risk to the Portfolios because futures are exchange-traded and the exchange's clearinghouse, as counterparty to all exchange-traded futures, guarantees against default. Delaware Ivy VIP Asset Strategy posted $485,650 and Delaware Ivy VIP Balanced posted $101,090 cash collateral as margin for open futures contracts, which is included in "Cash collateral due from broker on futures contracts" on the "Statements of assets and liabilities." Open futures contracts, if any, are disclosed on the "Schedules of investments." During the year ended December 31, 2022, Delaware Ivy VIP Asset Strategy and Delaware Ivy VIP Balanced invested in futures contracts to hedge each Portfolio's existing portfolio securities against fluctuations in value caused by changes in interest rates or market conditions.

**Options Contracts** — During the year ended December 31, 2022, Delaware Ivy VIP Mid Cap Growth entered into options contracts in the normal course of pursuing its investment objective. The Portfolio may buy or write options contracts for any number of reasons, including without limitation: to manage the Portfolio's exposure to changes in securities prices caused by interest rates or market conditions and foreign

[**Table of Contents**](#toc1)

currencies; as an efficient means of adjusting the Portfolio's overall exposure to certain markets; to protect the value of portfolio securities; and as a cash management tool. The Portfolio may buy or write call or put options on securities, futures, swaps, swaptions, financial indices, and foreign currencies. When the Portfolio buys an option, a premium is paid and an asset is recorded and adjusted on a daily basis to reflect the current market value of the option purchased. When the Portfolio writes an option, a premium is received and a liability is recorded and adjusted on a daily basis to reflect the current market value of the option written. Premiums received from writing options that expire unexercised are treated by the Portfolio on the expiration date as realized gains. The difference between the premium received and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is treated as realized gain or loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security in determining whether the Portfolio has a realized gain or loss. If a put option is exercised, the premium reduces the cost basis of the securities purchased by the Portfolio. The Portfolio, as writer of an option, bears the market risk of an unfavorable change in the price of the security underlying the written option. When writing options, the Portfolio is subject to minimal counterparty risk because the counterparty is only obligated to pay premiums and does not bear the market risk of an unfavorable market change. Delaware Ivy VIP Mid Cap Growth pledged securities collateral valued at $184,800 as collateral for open options contracts. Open options contracts, if any, are disclosed on the "Schedules of investments." During the year ended December 31, 2022, Delaware Ivy VIP Mid Cap Growth used options contracts to facilitate investments in portfolio securities.

**Swap Contracts —** Each Portfolio may enter into CDS contracts in the normal course of pursuing its investment objective. Each Portfolio may enter into CDS contracts in order to hedge against a credit event, to enhance total return or to gain exposure to certain securities or markets. Swap agreements are bilaterally negotiated agreements between a Portfolio and counterparty to exchange or swap investment cash flows, assets, foreign currencies or market-linked returns at specified, future intervals. Swap agreements are privately negotiated in the over-the-counter market (OTC swaps). If the OTC swap entered is one of the swaps identified by a relevant regulator as a swap that is required to be cleared, then it will be cleared through a third party, known as a central counterparty or derivatives clearing organization (centrally cleared swaps).

*Credit Default Swaps.* A CDS contract is a risk-transfer instrument through which one party (purchaser of protection) transfers to another party (seller of protection) the financial risk of a credit event (as defined in the CDS agreement), as it relates to a particular reference security or basket of securities (such as an index). In exchange for the protection offered by the seller of protection, the purchaser of protection agrees to pay the seller of protection a periodic amount at a stated rate that is applied to the notional amount of the CDS contract. In addition, an upfront payment may be made or received by the Portfolio in connection with an unwinding or assignment of a CDS contract. Upon the occurrence of a credit event, the seller of protection would pay the par (or other agreed-upon) value of the reference security (or basket of securities) to the counterparty. Credit events generally include, among others, bankruptcy, failure to pay, and obligation default.

During the year ended December 31, 2022, Delaware Ivy VIP Balanced entered into CDS contracts as a purchaser of protection. Periodic payments (receipts) on such contracts are accrued daily and recorded as unrealized losses (gains) on swap contracts. Upon payment (receipt), such amounts are recorded as realized losses (gains) on swap contracts. Upfront payments made or received in connection with CDS contracts are amortized over the expected life of the CDS contracts as unrealized losses (gains) on swap contracts. The change in value of CDS contracts is recorded daily as unrealized appreciation or depreciation. A realized gain or loss is recorded upon a credit event (as defined in the CDS agreement) or the maturity or termination of the agreement. Initial margin and variation margin are posted to central counterparties for centrally cleared CDS basket trades, as determined by the applicable central counterparty.

CDS contracts may involve greater risks than if the Portfolio had invested in the reference obligation directly. CDS contracts are subject to general market risk, liquidity risk, counterparty risk, and credit risk. The Portfolio's maximum risk of loss from counterparty credit risk, either as the seller of protection or the buyer of protection, is the fair value of the contract. This risk is mitigated by (1) for bilateral swap contracts, having a netting arrangement between the Portfolio and the counterparty and by the posting of collateral by the counterparty to the Portfolio to cover the Portfolio's exposure to the counterparty, and (2) for cleared swaps, trading these instruments through a central counterparty. No CDS contracts were outstanding at December 31, 2022.

During the year ended December 31, 2022, Delaware Ivy VIP Balanced used CDS contracts to hedge against credit events.

*Swaps Generally.* For centrally cleared swaps, payments are received from the broker or paid to the broker each day, based on the daily fluctuation in the market value of the contract. These receipts or payments are known as "variation margin" and are recorded by the Portfolio as unrealized gains or losses until the contracts are closed. When the contracts are closed, the Portfolio records a realized gain or loss equal to the

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**10. Derivatives (continued)** 

difference between the value of the contract at the time it was opened and the value at the time it was closed. The value of open swaps may differ from that which would be realized in the event the Portfolio terminated its position in the contract on a given day. Risks of entering into these contracts include the potential inability of the counterparty to meet the terms of the contracts. This type of risk is generally limited to the amount of favorable movement in the value of the underlying security, instrument, or basket of instruments, if any, at the day of default. Risks also arise from potential losses from adverse market movements and such losses could exceed the unrealized amounts shown on the "Schedules of investments."

The effect of derivative instruments on the "Statements of operations" for the year ended December 31, 2022 was as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP Asset Strategy | Delaware Ivy VIP Asset Strategy | Delaware Ivy VIP Asset Strategy |
|  | Net Realized Gain (Loss) on: | Net Realized Gain (Loss) on: | Net Realized Gain (Loss) on: |
|  | Foreign<br>Currency<br>Exchange<br>Contracts |<br>Futures<br>Contracts |<br><br>Total |
| Currency |  |  |  |
| &nbsp;&nbsp;&nbsp;contracts | $(354355) | $— | $(354355) |
| Interest rate |  |  |  |
| &nbsp;&nbsp;&nbsp;contracts |  | (615677) | (615677) |
| Total | $(354355) | $(615677) | $(970032) |

---

---

| | | |
|:---|:---|:---|
|  | Net Change in Unrealized | Net Change in Unrealized |
|  | Appreciation (Depreciation) on: | Appreciation (Depreciation) on: |
|  | Futures<br>Contracts |<br>Total |
| Interest rate |  |  |
| contracts | $(49688) | $(49688) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP Balanced | Delaware Ivy VIP Balanced | Delaware Ivy VIP Balanced |
|  | Net Realized Gain (Loss) on: | Net Realized Gain (Loss) on: | Net Realized Gain (Loss) on: |
|  | Futures<br>Contracts | Swap<br>Contracts |<br>Total |
| Interest rate |  |  |  |
| &nbsp;&nbsp;&nbsp;contracts | $(69543) | $— | $(69543) |
| Credit |  |  |  |
| &nbsp;&nbsp;&nbsp;contracts |  | 7094 | 7094 |
| Total | $(69543) | $7094 | $(62449) |

---

---

| | | |
|:---|:---|:---|
|  | Net Change in Unrealized | Net Change in Unrealized |
|  | Appreciation (Depreciation) on: | Appreciation (Depreciation) on: |
|  | Futures<br>Contracts |<br>Total |
| Interest rate |  |  |
| &nbsp;&nbsp;&nbsp;contracts | $1015 | $1015 |

---

During the year ended December 31 , 2022, Delaware Ivy VIP High Income, Delaware Ivy VIP International Core Equity and Delaware Ivy VIP Natural Resources experienced net realized and unrealized gains or losses attributable to foreign currency exchange contracts, which are disclosed on the "Statements of assets and liabilities" and/or "Statements of operations."

During the year ended December 31, 2022, Delaware Ivy VIP Energy, Delaware Ivy VIP Growth and Delaware Ivy VIP Science and Technology experienced net realized and unrealized gains or losses attributable to foreign currency holdings, which are disclosed on the "Statements of operations."

[**Table of Contents**](#toc1)

During the year ended December 31, 2022, Delaware Ivy VIP Asset Strategy and Delaware Ivy VIP Balanced experienced net realized and unrealized gains or losses attributable to futures contracts, which are disclosed on the "Statements of assets and liabilities."

During the year ended December 31, 2022, Delaware Ivy VIP Mid Cap Growth experienced net realized and unrealized gains or losses attributable to options contracts, which are disclosed on the "Statements of operations."

The table below summarizes the average quarterly balance of derivative holdings by each Portfolio during the year ended December 31, 2022:

---

| | | | |
|:---|:---|:---|:---|
|  | Long Derivative Volume | Long Derivative Volume | Long Derivative Volume |
|  | Delaware Ivy<br>VIP Asset<br>Strategy |<br>Delaware Ivy<br>VIP Balanced |<br>Delaware Ivy<br>VIP Energy |
| Foreign currency exchange contracts (average notional value) | $325784 |  | $105424 |
| Futures contracts (average notional value) | 8501969 | 4215625 |  |

---

---

| | | |
|:---|:---|:---|
|  | Long Derivative Volume | Long Derivative Volume |
|  | Delaware Ivy VIP High Income | Delaware Ivy VIP International Core Equity |
| Foreign currency exchange contracts (average notional value) | $2870233 | $1579616 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Long Derivative Volume | Long Derivative Volume | Long Derivative Volume |
|  |<br>Delaware Ivy<br>VIP Mid Cap<br>Growth |<br>Delaware Ivy<br>VIP Natural<br>Resources | Delaware Ivy<br>VIP Science<br>and<br>Technology |
| Foreign currency exchange contracts (average notional value) | $— | $68338 | $133033 |
| Options contracts (average notional value)\* | 2480 |  |  |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Short Derivative Volume | Short Derivative Volume | Short Derivative Volume |
|  | Delaware Ivy<br>VIP Asset<br>Strategy |<br>Delaware Ivy<br>VIP Balanced |<br>Delaware Ivy<br>VIP Energy |
| Foreign currency exchange contracts (average notional value) | $1427256 | $— | $122061 |
| Futures contracts (average notional value) |  | 1598231 |  |
| CDS contracts (average notional value)\*\* |  | 701 |  |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Short Derivative Volume | Short Derivative Volume | Short Derivative Volume |
|  | Delaware Ivy<br> VIP Growth | Delaware Ivy VIP High Income | Delaware Ivy VIP International Core Equity |
| Foreign currency exchange contracts |  |  |  |
| &nbsp;&nbsp;&nbsp;(average notional value) | $14004 | $6729521 | $2593711 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Short Derivative Volume | Short Derivative Volume | Short Derivative Volume |
|  |<br>Delaware Ivy<br>VIP Mid Cap<br>Growth |<br>Delaware Ivy<br>VIP Natural<br>Resources | Delaware Ivy<br>VIP Science<br>and<br>Technology |
| Foreign currency exchange contracts (average notional value) | $— | $65077 | $1453214 |
| Options contracts (average notional value)\* | 462859 |  |  |

---

\* Long represents purchased options and short represents written options.

\*\* Long represents buying protection and short represents selling protection.

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**11. Offsetting**

Each Portfolio entered into an International Swaps and Derivatives Association, Inc. Master Agreement (ISDA Master Agreement) or a similar agreement with certain of its derivative contract counterparties in order to better define its contractual rights and to secure rights that will help each Portfolio mitigate its counterparty risk. An ISDA Master Agreement is a bilateral agreement between each Portfolio and a counterparty that governs over-the-counter (OTC) derivatives and foreign exchange contracts and typically contains, among other things, collateral posting items and netting provisions in the event of a default and/or termination event. Under an ISDA Master Agreement, each Portfolio may, under certain circumstances, offset with the counterparty certain derivative financial instruments' payables and/or receivables with collateral held and/or posted and create one single net payment. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of default (close-out), including the bankruptcy or insolvency of the counterparty. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against the right of offset in bankruptcy, insolvency, or other events.

For financial reporting purposes, each Portfolio does not offset derivative assets and derivative liabilities that are subject to netting arrangements on the "Statements of assets and liabilities." At December 31, 2022, each Portfolio had the following assets and liabilities subject to offsetting provisions:

**Offsetting of Financial Assets and Liabilities and Derivative Assets and Liabilities**

<u>Delaware Ivy VIP High Income</u>

---

| | | | |
|:---|:---|:---|:---|
|  | | Gross Value of | |
|  | Gross Value of | Derivative | |
| <u>Counterparty</u> | Derivative Asset | Liability | Net Position |
| TD Bank | $84180 | $— | $84180 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | Fair Value of | | Fair Value of | | |
|  | | Non-Cash | Cash Collateral | Non-Cash | Cash Collateral | |
| <u>Counterparty</u> | Net Position | Collateral Received | Received<sup>(a)</sup> | Collateral Pledged | Pledged | Net Exposure<sup>(b)</sup> |
| TD Bank | $84180 | $— | $(84180) | $— | $— | $— |

---

**Securities Lending**

Securities lending transactions are entered into by the Portfolios under master securities lending agreements (each, an MSLA) which provide the right, in the event of default (including bankruptcy or insolvency), for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Portfolios, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty's bankruptcy or insolvency. Under the MSLA, the borrower can resell or re-pledge the loaned securities, and the Portfolios can reinvest cash collateral, or, upon an event of default, resell, or re-pledge the collateral (See also Note 12).

As of December 31, 2022, the following table is a summary of the Portfolios' securities lending agreements by counterparty which are subject to offset under an MSLA:<u> </u>

<u>Delaware Ivy VIP Asset Strategy</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | | Fair Value of | | |
|  | Securities | Cash | Non-Cash | Net | |
|  | Loaned | Collateral | Collateral | Collateral | |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $17116801 | $(13283687) | $(3833114) | $(17116801) | $— |

---

[**Table of Contents**](#toc1)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Delaware Ivy VIP Balanced</u> |  |  |  |  |  |
|  |  |  | Fair Value of |  |  |
|  | Securities | Cash | Non-Cash | Net |  |
|  | Loaned | Collateral | Collateral | Collateral |  |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $6998190 | $(1322592) | $(5675598) | $(6998190) | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Delaware Ivy VIP Energy</u> |  |  |  |  |  |
|  |  |  | Fair Value of |  |  |
|  | Securities | Cash | Non-Cash | Net |  |
|  | Loaned | Collateral | Collateral | Collateral |  |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $10672836 | $(1975942) | $(8696894) | $(10672836) | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Delaware Ivy VIP Growth</u> |  |  |  |  |  |
|  |  |  | Fair Value of |  |  |
|  | Securities | Cash | Non-Cash | Net |  |
|  | Loaned | Collateral | Collateral | Collateral |  |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $40780181 | $— | $(40780181) | $(40780181) | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Delaware Ivy VIP High Income</u> |  |  |  |  |  |
|  |  |  | Fair Value of |  |  |
|  | Securities | Cash | Non-Cash | Net |  |
|  | Loaned | Collateral | Collateral | Collateral |  |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $38792042 | $(35155427) | $(3636615) | $(38792042) | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Delaware Ivy VIP International Core Equity</u> | <u>Delaware Ivy VIP International Core Equity</u> |  |  |  |  |
|  |  |  | Fair Value of |  |  |
|  | Securities | Cash | Non-Cash | Net |  |
|  | Loaned | Collateral | Collateral | Collateral |  |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $25427392 | $(6246624) | $(19180768) | $(25427392) | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Delaware Ivy VIP Mid Cap Growth</u> |  |  |  |  |  |
|  |  |  | Fair Value of |  |  |
|  | Securities | Cash | Non-Cash | Net |  |
|  | Loaned | Collateral | Collateral | Collateral |  |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $16635152 | $— | $(16635152) | $(16635152) | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Delaware Ivy VIP Natural Resources</u> |  |  |  |  |  |
|  |  |  | Fair Value of |  |  |
|  | Securities | Cash | Non-Cash | Net |  |
|  | Loaned | Collateral | Collateral | Collateral |  |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $8496793 | $(3598939) | $(4897854) | $(8496793) | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Delaware Ivy VIP Science and Technology</u> | <u>Delaware Ivy VIP Science and Technology</u> |  |  |  |  |
|  |  |  | Fair Value of |  |  |
|  | Securities | Cash | Non-Cash | Net |  |
|  | Loaned | Collateral | Collateral | Collateral |  |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $12389802 | $(277992) | $(12111810) | $(12389802) | $— |

---

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**11. Offsetting (continued)**

<u>Delaware Ivy VIP Small Cap Growth</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | | Fair Value of | | |
|  | Securities | Cash | Non-Cash | Net | |
|  | Loaned | Collateral | Collateral | Collateral | |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $7458683 | $— | $(7458683) | $(7458683) | $— |

---

<u>Delaware Ivy VIP Smid Cap Core</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | | Fair Value of | | |
|  | Securities | Cash | Non-Cash | Net | |
|  | Loaned | Collateral | Collateral | Collateral | |
| <u>Counterparty</u> | at Value | Received | Received | Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $6570947 | $— | $(6570947) | $(6570947) | $— |

---

<sup>(a)</sup> The value of the related collateral exceeded the value of the derivatives and securities lending transactions as of December 31, 2022, as applicable.

<sup>(b)</sup> Net exposure represents the receivable (payable) that would be due from (to) the counterparty in the event of default.

**12. Securities Lending**

Each Portfolio, along with other funds in the Delaware Funds, may lend its securities pursuant to a security lending agreement (Lending Agreement) with The Bank of New York Mellon (BNY Mellon). At the time a security is loaned, the borrower must post collateral equal to the required percentage of the market value of the loaned security, including any accrued interest. The required percentage is: (1) 102% with respect to US securities and foreign securities that are denominated and payable in US dollars; and (2) 105% with respect to foreign securities. With respect to each loan, if on any business day the aggregate market value of securities collateral plus cash collateral held is less than the aggregate market value of the securities which are the subject of such loan, the borrower will be notified to provide additional collateral by the end of the following business day, which, together with the collateral already held, will be not less than the applicable initial collateral requirements for such security loan. If the aggregate market value of securities collateral and cash collateral held with respect to a security loan exceeds the applicable initial collateral requirement, upon the request of the borrower, BNY Mellon must return enough collateral to the borrower by the end of the following business day to reduce the value of the remaining collateral to the applicable initial collateral requirement for such security loan. As a result of the foregoing, the value of the collateral held with respect to a loaned security on any particular day, may be more or less than the value of the security on loan. The collateral percentage with respect to the market value of the loaned security is determined by the security lending agent.

Cash collateral received by each Portfolio of the Trust is generally invested in a series of individual separate accounts, each corresponding to a Portfolio. The investment guidelines permit each separate account to hold certain securities that would be considered eligible securities for a money market fund. Cash collateral received is generally invested in government securities; certain obligations issued by government sponsored enterprises; repurchase agreements collateralized by US Treasury securities; obligations issued by the central government of any Organization for Economic Cooperation and Development (OECD) country or its agencies, instrumentalities, or establishments; obligations of supranational organizations; commercial paper, notes, bonds, and other debt obligations; certificates of deposit, time deposits, and other bank obligations; certain money market funds; and asset-backed securities. Each Portfolio can also accept US government securities and letters of credit (non-cash collateral) in connection with securities loans.

In the event of default or bankruptcy by the lending agent, realization and/or retention of the collateral may be subject to legal proceedings. In the event the borrower fails to return loaned securities and the collateral received is insufficient to cover the value of the loaned securities and provided such collateral shortfall is not the result of investment losses, the lending agent has agreed to pay the amount of the shortfall to each Portfolio or, at the discretion of the lending agent, replace the loaned securities. Each Portfolio continues to record dividends or interest, as applicable, on the securities loaned and is subject to changes in value of the securities loaned that may occur during the term of the loan. Each Portfolio has the right under the Lending Agreement to recover the securities from the borrower on demand. With respect to security loans collateralized by non-cash collateral, each Portfolio receives loan premiums paid by the borrower. With respect to security loans collateralized

[**Table of Contents**](#toc1)

by cash collateral, the earnings from the collateral investments are shared among each Portfolio, the security lending agent, and the borrower. Each Portfolio records security lending income net of allocations to the security lending agent and the borrower.

Each Portfolio may incur investment losses as a result of investing securities lending collateral. This could occur if an investment in each collateral investment account defaulted or became impaired. Under those circumstances, the value of each Portfolio's cash collateral account may be less than the amount each Portfolio would be required to return to the borrowers of the securities and each Portfolio would be required to make up for this shortfall.

The following table reflects a breakdown of transactions accounted for as secured borrowings, the gross obligation by the type of collateral pledged, and the remaining contractual maturity of those transactions as of December 31, 2022:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Overnight | | | | |
|  | and | Under | Between | Over | |
| Securities Lending Transactions | continuous | 30 days | 30 & 90 days | 90 Days | Total |
| **Delaware Ivy VIP Asset Strategy** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market mutual fund | $13818320 | $— | $— | $— | $13818320 |
| **Delaware Ivy VIP Balanced** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market mutual fund | 1496265 |  |  |  | 1496265 |
| **Delaware Ivy VIP Energy** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market mutual fund | 2302463 |  |  |  | 2302463 |
| **Delaware Ivy VIP High Income** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market mutual fund | 36258877 |  |  |  | 36258877 |
| **Delaware Ivy VIP International Core Equity** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market mutual fund | 7445419 |  |  |  | 7445419 |
| **Delaware Ivy VIP Mid Cap Growth** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market mutual fund | 195750 |  |  |  | 195750 |
| **Delaware Ivy VIP Natural Resources** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market mutual fund | 3858940 |  |  |  | 3858940 |
| **Delaware Ivy VIP Science and Technology** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market mutual fund | 652255 |  |  |  | 652255 |
| **Delaware Ivy VIP Small Cap Growth** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market mutual fund | 168219 |  |  |  | 168219 |

---

The following is a summary of each Portfolio's securities lending positions and related cash and non-cash collateral received as of December 31, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Values of securities on loan | Values of non-cash collateral | Values of invested collateral | Total |
| Delaware Ivy VIP Asset Strategy | $17116801 | $3833114 | $13818320 | $17651434 |
| Delaware Ivy VIP Balanced | 6998190 | 5675598 | 1496265 | 7171863 |
| Delaware Ivy VIP Energy | 10672836 | 8696894 | 2302463 | 10999357 |
| Delaware Ivy VIP Growth | 40780181 | 41710267 |  | 41710267 |
| Delaware Ivy VIP High Income | 38792042 | 3636615 | 36258877 | 39895492 |
| Delaware Ivy VIP International Core Equity | 25427392 | 19180768 | 7445419 | 26626187 |
| Delaware Ivy VIP Mid Cap Growth | 16635152 | 16762042 | 195750 | 16957792 |
| Delaware Ivy VIP Natural Resources | 8496793 | 4897854 | 3858940 | 8756794 |
| Delaware Ivy VIP Science and Technology | 12389802 | 12111810 | 652255 | 12764065 |
| Delaware Ivy VIP Small Cap Growth | 7458683 | 7482590 | 168219 | 7650809 |
| Delaware Ivy VIP Smid Cap Core | 6570947 | 6781009 |  | 6781009 |

---

Investments purchased with cash collateral are presented on the "Schedules of investments" under the caption "Securities Lending Collateral."

**13. Credit and Market Risk**

An outbreak of infectious respiratory illness caused by a novel coronavirus known as COVID-19 was first detected in China in December 2019 and has now been detected globally. This coronavirus has resulted in travel restrictions, closed international borders, enhanced health

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**13. Credit and Market Risk (continued)** screenings at ports of entry and elsewhere, disruption of and delays in healthcare service preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions, and lower consumer demand, as well as general concern and uncertainty. The impact of COVID-19, and other infectious illness outbreaks that may arise in the future, could adversely affect the economies of many nations or the entire global economy, individual issuers and capital markets in ways that cannot necessarily be foreseen. In addition, the impact of infectious illnesses in emerging market countries may be greater due to generally less established healthcare systems. Public health crises caused by the COVID-19 outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. The duration of the COVID-19 outbreak and its effects cannot be determined with certainty.

When interest rates rise, fixed income securities (i.e. debt obligations) generally will decline in value. These declines in value are greater for fixed income securities with longer maturities or durations.

IBOR is the risk that changes related to the use of the London interbank offered rate (LIBOR) and other interbank offered rate (collectively, IBORs) could have adverse impacts on financial instruments that reference LIBOR (or the corresponding IBOR). The abandonment of LIBOR could affect the value and liquidity of instruments that reference LIBOR. The use of alternative reference rate products may impact investment strategy performance. These risks may also apply with respect to changes in connection with other IBORs, such as the euro overnight index average (EONIA), which are also the subject of recent reform.

Investments in equity securities in general are subject to market risks that may cause their prices to fluctuate over time. Fluctuations in the value of equity securities in which the Portfolio invests will cause the NAV of the Portfolio to fluctuate.

Some countries in which the Portfolios may invest require governmental approval for the repatriation of investment income, capital, or the proceeds of sales of securities by foreign investors. In addition, if there is deterioration in a country's balance of payments or for other reasons, a country may impose temporary restrictions on foreign capital remittances abroad.

The securities exchanges of certain foreign markets are substantially smaller, less liquid, and more volatile than the major securities markets in the United States. Consequently, acquisition and disposition of securities by the Portfolios may be inhibited. In addition, a significant portion of the aggregate market value of securities listed on the major securities exchanges in emerging markets is held by a smaller number of investors. This may limit the number of shares available for acquisition or disposition by the Portfolios.

Certain Portfolios invest a portion of its assets in high yield fixed income securities, which are securities rated lower than BBB- by S&P and lower than Baa3 by Moody's, or similarly rated by another nationally recognized statistical rating organization. Investments in these higher yielding securities are generally accompanied by a greater degree of credit risk than higher-rated securities. Additionally, lower-rated securities may be more susceptible to adverse economic and competitive industry conditions than investment grade securities.

Certain Portfolios invest in fixed income securities whose value is derived from an underlying pool of mortgages or consumer loans. The value of these securities is sensitive to changes in economic conditions, including delinquencies and/or defaults, and may be adversely affected by shifts in the market's perception of the issuers and changes in interest rates. Investors receive principal and interest payments as the underlying mortgages and consumer loans are paid back. Some of these securities are CMOs. CMOs are debt securities issued by US government agencies or by financial institutions and other mortgage lenders, which are collateralized by a pool of mortgages held under an indenture. Prepayment of mortgages may shorten the stated maturity of the obligations and can result in a loss of premium, if any has been paid. Certain of these securities may be stripped (securities which provide only the principal or interest feature of the underlying security). The yield to maturity on an interest-only CMO is extremely sensitive not only to changes in prevailing interest rates, but also to the rate of principal payments (including prepayments) on the related underlying mortgage assets. A rapid rate of principal payments may have a material adverse effect on a Portfolios' yield to maturity. If the underlying mortgage assets experience greater than anticipated prepayments of principal, a Portfolio may fail to fully recoup its initial investment in these securities even if the securities are rated in the highest rating categories.

Certain Portfolios invest in bank loans and other securities that may subject them to direct indebtedness risk, the risk that the Portfolios will not receive payment of principal, interest, and other amounts due in connection with these investments and will depend primarily on the financial condition of the borrower. Loans that are fully secured offer the Portfolio more protection than unsecured loans in the event of non-payment of scheduled interest or principal, although there is no assurance that the liquidation of collateral from a secured loan would satisfy the corporate borrower's obligation, or that the collateral can be liquidated. Some loans or claims may be in default at the time of purchase. Certain of the loans and the other direct indebtedness acquired by the Portfolio may involve revolving credit facilities or other standby financing commitments

[**Table of Contents**](#toc1)

that obligate the Portfolio to pay additional cash on a certain date or on demand. These commitments may require each Portfolio to increase its investment in a company at a time when the Portfolio might not otherwise decide to do so (including at a time when the company's financial condition makes it unlikely that such amounts will be repaid). To the extent that each Portfolio is committed to advance additional funds, it will at all times hold and maintain cash or other high grade debt obligations in an amount sufficient to meet such commitments. When a loan agreement is purchased, the Portfolio may pay an assignment fee. On an ongoing basis, the Portfolio may receive a commitment fee based on the undrawn portion of the underlying line of credit portion of a loan agreement. Prepayment penalty fees are received upon the prepayment of a loan agreement by the borrower. Prepayment penalty, facility, commitment, consent, and amendment fees are recorded to income as earned or paid.

As the Portfolio may be required to rely upon another lending institution to collect and pass on to the Portfolio amounts payable with respect to the loan and to enforce the Portfolio's rights under the loan and other direct indebtedness, an insolvency, bankruptcy, or reorganization of the lending institution may delay or prevent the Portfolio from receiving such amounts. The highly leveraged nature of many loans may make them especially vulnerable to adverse changes in economic or market conditions. Investments in such loans and other direct indebtedness may involve additional risk to the Portfolio.

Certain Portfolios invest in certain obligations that may have liquidity protection designed to ensure that the receipt of payments due on the underlying security is timely. Such protection may be provided through guarantees, insurance policies, or letters of credit obtained by the issuer or sponsor through third parties, through various means of structuring the transaction, or through a combination of such approaches. The Portfolios will not pay any additional fees for such credit support, although the existence of credit support may increase the price of a security.

Certain Portfolios may invest in REITs and are subject to the risks associated with that industry. If a Portfolio holds real estate directly or receives rental income directly from real estate holdings, its tax status as a regulated investment company may be jeopardized. There were no direct real estate holdings during the year ended December 31, 2022. The Portfolios' REIT holdings are also affected by interest rate changes, particularly if the REITs they hold use floating rate debt to finance their ongoing operations. The Portfolios also invest in real estate acquired as a result of ownership of securities or other instruments, including issuers that invest, deal, or otherwise engage in transactions in real estate or interests therein. These instruments may include interests in private equity limited partnerships or limited liability companies that hold real estate investments (Real Estate Limited Partnerships). The Portfolios will limit their investments in Real Estate Limited Partnerships to 5% of their total assets at the time of purchase.

Each Portfolio may invest up to 15% of its net assets in illiquid securities, which may include securities with contractual restrictions on resale, securities exempt from registration under Rule 144A promulgated under the Securities Act of 1933, as amended and other securities which may not be readily marketable. The relative illiquidity of these securities may impair each Portfolio from disposing of them in a timely manner and at a fair price when it is necessary or desirable to do so. While maintaining oversight, the Board has delegated to DMC, the day-to-day functions of determining whether individual securities are liquid for purposes of the Portfolios' limitation on investments in illiquid securities. Securities eligible for resale pursuant to Rule 144A, which are determined to be liquid, are not subject to the Portfolios' 15% limit on investments in illiquid securities. Rule 144A securities have been identified on the "Schedules of investments."

**14. Contractual Obligations**

Each Portfolio enters into contracts in the normal course of business that contain a variety of indemnifications. Each Portfolio's maximum exposure under these arrangements is unknown. However, each Portfolio has not had prior claims or losses pursuant to these contracts. Management has reviewed each Portfolio's existing contracts and expects the risk of loss to be remote.

**15. Recent Accounting Pronouncements**

In March 2020, FASB issued an Accounting Standards Update (ASU), ASU 2020-04, Reference Rate Reform (Topic 848) – Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in ASU 2020-04 provide optional temporary financial reporting relief from the effect of certain types of contract modifications due to the planned discontinuation of LIBOR and other interbank-offered based reference rates as of the end of 2021. In March 2021, the administrator for LIBOR announced the extension of the publication of a majority of the USD LIBOR settings to June 30, 2023. On December 21, 2022, FASB issued ASU 2022-06 to defer the sunset date of Accounting Standards Codification Topic 848 until December 31, 2024. ASU 2020-04 is effective for certain reference rate-related contract modifications

[**Table of Contents**](#toc1)

Notes to financial statements

Ivy Variable Insurance Portfolios

**15. Recent Accounting Pronouncements (continued)** that occur during the period March 12, 2020 through December 31, 2024. Management is currently evaluating ASU 2020-04 and ASU 2022-06, but does not believe there will be a material impact.

**16. Subsequent Events**

Management has determined that no material events or transactions occurred subsequent to December 31, 2022, that would require recognition or disclosure in the Portfolios' financial statements.

[**Table of Contents**](#toc1)

Report of independent registered public accounting firm

To the Board of Trustees of Ivy Variable Insurance Portfolios and Shareholders of Delaware Ivy VIP Asset Strategy, Delaware Ivy VIP Balanced, Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, Delaware Ivy VIP High Income, Delaware Ivy VIP International Core Equity, Delaware Ivy VIP Mid Cap Growth, Delaware Ivy VIP Natural Resources, Delaware Ivy VIP Science and Technology, Delaware Ivy VIP Small Cap Growth and Delaware Ivy VIP Smid Cap Core

**Opinions on the Financial Statements**

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of each of the portfolios listed in the table below (eleven of the portfolios constituting Ivy Variable Insurance Portfolios, hereafter collectively referred to as the "Portfolios") as of December 31, 2022, the related statements of operations and of changes in net assets for each of the periods indicated in the table below, including the related notes, and the financial highlights for each of periods indicated in the table below (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Portfolios as of December 31, 2022, the results of each of their operations, the changes in each of their net assets, and each of the financial highlights for each of the periods indicated in the table below, in conformity with accounting principles generally accepted in the United States of America.

---

| |
|:---|
| Delaware Ivy VIP Asset Strategy<sup>(1)</sup> |
| Delaware Ivy VIP Balanced<sup>(2)</sup> Delaware Ivy VIP Natural Resources<sup>(2)</sup> |
| Delaware Ivy VIP Energy<sup>(2)</sup> Delaware Ivy VIP Science and Technology<sup>(2)</sup> |
| Delaware Ivy VIP Growth<sup>(2)</sup> Delaware Ivy VIP Small Cap Growth<sup>(2)</sup> |
| Delaware Ivy VIP High Income<sup>(2)</sup> Delaware Ivy VIP Smid Cap Core<sup>(2)</sup> |
| Delaware Ivy VIP International Core Equity<sup>(2)</sup> |

---

<sup>(1)</sup> Consolidated statement of assets and liabilities, including the consolidated schedule of investments, as of December 31, 2022, the related consolidated statement of operations for the year ended December 31, 2022, and the consolidated statements of changes in net assets and the consolidated financial highlights for each of the two years in the period ended December 31, 2022.

<sup>(2)</sup> Statement of assets and liabilities, including the schedule of investments, as of December 31, 2022, the related statement of operations for the year ended December 31, 2022, and the statements of changes in net assets and the financial highlights for each of the two years in the period ended December 31, 2022.

The financial statements of the Portfolios as of and for the year ended December 31, 2020 and the financial highlights for each of the periods ended on or prior to December 31, 2020 (not presented herein, other than the financial highlights) were audited by other auditors whose report dated February 12, 2021 expressed an unqualified opinion on those financial statements and financial highlights.

**Basis for Opinions**

These financial statements are the responsibility of the Portfolios' management. Our responsibility is to express an opinion on the Portfolios' financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Portfolios in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian, transfer agents, portfolio company investees, agent banks and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/PricewaterhouseCoopers LLP <br> Philadelphia, Pennsylvania <br> February 23, 2023

We have served as the auditor of one or more investment companies in Delaware Funds by Macquarie<sup>®</sup> since 2010.

[**Table of Contents**](#toc1)

Other Portfolio information (Unaudited)

Ivy Variable Insurance Portfolios

**Tax Information**

All disclosures are based on financial information available as of the date of this annual report and, accordingly are subject to change. For any and all items requiring reporting, it is the intention of each Portfolio to report the maximum amount permitted under the Internal Revenue Code and the regulations thereunder.

For the fiscal year ended December 31, 2022, each Portfolio reports distributions paid during the year as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | (A)<br>Long-Term<br>Capital<br>Gains<br>Distributions<br>(Tax<br>Basis) |<br>(B)<br>Ordinary<br>Income<br>Distributions<br>(Tax<br>Basis) |<br>(C)<br>Return of<br>Capital<br>(Tax<br>Basis) |<br><br>Total<br>Distributions<br>(Tax<br>Basis) |<br><br>(D)<br>Qualifying<br>Dividends<sup>1</sup> |
| Delaware Ivy VIP Asset Strategy | 78.03% | 21.13% | 0.84% | 100.00% | 7.03% |
| Delaware Ivy VIP Balanced | 89.78% | 10.22% |  | 100.00% | 35.96% |
| Delaware Ivy VIP Energy |  | 100.00% |  | 100.00% | 75.59% |
| Delaware Ivy VIP Growth | 85.73% | 14.27% |  | 100.00% | 21.80% |
| Delaware Ivy VIP High Income |  | 100.00% |  | 100.00% |  |
| Delaware Ivy VIP International Core Equity |  | 100.00% |  | 100.00% |  |
| Delaware Ivy VIP Mid Cap Growth | 99.67% | 0.33% |  | 100.00% | 100.00% |
| Delaware Ivy VIP Natural Resources |  | 100.00% |  | 100.00% | 99.42% |
| Delaware Ivy VIP Science and Technology | 99.15% | 0.85% |  | 100.00% | 23.86% |
| Delaware Ivy VIP Small Cap Growth | 95.87% | 4.13% |  | 100.00% | 47.83% |
| Delaware Ivy VIP Smid Cap Core | 35.35% | 64.65% |  | 100.00% | 7.85% |

---

(A), (B) and (C) are based on a percentage of each Portfolio's total distributions.

<sup>1</sup>Qualified dividends represent dividends which qualify for corporate dividends received deduction.

For the fiscal year ended December 31, 2022, certain dividends paid by the Portfolio, determined to be Qualified Short-Term Capital Gains, may be subject to relief from US withholding for foreign shareholders, as provided by the American Jobs Creation Act of 2004; the Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010; and as extended by the American Taxpayer Relief Act of 2012. For the fiscal year ended December 31, 2022, Delaware Ivy VIP Smid Cap Core has reported maximum distributions of Qualified Short-Term Capital Gains of $1,555,977.

Delaware Ivy VIP International Core Equity intends to pass through foreign tax credits in the maximum amount of $1,179,630. The gross foreign source income earned during the fiscal year 2022 by the Portfolio was $17,246,460. The Portfolio has received a refund of foreign taxes previously reported and passed through in prior years (a "foreign tax redetermination"). Shareholders who claimed foreign tax credits with respect to such foreign taxes previously reported in prior years may also have a foreign tax redetermination and may need to file amended tax returns to account for such taxes refunded to the Portfolio. The amount of tax refunded, and years to which the tax relates, will be available upon request, along with certain other information about the refunded tax. Please consult your tax advisor. The amount reported above has not been reduced for any foreign tax redeterminations.

**Board Consideration of Investment Management Agreements and Sub-Advisory Agreements at a Meeting Held on August 9-11, 2022**

At a meeting held on August 9-11, 2022 (the "Annual Contract Renewal Meeting"), the Board of Trustees (the "Board"), including a majority of Trustees each of whom is not an "interested person" as defined under the Investment Company Act of 1940 (the "Independent Trustees"), approved the renewal of the Delaware Ivy VIP Asset Strategy, Delaware Ivy VIP Balanced, Delaware Ivy VIP Energy, Delaware Ivy VIP Growth, Delaware Ivy VIP High Income, Delaware Ivy VIP International Core Equity, Delaware Ivy VIP Mid Cap Growth, Delaware Ivy VIP Natural Resources, Delaware Ivy VIP Science and Technology, Delaware Ivy VIP Small Cap Growth, Delaware Ivy VIP Smid Cap Core (each, a "Fund" and together, the "Funds") Investment Management Agreements with Delaware Management Company ("DMC"); and the Sub-Advisory Agreements with Macquarie Investment Management Global Limited ("MIMGL"), Macquarie Investment Management Austria Kapitalanlage AG ("MIMAK"), Macquarie Investment Management Europe Limited ("MIMEL") and Macquarie Funds Management Hong Kong Limited ("MFMHKL" and together with MIMGL, MIMAK and MIMEL, the "Affiliated Sub-Advisers"), as applicable.

[**Table of Contents**](#toc1)

Prior to the Meeting, including at a Board meeting held in May 2022, the Trustees conferred extensively among themselves and with representatives of DMC about these matters. Also, the Board was assisted by the applicable Investment Committee, with each Investment Committee assisting the full Board in the discharge of its duties in reviewing investment performance and other matters throughout the year. The Independent Trustees were assisted in their evaluation of the Investment Management Agreements and the Sub-Advisory Agreements by independent legal counsel, from whom they received separate legal advice and with whom they met separately.

In providing information to the Board, DMC was guided by a detailed set of requests for information submitted to them by independent legal counsel on behalf of the Independent Trustees at the start of the Board's annual contract renewal process earlier in 2022. In considering and approving the Investment Management Agreements and the Sub-Advisory Agreements, the Trustees considered the information they believed relevant, including but not limited to the information discussed below. The Board considered not only the specific information presented in connection with the Meeting, but also the knowledge gained over time through interaction with DMC about various topics. In this regard, the Board reviewed reports of DMC at each of its quarterly meetings, which included information about, among other things, Fund performance, investment strategies, and expenses. In addition, the Investment Committees confer with portfolio managers at various times throughout the year. In considering information relating to the approval of the Funds' Investment Management Agreements and the Sub-Advisory Agreements, the Independent Trustees also received information from an independent fund consultant, JDL Consultants, LLC ("JDL").

The Board did not identify any particular information or consideration that was all-important or controlling, and each individual Trustee may have attributed different weights to various factors.

After its deliberations, the Board unanimously approved the continuation of the Investment Management Agreements and the Sub-Advisory Agreements for a one-year term. The following summarizes a number of important, but not necessarily all, factors considered by the Board in support of its approval.

**Nature, extent, and quality of services.** The Board received and considered various information regarding the nature, extent, and quality of the advisory services provided to the Funds by DMC under its Investment Management Agreements and the experience of the officers and employees of DMC who provide these services, including each Fund's portfolio manager(s). The Board's review included consideration of DMC's investment process and oversight and research and analysis capabilities, and its ability to attract and retain qualified investment professionals. The Board considered information regarding DMC's programs for risk management, including investment, operational, liquidity, valuation, and compliance risks. The Board received information with respect to the cybersecurity program and business continuity plans of DMC and its affiliates. The Board also considered non-advisory services that DMC and its affiliates provide to the Delaware Funds, including third party oversight, transfer agent, internal audit, valuation, portfolio trading, and legal and compliance. The Board took into account the benefits to shareholders of investing in a Fund that is part of a family of funds managed by an affiliate of Macquarie Group Ltd. ("Macquarie"), the parent company of DMC, and the resources available to DMC as part of Macquarie's global asset management business.

The Board received and considered various information with respect to the services provided by the Affiliated Sub-Advisers under the Sub-Advisory Agreements and the credentials and experience of the officers and employees of the Affiliated Sub-Advisers who provide these services, including each Fund's portfolio manager(s). The Board considered the division of responsibilities between DMC and the Affiliated Sub-Advisers and the oversight provided by DMC. The Board considered the expertise of the Affiliated Sub-Advisers with respect to certain asset classes and/or investment styles. The Affiliated Sub-Advisers are part of Macquarie's global investment platform that has offices and personnel that are located around the world. As a result, the Board noted that DMC had stated that the Affiliated Sub-Advisers can provide research, investment and trading analysis on the markets and economies of various countries in which the Funds may invest, make recommendations regarding securities and assist with security trades, as applicable. The Board took into account that the Sub-Advisory Agreements may benefit the Funds and their shareholders by permitting DMC to use the resources and talents of the Affiliated Sub-Advisers in managing the Funds.

The Board concluded that, overall, it was satisfied with the nature, extent and quality of services provided (and expected to be provided) to the Funds by DMC and the Affiliated Sub-Advisers.

**Investment performance.** The Board received and considered information with respect to the investment performance of the Funds, including performance reports and discussions with portfolio managers at meetings of the Board's Investment Committees throughout the year as well as reports provided by Broadridge Financial Solutions, an independent investment company data provider ("Broadridge"), furnished for the Annual Contract Renewal Meeting. The Broadridge reports prepared for each Fund showed its investment performance in comparison to a group of similar funds (the "Performance Universe"). The Board received a description of the methodology used by Broadridge to select the funds in the Performance Universe. Comparative annualized performance for each Fund was shown for the past 1-, 3-, 5-, and 10-year or since inception

[**Table of Contents**](#toc1)

Other Portfolio information (Unaudited)

Ivy Variable Insurance Portfolios

**Board Consideration of Investment Management Agreements and Sub-Advisory Agreements at a Meeting Held on August 9-11, 2022 (continued)** 

periods, as applicable, ended December 31, 2021. The Board considered that the Funds were managed by Ivy Investment Management Company prior to the acquisition of its parent company, Waddell & Reed Financial, Inc. and its subsidiaries (the "Transaction"), and that each Fund's performance prior to the closing of the Transaction on April 30, 2021 is that of its predecessor manager.

*Delaware Ivy VIP Asset Strategy* – The Performance Universe for the Fund consisted of the Fund and all alternative other funds underlying variable insurance product, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the second quartile and for the 3-year and since inception periods was in the first quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1- and 3-year and since inception periods was above the median of its Performance Universe. The Board also noted that the Fund underperformed its benchmark index for the 1- and 3-year and since inception periods. The Board, however, noted that the Fund changed its investment strategy in November 2021 and that the investment performance of a majority of the current portfolio management team only began as of November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review. The Board also noted the limited period of performance data available and that it would continue to evaluate the Fund's performance.

*Delaware Ivy VIP Balanced* – The Performance Universe for the Fund consisted of the and all mixed-asset target allocation growth funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the first quartile and for the 3-, 5-, and 10-year periods was in the second quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5-, and 10-year periods was above the median of its Performance Universe. The Board also noted that the Fund underperformed its benchmark index for the 1-, 3-, 5-, and 10-year periods. The Board, however, noted that the Fund changed its investment strategy in November 2021 and that the investment performance of the current portfolio management team only began as of November 2021.The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review.

*Delaware Ivy VIP Energy* – The Performance Universe for the Fund consisted of the Fund and all natural resources funds underlying variable insurance products, regardless of asset size or primary channel of distribution The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the first quartile and for the 3-year and since inception periods was in the fourth quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-year period was above and for the 3-year and since inception periods was below the median of its Performance Universe. The Board also noted that the Fund underperformed its benchmark index for the 1- and 3-year and since inception periods. The Board, however, noted that the Fund changed its investment strategy in November 2021 and that the investment performance of the current portfolio management team only began as of November 2021. The Board also noted the limited period of performance data available and would continue to evaluate the Fund's performance. The Board noted the explanations from DMC concerning the reasons for the Fund's relative performance versus the Performance Universe and its benchmark for the various periods.

*Delaware Ivy VIP Growth* – The Performance Universe for the Fund consisted of the Fund and all large-cap growth funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the first quartile and for the 3-, 5-, and 10-year periods was in the second quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5-, and 10-year periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-year period and underperformed its benchmark index for the 3-, 5-, and 10-year periods. The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review.

*Delaware Ivy VIP High Income* – The Performance Universe for the Fund consisted of the Fund and all high yield funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the first quartile, for the 3-year period was in the third quartile and for the since inception period was in second quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-year and since inception periods was above the median and for the 3-year period was below the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-year period and underperformed its benchmark index for the 3-year and since inception periods. The Board, however, noted that the Fund changed its investment strategy in November 2021 and that the investment

[**Table of Contents**](#toc1)

performance of the current portfolio management team only began in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review. The Board noted the limited period of performance data available and would continue to evaluate the Fund's performance.

*Delaware Ivy VIP International Core Equity* – The Performance Universe for the Fund consisted of the Fund and all international large-cap core funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3-, and 10-year periods was in the first quartile and for the 5-year period was in the third quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, and 10-year periods was above the median and for the 5-year period was below the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-, 3-, and 10-year periods and underperformed its benchmark index for the and 5-year period. The Board, however, noted that the Fund changed its investment strategy in November 2021 and that the investment performance of the current portfolio management team only began in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe and benchmark during the periods under review.

*Delaware Ivy VIP Mid Cap Growth* – The Performance Universe for the Fund consisted of the Fund and all mid-cap growth funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the second quartile and for the 3-year and since inception periods was in the first quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1- and 3-year and since inception periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1- and 3-year and since inception periods. The Board, however, noted that one of the Fund's three portfolio managers began managing the Fund in October 2016 and another in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe and benchmark during the periods under review.

*Delaware Ivy VIP Natural Resources* – The Performance Universe for the Fund consisted of the Fund and all natural resources funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3-, and 5-year periods was in the third quartile and for the 10-year period was in the fourth quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5-, and 10-year periods was below the median of its Performance Universe. The Board also noted that the Fund underperformed its benchmark index for the 1-year period and outperformed its benchmark index for the 3-, 5-, and 10-year periods. The Board, however, noted that the Fund changed its investment strategy in November 2021 and that the investment performance of the current portfolio management team only began in November 2021. The Board noted the explanations from DMC concerning the reasons for the Fund's relative performance versus the Performance Universe and its benchmark for the various periods.

*Delaware Ivy VIP Science and Technology* – The Performance Universe for the Fund consisted of the Fund and all science and technology funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1- and 3-year and since inception periods was in the third quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1- and 3-year and since inception periods was below the median of its Performance Universe. The Board also noted that the Fund underperformed its benchmark index for the 1- and 3-year and since inception periods. The Board, however, noted that one of the Fund's two portfolio managers only began managing the Fund in November 2021. The Board noted the explanations from DMC concerning the reasons for the Fund's relative performance versus the Performance Universe and its benchmark for the various periods.

*Delaware Ivy VIP Small Cap Growth* – The Performance Universe for the Fund consisted of the Fund and all small-cap growth funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the third quartile and for the 3-year and since inception periods was in the fourth quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, and since inception periods was below the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-year period and underperformed its benchmark index for the 3-year and since inception periods. The Board, however, noted that one of the Fund's two portfolio managers began managing the Fund in October 2016. The Board noted the explanations from DMC concerning the reasons for the Fund's relative performance versus the Performance Universe and its benchmark for the various periods.

[**Table of Contents**](#toc1)

Other Portfolio information (Unaudited)

Ivy Variable Insurance Portfolios

**Board Consideration of Investment Management Agreements and Sub-Advisory Agreements at a Meeting Held on August 9-11, 2022 (continued)**

*Delaware Ivy VIP Smid Cap Core* – The Performance Universe for the Fund consisted of the Fund and all small-cap core funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1- and 5-year periods was in the third quartile, for the 3-year period was in the fourth quartile and for the 10-year period was in the second quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, and 5-year periods was below the median and for the 10-year period was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark for the 1-year period and underperformed its benchmark index for the 3-, 5-, and 10-year periods. The Board, however, noted that the Fund changed its investment strategy in November 2021 and that the investment performance of the current portfolio management team only began in November 2021. The Board noted the explanations from DMC concerning the reasons for the Fund's relative performance versus the Performance Universe and its benchmark for the various periods.

**Comparative expenses.** The Board received and considered expense data for the Funds. Management provided the Board with information on pricing levels and fee structures for each Fund as of its most recently completed fiscal year. The Board also considered on the comparative analysis of contractual management fees and actual total expense ratios of each Fund versus contractual management fees and actual total expense ratios of a group of similar funds as selected by Broadridge (the "Expense Group"). In reviewing comparative costs, each Fund's contractual management fee and the actual management fee incurred by each Fund were compared with the contractual management fees (assuming all funds were similar in size to each Fund) and actual management fees, taking into account any applicable breakpoints and fee waivers, with a Fund's expense universe, which is comprised of the Fund, its Expense Group and all other similar funds underlying variable insurance products with similar 12b-1/non-12b-1 structures, excluding outliers (the "Expense Universe"). Each Fund's total expenses were also compared with those of its Expense Universe.

*Delaware Ivy VIP Asset Strategy* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Balanced* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Energy* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Growth* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP High Income* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP International Core Equity* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Mid Cap Growth* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were below its Expense Group average.

*Delaware Ivy VIP Natural Resources* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Science and Technology* – The expense comparisons for the Fund showed that its actual management fee was equal to the median of its Expense Universe and its actual total expenses were below its Expense Group average.

*Delaware Ivy VIP Small Cap Growth* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Smid Cap Core* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

[**Table of Contents**](#toc1)

The Board also received and considered information about the nature and extent of services offered and fee rates charged by DMC to other types of clients with investment strategies similar to those of the Funds. In this regard, the Board received information about the significantly greater scope of services, and compliance, reporting and other legal burdens and risks of managing registered investment companies compared with those associated with managing assets of other types of clients, including third-party sub-advised fund clients, unregistered funds and separately managed accounts.

The Board noted that DMC, and not the Funds, pays the sub-advisory fees to the Affiliated Sub-Advisers and, accordingly, that the retention of the Affiliated Sub-Advisers does not increase the fees and expenses incurred by the Funds.

Based on its consideration of the factors and information it deemed relevant, including those described here, the Board determined that the compensation payable to DMC under the Investment Management Agreements and to the Affiliated Sub-Advisers under the Sub-Advisory Agreements was reasonable.

**Economies of scale.** The Board received and considered information about the potential for DMC to realize economies of scale in the provision of management services to the Fund, the difficulties of calculating economies of scale at an individual Fund level, and the extent to which potential scale benefits are shared with shareholders, including the extent to which any economies of scale are reflected in the level of management fees charged. DMC discussed its advisory fee pricing and structure for the Delaware Funds complex, including the current breakpoints. The Board noted that, as of March 31, 2022, the net assets of the Delaware Ivy VIP Growth and Delaware Ivy VIP High Income each exceeded their first breakpoint level and that breakpoints result in a lower advisory fee than would otherwise be the case in the absence of breakpoints, when the asset levels specified in the breakpoints schedule are exceeded. The Board noted that each Fund may also benefit from economies of scale through initial fee setting, fee waivers and expense reimbursements, as well as DMC's investment in its business, including investments in business infrastructure, technology and cybersecurity.

**Management profitability.** The Board received and considered the Investment Management Profitability Analysis that addressed the overall profitability of DMC's business in providing management and other services to each Fund and the Delaware Funds as a whole, including the methodology used by DMC in allocating costs for the purpose of determining profitability. The Board also reviewed a report prepared by JDL regarding DMC's profitability as compared to certain peer fund complexes and the Independent Trustees discussed DMC's profitability in such context with representatives from JDL. Based on its review, the Board determined that DMC's profitability was not excessive in light of the nature, extent and quality of the services provided to each Fund.

**Ancillary benefits.** The Board received and considered information regarding the extent to which DMC and its affiliates might derive ancillary benefits from fund operations, including the potential for procuring additional business as a result of the prestige and visibility associated with its role as investment manager to the Delaware Funds; the benefits from allocation of fund brokerage to improve trading efficiencies; and the fees that various affiliates received for serving as transfer agent and for overseeing fund accounting and financial administration services to the Delaware Funds. The Board received information from DMC regarding its view of the performance of its affiliates in providing transfer agent and fund accounting and financial administration oversight services and the organizational structure employed to provide these services pursuant to their contracts with the Funds.

Based on its consideration of the factors and information it deemed relevant, including the costs of providing investment management and other services to the Funds and the ongoing commitment of DMC and its affiliates to the Funds, the Board did not find that any ancillary benefits received by DMC and its affiliates were unreasonable.

**Conclusion.** Based on its review, consideration and evaluation of all factors it believed relevant, including the above-described factors and conclusions, the Board, including all of the Independent Trustees, approved the continuation of DMC's Investment Management Agreements and of the Affiliated Sub-Advisers' Sub-Advisory Agreements for an additional one-year period.

[**Table of Contents**](#toc1)

Board of trustees / directors and officers addendum

Delaware Funds by Macquarie<sup>®</sup>

A mutual fund is governed by a Board of Trustees/Directors ("Trustees"), which has oversight responsibility for the management of a fund's business affairs. Trustees establish procedures and oversee and review the performance of the investment manager, the distributor, and others who perform services for the fund. The independent fund trustees, in particular, are advocates for shareholder interests. Each trustee has served in that capacity since he or she was elected to or appointed to the Board of Trustees, and will continue to serve until his or her retirement or the election of a new trustee in his or her place. The following is a list of the Trustees and Officers with certain background and related information.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <br>**Name,**<br>**Address,**<br>**and Birth Year** | <br>**Position(s)**<br>**Held with**<br>**the Trust** | <br>**Length of Time**<br>**Served<sup>1</sup>** | <br>**Number of**<br>**Funds in Fund**<br>**Complex Overseen**<br>**by Trustee** | <br>**Principal**<br>**Occupation(s)**<br>**During the**<br>**Past Five Years** | **Other**<br>**Directorships**<br>**Held by Trustee**<br>**During the**<br>**Past Five Years** |
| **Interested Trustee** | **Interested Trustee** | **Interested Trustee** | **Interested Trustee** | **Interested Trustee** | **Interested Trustee** |
| **Shawn K. Lytle**<sup>2</sup> | President, | President and | 126 | Macquarie Asset |  |
| 100 Independence | Chief Executive Officer, | Chief Executive Officer |  | Management<sup>3</sup> |  |
| 610 Market Street | and Trustee | since August 2015 |  | (2015–Present) |  |
| Philadelphia, PA |  |  |  | -Global Head of |  |
| 19106-2354 |  | Trustee since |  | Macquarie Asset |  |
| 1970 |  | September 2015 |  | Management Public |  |
|  |  |  |  | Investments |  |
|  |  |  |  | (2019–Present) |  |
|  |  |  |  | -Head of Americas of |  |
|  |  |  |  | Macquarie Group |  |
|  |  |  |  | (2017–Present) |  |
| **Independent Trustees** | **Independent Trustees** | **Independent Trustees** | **Independent Trustees** | **Independent Trustees** | **Independent Trustees** |
| **Jerome D. Abernathy** | Trustee | Since January 2019 | 126 | Stonebrook Capital |  |
| 100 Independence |  |  |  | Management, LLC |  |
| 610 Market Street |  |  |  | (financial |  |
| Philadelphia, PA |  |  |  | technology: macro |  |
| 19106-2354 |  |  |  | factors and databases) |  |
| 1959 |  |  |  | -Managing Member |  |
|  |  |  |  | (1993-Present) |  |
| **Ann D. Borowiec** | Trustee | Since March 2015 | 126 | J.P. Morgan Chase & | Banco Santander |
| 100 Independence |  |  |  | Co. (1987-2013) | International |
| 610 Market Street |  |  |  | -Chief Executive Officer, | (2016–2019) |
| Philadelphia, PA |  |  |  | Private Wealth | Santander Bank, N.A. |
| 19106-2354 |  |  |  | Management (2011– | (2016-2019) |
| 1958 |  |  |  | 2013) |  |
| **Joseph W. Chow** | Trustee | Since January 2013 | 126 | Private Investor |  |
| 100 Independence |  |  |  | (2011–Present) |  |
| 610 Market Street |  |  |  |  |  |
| Philadelphia, PA |  |  |  |  |  |
| 19106-2354 |  |  |  |  |  |
| 1953 |  |  |  |  |  |
| **H. Jeffrey Dobbs** | Trustee | Since April 2019<sup>4</sup> | 126 | KPMG LLP | TechAccel LLC |
| 100 Independence |  |  |  | (2002-2015) | (2015–Present) |
| 610 Market Street |  |  |  | -Global Sector | PatientsVoices, Inc. |
| Philadelphia, PA |  |  |  | Chairman, | (2018–Present) |
| 19106-2354 |  |  |  | Industrial Manufacturing | Valparaiso University |
| 1955 |  |  |  | (2010-2015) | Board |
|  |  |  |  |  | (2012-Present) |
|  |  |  |  |  | Ivy Funds Complex (2019- |
|  |  |  |  |  | 2021) |

---

[**Table of Contents**](#toc1)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <br>**Name,**<br>**Address,**<br>**and Birth Year** | <br>**Position(s)**<br>**Held with**<br>**the Trust** | <br>**Length of Time**<br>**Served<sup>1</sup>** | <br>**Number of**<br>**Funds in Fund**<br>**Complex Overseen**<br>**by Trustee** | <br>**Principal**<br>**Occupation(s)**<br>**During the**<br>**Past Five Years** | **Other**<br>**Directorships**<br>**Held by Trustee**<br>**During the**<br>**Past Five Years** |
| **John A. Fry** | Trustee | Since January 2001 | 126 | Drexel University | Federal Reserve |
| 100 Independence |  |  |  | -President | Bank of Philadelphia |
| 610 Market Street |  |  |  | (2010–Present) | (2020–Present) |
| Philadelphia, PA |  |  |  |  | FS Credit Real Estate |
| 19106-2354 |  |  |  |  | Income Trust, Inc. |
| 1960 |  |  |  |  | (2018–Present) |
|  |  |  |  |  | vTv Therapeutics Inc. |
|  |  |  |  |  | (2017–Present) |
|  |  |  |  |  | Community Health |
|  |  |  |  |  | Systems |
|  |  |  |  |  | (2004–Present) |
|  |  |  |  |  | Drexel Morgan & Co. |
|  |  |  |  |  | (2015–2019) |
| **Joseph Harroz, Jr.** | Trustee | Since November 1998<sup>4</sup> | 126 | University of Oklahoma | OU Medicine, Inc. |
| 100 Independence |  |  |  | -President | (2020–Present) |
| 610 Market Street |  |  |  | (2020–Present) | Big 12 Athletic Conference |
| Philadelphia, PA |  |  |  | -Interim President | (2019-Present) |
| 19106-2354 |  |  |  | (2019–2020) | Valliance Bank |
| 1967 |  |  |  | -Vice President and | (2007–Present) |
|  |  |  |  | Dean, College of Law | Ivy Funds Complex |
|  |  |  |  | (2010–2019) | (1998-2021) |
|  |  |  |  | Brookhaven |  |
|  |  |  |  | Investments LLC |  |
|  |  |  |  | (commercial |  |
|  |  |  |  | enterprises) |  |
|  |  |  |  | -Managing Member |  |
|  |  |  |  | (2019–Present) |  |
|  |  |  |  | St. Clair, LLC |  |
|  |  |  |  | (commercial |  |
|  |  |  |  | enterprises) |  |
|  |  |  |  | -Managing Member |  |
|  |  |  |  | (2019–Present) |  |
| **Sandra A.J. Lawrence** | Trustee | Since April 2019<sup>4</sup> | 126 | Children's Mercy | Brixmor Property |
| 100 Independence |  |  |  | Hospitals and Clinics | Group Inc. (2021-Present) |
| 610 Market Street |  |  |  | (2005–2019) | Sera Prognostics Inc. |
| Philadelphia, PA |  |  |  | -Chief Administrative | (biotechnology) |
| 19106-2354 |  |  |  | Officer | (2021-Present) |
| 1957 |  |  |  | (2016–2019) | Recology (resource |
|  |  |  |  |  | recovery) (2021-Present) |
|  |  |  |  |  | Evergy, Inc., Kansas City |
|  |  |  |  |  | Power & Light Company, |
|  |  |  |  |  | KCP&L Greater Missouri |
|  |  |  |  |  | Operations Company, |
|  |  |  |  |  | Westar Energy, Inc. and |
|  |  |  |  |  | Kansas Gas and Electric |
|  |  |  |  |  | Company (related utility |
|  |  |  |  |  | companies) |
|  |  |  |  |  | (2018-Present) |
|  |  |  |  |  | National Association of |
|  |  |  |  |  | Corporate Directors |
|  |  |  |  |  | (2017-Present) |
|  |  |  |  |  | Ivy Funds Complex |
|  |  |  |  |  | (2019-2021) |
|  |  |  |  |  | American Shared Hospital |
|  |  |  |  |  | Services (medical device) |
|  |  |  |  |  | (2017-2021) |
|  |  |  |  |  | Westar Energy (utility) |
|  |  |  |  |  | (2004-2018) |

---

[**Table of Contents**](#toc1)

Board of trustees / directors and officers addendum

Delaware Funds by Macquarie<sup>®</sup>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <br>**Name,**<br>**Address,**<br>**and Birth Year** | <br>**Position(s)**<br>**Held with**<br>**the Trust** | <br>**Length of Time**<br>**Served<sup>1</sup>** | <br>**Number of**<br>**Funds in Fund**<br>**Complex Overseen**<br>**by Trustee** | <br>**Principal**<br>**Occupation(s)**<br>**During the**<br>**Past Five Years** | **Other**<br>**Directorships**<br>**Held by Trustee**<br>**During the**<br>**Past Five Years** |
| **Frances A.** | Trustee | Since September 2011 | 126 | Banco Itaú International | Florida Chapter of |
| **Sevilla-Sacasa** |  |  |  | -Chief Executive Officer | National Association of |
| 100 Independence |  |  |  | (2012–2016) | Corporate Directors |
| 610 Market Street |  |  |  |  | (2021-Present) |
| Philadelphia, PA |  |  |  |  | Callon Petroleum |
| 19106-2354 |  |  |  |  | Company (2019-Present) |
| 1956 |  |  |  |  | Camden Property Trust |
|  |  |  |  |  | (2011-Present) |
|  |  |  |  |  | New Senior Investment |
|  |  |  |  |  | Group Inc. (2021) |
|  |  |  |  |  | Carrizo Oil & Gas, Inc. |
|  |  |  |  |  | (2018-2019) |
| **Thomas K. Whitford** | Chair and Trustee | Trustee since January | 126 | PNC Financial Services | HSBC USA Inc. |
| 100 Independence |  | 2013 |  | Group (1983–2013) | (2014–2022) |
| 610 Market Street |  |  |  | -Vice Chairman (2009- | HSBC North America |
| Philadelphia, PA |  | Chair since January |  | 2013) | Holdings Inc. |
| 19106-2354 |  | 2023 |  |  | (2013–2022) |
| 1956 |  |  |  |  | HSBC Finance |
|  |  |  |  |  | Corporation |
|  |  |  |  |  | (2013–2018) |
| **Christianna Wood** | Trustee | Since January 2019 | 126 | Gore Creek | The Merger Fund |
| 100 Independence |  |  |  | Capital, Ltd. | (2013–2021), |
| 610 Market Street |  |  |  | -Chief Executive Officer | The Merger Fund VL |
| Philadelphia, PA |  |  |  | and President (2009– | (2013–2021), |
| 19106-2354 |  |  |  | Present) | WCM Alternatives: Event- |
| 1959 |  |  |  |  | Driven Fund (2013–2021), |
|  |  |  |  |  | and WCM |
|  |  |  |  |  | Alternatives: Credit Event |
|  |  |  |  |  | Fund (2017–2021) |
|  |  |  |  |  | Grange Insurance |
|  |  |  |  |  | (2013–Present) |
|  |  |  |  |  | H&R Block Corporation |
|  |  |  |  |  | (2008–Present) |
| **Janet L. Yeomans** | Trustee | Since April 1999 | 126 | 3M Company | Okabena Company |
| 100 Independence |  |  |  | (1995-2012) | (2009–2017) |
| 610 Market Street |  |  |  | -Vice President and |  |
| Philadelphia, PA |  |  |  | Treasurer (2006–2012) |  |
| 19106-2354 |  |  |  |  |  |
| 1948 |  |  |  |  |  |
| **Officers** |  |  |  |  |  |
| **David F. Connor** | Senior Vice President, | Senior Vice President, | 126 | David F. Connor has | None<sup>5</sup> |
| 100 Independence | General Counsel, and | since May 2013; General |  | served in various |  |
| 610 Market Street | Secretary | Counsel since May |  | capacities at different |  |
| Philadelphia, PA |  | 2015; Secretary since |  | times at Macquarie |  |
| 19106-2354 |  | October 2005 |  | Asset Management. |  |
| 1963 |  |  |  |  |  |
| **Daniel V. Geatens** | Senior Vice President | Senior Vice President | 126 | Daniel V. Geatens has | None<sup>5</sup> |
| 100 Independence | and Treasurer | and Treasurer since |  | served in various |  |
| 610 Market Street |  | October 2007 |  | capacities at different |  |
| Philadelphia, PA |  |  |  | times at Macquarie |  |
| 19106-2354 |  |  |  | Asset Management. |  |
| 1972 |  |  |  |  |  |

---

[**Table of Contents**](#toc1)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <br>**Name,**<br>**Address,**<br>**and Birth Year** | <br>**Position(s)**<br>**Held with**<br>**the Trust** | <br>**Length of Time**<br>**Served<sup>1</sup>** | <br>**Number of**<br>**Funds in Fund**<br>**Complex Overseen**<br>**by Trustee** | <br>**Principal**<br>**Occupation(s)**<br>**During the**<br>**Past Five Years** | **Other**<br>**Directorships**<br>**Held by Trustee**<br>**During the**<br>**Past Five Years** |
| **Richard Salus** | Senior Vice President | Senior Vice President | 126 | Richard Salus has |  |
| 100 Independence | and Chief Financial | and Chief Financial |  | served in various |  |
| 610 Market Street | Officer | Officer since November |  | capacities at different |  |
| Philadelphia, PA |  | 2006 |  | times at Macquarie |  |
| 19106-2354 |  |  |  | Asset Management. |  |
| 1963 |  |  |  |  |  |

---

<sup>1</sup> "Length of Time Served" refers to the time since the Trustee or officer began serving one or more of the Trusts in the Delaware Funds complex. <sup>2</sup> Shawn K. Lytle is considered to be an "Interested Trustee" because he is an executive officer of the Portfolios' investment advisor.

<sup>3</sup> Macquarie Asset Management is the marketing name for certain companies comprising the asset management division of Macquarie Group, including the Portfolios' investment advisor, principal underwriter, and transfer agent.

<sup>4</sup> Includes time served on the Board of Ivy Funds prior to the date when Ivy Funds joined the Delaware Funds complex.

<sup>5</sup> David F. Connor and Daniel V. Geatens serve in similar capacities for the six portfolios of the Optimum Fund Trust, which have the same investment manager, principal underwriter, and transfer agent as the Funds. Mr. Geatens also serves as the Chief Financial Officer of the Optimum Fund Trust, and he is Chief Financial Officer and Treasurer for Macquarie Global Infrastructure Total Return Fund Inc., which has the same investment manager as the Funds.

The Statement of Additional Information for the Fund(s) includes additional information about the Trustees and Officers and is available, without charge, upon request by calling 800 523-1918.

[**Table of Contents**](#toc1)

Each Portfolio files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year on Form N-PORT. Each Portfolio's Form N-PORT, as well as a description of the policies and procedures that each Portfolio uses to determine how to vote proxies (if any) relating to portfolio securities, is available without charge (i) upon request, by calling 800 523-1918; and (ii) on the SEC's website at sec.gov. In addition, a description of the policies and procedures that each Portfolio uses to determine how to vote proxies (if any) relating to portfolio securities and the Schedule of Investments included in each Portfolio's most recent Form N-PORT are available without charge on the Portfolios' website at delawarefunds.com/vip/literature.

Information (if any) regarding how each Portfolio voted proxies relating to portfolio securities during the most recently disclosed 12-month period ended June 30 is available without charge (i) through the Portfolios' website at delawarefunds.com/proxy; and (ii) on the SEC's website at sec.gov.

(2709202) **ANN-VIP1-0223**

---

| | |
|:---|:---|
| ![](mimivip4167571-ncsrx1x2.jpg) | ![](mimivip4167571-ncsrx1x1.jpg) |

---

**Annual report**

**Ivy Variable Insurance Portfolios**

Delaware Ivy VIP Core Equity

Delaware Ivy VIP Corporate Bond

Delaware Ivy VIP Global Growth

Delaware Ivy VIP Limited-Term Bond

Delaware Ivy VIP Value

Delaware VIP Global Value Equity\*

Delaware VIP Real Estate Securities\*\*

December 31, 2022

\*Effective July 29, 2022, the name of Delaware Ivy VIP Global Equity Income changed to Delaware VIP Global Value Equity.

\*\*Effective July 29, 2022, the name of Delaware Ivy VIP Securian Real Estate Securities changed to Delaware VIP Real Estate Securities.

[**Table of Contents**](#toc2)

**Table of contents**

---

| | |
|:---|:---|
| **[Portfolio management reviews](#b001)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[1](#b001)** |
| **[Performance summaries](#b002)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[16](#b002)** |
| **[Disclosure of Portfolio expenses](#b003)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[30](#b003)** |
| **[Security type / sector / country allocations and top 10 equity holdings](#b004)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[32](#b004)** |
| **[Schedules of investments](#b005)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[39](#b005)** |
| **[Statements of assets and liabilities](#b006)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[63](#b006)** |
| **[Statements of operations](#b007)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[65](#b007)** |
| **[Statements of changes in net assets](#b008)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[67](#b008)** |
| **[Financial highlights](#b009)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[71](#b009)** |
| **[Notes to financial statements](#b010)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[78](#b010)** |
| **[Report of independent registered public accounting firm.](#b011)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[99](#b011)** |
| **[Other Portfolio information](#b012)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[100](#b012)** |
| **[Board of trustees / directors and officers addendum](#b013)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**[105](#b013)** |

---

Macquarie Asset Management (MAM) is the asset management division of Macquarie Group. MAM is a full-service asset manager offering a diverse range of products across public and private markets including fixed income, equities, multi-asset solutions, private credit, infrastructure, renewables, natural assets, real estate, and asset finance. The Public Investments business is a part of MAM and includes the following investment advisers: Macquarie Investment Management Business Trust (MIMBT), Macquarie Funds Management Hong Kong Limited, Macquarie Investment Management Austria Kapitalanlage AG, Macquarie Investment Management Global Limited, Macquarie Investment Management Europe Limited, and Macquarie Investment Management Europe S.A.

**Other than Macquarie Bank Limited ABN 46 008 583 542 ("Macquarie Bank"), any Macquarie Group entity noted in this document is not an authorized deposit-taking institution for the purposes of the Banking Act 1959 (Commonwealth of Australia). The obligations of these other Macquarie Group entities do not represent deposits or other liabilities of Macquarie Bank. Macquarie Bank does not guarantee or otherwise provide assurance in respect of the obligations of these other Macquarie Group entities. In addition, if this document relates to an investment, (a) the investor is subject to investment risk including possible delays in repayment and loss of income and principal invested and (b) none of Macquarie Bank or any other Macquarie Group entity guarantees any particular rate of return on or the performance of the investment, nor do they guarantee repayment of capital in respect of the investment.**

The Portfolios are governed by US laws and regulations.

Unless otherwise noted, views expressed herein are current as of December 31, 2022, and subject to change for events occurring after such date.

The Portfolios are not FDIC insured and are not guaranteed. It is possible to lose the principal amount invested.

Advisory services provided by Delaware Management Company, a series of MIMBT, a US registered investment advisor.

The Portfolios are distributed by **Delaware Distributors, L.P.** (DDLP), an affiliate of MIMBT and Macquarie Group Limited.

All third-party marks cited are the property of their respective owners.© 2023 Macquarie Management Holdings, Inc. <br>

[**Table of Contents**](#toc2)

Portfolio management reviews

Delaware Ivy VIP Core Equity

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide capital growth and appreciation.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Core Equity (the "Portfolio") declined, although it outperformed its benchmark, the S&P 500<sup>®</sup> Index. The Portfolio's Class II shares declined 17.33%. Returns reflect reinvestment of all distributions. During the same period, the benchmark fell 18.11%. For complete, annualized performance of Delaware Ivy VIP Core Equity, please see the table on page 16.

**Market review**

The year 2022 turned out to be a very challenging year for market participants. Contrary to many market declines over the past 40 years, this time, having a strong allocation to fixed income securities failed to cushion the blow of a broad equity sell-off. The reason, of course, was the emergence of a strong inflationary impulse that began in early 2021 and built through June 2022 when the US Consumer Price Index (CPI) crested at a 9% year-over-year change, its highest reading since 1981. Interest rates responded to the rapid rise in inflation, with the 10-year Treasury bond yield rising from approximately 1.50% at the start of the year to a high of over 4.20% by October as market participants required higher yields to account for higher longer-run inflation expectations. The US Federal Reserve acted aggressively to cool economic growth by changing policy with respect to the two tools available to the Fed – higher short-term interest rates and through quantitative tightening whereby the central bank reduces the pace of reinvestment of proceeds from maturing government securities. Fed actions were unprecedented, and frankly late, given the Fed's position throughout 2021 that inflation was "transitory" in nature and a function of supply disruption from COVID-19. In reality, unprecedented government stimulus (estimated at $5 trillion through the pandemic) in the hands of consumers and businesses did exactly what it was intended to do – to pull the country rapidly out of a situation where greater than 13% of Americans were without jobs. Concerted efforts by the Fed began in March 2022 with a 0.25-percentage-point increase to the federal funds rate followed by another 4.00 percentage points of additional raises throughout 2022.

Sharply higher interest rates, aggressive Fed actions, and less in the way of pent-up demand provided the impetus for the current US economic slowdown we are experiencing. Throughout the first three quarters of 2022, equity markets declined sharply as market participants discounted the inevitable slowdown in corporate profit growth and adjusted the value of future profits to the higher level of interest rates. Expensive growth stocks led the market decline, with the Russell 1000<sup>®</sup> Growth Index (representative of higher-growth equities) declining more than 29% through the year while value-oriented equities, as represented by the Russell 1000<sup>®</sup> Value Index, fell by only 8% over the same period. The S&P 500 Index (the Portfolio's benchmark), made up of both growth and value equities, fell by just over 18% for the year.

As the US equity market has contracted, valuations have moved to more attractive levels. The price paid on forward 12-month earnings on the S&P 500 Index began the year at 20 times earnings but contracted to a low of 15 times earnings by the end of September, a market low for 2022. Today, under the assumption that forward consensus estimates are correct, the S&P 500 Index is trading at just over 17 times earnings. We believe the greatest uncertainty ahead is the effect of a weaker economy on expected forward profits for the market. That said, we believe that the starting point of a 3.5% national unemployment rate, healthy wage growth (particularly at the low end of the job market), and signs of cooling inflation provide some reasons for optimism that the current downturn will be relatively mild.

**Within the Portfolio**

Sector allocation essentially drove all the positive relative performance, benefiting from the Portfolio's lower-than-market exposure to consumer discretionary and communication services stocks. As a group, these stocks more than doubled the overall market's decline for the year. The Portfolio's overexposure to financials, our largest overweight allocation, also was positive. The relative underweight allocation to energy equities was problematic, however. A combination of modest investments in new supply (following years of subpar returns on capital), post-pandemic demand growth, an unforeseen conflict in Eastern Europe, and low starting-point valuations drove energy to the pole position in terms of performance. Cash provided a modest benefit to portfolio performance during the fiscal year given the decline in index returns.

Individual stock selection overall had little effect on relative performance. Strong gains in consumer discretionary and communication services, where we avoided names like Tesla Inc., Meta Platforms Inc., Comcast Corp., and Charter Communications Inc., were offset by weaker selection decisions within financials and staples. Within financials, exposure to alternative investment managers and our lone investment in a traditional asset manager, **Artisan Partners Asset Management Inc.**, detracted from performance. The fourth-quarter decline in **Costco Wholesale Corp.** following a weaker monthly sales reading in November drove the negative selection within consumer staples.

The 12-month period was a difficult one for investors. In a market that declined nearly 20%, we had our share of investments that underperformed, including **Blackstone Inc.**, **KKR & Co. Inc.**, **Aptiv PLC**, **Amazon.com Inc.**, and **Alphabet Inc.** Yet we also had a group of <br>

[**Table of Contents**](#toc2)

Portfolio management reviews

Delaware Ivy VIP Core Equity

defensive performers that included **AutoZone Inc.**, **The Progressive Corp.**, **Aon PLC**, **Eli Lilly & Co.**, **Deere & Co.**, and **Linde PLC**. Throughout the year, we deliberately carried below-market risk (as measured by standard deviation and beta) during a time of unprecedented inflationary pressures and a Fed that raised short-term borrowing rates at the fastest pace since the early 1980s.

Real uncertainties continue to exist with respect to the outlook on inflation but a structurally tight US labor market and the emergence of resource-thirsty China from strict lockdowns may very well keep the Fed's 2% inflation target out of reach over the medium term. The Portfolio's overall risk remains roughly consistent with the broader market.

We added a position in **Zebra Technologies Corp.** to the Portfolio during the fourth quarter. Zebra Technologies manufactures devices and software that enable companies to track and manage inventories, whether that inventory is at an Amazon fulfillment center, hospital, retailer, or warehouse. Since the company has experienced component supply problems in 2022, the stock's valuation has compressed substantially and no longer embeds a pandemic premium. We believe Zebra Technologies has the potential to grow 5% to 7% over the long run, and we initiated the Portfolio's position as a result.

We also re-initiated the Portfolio's position in **Discover Financial Services**. We first invested in Discover in early 2020 after the stock corrected during the pandemic. We think the market has already priced a modest recession into the valuation of its shares and, in our view, the company's single-digit price-to-earnings (P/E) multiple doesn't fully capture its longer-run earnings potential.

From a sector standpoint, we remain overweight the financials, industrials, and materials sectors, though our weightings are based on company-specific opportunities. Within the financials sector, our heaviest overweight position, we have companies tied to alternative investments, capital markets recovery, insurance brokerage, exchanges (representing a view on market volatility), consumer finance, and property casualty insurance. This is an eclectic mix not tied to a single market factor. Within the industrials and materials sectors, we believe companies with reasonable valuations with exposure to decarbonization, reshoring/domestic capital investment, and commercial aerospace should allow shareholders to participate in more robust growth dynamics over the course of the next economic cycle. We remain more cautious through our underweight positions in the consumer discretionary, information technology, and communications services sectors though some valuations within these sectors have become more attractive and reflective of slowdowns in consumption and advertising. We also continue to hold a modest position in cash that affords us to take advantage of market volatility. <br>

[**Table of Contents**](#toc2)

Portfolio management reviews

Delaware Ivy VIP Corporate Bond

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide current income consistent with preservation of capital.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Corporate Bond (the "Portfolio") posted a negative return that underperformed its benchmark, the Bloomberg US Corporate Investment Grade Index, which also declined for the period. The Portfolio's Class II shares declined 15.86% (return reflects all distributions reinvested). During the same period, the benchmark declined 15.76%. For complete, annualized performance of Delaware Ivy VIP Corporate Bond, please see the table on page 18.

**Market review**

It quickly became apparent as the Portfolio's fiscal year began in January 2022 that inflation had shifted from being real but transitory to becoming severe and sticky, owing to a combination of labor shortages, low unemployment, high consumer demand, and supply chain shortages.

We foresaw, like many investors, that the US Federal Reserve would react by raising rates. What we did not anticipate was just how fast, steep, and tenacious those increases would be. Investors expected that rates would rise gradually. They were surprised then by the Fed's pace of hikes that began with a 0.25-percentage-point increase in mid-March followed by a 0.50-percentage-point hike in early May and increases of 0.75 percentage points at the next four meetings before ending the year with a 0.50-percentage-point hike in December. Though the Fed was initially constrained by the need to reduce its balance sheet, by the time it acted, a more aggressive approach seemed necessary.

The Russia-Ukraine war and China's economic lockdowns to prevent the spread of COVID-19 also surprised investors. Both caused severe disruptions of the global supply chain, putting significant pressure on inflation. The world learned an expensive lesson on just how important Ukraine is to the global supply of agricultural and industrial products. While less surprising, the disruption in the supply of Russian energy was also painful, particularly to European economies that have been reliant on cheap Russian natural gas. The problems in China were unexpected as the spread of the virus began to increase despite the onset of warmer weather. Rather than take a more moderate approach to managing the virus, China reacted with a broad swath of shutdowns that sharply curtailed industrial output.

All three events – the Fed's aggressive response to inflation, the Russia-Ukraine war, and China's zero-COVID policy – had a dramatic effect on bond markets during the Portfolio's fiscal year. Driven primarily by rates and inflation, 2022 was the worst annual performance on record and only the second time in history the Bloomberg US Corporate Investment Grade Index would post back-to-back annual losses – the other time was in 1979-1980. This was attributable mainly to duration, a measure of a portfolio's sensitivity to higher interest rates, since the longer the duration of a portfolio, the more sensitive it is to interest rates.

There was significant rate volatility throughout the year. When the Fed started to raise rates aggressively, investors began talking of an impending recession. (The federal funds rate was raised 4.25 percentage points in 2022.) As a result, spreads reacted negatively and began to widen. The 10-year Treasury yield rose from 1.51% on December 31, 2021 to 3.88% at year-end 2022, an increase of 237 basis points (or 2.37 percentage points), which sharply stung long-duration credits. While spreads in the investment grade market increased only about 38 basis points over the course of the year, the combination of rising rates and widening spreads was both unusual and painful to investors.

Looking at the relative performance of investment grade versus high yield securities, duration was the key differentiator. High yield performed much better than investment grade, with most of the damage in the investment grade market resulting from duration rather than from widening spreads. Because high yield tends to be a shorter-duration asset class, it held up better. For calendar year 2022, investment grade bonds, as measured by the Bloomberg US Corporate Investment Grade Index, declined 15.76%. High yield bonds, as measured by the Bloomberg US Corporate High-Yield Index, declined 11.19%, just three-quarters of the loss sustained by investment grade bonds.

Although 2022 was another strong year for issuance in the US investment grade corporate bond market, issuance was 20% lower than the previous year. It is noteworthy that 2021 marked the second highest amount of proceeds ever raised in the investment grade market. Some sectors, particularly banking, unexpectedly flooded the market with new issuance in 2022, as companies looked to obtain financing once the Fed began its torrid pace of aggressive rate hikes early in the year.

Even though 2022 was the worst year on record for total returns within the investment grade US corporate bond market, corporate profitability was never higher, with record-setting margins and healthy cash flows. From a fundamental standpoint, this allowed issuers in the US corporate <br>

[**Table of Contents**](#toc2)

Portfolio management reviews

Delaware Ivy VIP Corporate Bond

bond market to enter this weakening macroeconomic backdrop with strong balance sheets and liquidity. However, third-quarter results indicated noticeable slowdowns across many sectors while guidance and overall sentiment began to shift more negatively as we headed toward year-end and into 2023.

**Within the Portfolio**

Yield curve positioning was the main contributor to the Portfolio's relative performance during the fiscal year. The Portfolio's underweight to spread duration in the long end of the curve helped performance as higher interest rates drove the price of credits held in the benchmark sharply lower. Similarly, the Portfolio's slight overweight to the front end of the curve was beneficial to performance as these securities outperformed on a relative basis for the same reason; the shorter the duration, the less of an impact to performance from rates was experienced. The Portfolio benefited from a small allocation to out-of-benchmark investments in high yield securities, which generally outperformed their investment grade counterparts for the fiscal year by virtue of their lower-duration nature. Even though Delaware Ivy VIP Corporate Bond is allowed to invest up to 20% of its assets in high yield securities, it maintained a portfolio allocation that varied throughout the fiscal year.

We think most of the relative performance was attributable to rising rates and higher duration. Still, credit spreads widened meaningfully as well – a phenomenon that we acknowledge is rather rare when rates and spreads widen at the same time. Usually spreads increase in the face of a potential recession and consequently weigh on issuers' earnings. But this year, rates and spreads moved in the same direction, resulting in the corporate bond market's worst calendar year total return since its inception.

On a sector basis, banking detracted the most from the Portfolio's performance. Ironically, the credit quality in the banking industry has generally been pristine, much stronger today than it was during the recession of 2008-2009. The Portfolio underperformed due to a combination of security selection and an underweight allocation to the sector. In an effort to add yield, we invested in subordinated instruments while maintaining the Portfolio's underweight to the front end of the curve where yields were less attractive, under the assumption that fundamentals were strong, and we thought valuations were attractive relative to other sectors. As the year progressed, the impact of higher rates proved detrimental for such a strategy. Additionally, given the sector's shorter duration profile, it outperformed the broader Bloomberg US Corporate Investment Grade Index and, as a result, the Portfolio's underweight also partially detracted from performance. Banking credits that the Portfolio owned included **Credit Agricole SA** and **Bank of America Corp.**

The Portfolio also held bonds issued by companies in the electric utility sector. These were typically long duration and given the Portfolio's overweight positions to longer-dated issues, they detracted from performance. Portfolio holdings in this sector included regulated utility operators **Exelon Corp.** and **Entergy Corp.**

Among contributors to performance during the fiscal year, the Portfolio benefited from both security selection and an underweight to consumer non-cyclicals as the sector underperformed given its longer duration profile and the surge in rates over the period. The Portfolio's underweight to longer-dated issues, especially in the healthcare subsector, as well as its overweight to shorter maturities in subsectors such as food/beverage, given the lack of relative value in this defensive sector, added to performance. **Boston Scientific Corp.**, a medical device manufacturer, and **McCormick & Company Inc.**, a food and beverage company, were among the Portfolio's holdings in the sector.

In addition, the Portfolio's out-of-benchmark allocation to risk-free assets, including cash, Treasurys, and short-duration sectors, such as asset-backed securities (ABS) (auto loans), added to performance.

Once higher rates and wider spreads had done material damage to the asset class, we sought to increase the Portfolio's credit quality. With prices at historic lows, we began buying lower-priced bonds. The asset class experienced some of the lowest dollar prices on securities in the past 30 to 40 years. Consequently, we viewed the decision to buy bonds of high-quality issuers at historically low prices as an attractive opportunity.

At fiscal year end, the Portfolio was positioned with 98% of its assets in investment grade securities and the balance in high yield. Earlier in the fiscal year, the Portfolio had as much as 3.5% in high yield. We also reduced the Portfolio's BBB-rated allocation within investment grade, having moved up in quality within the asset class. <br>

[**Table of Contents**](#toc2)

During the fiscal year, Delaware Ivy VIP Corporate Bond used a small position in options as a way to add incremental performance gains. These options contracts also would have allowed the Portfolio to purchase underlying securities at a price lower than the current market value of the security. The position did not have a material impact on the Portfolio's performance during the fiscal year.

We believe credit fundamentals are likely to weaken over the next several quarters, with the highest risks in industries most exposed to consumer demand and interest rates. The ultimate impact on balance sheets will depend on the extent of earnings deceleration from profit margin erosion. We do not believe that the current spread level of the overall Bloomberg US Corporate Investment Grade Index – at +130 basis points at year end – reflects the risks surrounding current monetary and economic policies or the technical risk around supply issuance that we believe is looming for the beginning of 2023. For this reason, the Portfolio is carrying more cash than usual entering the new year, as we anticipate widening in secondary spreads from an active new-issue calendar and weak fourth-quarter earnings and guidance.

Along with global central banks ratcheting up rates, commercial and retail banks are also aggressively tightening lending conditions. In light of this, we think the next shoe to drop in the global economy could be a series of weaker profits around quarterly earnings announcements. Given our view that spreads should be wider than where they are now, we think spreads could remain range-bound (and not hit the +200-basis-point levels often associated with a full-blown recessionary environment).

Our thesis about spreads remaining range-bound, albeit at wider levels, is predicated on the fact that: (1) corporate fundamentals (broadly speaking) have never been stronger coming into this backdrop of softening demand and tighter lending/monetary conditions, (2) the level of all-in total yields should be supportive of investor inflows, and (3) investors should be mindful of the "Fed put" that could be reinitiated to restore market stability if spread levels were to surpass +200 basis points. Thus, we believe the latter two points could prompt buying and offer a potential snap-back from wider spread levels given the strength of corporate balance sheets. <br>

[**Table of Contents**](#toc2)

Portfolio management reviews

Delaware Ivy VIP Global Growth

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide growth of capital.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Global Growth (the "Portfolio") experienced a negative return but outperformed its benchmark, the MSCI ACWI (All Country World Index). The Portfolio's Class II shares declined 17.49%. Returns reflect reinvestment of all distributions. During the same period, the benchmark declined 18.36% (net) and 17.96% (gross). For complete, annualized performance of Delaware Ivy VIP Global Growth, please see the table on page 20.

**Market review**

The year 2022 may mark one of the greatest paradigm shifts for global markets and economies in recent history. A confluence of events, including fallout from pandemic spending and loose monetary policy, catalyzed what had been years in the making.

Major central bank policy shifts, inflation, changes to global supply chains, the end of cheap Russian energy for Europe, and labor shortages created broad-based asset price declines with few exceptions. Equities fell along with bond markets, which typically provide protection, as investors scrambled to face, what we believe will be, a new reality.

Years of lower interest rates and quantitative easing finally came to an end and manifested in the form of inflation. Perpetuating inflationary pressure, the war in Ukraine drove increases to energy and food prices, particularly in Europe. Responding to the invasion, Western nations implemented sanctions against Russia, effectively preventing Russia from supplying its natural gas, oil, wheat, and other commodities to most of the world. In addition, home prices and wage growth became concerning. Home affordability was historically low and labor shortages along with demographic shifts created a challenging economic scenario for central banks to navigate.

In response, the US Federal Reserve initiated a series of interest rate hikes. Other central banks quickly followed. The US increased rates 4.25 percentage points and the European Central Bank (ECB) increased rates 2.5 percentage points, abandoning negative rate policy. With higher rates, market valuations quickly declined. Extremely high multiples, afforded by longer-duration growth companies through the low-rate environment over the past decade, were hit particularly hard.

China maintained its zero-COVID policy throughout most of the year before opening up in December as the pressure from China's population and its weakening economy became too great. We believe that this should enable growth to resume in China and ease supply chain disruptions globally.

There were few places for investors to seek refuge during the fiscal year. From an equity sector perspective, energy was the only area of the market in positive territory. Years of underinvestment and supply shortages became a challenge for the world when Russian commodities were cut off. Investment in traditional energy became a focus with the acknowledgment that it will be many years before alternative energy sources replace fossil fuels to a significant degree.

**Within the Portfolio**

Stock selection in the communication services and consumer discretionary sectors contributed the most to relative performance while stock selection in the consumer staples and information technology sectors detracted from performance. At a country level, the US and Canada contributed the most while Germany was the biggest drag on relative performance.

On an individual stock basis, **ConocoPhillips,** a US-based integrated energy company, and **Canadian Natural Resources Ltd.,** a Canadian energy company primarily focused on exploration and production, were the largest contributors to performance. Both companies had significant growth resulting from higher energy prices. While we are valuation sensitive and trimmed energy positions as these stocks rallied, the Portfolio remains overweight the sector.

The largest detractors from performance were **Ambarella Inc.** and **HelloFresh SE**. Ambarella is a US-based semiconductor company with significant sales to the automobile industry. While its shares were up sharply in the fourth quarter in anticipation of a recovery in autos, the industry was hindered most of the year by supply chain disruptions. We continue to think that Ambarella is well positioned to benefit from the increasing use of electronics in motor vehicles.

HelloFresh is a German food-delivery service popular in the US and overseas. The company had benefited from the pandemic as more people opted for food delivery, but despite continued sales growth HelloFresh had to spend more on customer acquisition and marketing expenses. <br>

[**Table of Contents**](#toc2)

While we believe it may be able to convert new customers into future sales growth, we thought there are better opportunities in companies with similar growth profiles, particularly in the US, and we exited the Portfolio's position.

The Portfolio's use of foreign exchange (FX) currency positions had a limited effect during the fiscal year. Overall, derivatives were immaterial to the Portfolio's performance during the fiscal year. <br>

[**Table of Contents**](#toc2)

Portfolio management reviews

Delaware Ivy VIP Limited-Term Bond

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide current income consistent with preservation of capital.

For its fiscal year ended December 31, 2022, Delaware Ivy VIP Limited-Term Bond (the "Portfolio") posted a negative return that underperformed its benchmark, the Bloomberg 1-3 Year US Government/Credit Index, which also declined for the period. The Portfolio's Class II shares declined 4.20% (return reflects all distributions reinvested). During the same period, the benchmark declined 3.69%. For complete, annualized performance of Delaware Ivy VIP Limited-Term Bond, please see the table on page 22.

**Market review**

Russia's invasion of Ukraine in late February 2022 was notable not just for its human tragedy; it also marked the most substantial use of unconventional economic weapons in response to the conventional weapons of modern warfare. As such, the war in Ukraine had significant economic ramifications, not the least of which was global inflation that climbed to a multidecade high before the year ended.

The war created severe disruptions in the production of Ukrainian agricultural and other commodities. Combined with the economic sanctions imposed on Russia, significant disruptions to global supply chains resulted. Energy and food markets, already confronting shortages and soaring prices stemming from the COVID-19 pandemic, were pressured further.

Central banks around the world attempted to control inflation, which was fueled by supply shortages combined with resilient consumer demand. In particular, Europe felt the brunt of rising energy prices because of its heavy reliance on imports from Russia, complicating the mission of the European Central Bank.

Generally during periods of heightened geopolitical risk and increasing volatility, central banks slow or reverse the pace of interest rate hikes, but this past year was an exception, and inflation remained well above their target. The US Federal Reserve raised interest rates and stopped quantitative easing, abandoning the tools that it had previously used to stimulate the economy.

The abrupt rise in interest rates – the US federal funds rate increased from near zero to a range of 4.25% to 4.50% by year end – took a bite out of the interest-rate-sensitive sectors of the economy. Housing felt the burden of higher mortgage rates after enjoying significant appreciation during the pandemic.

Political unrest in China, especially that related to restrictions imposed to control the spread of COVID-19, also contributed to global economic problems. Throughout much of the year, China maintained its aggressive lockdowns of major cities. The zero-COVID policy contributed to ongoing supply chain disruptions and inflationary pressure. In December, China abruptly eased its restrictions, opening the door to a potential surge in demand. That could pose new challenges to central banks early in 2023 as they attempt to bring inflation down to acceptable levels.

The US dollar maintained strength for most of the year while the euro declined below parity with the dollar. The war in Ukraine and central banks' aggressive anti-inflationary monetary policies combined to cause idiosyncratic stressors to bubble to the surface. For example, an acute financial crisis in the UK related to pension plans led the Bank of England to intervene to stabilize the country's interest rates even though it had been raising rates to fight inflation.

Against this highly volatile backdrop, credit markets behaved reasonably well in 2022, albeit while sustaining broad losses due largely to the move higher in interest rates. However, higher yields were viewed as an opportunity for many fixed income investors and may have provided important technical support at a time when central banks across most of the developed world were raising short-term rates.

**Within the Portfolio**

Investors widely expected that the Fed would be active throughout most of the fiscal year. That expectation became reality at the end of March when the Fed began raising rates. Investors then shifted focus to just how much tightening the Fed would do.

In managing the Portfolio, we try to provide rather than take liquidity. Liquidity enables us to take advantage of periods of uncertainty. It provides us with the investment flexibility to take advantage of market opportunities as they arise.

We entered 2022 with an overweight to investment grade corporate credit, which detracted from performance. That was in large part because of our overweight to BBB-rated credit, which underperformed. We were attracted to the higher income provided by BBB-rated bonds. Yield opportunities in shorter-term securities moved materially higher. Meanwhile, we maintained the Portfolio's overweight to investment grade corporate credit. <br>

[**Table of Contents**](#toc2)

Some key drivers that weighed on performance within investment grade corporate credit included **Avolon Holdings Ltd.**, which leases commercial jet aircraft. Avolon had disappointing financial results and we exited that credit. However, we have maintained exposure to the industry, as we remain constructive on its economic fundamentals.

Exposure to **Royalty Pharma PLC**, an acquirer of biopharmaceutical royalties, also detracted from performance. It underperformed the benchmark in part because of the longer average maturity of its holdings. However, we do maintain exposure to Royalty Pharma as we see the credit as undervalued at this time.

The Portfolio also had a modest exposure to agency mortgage-backed securities (MBS), which detracted from performance based on the mortgage market's sensitivity to the uncertainties associated with rising interest rates. The rising interest rate environment added to volatility within the MBS market, but we believe that relative to investment grade corporate credit, MBS looks reasonably attractive, and we maintain exposure there.

Yield curve management also detracted from performance. We generally maintained greater interest rate sensitivity in the Portfolio than the overall benchmark.

Out-of-benchmark exposure to asset-backed securities (ABS) detracted as well but was diversified across multiple subsectors, including lease and equipment, floor planning, and high-quality auto segments.

Contributors to the Portfolio's relative performance included an underweight to government-related non-corporate issuers, as their performance generated negative excess returns. Conversely, the Portfolio's allocation to high yield bonds outperformed the benchmark return. That came from positive security selection, including exposure to senior secure bonds issued by lower-rated insurance broker **USI Inc.** We remain comfortable owning the bond as we see a favorable insurance-rate environment continuing into the new year.

The Portfolio also benefited from good security selection in emerging markets relative to the benchmark. This included exposure to higher-quality names within that space. One was a modest allocation to **Banco de Credito e Inversiones SA**, a Chilean banking company. With commodity prices rising throughout 2022, some exposure to **First Quantum Minerals Ltd.** benefited performance. We continue to own both emerging market securities.

**Key risks and opportunities**

Monetary policy in the US remains one of the largest uncertainties as we embark on a new year. Markets continue to price in a lower terminal rate (peak interest rate) than the Fed. That indicates that the Fed is likely to tighten more than investors expect. That divergence will be resolved one way or the other and will be determined largely by the trajectory of inflation, which remains well above the Fed's 2% target rate. The discrepancy in expectations between investors and the Fed suggests there will likely be more market volatility in the coming months.

We expect credit spreads to widen because of that uncertainty. We could also see a shallow recession in late 2023 or early 2024. However, if we are wrong, the risk most likely would be skewed to the downside – a potentially deeper or longer recession.

We are watching for signs that economic slowing could be occurring more quickly than expected. We believe this would increase the risk of a policy mistake by the Fed, further adding to volatility.

We believe that fixed income still offers attractive yields, which should provide a positive factor as investors look at break-even levels and attractiveness relative to other asset classes. Effectively, a yield of 5% or 6% now on a fixed income fund compared with 1% or 2% in January 2022 could provide a buffer if yield spreads materially widen. Now, you'd have to see interest rates move materially higher before that 6% yield disappears. Accordingly, this reduces the likelihood of negative returns in fixed income assets today compared with 2022.

The Portfolio used derivatives, including interest rate futures and high yield credit default swaps (CDX) to tactically gain access to the high yield asset class. Derivatives detracted less than 50 basis points (half a percentage point) from performance. <br>

[**Table of Contents**](#toc2)

Portfolio management reviews

Delaware Ivy VIP Value

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide capital appreciation.

The portfolio management team for Delaware Ivy VIP Value changed effective December 5, 2022. Please read the latest prospectus, including the supplement dated December 5, 2022, for more information concerning this event.

For the fiscal year ended December 31, 2022, Delaware Ivy VIP Value (the "Portfolio") experienced a negative return but outperformed its benchmark, the Russell 1000 Value Index. The Portfolio's Class II shares declined 4.90% (return reflects reinvestment of all dividends). During the same period, the benchmark declined 7.54%. For complete, annualized performance of Delaware Ivy VIP Value, please see the table on page 24.

**Market review**

On the heels of three consecutive quarterly losses, US stocks rallied in the fourth quarter of 2022. The broad market S&P 500<sup>®</sup> Index posted a total return of 7.6% even though it lost ground in December. Investors' embrace of stocks in October and November seemed to be driven in part by better-than-expected corporate earnings, moderating inflation data, and hopes that the US Federal Reserve might soon slow the pace of interest rate increases. In addition, a consensus view that the Fed would engineer a "soft landing" for the economy and that any recession in 2023 would be mild appeared to take root. Still, stocks were broadly lower for the year. The S&P 500 Index was down -18.1% in 2022. By comparison, the technology-heavy NASDAQ Composite Index fell -33.1%. (Source: FactSet Research Systems.)

The Fed implemented its sixth and seventh interest rate hikes of the year during the fourth quarter, lifting the federal funds rate to a range between 4.25% and 4.50%, its highest level since December 2007. The most recent move, a 0.50-percentage-point increase in mid-December, was a step down from the previous four hikes of 0.75 percentage points each. Following the November rate announcement, Fed Chair Jerome Powell said the pace of interest rate increases could slow down in the coming months. Nonetheless, the Fed said it "anticipates that ongoing increases in the target range will be appropriate in order to attain a stance of monetary policy that is sufficiently restrictive to return inflation to 2 percent over time."

Inflation readings continued to moderate incrementally as year end approached. According to the most recent data from the Bureau of Economic Analysis, the Personal Consumption Expenditures Price Index (PCE) rose 5.5% in November from a year earlier, down from a high of 7.0% in June. The Core Personal Consumption Expenditures Price Index (Core PCE), the Fed's preferred inflation gauge, which excludes food and energy prices, increased 4.7% in November year over year, down from highs of 5.4% in both February and March. The price of West Texas Intermediate (WTI) crude oil ended the year at $81 per barrel, up 7% for the period but down from highs of more than $120 in both March and June. Employment growth slowed for much of the year. Job gains averaged 375,000 per month in 2022 with the lowest monthly reading (223,000) coming in the last month of the year. The unemployment rate ended the year at 3.5%. (Sources: FactSet, US Bureau of Labor Statistics.)

**Within the Portfolio**

Healthcare, industrials, and energy were the three leading sectors that affected relative performance for the year. Stock selection was the performance driver for the healthcare and industrials sectors while stock selection and allocation effect were positive for the energy sector. The Portfolio's slight overweight to the energy sector added to performance. The three largest detractors from a sector perspective were financials, materials, and information technology. Stock selection was the primary driver for these three sector detractors. The Portfolio's average cash position of approximately 2.0% contributed slightly to relative performance. The leading contributors for the Portfolio for the year were **Marathon Petroleum Corp.**, **EOG Resources Inc.**, **McKesson Corp.**, **Northrop Grumman Corp.**, and **Vertex Pharmaceuticals Inc.** The leading detractors were **Seagate Technology Holdings PLC**, **Celanese Corp.**, **Chevron Corp.**, **Capital One Financial Corp.**, and **Liberty Global PLC**. Each of these positions was held in the Portfolio through the end of the fiscal year.

The Portfolio slightly outperformed its benchmark during the first quarter of 2022. The healthcare and industrials sectors each added to relative performance along with the consumer discretionary sector. The Portfolio's weakest-performing relative sectors were financials and information technology.

For the second quarter of 2022, the Portfolio experienced a negative return but outperformed its benchmark, with allocations to the industrials, materials, and energy sectors adding to relative performance. The Portfolio's strongest relative contributors were in the healthcare sector. The Portfolio's weakest relative sectors overall were healthcare and consumer staples. <br>

[**Table of Contents**](#toc2)

The Portfolio experienced a negative return, slightly outperforming its benchmark during the third quarter of its fiscal year. The healthcare, consumer discretionary, and energy sectors added to relative performance, while its leading relative contributor came from the energy sector. In fact, energy was the only sector to have an overall positive return in the market.

Although the Portfolio had a positive return in the last quarter of its fiscal year, it slightly underperformed its benchmark. Stock selection contributed modestly to relative returns while sector allocation modestly detracted. At the sector level, stock selection made notable contributions in the communication services, real estate, industrials, and utilities sectors. Negative stock selection results in the healthcare, consumer discretionary, financials, and materials sectors largely offset these, however. In terms of sector allocation, the Portfolio's underweight in communication services had a positive effect while an underweight in industrials had a negative effect. In addition, the Portfolio's average cash position of approximately 2.0% detracted from relative performance given the benchmark's strong, double-digit return at this time.

We believe corporate earnings growth in 2023 could disappoint relative to investors' expectations. As intended, the Fed's deliberate moves to slow the economy and bring inflation under control will likely weaken aggregate demand. Since the economic impact of Fed interest rate increases tends to work with a lag, there could be pressure on corporate earnings in 2023 and possibly into 2024. In this environment, we remain focused on mitigating downside exposure while staying attuned to investment opportunities that ongoing market volatility may create. <br>

[**Table of Contents**](#toc2)

Portfolio management reviews

Delaware VIP Global Value Equity<br> (formerly, Delaware Ivy VIP Global Equity Income)

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide total return through a combination of current income and capital appreciation.

For the fiscal year ended December 31, 2022, Delaware VIP Global Value Equity (the "Portfolio") declined, although it outperformed its benchmark, the MSCI World Index, which also declined. The Portfolio's Class II shares declined 11.32% (return reflects all distributions reinvested). During the same period, the benchmark declined 18.14% (net) and 17.73% (gross). For complete, annualized performance of Delaware VIP Global Value Equity, please see the table on page 26.

**Market review**

Central bank rhetoric started to change in late 2021. Nervousness then spread across markets as inflation, liquidity crunches, and higher interest rates, combined with geopolitical tensions and Russia's invasion of Ukraine in February 2022, raised investor concerns. Several times during 2022, however, investors breathed a sigh of relief when there appeared to be sufficient consensus expectation that the worst is over and that the US central bank would mutate from a hawk to a dove and would soon lower interest rates again.

The strongly rising inflation rate has resulted in large interest rate increases, particularly in the US, but also in Europe, with both beginning at a historically low level. Although the high inflation level means that higher returns on interest-bearing investments are mostly counterbalanced by price increases, today these investments offer an alternative to buying shares, especially for those who believe that inflation is a passing phenomenon. At the same time, interest rate increases (nominal) mean that price-to-earnings (P/E) multiples in the stock market have fallen. Until the end of 2021, there was a strong belief that interest rates would remain low, and this was reflected in the pricing of certain parts of the stock market, bringing back memories of the bursting of the tech bubble in 2000. But gravity always strikes, and 2022 brought a solid wake-up call for global investors.

**Within the Portfolio**

The portfolio management team invests with the mindset of long-term business owners. Our research is focused on how well we think a company can deploy its capital and redeploy retained earnings. Therefore, the Portfolio is built bottom-up (stock-by-stock) by selecting company stocks based on quantitative insights and qualitative assessments.

We use a multivariate risk model to identify what we view as potential contributors to and detractors from the Portfolio's performance against its benchmark. For the year ended December 31, 2022, active country and region weights had an overall positive impact on performance. Despite a negative allocation effect from Germany and Sweden, on balance the allocation to countries and regions contributed to the Portfolio's return. Denmark, the UK, the US, and overweight positioning in France all had a positive impact. However, the opposite was true for the overweight positioning in Germany, with negative attribution from all four German companies. Germany was the single largest detractor from performance for the fiscal year. There were negative selection effects in the UK, Spain, and Germany, whereas Switzerland, Sweden, the Netherlands, France, Denmark, and the US showed positive selection effects.

At the sector level, having no exposure to financials and energy caused the largest drags on performance, with the rest of the Portfolio's sector allocations yielding a positive result. On balance, the stock selection within the Portfolio also contributed to relative performance. The only negative result was within industrials. The most positive results came from the consumer staples, consumer discretionary, communication services, and information technology sectors. The Portfolio's relative outperformance came from both allocation and stock selection.

Three of the largest individual contributors to active performance were **Novo Nordisk A/S**, **Merck & Co. Inc.**, and **Lamb Weston Holdings Inc.**

Danish world-leading diabetes care company Novo Nordisk posted strong performance and raised its guidance three times in 2022, growing both sales and earnings by double-digit rates, including some tailwind effect from a strong US dollar. The company's key franchises, diabetes (GLP-1) and obesity care, have strong growth rates and offer what we view as a very attractive combination of large and expanding addressable markets. Novo Nordisk is a leader in both. Obesity care is a big opportunity: globally, more than 760 million people are obese, but today very few are treated. With highly efficient drugs, obesity is becoming a therapeutic area that could play an important role in preventing other severe health implications related to obesity, such as risk of heart disease, stroke, and high blood pressure.

Merck & Co., the US-based global healthcare company with a strong franchise in cancer medicine, has surprised the stock market positively several times this year. The latest news from the company also shows successful trials treating pulmonary hypertension, a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. <br>

[**Table of Contents**](#toc2)

US-based Lamb Weston Holdings, with a strong global footprint within the frozen potato business, is one of three companies that dominate the production and distribution of french fries worldwide. The industry has faced several challenges lately: the impact of the COVID-19 pandemic on demand and the loss of supply caused by a lower-than-normal-quality potato harvest while operating under a cloud of logistic constraints and higher transportation costs. Recently, Lamb Weston beat expectations by raising prices, improving manufacturing productivity, and selling more french fries than it had the last year. The most recent quarterly reporting shows activity levels well above pre-pandemic levels, and strong pricing activity with limited loss of volume.

Conversely, three of the largest detractors from performance during the year were **adidas AG, Fresenius Medical Care AG & Co. KGaA**, and **Amadeus IT Group SA**.

German worldwide sports apparel company adidas's shares were hurt by a challenging trading environment in China, caused by COVID-19 restrictions and industrywide supply chain disruptions. In 2022, the company lowered its outlook a few times. China is a major driver behind the company's growth challenges, as China is a profitable market for adidas as well as an important sourcing market. In effect, China's zero-COVID policy significantly affected adidas and overshadowed its positive attributes as a company. Despite the current challenges, we are still confident that adidas will remain a very strong brand and has the ability to restore profitability relatively fast. We think the underlying profit margin potential is substantially higher for adidas than the current level, driven by operating leverage, higher direct-to-consumer content, and cost reductions after the sale of Reebok. In our opinion, once adidas reduces inventory at mark-down prices it can then sustain higher margins.

We believe the world's leading kidney dialysis company Fresenius Medical Care was in a perfect storm together with its competitors. COVID-19 has reduced the patient population, slowed clinic traffic, and increased patient costs. The industry works on a contract basis, and the final payors and prices for dialysis services have yet to be adjusted higher to reflect inflation. In essence, Fresenius Medical Care must absorb these higher costs until prices are renegotiated. In the management ranks there have been quite a few changes and more than we like. There have been different strategic views within the firm's executive ranks. Due to these challenges, the stock price has suffered a lot, and we believe that the valuation is now attractive, provided that increased input costs can be passed on.

Amadeus IT Group is the global leader in ticketing software for the airline industry, with a dominant market share. The profits of Amadeus IT Group are driven by the number of tickets sold, not the ticket price, which makes Amadeus a more stable business than its competitors. Global air travel is now recovering after COVID-19. Amadeus IT Group has confirmed an accelerating travel recovery approaching pre-pandemic levels. The US market is already above that level while Asia Pacific and Europe are still below, but in rapid recovery. With the business model of Amadeus IT Group having minimal additional costs associated with issuing more tickets, we expect to see earnings improve rapidly as travel volumes recover.

The Portfolio used foreign currency exchange contracts to facilitate the purchase and sale of equities traded on international exchanges. The effect of these contracts on performance was immaterial. <br>

[**Table of Contents**](#toc2)

Portfolio management reviews

Delaware VIP Real Estate Securities<br> (formerly, Delaware Ivy VIP Securian Real Estate Securities)

December 31, 2022 (Unaudited)

The investment objective of the Portfolio is to seek to provide total return through capital appreciation and current income.

On May 19, 2022, the Board of Trustees of the Ivy Variable Insurance Portfolios ("Board") approved the termination of the Sub-Advisory Agreement between Delaware Management Company (the "Manager" or "DMC"), and Securian Asset Management, Inc. as it relates to the Fund. In addition, the Board approved the transition of day-to-day portfolio management responsibilities to the Macquarie Global Listed Real Estate team ("GLRE team"), whose members provide services via DMC and DMC's affiliated sub-advisors. Accordingly, the Board approved the appointment of the following affiliated sub-advisors of the Manager, Macquarie Investment Management Global Limited ("MIMGL"), Macquarie Investment Management Europe Limited ("MIMEL"), and Macquarie Funds Management Hong Kong Limited ("MFMHKL"). In addition, the Board approved the appointment of MFMHKL and MIMGL to provide trading and quantitative support, to the Fund. Further, the Board approved a name change of the Fund, with all such changes to take effect on or about July 29, 2022 (the "Effective Date").

For the fiscal year ended December 31, 2022, Delaware VIP Real Estate Securities (the "Portfolio") experienced a negative return, slightly underperforming its benchmark, the FTSE Nareit Equity REITs Index. The Portfolio's Class II shares declined 24.87%. Returns reflect reinvestment of all distributions. During the same period, the benchmark declined 24.37%. For complete, annualized performance of Delaware VIP Real Estate Securities, please see the table on page 28.

**Market review**

Investors clearly worried as inflation took hold in 2022. With its inflation-fighting credentials in question, the US Federal Reserve began a tightening cycle at the same time the economy began slowing and worries about a recession took hold.

Markets were highly volatile, stocks entered a bear market, and fixed income did not provide a haven as all major asset classes ended in the red for the first half of 2022. Following a big move in rates in the first quarter, Treasury yields continued their rise across the curve, with the 10-year reaching nearly 3.5% in mid-June. They have since pulled back to nearly 2.5% as new signs of peaking inflation, the potential for a Fed pivot, and the prospect of recessionary backdrop have emerged. Spreads widened and, along with higher rates, yields rose to a more attractive level than had been seen in some time. The S&P 500<sup>®</sup> Index's total return ended the second quarter of 2022 in bear market territory. The growth-oriented NASDAQ Composite Index's total return ended the first half of the year down nearly 20%.

Real estate stocks struggled under the same forces as the broader equities market, with the added dread that stagflation may be on the horizon. Amid a constant barrage of higher inflation readings, aggressive Fed action, and plummeting consumer confidence, the sector delivered poor results, with the FTSE Nareit Equity REITs Index declining 24.37% for 2022. Returns were almost uniformly negative, leaving few places to hide as investors mulled the end-result of higher rates and lower growth expectations. Not even those property sectors featuring strong inflation-resistant characteristics materially outperformed the index.

**Within the Portfolio**

Office companies struggled once again under the continued pressure of return to office not materializing as many had expected. Office utilization rates remain stubbornly low and the prospect of significant layoffs in the technology sector has not helped sentiment. The sector, on average, declined 21.79% with few favorable outliers. The Portfolio's underweighting to office contributed positively toward index-relative results but was constrained by an overweighting to **Alexandria Real Estate Equities Inc.** Alexandria is the industry's bellwether owner of biotech and life science real estate. Despite favorable business fundamentals and attractive growth prospects, Alexandria had disappointing returns during the period.

Amazon's recent announcement that it would scale back its warehouse expansion spooked the industrial sector. Warehouse owners have enjoyed record occupancy and record rental rate escalations; and by all indication business fundamentals remain very robust. The Portfolio has been underweight industrial owners this year, as we viewed valuations as unsustainably high. This underweight position boosted index-relative performance.

The Portfolio was overweight single-family rental and apartment owners. Rent growth remains strong for single-family rental real estate investment trusts (REITs) as more potential homeowners are being priced out of the housing market. Given the significant spike in mortgage rates and a still solid job market, we think this sector's positive momentum will continue as demand overwhelms current supply deliveries in most markets. In the multifamily sector, the Portfolio benefited from the privatization of American Campus Communities Inc. The Portfolio was overweight this company as we saw the potential for sizable cash flow growth driven by college students returning to campus post-COVID. <br>

[**Table of Contents**](#toc2)

Net lease REITs were among the sector's better performers, returning 0.94% on average. Investors looked past this sector's long-term, low-growth lease structures and instead focused on the "defensive" nature of the companies' cash flows. Like the bond market, one does not typically favor long-duration cash flows in a period of sharply rising interest rates. In addition, the companies are heavily reliant on highly valued stock prices to raise equity to fund acquisitions. The Portfolio was underweight this sector, and that proved to be a significant detractor from index-relative performance. However, the performance detraction was offset to a degree by an overweighting to **Agree Realty Corp.** Agree Realty raised equity earlier this year at attractive stock pricing and has put the proceeds to use in an accretive manner.

While the healthcare sector continues to improve post-COVID with occupancies and rental rates improving, headwinds from pressure on payrolls due to labor shortages, and general elevation of overall property expenses persist. These are primarily issues for skilled-nursing facilities and senior housing, whose occupancy recoveries were choppy due first to the COVID-19 Delta variant and later to the Omicron variant. Medical office buildings appear further along in recovery as elective surgeries have resumed, and growing demand from private investors raised market valuations, providing a tailwind.

The Portfolio's use of foreign exchange (FX) currency positions had a limited effect during the fiscal year. Overall, derivatives were immaterial to the Portfolio's performance during the fiscal year.

As we head into 2023, we believe we will still see strength in earnings profiles across our favored sectors, particularly those that have been able to pass on inflation-linked leases to tenants and have tenants that are able to withstand or even benefit from a more challenging economic climate. On a company-specific level, we continued to favor quality companies with strong balance sheets that not only are able to endure rising rates, but can even potentially capitalize on any dislocation in markets that may present itself. Given the extent of the disparity in pricing between listed and direct real estate, we expect to continue seeing movement in valuation across the sector and believe this can present opportunities for investors.

Across the asset class, we continue to monitor the spread between cap rates and interest costs as a guide to where asset values will settle. We tend to favor sectors where rental income is growing at a rate that can sustain cap rate expansion, ensuring relative stability of asset values. We expect to continue to see movements in asset values across all sectors and remain keenly abreast of transactional evidence in the direct market, which will point to the disparity between listed and direct real estate valuations narrowing once again.

Real estate fundamentals remain our primary focus in portfolio construction and security underwriting, as always. Although we consider in economic factors, we allocate our risk budget to stock and sector selection in line with long-term fundamentals and structural trends as opposed to investing for particular macroeconomic events. We will continue to navigate a challenging economic environment of inflationary and recessionary pressures and are enthused by the potential for a return to an environment that favors stock selection. <br>

[**Table of Contents**](#toc2)

Performance summaries (Unaudited)

Delaware Ivy VIP Core Equity

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on July 16, 1991) | -17.33% | +9.01% | +10.15% | +11.44% |
| S&P 500<sup>®</sup> Index | -18.11% | +7.66% | +9.42% | +12.56% |

---

Returns reflect the reinvestment of all distributions. Please see page 17 for a description of the index.

As described in the Portfolio's most recent prospectus, the net expense ratio for Class II shares of the Portfolio was 0.95%, while total operating expenses for Class II shares were 0.99%. The management fee was 0.70%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratios may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratios in the prospectus include acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus. Investments in variable products involve risk.

Risk is increased in a concentrated portfolio since it holds a limited number of securities with each investment having a greater effect on the overall performance.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc2)

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167571-ncsrx19x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167571-ncsrx19x2.jpg) | S&P 500 Index | $10000 | $32654 |
| ![](mimivip4167571-ncsrx19x3.jpg) | Delaware Ivy VIP Core Equity — Class II shares | $10000 | $29536 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Core Equity Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the S&P 500 Index for the period from December 31, 2012 through December 31, 2022.

The S&P 500 Index measures the performance of 500 mostly large-cap stocks weighted by market value, and is often used to represent performance of the US stock market.

The US Consumer Price Index, mentioned on page 1, is a measure of inflation that is calculated by the US Department of Labor, representing changes in prices of all goods and services purchased for consumption by urban households.

The Russell 1000 Growth Index, mentioned on page 1, measures the performance of the large-cap growth segment of the US equity universe. It includes those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values

The Russell 1000 Value Index, mentioned on page 1, measures the performance of the large-cap value segment of the US equity universe. It includes those Russell 1000 companies with lower price-to-book ratios and lower forecasted growth values.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc2)

Performance summaries (Unaudited)

Delaware Ivy VIP Corporate Bond

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on July 13, 1987) | -15.86% | -2.54% | +0.37% | +1.21% |
| Bloomberg US Corporate Investment Grade Index | -15.76% | -2.88% | +0.45% | +1.96% |

---

Returns reflect the reinvestment of all distributions. Please see page 19 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 0.76%. The management fee was 0.47%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

High yielding, non-investment-grade bonds (junk bonds) involve higher risk than investment grade bonds. The high yield secondary market is particularly susceptible to liquidity problems when institutional investors, such as mutual funds and certain other financial institutions, temporarily stop buying bonds for regulatory, financial, or other reasons. In addition, a less liquid secondary market makes it more difficult to obtain precise valuations of the high yield securities.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue. <br>

[**Table of Contents**](#toc2)

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167571-ncsrx21x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167571-ncsrx19x2.jpg) | Bloomberg US Corporate Investment Grade Index | $10000 | $12139 |
| ![](mimivip4167571-ncsrx19x3.jpg) | Delaware Ivy VIP Corporate Bond — Class II shares | $10000 | $11284 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Corporate Bond Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the Bloomberg US Corporate Investment Grade Index for the period from December 31, 2012 through December 31, 2022.

The Bloomberg US Corporate Investment Grade Index is composed of US dollar-denominated, investment grade corporate bonds that are US Securities and Exchange Commission (SEC)-registered or 144A with registration rights, and issued by industrial, utility, and financial companies. All bonds in the index have at least one year to maturity.

The Bloomberg US Corporate High-Yield Index, mentioned on page 3, is composed of US dollar-denominated, non-investment-grade corporate bonds for which the middle rating among Moody's Investors Service, Inc., Fitch, Inc., and Standard & Poor's is Ba1/BB+/BB+ or below.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc2)

Performance summaries (Unaudited)

Delaware Ivy VIP Global Growth

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on May 3, 1994) | -17.49% | +5.45% | +6.72% | +7.60% |
| MSCI ACWI Index (net) | -18.36% | +4.00% | +5.23% | +7.98% |
| MSCI ACWI Index (gross) | -17.96% | +4.49% | +5.75% | +8.54% |

---

Returns reflect the reinvestment of all distributions. Please see page 21 for a description of the index.

As described in the Portfolio's most recent prospectus, the net expense ratio for Class II shares of the Portfolio was 1.13%, while total operating expenses for Class II shares were 1.18%. The management fee was 0.85%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratios may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratios in the prospectus include acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus. Investments in variable products involve risk.

Risk is increased in a concentrated portfolio since it holds a limited number of securities with each investment having a greater effect on the overall performance.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc2)

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167571-ncsrx23x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167571-ncsrx23x2.jpg) | MSCI ACWI Index (gross) | $10000 | $22686 |
| ![](mimivip4167571-ncsrx19x2.jpg) | MSCI ACWI Index (net) | $10000 | $21545 |
| ![](mimivip4167571-ncsrx19x3.jpg) | Delaware Ivy VIP Global Growth — Class II shares | $10000 | $20798 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Global Growth Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the MSCI ACWI Index for the period from December 31, 2012 through December 31, 2022.

The MSCI ACWI (All Country World Index) represents large- and mid-cap stocks across developed and emerging markets worldwide. The index covers approximately 85% of the global investable equity opportunity set. Index "net" return approximates the minimum possible dividend reinvestment, after deduction of withholding tax at the highest possible rate. Index "gross" return approximates the maximum possible dividend reinvestment.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc2)

Performance summaries (Unaudited)

Delaware Ivy VIP Limited-Term Bond

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on August 23, 2010) | -4.20% | -0.24% | +0.84% | +0.88% |
| Bloomberg 1-3 Year US Government/Credit Index | -3.69% | -0.32% | +0.92% | +0.88% |

---

Returns reflect the reinvestment of all distributions. Please see page 23 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 0.79%. The management fee was 0.50%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

High yielding, non-investment-grade bonds (junk bonds) involve higher risk than investment grade bonds. The high yield secondary market is particularly susceptible to liquidity problems when institutional investors, such as mutual funds and certain other financial institutions, temporarily stop buying bonds for regulatory, financial, or other reasons. In addition, a less liquid secondary market makes it more difficult to obtain precise valuations of the high yield securities.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue. <br>

[**Table of Contents**](#toc2)

If and when the Portfolio invests in forward foreign currency contracts or use other investments to hedge against currency risks, the Portfolio will be subject to special risks, including counterparty risk.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167571-ncsrx25x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167571-ncsrx19x3.jpg) | Delaware Ivy VIP Limited-Term Bond — Class II shares | $10000 | $10920 |
| ![](mimivip4167571-ncsrx19x2.jpg) | Bloomberg 1-3 Year US Government/Credit Index | $10000 | $10916 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Limited-Term Bond Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the Bloomberg 1-3 Year US Government/Credit Index for the period from December 31, 2012 through December 31, 2022.

The Bloomberg 1-3 Year US Government/Credit Index is a market value–weighted index of government fixed-rate debt securities and investment grade US and foreign fixed-rate debt securities with average maturities of one to three years.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc2)

Performance summaries (Unaudited)

Delaware Ivy VIP Value

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on May 1, 2001) | -4.90% | +8.36% | +8.31% | +10.40% |
| Russell 1000 Value Index | -7.54% | +5.96% | +6.67% | +10.29% |

---

Returns reflect the reinvestment of all distributions. Please see page 25 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.00%. The management fee was 0.70%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Risk is increased in a concentrated portfolio since it holds a limited number of securities with each investment having a greater effect on the overall performance.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc2)

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167571-ncsrx27x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167571-ncsrx19x3.jpg) | Delaware Ivy VIP Value — Class II shares | $10000 | $26891 |
| ![](mimivip4167571-ncsrx19x2.jpg) | Russell 1000 Value Index | $10000 | $26632 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Value Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the Russell 1000 Value Index for the period from December 31, 2012 through December 31, 2022.

The Russell 1000 Value Index measures the performance of the large-cap value segment of the US equity universe. It includes those Russell 1000 companies with lower price-to-book ratios and lower forecasted growth values.

The S&P 500 Index, mentioned on page 10, measures the performance of 500 mostly large-cap stocks weighted by market value and is often used to represent performance of the US stock market.

The NASDAQ Composite Index, mentioned on page 10, is a broad-based, market capitalization weighted index that measures all Nasdaq US-and international-based common type stocks listed on The NASDAQ Stock Market and includes more than 2,500 securities.

The Personal Consumption Expenditures Price Index (PCE), mentioned on page 10, is a measure of inflation that is calculated by the Bureau of Economic Analysis, representing changes in consumer spending on goods and services. It accounts for about two-thirds of domestic final spending. The "core" PCE excludes food and energy prices.

Frank Russell Company is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc2)

Performance summaries (Unaudited)

Delaware VIP Global Value Equity

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on December 30, 2003) | -11.32% | +2.28% | +3.08% | +7.21% |
| MSCI World Index (net) | -18.14% | +4.94% | +6.14% | +8.85% |
| MSCI World Index (gross) | -17.73% | +5.45% | +6.69% | +9.44% |

---

Returns reflect the reinvestment of all distributions. Please see page 27 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.01%. The management fee was 0.70%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile. <br>

[**Table of Contents**](#toc2)

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167571-ncsrx29x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167571-ncsrx23x2.jpg) | MSCI World Index (gross) | $10000 | $24640 |
| ![](mimivip4167571-ncsrx19x2.jpg) | MSCI World Index (net) | $10000 | $23357 |
| ![](mimivip4167571-ncsrx19x3.jpg) | Delaware VIP Global Value Equity — Class II shares | $10000 | $20058 |

---

The graph shows a $10,000 investment in Delaware VIP Global Value Equity Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the MSCI World Index for the period from December 31, 2012 through December 31, 2022.

The MSCI World Index represents large- and mid-cap stocks across 23 developed market countries: Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland, the United Kingdom, and the United States. The index covers approximately 85% of the free float- adjusted market capitalization in each country. Index "net" return approximates the minimum possible dividend reinvestment, after deduction of withholding tax at the highest possible rate. Index "gross" return approximates the maximum possible dividend reinvestment.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc2)

Performance summaries (Unaudited)

Delaware VIP Real Estate Securities

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on May 27, 2004) | -24.87% | +1.50% | +4.20% | +6.41% |
| FTSE Nareit Equity REITs Index | -24.37% | -0.11% | +3.68% | +6.53% |

---

Returns reflect the reinvestment of all distributions. Please see page 29 for a description of the index.

As described in the Portfolio's most recent prospectus, the net expense ratio for Class II shares of the Portfolio was 1.21%, while total operating expenses for Class II shares were 1.30%. The management fee was 0.90%, and the annual distribution and service (12b-1) fee was 0.25% of average daily net assets. The expense ratios may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratios in the prospectus include acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratios.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

REIT investments are subject to many of the risks associated with direct real estate ownership, including changes in economic conditions, credit risk, and interest rate fluctuations.

Investing in the real estate industry includes risks such as declines in real estate value, lack of availability of mortgage funds, overbuilding, extended vacancies, increases in property taxes, changes in zoning laws, costs from cleanup of environmental problems, uninsured damages, variations in rents, and changes in interest rates.

Fixed income securities and bond funds can lose value, and investors can lose principal as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

High yielding, non-investment-grade bonds (junk bonds) involve higher risk than investment grade bonds.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc2)

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimivip4167571-ncsrx31x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimivip4167571-ncsrx19x2.jpg) | FTSE Nareit Equity REITs Index | $10000 | $18821 |
| ![](mimivip4167571-ncsrx19x3.jpg) | Delaware VIP Real Estate Securities — Class II shares | $10000 | $18622 |

---

The graph shows a $10,000 investment in Delaware VIP Real Estate Securities Class II shares for the period from December 31, 2012 through December 31, 2022.

The graph also shows a $10,000 investment in the FTSE Nareit Equity REITs Index for the period from December 31, 2012 through December 31, 2022.

The FTSE Nareit Equity REITs Index contains all tax-qualified real estate investment trusts (REITs) traded on US exchanges, excluding timber and infrastructure REITs, with more than 50% of total assets in qualifying real estate assets other than mortgages secured by real property that also meet minimum size and liquidity criteria.

The NASDAQ Composite Index, mentioned on page 14, is a broad-based, market capitalization weighted index that measures all Nasdaq US-and international-based common type stocks listed on The NASDAQ Stock Market and includes more than 2,500 securities.

The S&P 500 Index, mentioned on page 14, measures the performance of 500 mostly large-cap stocks weighted by market value and is often used to represent performance of the US stock market.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc2)

Disclosure of Portfolio expenses

For the six-month period from July 1, 2022 to December 31, 2022 (Unaudited)

As a shareholder of the Portfolio, you incur ongoing costs, which may include management fees; distribution and service (12b-1) fees; and other Portfolio expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Portfolio and to compare these costs with the ongoing costs of investing in other mutual funds.

The examples are based on an investment of $1,000 invested at the beginning of the period and held for the entire six-month period from July 1, 2022 to December 31, 2022.

**Actual expenses**

The first section of the tables shown, "Actual Portfolio return," provides information about actual account values and actual expenses. You may use the information in this section of the table, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first section under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period.

**Hypothetical example for comparison purposes**

The second section of the tables shown, "Hypothetical 5% return," provides information about hypothetical account values and hypothetical expenses based on a Portfolio's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Portfolio's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in each Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the tables are meant to highlight your ongoing costs only. As a shareholder of the Portfolio, you do not incur any transaction costs, such as sales charges (loads), redemption fees or exchange fees, but shareholders of other funds may incur such costs. Also, the fees related to the variable annuity investment or the deferred sales charge that could apply have not been included. Therefore, the second section of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. The Portfolios' expenses shown in the tables reflect fee waivers in effect and assume reinvestment of all dividends and distributions.

**Delaware Ivy VIP Core Equity**

**Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1037.20 | 0.95% | $4.88 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1020.42 | 0.95% | $4.84 |

---

**Delaware Ivy VIP Corporate Bond**

**Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $982.10 | 0.82% | $4.10 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1021.07 | 0.82% | $4.18 |

---

**Delaware Ivy VIP Global Growth**

**Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1057.30 | 1.13% | $5.86 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1019.51 | 1.13% | $5.75 |

---

[**Table of Contents**](#toc2)

**Delaware Ivy VIP Limited-Term Bond**

**Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $996.30 | 0.83% | $4.18 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1021.02 | 0.83% | $4.23 |

---

**Delaware Ivy VIP Value**

**Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1063.50 | 1.01% | $5.25 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1020.11 | 1.01% | $5.14 |

---

**Delaware VIP Global Value Equity**

**Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1039.90 | 1.11% | $5.71 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1019.61 | 1.11% | $5.65 |

---

**Delaware VIP Real Estate Securities**

**Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $938.70 | 1.21% | $5.91 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1019.11 | 1.21% | $6.16 |

---

\*"Expenses Paid During Period" are equal to the relevant Portfolio's annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period).

<sup>†</sup>Because actual returns reflect only the most recent six-month period, the returns shown may differ significantly from fiscal year returns.

In addition to the Portfolios' expenses reflected above and on the previous page, each Portfolio also indirectly bears its portion of the fees and expenses of any investment companies (Underlying Funds) in which it invests, including exchange-traded funds. The tables above and on the previous page do not reflect the expenses of any applicable Underlying Funds. <br>

[**Table of Contents**](#toc2)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Core Equity

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Common Stocks** | **96.72%** |
| Communication Services | 4.90% |
| Consumer Discretionary | 6.35% |
| Consumer Staples | 4.18% |
| Energy | 3.81% |
| Financials | 17.95% |
| Healthcare | 15.33% |
| Industrials | 12.73% |
| Information Technology | 23.36% |
| Materials | 4.78% |
| Utilities | 3.33% |
| **Short-Term Investments** | **3.41%** |
| **Total Value of Securities** | **100.13%** |
| **Liabilities Net of Receivables and Other Assets** | **(0.13** **%)** |
| **Total Net Assets** | **100.00%** |

---

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Microsoft | 7.62% |
| UnitedHealth Group | 5.68% |
| NextEra Energy | 3.33% |
| United Rentals | 3.33% |
| Alphabet Class A | 3.26% |
| Progressive | 3.00% |
| Apple | 2.86% |
| Linde | 2.85% |
| Microchip Technology | 2.63% |
| TE Connectivity | 2.62% |

---

[**Table of Contents**](#toc2)

Security type / sector allocations

Delaware Ivy VIP Corporate Bond

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Agency Collateralized Mortgage Obligations** | **0.00%** |
| **Convertible Bonds** | **0.24%** |
| **Corporate Bonds** | **91.07%** |
| Banking | 22.63% |
| Basic Industry | 1.20% |
| Brokerage | 2.29% |
| Capital Goods | 6.19% |
| Communications | 8.29% |
| Consumer Cyclical | 6.00% |
| Consumer Non-Cyclical | 7.23% |
| Electric | 7.08% |
| Energy | 4.95% |
| Finance Companies | 2.76% |
| Industrials | 0.08% |
| Insurance | 4.32% |
| Natural Gas | 1.44% |
| Real Estate Investment Trusts | 1.82% |
| Technology | 12.84% |
| Transportation | 1.33% |
| Utilities | 0.62% |
| **Municipal Bonds** | **0.86%** |
| **Non-Agency Asset-Backed Securities** | **1.19%** |
| **Sovereign Bonds** | **0.49%** |
| **US Treasury Obligation** | **0.41%** |
| **Short-Term Investments** | **4.95%** |
| **Securities Lending Collateral** | **0.12%** |
| **Total Value of Securities** | **99.33%** |
| **Obligation to Return Securities Lending Collateral** | **(0.12** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **0.79%** |
| **Total Net Assets** | **100.00%** |

---

[**Table of Contents**](#toc2)

Security type / sector and country allocations

Delaware Ivy VIP Global Growth

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / country | Percentage<br> of net assets |
| **Common Stocks by Country** | **99.18%** |
| Canada | 3.17% |
| China | 5.75% |
| Denmark | 2.07% |
| France | 7.88% |
| Germany | 5.11% |
| Hong Kong | 1.47% |
| India | 5.39% |
| Israel | 1.83% |
| Italy | 1.25% |
| Japan | 4.00% |
| Netherlands | 0.80% |
| Taiwan | 1.64% |
| United Kingdom | 3.57% |
| United States | 55.25% |
| **Short-Term Investments** | **0.72%** |
| **Securities Lending Collateral** | **0.88%** |
| **Total Value of Securities** | **100.78%** |
| **Obligation to Return Securities Lending Collateral** | **(0.88** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **0.10%** |
| **Total Net Assets** | **100.00%** |

---

---

| | |
|:---|:---|
| Common stocks by sector | Percentage<br> of net assets |
| Communication Services | 7.16% |
| Consumer Discretionary | 12.98% |
| Consumer Staples | 7.34% |
| Energy | 6.76% |
| Financials | 12.93% |
| Healthcare | 16.76% |
| Industrials | 11.59% |
| Information Technology | 20.44% |
| Materials | 0.87% |
| Utilities | 2.35% |
| **Total** | **99.18%** |

---

[**Table of Contents**](#toc2)

Security type / sector allocations

Delaware Ivy VIP Limited-Term Bond

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Agency Collateralized Mortgage Obligations** | **0.16%** |
| **Agency Commercial Mortgage-Backed Securities** | **11.04%** |
| **Agency Mortgage-Backed Security** | **0.07%** |
| **Collateralized Debt Obligations** | **7.06%** |
| **Corporate Bonds** | **55.15%** |
| Banking | 15.00% |
| Basic Industry | 1.09% |
| Brokerage | 0.16% |
| Capital Goods | 4.73% |
| Communications | 4.96% |
| Consumer Cyclical | 4.55% |
| Consumer Non-Cyclical | 4.48% |
| Electric | 2.93% |
| Energy | 4.12% |
| Finance Companies | 0.96% |
| Insurance | 4.17% |
| Natural Gas | 0.35% |
| Real Estate Investment Trusts | 2.72% |
| Technology | 4.73% |
| Transportation | 0.20% |
| **Non-Agency Asset-Backed Securities** | **4.55%** |
| **Supranational Banks** | **0.16%** |
| **US Treasury Obligations** | **20.59%** |
| **Securities Lending Collateral** | **0.81%** |
| **Total Value of Securities** | **99.59%** |
| **Obligation to Return Securities Lending Collateral** | **(0.81** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **1.22%** |
| **Total Net Assets** | **100.00%** |

---

[**Table of Contents**](#toc2)

Security type / sector allocations and top 10 equity holdings

Delaware Ivy VIP Value

As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Common Stocks** | **96.71%** |
| Communication Services | 7.50% |
| Consumer Discretionary | 7.43% |
| Consumer Staples | 6.82% |
| Energy | 8.19% |
| Financials | 18.77% |
| Healthcare | 16.07% |
| Industrials | 9.96% |
| Information Technology | 7.79% |
| Materials | 4.76% |
| Real Estate | 4.23% |
| Utilities | 5.19% |
| **Short-Term Investments** | **3.28%** |
| **Total Value of Securities Before Options Written** | **99.99%** |
| **Options Written** | **(0.01** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **0.02%** |
| **Total Net Assets** | **100.00%** |

---

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Exxon Mobil | 5.23% |
| Philip Morris International | 3.64% |
| Bank of America | 3.53% |
| AGNC Investment | 3.28% |
| Walmart | 3.18% |
| Raytheon Technologies | 3.06% |
| Allstate | 3.05% |
| Elevance Health | 3.02% |
| CVS Health | 2.99% |
| Marathon Petroleum | 2.97% |

---

[**Table of Contents**](#toc2)

Security type / sector and country allocations

Delaware VIP Global Value Equity As of December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / country | Percentage<br> of net assets |
| **Common Stocks by Country** | **98.73%** |
| Denmark | 2.71% |
| France | 11.62% |
| Germany | 9.63% |
| Japan | 4.93% |
| Netherlands | 4.94% |
| Spain | 3.79% |
| Sweden | 7.79% |
| Switzerland | 2.75% |
| United Kingdom | 13.89% |
| United States | 36.68% |
| **Exchange-Traded Fund** | **0.87%** |
| **Short-Term Investments** | **0.19%** |
| **Securities Lending Collateral** | **4.32%** |
| **Total Value of Securities** | **104.11%** |
| **Obligation to Return Securities Lending Collateral** | **(4.32** **%)** |
| **Receivables and Other Assets Net of Liabilities** | **0.21%** |
| **Total Net Assets** | **100.00%** |

---

---

| | |
|:---|:---|
| Common stocks by sector | Percentage<br> of net assets |
| Communication Services | 2.13% |
| Consumer Discretionary | 10.25% |
| Consumer Staples\* | 41.83% |
| Healthcare | 20.78% |
| Industrials | 10.47% |
| Information Technology | 9.59% |
| Materials | 3.68% |
| **Total** | **98.73%** |

---

\*To monitor compliance with the Portfolio's concentration guidelines as described in the Portfolio's Prospectus and Statement of Additional Information, the Consumer Staples sector (as disclosed herein for financial reporting purposes) is subdivided into a variety of "industries" (in accordance with the requirements of the Investment Company Act of 1940, as amended). The Consumer Staples sector consisted of Beverages, Cosmetics/Personal Care, Food, and Household Products/Wares. As of December 31, 2022, such amounts, as a percentage of total net assets were 5.11%, 9.49%, 19.79%, and 7.44%, respectively. The percentage in any such single industry will comply with the Portfolio's concentration policy even if the percentage in the Consumer Staples sector for financial reporting purposes may exceed 25%. <br>

[**Table of Contents**](#toc2)

Security type / sector allocations and top 10 equity holdings

Delaware VIP Real Estate Securities As of

December 31, 2022 (Unaudited)

Sector designations may be different from the sector designations presented in other Portfolio materials. The sector designations may represent the investment manager's internal sector classifications, which may result in the sector designations for one fund being different from another fund's sector designations.

---

| | |
|:---|:---|
| Security type / sector | Percentage<br> of net assets |
| **Common Stocks** | **96.87%** |
| Real Estate Operating Companies/Developer | 0.34% |
| REIT Diversified | 26.06% |
| REIT Healthcare | 8.82% |
| REIT Hotel | 2.76% |
| REIT Industrial | 14.47% |
| REIT Multifamily | 19.88% |
| REIT Office | 6.49% |
| REIT Retail | 18.05% |
| **Short-Term Investments** | **2.67%** |
| **Total Value of Securities** | **99.54%** |
| **Receivables and Other Assets Net of Liabilities** | **0.46%** |
| **Total Net Assets** | **100.00%** |

---

Holdings are for informational purposes only and are subject to change at any time. They are not a recommendation to buy, sell, or hold any security.

---

| | |
|:---|:---|
| Top 10 equity holdings | Percentage<br> of net assets |
| Prologis | 8.98% |
| Public Storage | 6.22% |
| Welltower | 5.58% |
| Equinix | 5.17% |
| VICI Properties | 5.03% |
| Realty Income | 4.91% |
| Alexandria Real Estate Equities | 4.73% |
| Digital Realty Trust | 4.52% |
| Equity Residential | 3.76% |
| Extra Space Storage | 3.47% |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Core Equity

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 96.72%** | | |
| &nbsp;&nbsp;Communication Services — 4.90% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Alphabet Class A † | 220557 | $19459744 |
| &nbsp;&nbsp;&nbsp;&nbsp;Take-Two Interactive Software † | 94103 | 9798946 |
|  |  | 29258690 |
| &nbsp;&nbsp;Consumer Discretionary — 6.35% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amazon.com † | 126439 | 10620876 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aptiv † | 135705 | 12638207 |
| &nbsp;&nbsp;&nbsp;&nbsp;AutoZone † | 5938 | 14644177 |
|  |  | 37903260 |
| &nbsp;&nbsp;Consumer Staples — 4.18% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Costco Wholesale | 22137 | 10105540 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sysco | 194622 | 14878852 |
|  |  | 24984392 |
| &nbsp;&nbsp;Energy — 3.81% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ConocoPhillips | 127378 | 15030604 |
| &nbsp;&nbsp;&nbsp;&nbsp;Schlumberger | 144347 | 7716791 |
|  |  | 22747395 |
| &nbsp;&nbsp;Financials — 17.95% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Express | 50162 | 7411436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aon Class A | 27108 | 8136195 |
| &nbsp;&nbsp;&nbsp;&nbsp;Artisan Partners Asset <br> Management Class A \* | 213116 | 6329545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of America | 204720 | 6780326 |
| &nbsp;&nbsp;&nbsp;&nbsp;Blackstone | 115528 | 8571022 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charles Schwab | 154119 | 12831948 |
| &nbsp;&nbsp;&nbsp;&nbsp;CME Group | 36094 | 6069567 |
| &nbsp;&nbsp;&nbsp;&nbsp;Discover Financial Services | 24196 | 2367095 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intercontinental Exchange | 54037 | 5543656 |
| &nbsp;&nbsp;&nbsp;&nbsp;KKR & Co. | 232502 | 10792743 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley | 169888 | 14443878 |
| &nbsp;&nbsp;&nbsp;&nbsp;Progressive | 138113 | 17914637 |
|  |  | 107192048 |
| &nbsp;&nbsp;Healthcare — 15.33% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Danaher | 55664 | 14774339 |
| &nbsp;&nbsp;&nbsp;&nbsp;Eli Lilly & Co. | 20092 | 7350457 |
| &nbsp;&nbsp;&nbsp;&nbsp;HCA Healthcare | 64767 | 15541489 |
| &nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group | 63975 | 33918266 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals † | 26691 | 7707827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zoetis | 83816 | 12283235 |
|  |  | 91575613 |
| &nbsp;&nbsp;Industrials — 12.73% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Airbus ADR | 490503 | 14548319 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deere & Co. | 30809 | 13209667 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equifax | 60661 | 11790072 |
| &nbsp;&nbsp;&nbsp;&nbsp;Raytheon Technologies | 78971 | 7969753 |
| &nbsp;&nbsp;&nbsp;&nbsp;Union Pacific | 41902 | 8676647 |
| &nbsp;&nbsp;&nbsp;&nbsp;United Rentals † | 55900 | 19867978 |
|  |  | 76062436 |
| &nbsp;&nbsp;Information Technology — 23.36% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple | 131276 | 17056691 |
| &nbsp;&nbsp;&nbsp;&nbsp;Applied Materials | 108243 | 10540703 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intuit | 25723 | 10011906 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mastercard Class A | 29507 | 10260469 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microchip Technology | 223743 | 15717946 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microsoft | 189872 | 45535103 |
| &nbsp;&nbsp;&nbsp;&nbsp;TE Connectivity | 136209 | 15636793 |
| &nbsp;&nbsp;&nbsp;&nbsp;VeriSign † | 62120 | 12761933 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zebra Technologies Class A † | 7747 | 1986408 |
|  |  | 139507952 |
| &nbsp;&nbsp;Materials — 4.78% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Linde | 52281 | 17053017 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sherwin-Williams | 48474 | 11504334 |
|  |  | 28557351 |
| &nbsp;&nbsp;Utilities — 3.33% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;NextEra Energy | 237979 | 19895044 |
|  |  | 19895044 |
| &nbsp;&nbsp;**Total Common Stocks** <br> (cost $501,729,211) |  | **577684181** |
| &nbsp;&nbsp;**Short-Term Investments — 3.41%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 3.41% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day<br> effective yield 4.03%) | 5091117 | 5091117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio – <br> Class I (seven-day effective <br> yield 4.06%) | 5091117 | 5091117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 5091116 | 5091116 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield<br> 4.11%) | 5091117 | 5091117 |
| &nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $20,364,467) |  | **20364467** |
| &nbsp;&nbsp;**Total Value of Securities—100.13%** <br> (cost $522,093,678) |  | $**598,048,648■** |

---

---

| | |
|:---|:---|
| <sup>†</sup> | Non-income producing security. |
| <sup>\*</sup> | Fully or partially on loan. |
| ■ | Includes $3,782,830 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $3,903,410. |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Core Equity

**Summary of abbreviations:**

ADR – American Depositary Receipt

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Delaware Ivy VIP Corporate Bond

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Principal <br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Agency Collateralized Mortgage Obligations — 0.00%** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;GNMA |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2005-23 IO 1.00% 6/17/45 • | 3717 | $0 |
| &nbsp;&nbsp;**Total Agency Collateralized Mortgage <br> Obligations** <br> (cost $11) |  | 0 |
| &nbsp;&nbsp;**Convertible Bonds — 0.24%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Liberty Broadband 144A 2.75% <br> exercise price $857.56, <br> maturity date 9/30/50 # | 25000 | 24411 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liberty Broadband 144A 1.25% <br> exercise price $900.01, <br> maturity date 9/30/50 # | 689000 | 668330 |
| &nbsp;&nbsp;&nbsp;&nbsp;Spirit Airlines 1.00% exercise <br> price $49.07, maturity date <br> 5/15/26 | 567000 | 459270 |
| &nbsp;&nbsp;**Total Convertible Bonds**<br> (cost $1,188,890) |  | **1152011** |
| &nbsp;&nbsp;**Corporate Bonds — 91.07%** |  |  |
| &nbsp;&nbsp;Banking — 22.63% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of America |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.898% 7/23/31 µ | 1325000 | 1019833 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.299% 7/21/32 µ | 3225000 | 2491349 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.482% 9/21/36 µ | 1820000 | 1341444 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.496% 2/13/31 µ | 4000000 | 3259735 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.592% 4/29/31 µ | 3675000 | 3001124 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.974% 2/7/30 µ | 2500000 | 2275589 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.204% 11/10/28 µ | 1215000 | 1256636 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of New York Mellon |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.596% 7/26/30 µ | 1555000 | 1504566 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.70% 9/20/25 µ, ψ | 1750000 | 1684603 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.802% 10/25/28 µ | 301000 | 311790 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.834% 10/25/33 µ | 1065000 | 1107414 |
| &nbsp;&nbsp;&nbsp;&nbsp;Barclays |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.325% 11/2/26 µ | 1695000 | 1757533 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.00% 3/15/29 µ, ψ | 1715000 | 1607813 |
| &nbsp;&nbsp;&nbsp;&nbsp;Citigroup |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.572% 6/3/31 µ | 4872000 | 3951175 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 5/15/23 | 2260000 | 2249425 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.52% 10/27/28 µ | 1750000 | 1599583 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.412% 3/31/31 µ | 2735000 | 2517900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.61% 9/29/26 µ | 2495000 | 2508297 |
| &nbsp;&nbsp;&nbsp;&nbsp;Citizens Bank 6.064% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10/24/25 µ | 2565000 | 2595757 |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Suisse 1.00% 5/5/23 | 1535000 | 1499606 |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Suisse Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 3.091% 5/14/32 #, µ | 1680000 | 1164143 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.442% 8/11/28 #, µ | 1865000 | 1701185 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 9.016% 11/15/33 #, \*, µ | 625000 | 641656 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fifth Third Bancorp |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.337% 4/25/33 µ | 689000 | 631476 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.361% 10/27/28 µ | 471000 | 485443 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fifth Third Bank 5.852% <br> 10/27/25 µ | 1100000 | 1111897 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.542% 9/10/27 µ | 920000 | 794775 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.383% 7/21/32 µ | 3325000 | 2587925 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 11/16/26 | 2000000 | 1877545 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.80% 3/15/30 | 2550000 | 2298270 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.25% 10/21/25 | 3250000 | 3175271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Huntington National Bank |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.552% 5/17/28 µ | 573000 | 553771 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.65% 1/10/30 | 1140000 | 1151405 |
| &nbsp;&nbsp;&nbsp;&nbsp;JPMorgan Chase & Co. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.522% 4/22/31 µ | 10202000 | 8370696 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.22% 3/1/25 µ | 6000000 | 5834334 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.875% 9/10/24 | 1424000 | 1394846 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.882% 7/24/38 µ | 845000 | 704452 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 4/1/25 \*, µ, ψ | 1650000 | 1416938 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.851% 7/25/28 µ | 1900000 | 1855208 |
| &nbsp;&nbsp;&nbsp;&nbsp;KeyBank 5.85% 11/15/27 | 695000 | 718608 |
| &nbsp;&nbsp;&nbsp;&nbsp;KeyCorp 4.789% 6/1/33 µ | 843000 | 798421 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.794% 2/13/32 µ | 3525000 | 2657308 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.875% 1/27/26 | 3850000 | 3731306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.138% 10/16/26 µ | 1135000 | 1160445 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.296% 10/18/28 µ | 945000 | 977203 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.342% 10/18/33 µ | 2115000 | 2222872 |
| &nbsp;&nbsp;&nbsp;&nbsp;PNC Financial Services Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.671% 10/28/25 µ | 1645000 | 1663685 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.20% 9/15/27 µ, ψ | 1440000 | 1410840 |
| &nbsp;&nbsp;&nbsp;&nbsp;State Street |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.203% 2/7/28 µ | 1710000 | 1538533 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.164% 8/4/33 µ | 2425000 | 2247290 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.751% 11/4/26 µ | 375000 | 384274 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.82% 11/4/28 µ | 260000 | 268966 |
| &nbsp;&nbsp;&nbsp;&nbsp;SVB Financial Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 5/15/26 µ, ψ | 1360000 | 899327 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.57% 4/29/33 \*, µ | 1775000 | 1575324 |
| &nbsp;&nbsp;&nbsp;&nbsp;Truist Financial |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.95% 9/1/25 µ, ψ | 1765000 | 1691929 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.123% 10/28/33 \*, µ | 996000 | 1051133 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Bancorp |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.491% 11/3/36 µ | 2300000 | 1755749 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.548% 7/22/28 µ | 500000 | 489132 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.727% 10/21/26 µ | 1165000 | 1187833 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo & Co. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.879% 10/30/30 µ | 4080000 | 3474289 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.54% 8/15/26 µ | 655000 | 642525 |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Corporate Bond

---

| | | |
|:---|:---|:---|
|  | **Principal <br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** |  |  |
| &nbsp;&nbsp;Banking (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo & Co. <br> 4.808% 7/25/28 µ | 1380000 | $1350114 |
|  |  | 111189514 |
| &nbsp;&nbsp;Basic Industry — 1.20% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Celanese US Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.05% 3/15/25 | 2025000 | 2018833 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.165% 7/15/27 | 580000 | 573000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Graphic Packaging International <br> 144A 0.821% 4/15/24 # | 2480000 | 2322248 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mosaic 4.25% 11/15/23 | 400000 | 396801 |
| &nbsp;&nbsp;&nbsp;&nbsp;Newmont 2.60% 7/15/32 \* | 735000 | 587132 |
|  |  | 5898014 |
| &nbsp;&nbsp;Brokerage — 2.29% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Blackstone Holdings Finance |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 1.60% 3/30/31 # | 950000 | 692605 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 2.00% 1/30/32 # | 3760000 | 2771338 |
| &nbsp;&nbsp;&nbsp;&nbsp;Jefferies Financial Group 2.625% <br> 10/15/31 | 2130000 | 1629950 |
| &nbsp;&nbsp;&nbsp;&nbsp;KKR Group Finance VIII 144A <br> 3.50% 8/25/50 # | 4000000 | 2691008 |
| &nbsp;&nbsp;&nbsp;&nbsp;National Securities Clearing <br> 144A 1.50% 4/23/25 # | 3745000 | 3474661 |
|  |  | 11259562 |
| &nbsp;&nbsp;Capital Goods — 6.19% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ashtead Capital 144A 2.45% <br> 8/12/31 # | 605000 | 468481 |
| &nbsp;&nbsp;&nbsp;&nbsp;Boeing 3.75% 2/1/50 | 3375000 | 2331296 |
| &nbsp;&nbsp;&nbsp;&nbsp;Eaton 4.15% 3/15/33 | 4020000 | 3749780 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lennox International 1.35% <br> 8/1/25 | 2750000 | 2491665 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lockheed Martin 5.70% <br> 11/15/54 | 2390000 | 2519807 |
| &nbsp;&nbsp;&nbsp;&nbsp;Martin Marietta Materials 0.65% <br> 7/15/23 | 1165000 | 1135206 |
| &nbsp;&nbsp;&nbsp;&nbsp;Masco 1.50% 2/15/28 | 2225000 | 1845751 |
| &nbsp;&nbsp;&nbsp;&nbsp;Parker-Hannifin 4.25% 9/15/27 | 250000 | 242974 |
| &nbsp;&nbsp;&nbsp;&nbsp;Raytheon Technologies 2.25% <br> 7/1/30 | 4750000 | 3963761 |
| &nbsp;&nbsp;&nbsp;&nbsp;Republic Services |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.30% 3/1/30 | 3457000 | 2901016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.375% 3/15/33 \* | 2520000 | 2017053 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vontier 2.40% 4/1/28 | 2973000 | 2386414 |
| &nbsp;&nbsp;&nbsp;&nbsp;Waste Connections |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 5/1/29 | 3049000 | 2796010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.20% 1/15/33 | 1685000 | 1570175 |
|  |  | 30419389 |
| &nbsp;&nbsp;Communications — 8.29% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AMC Networks 4.25% 2/15/29 | 1130000 | 705761 |
| &nbsp;&nbsp;&nbsp;&nbsp;AT&T |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 6/1/41 | 2000000 | 1499270 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 9/15/53 | 2485000 | 1688396 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.55% 9/15/55 | 942000 | 632779 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.65% 6/1/51 | 3900000 | 2764442 |
| &nbsp;&nbsp;&nbsp;&nbsp;CCO Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.75% 2/1/32 #, \* | 1070000 | 869637 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 6.375% 9/1/29 # | 470000 | 442583 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charter Communications <br> Operating |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.85% 4/1/61 | 2565000 | 1492527 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.90% 6/1/52 | 1115000 | 704159 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 2/1/24 | 2306000 | 2279754 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comcast |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.887% 11/1/51 | 1446000 | 935213 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.25% 11/1/39 | 3875000 | 3034161 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.90% 3/1/38 | 500000 | 432862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Crown Castle |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.05% 7/15/26 | 2500000 | 2163060 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.15% 7/15/23 | 175000 | 173079 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.20% 9/1/24 | 2250000 | 2174101 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 3/1/27 | 2000000 | 1910799 |
| &nbsp;&nbsp;&nbsp;&nbsp;Directv Financing 144A 5.875% <br> 8/15/27 # | 1050000 | 941388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Discovery Communications <br> 4.00% 9/15/55 | 1710000 | 1033498 |
| &nbsp;&nbsp;&nbsp;&nbsp;Omnicom Group 3.65% 11/1/24 | 1260000 | 1236219 |
| &nbsp;&nbsp;&nbsp;&nbsp;Paramount Global 4.75% <br> 5/15/25 | 1776000 | 1750043 |
| &nbsp;&nbsp;&nbsp;&nbsp;T-Mobile USA |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.30% 2/15/51 | 425000 | 285488 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 4/15/25 \* | 5555000 | 5347086 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.375% 4/15/40 | 575000 | 493069 |
| &nbsp;&nbsp;&nbsp;&nbsp;Verizon Communications |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.65% 11/20/40 | 1250000 | 848341 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.875% 11/20/50 | 1540000 | 972135 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 8/10/33 | 3575000 | 3356617 |
| &nbsp;&nbsp;&nbsp;&nbsp;VZ Secured Financing 144A <br> 5.00% 1/15/32 # | 705000 | 574174 |
|  |  | 40740641 |
| &nbsp;&nbsp;Consumer Cyclical — 6.00% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ADT Security 144A 4.875% <br> 7/15/32 # | 969000 | 825204 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amazon.com |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.50% 6/3/50 | 4610000 | 2926349 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.875% 8/22/37 | 5677000 | 5052089 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aptiv 3.10% 12/1/51 | 2058000 | 1224200 |
| &nbsp;&nbsp;&nbsp;&nbsp;DR Horton 2.60% 10/15/25 | 3080000 | 2870703 |
| &nbsp;&nbsp;&nbsp;&nbsp;General Motors Financial <br> 1.25% 1/8/26 | 2125000 | 1873481 |

---

[**Table of Contents**](#toc2)

---

| | | |
|:---|:---|:---|
|  | **Principal <br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** | | |
| &nbsp;&nbsp;Consumer Cyclical (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;General Motors Financial <br> 2.40% 10/15/28 | 1420000 | $1180049 |
| &nbsp;&nbsp;&nbsp;&nbsp;Home Depot |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.30% 4/15/40 | 4500000 | 3601545 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.20% 4/1/43 | 1670000 | 1469177 |
| &nbsp;&nbsp;&nbsp;&nbsp;Levi Strauss & Co. 144A 3.50% <br> 3/1/31 #, \* | 225000 | 178873 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mercedes-Benz Finance North <br> America 144A 5.25% <br> 11/29/27 # | 1060000 | 1067212 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nissan Motor 144A 3.522% <br> 9/17/25 # | 850000 | 790396 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nordstrom 2.30% 4/8/24 | 450000 | 422467 |
| &nbsp;&nbsp;&nbsp;&nbsp;NVR 3.00% 5/15/30 | 4022000 | 3385477 |
| &nbsp;&nbsp;&nbsp;&nbsp;Toll Brothers Finance 4.375% <br> 4/15/23 | 470000 | 467993 |
| &nbsp;&nbsp;&nbsp;&nbsp;VICI Properties 4.95% 2/15/30 | 2230000 | 2125786 |
|  |  | 29461001 |
| &nbsp;&nbsp;Consumer Non-Cyclical — 7.23% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amgen 2.80% 8/15/41 | 1750000 | 1219170 |
| &nbsp;&nbsp;&nbsp;&nbsp;Boston Scientific 1.90% 6/1/25 | 2000000 | 1868612 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bunge Limited Finance 2.75% <br> 5/14/31 | 1725000 | 1420021 |
| &nbsp;&nbsp;&nbsp;&nbsp;Clorox 3.90% 5/15/28 | 4676000 | 4465714 |
| &nbsp;&nbsp;&nbsp;&nbsp;Coca-Cola Europacific Partners <br> 144A 0.80% 5/3/24 # | 2270000 | 2133131 |
| &nbsp;&nbsp;&nbsp;&nbsp;CVS Health |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.70% 8/21/40 | 1417000 | 984259 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.78% 3/25/38 | 1105000 | 1010990 |
| &nbsp;&nbsp;&nbsp;&nbsp;GE HealthCare Technologies <br> 144A 5.60% 11/15/25 # | 980000 | 987087 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.65% 11/15/27 # | 980000 | 993185 |
| &nbsp;&nbsp;&nbsp;&nbsp;JBS USA LUX 144A 3.00% <br> 2/2/29 # | 1560000 | 1294511 |
| &nbsp;&nbsp;&nbsp;&nbsp;McCormick & Co. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.90% 2/15/26 | 3572000 | 3132803 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 9/1/23 | 771000 | 763056 |
| &nbsp;&nbsp;&nbsp;&nbsp;Merck & Co. 2.75% 12/10/51 | 2000000 | 1346060 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nestle Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 3.90% 9/24/38 # | 2480000 | 2216178 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.00% 9/24/48 # | 4020000 | 3405107 |
| &nbsp;&nbsp;&nbsp;&nbsp;Royalty Pharma |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.20% 9/2/25 | 3840000 | 3440247 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.30% 9/2/40 | 325000 | 226707 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.35% 9/2/51 | 958000 | 594327 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.55% 9/2/50 | 236000 | 151745 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tenet Healthcare 144A 4.25% <br> 6/1/29 # | 491000 | 426259 |
| &nbsp;&nbsp;&nbsp;&nbsp;Universal Health Services 1.65% <br> 9/1/26 | 2535000 | 2176056 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Foods 144A 4.75% 2/15/29 # | 775000 | 689052 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zoetis 5.40% 11/14/25 | 565000 | 576904 |
|  |  | 35521181 |
| &nbsp;&nbsp;Electric — 7.08% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ameren Illinois 5.90% 12/1/52 | 485000 | 529862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Appalachian Power 4.50% <br> 8/1/32 | 1005000 | 940033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Baltimore Gas and Electric <br> 4.25% 9/15/48 | 1500000 | 1265482 |
| &nbsp;&nbsp;&nbsp;&nbsp;Black Hills 1.037% 8/23/24 | 1650000 | 1539800 |
| &nbsp;&nbsp;&nbsp;&nbsp;CenterPoint Energy 4.25% <br> 11/1/28 | 505000 | 474581 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commonwealth Edison |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.75% 9/1/51 | 2500000 | 1611292 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.65% 6/15/46 | 3000000 | 2292255 |
| &nbsp;&nbsp;&nbsp;&nbsp;Duke Energy Carolinas 3.95% <br> 11/15/28 | 853000 | 820201 |
| &nbsp;&nbsp;&nbsp;&nbsp;Enel Finance International 144A <br> 6.80% 10/14/25 # | 1500000 | 1541860 |
| &nbsp;&nbsp;&nbsp;&nbsp;Entergy 3.75% 6/15/50 | 3550000 | 2630340 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fells Point Funding Trust 144A <br> 3.046% 1/31/27 # | 1205000 | 1098377 |
| &nbsp;&nbsp;&nbsp;&nbsp;Indianapolis Power & Light 144A <br> 5.65% 12/1/32 # | 1460000 | 1502016 |
| &nbsp;&nbsp;&nbsp;&nbsp;MidAmerican Energy 3.95% <br> 8/1/47 | 2000000 | 1638841 |
| &nbsp;&nbsp;&nbsp;&nbsp;National Rural Utilities <br> Cooperative Finance |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.15% 12/15/32 | 2230000 | 2066073 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.40% 11/1/48 | 2000000 | 1676006 |
| &nbsp;&nbsp;&nbsp;&nbsp;NextEra Energy Capital Holdings <br> 3.00% 1/15/52 | 2130000 | 1400256 |
| &nbsp;&nbsp;&nbsp;&nbsp;Oglethorpe Power 144A 4.50% <br> 4/1/47 # | 1450000 | 1158150 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pacific Gas and Electric 3.00% <br> 6/15/28 | 1771000 | 1534446 |
| &nbsp;&nbsp;&nbsp;&nbsp;PacifiCorp 5.35% 12/1/53 | 810000 | 806686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Southern California Edison |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.45% 2/1/52 | 800000 | 572969 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.125% 3/1/48 | 1275000 | 1023510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.70% 6/1/27 | 1255000 | 1230910 |
| &nbsp;&nbsp;&nbsp;&nbsp;Union Electric 3.90% 4/1/52 | 55000 | 44605 |
| &nbsp;&nbsp;&nbsp;&nbsp;Virginia Electric and Power <br> 4.60% 12/1/48 | 1736000 | 1512529 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vistra Operations 144A 5.125% <br> 5/13/25 # | 2110000 | 2067135 |
| &nbsp;&nbsp;&nbsp;&nbsp;WEC Energy Group 5.15% <br> 10/1/27 | 770000 | 779638 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wisconsin Electric Power 4.30% <br> 10/15/48 | 1250000 | 1025837 |
|  |  | 34783690 |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Corporate Bond

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** | | |
| &nbsp;&nbsp;Energy — 4.95% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BP Capital Markets America <br> 2.939% 6/4/51 | 3295000 | $2184586 |
| &nbsp;&nbsp;&nbsp;&nbsp;Colorado Interstate Gas 144A <br> 4.15% 8/15/26 # | 1000000 | 952387 |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy Transfer |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 5/15/50 | 580000 | 465966 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.75% 2/15/33 | 790000 | 774425 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.25% 4/15/49 | 280000 | 261713 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kinder Morgan |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.45% 8/1/52 | 1740000 | 1570829 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.55% 6/1/45 | 1000000 | 916491 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marathon Oil 5.20% 6/1/45 | 2830000 | 2434587 |
| &nbsp;&nbsp;&nbsp;&nbsp;NuStar Logistics 5.625%<br> 4/28/27 | 220000 | 206091 |
| &nbsp;&nbsp;&nbsp;&nbsp;ONEOK 6.10% 11/15/32 | 1775000 | 1780356 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plains All American Pipeline <br> 3.60% 11/1/24 \* | 1031000 | 997539 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sabal Trail Transmission 144A <br> 4.246% 5/1/28 # | 2500000 | 2321362 |
| &nbsp;&nbsp;&nbsp;&nbsp;Targa Resources Partners 5.00% <br> 1/15/28 | 2510000 | 2398527 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transcontinental Gas Pipe Line |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.25% 5/15/30 | 1225000 | 1065877 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.60% 3/15/48 | 1000000 | 835906 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valero Energy 3.65% 12/1/51 | 3380000 | 2401743 |
| &nbsp;&nbsp;&nbsp;&nbsp;Williams Cos. 4.85% 3/1/48 | 3250000 | 2762209 |
|  |  | 24330594 |
| &nbsp;&nbsp;Finance Companies — 2.76% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AerCap Ireland Capital DAC |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.65% 10/29/24 | 1375000 | 1269225 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.75% 1/30/26 | 2182000 | 1922018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.00% 10/29/28 | 4075000 | 3421310 |
| &nbsp;&nbsp;&nbsp;&nbsp;Air Lease |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.20% 1/15/27 | 1750000 | 1527446 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.875% 1/15/32 \* | 1850000 | 1474392 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.125% 12/15/26 µ, Ψ | 1532000 | 1053250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.85% 12/15/27 | 990000 | 990628 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aviation Capital Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 1.95% 1/30/26 # | 754000 | 657210 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 3.50% 11/1/27 # | 255000 | 223128 |
| &nbsp;&nbsp;&nbsp;&nbsp;Avolon Holdings Funding 144A <br> 3.25% 2/15/27 # | 540000 | 462843 |
| &nbsp;&nbsp;&nbsp;&nbsp;Owl Rock Capital 4.00% 3/30/25 | 575000 | 539687 |
|  |  | 13541137 |
| &nbsp;&nbsp;Industrials — 0.08% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;University of Southern California <br> 3.028% 10/1/39 | 500000 | 395867 |
|  |  | 395867 |
| &nbsp;&nbsp;Insurance — 4.32% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Aon |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.80% 5/15/30 | 4900000 | 4190154 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.00% 9/12/32 | 1225000 | 1215201 |
| &nbsp;&nbsp;&nbsp;&nbsp;Athene Global Funding 144A <br> 1.985% 8/19/28 # | 5885000 | 4745107 |
| &nbsp;&nbsp;&nbsp;&nbsp;Berkshire Hathaway Finance <br> 3.85% 3/15/52 | 645000 | 517527 |
| &nbsp;&nbsp;&nbsp;&nbsp;Brighthouse Financial 3.85% <br> 12/22/51 | 647000 | 410835 |
| &nbsp;&nbsp;&nbsp;&nbsp;First American Financial 2.40% <br> 8/15/31 | 2100000 | 1539898 |
| &nbsp;&nbsp;&nbsp;&nbsp;Humana |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.75% 3/1/28 | 505000 | 516562 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.875% 3/1/33 | 415000 | 429747 |
| &nbsp;&nbsp;&nbsp;&nbsp;Northwestern Mutual Life <br> Insurance 144A 3.85% <br> 9/30/47 # | 3000000 | 2302745 |
| &nbsp;&nbsp;&nbsp;&nbsp;Principal Life Global Funding II <br> 144A 3.00% 4/18/26 # | 1000000 | 928900 |
| &nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.05% 5/15/41 | 3685000 | 2784190 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.70% 8/15/49 | 1000000 | 796455 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 5/15/29 | 880000 | 842341 |
|  |  | 21219662 |
| &nbsp;&nbsp;Natural Gas — 1.44% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Atmos Energy 5.75% 10/15/52 | 1735000 | 1821980 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sempra Energy 4.875% <br> 10/15/25 µ, Ψ | 1505000 | 1395406 |
| &nbsp;&nbsp;&nbsp;&nbsp;Southern California Gas |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.30% 1/15/49 | 2505000 | 2074008 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.35% 11/15/52 | 1270000 | 1397352 |
| &nbsp;&nbsp;&nbsp;&nbsp;Southern Co. Gas Capital 5.15% <br> 9/15/32 | 417000 | 410544 |
|  |  | 7099290 |
| &nbsp;&nbsp;Real Estate Investment Trusts — 1.82% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Homes 4 Rent 3.625% <br> 4/15/32 | 890000 | 751016 |
| &nbsp;&nbsp;&nbsp;&nbsp;American Tower Trust #1 Series<br> 13 2A 144A 3.07% 3/15/48 # | 1500000 | 1491602 |
| &nbsp;&nbsp;&nbsp;&nbsp;Digital Realty Trust 5.55% <br> 1/15/28 | 1765000 | 1779847 |
| &nbsp;&nbsp;&nbsp;&nbsp;Extra Space Storage |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.35% 3/15/32 | 2892000 | 2195651 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.55% 6/1/31 | 3485000 | 2734876 |
|  |  | 8952992 |
| &nbsp;&nbsp;Technology — 12.84% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adobe 2.30% 2/1/30 | 3417000 | 2921327 |
| &nbsp;&nbsp;&nbsp;&nbsp;Alphabet 2.05% 8/15/50 | 2756000 | 1623176 |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple <br> 2.65% 5/11/50 | 675000 | 449792 |

---

[**Table of Contents**](#toc2)

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** | | |
| &nbsp;&nbsp;Technology (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.65% 2/8/51 | 1075000 | $714106 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.70% 8/5/51 | 1125000 | 747058 |
| &nbsp;&nbsp;&nbsp;&nbsp;Autodesk |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.40% 12/15/31 \* | 460000 | 368654 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.85% 1/15/30 | 5231000 | 4509254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Broadcom |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 3.419% 4/15/33 # | 2500000 | 2011216 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 3.469% 4/15/34 # | 1483000 | 1187440 |
| &nbsp;&nbsp;&nbsp;&nbsp;CDW |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.67% 12/1/26 | 815000 | 725100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.276% 12/1/28 | 3590000 | 3080346 |
| &nbsp;&nbsp;&nbsp;&nbsp;CoStar Group 144A 2.80% <br> 7/15/30 # | 2431000 | 1990817 |
| &nbsp;&nbsp;&nbsp;&nbsp;Entegris Escrow |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 4.75% 4/15/29 # | 1690000 | 1544579 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.95% 6/15/30 # | 955000 | 881942 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equinix 2.625% 11/18/24 | 4895000 | 4664971 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity National Information <br> Services 1.65% 3/1/28 \* | 2225000 | 1845651 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fiserv 3.85% 6/1/25 | 4646000 | 4505267 |
| &nbsp;&nbsp;&nbsp;&nbsp;Global Payments 2.65% 2/15/25 | 4000000 | 3766539 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microchip Technology |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.972% 2/15/24 | 1250000 | 1187570 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.983% 9/1/24 | 2685000 | 2487868 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microsoft 2.921% 3/17/52 | 2975000 | 2120200 |
| &nbsp;&nbsp;&nbsp;&nbsp;NXP 3.875% 6/18/26 | 2800000 | 2663448 |
| &nbsp;&nbsp;&nbsp;&nbsp;Oracle |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.80% 11/10/25 \* | 380000 | 388930 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.15% 11/9/29 | 815000 | 847871 |
| &nbsp;&nbsp;&nbsp;&nbsp;PayPal Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.30% 6/1/30 | 2110000 | 1738159 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.25% 6/1/50 | 1100000 | 752497 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.90% 6/1/27 \* | 445000 | 428915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sensata Technologies 144A <br> 3.75% 2/15/31 # | 1115000 | 918955 |
| &nbsp;&nbsp;&nbsp;&nbsp;Texas Instruments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.875% 3/15/39 | 2994000 | 2650368 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.15% 5/15/48 | 400000 | 356177 |
| &nbsp;&nbsp;&nbsp;&nbsp;Thomson Reuters 3.35% <br> 5/15/26 | 2760000 | 2614384 |
| &nbsp;&nbsp;&nbsp;&nbsp;Visa |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.70% 4/15/40 | 4897000 | 3729731 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.30% 12/14/45 | 415000 | 381067 |
| &nbsp;&nbsp;&nbsp;&nbsp;VMware 4.50% 5/15/25 | 1650000 | 1619502 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workday |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 4/1/27 | 275000 | 257422 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.70% 4/1/29 | 425000 | 390805 |
|  |  | 63071104 |
| &nbsp;&nbsp;Transportation — 1.33% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Burlington Northern Santa Fe |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.875% 6/15/52 | 1450000 | 973661 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.55% 9/1/44 | 1000000 | 909098 |
| &nbsp;&nbsp;&nbsp;&nbsp;Delta Air Lines 2020-1 Class AA <br> Pass Through Trust 2.00% <br> 12/10/29 ⧫ | 1342628 | 1145398 |
| &nbsp;&nbsp;&nbsp;&nbsp;Union Pacific 3.55% 8/15/39 | 1875000 | 1556037 |
| &nbsp;&nbsp;&nbsp;&nbsp;United Airlines 2016-1 Class AA <br> Pass Through Trust 3.10% <br> 1/7/30 ⧫ | 2171698 | 1957765 |
|  |  | 6541959 |
| &nbsp;&nbsp;Utilities — 0.62% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Water Capital 4.15% <br> 6/1/49 | 2600000 | 2155443 |
| &nbsp;&nbsp;&nbsp;&nbsp;Electricite de France 144A 5.25% <br> 1/29/23 #, µ, Ψ | 875000 | 873094 |
|  |  | 3028537 |
| &nbsp;&nbsp;**Total Corporate Bonds**<br> (cost $517,574,391) |  | **447454134** |
| &nbsp;&nbsp;**Municipal Bonds — 0.86%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commonwealth of Puerto Rico <br> (Restructured) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series A-1 2.986% 7/1/24 ^ | 16942 | 15709 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series A-1 4.00% 7/1/35 | 36981 | 31210 |
| &nbsp;&nbsp;&nbsp;&nbsp;GDB Debt Recovery Authority of <br> Puerto Rico <br> 7.50% 8/20/40 | 1618977 | 1355893 |
| &nbsp;&nbsp;&nbsp;&nbsp;New York City Industrial <br> Development Agency <br> (Yankee Stadium Project) <br> 144A 11.00% 3/1/29 # | 2410000 | 2816109 |
| &nbsp;&nbsp;**Total Municipal Bonds** <br> (cost $4,001,894) |  | **4218921** |
| &nbsp;&nbsp;**Non-Agency Asset-Backed Securities — 1.19%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Enterprise Fleet Financing <br> Series 2022-2 A2 144A 4.65% <br> 5/21/29 # | 1605000 | 1582546 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ford Credit Floorplan Master <br> Owner Trust <br> Series 2019-2 A 3.06% <br> 4/15/26 | 1425000 | 1382044 |
| &nbsp;&nbsp;&nbsp;&nbsp;Toyota Auto Loan Extended Note <br> Trust <br> Series 2022-1A A 144A 3.82% <br> 4/25/35 # | 1605000 | 1520434 |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Corporate Bond

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Non-Agency Asset-Backed Securities (continued)** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Volkswagen Auto Lease Trust <br> Series 2022-A A3 3.44% <br> 7/21/25 | 1400000 | $1369907 |
| &nbsp;&nbsp;**Total Non-Agency Asset-Backed Securities** <br> (cost $6,028,730) |  | **5854931** |
| &nbsp;&nbsp;**Sovereign BondsΔ — 0.49%** |  |  |
| &nbsp;&nbsp;Colombia — 0.14% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Colombia Government <br> International Bond <br> 3.25% 4/22/32 | 925000 | 675664 |
|  |  | 675664 |
| &nbsp;&nbsp;Mexico — 0.16% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mexico Government International <br> Bond <br> 3.75% 4/19/71 | 1250000 | 781327 |
|  |  | 781327 |
| &nbsp;&nbsp;United States — 0.19% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Tennessee Valley Authority <br> 2.875% 2/1/27 | 1000000 | 947086 |
|  |  | 947086 |
| &nbsp;&nbsp;**Total Sovereign Bonds** <br> (cost $3,149,187) |  | **2404077** |
| &nbsp;&nbsp;**US Treasury Obligation — 0.41%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Bonds <br> 3.00% 8/15/52 | 2445000 | 2015215 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total US Treasury Obligation** <br> (cost $2,123,453) |  | **2015215** |
|  | **Number of<br> shares** |  |
| &nbsp;&nbsp;**Short-Term Investments — 4.95%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 4.95% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven- <br> day effective yield 4.03%) | 6077282 | 6077282 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio <br> – Class I (seven-day effective <br> yield 4.06%) | 6077282 | 6077282 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial <br> Square Government Fund – <br> Institutional Shares (seven- <br> day effective yield 4.23%) | 6077282 | 6077282 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 6077282 | 6077282 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $24,309,128) |  | **24309128** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral—99.21%** <br> (cost $558,375,684) |  | **487408417** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 0.12%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 0.12% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference <br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 627300 | 627300 |
| &nbsp;&nbsp;**Total Securities Lending Collateral** <br> (cost $627,300) |  | **627300** |
| **Total Value of Securities—99.33%** <br> (cost $559,002,984) |  | $**488,035,717■** |

---

---

| | |
|:---|:---|
| ° | Principal amount shown is stated in USD unless noted that the security is denominated in another currency. |
| • | Variable rate investment. Rates reset periodically. Rate shown reflects the rate in effect at December 31, 2022. For securities based on a published reference rate and spread, the reference rate and spread are indicated in their descriptions. The reference rate descriptions (i.e. LIBOR03M, LIBOR06M, etc.) used in this report are identical for different securities, but the underlying reference rates may differ due to the timing of the reset period. Certain variable rate securities are not based on a published reference rate and spread but are determined by the issuer or agent and are based on current market conditions, or for mortgage-backed securities, are impacted by the individual mortgages which are paying off over time. These securities do not indicate a reference rate and spread in their descriptions. |
| # | Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. At December 31, 2022, the aggregate value of Rule 144A securities was $71,233,997, which represents 14.50% of the Portfolio's net assets. See Note 12 in "Notes to financial statements." |
| <sup>µ</sup> | Fixed to variable rate investment. The rate shown reflects the fixed rate in effect at December 31, 2022. Rate will reset at a future date. |
| <sup>ψ</sup> | Perpetual security. Maturity date represents next call date. |
| \* | Fully or partially on loan. |

---

[**Table of Contents**](#toc2)

---

| | |
|:---|:---|
| ⧫ | Pass Through Agreement. Security represents the contractual right to receive a proportionate amount of underlying payments due to the counterparty pursuant to various agreements related to the rescheduling of obligations and the exchange of certain notes. |
| ^ | Zero-coupon security. The rate shown is the effective yield at the time of purchase. |
| Δ | Securities have been classified by country of risk. |
| <sup>\*\*</sup> | See Note 11 in "Notes to financial statements" for additional information on securities lending collateral and non-cash collateral. |
| ■ | Includes $14,680,075 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $14,477,244. |

---

**Summary of abbreviations:**

DAC – Designated Activity Company

GNMA – Government National Mortgage Association

ICE – Intercontinental Exchange, Inc.

LIBOR – London Interbank Offered Rate

LIBOR03M – ICE LIBOR USD 3 Month

LIBOR06M – ICE LIBOR USD 6 Month

USD – US Dollar

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Global Growth

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks – 99.18%Δ** | | |
| &nbsp;&nbsp;Canada - 3.17% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Barrick Gold | 59389 | $1020303 |
| &nbsp;&nbsp;&nbsp;&nbsp;Canadian Natural Resources | 48592 | 2698314 |
|  |  | 3718617 |
| &nbsp;&nbsp;China - 5.75% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;China Mengniu Dairy † | 483000 | 2190546 |
| &nbsp;&nbsp;&nbsp;&nbsp;H World Group ADR | 36682 | 1556050 |
| &nbsp;&nbsp;&nbsp;&nbsp;JD.com ADR | 27636 | 1551209 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tencent Holdings | 33800 | 1446323 |
|  |  | 6744128 |
| &nbsp;&nbsp;Denmark - 2.07% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Genmab † | 5720 | 2421621 |
|  |  | 2421621 |
| &nbsp;&nbsp;France - 7.88% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Airbus | 19219 | 2284012 |
| &nbsp;&nbsp;&nbsp;&nbsp;BNP Paribas | 32778 | 1868394 |
| &nbsp;&nbsp;&nbsp;&nbsp;LVMH Moet Hennessy Louis <br> Vuitton | 1537 | 1118627 |
| &nbsp;&nbsp;&nbsp;&nbsp;Thales | 12508 | 1597330 |
| &nbsp;&nbsp;&nbsp;&nbsp;TotalEnergies \* | 15537 | 975443 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vinci | 13976 | 1395675 |
|  |  | 9239481 |
| &nbsp;&nbsp;Germany - 5.11% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bayer | 30611 | 1583492 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deutsche Telekom | 140979 | 2812679 |
| &nbsp;&nbsp;&nbsp;&nbsp;RWE | 35892 | 1597912 |
|  |  | 5994083 |
| &nbsp;&nbsp;Hong Kong - 1.47% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prudential | 126581 | 1725414 |
|  |  | 1725414 |
| &nbsp;&nbsp;India - 5.39% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ICICI Bank | 118202 | 1272818 |
| &nbsp;&nbsp;&nbsp;&nbsp;Larsen & Toubro | 98106 | 2473462 |
| &nbsp;&nbsp;&nbsp;&nbsp;NTPC | 578700 | 1164325 |
| &nbsp;&nbsp;&nbsp;&nbsp;State Bank of India | 189179 | 1403350 |
|  |  | 6313955 |
| &nbsp;&nbsp;Israel - 1.83% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Check Point Software <br> Technologies † | 17023 | 2147622 |
|  |  | 2147622 |
| &nbsp;&nbsp;Italy - 1.25% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ferrari | 6863 | 1470769 |
|  |  | 1470769 |
| &nbsp;&nbsp;Japan - 4.00% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asahi Group Holdings | 18800 | 590043 |
| &nbsp;&nbsp;&nbsp;&nbsp;ORIX | 171200 | 2763541 |
| &nbsp;&nbsp;&nbsp;&nbsp;Subaru | 86500 | $1336321 |
|  |  | 4689905 |
| &nbsp;&nbsp;Netherlands - 0.80% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shell | 33037 | 936451 |
|  |  | 936451 |
| &nbsp;&nbsp;Taiwan - 1.64% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Taiwan Semiconductor <br> Manufacturing | 132000 | 1926177 |
|  |  | 1926177 |
| &nbsp;&nbsp;United Kingdom - 3.57% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AstraZeneca | 14405 | 1953606 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reckitt Benckiser Group | 32054 | 2229772 |
|  |  | 4183378 |
| &nbsp;&nbsp;United States - 55.25% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Abbott Laboratories | 14239 | 1563300 |
| &nbsp;&nbsp;&nbsp;&nbsp;AGNC Investment | 155759 | 1612106 |
| &nbsp;&nbsp;&nbsp;&nbsp;Alphabet Class A † | 23254 | 2051700 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amazon.com † | 10177 | 854868 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ambarella † | 20613 | 1695007 |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple | 14457 | 1878398 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aptiv † | 18422 | 1715641 |
| &nbsp;&nbsp;&nbsp;&nbsp;Autodesk † | 6889 | 1287347 |
| &nbsp;&nbsp;&nbsp;&nbsp;Burlington Stores † | 7574 | 1535704 |
| &nbsp;&nbsp;&nbsp;&nbsp;Casey's General Stores | 5083 | 1140371 |
| &nbsp;&nbsp;&nbsp;&nbsp;ConocoPhillips | 23068 | 2722024 |
| &nbsp;&nbsp;&nbsp;&nbsp;Darden Restaurants | 16658 | 2304301 |
| &nbsp;&nbsp;&nbsp;&nbsp;Eli Lilly & Co. | 4521 | 1653963 |
| &nbsp;&nbsp;&nbsp;&nbsp;First Republic Bank | 13145 | 1602244 |
| &nbsp;&nbsp;&nbsp;&nbsp;Frontier Communications Parent † | 34098 | 868817 |
| &nbsp;&nbsp;&nbsp;&nbsp;Generac Holdings † | 1881 | 189341 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ingersoll Rand | 29107 | 1520841 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intercontinental Exchange | 12590 | 1291608 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intuit | 5170 | 2012267 |
| &nbsp;&nbsp;&nbsp;&nbsp;KLA | 2698 | 1017227 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mastercard Class A | 7920 | 2754022 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microchip Technology | 15620 | 1097305 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microsoft | 12449 | 2985519 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley | 19059 | 1620396 |
| &nbsp;&nbsp;&nbsp;&nbsp;NVIDIA | 7708 | 1126447 |
| &nbsp;&nbsp;&nbsp;&nbsp;PayPal Holdings † | 17388 | 1238373 |
| &nbsp;&nbsp;&nbsp;&nbsp;Procter & Gamble | 16257 | 2463911 |
| &nbsp;&nbsp;&nbsp;&nbsp;Raytheon Technologies | 23299 | 2351335 |
| &nbsp;&nbsp;&nbsp;&nbsp;Regeneron Pharmaceuticals † | 3007 | 2169520 |
| &nbsp;&nbsp;&nbsp;&nbsp;Schlumberger | 11153 | 596239 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seagate Technology Holdings | 16432 | 864488 |
| &nbsp;&nbsp;&nbsp;&nbsp;Skechers USA Class A † | 42630 | 1788329 |
| &nbsp;&nbsp;&nbsp;&nbsp;Thermo Fisher Scientific | 2460 | 1354697 |

---

[**Table of Contents**](#toc2)

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common StocksΔ (continued)** |  |  |
| &nbsp;&nbsp;United States (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;T-Mobile US † | 8706 | $1218840 |
| &nbsp;&nbsp;&nbsp;&nbsp;Union Pacific | 8609 | 1782666 |
| &nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group | 5437 | 2882589 |
| &nbsp;&nbsp;&nbsp;&nbsp;VeriSign † | 9340 | 1918810 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals † | 7456 | 2153144 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zimmer Biomet Holdings | 14950 | 1906125 |
|  |  | 64789830 |
| &nbsp;&nbsp;**Total Common Stocks**<br> (cost $106,717,508) |  | **116301431** |
| &nbsp;&nbsp;**Short-Term Investments – 0.72%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds – 0.72% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day <br> effective yield 4.03%) | 212185 | 212185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money <br> Market Government Portfolio – <br> Class I (seven-day effective <br> yield 4.06%) | 212185 | 212185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 212185 | 212185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 212184 | 212184 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $848,739) |  | **848739** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral-99.90%** <br> (cost $107,566,247) |  | **117150170** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* – 0.88%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund - 0.88% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference <br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 1033379 | 1033379 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Securities Lending Collateral** <br> (cost $1,033,379) |  | **1033379** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities-100.78%**<br> (cost $108,599,626) |  | $**118,183,549■** |

---

---

| | |
|:---|:---|
| <sup>Δ</sup> | Securities have been classified by country of risk. Aggregate classification by business sector has been presented on page 33 in "Security type / country and sector allocations." |
| <sup>†</sup> | Non-income producing security. |
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>\*\*</sup> | See Note 11 in "Notes to financial statements" for additional information on securities lending collateral. |
| <sup>■</sup> | Includes $975,442 of securities loaned. |

---

**Summary of abbreviations:**

ADR - American Depositary Receipt

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Limited-Term Bond

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Principal <br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Agency Collateralized Mortgage Obligations — 0.16%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Freddie Mac REMICs |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 4505 PE 2.50% <br> 5/15/44 | 248004 | $228777 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GNMA Series 2012-39 PA 2.00% <br> 3/16/42 | 311166 | 280335 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Agency Collateralized Mortgage Obligations**<br> (cost $561,516) |  | **509112** |
| &nbsp;&nbsp;**Agency Commercial Mortgage-Backed Securities — 11.04%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;FREMF Mortgage Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2013-K30 C 144A <br> 3.547% 6/25/45 #, • | 1000000 | 984624 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2013-K31 C 144A <br> 3.627% 7/25/46 #, • | 2000000 | 1975849 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2013-K33 B 144A <br> 3.495% 8/25/46 #, • | 1009000 | 990525 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2013-K33 C 144A <br> 3.495% 8/25/46 #, • | 1250000 | 1223756 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2013-K35 B 144A <br> 3.932% 12/25/46 #, • | 1270000 | 1251974 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2015-K47 B 144A <br> 3.586% 6/25/48 #, • | 1170000 | 1109831 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2015-KF12 B 144A <br> 11.242% (LIBOR01M + <br> 7.10%, Floor 7.10%) <br> 9/25/22 #, • | 626579 | 625409 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2016-K723 B 144A <br> 3.568% 11/25/23 #, • | 3500000 | 3421415 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2016-K723 C 144A <br> 3.568% 11/25/23 #, • | 7370000 | 7165324 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2017-K724 C 144A <br> 3.498% 12/25/49 #, • | 600000 | 582841 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2017-K728 B 144A <br> 3.651% 11/25/50 #, • | 5650000 | 5435103 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2017-K729 B 144A <br> 3.673% 11/25/49 # | 1900000 | 1812829 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2017-KF33 B 144A <br> 6.692% (LIBOR01M + 2.55%, |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Floor 2.55%) 6/25/27 #, • | 414873 | 406884 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2017-KF39 B 144A <br> 6.642% (LIBOR01M + 2.50%, |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Floor 2.50%) 11/25/24 #, • | 297733 | 292830 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2017-KF40 B 144A <br> 6.842% (LIBOR01M + 2.70%, <br> Floor 2.70%) 11/25/27 #, • | 484433 | 467981 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2018-K732 B 144A <br> 4.052% 5/25/25 #, • | 225000 | 214083 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2018-KF46 B 144A <br> 6.092% (LIBOR01M + 1.95%,<br> Floor 1.95%) 3/25/28 #, • | 490022 | 467959 |
| &nbsp;&nbsp;&nbsp;&nbsp;FREMF Mortgage Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2018-KF47 B 144A <br> 6.142% (LIBOR01M + 2.00%, <br> Floor 2.00%) 5/25/25 #, • | 423985 | 414277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2018-KF48 B 144A <br> 6.192% (LIBOR01M + 2.05%, <br> Floor 2.05%) 6/25/28 #, • | 266108 | 250037 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2018-KF51 B 144A <br> 5.992% (LIBOR01M + 1.85%, <br> Floor 1.85%) 8/25/25 #, • | 840716 | 818718 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2019-KF60 B 144A <br> 6.492% (LIBOR01M + 2.35%, <br> Floor 2.35%) 2/25/26 #, • | 1125820 | 1050572 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2019-KF61 B 144A <br> 6.342% (LIBOR01M + 2.20%, <br> Floor 2.20%) 4/25/29 #, • | 399169 | 370245 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2019-KF68 B 144A <br> 6.342% (LIBOR01M + 2.20%, <br> Floor 2.20%) 7/25/26 #, • | 702869 | 649431 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2019-KF69 B 144A <br> 6.442% (LIBOR01M + 2.30%, <br> Floor 2.30%) 8/25/29 #, • | 648990 | 606010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2019-KF70 B 144A <br> 6.442% (LIBOR01M + 2.30%, <br> Floor 2.30%) 9/25/29 #, • | 379124 | 366430 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2019-KF73 B 144A <br> 6.592% (LIBOR01M + 2.45%, <br> Floor 2.45%) 11/25/29 #, • | 984367 | 951001 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2020-KF74 B 144A <br> 6.292% (LIBOR01M + 2.15%, <br> Floor 2.15%) 1/25/27 #, • | 236890 | 230762 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2020-KF75 B 144A <br> 6.392% (LIBOR01M + 2.25%, <br> Floor 2.25%) 12/25/29 #, • | 440930 | 406551 |
| &nbsp;&nbsp;**Total Agency Commercial Mortgage-Backed <br> Securities** <br> (cost $35,991,544) |  | **34543251** |
| &nbsp;&nbsp;**Agency Mortgage-Backed Security — 0.07%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Freddie Mac S.F. 20 yr <br> 4.50% 8/1/30 | 219817 | 218363 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Agency Mortgage-Backed Security**<br> (cost $230,374) |  | **218363** |
| &nbsp;&nbsp;**Collateralized Debt Obligations — 7.06%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefit Street Partners CLO XX <br> Series 2020-20A AR 144A <br> 5.249% (LIBOR03M + 1.17%, <br> Floor 1.17%) 7/15/34 #, • | 2000000 | 1938070 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bethpage Park CLO <br> Series 2021-1A A 144A <br> 5.209% (LIBOR03M + 1.13%, <br> Floor 1.13%) 1/15/35 #, • | 600000 | 585227 |

---

[**Table of Contents**](#toc2)

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Collateralized Debt Obligations (continued)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlueMountain CLO XXX <br> Series 2020-30A AR 144A <br> 5.234% (TSFR03M + 1.37%, <br> Floor 1.37%) 4/15/35 #, • | 1000000 | $965008 |
| &nbsp;&nbsp;&nbsp;&nbsp;Canyon CLO Series 2020-1A AR <br> 144A 5.259% (LIBOR03M + <br> 1.18%, Floor 1.18%) <br> 7/15/34 #, • | 2200000 | 2138327 |
| &nbsp;&nbsp;&nbsp;&nbsp;CIFC Funding Series 2022-2A A1 <br> 144A 5.275% (TSFR03M + <br> 1.32%, Floor 1.32%) <br> 4/19/35 #, • | 2000000 | 1933430 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dryden 77 CLO <br> Series 2020-77A AR 144A<br> 5.795% (LIBOR03M + 1.12%, <br> Floor 1.12%) 5/20/34 #, • | 1100000 | 1068766 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dryden 83 CLO <br> Series 2020-83A A 144A <br> 5.414% (LIBOR03M + 1.22%, <br> Floor 1.22%) 1/18/32 #, • | 1935000 | 1894373 |
| &nbsp;&nbsp;&nbsp;&nbsp;Galaxy XXI CLO <br> Series 2015-21A AR 144A <br> 5.263% (LIBOR03M + 1.02%) <br> 4/20/31 #, • | 2000000 | 1964954 |
| &nbsp;&nbsp;&nbsp;&nbsp;KKR CLO 41Series 2022-41A A1 <br> 144A 5.194% (TSFR03M + <br> 1.33%, Floor 1.33%) <br> 4/15/35 #, • | 2000000 | 1915438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Octagon Investment Partners <br> 48 Series 2020-3A AR 144A <br> 5.393% (LIBOR03M + 1.15%, <br> Floor 1.15%) 10/20/34 #, • | 2000000 | 1942058 |
| &nbsp;&nbsp;&nbsp;&nbsp;Regatta XIX Funding <br> Series 2022-1A A1 144A <br> 5.283% (TSFR03M + 1.32%, <br> Floor 1.32%) 4/20/35 #, • | 2000000 | 1936846 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sound Point CLO XXV <br> Series 2019-4A A1R 144A <br> 5.34% (TSFR03M + 1.28%, <br> Floor 1.28%) 4/25/33 #, • | 2000000 | 1943460 |
| &nbsp;&nbsp;&nbsp;&nbsp;Venture 42 CLO<br> Series 2021-42A A1A 144A <br> 5.209% (LIBOR03M + 1.13%, <br> Floor 1.13%) 4/15/34 #, • | 415000 | 396027 |
| &nbsp;&nbsp;&nbsp;&nbsp;Voya CLO Series 2020-3A AR <br> 144A 5.393% (LIBOR03M + <br> 1.15%, Floor 1.15%) <br> 10/20/34 #, • | 1500000 | 1464621 |
| &nbsp;&nbsp;**Total Collateralized Debt Obligations**<br> (cost $22,653,936) |  | **22086605** |
| &nbsp;&nbsp;**Corporate Bonds — 55.15%** |  |  |
| &nbsp;&nbsp;Banking — 15.00% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ally Financial 1.45% 10/2/23 | 3060000 | 2967292 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of America |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.523% 6/14/24 µ | 825000 | 805521 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.843% 2/4/25 µ | 675000 | 647454 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.00% 1/22/25 | 1000000 | 979553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.125% 1/22/24 | 1000000 | 991808 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.20% 8/26/24 | 1325000 | 1305356 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of New York Mellon 5.802% <br> 10/25/28 µ | 573000 | 593541 |
| &nbsp;&nbsp;&nbsp;&nbsp;Barclays 7.325% 11/2/26 µ | 315000 | 326621 |
| &nbsp;&nbsp;&nbsp;&nbsp;Citigroup |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.014% 1/25/26 µ | 1275000 | 1182601 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.07% 2/24/28 µ | 215000 | 194136 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 5/15/23 | 1510000 | 1502934 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.50% 9/13/25 | 1000000 | 1007161 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.61% 9/29/26 µ | 175000 | 175933 |
| &nbsp;&nbsp;&nbsp;&nbsp;Citizens Bank 4.119% 5/23/25 µ | 1460000 | 1429427 |
| &nbsp;&nbsp;&nbsp;&nbsp;Citizens Bank 6.064% <br> 10/24/25 µ | 525000 | 531295 |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Suisse Group 144A <br> 6.442% 8/11/28 #, µ | 340000 | 310136 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fifth Third Bank 5.852% <br> 10/27/25 µ | 875000 | 884463 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Group |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.85% 7/8/24 | 1500000 | 1468671 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.25% 10/21/25 | 2500000 | 2442516 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.069% (SOFR + 0.79%) <br> 12/9/26 • | 1300000 | 1252330 |
| &nbsp;&nbsp;&nbsp;&nbsp;Huntington National Bank |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.008% 5/16/25 µ | 840000 | 822171 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.65% 1/10/30 | 250000 | 252501 |
| &nbsp;&nbsp;&nbsp;&nbsp;JPMorgan Chase & Co. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.653% 9/16/24 µ | 1000000 | 964622 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.875% 9/10/24 | 847000 | 829659 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.08% 4/26/26 µ | 4090000 | 3974675 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.851% 7/25/28 µ | 225000 | 219696 |
| &nbsp;&nbsp;&nbsp;&nbsp;KeyBank |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.15% 8/8/25 | 835000 | 816607 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.85% 11/15/27 | 130000 | 134416 |
| &nbsp;&nbsp;&nbsp;&nbsp;KeyCorp 3.878% 5/23/25 µ | 730000 | 714674 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mizuho Financial Group 0.849% <br> 9/8/24 µ | 1800000 | 1737635 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.835% (LIBOR03M + 0.79%) <br> 5/31/23 • | 300000 | 300128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.138% 10/16/26 µ | 5120000 | 5234785 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.296% 10/18/28 µ | 325000 | 336075 |
| &nbsp;&nbsp;&nbsp;&nbsp;National Bank of Canada 2.10% <br> 2/1/23 | 1400000 | 1397009 |
| &nbsp;&nbsp;&nbsp;&nbsp;PNC Financial Services Group <br> 5.671% 10/28/25 µ | 310000 | 313521 |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Limited-Term Bond

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** | | |
| &nbsp;&nbsp;Banking (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;State Street |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.751% 11/4/26 µ | 70000 | $71731 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.82% 11/4/28 µ | 50000 | 51724 |
| &nbsp;&nbsp;&nbsp;&nbsp;Svenska Handelsbanken 144A <br> 0.625% 6/30/23 # | 1500000 | 1467548 |
| &nbsp;&nbsp;&nbsp;&nbsp;Toronto-Dominion Bank 4.108% <br> 6/8/27 \* | 2520000 | 2440022 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Bancorp |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.375% 7/22/26 | 844000 | 779880 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.727% 10/21/26 µ | 215000 | 219214 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo & Co. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.908% 4/25/26 µ | 2620000 | 2548711 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.808% 7/25/28 µ | 310000 | 303287 |
|  |  | 46929040 |
| &nbsp;&nbsp;Basic Industry — 1.09% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Celanese US Holdings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.05% 3/15/25 | 140000 | 139573 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.165% 7/15/27 | 525000 | 518664 |
| &nbsp;&nbsp;&nbsp;&nbsp;Graphic Packaging International <br> 144A 0.821% 4/15/24 # | 1350000 | 1264127 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mosaic 4.25% 11/15/23 | 250000 | 248001 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nucor 3.95% 5/23/25 | 345000 | 337855 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nutrien 5.95% 11/7/25 | 870000 | 888651 |
|  |  | 3396871 |
| &nbsp;&nbsp;Brokerage — 0.16% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;LSEGA Financing 144A 0.65% <br> 4/6/24 # | 540000 | 507189 |
|  |  | 507189 |
| &nbsp;&nbsp;Capital Goods — 4.73% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Avery Dennison 0.85% 8/15/24 | 375000 | 350132 |
| &nbsp;&nbsp;&nbsp;&nbsp;Boeing 2.80% 3/1/23 | 2250000 | 2241756 |
| &nbsp;&nbsp;&nbsp;&nbsp;CNH Industrial Capital 1.95% <br> 7/2/23 | 1550000 | 1523872 |
| &nbsp;&nbsp;&nbsp;&nbsp;General Electric 5.012% 1/1/24 | 364774 | 364183 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lennox International 1.35% <br> 8/1/25 | 2150000 | 1948029 |
| &nbsp;&nbsp;&nbsp;&nbsp;Parker-Hannifin |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.65% 6/15/24 | 1430000 | 1399994 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.25% 9/15/27 | 1070000 | 1039930 |
| &nbsp;&nbsp;&nbsp;&nbsp;Republic Services 0.875% <br> 11/15/25 | 1800000 | 1613994 |
| &nbsp;&nbsp;&nbsp;&nbsp;Roper Technologies 1.00% <br> 9/15/25 | 1400000 | 1255710 |
| &nbsp;&nbsp;&nbsp;&nbsp;Teledyne Technologies 0.95% <br> 4/1/24 | 1385000 | 1309059 |
| &nbsp;&nbsp;&nbsp;&nbsp;Waste Management 0.75% <br> 11/15/25 | 1955000 | 1750037 |
|  |  | 14796696 |
| &nbsp;&nbsp;Communications — 4.96% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Tower |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.60% 1/15/24 | 1300000 | 1239675 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.30% 9/15/25 | 795000 | 718403 |
| &nbsp;&nbsp;&nbsp;&nbsp;AT&T |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.70% 3/25/26 | 1350000 | 1218177 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.95% 7/15/26 | 1250000 | 1164666 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charter Communications Operating |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.50% 2/1/24 | 1215000 | 1201171 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.908% 7/23/25 | 1485000 | 1456886 |
| &nbsp;&nbsp;&nbsp;&nbsp;Crown Castle 3.15% 7/15/23 | 400000 | 395610 |
| &nbsp;&nbsp;&nbsp;&nbsp;Crown Castle Towers 144A |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.663% 5/15/45 # | 950000 | 920283 |
| &nbsp;&nbsp;&nbsp;&nbsp;Netflix 5.875% 2/15/25 | 1250000 | 1267788 |
| &nbsp;&nbsp;&nbsp;&nbsp;Omnicom Group 3.65% 11/1/24 | 700000 | 686788 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sprint 7.875% 9/15/23 | 1721000 | 1748856 |
| &nbsp;&nbsp;&nbsp;&nbsp;T-Mobile USA 3.75% 4/15/27 | 2000000 | 1886842 |
| &nbsp;&nbsp;&nbsp;&nbsp;Warnermedia Holdings 144A <br> 3.638% 3/15/25 # | 1690000 | 1608515 |
|  |  | 15513660 |
| &nbsp;&nbsp;Consumer Cyclical — 4.55% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;7-Eleven 144A 0.80% 2/10/24 # | 1000000 | 952045 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aptiv 2.396% 2/18/25 | 1035000 | 976823 |
| &nbsp;&nbsp;&nbsp;&nbsp;DR Horton 2.60% 10/15/25 | 625000 | 582529 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ford Motor Credit |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.70% 8/10/26 | 550000 | 478308 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.375% 11/13/25 | 1355000 | 1227336 |
| &nbsp;&nbsp;&nbsp;&nbsp;General Motors 4.875% 10/2/23 | 1000000 | 997190 |
| &nbsp;&nbsp;&nbsp;&nbsp;General Motors Financial 1.20% <br> 10/15/24 | 825000 | 764306 |
| &nbsp;&nbsp;&nbsp;&nbsp;GLP Capital 5.375% 11/1/23 | 280000 | 279483 |
| &nbsp;&nbsp;&nbsp;&nbsp;Hyundai Capital America 144A <br> 1.25% 9/18/23 # | 800000 | 775557 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mercedes-Benz Finance North <br> America 144A 5.25% <br> 11/29/27 # | 200000 | 201361 |
| &nbsp;&nbsp;&nbsp;&nbsp;MGM Resorts International <br> 5.75% 6/15/25 \* | 1780000 | 1732538 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nissan Motor 144A 3.043% <br> 9/15/23 # | 1250000 | 1225061 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nordstrom 2.30% 4/8/24 | 270000 | 253480 |
| &nbsp;&nbsp;&nbsp;&nbsp;PVH 4.625% 7/10/25 | 1500000 | 1449829 |
| &nbsp;&nbsp;&nbsp;&nbsp;VICI Properties 4.95% 2/15/30 | 595000 | 567194 |
| &nbsp;&nbsp;&nbsp;&nbsp;Volkswagen Group of America <br> Finance 144A 0.875% <br> 11/22/23 # | 1850000 | 1780133 |
|  |  | 14243173 |

---

[**Table of Contents**](#toc2)

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** |  |  |
| &nbsp;&nbsp;Consumer Non-Cyclical — 4.48% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bayer US Finance II |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 2.85% 4/15/25 # | 1260000 | $1181290 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 3.875% 12/15/23 # | 1400000 | 1380265 |
| &nbsp;&nbsp;&nbsp;&nbsp;Darling Ingredients 144A 5.25% <br> 4/15/27 # | 1647500 | 1588289 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diageo Capital 3.50% 9/18/23 | 1000000 | 990527 |
| &nbsp;&nbsp;&nbsp;&nbsp;GE HealthCare Technologies |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.60% 11/15/25 # | 180000 | 181302 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.65% 11/15/27 # | 180000 | 182422 |
| &nbsp;&nbsp;&nbsp;&nbsp;Keurig Dr Pepper 0.75% 3/15/24 | 680000 | 645809 |
| &nbsp;&nbsp;&nbsp;&nbsp;McCormick & Co. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.90% 2/15/26 | 1025000 | 898971 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50% 9/1/23 | 475000 | 470106 |
| &nbsp;&nbsp;&nbsp;&nbsp;Novartis Capital 3.00% 11/20/25 | 1250000 | 1199590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Royalty Pharma |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.75% 9/2/23 | 1800000 | 1744283 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.20% 9/2/25 | 1647000 | 1475543 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tyson Foods 3.95% 8/15/24 | 2000000 | 1969042 |
| &nbsp;&nbsp;&nbsp;&nbsp;Zoetis 5.40% 11/14/25 | 105000 | 107212 |
|  |  | 14014651 |
| &nbsp;&nbsp;Electric — 2.93% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Black Hills 1.037% 8/23/24 | 1000000 | 933212 |
| &nbsp;&nbsp;&nbsp;&nbsp;Duke Energy Carolinas 3.95% <br> 11/15/28 | 1150000 | 1105781 |
| &nbsp;&nbsp;&nbsp;&nbsp;Edison International 3.55% <br> 11/15/24 | 1300000 | 1255918 |
| &nbsp;&nbsp;&nbsp;&nbsp;Enel Finance International 144A 4.25% <br> 6/15/25 # | 295000 | 285899 |
| &nbsp;&nbsp;&nbsp;&nbsp;Eversource Energy 2.90% <br> 3/1/27 | 225000 | 207489 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fells Point Funding Trust 144A <br> 3.046% 1/31/27 # | 210000 | 191418 |
| &nbsp;&nbsp;&nbsp;&nbsp;MidAmerican Energy 3.70% <br> 9/15/23 | 1045000 | 1035507 |
| &nbsp;&nbsp;&nbsp;&nbsp;National Rural Utilities <br> Cooperative Finance 1.875% <br> 2/7/25 | 1350000 | 1267058 |
| &nbsp;&nbsp;&nbsp;&nbsp;Virginia Electric and Power <br> 2.75% 3/15/23 | 2515000 | 2504923 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vistra Operations 144A 5.125% <br> 5/13/25 # | 385000 | 377179 |
|  |  | 9164384 |
| &nbsp;&nbsp;Energy — 4.12% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ConocoPhillips 2.40% 3/7/25 | 1060000 | 1008334 |
| &nbsp;&nbsp;&nbsp;&nbsp;Eastern Energy Gas Holdings <br> 3.55% 11/1/23 | 1235000 | 1219263 |
| &nbsp;&nbsp;&nbsp;&nbsp;Enbridge 2.50% 2/14/25 | 820000 | 774278 |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy Transfer |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.25% 4/1/24 | 1132000 | 1112180 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.55% 2/15/28 | 1295000 | 1286233 |
| &nbsp;&nbsp;&nbsp;&nbsp;Galaxy Pipeline Assets Bidco <br> 144A 1.75% 9/30/27 # | 1217985 | 1130323 |
| &nbsp;&nbsp;&nbsp;&nbsp;Harvest Operations 144A 1.00% <br> 4/26/24 # | 1400000 | 1323371 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kinder Morgan Energy Partners <br> 3.45% 2/15/23 | 1000000 | 997886 |
| &nbsp;&nbsp;&nbsp;&nbsp;Occidental Petroleum 5.875% <br> 9/1/25 \* | 1690000 | 1686635 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plains All American Pipeline <br> 3.85% 10/15/23 | 1800000 | 1775251 |
| &nbsp;&nbsp;&nbsp;&nbsp;Targa Resources Partners 5.00% <br> 1/15/28 | 580000 | 554241 |
|  |  | 12867995 |
| &nbsp;&nbsp;Finance Companies — 0.96% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AerCap Ireland Capital DAC <br> 1.65% 10/29/24 | 2000000 | 1846146 |
| &nbsp;&nbsp;&nbsp;&nbsp;Air Lease 5.85% 12/15/27 | 185000 | 185117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aviation Capital Group 144A <br> 4.375% 1/30/24 # | 1000000 | 975345 |
|  |  | 3006608 |
| &nbsp;&nbsp;Insurance — 4.17% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Athene Global Funding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 0.914% 8/19/24 # | 850000 | 780439 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 0.95% 1/8/24 # | 1750000 | 1665767 |
| &nbsp;&nbsp;&nbsp;&nbsp;Elevance Health 3.35% 12/1/24 | 2000000 | 1940023 |
| &nbsp;&nbsp;&nbsp;&nbsp;Humana 5.75% 3/1/28 | 288000 | 294594 |
| &nbsp;&nbsp;&nbsp;&nbsp;MassMutual Global Funding II <br> 144A 0.60% 4/12/24 # | 1900000 | 1794544 |
| &nbsp;&nbsp;&nbsp;&nbsp;Met Tower Global Funding 144A <br> 3.70% 6/13/25 # | 1280000 | 1242388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Metropolitan Life Global Funding I <br> 144A 0.90% 6/8/23 # | 1250000 | 1229466 |
| &nbsp;&nbsp;&nbsp;&nbsp;Principal Life Global Funding II <br> 144A 0.75% 4/12/24 # | 800000 | 756032 |
| &nbsp;&nbsp;&nbsp;&nbsp;Protective Life Global Funding <br> 144A 0.631% 10/13/23 # | 750000 | 723411 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 1.618% 4/15/26 # | 1350000 | 1213770 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reliance Standard Life Global <br> Funding II 144A 2.15% <br> 1/21/23 # | 1400000 | 1397737 |
|  |  | 13038171 |
| &nbsp;&nbsp;Natural Gas — 0.35% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Sempra Energy 3.30% 4/1/25 | 1145000 | 1098976 |
|  |  | 1098976 |
| &nbsp;&nbsp;Real Estate Investment Trusts — 2.72% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Tower Trust #1 Series <br> 13 2A 144A 3.07% 3/15/48 # | 3545000 | 3525152 |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Limited-Term Bond

---

| | | |
|:---|:---|:---|
|  | **Principal<br> amount<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Corporate Bonds (continued)** |  |  |
| &nbsp;&nbsp;Real Estate Investment Trusts (continued) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Digital Realty Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.45% 7/15/28 | 190000 | $180243 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.55% 1/15/28 | 335000 | 337818 |
| &nbsp;&nbsp;&nbsp;&nbsp;SBA Tower Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 1.884% 1/15/26 # | 1155000 | 1015798 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 2.836% 1/15/50 # | 1621000 | 1527820 |
| &nbsp;&nbsp;&nbsp;&nbsp;Series 3.869 10/08/24 144A <br> 3.869% 10/8/49 #, φ | 2000000 | 1910980 |
|  |  | 8497811 |
| &nbsp;&nbsp;Technology — 4.73% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple 3.00% 2/9/24 | 355000 | 348055 |
| &nbsp;&nbsp;&nbsp;&nbsp;Baidu 1.72% 4/9/26 | 379000 | 337594 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity National Information<br> Services 4.70% 7/15/27 | 1460000 | 1426766 |
| &nbsp;&nbsp;&nbsp;&nbsp;Infor 144A 1.45% 7/15/23 # | 877000 | 856663 |
| &nbsp;&nbsp;&nbsp;&nbsp;Leidos 2.95% 5/15/23 | 1870000 | 1855238 |
| &nbsp;&nbsp;&nbsp;&nbsp;Microchip Technology 0.983% <br> 9/1/24 | 1850000 | 1714173 |
| &nbsp;&nbsp;&nbsp;&nbsp;Oracle 5.80% 11/10/25 \* | 70000 | 71645 |
| &nbsp;&nbsp;&nbsp;&nbsp;S&P Global 144A 2.45% 3/1/27 # | 740000 | 676930 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seagate HDD Cayman 4.75% <br> 6/1/23 | 650000 | 647478 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sensata Technologies |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.00% 10/1/25 # | 1390000 | 1359880 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144A 5.625% 11/1/24 # | 355000 | 353317 |
| &nbsp;&nbsp;&nbsp;&nbsp;Thomson Reuters 4.30% <br> 11/23/23 | 1269000 | 1260559 |
| &nbsp;&nbsp;&nbsp;&nbsp;TSMC Global 144A 1.25% <br> 4/23/26 #, \* | 1500000 | 1345217 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workday 3.50% 4/1/27 | 50000 | 46804 |
| &nbsp;&nbsp;&nbsp;&nbsp;Xilinx 2.95% 6/1/24 | 2575000 | 2506403 |
|  |  | 14806722 |
| &nbsp;&nbsp;Transportation — 0.20% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Penske Truck Leasing 144A <br> 4.40% 7/1/27 # | 670000 | 636837 |
|  |  | 636837 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Corporate Bonds** <br> (cost $180,514,773) |  | **172518784** |
| &nbsp;&nbsp;**Non-Agency Asset-Backed Securities — 4.55%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BMW Vehicle Lease Trust <br> Series 2022-1 A3 1.10% <br> 3/25/25 | 2250000 | 2176739 |
| &nbsp;&nbsp;&nbsp;&nbsp;Enterprise Fleet Financing <br> Series 2022-2 A2 144A 4.65% <br> 5/21/29 # | 830000 | 818388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ford Credit Auto Owner Trust <br> Series 2022-A B 1.91% <br> 7/15/27 | 1350000 | 1233639 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ford Credit Floorplan Master <br> Owner Trust A <br> Series 2020-2 A 1.06% <br> 9/15/27 | 3000000 | 2696020 |
| &nbsp;&nbsp;&nbsp;&nbsp;GM Financial Automobile <br> Leasing Trust Series 2022-1 B <br> 2.23% 2/20/26 | 1600000 | 1516022 |
| &nbsp;&nbsp;&nbsp;&nbsp;Toyota Lease Owner Trust <br> Series 2021-B A3 144A 0.42% <br> 10/21/24 # | 1800000 | 1749832 |
| &nbsp;&nbsp;&nbsp;&nbsp;Verizon Master Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-2 A 1.53% <br> 7/20/28 | 1500000 | 1401967 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series 2022-2 B 1.83% <br> 7/20/28 | 1350000 | 1258360 |
| &nbsp;&nbsp;&nbsp;&nbsp;Volkswagen Auto Lease Trust <br> Series 2022-A A3 3.44% <br> 7/21/25 | 1400000 | 1369907 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Non-Agency Asset-Backed Securities** <br> (cost $14,671,606) |  | **14220874** |
| &nbsp;&nbsp;**Supranational Banks — 0.16%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corp Andina de Fomento <br> 2.375% 5/12/23 | 500000 | 494380 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Supranational Banks** <br> (cost $499,860) |  | **494380** |
| &nbsp;&nbsp;&nbsp;&nbsp;**US Treasury Obligations — 20.59%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Floating Rate Note <br> 4.60% (USBMMY3M + 0.14%) <br> 10/31/24 • | 25260000 | 25234023 |
| &nbsp;&nbsp;&nbsp;&nbsp;US Treasury Notes |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.625% 5/31/27 | 9005000 | 8489674 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.125% 10/31/27 | 22130000 | 22212987 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.25% 12/31/24 | 3305000 | 3293768 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.25% 10/15/25 | 5175000 | 5171766 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total US Treasury Obligations** <br> (cost $64,203,713) |  | **64402218** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral—98.78%**<br> (cost $319,327,322) |  | **308993587** |

---

[**Table of Contents**](#toc2)

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares<sup>°</sup>** | **Value (US $)** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* — 0.81%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund — 0.81% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference<br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 2533450 | $2533450 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Securities Lending Collateral** <br> (cost $2,533,450) |  | **2533450** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—99.59%** <br> (cost $321,860,772) |  | $**311,527,037■** |

---

---

| | |
|:---|:---|
| <sup>°</sup> | Principal amount shown is stated in USD unless noted that the security is denominated in another currency. |
| <sup>#</sup> | Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. At December 31, 2022, the aggregate value of Rule 144A securities was $103,019,282, which represents 32.93% of the Portfolio's net assets. See Note 12 in "Notes to financial statements." |
| <sup>•</sup> | Variable rate investment. Rates reset periodically. Rate shown reflects the rate in effect at December 31, 2022. For securities based on a published reference rate and spread, the reference rate and spread are indicated in their descriptions. The reference rate descriptions (i.e. LIBOR03M, LIBOR06M, etc.) used in this report are identical for different securities, but the underlying reference rates may differ due to the timing of the reset period. Certain variable rate securities are not based on a published reference rate and spread but are determined by the issuer or agent and are based on current market conditions, or for mortgage-backed securities, are impacted by the individual mortgages which are paying off over time. These securities do not indicate a reference rate and spread in their descriptions. |
| <sup>µ</sup> | Fixed to variable rate investment. The rate shown reflects the fixed rate in effect at December 31, 2022. Rate will reset at a future date. |
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>φ</sup> | Step coupon bond. Stated rate in effect at December 31, 2022 through maturity date. |
| <sup>\*\*</sup> | See Note 11 in "Notes to financial statements" for additional information on securities lending collateral and non-cash collateral. |
| ■ | Includes $4,253,945 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $1,910,546. |

---

The following futures contracts were outstanding at December 31, 2022:<sup>1</sup>

**Futures Contracts <br> Exchange-Traded**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Contracts to Buy (Sell) | Notional<br> Amount | Notional<br> Cost<br> (Proceeds) | Expiration<br> Date | Value/<br> Unrealized<br> Appreciation | Value/<br> Unrealized<br> Depreciation | Variation<br> Margin<br> Due from<br> (Due to)<br> Brokers |
| 160 | US Treasury 2 yr Notes | $32812500 | $32782871 | 3/31/23 | $29629 | $— | $(25000) |
| (14) | US Treasury 5 yr Notes | (1511016) | (1510764) | 3/31/23 |  | (252) | 1203 |
|  | Total Futures Contracts |  | $31272107 |  | $29629 | $(252) | $(23797) |

---

The use of futures contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The notional amounts presented above represent the Portfolio's total exposure in such contracts, whereas only the variation margin is reflected in the Portfolio's net assets.

<sup>1</sup>See Note 9 in "Notes to financial statements."<br>

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Limited-Term Bond

**Summary of abbreviations:**

CLO – Collateralized Loan Obligation

DAC – Designated Activity Company

FREMF – Freddie Mac Multifamily

GNMA – Government National Mortgage Association

ICE – Intercontinental Exchange, Inc.

LIBOR – London Interbank Offered Rate

LIBOR01M – ICE LIBOR USD 1 Month

LIBOR03M – ICE LIBOR USD 3 Month

LIBOR06M – ICE LIBOR USD 6 Month

S&P – Standard & Poor's Financial Services LLC

S.F. – Single Family

SOFR – Secured Overnight Financing Rate

TSFR03M – 3 Month Term Secured Overnight Financing Rate

USBMMY3M – US Treasury 3 Month Bill Money Market Yield

USD – US Dollar

yr – Year

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Delaware Ivy VIP Value

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 96.71%** |  |  |
| &nbsp;&nbsp;Communication Services — 7.50% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AT&T | 378700 | $6971867 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liberty Global Class C \*, † | 514773 | 10002039 |
| &nbsp;&nbsp;&nbsp;&nbsp;Meta Platforms Class A † | 79700 | 9591098 |
|  |  | 26565004 |
| &nbsp;&nbsp;Consumer Discretionary — 7.43% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;APA | 100500 | 4691340 |
| &nbsp;&nbsp;&nbsp;&nbsp;AutoZone † | 3531 | 8708082 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lowe's | 27700 | 5518948 |
| &nbsp;&nbsp;&nbsp;&nbsp;Target | 49601 | 7392533 |
|  |  | 26310903 |
| &nbsp;&nbsp;Consumer Staples — 6.82% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Philip Morris International | 127495 | 12903769 |
| &nbsp;&nbsp;&nbsp;&nbsp;Walmart | 79420 | 11260962 |
|  |  | 24164731 |
| &nbsp;&nbsp;Energy — 8.19% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exxon Mobil | 167900 | 18519370 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marathon Petroleum | 90268 | 10506293 |
|  |  | 29025663 |
| &nbsp;&nbsp;Financials — 18.77% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AGNC Investment | 1123918 | 11632551 |
| &nbsp;&nbsp;&nbsp;&nbsp;Allstate | 79800 | 10820880 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ameriprise Financial | 28099 | 8749186 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of America | 377000 | 12486240 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital One Financial ~ | 35817 | 3329548 |
| &nbsp;&nbsp;&nbsp;&nbsp;Discover Financial Services | 29900 | 2925117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Synchrony Financial | 195449 | 6422454 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo & Co. | 245475 | 10135663 |
|  |  | 66501639 |
| &nbsp;&nbsp;Healthcare — 16.07% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;CVS Health | 113824 | 10607258 |
| &nbsp;&nbsp;&nbsp;&nbsp;Elevance Health | 20871 | 10706197 |
| &nbsp;&nbsp;&nbsp;&nbsp;HCA Healthcare | 38001 | 9118720 |
| &nbsp;&nbsp;&nbsp;&nbsp;McKesson | 27151 | 10184883 |
| &nbsp;&nbsp;&nbsp;&nbsp;Regeneron |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Pharmaceuticals † | 12285 | 8863505 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals † | 25862 | 7468428 |
|  |  | 56948991 |
| &nbsp;&nbsp;Industrials — 9.96% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Lockheed Martin | 17900 | 8708171 |
| &nbsp;&nbsp;&nbsp;&nbsp;Norfolk Southern | 40487 | 9976806 |
| &nbsp;&nbsp;&nbsp;&nbsp;Parker-Hannifin | 19800 | 5761800 |
| &nbsp;&nbsp;&nbsp;&nbsp;Raytheon Technologies | 107318 | 10830533 |
|  |  | 35277310 |
| &nbsp;&nbsp;Information Technology — 7.79% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Broadcom | 18722 | 10468032 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity National Information <br> Services | 49229 | 3340188 |
| &nbsp;&nbsp;&nbsp;&nbsp;NXP Semiconductors | 32477 | 5132340 |
| &nbsp;&nbsp;&nbsp;&nbsp;Seagate Technology <br> Holdings \* | 164349 | 8646401 |
|  |  | 27586961 |
| &nbsp;&nbsp;Materials — 4.76% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Celanese | 81700 | 8353008 |
| &nbsp;&nbsp;&nbsp;&nbsp;LyondellBasell Industries <br> Class A | 102500 | 8510575 |
|  |  | 16863583 |
| &nbsp;&nbsp;Real Estate — 4.23% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;CBRE Group Class A † | 99741 | 7676067 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weyerhaeuser | 235900 | 7312900 |
|  |  | 14988967 |
| &nbsp;&nbsp;Utilities — 5.19% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Electric Power | 98800 | 9381060 |
| &nbsp;&nbsp;&nbsp;&nbsp;Exelon | 208500 | 9013455 |
|  |  | 18394515 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Common Stocks** <br> (cost $330,327,733) |  | **342628267** |
| &nbsp;&nbsp;**Short-Term Investments — 3.28%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 3.28% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund <br> – Institutional Shares <br> (seven-day effective yield <br> 4.03%) | 2900032 | 2900032 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money<br> Market Government <br> Portfolio – Class I (seven- <br> day effective yield 4.06%) | 2900033 | 2900033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial <br> Square Government Fund <br> – Institutional Shares <br> (seven-day effective yield <br> 4.23%) | 2900032 | 2900032 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds <br> Government Portfolio – <br> Institutional Class (seven- <br> day effective yield <br> 4.11%) | 2900032 | 2900032 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $11,600,129) |  | **11600129** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities Before <br> Options Written—99.99%** <br> (cost $341,927,862) |  | **354,228,396■** |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware Ivy VIP Value

---

| | | |
|:---|:---|:---|
|  | **Number of<br> contracts** | **Value (US $)** |
| &nbsp;&nbsp;**Options Written — (0.01%)** |  |  |
| &nbsp;&nbsp;Equity Call Options — (0.01%) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AutoZone, strike price <br> $2,500, expiration date <br> 1/20/23, notional amount <br> $(1250000) | (5) | $(22125) |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank of America, strike price <br> $43, expiration date <br> 2/17/23, notional amount <br> $(1612500) | (375) | (1313) |
| &nbsp;&nbsp;&nbsp;&nbsp;Parker-Hannifin, strike price<br> $350, expiration date <br> 2/17/23, notional amount <br> $(1505000) | (43) | (2150) |
| &nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo & Co., strike price <br> $55, expiration date <br> 1/20/23, notional amount <br> $(1721500) | (313) | (313) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Options Written** <br> (premium received $105,430) |  | **(25901)** |

---

---

| | |
|:---|:---|
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>†</sup> | Non-income producing security. |
| <sup>~</sup> | All or portion of the security has been pledged as collateral for outstanding options written. |
| ■ | Includes $6,092,738 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $6,274,773. |

---

See accompanying notes, which are an integral part of the financial statements.

[**Table of Contents**](#toc2)

Delaware VIP Global Value Equity

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks – 98.73%Δ** |  |  |
| &nbsp;&nbsp;Denmark - 2.71% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Novo Nordisk Class B | 45860 | $6192301 |
|  |  | 6192301 |
| &nbsp;&nbsp;France - 11.62% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Air Liquide | 59430 | 8422870 |
| &nbsp;&nbsp;&nbsp;&nbsp;Danone | 124890 | 6581485 |
| &nbsp;&nbsp;&nbsp;&nbsp;Orange | 491150 | 4879500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sodexo \* | 69930 | 6698166 |
|  |  | 26582021 |
| &nbsp;&nbsp;Germany - 9.63% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;adidas AG | 45200 | 6167068 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fresenius Medical Care AG & Co. | 112900 | 3694501 |
| &nbsp;&nbsp;&nbsp;&nbsp;Knorr-Bremse | 72490 | 3960547 |
| &nbsp;&nbsp;&nbsp;&nbsp;SAP | 79360 | 8188418 |
|  |  | 22010534 |
| &nbsp;&nbsp;Japan - 4.93% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asahi Group Holdings \* | 72500 | 2275431 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kao \* | 137000 | 5485637 |
| &nbsp;&nbsp;&nbsp;&nbsp;Makita | 150100 | 3522615 |
|  |  | 11283683 |
| &nbsp;&nbsp;Netherlands - 4.94% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Koninklijke Ahold Delhaize | 393280 | 11299280 |
|  |  | 11299280 |
| &nbsp;&nbsp;Spain - 3.79% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amadeus IT Group † | 166860 | 8671772 |
|  |  | 8671772 |
| &nbsp;&nbsp;Sweden - 7.79% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Essity Class B | 255490 | 6691560 |
| &nbsp;&nbsp;&nbsp;&nbsp;H & M Hennes & Mauritz <br> Class B \* | 398820 | 4289813 |
| &nbsp;&nbsp;&nbsp;&nbsp;Securitas Class B \* | 820970 | 6841646 |
|  |  | 17823019 |
| &nbsp;&nbsp;Switzerland - 2.75% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Swatch Group | 22130 | 6294479 |
|  |  | 6294479 |
| &nbsp;&nbsp;United Kingdom - 13.89% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Diageo | 213010 | 9399423 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intertek Group | 93940 | 4581364 |
| &nbsp;&nbsp;&nbsp;&nbsp;Smith & Nephew | 616820 | 8273592 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unilever | 188280 | 9519114 |
|  |  | 31773493 |
| &nbsp;&nbsp;United States - 36.68% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Clorox | 61340 | 8607842 |
| &nbsp;&nbsp;&nbsp;&nbsp;Conagra Brands | 77180 | 2986866 |
| &nbsp;&nbsp;&nbsp;&nbsp;Henry Schein † | 116800 | 9328816 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ingredion | 72350 | 7085236 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kimberly-Clark | 61980 | 8413785 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lamb Weston Holdings | 70830 | $6329369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Merck & Co. | 82120 | 9111214 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nestle | 94800 | 10984558 |
| &nbsp;&nbsp;&nbsp;&nbsp;Otis Worldwide | 31640 | 2477728 |
| &nbsp;&nbsp;&nbsp;&nbsp;Parker-Hannifin | 8880 | 2584080 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pfizer | 107720 | 5519573 |
| &nbsp;&nbsp;&nbsp;&nbsp;Roche Holding | 17130 | 5381782 |
| &nbsp;&nbsp;&nbsp;&nbsp;Visa Class A \* | 24410 | 5071422 |
|  |  | 83882271 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Common Stocks** <br> (cost $252,294,758) |  | **225812853** |
| &nbsp;&nbsp;**Exchange-Traded Fund – 0.87%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Vanguard S&P 500 ETF | 5650 | 1985071 |
| &nbsp;&nbsp;**Total Exchange-Traded Fund**<br> (cost $2,182,005) |  | **1985071** |
| &nbsp;&nbsp;**Short-Term Investments – 0.19%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds – 0.19% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund –<br> Institutional Shares (seven-day <br> effective yield 4.03%) | 107103 | 107103 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money<br> Market Government Portfolio – <br> Class I (seven-day effective <br> yield 4.06%) | 107102 | 107102 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – <br> Institutional Shares (seven-day <br> effective yield 4.23%) | 107102 | 107102 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield <br> 4.11%) | 107103 | 107103 |
| &nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $428,410) |  | **428410** |
| &nbsp;&nbsp;**Total Value of Securities Before <br> Securities Lending Collateral-99.79%** <br> (cost $254,905,173) |  | **228226334** |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware VIP Global Value Equity

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Securities Lending Collateral\*\* – 4.32%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Fund - 4.32% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dreyfus Institutional Preference <br> Government Money Market <br> Fund - Institutional Shares <br> (seven-day effective yield <br> 4.31%) | 9882610 | $9882610 |
| &nbsp;&nbsp;**Total Securities Lending Collateral**<br> (cost $9,882,610) |  | **9882610** |
| &nbsp;&nbsp;**Total Value of Securities-104.11%**<br> (cost $264,787,783) |  | $**238,108,944■** |

---

---

| | |
|:---|:---|
| <sup>Δ</sup> | Securities have been classified by country of risk. Aggregate classification by business sector has been presented on page 36 in "Security type / country and sector allocations." |
| <sup>\*</sup> | Fully or partially on loan. |
| <sup>†</sup> | Non-income producing security. |
| <sup>\*\*</sup> | See Note 11 in "Notes to financial statements" for additional information on securities lending collateral and non-cash collateral. |
| ■ | Includes $16,781,037 of securities loaned for which the counterparty pledged additional non-cash collateral valued at $7,551,767. |

---

**Summary of abbreviations:**

AG - Aktiengesellschaft

ETF - Exchange-Traded Fund

S&P - Standard & Poor's Financial Services LLC

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Delaware VIP Real Estate Securities

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;**Common Stocks — 96.87%** |  |  |
| &nbsp;&nbsp;Real Estate Operating Companies/Developer — 0.34% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;DigitalBridge Group | 8656 | $94697 |
|  |  | 94697 |
| &nbsp;&nbsp;REIT Diversified — 26.06% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Tower | 1278 | 270757 |
| &nbsp;&nbsp;&nbsp;&nbsp;Digital Realty Trust | 12545 | 1257887 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equinix | 2197 | 1439101 |
| &nbsp;&nbsp;&nbsp;&nbsp;Extra Space Storage | 6571 | 967120 |
| &nbsp;&nbsp;&nbsp;&nbsp;Public Storage | 6177 | 1730733 |
| &nbsp;&nbsp;&nbsp;&nbsp;SBA Communications | 677 | 189770 |
| &nbsp;&nbsp;&nbsp;&nbsp;VICI Properties | 43205 | 1399842 |
|  |  | 7255210 |
| &nbsp;&nbsp;REIT Healthcare — 8.82% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Healthpeak Properties | 35925 | 900640 |
| &nbsp;&nbsp;&nbsp;&nbsp;Welltower | 23710 | 1554190 |
|  |  | 2454830 |
| &nbsp;&nbsp;REIT Hotel — 2.76% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Apple Hospitality REIT | 21024 | 331759 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ryman Hospitality Properties | 3599 | 294326 |
| &nbsp;&nbsp;&nbsp;&nbsp;Xenia Hotels & Resorts | 10925 | 143992 |
|  |  | 770077 |
| &nbsp;&nbsp;REIT Industrial — 14.47% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Americold Realty Trust | 16088 | 455451 |
| &nbsp;&nbsp;&nbsp;&nbsp;First Industrial Realty Trust | 9013 | 434967 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prologis | 22175 | 2499788 |
| &nbsp;&nbsp;&nbsp;&nbsp;Rexford Industrial Realty | 10518 | 574704 |
| &nbsp;&nbsp;&nbsp;&nbsp;Summit Industrial Income REIT | 3798 | 63646 |
|  |  | 4028556 |
| &nbsp;&nbsp;REIT Multifamily — 19.88% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;American Homes 4 Rent Class A | 18385 | 554124 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity LifeStyle Properties | 8794 | 568092 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity Residential | 17745 | 1046955 |
| &nbsp;&nbsp;&nbsp;&nbsp;Essex Property Trust | 3503 | 742356 |
| &nbsp;&nbsp;&nbsp;&nbsp;Independence Realty Trust | 15393 | 259526 |
| &nbsp;&nbsp;&nbsp;&nbsp;Invitation Homes | 13365 | 396139 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mid-America Apartment <br> Communities | 957 | 150239 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sun Communities | 6331 | 905333 |
| &nbsp;&nbsp;&nbsp;&nbsp;UDR | 23536 | 911549 |
|  |  | 5534313 |
| &nbsp;&nbsp;REIT Office — 6.49% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Alexandria Real Estate Equities | 9050 | 1318313 |
| &nbsp;&nbsp;&nbsp;&nbsp;Boston Properties | 7258 | 490496 |
|  |  | 1808809 |
| &nbsp;&nbsp;REIT Retail — 18.05% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Agree Realty | 8370 | 593684 |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal Realty Investment Trust | 3855 | 389509 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kimco Realty | 34164 | 723594 |
| &nbsp;&nbsp;&nbsp;&nbsp;Kite Realty Group Trust | 26781 | 563740 |
| &nbsp;&nbsp;&nbsp;&nbsp;NETSTREIT | 16804 | 308017 |
| &nbsp;&nbsp;&nbsp;&nbsp;Realty Income | 21548 | 1366790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Simon Property Group | 6184 | 726496 |
| &nbsp;&nbsp;&nbsp;&nbsp;Spirit Realty Capital | 8846 | 353221 |
|  |  | 5025051 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Common Stocks** <br> (cost $30,865,484) |  | **26971543** |
| &nbsp;&nbsp;**Short-Term Investments — 2.67%** |  |  |
| &nbsp;&nbsp;Money Market Mutual Funds — 2.67% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – <br> Institutional Shares (seven-day <br> effective yield 4.03%) | 185465 | 185465 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market <br> Government Portfolio – Class I <br> (seven-day effective yield 4.06%) | 185465 | 185465 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square <br> Government Fund – Institutional <br> Shares (seven-day effective yield <br> 4.23%) | 185465 | 185465 |
| &nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional <br> Liquidity Funds Government <br> Portfolio – Institutional Class <br> (seven-day effective yield 4.11%) | 185465 | 185465 |
| &nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $741,860) |  | **741860** |
| &nbsp;&nbsp;**Total Value of Securities—99.54%** <br> (cost $31,607,344) |  | $**27713403** |

---

The following foreign currency exchange contracts were outstanding at December 31, 2022:<sup>1</sup>

**Foreign Currency Exchange Contracts**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Counterparty</u> | Currency to<br> Receive (Deliver) | In Exchange For | In Exchange For | Settlement<br> Date | Unrealized<br> Depreciation |
| BNYM CAD | (23474) | USD | 17305 | 1/4/23 | $(20) |

---

[**Table of Contents**](#toc2)

Schedules of investments

Delaware VIP Real Estate Securities

The use of foreign currency exchange contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The foreign currency exchange contracts presented above represent the Portfolio's total exposure in such contracts, whereas only the net unrealized appreciation (depreciation) is reflected in the Portfolio's net assets.

<sup>1</sup>See Note 9 in "Notes to financial statements."

**Summary of abbreviations:**

BNYM – Bank of New York Mellon

REIT – Real Estate Investment Trust

**Summary of currencies:**

CAD – Canadian Dollar

USD – US Dollar

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Statements of assets and liabilities

December 31, 2022

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Delaware Ivy<br> VIP Core<br> Equity | Delaware Ivy<br> VIP Corporate<br> Bond | Delaware Ivy<br> VIP Global<br> Growth | Delaware Ivy<br> VIP Limited-<br> Term Bond |
| **Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments, at value\*<sup>,†</sup> | $598048648 | $487408417 | $117150170 | $308993587 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments held as collateral for loaned securities, at value<sup>=</sup> |  | 627300 | 1033379 | 2533450 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash |  |  |  | 5198320 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash collateral due from broker on futures contracts |  |  |  | 198256 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies, at value<sup>Δ</sup> |  |  | 195821 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend and interest receivable | 404394 | 4635579 | 253310 | 2121324 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable for portfolio shares sold | 1644 | 1300 | 190 | 34597 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax reclaims receivable |  |  | 52358 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses |  | 523 |  | 186 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 1230 | 1480 | 307 | 600 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Assets | 598455916 | 492674599 | 118685535 | 319080320 |
| **Liabilities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Due to custodian |  | 45593 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for portfolio shares redeemed | 285692 | 166680 | 85521 | 148131 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for portfolio securities purchased | 284729 |  |  | 3295062 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment management fees payable to affiliates | 258586 | 202977 | 54816 | 134106 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | 158490 | 156466 | 82848 | 104548 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution fees payable to affiliates | 130213 | 106830 | 25398 | 3397 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administration expenses payable to affiliates | 62340 | 60828 | 13209 | 37452 |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligation to return securities lending collateral |  | 627300 | 1033379 | 2533450 |
| &nbsp;&nbsp;&nbsp;&nbsp;Variation margin due to broker on future contracts |  |  |  | 23797 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued capital gains taxes on appreciated securities |  |  | 122493 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | 1180050 | 1366674 | 1417664 | 6279943 |
| **Total Net Assets** | $597275866 | $491307925 | $117267871 | $312800377 |
| **Net Assets Consist of:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | $462064387 | $582864567 | $83849874 | $328800653 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total distributable earnings (loss) | 135211479 | (91556642) | 33417997 | (16000276) |
| **Total Net Assets** | $597275866 | $491307925 | $117267871 | $312800377 |
| **Net Asset Value** |  |  |  |  |
| **Class II:** |  |  |  |  |
| Net assets | $597275866 | $491307925 | $117267871 | $312800377 |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 51933531 | 109522931 | 35190208 | 68228668 |
| Net asset value per share | $11.50 | $4.49 | $3.33 | $4.58 |
| <sup>\*</sup>Investments, at cost | $522093678 | $558375684 | $107566247 | $319327322 |
| <sup>†</sup>Including securities on loan | 3782830 | 14680075 | 975442 | 4253945 |
| <sup>=</sup>Short-term investments held as collateral for loaned securities, at cost |  | 627300 | 1033379 | 2533450 |
| <sup>Δ</sup>Foreign currencies, at cost |  |  | 189583 |  |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Statements of assets and liabilities

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy <br>VIP Value | Delaware VIP <br>Global <br>Value Equity | Delaware VIP <br>Real Estate <br>Securities |
| **Assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments, at value\*<sup>,†</sup> | $354228396 | $228226334 | $27713403 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments held as collateral for loaned securities, at value<sup>=</sup> |  | 9882610 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash | 4452 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend and interest receivable | 598943 | 293741 | 116092 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax reclaims receivable | 27542 | 509391 | 169 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable for portfolio shares sold | 337 | 21487 | 17558 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 127 | 255 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable for securities sold |  |  | 24377 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivable due from Advisor |  |  | 4695 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 719 | 451 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Assets | 354860516 | 238934269 | 27876294 |
| **Liabilities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Options written, at value<sup>Σ</sup> | 25901 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Due to custodian |  | 30 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment management fees payable to affiliates | 213187 | 137814 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for portfolio shares redeemed | 120917 | 51348 | 20426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | 95239 | 128730 | 10318 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution fees payable to affiliates | 75976 | 2338 | 186 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administration expenses payable to affiliates | 39635 | 26979 | 2936 |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligation to return securities lending collateral |  | 9882610 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized depreciation on foreign currency exchange contracts |  |  | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | 570855 | 10229849 | 33886 |
| **Total Net Assets** | $354289661 | $228704420 | $27842408 |
| **Net Assets Consist of:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | $286844675 | $249935805 | $28631128 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total distributable earnings (loss) | 67444986 | (21231385) | (788720) |
| **Total Net Assets** | $354289661 | $228704420 | $27842408 |
| **Net Asset Value** |  |  |  |
| **Class II:** |  |  |  |
| Net assets | $354289661 | $228704420 | $27842408 |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 63673010 | 51874833 | 4416565 |
| Net asset value per share | $5.56 | $4.41 | $6.30 |
| \*Investments, at cost | $341927862 | $254905173 | $31607344 |
| <sup>†</sup>Including securities on loan | 6092738 | 16781037 |  |
| <sup>=</sup>Short-term investments held as collateral for loaned securities, at cost |  | 9882610 |  |
| <sup>Σ</sup>Options written, premium received | (105430) |  |  |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Statements of operations

Year ended December 31, 2022

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP Core<br> Equity | Delaware Ivy<br> VIP Corporate<br> Bond | Delaware Ivy<br> VIP Global<br> Growth | Delaware Ivy<br> VIP Limited-<br> Term Bond |
| **Investment Income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends | $8566758 | $296152 | $2070897 | $18411 |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities lending income | 1255 | 16666 | 6301 | 43774 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest |  | 17429943 |  | 7971764 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax withheld | (35560) |  | (163142) |  |
|  | 8532453 | 17742761 | 1914056 | 8033949 |
| **Expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment advisory fees | 4561159 | 2596457 | 1081781 | 1685750 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution expenses — Class II | 1628985 | 1366556 | 318171 | 842875 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounting and administration expenses | 175620 | 160527 | 62640 | 105544 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trustees' fees and expenses | 69306 | 52425 | 24355 | 41865 |
| &nbsp;&nbsp;&nbsp;&nbsp;Audit and tax fees | 32695 | 45695 | 34439 | 45108 |
| &nbsp;&nbsp;&nbsp;&nbsp;Custodian fees | 29952 | 24423 | 14278 | 8153 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal fees | 28844 | 14186 | 1552 | 6126 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend disbursing and transfer agent fees and expenses | 24124 | 20433 | 4350 | 10591 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reports and statements to shareholders servicing expenses | 17693 | 19854 | 14498 | 9804 |
| &nbsp;&nbsp;&nbsp;&nbsp;Registration fees | 7 | 7 | 7 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 17756 | 51351 | 22144 | 10006 |
|  | 6586141 | 4351914 | 1578215 | 2765829 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less expenses waived | (282062) |  | (100878) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less waived distribution expenses — Class II | (107214) |  | (38027) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 6196865 | 4351914 | 1439310 | 2765829 |
| **Net Investment Income (Loss)** | 2335588 | 13390847 | 474746 | 5268120 |
| **Net Realized and Unrealized Gain (Loss):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments | 57011657 | (33708999) | 24055570 | (9736085) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies |  |  | (10607) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange contracts |  |  | (36457) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Futures contracts |  |  |  | (1215778) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options written |  | 1950 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Swap contracts |  |  |  | 136960 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 57011657 | (33707049) | 24008506 | (10814903) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments<sup>1</sup> | (186851659) | (81820354) | (51897668) | (10016549) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies |  |  | (27158) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Futures contracts |  |  |  | 29377 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (186851659) | (81820354) | (51924826) | (9987172) |
| **Net Realized and Unrealized Gain (Loss)** | (129840002) | (115527403) | (27916320) | (20802075) |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | $(127504414) | $(102136556) | $(27441574) | $(15533955) |

---

<sup>1</sup> Includes $96,092 capital gains taxes paid and $122,493 increase in capital gains tax accrued for Delaware Ivy VIP Global Growth.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Statements of operations

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy <br>VIP Value | Delaware VIP Global <br>Value Equity | Delaware VIP <br>Real Estate <br>Securities |
| **Investment Income:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends | $8960898 | $6354696 | $909335 |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities lending income | 2718 | 69021 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign tax withheld | (19051) | (621507) | (256) |
|  | 8944565 | 5802210 | 909079 |
| **Expenses:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment advisory fees | 2630548 | 1716301 | 268335 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution expenses — Class II | 939481 | 612965 | 82820 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounting and administration expenses | 117161 | 89856 | 39705 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trustees' fees and expenses | 40260 | 44988 | 14059 |
| &nbsp;&nbsp;&nbsp;&nbsp;Audit and tax fees | 34796 | 33598 | 30660 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reports and statements to shareholders servicing expenses | 13813 | 25940 | 8177 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend disbursing and transfer agent fees and expenses | 7474 | 24450 | 2185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Custodian fees | 6426 | 28232 | 3705 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal fees | 6182 | 15389 | 1267 |
| &nbsp;&nbsp;&nbsp;&nbsp;Registration fees | 7 | 7 | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 11815 | 27392 | 6304 |
|  | 3807963 | 2619118 | 457223 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less expenses waived |  |  | (49006) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 3807963 | 2619118 | 408217 |
| **Net Investment Income (Loss)** | 5136602 | 3183092 | 500862 |
| **Net Realized and Unrealized Gain (Loss):** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) on: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments | 49395357 | 2577899 | 2648729 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies |  | 25693 | (5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange contracts |  | (170907) | (287) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options written | 624746 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 50020103 | 2432685 | 2648437 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments | (73838077) | (38176401) | (12984121) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currencies |  | (29185) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange contracts |  |  | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options written | 105054 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (73733023) | (38205586) | (12984140) |
| **Net Realized and Unrealized Gain (Loss)** | (23712920) | (35772901) | (10335703) |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | $(18576318) | $(32589809) | $(9834841) |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Statements of changes in net assets

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Core Equity | Delaware Ivy VIP<br> Core Equity | Delaware Ivy VIP<br> Corporate Bond | Delaware Ivy VIP<br> Corporate Bond |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** | **Increase (Decrease) in Net Assets from Operations:** | **Increase (Decrease) in Net Assets from Operations:** | **Increase (Decrease) in Net Assets from Operations:** | **Increase (Decrease) in Net Assets from Operations:** |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $2335588 | $1422057 | $13390847 | $13574293 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 57011657 | 131044552 | (33707049) | 15406467 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (186851659) | 57504604 | (81820354) | (33377861) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (127504414) | 189971213 | (102136556) | (4397101) |
| **Dividends and Distributions to Shareholders from:** | **Dividends and Distributions to Shareholders from:** | **Dividends and Distributions to Shareholders from:** | **Dividends and Distributions to Shareholders from:** | **Dividends and Distributions to Shareholders from:** |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (132497095) | (32448455) | (29175316) | (44859981) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 103729316 | 11448424 | 44249907 | 159640862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 132497095 | 32448455 | 29175316 | 44859981 |
|  | 236226411 | 43896879 | 73425223 | 204500843 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (114008874) | (203035096) | (118783168) | (172078010) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | 122217537 | (159138217) | (45357945) | 32422833 |
| **Net Decrease in Net Assets** | (137783972) | (1615459) | (176669817) | (16834249) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 735059838 | 736675297 | 667977742 | 684811991 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $597275866 | $735059838 | $491307925 | $667977742 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Statements of changes in net assets

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Global Growth | Delaware Ivy VIP<br> Global Growth | Delaware Ivy VIP<br> Limited-Term Bond | Delaware Ivy VIP<br> Limited-Term Bond |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $474746 | $686119 | $5268120 | $4572157 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 24008506 | 18651214 | (10814903) | 2511437 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (51924826) | 6928975 | (9987172) | (9169615) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (27441574) | 26266308 | (15533955) | (2086021) |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (19702418) | (7648661) | (7185516) | (8512000) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 3494999 | 3184819 | 40046133 | 76582643 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 19702418 | 7648661 | 7185516 | 8512000 |
|  | 23197417 | 10833480 | 47231649 | 85094643 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (18458069) | (25448721) | (102816836) | (113364993) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | 4739348 | (14615241) | (55585187) | (28270350) |
| **Net Increase (Decrease) in Net Assets** | (42404644) | 4002406 | (78304658) | (38868371) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 159672515 | 155670109 | 391105035 | 429973406 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $117267871 | $159672515 | $312800377 | $391105035 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP Value | Delaware Ivy VIP Value | Delaware VIP<br> Global Value Equity | Delaware VIP<br> Global Value Equity |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $5136602 | $4999687 | $3183092 | $6757953 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 50020103 | 105775425 | 2432685 | 65870874 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (73733023) | 15520747 | (38205586) | (22867702) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (18576318) | 126295859 | (32589809) | 49761125 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (107862773) | (8558450) | (68169217) | (7041544) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 89536158 | 13690753 | 25275803 | 18193437 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 107862773 | 8558450 | 68169217 | 7041544 |
|  | 197398931 | 22249203 | 93445020 | 25234981 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (86414422) | (235244706) | (58341351) | (88834690) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | 110984509 | (212995503) | 35103669 | (63599709) |
| **Net Decrease in Net Assets** | (15454582) | (95258094) | (65655357) | (20880128) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 369744243 | 465002337 | 294359777 | 315239905 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $354289661 | $369744243 | $228704420 | $294359777 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Statements of changes in net assets

Ivy Variable Insurance Portfolios

---

| | | |
|:---|:---|:---|
|  | Delaware VIP<br> Real Estate Securities | Delaware VIP<br> Real Estate Securities |
|  | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income (loss) | $500862 | $260655 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain (loss) | 2648437 | 4410047 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (12984140) | 8483264 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (9834841) | 13153966 |
| **Dividends and Distributions to Shareholders from:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (4613545) | (881706) |
| **Capital Share Transactions:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 3868818 | 4942031 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 4613545 | 881706 |
|  | 8482363 | 5823737 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (7599015) | (7785920) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | 883348 | (1962183) |
| **Net Increase (Decrease) in Net Assets** | (13565038) | 10310077 |
| **Net Assets:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 41407446 | 31097369 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $27842408 | $41407446 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Financial highlights

Delaware Ivy VIP Core Equity Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $17.69 | $14.36 | $12.63 | $10.80 | $12.30 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.05 | 0.03 | 0.06 | 0.06 | 0.07 |
| Net realized and unrealized gain (loss) | (3.18) | 4.01 | 2.44 | 3.10 | (0.53) |
| Total from investment operations | (3.13) | 4.04 | 2.50 | 3.16 | (0.46) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.03) | (0.09) | (0.07) | (0.07) | (0.06) |
| Net realized gain | (3.03) | (0.62) | (0.70) | (1.26) | (0.98) |
| Total dividends and distributions | (3.06) | (0.71) | (0.77) | (1.33) | (1.04) |
| **Net asset value, end of period** | $11.50 | $17.69 | $14.36 | $12.63 | $10.80 |
| **Total return<sup>2</sup>** | (17.33%) | 28.94% | 21.52% | 31.09% | (4.51%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $597276 | $735<sup>3</sup> | $737<sup>3</sup> | $723<sup>3</sup> | $626<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.95% | 0.95% | 0.95% | 0.95% | 0.95% |
| Ratio of expenses to average net assets prior to fees waived<sup>4</sup> | 1.01% | 0.99% | 1.00% | 1.00% | 1.00% |
| Ratio of net investment income to average net assets | 0.36% | 0.19% | 0.51% | 0.53% | 0.59% |
| Ratio of net investment income to average net assets prior to fees waived | 0.30% | 0.15% | 0.46% | 0.48% | 0.54% |
| Portfolio turnover | 47% | 29% | 58% | 80% | 99% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle. Total return during the period shown reflects waivers by the manager and/or distributor. Performance would have been lower had the waivers not been in effect.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Financial highlights

Delaware Ivy VIP Corporate Bond Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
|  | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $5.63 | $6.05 | $5.60 | $5.13 | $5.35 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.12 | 0.11 | 0.14 | 0.15 | 0.14 |
| Net realized and unrealized gain (loss) | (1.00) | (0.17) | 0.46 | 0.47 | (0.24) |
| Total from investment operations | (0.88) | (0.06) | 0.60 | 0.62 | (0.10) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.12) | (0.12) | (0.15) | (0.15) | (0.11) |
| Net realized gain | (0.14) | (0.24) |  |  | (0.01) |
| Total dividends and distributions | (0.26) | (0.36) | (0.15) | (0.15) | (0.12) |
| **Net asset value, end of period** | $4.49 | $5.63 | $6.05 | $5.60 | $5.13 |
| **Total return<sup>2</sup>** | (15.86%) | (0.85%) | 10.97% | 12.18% | (1.90%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $491308 | $668<sup>3</sup> | $685<sup>3</sup> | $600<sup>3</sup> | $544<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.80% | 0.76% | 0.77% | 0.77% | 0.77% |
| Ratio of net investment income to average net assets | 2.45% | 1.90% | 2.34% | 2.73% | 2.77% |
| Portfolio turnover | 67% | 85% | 95% | 66% | 63% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Delaware Ivy VIP Global Growth Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
|  | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $4.81 | $4.29 | $3.58 | $8.67 | $9.87 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.01 | 0.02 |  | 0.02 | 0.05 |
| Net realized and unrealized gain (loss) | (0.87) | 0.72 | 0.72 | 1.45 | (0.58) |
| Total from investment operations | (0.86) | 0.74 | 0.72 | 1.47 | (0.53) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.03) |  | (0.01) | (0.06) | (0.05) |
| Net realized gain | (0.59) | (0.22) |  | (6.50) | (0.62) |
| Total dividends and distributions | (0.62) | (0.22) | (0.01) | (6.56) | (0.67) |
| **Net asset value, end of period** | $3.33 | $4.81 | $4.29 | $3.58 | $8.67 |
| **Total return<sup>2</sup>** | (17.49%) | 17.86% | 20.58% | 25.93% | (6.27%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $117268 | $160<sup>3</sup> | $156<sup>3</sup> | $148<sup>3</sup> | $134<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% |
| Ratio of expenses to average net assets prior to fees waived<sup>4</sup> | 1.24% | 1.18% | 1.23% | 1.21% | 1.18% |
| Ratio of net investment income to average net assets | 0.37% | 0.43% | 0.06% | 0.41% | 0.46% |
| Ratio of net investment income (loss) to average net assets prior to fees waived | 0.26% | 0.38% | (0.04%) | 0.33% | 0.41% |
| Portfolio turnover | 72% | 22% | 33% | 26% | 40% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle. Total return during the period shown reflects waivers by the manager and/or distributor. Performance would have been lower had the waivers not been in effect.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Financial highlights

Delaware Ivy VIP Limited-Term Bond Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $4.89 | $5.01 | $4.95 | $4.84 | $4.88 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.07 | 0.05 | 0.08 | 0.09 | 0.09 |
| Net realized and unrealized gain (loss) | (0.28) | (0.07) | 0.12 | 0.11 | (0.05) |
| Total from investment operations | (0.21) | (0.02) | 0.20 | 0.20 | 0.04 |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.06) | (0.08) | (0.14) | (0.09) | (0.08) |
| Net realized gain | (0.04) | (0.02) |  |  |  |
| Total dividends and distributions | (0.10) | (0.10) | (0.14) | (0.09) | (0.08) |
| **Net asset value, end of period** | $4.58 | $4.89 | $5.01 | $4.95 | $4.84 |
| **Total return<sup>2</sup>** | (4.20%) | (0.49%) | 4.14% | 4.23% | 0.78% |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $312800 | $391<sup>3</sup> | $430<sup>3</sup> | $453<sup>3</sup> | $542<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.82% | 0.79% | 0.81% | 0.79% | 0.79% |
| Ratio of net investment income to average net assets | 1.56% | 1.05% | 1.60% | 1.89% | 1.91% |
| Portfolio turnover | 144% | 48% | 74% | 54% | 53% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Delaware Ivy VIP Value Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
|  | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $8.24 | $6.40 | $6.72 | $5.69 | $6.44 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.09 | 0.08 | 0.09 | 0.11 | 0.07 |
| Net realized and unrealized gain (loss) | (0.51) | 1.90 | (0.05) | 1.32 | (0.51) |
| Total from investment operations | (0.42) | 1.98 | 0.04 | 1.43 | (0.44) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.10) | (0.14) | (0.12) | (0.05) | (0.12) |
| Net realized gain | (2.16) |  | (0.24) | (0.35) | (0.19) |
| Total dividends and distributions | (2.26) | (0.14) | (0.36) | (0.40) | (0.31) |
| **Net asset value, end of period** | $5.56 | $8.24 | $6.40 | $6.72 | $5.69 |
| **Total return<sup>2</sup>** | (4.90%) | 31.18% | 1.98% | 26.33% | (7.24%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $354290 | $370<sup>3</sup> | $465<sup>3</sup> | $511<sup>3</sup> | $446<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 1.01% | 1.00% | 1.01% | 1.00% | 1.00% |
| Ratio of net investment income to average net assets | 1.37% | 1.11% | 1.57% | 1.81% | 1.09% |
| Portfolio turnover | 72% | 41% | 63% | 62% | 56% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Financial highlights

Delaware VIP Global Value Equity Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
|  | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $6.89 | $6.02 | $6.01 | $6.89 | $8.58 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.06 | 0.14 | 0.12 | 0.16 | 0.16 |
| Net realized and unrealized gain (loss) | (0.85) | 0.87 | 0.03 | 1.17 | (1.07) |
| Total from investment operations | (0.79) | 1.01 | 0.15 | 1.33 | (0.91) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.23) | (0.14) | (0.14) | (0.22) | (0.14) |
| Net realized gain | (1.46) |  |  | (1.99) | (0.64) |
| Total dividends and distributions | (1.69) | (0.14) | (0.14) | (2.21) | (0.78) |
| **Net asset value, end of period** | $4.41 | $6.89 | $6.02 | $6.01 | $6.89 |
| **Total return<sup>2</sup>** | (11.32%) | 16.97% | 3.15% | 23.15% | (11.68%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $228704 | $294<sup>3</sup> | $315<sup>3</sup> | $297<sup>3</sup> | $284<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 1.07% | 1.01% | 1.03% | 1.02% | 1.01% |
| Ratio of net investment income to average net assets | 1.30% | 2.14% | 2.19% | 2.52% | 2.01% |
| Portfolio turnover | 47% | 109% | 73% | 39% | 93% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Delaware VIP Real Estate Securities Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
|  | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $9.77 | $6.97 | $8.05 | $6.60 | $7.64 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.11 | 0.06 | 0.07 | 0.17 | 0.10 |
| Net realized and unrealized gain (loss) | (2.44) | 2.95 | (0.46) | 1.43 | (0.54) |
| Total from investment operations | (2.33) | 3.01 | (0.39) | 1.60 | (0.44) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.07) | (0.08) | (0.12) | (0.12) | (0.11) |
| Net realized gain | (1.07) | (0.13) | (0.57) | (0.03) | (0.49) |
| Total dividends and distributions | (1.14) | (0.21) | (0.69) | (0.15) | (0.60) |
| **Net asset value, end of period** | $6.30 | $9.77 | $6.97 | $8.05 | $6.60 |
| **Total return<sup>2</sup>** | (24.87%) | 43.68% | (3.13%) | 24.43% | (5.57%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $27842 | $41<sup>3</sup> | $31<sup>3</sup> | $35<sup>3</sup> | $34<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 1.23% | 1.21% | 1.37% | 1.26% | 1.24% |
| Ratio of expenses to average net assets prior to fees waived<sup>4</sup> | 1.38% | 1.30% | 1.46% | 1.35% | 1.33% |
| Ratio of net investment income to average net assets | 1.51% | 0.71% | 1.06% | 1.36% | 1.45% |
| Ratio of net investment income to average net assets prior to fees waived | 1.36% | 0.62% | 0.97% | 1.27% | 1.36% |
| Portfolio turnover | 59% | 57% | 72% | 54% | 71% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle. Total return during the period shown reflects waivers by the manager and/or distributor. Performance would have been lower had the waivers not been in effect.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

December 31, 2022

Ivy Variable Insurance Portfolios (Trust) is organized as a Delaware statutory trust and offers 26 portfolios. These financial statements and the related notes pertain to 7 portfolios: Delaware Ivy VIP Core Equity, Delaware Ivy VIP Corporate Bond, Delaware Ivy VIP Global Growth, Delaware Ivy VIP Limited-Term Bond, Delaware Ivy VIP Value, Delaware VIP Global Value Equity (formerly, Delaware Ivy VIP Global Equity Income), and Delaware VIP Real Estate Securities (formerly Delaware Ivy VIP Securian Real Estate Securities), (each, a Portfolio and collectively, the Portfolios). The Trust is an open-end investment company. Each of the Portfolios are diversified as defined in the Investment Company Act of 1940, as amended (1940 Act).

Each Portfolio offers Class II shares. The Class II shares carry a distribution and service (12b-1) fee. The shares of the Portfolios are sold only to variable life insurance separate accounts and variable annuity separate accounts.

**1. Significant Accounting Policies**

Each Portfolio follows accounting and reporting guidance under Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946, Financial Services — Investment Companies. The following accounting policies are in accordance with US generally accepted accounting principles (US GAAP) and are consistently followed by the Portfolios.

**Security Valuation** — Equity securities and exchange-traded funds (ETFs), except those traded on the Nasdaq Stock Market LLC (Nasdaq), are valued at the last quoted sales price as of the time of the regular close of the New York Stock Exchange on the valuation date. Equity securities and ETFs traded on the Nasdaq are valued in accordance with the Nasdaq Official Closing Price, which may not be the last sales price. If, on a particular day, an equity security or ETF does not trade, the mean between the bid and the ask prices will be used, which approximates fair value. Equity securities listed on a foreign exchange are normally valued at the last quoted sales price on the valuation date. US government and agency securities are valued at the mean between the bid and the ask prices, which approximates fair value. Other debt securities are valued based upon valuations provided by an independent pricing service or broker and reviewed by management. To the extent current market prices are not available, the pricing service may take into account developments related to the specific security, as well as transactions in comparable securities. Valuations for fixed income securities utilize matrix systems, which reflect such factors as security prices, yields, maturities, and ratings, and are supplemented by dealer and exchange quotations. For asset-backed securities, collateralized mortgage obligations (CMOs), commercial mortgage securities, and US government agency mortgage securities, pricing vendors utilize matrix pricing which considers prepayment speed, attributes of the collateral, yield or price of bonds of comparable quality, coupon, maturity, and type as well as broker/dealer-supplied prices. Foreign currency exchange contracts and foreign cross currency exchange contracts are valued at the mean between the bid and the ask prices, which approximates fair value. Interpolated values are derived when the settlement date of the contract is an interim date for which quotations are not available. Futures contracts and options on futures contracts are valued at the daily quoted settlement prices. Exchange-traded options are valued at the last reported sale price or, if no sales are reported, at the mean between the last reported bid and the ask prices, which approximates fair value. Open-end investment companies are valued at their published net asset value (NAV). Generally, other securities and assets for which market quotations are not readily available are valued at fair value as determined in good faith by each Portfolio's valuation designee, Delaware Management Company (DMC). Subject to the oversight of each Trust's Board of Trustees (Board), DMC, as valuation designee, has adopted policies and procedures to fair value securities for which market quotations are not readily available consistent with the requirements of Rule 2a-5 under the 1940 Act. In determining whether market quotations are readily available or fair valuation will be used, various factors will be taken into consideration, such as market closures or suspension of trading in a security. Restricted securities and private placements are valued at fair value.

**Federal and Foreign Income Taxes** — No provision for federal income taxes has been made as each Portfolio intends to continue to qualify for federal income tax purposes as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended, and make the requisite distributions to shareholders. Each Portfolio evaluates tax positions taken or expected to be taken in the course of preparing each Portfolio's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the "more-likely-than-not" threshold are recorded as a tax benefit or expense in the current year. Management has analyzed each Portfolio's tax positions taken or expected to be taken on each Portfolio's federal income tax returns through the year ended December 31, 2022, and for all open tax years (years ended December 31, 2019-December 31, 2021), and has concluded that no provision for federal income tax is required in each Portfolio's financial statements. In regard to foreign taxes only, each Portfolio has open tax years in certain foreign countries in which it invests in that may date back to the inception of each Portfolio. If applicable, each Portfolio recognizes interest accrued on unrecognized tax benefits in interest expense and penalties in "Other" on the "Statements of operations." During the year ended December 31, 2022, the Portfolios did not incur any interest or tax penalties. <br>

[**Table of Contents**](#toc2)

**Foreign Currency Transactions** — Transactions denominated in foreign currencies are recorded at the prevailing exchange rates on the valuation date. The value of all assets and liabilities denominated in foreign currencies is translated daily into US dollars at the exchange rate of such currencies against the US dollar. Transaction gains or losses resulting from changes in exchange rates during the reporting period or upon settlement of the foreign currency transaction are reported in operations for the current period. The Portfolios generally bifurcate that portion of realized gains and losses on investments in debt securities which is due to changes in foreign exchange rates from that which is due to changes in market prices of debt securities. That portion of gains (losses), which is due to changes in foreign exchange rates, is included on the "Statements of operations" under "Net realized gain (loss) on foreign currencies." For foreign equity securities, the realized gains and losses are included on the "Statements of operations" under "Net realized gain (loss) on investments." The Portfolios report certain foreign currency related transactions as components of realized gains (losses) for financial reporting purposes, whereas such components are treated as ordinary income (loss) for federal income tax purposes.

**Derivative Financial Instruments** — The Portfolios may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other assets without owning or taking physical custody of securities, commodities and/or other referenced assets or to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/ or other risks. Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction or illiquidity of the instrument. Pursuant to Rule 18f-4 under the 1940 Act, among other things, the Portfolios must either use derivative financial instruments with embedded leverage in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. The Portfolios' successful use of a derivative financial instrument depends on the investment adviser's ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the amount of appreciation the Portfolios can realize on an investment and/or may result in lower distributions paid to shareholders. The Portfolios' investments in these instruments, if any, are discussed in detail in the Notes to Financial Statements.

**Segregation and Collateralizations** — In certain cases, based on requirements and agreements with certain exchanges and third-party broker-dealers, the Portfolios may deliver or receive collateral in connection with certain investments (e.g., futures contracts, foreign currency exchange contracts, options written, securities with extended settlement periods, and swaps). Certain countries require that cash reserves be held while investing in companies incorporated in that country. These cash reserves and cash collateral that has been pledged/received to cover obligations of the Portfolios under derivative contracts, if any, will be reported separately on the "Statements of assets and liabilities" as cash collateral due to/from broker. Securities collateral pledged for the same purpose, if any, is noted on the "Schedules of investments."

**Use of Estimates** — The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the fair value of investments, the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and the differences could be material.

**Other** — Expenses directly attributable to a Portfolio are charged directly to that Portfolio. Other expenses common to various funds within the Delaware Funds by Macquarie<sup>®</sup> (Delaware Funds) are generally allocated among such funds on the basis of average net assets. Management fees and certain other expenses are paid monthly. Security transactions are recorded on the date the securities are purchased or sold (trade date) for financial reporting purposes. Costs used in calculating realized gains and losses on the sale of investment securities are those of the specific securities sold. Dividend income is recorded on the ex-dividend date and interest income is recorded on the accrual basis. Income and capital gain distributions from any investment companies (Underlying Funds) in which the Portfolio invests are recorded on the ex-dividend date. Discounts and premiums on debt securities are accreted or amortized to interest income, respectively, over the lives of the respective securities using the effective interest method. Premiums on callable debt securities are amortized to interest income to the earliest call date using the effective interest method. Realized gains (losses) on paydowns of asset- and mortgage-backed securities are classified as interest income. Distributions received from investments in real estate investment trusts (REITs) are recorded as dividend income on the ex-dividend date, subject to reclassification upon notice of the character of such distributions by the issuer, which are estimated. Foreign dividends are also recorded on the ex-dividend date or as soon after the ex-dividend date that the Portfolios are aware of such dividends, net of all tax withholdings, a portion of which may be reclaimable. Withholding taxes and reclaims on foreign dividends and interest have been recorded in accordance with the Portfolios' understanding of the applicable country's tax rules and rates. Each Portfolio may pay foreign capital gains taxes on certain foreign securities held, which are reported as components of realized losses for financial reporting purposes, whereas such components are treated as ordinary loss for federal income tax purposes. The Portfolios declare and pay dividends from net investment income <br>

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**1. Significant Accounting Policies (continued)**

and distributions from net realized gain on investments, if any, following the close of the fiscal year. The Portfolios may distribute more frequently, if necessary for tax purposes. Dividends and distributions, if any, are recorded on the ex-dividend date.

**2. Investment Management, Administration Agreements, and Other Transactions with Affiliates**

In accordance with the terms of its respective investment management agreement, each Portfolio pays DMC, a series of Macquarie Investment Management Business Trust and the investment manager, an annual fee which is calculated daily and paid monthly, based on each Portfolio's average daily net assets as follows:

---

| | |
|:---|:---|
| Portfolio | Management Fee (annual rate as a percentage of average daily net assets) |
| Delaware Ivy VIP Core Equity | 0.70% of net assets up to $1 billion; |
|  | 0.65% of net assets over $1 billion and up to $2 billion; |
|  | 0.60% of net assets over $2 billion and up to $3 billion; |
|  | 0.55% of net assets over $3 billion. |
| Delaware Ivy VIP Corporate Bond | 0.475% of net assets up to $1 billion; |
|  | 0.450% of net assets over $1 billion and up to $1.5 billion; |
|  | 0.40% of net assets over $1.5 billion. |
| Delaware Ivy VIP Global Growth | 0.85% of net assets up to $1 billion; |
|  | 0.83% of net assets over $1 billion and up to $2 billion; |
|  | 0.80% of net assets over $2 billion and up to $3 billion; |
|  | 0.76% of net assets over $3 billion. |
| Delaware Ivy VIP Limited-Term Bond | 0.50% of net assets up to $500 million; |
|  | 0.45% of net assets over $500 million and up to $1 billion; |
|  | 0.40% of net assets over $1 billion and up to $1.5 billion; |
|  | 0.35% of net assets over $1.5 billion. |
| Delaware Ivy VIP Value | 0.70% of net assets up to $1 billion; |
|  | 0.65% of net assets over $1 billion and up to $2 billion; |
|  | 0.60% of net assets over $2 billion and up to $3 billion; |
|  | 0.55% of net assets over $3 billion. |
| Delaware VIP Global Value Equity | 0.70% of net assets up to $1 billion; |
|  | 0.65% of net assets over $1 billion and up to $2 billion; |
|  | 0.60% of net assets over $2 billion and up to $3 billion; |
|  | 0.55% of net assets over $3 billion. |
| Delaware VIP Real Estate Securities | 0.90% of net assets up to $1 billion; |
|  | 0.87% of net assets over $1 billion and up to $2 billion; |
|  | 0.84% of net assets over $2 billion and up to $3 billion; |
|  | 0.80% of net assets over $3 billion. |

---

DMC has entered into sub-advisory agreements with the following entities on behalf of the Portfolios:

Prior to July 29, 2022, under an agreement between DMC and Securian Asset Management, Inc. (Securian AM), Securian AM served as sub-adviser to Delaware VIP Real Estate Securities. The sub-adviser made investment decisions in accordance with the Portfolio's investment objectives, policies and restrictions under the supervision of DMC and the oversight of the Board. DMC paid all applicable costs of the sub-adviser. Following July 29, 2022, under agreements between DMC and each of Macquarie Funds Management Hong Kong Limited (MFMHKL), Macquarie Investment Management Europe Limited (MIMEL) and Macquarie Investment Management Global Limited (MIMGL), each of MFMHKL, MIMEL and MIMGL serves as sub-advisor to Delaware VIP Real Estate Securities, and along with DMC, are responsible for <br>

[**Table of Contents**](#toc2)

its day to day management. In addition, each of the Portfolios may use MIMGL and MFMHKL to execute Portfolio security trades. For their services, each of MFMHKL, MIMEL and MIMGL receive a sub-advisory fee from DMC.

Each of Macquarie Investment Management Austria Kapitalanlage AG (MIMAK), MIMEL, MIMGL, and MFMHKL is an affiliate of DMC and is a part of Macquarie Asset Management (MAM). MAM is the marketing name for certain companies comprising the asset management division of Macquarie Group Limited.

With respect to Delaware Ivy VIP Core Equity, Delaware Ivy VIP Global Growth, and Delaware VIP Global Value Equity, DMC has principal responsibility for the portfolio and may utilize MIMGL and MFMHKL to execute Portfolio security trades on behalf of DMC.

With respect to Delaware Ivy VIP Corporate Bond and Delaware Ivy VIP Limited-Term Bond, DMC may seek investment advice and recommendations from MIMAK, MIMEL, and MIMGL and may permit each to exercise investment discretion in certain markets where DMC believes it will be beneficial to utilize the specialized market knowledge of each of MIMAK, MIMEL, and/or MIMGL.

Pursuant to the terms of the relevant sub-advisory agreement, an investment sub-advisory fee is paid by DMC to each Affiliated Sub-Advisor.

Prior to January 18, 2022 (for Delaware Ivy VIP Core Equity, Delaware Ivy VIP Global Growth, Delaware Ivy VIP Value and Delaware VIP Global Value Equity), January 31, 2022 (for Delaware Ivy VIP Corporate Bond and Delaware Ivy VIP Limited-Term Bond) and February 28, 2022 (for Delaware VIP Real Estate Securities), the Portfolios had an Accounting Services Agreement with Waddell & Reed Services Company (WRSCO), doing business as WI Services Company (WISC). Under the agreement, WISC acted as the agent in providing bookkeeping and accounting services and assistance to each Portfolio, including maintenance of Portfolio records, pricing of Portfolio shares and preparation of certain shareholder reports. For these services, each Portfolio paid WISC a monthly fee of one-twelfth of the annual fee based on the average net asset levels shown in the following table:

---

| | |
|:---|:---|
| (M - Millions) | Annual Fee Rate |
| $0 to $10M | $0 |
| $10 to $25M | 11496 |
| $25 to $50M | 23100 |
| $50 to $100M | 35496 |
| $100 to $200M | 48396 |
| $200 to $350M | 63204 |
| $350 to $550M | 82500 |
| $550 to $750M | 96300 |
| $750 to $1,000M | 121596 |
| Over $1,000M | 148500 |

---

In addition, each Portfolio paid WISC a monthly administrative fee at the annual rate of 0.01%, or one basis point, for the first $1 billion of net assets with no fee charged for net assets in excess of $1 billion. This fee was voluntarily waived by WISC until each Portfolio's net assets were at least $10 million and is included in "Accounting and administration expenses" on the "Statements of operations."

Effective January 18, 2022 (for Delaware Ivy VIP Core Equity, Delaware Ivy VIP Global Growth, Delaware Ivy VIP Value and Delaware VIP Global Value Equity), January 31, 2022 (for Delaware Ivy VIP Corporate Bond and Delaware Ivy VIP Limited-Term Bond) and February 28, 2022 (for Delaware VIP Real Estate Securities), Delaware Investments Fund Services Company (DIFSC), an affiliate of DMC, provides fund accounting and financial administrative oversight services to each Portfolio. For these services, DIFSC's fees are calculated daily and paid monthly, based on the aggregate daily net assets of all funds within the Delaware Funds at the following annual rates: 0.00475% of the first $35 billion; 0.0040% of the next $10 billion; 0.0025% of the next $45 billion; and 0.0015% of aggregate average daily net assets in excess of $90 billion (Total Fee). Each fund in the Delaware Funds pays a minimum of $4,000, which, in aggregate, is subtracted from the Total Fee. Each fund then pays its portion of the remainder of the Total Fee on a relative NAV basis. These amounts are included on the "Statements of operations" under "Accounting and administration expenses." From the effective dates mentioned above to December 31, 2022, each Portfolio paid for these services as follows:

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Core Equity | $18272 |
| Delaware Ivy VIP Corporate Bond | 20428 |

---

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**2. Investment Management, Administration Agreements, and Other Transactions with Affiliates (continued)**

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Global Growth | $6828 |
| Delaware Ivy VIP Limited-Term Bond | 15356 |
| Delaware Ivy VIP Value | 11976 |
| Delaware VIP Global Value Equity | 9881 |
| Delaware VIP Real Estate Securities | 3591 |

---

Prior to June 27, 2022, under a Transfer Agency Agreement between the Trust and WISC, each Portfolio reimbursed WISC for certain out-of-pocket costs. Effective June 27, 2022, DIFSC is also the transfer agent and dividend disbursing agent of the Portfolios. For these services, DIFSC's fees are calculated daily and paid monthly, at the annual rate of 0.0075% of the Portfolios' average daily net assets. This amount is included on the "Statements of operations" under "Dividend disbursing and transfer agent fees and expenses." From June 27, 2022 through December 31, 2022, each Portfolio paid for these services as follows:

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Core Equity | $19455 |
| Delaware Ivy VIP Corporate Bond | 15914 |
| Delaware Ivy VIP Global Growth | 3682 |
| Delaware Ivy VIP Limited-Term Bond | 10014 |
| Delaware Ivy VIP Value | 11435 |
| Delaware VIP Global Value Equity | 7214 |
| Delaware VIP Real Estate Securities | 949 |

---

Pursuant to a sub-transfer agency agreement between DIFSC and BNY Mellon Investment Servicing (US) Inc. (BNYMIS), effective June 27, 2022, BNYMIS provides certain sub-transfer agency services to each Portfolio. Sub-transfer agency fees are paid by each Portfolio and are also included on the "Statements of operations" under "Dividend disbursing and transfer agent fees and expenses." The fees that are calculated daily and paid as invoices are received on a monthly or quarterly basis.

Pursuant to a distribution agreement and distribution plan, each Portfolio pays DDLP, the distributor and an affiliate of DMC, an annual 12b-1 fee of 0.25% of the average daily net assets of the Class II shares. The fees are calculated daily and paid monthly.

From January 1, 2022, (except as noted below) DMC (through April 29, 2023) and WRSCO (until June 27, 2022) have contractually agreed to waive all or a portion of its investment advisory fees and/or pay/reimburse expenses (excluding acquired fund fees and expenses, taxes, interest, short sale dividend and interest expenses, brokerage fees, certain insurance costs, and nonroutine expenses or costs, including, but not limited to, those relating to reorganizations, litigation, conducting shareholder meetings, and liquidations) as follows:

---

| | |
|:---|:---|
| Portfolio | Operating expense<br> limitation as a<br> percentage of average<br> daily net assets<br> Class II Shares |
| Delaware Ivy VIP Core Equity | 0.95% |
| Delaware Ivy VIP Global Growth | 1.13% |
| Delaware VIP Real Estate Securities<sup>1</sup> | 1.21% |

---

<sup>1</sup> Effective April 29, 2022. Prior to April 29, 2022, the Portfolio's investment management fee is being reduced by 0.09% of average daily net assets.

As provided in the investment management agreement, each Portfolio bears a portion of the cost of certain resources shared with DMC, including the cost of internal personnel of DMC and/or its affiliates that provide legal and regulatory reporting services to each Portfolio. These amounts are included on the "Statements of operations" under "Legal fees." For the year ended December 31, 2022, each Portfolio paid for internal legal and regulatory reporting services provided by DMC and/or its affiliates' employees as follows: <br>

[**Table of Contents**](#toc2)

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Core Equity | $19469 |
| Delaware Ivy VIP Corporate Bond | 16371 |
| Delaware Ivy VIP Global Growth | 3844 |
| Delaware Ivy VIP Limited-Term Bond | 9990 |
| Delaware Ivy VIP Value | 11141 |
| Delaware VIP Global Value Equity | 19350 |
| Delaware VIP Real Estate Securities | 27231 |

---

Trustees' fees include expenses accrued by each Portfolio for each Trustee's retainer and meeting fees. Certain officers of DMC, DIFSC, and DDLP are officers and/or Trustees of the Trust. These officers and Trustees are paid no compensation by the Portfolios.

In addition to the management fees and other expenses of a Portfolio, a Portfolio indirectly bears the investment management fees and other expenses of any Underlying Funds including ETFs in which it invests. The amount of these fees and expenses incurred indirectly by a Portfolio will vary based upon the expense and fee levels of any Underlying Funds and the number of shares that are owned of any Underlying Funds at different times.

Cross trades for the year ended December 31, 2022, were executed by the Portfolios pursuant to procedures adopted by the Board designed to ensure compliance with Rule 17a-7 under the 1940 Act. Cross trading is the buying or selling of portfolio securities between funds of investment companies, or between a fund of an investment company and another entity, that are or could be considered affiliates by virtue of having a common investment advisor (or affiliated investment advisors), common directors/trustees and/or common officers. At its regularly scheduled meetings, the Board reviews a report related to the Portfolios' compliance with the procedures adopted by the Board. Pursuant to these procedures, for the year ended December 31, 2022, the following Portfolios engaged in Rule 17a-7 securities purchases and securities sales, which resulted in net gains or losses as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Purchases | Sales | Net realized gain (loss) |
| Delaware Ivy VIP Global Growth | $— | $1126527 | $225645 |

---

**3. Investments**

For the year ended December 31, 2022, each Portfolio made purchases and sales of investment securities other than short-term investments as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Portfolio | Purchases<br> other than<br> US government<br> securities | Purchases of<br> US government<br> securities | Sales<br> other than<br> US government<br> securities | Sales of<br> US government<br> securities |
| Delaware Ivy VIP Core Equity | $292612939 | $— | $313779660 | $— |
| Delaware Ivy VIP Corporate Bond | 331280868 | 27376931 | 412824151 | 25578414 |
| Delaware Ivy VIP Global Growth | 91042582 |  | 104455839 |  |
| Delaware Ivy VIP Limited-Term Bond | 112523462 | 365122709 | 147944870 | 389670370 |
| Delaware Ivy VIP Value | 265716406 |  | 261623242 |  |
| Delaware VIP Global Value Equity | 114719170 |  | 143580561 |  |
| Delaware VIP Real Estate Securities | 19569664 |  | 23227519 |  |

---

The tax cost of investments and derivatives includes adjustments to net unrealized appreciation (depreciation) which may not necessarily be the final tax cost basis adjustments but which approximate the tax basis unrealized gains and losses that may be realized and distributed to shareholders. At December 31, 2022, the cost and unrealized appreciation (depreciation) of investments and derivatives for federal income tax purposes for each Portfolio were as follows: <br>

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**3. Investments (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| Portfolio | Cost of<br> investments<br> and derivatives | Aggregate<br> unrealized<br> appreciation<br> of investments<br> and derivatives | Aggregate<br> unrealized<br> depreciation<br> of investments<br> and derivatives | Net unrealized<br> appreciation<br> (depreciation)<br> of investments<br> and derivatives |
| Delaware Ivy VIP Core Equity | $522768870 | $95755353 | $(20475575) | $75279778 |
| Delaware Ivy VIP Corporate Bond | 559055836 | 2325773 | (73345892) | (71020119) |
| Delaware Ivy VIP Global Growth | 109206929 | 19506586 | (10529966) | 8976620 |
| Delaware Ivy VIP Limited-Term Bond | 321892097 | 506695 | (10842378) | (10335683) |
| Delaware Ivy VIP Value | 341981816 | 46570592 | (34349913) | 12220679 |
| Delaware VIP Global Value Equity | 265015775 | 9781647 | (36688478) | (26906831) |
| Delaware VIP Real Estate Securities | 31653374 | 399740 | (4339730) | (3939990) |

---

US GAAP defines fair value as the price that each Portfolio would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. A three-level hierarchy for fair value measurements has been established based upon the transparency of inputs to the valuation of an asset or liability. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the reporting entity's own assumptions about the assumptions that market participants would use in pricing the asset or liability based on the best information available under the circumstances. Each Portfolio's investment in its entirety is assigned a level based upon the observability of the inputs which are significant to the overall valuation. The three-level hierarchy of inputs is summarized as follows:

---

| | |
|:---|:---|
| Level 1 - | Inputs are quoted prices in active markets for identical investments. (Examples: equity securities, open-end investment companies, futures contracts, and exchange-traded options contracts) |
| Level 2 - | Other observable inputs, including, but not limited to: quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks, and default rates) or other market-corroborated inputs. (Examples: debt securities, government securities, swap contracts, foreign currency exchange contracts, foreign securities utilizing international fair value pricing, broker-quoted securities, and fair valued securities) |
| Level 3 - | Significant unobservable inputs, including each Portfolio's own assumptions used to determine the fair value of investments. (Examples: broker-quoted securities and fair valued securities) |

---

Level 3 investments are valued using significant unobservable inputs. Each Portfolio may also use an income-based valuation approach in which the anticipated future cash flows of the investment are discounted to calculate fair value. Discounts may also be applied due to the nature or duration of any restrictions on the disposition of the investments. Valuations may also be based upon current market prices of securities that are comparable in coupon, rating, maturity, and industry. The derived value of a Level 3 investment may not represent the value which is received upon disposition and this could impact the results of operations. <br>

[**Table of Contents**](#toc2)

The following tables summarize the valuation of each Portfolio's investments by fair value hierarchy levels as of December 31, 2022:

---

| | |
|:---|:---|
|  | Delaware Ivy<br> VIP Core Equity |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Common Stocks | $577684181 |
| Short-Term Investments | 20364467 |
| Total Value of Securities | $598048648 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP Corporate Bond | Delaware Ivy VIP Corporate Bond | Delaware Ivy VIP Corporate Bond |
|  | Level 1 | Level 2 | Total |
| <u>Securities</u> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Agency Collateralized Mortgage Obligations | $— | $— | $— |
| Convertible Bonds |  | 1152011 | 1152011 |
| Corporate Bonds |  | 447454134 | 447454134 |
| Municipal Bonds |  | 4218921 | 4218921 |
| Non-Agency Asset-Backed Securities |  | 5854931 | 5854931 |
| Sovereign Bonds |  | 2404077 | 2404077 |
| US Treasury Obligation |  | 2015215 | 2015215 |
| Short-Term Investments | 24309128 |  | 24309128 |
| Securities Lending Collateral | 627300 |  | 627300 |
| Total Value of Securities | $24936428 | $463099289 | $488035717 |

---

---

| | |
|:---|:---|
|  | Delaware Ivy<br> VIP Global<br> Growth |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Common Stocks | $116301431 |
| Short-Term Investments | 848739 |
| Securities Lending Collateral | 1033379 |
| Total Value of Securities | $118183549 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP Limited-Term Bond | Delaware Ivy VIP Limited-Term Bond | Delaware Ivy VIP Limited-Term Bond |
|  | Level 1 | Level 2 | Total |
| <u>Securities</u> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Agency Collateralized Mortgage Obligations | $— | $509112 | $509112 |
| Agency Commercial Mortgage-Backed Securities |  | 34543251 | 34543251 |
| Agency Mortgage-Backed Security |  | 218363 | 218363 |
| Collateralized Debt Obligations |  | 22086605 | 22086605 |
| Corporate Bonds |  | 172518784 | 172518784 |
| Non-Agency Asset-Backed Securities |  | 14220874 | 14220874 |
| Supranational Banks |  | 494380 | 494380 |

---

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**3. Investments (continued)**

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy VIP Limited-Term Bond | Delaware Ivy VIP Limited-Term Bond | Delaware Ivy VIP Limited-Term Bond |
|  | Level 1 | Level 2 | Total |
| US Treasury Obligations | $— | $64402218 | $64402218 |
| Securities Lending Collateral | 2533450 |  | 2533450 |
| Total Value of Securities | $2533450 | $308993587 | $311527037 |
| <u>Derivatives<sup>1</sup></u> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Futures Contracts | $29629 | $— | $29629 |
| <u>Liabilities:</u> |  |  |  |
| Futures Contracts | $(252) | $— | $(252) |

---

<sup>1</sup> Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

---

| | |
|:---|:---|
|  | Delaware Ivy<br> VIP Value |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Common Stocks | $342628267 |
| Short-Term Investments | 11600129 |
| Total Value of Securities Before Options Written | $354228396 |
| <u>Liabilities:</u> |  |
| Options Written | $(25901) |
|  | Delaware VIP<br> Global Value<br> Equity |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Common Stocks | $225812853 |
| Exchange-Traded Fund | 1985071 |
| Short-Term Investments | 428410 |
| Securities Lending Collateral | 9882610 |
| Total Value of Securities | $238108944 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware VIP Real Estate Securities | Delaware VIP Real Estate Securities | Delaware VIP Real Estate Securities |
|  | Level 1 | Level 2 | Total |
| <u>Securities</u> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Common Stocks | $26971543 | $— | $26971543 |
| Short-Term Investments | 741860 |  | 741860 |
| Total Value of Securities | $27713403 | $— | $27713403 |

---

[**Table of Contents**](#toc2)

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware VIP Real Estate Securities | Delaware VIP Real Estate Securities | Delaware VIP Real Estate Securities |
|  | Level 1 | Level 2 | Total |
| <u>Derivatives<sup>1</sup></u> |  |  |  |
| <u>Assets:</u> |  |  |  |
| Foreign Currency Exchange Contracts | $— | $(20) | $(20) |

---

<sup>1</sup> Foreign currency exchange contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

During the year ended December 31, 2022, there were no transfers into or out of Level 3 investments that had a significant impact to each Portfolio. Each Portfolio's policy is to recognize transfers into or out of Level 3 investments based on fair value at the beginning of the reporting period.

A reconciliation of Level 3 investments is presented when a Portfolio has a significant amount of Level 3 investments at the beginning or end of the period in relation to each Portfolio's net assets. During the year ended December 31, 2022, there were no Level 3 investments.

**4. Dividend and Distribution Information**

Income and long-term capital gain distributions are determined in accordance with federal income tax regulations, which may differ from US GAAP. Additionally, distributions from net gains on foreign currency transactions and net short-term gains on sales of investment securities are treated as ordinary income for federal income tax purposes. The tax character of dividends and distributions paid during the years ended December 31, 2022 and 2021 were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Ordinary<br> income | Long-term<br> capital<br> gains | Total |
| <u>Year ended December 31, 2022:</u> |  |  |  |
| Delaware Ivy VIP Core Equity | $19922101 | $112574994 | $132497095 |
| Delaware Ivy VIP Corporate Bond | 18101806 | 11073510 | 29175316 |
| Delaware Ivy VIP Global Growth | 2435130 | 17267288 | 19702418 |
| Delaware Ivy VIP Limited-Term Bond | 5071490 | 2114026 | 7185516 |
| Delaware Ivy VIP Value | 37082297 | 70780476 | 107862773 |
| Delaware VIP Global Value Equity | 21825404 | 46343813 | 68169217 |
| Delaware VIP Real Estate Securities | 2101458 | 2512087 | 4613545 |
| <u>Year ended December 31, 2021:</u> |  |  |  |
| Delaware Ivy VIP Core Equity | 4049 | 28399 | 32448 |
| Delaware Ivy VIP Corporate Bond | 32013 | 12847 | 44860 |
| Delaware Ivy VIP Global Growth | 89 | 7560 | 7649 |
| Delaware Ivy VIP Limited-Term Bond | 8512 |  | 8512 |
| Delaware Ivy VIP Value | 8558 |  | 8558 |
| Delaware VIP Global Value Equity | 7042 |  | 7042 |
| Delaware VIP Real Estate Securities | 329 | 553 | 882 |

---

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**5. Components of Net Assets on a Tax Basis**

As of December 31, 2022, the components of net assets on a tax basis were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP<br> Core Equity | Delaware Ivy<br> VIP<br> Corporate Bond | Delaware Ivy<br> VIP<br> Global Growth |
| Shares of beneficial interest | $462064387 | $582864567 | $83849874 |
| Undistributed ordinary income | 2255334 | 13223347 | 78885 |
| Undistributed long-term capital gains | 57751879 |  | 24558987 |
| Capital loss carry forwards |  | (33707576) |  |
| Deferred directors fees | (75513) | (52293) | (34672) |
| Unrealized appreciation (depreciation) of investments, foreign currencies, and derivatives | 75279779 | (71020120) | 8814797 |
| Net assets | $597275866 | $491307925 | $117267871 |
|  | Delaware Ivy<br> VIP<br> Limited-Term<br> Bond | Delaware Ivy<br> VIP Value | Delaware VIP<br> Global Value<br> Equity |
| Shares of beneficial interest | $328800653 | $286844675 | $249935805 |
| Undistributed ordinary income | 5216736 | 8277768 | 3810692 |
| Undistributed long-term capital gains |  | 46986940 | 1900182 |
| Capital loss carryforwards | (10870955) |  |  |
| Unamortized organizational costs | (1191) |  |  |
| Deferred directors fees | (9183) | (40400) | (26464) |
| Unrealized appreciation (depreciation) of investments, foreign currencies, and derivatives | (10335683) | 12220678 | (26915795) |
| Net assets | $312800377 | $354289661 | $228704420 |
|  | Delaware VIP<br> Real Estate<br> Securities |  |  |
| Shares of beneficial interest | $28631128 |  |  |
| Undistributed ordinary income | 554395 |  |  |
| Undistributed long-term capital gains | 2601329 |  |  |
| Deferred directors fees | (4454) |  |  |
| Unrealized appreciation (depreciation) of investments, foreign currencies, and derivatives | (3939990) |  |  |
| Net assets | $27842408 |  |  |

---

Differences between components of net assets unrealized and tax cost unrealized may arise due to certain foreign currency transactions, foreign capital gains taxes, and amortization of callable bond premiums in accordance with ASU 2017-08.

The differences between book basis and tax basis components of net assets are primarily attributable to tax deferral of losses on wash sales, mark-to-market on foreign currency exchange contracts, tax treatment of passive foreign investment companies (PFICS), mark-to-market on futures, and tax deferral on straddle losses.

For financial reporting purposes, capital accounts are adjusted to reflect the tax character of permanent book/tax differences. Results of operations and net assets were not affected by these reclassifications. For the year ended December 31, 2022, the Portfolios had no reclassifications.

At December 31, 2022, capital loss carryforwards available to offset future realized capital gains are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Loss carryforward character | Loss carryforward character | |
|  | Short-term | Long-term | Total |
| Delaware Ivy VIP Corporate Bond | $17768478 | $15939098 | $33707576 |
| Delaware Ivy VIP Limited-Term Bond | 5905522 | 4965433 | 10870955 |

---

[**Table of Contents**](#toc2)

**6. Capital Shares**

Transactions in capital shares were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Core Equity | Delaware Ivy VIP<br> Core Equity | Delaware Ivy VIP<br> Corporate Bond | Delaware Ivy VIP<br> Corporate Bond | Delaware VIP<br> Global Value Equity | Delaware VIP<br> Global Value Equity |
|  | Year ended | Year ended | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 7334597 | 725598 | 9529153 | 27486227 | 5661424 | 2753932 |
| Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 11746196 | 2139397 | 6328702 | 8183440 | 15493004 | 1077479 |
|  | 19080793 | 2864995 | 15857855 | 35669667 | 21154428 | 3831411 |
| Shares redeemed: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | (8696962) | (12603405) | (24951447) | (30213037) | (12011799) | (13470189) |
| Net increase (decrease) | 10383831 | (9738410) | (9093592) | 5456630 | 9142629 | (9638778) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Global Growth | Delaware Ivy VIP<br> Global Growth | Delaware Ivy VIP<br> Limited-Term Bond | Delaware Ivy VIP<br> Limited-Term Bond | Delaware VIP<br> Real Estate Securities | Delaware VIP<br> Real Estate Securities |
|  | Year ended | Year ended | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 956613 | 697690 | 8694870 | 15426726 | 511994 | 599493 |
| Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 6062282 | 1757384 | 1555307 | 1730961 | 660966 | 112146 |
|  | 7018895 | 2455074 | 10250177 | 17157687 | 1172960 | 711639 |
| Shares redeemed: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | (4999033) | (5540553) | (22012355) | (23001819) | (995485) | (932336) |
| Net increase | 2019862 | (3085479) | (11762178) | (5844132) | 177475 | (220697) |

---

---

| | | |
|:---|:---|:---|
|  | Delaware Ivy VIP Value | Delaware Ivy VIP Value |
|  | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 13056901 | 1830507 |
| Shares issued upon reinvestment of dividends and distributions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 19434734 | 1136610 |
|  | 32491635 | 2967117 |
| Shares redeemed: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | (13697429) | (30759047) |
| Net increase (decrease) | 18794206 | (27791930) |

---

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**7. Line of Credit**

Each Portfolio, along with certain other funds in the Delaware Funds (Participants), was a participant in a $355,000,000 revolving line of credit (Agreement) intended to be used for temporary or emergency purposes as an additional source of liquidity to fund redemptions of investor shares. Under the Agreement, the Participants are charged an annual commitment fee of 0.15%, which is allocated across the Participants based on a weighted average of the respective net assets of each Participant. The Participants were permitted to borrow up to a maximum of one-third of their net assets under the Agreement. Each Participant was individually, and not jointly, liable for its particular advances, if any, under the line of credit. The line of credit available under the Agreement expired on October 31, 2022.

On October 31, 2022, each Portfolio, along with the other Participants, entered into an amendment to the Agreement for a $355,000,000 revolving line of credit to be used as described above. It operates in substantially the same manner as the original Agreement. Under the amendment to the Agreement, the Participants are charged an annual commitment fee of 0.15%, which is allocated across the Participants based on a weighted average of the respective net assets of each Participant. The line of credit available under the Agreement expires on October 30, 2023.

Each Portfolio had no amounts outstanding as of December 31, 2022, or at any time during the year then ended.

**8. Interfund Lending Program**

Pursuant to an exemptive order issued by the SEC (Order), the Ivy Funds and Ivy Variable Insurance Portfolios (collectively, the Funds only for purposes of this Note 8) have the ability to lend money to, and borrow money from, each other pursuant to a master interfund lending agreement (Interfund Lending Program). Under the Interfund Lending Program, the Funds may lend or borrow money for temporary purposes directly to or from one another (each, an Interfund Loan), subject to meeting the conditions of the Order. The interest rate to be charged on an Interfund Loan is the average of the overnight repurchase agreement rate and the short-term bank loan rate. This program is in existence but is not currently in use. The Funds made no Interfund Loans under the Interfund Lending Program during the year ended December 31, 2022.

**9. Derivatives**

US GAAP requires disclosures that enable investors to understand: (1) how and why an entity uses derivatives; (2) how they are accounted for; and (3) how they affect an entity's results of operations and financial position.

**Foreign Currency Exchange Contracts** — Each Portfolio may enter into foreign currency exchange contracts and foreign cross currency exchange contracts as a way of managing foreign exchange rate risk. Each Portfolio may enter into these contracts to fix the US dollar value of a security that it has agreed to buy or sell for the period between the date the trade was entered into and the date the security is delivered and paid for. Each Portfolio may also enter into these contracts to hedge the US dollar value of securities it already owns that are denominated in foreign currencies. In addition, each Portfolio may enter into these contracts to facilitate or expedite the settlement of portfolio transactions. The change in value is recorded as an unrealized gain or loss. When the contract is closed, a realized gain or loss is recorded equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed.

The use of foreign currency exchange contracts and foreign cross currency exchange contracts does not eliminate fluctuations in the underlying prices of the securities, but does establish a rate of exchange that can be achieved in the future. Although foreign currency exchange contracts and foreign cross currency exchange contracts limit the risk of loss due to an unfavorable change in the value of the hedged currency, they also limit any potential gain that might result should the value of the currency change favorably. In addition, each Portfolio could be exposed to risks if the counterparties to the contracts are unable to meet the terms of their contracts. Each Portfolio's maximum risk of loss from counterparty credit risk is the value of its currency exchanged with the counterparty. The risk is generally mitigated by having a netting arrangement between each Portfolio and the counterparty and by the posting of collateral by the counterparty to the Portfolio to cover each Portfolio's exposure to the counterparty. Open foreign currency exchange contracts, if any, are disclosed on the "Schedules of investments."

During the year ended December 31, 2022, Delaware Ivy VIP Global Growth and Delaware VIP Real Estate Securities used foreign currency exchange contracts to facilitate or expedite the settlement of portfolio transactions and Delaware VIP Global Value Equity used foreign currency exchange contracts to fix the US dollar value of a security between trade date and settlement date. <br>

[**Table of Contents**](#toc2)

During the year ended December 31, 2022, Delaware Ivy VIP Global Growth and Delaware VIP Global Value Equity experienced net realized and unrealized gains or losses attributable to foreign currency holdings, which are disclosed on the "Statements of operations."

**Futures Contracts** — A futures contract is an agreement in which the writer (or seller) of the contract agrees to deliver to the buyer an amount of cash or securities equal to a specific dollar amount times the difference between the value of a specific security or index at the close of the last trading day of the contract and the price at which the agreement is made. The Portfolios may use futures in the normal course of pursuing its investment objective. The Portfolios may invest in futures contracts to hedge its existing portfolio securities against fluctuations in fair value caused by changes in prevailing interest rates or market condition. Upon entering into a futures contract, the Portfolios deposit cash or pledge US government securities to a broker, equal to the minimum "initial margin" requirements of the exchange on which the contract is traded. Subsequent payments are received from the broker or paid to the broker each day, based on the daily fluctuation in the market value of the contract. These receipts or payments are known as "variation margin" and are recorded daily by the Portfolios as unrealized gains or losses until the contracts are closed. When the contracts are closed, the Portfolios record a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Risks of entering into futures contracts include potential imperfect correlation between the futures contracts and the underlying securities and the possibility of an illiquid secondary market for these instruments. When investing in futures, there is reduced counterparty credit risk to the Portfolios because futures are exchange-traded and the exchange's clearinghouse, as counterparty to all exchange-traded futures, guarantees against default. Delaware Ivy VIP Limited-Term Bond posted $198,256 cash collateral as margin for open futures contracts, which is included in "Cash collateral due from broker on futures contracts" on the "Statements of assets and liabilities." Open futures contracts, if any, are disclosed on the "Schedules of investments."

During the year ended December 31, 2022, Delaware Ivy VIP Limited-Term Bond invested in futures contracts to hedge the Portfolio's existing portfolio securities against fluctuations in value caused by changes in interest rates or market conditions.

During the year ended December 31, 2022, Delaware Ivy Limited-Term Bond experienced net realized and unrealized gains or losses attributable to futures contracts, which are disclosed on the "Statements of operations."

**Options Contracts** — During the year ended December 31, 2022, Delaware Ivy VIP Corporate Bond and Delaware Ivy VIP Value entered into options contracts in the normal course of pursuing its investment objective. The Portfolio may buy or write options contracts for any number of reasons, including without limitation: to manage each exposure to changes in securities prices caused by interest rates or market conditions and foreign currencies; as an efficient means of adjusting the Portfolio's overall exposure to certain markets; to protect the value of portfolio securities; and as a cash management tool. The Portfolio may buy or write call or put options on securities, futures, swaps, swaptions, financial indices, and foreign currencies. When the Portfolio buys an option, a premium is paid and an asset is recorded and adjusted on a daily basis to reflect the current market value of the option purchased. When the Portfolio writes an option, a premium is received and a liability is recorded and adjusted on a daily basis to reflect the current market value of the option written. Premiums received from writing options that expire unexercised are treated by the Portfolio on the expiration date as realized gains. The difference between the premium received and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is treated as realized gain or loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security in determining whether the Portfolio has a realized gain or loss. If a put option is exercised, the premium reduces the cost basis of the securities purchased by the Portfolio. The Portfolio, as writer of an option, bears the market risk of an unfavorable change in the price of the security underlying the written option. When writing options, the Portfolio is subject to minimal counterparty risk because the counterparty is only obligated to pay premiums and does not bear the market risk of an unfavorable market change. Delaware Ivy VIP Value pledged securities collateral valued at $21,381 as collateral for open options contracts. Open options contracts, if any, are disclosed on the "Schedules of investments."

During the year ended December 31, 2022, Delaware Ivy Corporate Bond and Delaware Ivy VIP Value used options contracts to receive premiums for writing options. Delaware Ivy Corporate Bond also used options contracts to manage the Portfolio's exposure to changes in securities prices caused by interest rates or market conditions and selling put options to purchase the underlying security for the Portfolio at a price lower than the current market value of the security.

During the year ended December 31, 2022, Delaware Ivy Corporate Bond and Delaware Ivy VIP Value experienced net realized and unrealized gains or losses attributable to options contracts, which are disclosed on the "Statements of operations."

**Swap Contracts** — Each Portfolio may enter into CDS contracts in the normal course of pursuing its investment objective. Each Portfolio may enter into CDS contracts in order to hedge against a credit event, to enhance total return or to gain exposure to certain securities or markets. Swap agreements are bilaterally negotiated agreements between a Portfolio and counterparty to exchange or swap investment cash flows, <br>

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**9. Derivatives (continued)**

assets, foreign currencies or market-linked returns at specified, future intervals. Swap agreements are privately negotiated in the over-the-counter market (OTC swaps). If the OTC swap entered is one of the swaps identified by a relevant regulator as a swap that is required to be cleared, then it will be cleared through a third party, known as a central counterparty or derivatives clearing organization (centrally cleared swaps).

*Credit Default Swaps.* A CDS contract is a risk-transfer instrument through which one party (purchaser of protection) transfers to another party (seller of protection) the financial risk of a credit event (as defined in the CDS agreement), as it relates to a particular reference security or basket of securities (such as an index). In exchange for the protection offered by the seller of protection, the purchaser of protection agrees to pay the seller of protection a periodic amount at a stated rate that is applied to the notional amount of the CDS contract. In addition, an upfront payment may be made or received by the Portfolio in connection with an unwinding or assignment of a CDS contract. Upon the occurrence of a credit event, the seller of protection would pay the par (or other agreed-upon) value of the reference security (or basket of securities) to the counterparty. Credit events generally include, among others, bankruptcy, failure to pay, and obligation default.

During the year ended December 31, 2022, Delaware Ivy VIP Limited-Term Bond entered into CDS contracts as a seller of protection. Periodic payments (receipts) on such contracts are accrued daily and recorded as unrealized losses (gains) on swap contracts. Upon payment (receipt), such amounts are recorded as realized losses (gains) on swap contracts. Upfront payments made or received in connection with CDS contracts are amortized over the expected life of the CDS contracts as unrealized losses (gains) on swap contracts. The change in value of CDS contracts is recorded daily as unrealized appreciation or depreciation. A realized gain or loss is recorded upon a credit event (as defined in the CDS agreement) or the maturity or termination of the agreement. Initial margin and variation margin are posted to central counterparties for centrally cleared CDS basket trades, as determined by the applicable central counterparty. During the year ended December 31, 2022, Delaware Ivy Limited-Term Bond did not enter into any CDS contracts as a purchaser of protection.

CDS contracts may involve greater risks than if the Portfolio had invested in the reference obligation directly. CDS contracts are subject to general market risk, liquidity risk, counterparty risk, and credit risk. The Portfolio's maximum risk of loss from counterparty credit risk, either as the seller of protection or the buyer of protection, is the fair value of the contract. This risk is mitigated by (1) for bilateral swap contracts, having a netting arrangement between the Portfolio and the counterparty and by the posting of collateral by the counterparty to the Portfolio to cover the Portfolio's exposure to the counterparty, and (2) for cleared swaps, trading these instruments through a central counterparty. No CDS contracts were outstanding at December 31, 2022.

During the year ended December 31, 2022, Delaware Ivy VIP Limited-Term Bond used CDS contracts to hedge against credit events.

Swaps Generally. For centrally cleared swaps, payments are received from the broker or paid to the broker each day, based on the daily fluctuation in the market value of the contract. These receipts or payments are known as "variation margin" and are recorded by the Portfolio as unrealized gains or losses until the contracts are closed. When the contracts are closed, the Portfolio records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. The value of open swaps may differ from that which would be realized in the event the Portfolio terminated its position in the contract on a given day. Risks of entering into these contracts include the potential inability of the counterparty to meet the terms of the contracts. This type of risk is generally limited to the amount of favorable movement in the value of the underlying security, instrument, or basket of instruments, if any, at the day of default. Risks also arise from potential losses from adverse market movements and such losses could exceed the unrealized amounts shown on the "Schedules of investments." The table below summarizes the average quarterly balance of derivative holdings by certain Portfolio during the year ended December 31, 2022:

---

| | | |
|:---|:---|:---|
|  | Long Derivative Volume | Long Derivative Volume |
|  | Delaware Ivy VIP <br> Corporate Bond | Delaware Ivy VIP<br> Global Growth |
| Foreign currency exchange contracts (average notional value) | $— | $112958 |
| Options contracts (average notional value)\* | 1750 |  |

---

[**Table of Contents**](#toc2)

---

| | | |
|:---|:---|:---|
|  | Long Derivative Volume | Long Derivative Volume |
|  | Delaware Ivy VIP<br> Limited-Term Bond | Delaware VIP<br> Global Value Equity |
| Foreign currency exchange contracts (average notional value) | $— | $337425 |
| Futures contracts (average notional value) | 27580241 |  |
|  | Short Derivative Volume | Short Derivative Volume |
|  | Delaware Ivy VIP<br> Corporate Bond | Delaware Ivy VIP<br> Global Growth |
| Foreign currency exchange contracts (average notional value) | $— | $2393914 |
| Options contracts (average notional value)\* | 1749 |  |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Short Derivative Volume | Short Derivative Volume | Short Derivative Volume |
|  | Delaware Ivy VIP<br> Limited-Term Bond | Delaware Ivy VIP Value | Delaware VIP<br> Global Value Equity |
| Foreign currency exchange contracts (average notional value) | $— | $— | $105915 |
| Futures contracts (average notional value) | 5422739 |  |  |
| Options contracts (average notional value)\* |  | 137352 |  |
| CDS contracts (average notional value)\*\* | 13534 |  |  |

---

---

| | |
|:---|:---|
|  | Short Derivative Volume |
|  | Delaware VIP<br> Real Estate Securities |
| Foreign currency exchange contracts (average notional value) | $5065 |

---

\* Long represents purchased options and short represents written options.

\*\* Long represents buying protection and short represents selling protection.

**10. Offsetting**

Each Portfolio entered into an International Swaps and Derivatives Association, Inc. Master Agreement (ISDA Master Agreement) or a similar agreement with certain of its derivative contract counterparties in order to better define its contractual rights and to secure rights that will help each Portfolio mitigate its counterparty risk. An ISDA Master Agreement is a bilateral agreement between each Portfolio and a counterparty that governs over-the-counter (OTC) derivatives and foreign exchange contracts and typically contains, among other things, collateral posting items and netting provisions in the event of a default and/or termination event. Under an ISDA Master Agreement, each Portfolio may, under certain circumstances, offset with the counterparty certain derivative financial instruments' payables and/or receivables with collateral held and/or posted and create one single net payment. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of default (close-out), including the bankruptcy or insolvency of the counterparty. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against the right of offset in bankruptcy, insolvency, or other events.

For financial reporting purposes, each Portfolio does not offset derivative assets and derivative liabilities that are subject to netting arrangements on the "Statements of assets and liabilities."

Securities lending transactions are entered into by the Portfolios under master securities lending agreements (each, an MSLA) which provide the right, in the event of default (including bankruptcy or insolvency), for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Portfolios, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty's bankruptcy or insolvency. Under the MSLA, the borrower can resell or re-pledge the loaned securities, and the Portfolios can reinvest cash collateral, or, upon an event of default, resell or re-pledge the collateral (see also Note 11). <br>

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**10. Offsetting (continued)**

As of December 31, 2022, the following table is a summary of the Portfolios' securities lending agreements by counterparty which are subject to offset under an MSLA:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <u>Delaware Ivy VIP Core Equity</u> |  |  |  |  |  |
| <u>Counterparty</u> | Securities<br> Loaned<br> at Value | Cash<br> Collateral<br> Received | Fair Value of<br> Non-Cash<br> Collateral<br> Received | Net<br> Collateral<br> Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $3782830 | $— | $(3782830) | $(3782830) | $— |
| <u>Delaware Ivy VIP Corporate Bond</u> |  |  |  |  |  |
| <u>Counterparty</u> | Securities<br> Loaned<br> at Value | Cash<br> Collateral<br> Received | Fair Value of<br> Non-Cash<br> Collateral<br> Received | Net<br> Collateral<br> Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $14680075 | $(202831) | $(14477244) | $(14680075) | $— |
| <u>Delaware Ivy VIP Global Growth</u> |  |  |  |  |  |
| <u>Counterparty</u> | Securities<br> Loaned<br> at Value | Cash<br> Collateral<br> Received | Fair Value of<br> Non-Cash<br> Collateral<br> Received | Net<br> Collateral<br> Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $975442 | $(975442) | $— | $(975442) | $— |
| <u>Delaware Ivy VIP Limited-Term Bond</u> |  |  |  |  |  |
| <u>Counterparty</u> | Securities<br> Loaned<br> at Value | Cash<br> Collateral<br> Received | Fair Value of<br> Non-Cash<br> Collateral<br> Received | Net<br> Collateral<br> Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $4253945 | $(2343399) | $(1910546) | $(4253945) | $— |
| <u>Delaware Ivy VIP Value</u> |  |  |  |  |  |
| <u>Counterparty</u> | Securities<br> Loaned<br> at Value | Cash<br> Collateral<br> Received | Fair Value of<br> Non-Cash<br> Collateral<br> Received | Net<br> Collateral<br> Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $6092738 | $— | $(6092738) | $(6092738) | $— |
| <u>Delaware VIP Global Value Equity</u> |  |  |  |  |  |
| <u>Counterparty</u> | Securities<br> Loaned<br> at Value | Cash<br> Collateral<br> Received | Fair Value of<br> Non-Cash<br> Collateral<br> Received | Net<br> Collateral<br> Received<sup>(a)</sup> | Net Exposure<sup>(b)</sup> |
| Bank of New York Mellon | $16781037 | $(9229270) | $(7551767) | $(16781037) | $— |

---

<sup>(a)</sup> The value of the related collateral exceeded the value of the derivatives and securities lending transactions as of December 31, 2022, as applicable.

<sup>(b)</sup> Net exposure represents the receivable (payable) that would be due from (to) the counterparty in the event of default.

**11. Securities Lending**

Each Portfolio, along with other funds in the Delaware Funds, may lend its securities pursuant to a security lending agreement (Lending Agreement) with The Bank of New York Mellon (BNY Mellon). At the time a security is loaned, the borrower must post collateral equal to the <br>

[**Table of Contents**](#toc2)

required percentage of the market value of the loaned security, including any accrued interest. The required percentage is: (1) 102% with respect to US securities and foreign securities that are denominated and payable in US dollars; and (2) 105% with respect to foreign securities. With respect to each loan, if on any business day the aggregate market value of securities collateral plus cash collateral held is less than the aggregate market value of the securities which are the subject of such loan, the borrower will be notified to provide additional collateral by the end of the following business day, which, together with the collateral already held, will be not less than the applicable initial collateral requirements for such security loan. If the aggregate market value of securities collateral and cash collateral held with respect to a security loan exceeds the applicable initial collateral requirement, upon the request of the borrower, BNY Mellon must return enough collateral to the borrower by the end of the following business day to reduce the value of the remaining collateral to the applicable initial collateral requirement for such security loan. As a result of the foregoing, the value of the collateral held with respect to a loaned security on any particular day, may be more or less than the value of the security on loan. The collateral percentage with respect to the market value of the loaned security is determined by the security lending agent.

Cash collateral received by each Portfolio of the Trust is generally invested in a series of individual separate accounts, each corresponding to a Portfolio. The investment guidelines permit each separate account to hold certain securities that would be considered eligible securities for a money market fund. Cash collateral received is generally invested in government securities; certain obligations issued by government sponsored enterprises; repurchase agreements collateralized by US Treasury securities; obligations issued by the central government of any Organization for Economic Cooperation and Development (OECD) country or its agencies, instrumentalities, or establishments; obligations of supranational organizations; commercial paper, notes, bonds, and other debt obligations; certificates of deposit, time deposits, and other bank obligations; certain money market funds; and asset-backed securities. Each Portfolio can also accept US government securities and letters of credit (non-cash collateral) in connection with securities loans.

In the event of default or bankruptcy by the lending agent, realization and/or retention of the collateral may be subject to legal proceedings. In the event the borrower fails to return loaned securities and the collateral received is insufficient to cover the value of the loaned securities and provided such collateral shortfall is not the result of investment losses, the lending agent has agreed to pay the amount of the shortfall to each Portfolio or, at the discretion of the lending agent, replace the loaned securities. Each Portfolio continues to record dividends or interest, as applicable, on the securities loaned and is subject to changes in value of the securities loaned that may occur during the term of the loan. Each Portfolio has the right under the Lending Agreement to recover the securities from the borrower on demand. With respect to security loans collateralized by non-cash collateral, each Portfolio receives loan premiums paid by the borrower. With respect to security loans collateralized by cash collateral, the earnings from the collateral investments are shared among each Portfolio, the security lending agent, and the borrower. Each Portfolio records security lending income net of allocations to the security lending agent and the borrower.

Each Portfolio may incur investment losses as a result of investing securities lending collateral. This could occur if an investment in each collateral investment account defaulted or became impaired. Under those circumstances, the value of each Portfolio's cash collateral account may be less than the amount each Portfolio would be required to return to the borrowers of the securities and each Portfolio would be required to make up for this shortfall.

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**11. Securities Lending (continued)**

The following table reflects a breakdown of transactions accounted for as secured borrowings, the gross obligation by the type of collateral pledged, and the remaining contractual maturity of those transactions as of December 31, 2022:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Securities Lending Transactions | Overnight<br> and<br> continuous | Under<br> 30 days | Between<br> 30 & 90 days | Over<br> 90 Days | Total |
| **Delaware Ivy VIP Corporate Bond** <br> Money market mutual fund | $627300 | $— | $— | $— | $627300 |
| **Delaware Ivy VIP Global Growth Money**<br> market mutual fund | 1033379 |  |  |  | 1033379 |
| **Delaware Ivy VIP Limited-Term Bond** <br> Money market mutual fund | 2533450 |  |  |  | 2533450 |
| **Delaware VIP Global Value Equity**<br> Money market mutual fund | 9882610 |  |  |  | 9882610 |

---

The following is a summary of each Portfolio's securities lending positions and related cash and non-cash collateral received as of December 31, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Values of securities on loan | Values of non-<br> cash collateral | Values of invested collateral | Total |
| Delaware Ivy VIP Core Equity | $3782830 | $3903410 | $— | $3903410 |
| Delaware Ivy VIP Corporate Bond | 14680075 | 14477244 | 627300 | 15104544 |
| Delaware Ivy VIP Global Growth | 975442 |  | 1033379 | 1033379 |
| Delaware Ivy VIP Limited-Term Bond | 4253945 | 1910546 | 2533450 | 4443996 |
| Delaware Ivy VIP Value | 6092738 | 6274773 |  | 6274773 |
| Delaware VIP Global Value Equity | 16781037 | 7551767 | 9882610 | 17434377 |

---

Investments purchased with cash collateral are presented on the "Schedules of investments" under the caption "Securities Lending Collateral."

**12. Credit and Market Risk**

An outbreak of infectious respiratory illness caused by a novel coronavirus known as COVID-19 was first detected in China in December 2019 and has now been detected globally. This coronavirus has resulted in travel restrictions, closed international borders, enhanced health screenings at ports of entry and elsewhere, disruption of and delays in healthcare service preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions, and lower consumer demand, as well as general concern and uncertainty. The impact of COVID-19, and other infectious illness outbreaks that may arise in the future, could adversely affect the economies of many nations or the entire global economy, individual issuers and capital markets in ways that cannot necessarily be foreseen. In addition, the impact of infectious illnesses in emerging market countries may be greater due to generally less established healthcare systems. Public health crises caused by the COVID-19 outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. The duration of the COVID-19 outbreak and its effects cannot be determined with certainty.

When interest rates rise, fixed income securities (i.e. debt obligations) generally will decline in value. These declines in value are greater for fixed income securities with longer maturities or durations.

IBOR is the risk that changes related to the use of the London interbank offered rate (LIBOR) and other interbank offered rate (collectively, IBORs) could have adverse impacts on financial instruments that reference LIBOR (or the corresponding IBOR). The abandonment of LIBOR could affect the value and liquidity of instruments that reference LIBOR. The use of alternative reference rate products may impact investment strategy performance. These risks may also apply with respect to changes in connection with other IBORs, such as the euro overnight index average (EONIA), which are also the subject of recent reform.

Investments in equity securities in general are subject to market risks that may cause their prices to fluctuate over time. Fluctuations in the value of equity securities in which the Portfolio invests will cause the NAV of the Portfolio to fluctuate.

[**Table of Contents**](#toc2)

Some countries in which the Portfolios may invest require governmental approval for the repatriation of investment income, capital, or the proceeds of sales of securities by foreign investors. In addition, if there is deterioration in a country's balance of payments or for other reasons, a country may impose temporary restrictions on foreign capital remittances abroad.

The securities exchanges of certain foreign markets are substantially smaller, less liquid, and more volatile than the major securities markets in the United States. Consequently, acquisition and disposition of securities by the Portfolios may be inhibited. In addition, a significant portion of the aggregate market value of securities listed on the major securities exchanges in emerging markets is held by a smaller number of investors. This may limit the number of shares available for acquisition or disposition by the Portfolios.

Certain Portfolios invest a portion of its assets in high yield fixed income securities, which are securities rated lower than BBB- by S&P and lower than Baa3 by Moody's, or similarly rated by another nationally recognized statistical rating organization. Investments in these higher yielding securities are generally accompanied by a greater degree of credit risk than higher-rated securities. Additionally, lower-rated securities may be more susceptible to adverse economic and competitive industry conditions than investment grade securities.

Certain Portfolios invest in fixed income securities whose value is derived from an underlying pool of mortgages or consumer loans. The value of these securities is sensitive to changes in economic conditions, including delinquencies and/or defaults, and may be adversely affected by shifts in the market's perception of the issuers and changes in interest rates. Investors receive principal and interest payments as the underlying mortgages and consumer loans are paid back. Some of these securities are CMOs. CMOs are debt securities issued by US government agencies or by financial institutions and other mortgage lenders, which are collateralized by a pool of mortgages held under an indenture. Prepayment of mortgages may shorten the stated maturity of the obligations and can result in a loss of premium, if any has been paid. Certain of these securities may be stripped (securities which provide only the principal or interest feature of the underlying security). The yield to maturity on an interest-only CMO is extremely sensitive not only to changes in prevailing interest rates, but also to the rate of principal payments (including prepayments) on the related underlying mortgage assets. A rapid rate of principal payments may have a material adverse effect on a Portfolios' yield to maturity. If the underlying mortgage assets experience greater than anticipated prepayments of principal, a Portfolio may fail to fully recoup its initial investment in these securities even if the securities are rated in the highest rating categories.

Certain Portfolios invest in bank loans and other securities that may subject them to direct indebtedness risk, the risk that the Portfolios will not receive payment of principal, interest, and other amounts due in connection with these investments and will depend primarily on the financial condition of the borrower. Loans that are fully secured offer the Portfolio more protection than unsecured loans in the event of non-payment of scheduled interest or principal, although there is no assurance that the liquidation of collateral from a secured loan would satisfy the corporate borrower's obligation, or that the collateral can be liquidated. Some loans or claims may be in default at the time of purchase. Certain of the loans and the other direct indebtedness acquired by the Portfolio may involve revolving credit facilities or other standby financing commitments that obligate the Portfolio to pay additional cash on a certain date or on demand. These commitments may require each Portfolio to increase its investment in a company at a time when the Portfolio might not otherwise decide to do so (including at a time when the company's financial condition makes it unlikely that such amounts will be repaid). To the extent that each Portfolio is committed to advance additional funds, it will at all times hold and maintain cash or other high grade debt obligations in an amount sufficient to meet such commitments. When a loan agreement is purchased, the Portfolio may pay an assignment fee. On an ongoing basis, the Portfolio may receive a commitment fee based on the undrawn portion of the underlying line of credit portion of a loan agreement. Prepayment penalty fees are received upon the prepayment of a loan agreement by the borrower. Prepayment penalty, facility, commitment, consent, and amendment fees are recorded to income as earned or paid.

As the Portfolio may be required to rely upon another lending institution to collect and pass on to the Portfolio amounts payable with respect to the loan and to enforce the Portfolio's rights under the loan and other direct indebtedness, an insolvency, bankruptcy, or reorganization of the lending institution may delay or prevent the Portfolio from receiving such amounts. The highly leveraged nature of many loans may make them especially vulnerable to adverse changes in economic or market conditions. Investments in such loans and other direct indebtedness may involve additional risk to the Portfolio.

Certain Portfolios invest in certain obligations that may have liquidity protection designed to ensure that the receipt of payments due on the underlying security is timely. Such protection may be provided through guarantees, insurance policies, or letters of credit obtained by the issuer or sponsor through third parties, through various means of structuring the transaction, or through a combination of such approaches. The Portfolios will not pay any additional fees for such credit support, although the existence of credit support may increase the price of a security.

[**Table of Contents**](#toc2)

Notes to financial statements

Ivy Variable Insurance Portfolios

**12. Credit and Market Risk (continued)**

Certain Portfolios may invest in REITs and are subject to the risks associated with that industry. If a Portfolio holds real estate directly or receives rental income directly from real estate holdings, its tax status as a regulated investment company may be jeopardized. There were no direct real estate holdings during the year ended December 31, 2022. The Portfolios' REIT holdings are also affected by interest rate changes, particularly if the REITs they hold use floating rate debt to finance their ongoing operations. The Portfolios also invest in real estate acquired as a result of ownership of securities or other instruments, including issuers that invest, deal, or otherwise engage in transactions in real estate or interests therein. These instruments may include interests in private equity limited partnerships or limited liability companies that hold real estate investments (Real Estate Limited Partnerships). The Portfolios will limit their investments in Real Estate Limited Partnerships to 5% of their total assets at the time of purchase.

Each Portfolio may invest up to 15% of its net assets in illiquid securities, which may include securities with contractual restrictions on resale, securities exempt from registration under Rule 144A promulgated under the Securities Act of 1933, as amended and other securities which may not be readily marketable. The relative illiquidity of these securities may impair each Portfolio from disposing of them in a timely manner and at a fair price when it is necessary or desirable to do so. While maintaining oversight, the Board has delegated to DMC, the day-to-day functions of determining whether individual securities are liquid for purposes of the Portfolios' limitation on investments in illiquid securities. Securities eligible for resale pursuant to Rule 144A, which are determined to be liquid, are not subject to the Portfolios' 15% limit on investments in illiquid securities. Rule 144A securities have been identified on the "Schedules of investments."

**13. Contractual Obligations**

Each Portfolio enters into contracts in the normal course of business that contain a variety of indemnifications. Each Portfolio's maximum exposure under these arrangements is unknown. However, each Portfolio has not had prior claims or losses pursuant to these contracts. Management has reviewed each Portfolio's existing contracts and expects the risk of loss to be remote.

**14. Recent Accounting Pronouncements**

In March 2020, FASB issued an Accounting Standards Update (ASU), ASU 2020-04, Reference Rate Reform (Topic 848) – Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in ASU 2020-04 provide optional temporary financial reporting relief from the effect of certain types of contract modifications due to the planned discontinuation of LIBOR and other interbank-offered based reference rates as of the end of 2021. In March 2021, the administrator for LIBOR announced the extension of the publication of a majority of the USD LIBOR settings to June 30, 2023. On December 21, 2022, FASB issued ASU 2022-06 to defer the sunset date of Accounting Standards Codification Topic 848 until December 31, 2024. ASU 2020-04 is effective for certain reference rate-related contract modifications that occur during the period March 12, 2020 through December 31, 2024. Management is currently evaluating ASU 2020-04 and ASU 2022-06, but does not believe there will be a material impact.

**15. Subsequent Events**

Management has determined that no material events or transactions occurred subsequent to December 31, 2022, that would require recognition or disclosure in the Portfolios' financial statements.

[**Table of Contents**](#toc2)

Report of independent <br> registered public accounting firm

To the Board of Trustees of Ivy Variable Insurance Portfolios and Shareholders of Delaware Ivy VIP Core Equity, Delaware Ivy VIP Corporate Bond, Delaware Ivy VIP Global Growth, Delaware Ivy VIP Limited-Term Bond, Delaware Ivy VIP Value, Delaware VIP Global Value Equity and Delaware VIP Real Estate Securities

**Opinions on the Financial Statements**

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of Delaware Ivy VIP Core Equity, Delaware Ivy VIP Corporate Bond, Delaware Ivy VIP Global Growth, Delaware Ivy VIP Limited-Term Bond, Delaware Ivy VIP Value, Delaware VIP Global Value Equity and Delaware VIP Real Estate Securities (seven of the portfolios constituting Ivy Variable Insurance Portfolios, hereafter collectively referred to as the "Portfolios") as of December 31, 2022, the related statements of operations for the year ended December 31, 2022 and the statements of changes in net assets and the financial highlights for each of the two years in the period ended December 31, 2022, including the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Portfolios as of December 31, 2022, the results of each of their operations for the year December 31, 2022, and the changes in each of their net assets and each of the financial highlights for each of the two years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.

The financial statements of the Portfolios as of and for the year ended December 31, 2020 and the financial highlights for each of the periods ended on or prior to December 31, 2020 (not presented herein, other than the financial highlights) were audited by other auditors whose report dated February 12, 2021 expressed an unqualified opinion on those financial statements and financial highlights.

**Basis for Opinions**

These financial statements are the responsibility of the Portfolios' management. Our responsibility is to express an opinion on the Portfolios' financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Portfolios in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian, transfer agents and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/PricewaterhouseCoopers LLP<br> Philadelphia, Pennsylvania<br> February 23, 2023

We have served as the auditor of one or more investment companies in Delaware Funds by Macquarie<sup>®</sup> since 2010.

[**Table of Contents**](#toc2)

Other Portfolio information (Unaudited)

Ivy Variable Insurance Portfolios

**Tax Information**

All disclosures are based on financial information available as of the date of this annual report and, accordingly are subject to change. For any and all items requiring reporting, it is the intention of the Portfolio to report the maximum amount permitted under the Internal Revenue Code and the regulations thereunder.

For the fiscal year ended December 31, 2022, the Portfolios report distributions paid during the year as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | (A)<br> Long-Term<br> Capital Gains<br> Distributions<br> (Tax Basis) | (B)<br> Ordinary<br> Income<br> Distributions<br> (Tax Basis) | Total<br> Distributions<br> (Tax Basis) | (C)<br> Qualifying<br> Dividends<sup>1</sup> |
| Delaware Ivy VIP Core Equity | 84.96% | 15.04% | 100.00% | 39.17% |
| Delaware Ivy VIP Corporate Bond | 37.96% | 62.04% | 100.00% |  |
| Delaware Ivy VIP Global Growth | 87.64% | 12.36% | 100.00% | 37.74% |
| Delaware Ivy VIP Limited-Term Bond | 29.42% | 70.58% | 100.00% |  |
| Delaware Ivy VIP Value | 65.62% | 34.38% | 100.00% | 19.17% |
| Delaware VIP Global Value Equity | 67.98% | 32.02% | 100.00% | 13.27% |
| Delaware VIP Real Estate Securities | 54.45% | 45.55% | 100.00% |  |

---

(A) and (B) are based on a percentage of the Portfolio's total distributions.

(C) is based on the Portfolio's ordinary income distributions.

<sup>1</sup>Qualified dividends represent dividends which qualify for the corporate dividends received deduction.

For the fiscal year ended December 31, 2022, certain dividends paid by each Portfolio determined to be Qualified Short-Term Capital Gains may be subject to relief from US withholding for foreign shareholders, as provided by the American Jobs Creation Act of 2004, and by the Tax Relief Unemployment Insurance Reauthorization and Job Creations Act of 2010, and as extended by the American Taxpayer Relief Act of 2012. For the fiscal year ended December 31, 2022, each Portfolio reported maximum distributions of Qualified Short-Term Capital Gains as follows:

---

| | |
|:---|:---|
|  | Qualified<br> Short-Term<br> Capital Gains |
| Delaware Ivy VIP Value | $3164456 |
| Delaware VIP Global Value Equity | 845463 |

---

Each Portfolio intends to pass through foreign tax credits in the maximum amount and the gross foreign source income earned during the fiscal year 2022 by each Portfolio was as follows:

---

| | | |
|:---|:---|:---|
|  | Foreign Tax Credits | Gross Foreign Source Income Earned |
| Delaware VIP Global Value Equity | $294263 | $4264574 |

---

**Board Consideration of Investment Management Agreement and Sub-Advisory Agreements at a Meeting Held on August 9-11, 2022**

At a meeting held on August 9-11, 2022 (the "Annual Contract Renewal Meeting"), the Board of Trustees (the "Board"), including a majority of Trustees each of whom is not an "interested person" as defined under the Investment Company Act of 1940 (the "Independent Trustees"), approved the renewal of the Delaware Ivy VIP Core Equity; Delaware Ivy VIP Corporate Bond; Delaware VIP Global Value Equity (formerly, Delaware Ivy VIP Global Equity Income); Delaware Ivy VIP Global Growth; Delaware Ivy VIP Limited-Term Bond; Delaware VIP Real Estate Securities (formerly, Delaware Ivy VIP Securian Real Estate Securities); and Delaware Ivy VIP Value (each, a "Fund" and together, the "Funds") Investment Management Agreements with Delaware Management Company ("DMC"); and the Sub-Advisory Agreements with Macquarie Investment Management Global Limited ("MIMGL"), Macquarie Investment Management Austria Kapitalanlage AG ("MIMAK"), Macquarie Investment Management Europe Limited ("MIMEL"), and Macquarie Funds Management Hong Kong Limited ("MFMHKL" and together with MIMGL, MIMAK, and MIMEL, the "Affiliated Sub-Advisers").

Prior to the Meeting, including at a Board meeting held in May 2022, the Trustees conferred extensively among themselves and with representatives of DMC about these matters. Also, the Board was assisted by the applicable Investment Committee, with each Investment

[**Table of Contents**](#toc2)

Committee assisting the full Board in the discharge of its duties in reviewing investment performance and other matters throughout the year. The Independent Trustees were assisted in their evaluation of the Investment Management Agreement and the Sub-Advisory Agreements by independent legal counsel, from whom they received separate legal advice and with whom they met separately.

In providing information to the Board, DMC was guided by a detailed set of requests for information submitted to them by independent legal counsel on behalf of the Independent Trustees at the start of the Board's annual contract renewal process earlier in 2022. In considering and approving the Investment Management Agreement and the Sub-Advisory Agreements, the Trustees considered the information they believed relevant, including but not limited to the information discussed below. The Board considered not only the specific information presented in connection with the Meeting, but also the knowledge gained over time through interaction with DMC about various topics. In this regard, the Board reviewed reports of DMC at each of its quarterly meetings, which included information about, among other things, Fund performance, investment strategies, and expenses. In addition, the Investment Committees confer with portfolio managers at various times throughout the year. In considering information relating to the approval of the Funds' Investment Management Agreement and the Sub-Advisory Agreements, the Independent Trustees also received information from an independent fund consultant, JDL Consultants, LLC ("JDL").

The Board did not identify any particular information or consideration that was all-important or controlling, and each individual Trustee may have attributed different weights to various factors.

After its deliberations, the Board unanimously approved the continuation of the Investment Management Agreement and the Sub-Advisory Agreements for a one-year term. The following summarizes a number of important, but not necessarily all, factors considered by the Board in support of its approval.

**Nature, extent, and quality of services.** The Board received and considered various information regarding the nature, extent, and quality of the advisory services provided to the Funds by DMC under its Investment Management Agreement and the experience of the officers and employees of DMC who provide these services, including each Fund's portfolio manager(s). The Board's review included consideration of DMC's investment process and oversight and research and analysis capabilities, and its ability to attract and retain qualified investment professionals. The Board considered information regarding DMC's programs for risk management, including investment, operational, liquidity, valuation, and compliance risks. The Board received information with respect to the cybersecurity program and business continuity plans of DMC and its affiliates. The Board also considered non-advisory services that DMC and its affiliates provide to the Delaware Funds, including third party oversight, transfer agent, internal audit, valuation, portfolio trading, and legal and compliance. The Board took into account the benefits to shareholders of investing in a Fund that is part of a family of funds managed by an affiliate of Macquarie Group Ltd. ("Macquarie"), the parent company of DMC, and the resources available to DMC as part of Macquarie's global asset management business.

The Board received and considered various information with respect to the services provided by the Affiliated Sub-Advisers under the Sub-Advisory Agreements and the credentials and experience of the officers and employees of the Affiliated Sub-Advisers who provide these services, including each Fund's co-portfolio manager(s). The Board considered the division of responsibilities between DMC and the Affiliated Sub-Advisers and the oversight provided by DMC. The Board considered the expertise of the Affiliated Sub-Advisers with respect to certain asset classes and/or investment styles. The Affiliated Sub-Advisers are part of Macquarie's global investment platform that has offices and personnel that are located around the world. As a result, the Board noted that DMC had stated that the Affiliated Sub-Advisers can provide research, investment and trading analysis on the markets and economies of various countries in which the Funds may invest, make recommendations regarding securities and assist with security trades, as applicable. The Board took into account that the Sub-Advisory Agreements may benefit the Funds and their shareholders by permitting DMC to use the resources and talents of the Affiliated Sub-Advisers in managing the Funds.

The Board concluded that, overall, it was satisfied with the nature, extent and quality of services provided (and expected to be provided) to the Funds by DMC and the Affiliated Sub-Advisers.

**Investment performance.** The Board received and considered information with respect to the investment performance of the Funds, including performance reports and discussions with portfolio managers at meetings of the Board's Investment Committees throughout the year as well as reports provided by Broadridge Financial Solutions, an independent investment company data provider ("Broadridge"), furnished for the Annual Contract Renewal Meeting. The Broadridge reports prepared for each Fund showed its investment performance in comparison to a group of similar funds (the "Performance Universe"). The Board received a description of the methodology used by Broadridge to select the funds in the Performance Universe. Comparative annualized performance for each Fund was shown for the past 1-, 3-, 5- and 10-year or since inception periods, as applicable, ended December 31, 2021. The Board considered that the Funds were managed by Ivy Investment Management

[**Table of Contents**](#toc2)

Other Portfolio information (Unaudited)

Ivy Variable Insurance Portfolios

**Board Consideration of Investment Management Agreement and Sub-Advisory Agreements at a Meeting Held on August 9-11, 2022 (continued)**

Company prior to the acquisition of its parent company, Waddell & Reed Financial, Inc. and its subsidiaries (the "Transaction"), and that each Fund's performance prior to the closing of the Transaction on April 30, 2021 is that of its predecessor manager.

*Delaware Ivy VIP Core Equity* – The Performance Universe for the Fund consisted of the Fund and all large-cap core funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3- and 5-year periods was in the first quartile and for the 10-year period was in the second quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-, 3- and 5-year periods and underperformed its benchmark index for the 10-year period. The Board noted that the Fund was generally performing in line with its Performance Universe and benchmark during the periods under review.

*Delaware Ivy VIP Corporate Bond* – The Performance Universe for the Fund consisted of the Fund and all A-rated corporate debt funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1- and 10-year periods was in the third quartile and for the 3- and 5-year periods was in the first quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1- and 10-year periods was below the median and for the 3- and 5-year periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-year period and underperformed its benchmark for the 3-, 5- and 10-year periods. The Board, however, noted that the Fund changed its investment strategy in April 2018 to focus on corporate bonds and then also changed its investment strategy in November 2021 and that the investment performance of the current portfolio management team only began as of November 2021.

*Delaware VIP Global Value Equity* – The Performance Universe for the Fund consisted of the Fund and all equity income funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was in the fourth quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was below the median of its Performance Universe. The Board also noted that the Fund underperformed its benchmark index for the 1-, 3-, 5- and 10-year periods. The Board, however, noted that the Fund changed its investment strategy and objective in April 2018 to invest primarily in equity securities that are issued by companies of any size located largely in developed markets around the world and then also changed its investment strategy in November 2021 and that the investment performance of the current portfolio management team only began as of November 2021. The Board noted the explanations from DMC concerning the reasons for the Fund's relative performance versus the Performance Universe and its benchmark for the various periods.

*Delaware Ivy VIP Global Growth* – The Performance Universe for the Fund consisted of the Fund and all global large-cap growth funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the second quartile and for the 3-, 5- and 10-year periods was in the fourth quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-year period was above the median and for the 3-, 5- and 10-year periods was below the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 5-year period and underperformed its benchmark for the 1-, 3- and 10-year periods. The Board, however, noted that the investment performance of the current portfolio management team only began as of November 2021. The Board noted the explanations from DMC concerning the reasons for the Fund's relative performance versus the Performance Universe and its benchmark for the various periods.

*Delaware Ivy VIP Limited-Term Bond* – The Performance Universe for the Fund consisted of the Fund and all short-intermediate investment-grade debt funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3- and 5-year periods was in the third quartile and for the 10-year period was in the fourth quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was below the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 3-, 5- and 10-year periods and underperformed its benchmark for the 1-year period. The Board, however, noted that the Fund changed its investment strategy in November 2021 and that the investment performance of the current portfolio management team only began

[**Table of Contents**](#toc2)

as of November 2021. The Board noted the explanations from DMC and concerning the reasons for the Fund's relative performance versus the Performance Universe and its benchmark for the various periods.

*Delaware VIP Real Estate Securities* – The Performance Universe for the Fund consisted of the Fund and all real estate funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was in the second quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-, 3-, 5- and 10-year periods. The Board noted that the Fund was generally performing in line with its Performance Universe and benchmark during the periods under review. The Board, however, noted that the Fund's current portfolio management team, which is comprised of personnel from DMC and its Affiliated Sub-Advisers, began as of July 29, 2022 upon the termination of the sub-advisory agreement with Securian Asset Management.

*Delaware Ivy VIP Value* – The Performance Universe for the Fund consisted of the Fund and all multi-cap value funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the first quartile and for the 3-, 5- and 10-year periods was in the second quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-, 3- and 5-year periods and slightly underperformed its benchmark index for the 10-year period. The Board noted that the Fund was performing in line with its Performance Universe and benchmark during the periods under review.

**Comparative expenses.** The Board received and considered expense data for the Funds. Management provided the Board with information on pricing levels and fee structures for each Fund as of its most recently completed fiscal year. The Board also considered on the comparative analysis of contractual management fees and actual total expense ratios of each Fund versus contractual management fees and actual total expense ratios of a group of similar funds as selected by Broadridge (the "Expense Group"). In reviewing comparative costs, each Fund's contractual management fee and the actual management fee incurred by each Fund were compared with the contractual management fees (assuming all funds were similar in size to each Fund) and actual management fees, taking into account any applicable breakpoints and fee waivers, with a Fund's expense universe, which is comprised of the Fund, its Expense Group and all other similar underlying variable insurance product funds with similar 12b-1/non-12b-1 structures, excluding outliers (the "Expense Universe"). Each Fund's total expenses were also compared with those of its Expense Universe.

*Delaware Ivy VIP Core Equity* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Corporate Bond* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware VIP Global Value Equity* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Global Growth* – The expense comparisons for the Fund showed that its actual management fee was slightly above the median of its Expense Universe and its actual total expenses were slightly above its Expense Group average.

*Delaware Ivy VIP Limited-Term Bond* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were slightly above its Expense Group average.

*Delaware VIP Real Estate Securities* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Value* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

The Board also received and considered information about the nature and extent of services offered and fee rates charged by DMC to other types of clients with investment strategies similar to those of the Funds. In this regard, the Board received information about the significantly

[**Table of Contents**](#toc2)

Other Portfolio information (Unaudited)

Ivy Variable Insurance Portfolios

**Board Consideration of Investment Management Agreement and Sub-Advisory Agreements at a Meeting Held on August 9-11, 2022 (continued)** 

greater scope of services, and compliance, reporting and other legal burdens and risks of managing registered investment companies compared with those associated with managing assets of other types of clients, including third-party sub-advised fund clients, unregistered funds and separately managed accounts.

The Board noted that DMC, and not the Funds, pays the sub-advisory fees to the Affiliated Sub-Advisers and, accordingly, that the retention of the Affiliated Sub-Advisers does not increase the fees and expenses incurred by the Funds.

Based on its consideration of the factors and information it deemed relevant, including those described here, the Board determined that the compensation payable to DMC under the Investment Management Agreement and to the Affiliated Sub-Advisers under the Sub-Advisory Agreements was reasonable.

**Economies of scale.** The Board received and considered information about the potential for DMC to realize economies of scale in the provision of management services to the Fund, the difficulties of calculating economies of scale at an individual Fund level, and the extent to which potential scale benefits are shared with shareholders, including the extent to which any economies of scale are reflected in the level of management fees charged. DMC discussed its advisory fee pricing and structure for the Delaware Funds complex, including the current breakpoints. The Board noted that each Fund may also benefit from economies of scale through initial fee setting, fee waivers and expense reimbursements, as well as DMC's investment in its business, including investments in business infrastructure, technology and cybersecurity.

**Management profitability.** The Board received and considered the Investment Management Profitability Analysis that addressed the overall profitability of DMC's business in providing management and other services to each Fund and the Delaware Funds as a whole, including the methodology used by DMC in allocating costs for the purpose of determining profitability. The Board also reviewed a report prepared by JDL regarding DMC's profitability as compared to certain peer fund complexes and the Independent Trustees discussed DMC's profitability in such context with representatives from JDL. Based on its review, the Board determined that DMC's profitability was not excessive in light of the nature, extent and quality of the services provided to each Fund.

**Ancillary benefits.** The Board received and considered information regarding the extent to which DMC and its affiliates might derive ancillary benefits from fund operations, including the potential for procuring additional business as a result of the prestige and visibility associated with its role as investment manager to the Delaware Funds; the benefits from allocation of fund brokerage to improve trading efficiencies; and the fees that various affiliates received for serving as transfer agent and for overseeing fund accounting and financial administration services to the Delaware Funds. The Board received information from DMC regarding its view of the performance of its affiliates in providing transfer agent and fund accounting and financial administration oversight services and the organizational structure employed to provide these services pursuant to their contracts with the Funds.

Based on its consideration of the factors and information it deemed relevant, including the costs of providing investment management and other services to the Funds and the ongoing commitment of DMC and its affiliates to the Funds, the Board did not find that any ancillary benefits received by DMC and its affiliates were unreasonable.

**Conclusion.** Based on its review, consideration and evaluation of all factors it believed relevant, including the above-described factors and conclusions, the Board, including all of the Independent Trustees, approved the continuation of DMC's Investment Management Agreement and of the Affiliated Sub-Advisers' Sub-Advisory Agreements for an additional one-year period.

[**Table of Contents**](#toc2)

Board of trustees / directors and officers addendum

Delaware Funds by Macquarie<sup>®</sup>

A mutual fund is governed by a Board of Trustees/Directors ("Trustees"), which has oversight responsibility for the management of a fund's business affairs. Trustees establish procedures and oversee and review the performance of the investment manager, the distributor, and others who perform services for the fund. The independent fund trustees, in particular, are advocates for shareholder interests. Each trustee has served in that capacity since he or she was elected to or appointed to the Board of Trustees, and will continue to serve until his or her retirement or the election of a new trustee in his or her place. The following is a list of the Trustees and Officers with certain background and related information.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name,**<br> **Address,**<br> **and Birth Year** | **Position(s)**<br> **Held with**<br> **the Trust** | **Length of Time**<br> **Served<sup>1</sup>** | **Number of**<br> **Funds in Fund**<br> **Complex Overseen**<br> **by Trustee** | **Principal**<br> **Occupation(s)**<br> **During the**<br> **Past Five Years** | **Other**<br> **Directorships**<br> **Held by Trustee**<br> **During the**<br> **Past Five Years** |
| **Interested Trustee** | | | | | |
| **Shawn K. Lytle**<sup>2</sup> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1970 | President,<br> Chief Executive Officer,<br> and Trustee | President and<br> Chief Executive Officer<br> since August 2015<br> Trustee since<br> September 2015 | 126 | Macquarie Asset<br> Management<sup>3</sup><br> (2015–Present)<br> - Global Head of<br> Macquarie Asset<br> Management Public<br> Investments<br> (2019–Present)<br> - Head of Americas of<br> Macquarie Group<br> (2017–Present) |  |
| **Independent Trustees** |  |  |  |  |  |
| **Jerome D. Abernathy**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1959 | Trustee | Since January 2019 | 126 | Stonebrook Capital<br> Management, LLC<br> (financial<br> technology: macro<br> factors and databases)<br> - Managing Member<br> (1993-Present) |  |
| **Ann D. Borowiec**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1958 | Trustee | Since March 2015 | 126 | J.P. Morgan Chase &<br> Co. (1987-2013)<br> - Chief Executive Officer,<br> Private Wealth<br> Management (2011–<br> 2013) | Banco Santander<br> International<br> (2016–2019)<br> Santander Bank, N.A.<br> (2016-2019) |
| **Joseph W. Chow**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1953 | Trustee | Since January 2013 | 126 | Private Investor<br> (2011–Present) |  |
| **H. Jeffrey Dobbs**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1955 | Trustee | Since April 2019<sup>4</sup> | 126 | KPMG LLP<br> (2002-2015)<br> - Global Sector<br> Chairman,<br> Industrial Manufacturing<br> (2010-2015) | TechAccel LLC<br> (2015–Present)<br> PatientsVoices, Inc.<br> (2018–Present)<br> Valparaiso University<br> Board<br> (2012-Present)<br> Ivy Funds Complex<br> (2019-2021) |

---

[**Table of Contents**](#toc2)

Board of trustees / directors and officers addendum

Delaware Funds by Macquarie<sup>®</sup>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name,**<br> **Address,**<br> **and Birth Year** | **Position(s)**<br> **Held with**<br> **the Trust** | **Length of Time**<br> **Served<sup>1</sup>** | **Number of**<br> **Funds in Fund**<br> **Complex Overseen**<br> **by Trustee** | **Principal**<br> **Occupation(s)**<br> **During the**<br> **Past Five Years** | **Other**<br> **Directorships**<br> **Held by Trustee**<br> **During the**<br> **Past Five Years** |
| **John A. Fry**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1960 | Trustee | Since January 2001 | 126 | Drexel University<br> - President<br> (2010–Present) | Federal Reserve<br> Bank of Philadelphia<br> (2020–Present)<br> FS Credit Real Estate<br> Income Trust, Inc.<br> (2018–Present)<br> vTv Therapeutics Inc.<br> (2017–Present)<br> Community Health<br> Systems<br> (2004–Present)<br> Drexel Morgan & Co.<br> (2015–2019) |
| **Joseph Harroz, Jr.**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1967 | Trustee | Since November 1998<sup>4</sup> | 126 | University of Oklahoma<br> - President<br> (2020–Present)<br> - Interim President<br> (2019–2020)<br> - Vice President and<br> Dean, College of Law<br> (2010–2019)<br> Brookhaven<br> Investments LLC<br> (commercial<br> enterprises)<br> - Managing Member<br> (2019–Present)<br> St. Clair, LLC<br> (commercial<br> enterprises)<br> - Managing Member<br> (2019–Present) | OU Medicine, Inc.<br> (2020–Present)<br> Big 12 Athletic Conference<br> (2019-Present)<br> Valliance Bank<br> (2007–Present)<br> Ivy Funds Complex<br> (1998-2021) |
| **Sandra A.J. Lawrence**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1957 | Trustee | Since April 2019<sup>4</sup> | 126 | Children's Mercy<br> Hospitals and Clinics<br> (2005–2019)<br> - Chief Administrative<br> Officer<br> (2016–2019) | Brixmor Property<br> Group Inc. (2021-Present)<br> Sera Prognostics Inc.<br> (biotechnology)<br> (2021-Present)<br> Recology (resource<br> recovery) (2021-Present)<br> Evergy, Inc., Kansas City<br> Power & Light Company,<br> KCP&L Greater Missouri<br> Operations Company,<br> Westar Energy, Inc. and<br> Kansas Gas and Electric<br> Company (related utility<br> companies)<br> (2018-Present)<br> National Association of<br> Corporate Directors<br> (2017-Present)<br> Ivy Funds Complex<br> (2019-2021)<br> American Shared Hospital<br> Services (medical device)<br> (2017-2021)<br> Westar Energy (utility)<br> (2004-2018) |

---

[**Table of Contents**](#toc2)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name,**<br> **Address,**<br> **and Birth Year** | **Position(s)**<br> **Held with**<br> **the Trust** | **Length of Time**<br> **Served<sup>1</sup>** | **Number of**<br> **Funds in Fund**<br> **Complex Overseen**<br> **by Trustee** | **Principal**<br> **Occupation(s)**<br> **During the**<br> **Past Five Years** | **Other**<br> **Directorships**<br> **Held by Trustee**<br> **During the**<br> **Past Five Years** |
| **Frances A.**<br> **Sevilla-Sacasa**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1956 | Trustee | Since September 2011 | 126 | Banco Itaú International<br> - Chief Executive Officer<br> (2012–2016) | Florida Chapter of<br> National Association of<br> Corporate Directors<br> (2021-Present)<br> Callon Petroleum<br> Company (2019-Present)<br> Camden Property Trust<br> (2011-Present)<br> New Senior Investment<br> Group Inc. (2021)<br> Carrizo Oil & Gas, Inc.<br> (2018-2019) |
| **Thomas K. Whitford**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1956 | Chair and Trustee | Trustee since January<br> 2013<br> Chair since January<br> 2023 | 126 | PNC Financial Services<br> Group (1983–2013)<br> - Vice Chairman (2009-<br> 2013) | HSBC USA Inc.<br> (2014–2022)<br> HSBC North America<br> Holdings Inc.<br> (2013–2022)<br> HSBC Finance<br> Corporation<br> (2013–2018) |
| **Christianna Wood**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1959 | Trustee | Since January 2019 | 126 | Gore Creek<br> Capital, Ltd.<br> - Chief Executive Officer<br> and President (2009–<br> Present) | The Merger Fund<br> (2013–2021),<br> The Merger Fund VL<br> (2013–2021),<br> WCM Alternatives: Event-<br> Driven Fund (2013–2021),<br> and WCM<br> Alternatives: Credit Event<br> Fund (2017–2021)<br> Grange Insurance<br> (2013–Present)<br> H&R Block Corporation<br> (2008–Present) |
| **Janet L. Yeomans**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1948 | Trustee | Since April 1999 | 126 | 3M Company<br> (1995-2012)<br> - Vice President and<br> Treasurer (2006–2012) | Okabena Company<br> (2009–2017) |
| **Officers** |  |  |  |  |  |
| **David F. Connor**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1963 | Senior Vice President,<br> General Counsel, and<br> Secretary | Senior Vice President,<br> since May 2013; General<br> Counsel since May<br> 2015; Secretary since<br> October 2005 | 126 | David F. Connor has<br> served in various<br> capacities at different<br> times at Macquarie<br> Asset Management. | None<sup>5</sup> |
| **Daniel V. Geatens**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1972 | Senior Vice President<br> and Treasurer | Senior Vice President<br> and Treasurer since<br> October 2007 | 126 | Daniel V. Geatens has<br> served in various<br> capacities at different<br> times at Macquarie<br> Asset Management. | None<sup>5</sup> |

---

[**Table of Contents**](#toc2)

Board of trustees / directors and officers addendum

Delaware Funds by Macquarie<sup>®</sup>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name,**<br> **Address,**<br> **and Birth Year** | **Position(s)**<br> **Held with**<br> **the Trust** | **Length of Time**<br> **Served<sup>1</sup>** | **Number of**<br> **Funds in Fund**<br> **Complex Overseen**<br> **by Trustee** | **Principal**<br> **Occupation(s)**<br> **During the**<br> **Past Five Years** | **Other**<br> **Directorships**<br> **Held by Trustee**<br> **During the**<br> **Past Five Years** |
| **Richard Salus**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1963 | Senior Vice President<br> and Chief Financial<br> Officer | Senior Vice President<br> and Chief Financial<br> Officer since November<br> 2006 | 126 | Richard Salus has<br> served in various<br> capacities at different<br> times at Macquarie<br> Asset Management. |  |

---

<sup>1</sup> "Length of Time Served" refers to the time since the Trustee or officer began serving one or more of the Trusts in the Delaware Funds complex.

<sup>2</sup> Shawn K. Lytle is considered to be an "Interested Trustee" because he is an executive officer of the Portfolios' investment advisor.

<sup>3</sup> Macquarie Asset Management is the marketing name for certain companies comprising the asset management division of Macquarie Group, including the Portfolios' investment advisor, principal underwriter, and transfer agent.

<sup>4</sup> Includes time served on the Board of Ivy Funds prior to the date when Ivy Funds joined the Delaware Funds complex.

<sup>5</sup> David F. Connor and Daniel V. Geatens serve in similar capacities for the six portfolios of the Optimum Fund Trust, which have the same investment manager, principal underwriter, and transfer agent as the Funds. Mr. Geatens also serves as the Chief Financial Officer of the Optimum Fund Trust, and he is Chief Financial Officer and Treasurer for Macquarie Global Infrastructure Total Return Fund Inc., which has the same investment manager as the Funds.

The Statement of Additional Information for the Fund(s) includes additional information about the Trustees and Officers and is available, without charge, upon request by calling 800 523-1918. <br>

[**Table of Contents**](#toc2)

This page intentionally left blank. <br>

[**Table of Contents**](#toc2)

Each Portfolio files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year on Form N-PORT. Each Portfolio's Form N-PORT, as well as a description of the policies and procedures that each Portfolio uses to determine how to vote proxies (if any) relating to portfolio securities, is available without charge (i) upon request, by calling 800 523-1918; and (ii) on the SEC's website at sec.gov. In addition, a description of the policies and procedures that each Portfolio uses to determine how to vote proxies (if any) relating to portfolio securities and the Schedule of Investments included in each Portfolio's most recent Form N-PORT are available without charge on the Portfolios' website at delawarefunds.com/vip/literature.

Information (if any) regarding how each Portfolio voted proxies relating to portfolio securities during the most recently disclosed 12-month period ended June 30 is available without charge (i) through the Portfolios' website at delawarefunds.com/proxy; and (ii) on the SEC's website at sec.gov.

(2715369) **ANN-VIP2-0223**

---

| | |
|:---|:---|
| ![](mimdiaf4167581-ncsrsx1x1.jpg) | ![](mimdiaf4167581-ncsrsx1x2.jpg) |

---

**Annual report**

**Ivy Variable Insurance Portfolios**

Delaware Ivy VIP Pathfinder Aggressive

Delaware Ivy VIP Pathfinder Conservative

Delaware Ivy VIP Pathfinder Moderate

Delaware Ivy VIP Pathfinder Moderately Aggressive

Delaware Ivy VIP Pathfinder Moderately Conservative

Delaware Ivy VIP Pathfinder Moderate — Managed Volatility

Delaware Ivy VIP Pathfinder Moderately Aggressive — Managed Volatility

Delaware Ivy VIP Pathfinder Moderately Conservative — Managed Volatility

December 31, 2022 <br>

[**Table of Contents**](#toc3)

**Table of contents**

---

| | |
|:---|:---|
| [**Portfolio management review**](#c001) | [**1**](#c001) |
| [**Performance summaries**](#c002) | [**3**](#c002) |
| [**Disclosure of Portfolio expenses**](#c003) | [**26**](#c003) |
| [**Security type**](#c004) | [**28**](#c004) |
| [**Schedules of investments**](#c005) | [**29**](#c005) |
| [**Statements of assets and liabilities**](#c006) | [**37**](#c006) |
| [**Statements of operations**](#c007) | [**39**](#c007) |
| [**Statements of changes in net assets**](#c008) | [**41**](#c008) |
| [**Financial highlights**](#c009) | [**45**](#c009) |
| [**Notes to financial statements**.](#c010) | [**53**](#c010) |
| [**Report of independent registered public accounting firm**](#c011) | [**75**](#c011) |
| [**Other Portfolio information**](#c012) | [**76**](#c012) |
| [**Board of trustees / directors and officers addendum**](#c013) | [**82**](#c013) |

---

Macquarie Asset Management (MAM) is the asset management division of Macquarie Group. MAM is a full-service asset manager offering a diverse range of products across public and private markets including fixed income, equities, multi-asset solutions, private credit, infrastructure, renewables, natural assets, real estate, and asset finance. The Public Investments business is a part of MAM and includes the following investment advisers: Macquarie Investment Management Business Trust (MIMBT), Macquarie Funds Management Hong Kong Limited, Macquarie Investment Management Austria Kapitalanlage AG, Macquarie Investment Management Global Limited, Macquarie Investment Management Europe Limited, and Macquarie Investment Management Europe S.A.

**Other than Macquarie Bank Limited ABN 46 008 583 542 ("Macquarie Bank"), any Macquarie Group entity noted in this document is not an authorized deposit-taking institution for the purposes of the Banking Act 1959 (Commonwealth of Australia). The obligations of these other Macquarie Group entities do not represent deposits or other liabilities of Macquarie Bank. Macquarie Bank does not guarantee or otherwise provide assurance in respect of the obligations of these other Macquarie Group entities. In addition, if this document relates to an investment, (a) the investor is subject to investment risk including possible delays in repayment and loss of income and principal invested and (b) none of Macquarie Bank or any other Macquarie Group entity guarantees any particular rate of return on or the performance of the investment, nor do they guarantee repayment of capital in respect of the investment.**

The Portfolios are governed by US laws and regulations.

Unless otherwise noted, views expressed herein are current as of December 31, 2022, and subject to change for events occurring after such date.

The Portfolios are not FDIC insured and are not guaranteed. It is possible to lose the principal amount invested.

Advisory services provided by Delaware Management Company, a series of MIMBT, a US registered investment advisor.

The Portfolios are distributed by **Delaware Distributors, L.P.** (DDLP), an affiliate of MIMBT and Macquarie Group Limited.

All third-party marks cited are the property of their respective owners.© 2023 Macquarie Management Holdings, Inc. <br>

[**Table of Contents**](#toc3)

Portfolio management review

Ivy Variable Insurance Portfolios

December 31, 2022 (Unaudited)

The investment objective of Delaware Ivy VIP Pathfinder Aggressive is to seek to provide growth of capital consistent with a more aggressive level of risk as compared to the other Delaware Ivy VIP Pathfinder Portfolios.

The investment objective of Delaware Ivy VIP Pathfinder Conservative is to seek to provide total return consistent with a conservative level of risk as compared to the other Delaware Ivy VIP Pathfinder Portfolios.

The investment objective of Delaware Ivy VIP Pathfinder Moderate is to seek to provide total return consistent with a moderate level of risk compared to the other Delaware Ivy VIP Pathfinder Portfolios.

The investment objective of Delaware Ivy VIP Pathfinder Moderately Aggressive is to seek to provide growth of capital, but also to seek income consistent with a moderately aggressive level of risk as compared to the other Delaware Ivy VIP Pathfinder Portfolios.

The investment objective of Delaware Ivy VIP Pathfinder Moderately Conservative is to seek to provide total return consistent with a moderately conservative level of risk as compared to the other Delaware Ivy VIP Pathfinder Portfolios.

The investment objective of Delaware Ivy VIP Pathfinder Moderate – Managed Volatility is to seek to provide total return consistent with a moderate level of risk as compared to the other Delaware Ivy VIP Pathfinder Managed Volatility Portfolios, while seeking to manage volatility of investment return.

The investment objective of Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility is to seek to provide growth of capital, but also to seek income consistent with a moderately aggressive level of risk as compared to the other Delaware Ivy VIP Pathfinder Managed Volatility Portfolios, while seeking to manage volatility of investment return.

The investment objective of Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility is to seek to provide total return consistent with a moderately conservative level of risk compared to the other Delaware Ivy VIP Pathfinder Managed Volatility Portfolios, while seeking to manage volatility of investment return.

**Market review**

In January 2022, at the beginning of the Portfolios' fiscal year ended December 31, 2022, the US Federal Reserve was engaged in frequent and serious discussions about raising interest rates. Investors reacted by selling bonds, pushing yields higher and equity prices lower. Further downward pressure on equities resulted as Russia built up troops along the Ukraine border. The following month, Russia invaded Ukraine, prompting unprecedented sanctions including a freeze on Russian central bank reserves, an oil embargo, and a trading ban on Russian financial stocks. Equities sold off globally while commodity prices soared. Government bonds were briefly in demand as a short-term haven, but quickly resumed their downward trend.

Tighter central bank monetary policy characterized the rest of the fiscal year, with the Fed leading the way. Beginning in March, in an effort to bring inflation under control, the Fed raised the federal funds rate seven times, including four 0.75-percentage-point increases at the June, July, September, and November meetings of the Federal Open Market Committee (FOMC). As a result, the target short-term interest rate rose from a range of zero to 0.25% in January 2022 to a range of 4.25% to 4.50% by the end of the fiscal year.

Other central banks, including the Bank of England and the European Central Bank (ECB), also took repeated steps to tighten monetary policy in their jurisdictions. Meanwhile, equities and bonds posted historically poor performance throughout the period in the face of brutal headwinds and unrelenting negative news. The challenges confronting investors included soaring inflation, consequent aggressive monetary tightening, ongoing supply-chain problems, China's zero-COVID-policy-related lockdowns, the Russia-Ukraine war, and soaring energy prices. Higher energy prices and oil and gas supply disruptions hit Europe hardest as Russia cut off gas to several European Union (EU) countries. In turn, the Group of Seven (G7) nations and later the EU implemented an oil embargo.

Among major central banks, only the Bank of Japan maintained ultra-loose monetary policy as it attempted to keep Japanese yields stable by buying bonds. However, that led to a weakening of the Japanese yen, which fell to a 20-year low.

Markets rallied briefly in July 2022 when a near-term turnaround in inflation seemed possible. Despite investors' concern about economic growth slowing, stocks appreciated along with other risk-asset classes, including corporate, high yield, convertible, and emerging market bonds. A key reason for this appreciation was the decline in yields on US and euro-zone government bonds, leading to significant price gains. However, <br>

[**Table of Contents**](#toc3)

Portfolio management review

Ivy Variable Insurance Portfolios

the tide turned again in mid-August and the bear market returned for most asset classes as hope for an inflation slowdown was dashed. Central banks reaffirmed their intentions to continue aggressive tightening of monetary policy. Recession fears mounted and the energy crisis worsened as Russia announced it was shutting down a gas pipeline for maintenance. German bond yields rose sharply, and the euro fell below parity with the US dollar for the first time in 20 years.

The picture worsened further in September 2022, with heavy losses among virtually all asset classes. Energy prices continued to fall while the European inflation rate reached double-digit levels and central banks planned further interest rate hikes. In November, the markets staged a brief recovery. An anticipated interest rate hike of 0.75 percentage points at the beginning of the month was followed by poorer economic data and slightly declining inflation rates, fueling hope that rate hikes would soon slow down. Against this backdrop, both equities and bonds rose strongly. Thanks to sharply falling risk premiums, investment grade corporate and emerging market government bonds performed particularly well. The US dollar weakened, and the price of oil fell due to weaker demand. China relaxed its zero-COVID policy somewhat, but record-high infections led to new restrictions, resulting in protests and somewhat deteriorating market sentiment toward the end of the month.

Instead of a much-hoped-for year-end rally, equities and bonds suffered significant losses in December. Global inflation rates fell slightly and, as expected, the major central banks raised key interest rates, albeit by smaller amounts than before (the Fed and the ECB each raised rates by 0.50 percentage points). However, the ECB indicated that significantly higher interest rates were still needed, causing yields to rise sharply and prices to fall. In Europe, bonds lost much more than stocks, while the reverse occurred in the US, as tech stocks slipped again. China surprised many by ending its zero-COVID policy, and Japan slightly tightened its monetary policy, which helped firm up the yen. Meanwhile, the US dollar lost some ground.

**Within the Portfolios**

During the fiscal year ended December 31, 2022, the performance of the Portfolios relative to their respective benchmarks varied, reflecting the mix of returns in the underlying funds during the fiscal year and their allocation weightings. For complete, annualized performance for each Portfolio, see "Portfolio summaries."

In general, global/international equities and fixed income contributed to performance, while US equities detracted from performance. Within US equities, large- and mid-cap growth weighed on results while large-cap value helped alleviate some of the underperformance. Within global/ international equities, global value equities contributed positively while international core equities performed virtually in line with the international equity benchmark. Within fixed income, limited-term bonds helped performance while corporate investment grade bonds detracted from results given their longer-duration exposure in a rising interest rate environment. During the measurement period, we undertook modest changes in the weightings of the Portfolios' underlying funds to manage exposures commensurate with the Portfolios' investment objectives. <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Aggressive

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on March 4, 2008) | -16.72% | +4.65% | +6.22% | +8.55% |
| Current Blended Benchmark\* | -16.50% | +4.45% | +5.90% | +8.71% |

---

\*The Blended Benchmark is computed using a combination of 55% Russell 3000<sup>®</sup> Index + 30% MSCI EAFE Index + 15% Bloomberg US Credit Index.

Returns reflect the reinvestment of all distributions. Please see page 4 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.02%. The management fee was 0.00%. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal, as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity, at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Aggressive

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimdiaf4167581-ncsrsx6x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimdiaf4167581-ncsrsx6x2.jpg) | Russell 3000 Index | $10000 | $36279 |
| ![](mimdiaf4167581-ncsrsx6x3.jpg) | Current Blended Benchmark | $10000 | $23057 |
| ![](mimdiaf4167581-ncsrsx6x4.jpg) | Delaware Ivy VIP Pathfinder Aggressive — Class II shares | $10000 | $22714 |
| ![](mimdiaf4167581-ncsrsx6x6.jpg) | MSCI EAFE Index (gross) | $10000 | $16543 |
| ![](mimdiaf4167581-ncsrsx6x5.jpg) | Bloomberg US Credit Index | $10000 | $11973 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Pathfinder Aggressive Class II shares for the period from December 31, 2012, through December 31, 2022.

The graph also shows a $10,000 investment in the current blended benchmark consisting of 55% Russell 3000 Index + 30% MSCI EAFE Index + 15% Bloomberg US Credit Index, as well as each of the individual indices, for the period from December 31, 2012, through December 31, 2022.

The Russell 3000 Index measures the performance of the largest 3,000 US companies, representing approximately 98% of the investable US equity market.

The MSCI EAFE (Europe, Australasia, Far East) Index represents large- and mid-cap stocks across 21 developed markets, excluding the United States and Canada. The index covers approximately 85% of the free float-adjusted market capitalization in each country.

The Bloomberg US Credit Index measures the total return performance of nonconvertible, investment grade domestic corporate bonds and SEC-registered foreign issues. All bonds in the index have at least one year to maturity.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Conservative

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on March 13, 2008) | -14.09% | +2.17% | +3.70% | +4.97% |
| Current Blended Benchmark\* | -13.74% | +2.27% | +4.15% | +5.87% |

---

\*The Blended Benchmark is computed using a combination of 35% Russell 3000 Index + 35% Bloomberg US Credit Index + 20% Bloomberg 1-3 Year US Government/Credit Index + 10% MSCI EAFE Index.

Returns reflect the reinvestment of all distributions. Please see page 6 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 0.92%. The management fee was 0.00%. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal, as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity, at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Conservative

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimdiaf4167581-ncsrsx8x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimdiaf4167581-ncsrsx6x2.jpg) | Russell 3000 Index | $10000 | $36279 |
| ![](mimdiaf4167581-ncsrsx6x3.jpg) | Current Blended Benchmark | $10000 | $17698 |
| ![](mimdiaf4167581-ncsrsx6x7.jpg) | MSCI EAFE Index (gross) | $10000 | $16543 |
| ![](mimdiaf4167581-ncsrsx6x4.jpg) | Delaware Ivy VIP Pathfinder Conservative — Class II shares | $10000 | $16241 |
| ![](mimdiaf4167581-ncsrsx6x6.jpg) | Bloomberg US Credit Index | $10000 | $11973 |
| ![](mimdiaf4167581-ncsrsx6x5.jpg) | Bloomberg 1-3 Year US Government/Credit Index | $10000 | $10916 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Pathfinder Conservative Class II shares for the period from December 31, 2012, through December 31, 2022.

The graph also shows a $10,000 investment in the current blended benchmark consisting of 35% Russell 3000 Index + 35% Bloomberg US Credit Index + 20% Bloomberg 1-3 Year US Government/Credit Index + 10% MSCI EAFE Index, as well as each of the individual indices, for the period from December 31, 2012, through December 31, 2022.

The Russell 3000 Index measures the performance of the largest 3,000 US companies, representing approximately 98% of the investable US equity market.

The Bloomberg US Credit Index measures the total return performance of nonconvertible, investment grade domestic corporate bonds and SEC-registered foreign issues. All bonds in the index have at least one year to maturity.

The Bloomberg 1-3 Year US Government/Credit Index is a market value–weighted index of government fixed-rate debt securities and investment grade US and foreign fixed-rate debt securities with average maturities of one to three years.

The MSCI EAFE (Europe, Australasia, Far East) Index represents large- and mid-cap stocks across 21 developed markets, excluding the United States and Canada. The index covers approximately 85% of the free float-adjusted market capitalization in each country.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company. <br>

[**Table of Contents**](#toc3)

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderate

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on March 4, 2008) | -15.26% | +3.57% | +4.91% | +6.68% |
| Current Blended Benchmark\* | -15.08% | +3.43% | +5.08% | +7.33% |

---

\*The Blended Benchmark is computed using a combination of 45% Russell 3000 Index + 25% Bloomberg US Credit Index + 20% MSCI EAFE Index + 10% Bloomberg 1-3 Year US Government/Credit Index.

Returns reflect the reinvestment of all distributions. Please see page 9 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 0.94%. The management fee was 0.00%. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus. Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal, as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity, at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc3)

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimdiaf4167581-ncsrsx11x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimdiaf4167581-ncsrsx6x2.jpg) | Russell 3000 Index | $10000 | $36279 |
| ![](mimdiaf4167581-ncsrsx6x3.jpg) | Current Blended Benchmark | $10000 | $20283 |
| ![](mimdiaf4167581-ncsrsx6x4.jpg) | Delaware Ivy VIP Pathfinder Moderate — Class II shares | $10000 | $19092 |
| ![](mimdiaf4167581-ncsrsx6x6.jpg) | MSCI EAFE Index (gross) | $10000 | $16543 |
| ![](mimdiaf4167581-ncsrsx6x5.jpg) | Bloomberg US Credit Index | $10000 | $11973 |
| ![](mimdiaf4167581-ncsrsx6x7.jpg) | Bloomberg 1-3 Year US Government/Credit Index | $10000 | $10916 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Pathfinder Moderate Class II shares for the period from December 31, 2012, through December 31, 2022.

The graph also shows a $10,000 investment in the current blended benchmark consisting of 45% Russell 3000 Index + 25% Bloomberg US Credit Index + 20% MSCI EAFE Index + 10% Bloomberg 1-3 Year US Government/Credit Index, as well as each of the individual indices, for the period from December 31, 2012, through December 31, 2022.

The Russell 3000 Index measures the performance of the largest 3,000 US companies, representing approximately 98% of the investable US equity market.

The Bloomberg US Credit Index measures the total return performance of nonconvertible, investment grade domestic corporate bonds and SEC-registered foreign issues. All bonds in the index have at least one year to maturity.

The MSCI EAFE (Europe, Australasia, Far East) Index represents large- and mid-cap stocks across 21 developed markets, excluding the United States and Canada. The index covers approximately 85% of the free float-adjusted market capitalization in each country.

The Bloomberg 1-3 Year US Government/Credit Index is a market value–weighted index of government fixed-rate debt securities and investment grade US and foreign fixed-rate debt securities with average maturities of one to three years.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company. <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderate

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderately Aggressive

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on March 4, 2008) | -15.90% | +4.21% | +5.53% | +7.55% |
| Current Blended Benchmark\* | -15.79% | +3.96% | +5.51% | +8.03% |

---

\*The Blended Benchmark is computed using a combination of 50% Russell 3000 Index + 25% MSCI EAFE Index + 20% Bloomberg US Credit Index + 5% Bloomberg 1-3 Year US Government/Credit Index.

Returns reflect the reinvestment of all distributions. Please see page 12 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 0.97%. The management fee was 0.00%. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal, as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity, at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderately Aggressive

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimdiaf4167581-ncsrsx14x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimdiaf4167581-ncsrsx6x2.jpg) | Russell 3000 Index | $10000 | $36279 |
| ![](mimdiaf4167581-ncsrsx6x3.jpg) | Current Blended Benchmark | $10000 | $21645 |
| ![](mimdiaf4167581-ncsrsx6x4.jpg) | Delaware Ivy VIP Pathfinder Moderately Aggressive — Class II shares | $10000 | $20697 |
| ![](mimdiaf4167581-ncsrsx6x6.jpg) | MSCI EAFE Index (gross) | $10000 | $16543 |
| ![](mimdiaf4167581-ncsrsx6x5.jpg) | Bloomberg US Credit Index | $10000 | $11973 |
| ![](mimdiaf4167581-ncsrsx6x7.jpg) | Bloomberg 1-3 Year US Government/Credit Index | $10000 | $10916 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Pathfinder Moderately Aggressive Class II shares for the period from December 31, 2012, through December 31, 2022.

The graph also shows a $10,000 investment in the current blended benchmark consisting of 50% Russell 3000 Index + 25% MSCI EAFE Index + 20% Bloomberg US Credit Index + 5% Bloomberg 1-3 Year US Government/Credit Index, as well as each of the individual indices, for the period from December 31, 2012, through December 31, 2022.

The Russell 3000 Index measures the performance of the largest 3,000 US companies, representing approximately 98% of the investable US equity market.

The MSCI EAFE (Europe, Australasia, Far East) Index represents large- and mid-cap stocks across 21 developed markets, excluding the United States and Canada. The index covers approximately 85% of the free float-adjusted market capitalization in each country.

The Bloomberg US Credit Index measures the total return performance of nonconvertible, investment grade domestic corporate bonds and SEC-registered foreign issues. All bonds in the index have at least one year to maturity.

The Bloomberg 1-3 Year US Government/Credit Index is a market value–weighted index of government fixed-rate debt securities and investment grade US and foreign fixed-rate debt securities with average maturities of one to three years.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company. <br>

[**Table of Contents**](#toc3)

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderately Conservative

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | 10 year |
| Class II shares (commenced operations on March 12, 2008) | -14.71% | +2.85% | +4.35% | +5.84% |
| Current Blended Benchmark\* | -14.40% | +1.84% | +4.20% | +6.29% |

---

\*The Blended Benchmark is computed using a combination of 40% Russell 3000 Index + 30% Bloomberg US Credit Index + 15% MSCI EAFE Index + 15% Bloomberg 1-3 Year US Government/Credit Index.

Returns reflect the reinvestment of all distributions. Please see page 15 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 0.92%. The management fee was 0.00%. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus. Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal, as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity, at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc3)

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period December 31, 2012 through December 31, 2022*

![](mimdiaf4167581-ncsrsx17x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimdiaf4167581-ncsrsx6x2.jpg) | Russell 3000 Index | $10000 | $36279 |
| ![](mimdiaf4167581-ncsrsx6x3.jpg) | Current Blended Benchmark | $10000 | $23057 |
| ![](mimdiaf4167581-ncsrsx6x4.jpg) | Delaware Ivy VIP Pathfinder Moderately Conservative — Class II shares | $10000 | $17648 |
| ![](mimdiaf4167581-ncsrsx6x5.jpg) | MSCI EAFE Index (gross) | $10000 | $16543 |
| ![](mimdiaf4167581-ncsrsx6x6.jpg) | Bloomberg US Credit Index | $10000 | $11973 |
| ![](mimdiaf4167581-ncsrsx6x7.jpg) | Bloomberg 1-3 Year US Government/Credit Index | $10000 | $10916 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Pathfinder Moderately Conservative Class II shares for the period from December 31, 2012, through December 31, 2022.

The graph also shows a $10,000 investment in the current blended benchmark consisting of 40% Russell 3000 Index + 30% Bloomberg US Credit Index + 15% MSCI EAFE Index + 15% Bloomberg 1-3 Year US Government/Credit Index, as well as each individual indices, for the period from December 31, 2012, through December 31, 2022.

The Russell 3000 Index measures the performance of the largest 3,000 US companies, representing approximately 98% of the investable US equity market.

The Bloomberg US Credit Index measures the total return performance of nonconvertible, investment grade domestic corporate bonds and SEC-registered foreign issues. All bonds in the index have at least one year to maturity.

The MSCI EAFE (Europe, Australasia, Far East) Index represents large- and mid-cap stocks across 21 developed markets, excluding the United States and Canada. The index covers approximately 85% of the free float-adjusted market capitalization in each country.

The Bloomberg 1-3 Year US Government/Credit Index is a market value–weighted index of government fixed-rate debt securities and investment grade US and foreign fixed-rate debt securities with average maturities of one to three years.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company. <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderately Conservative

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderate – Managed Volatility

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | Lifetime |
| Class II shares (commenced operations on August 1, 2013) | -13.22% | +2.26% | +3.79% | +4.76% |
| Current Blended Benchmark\* | -15.08% | +3.43% | +5.08% | +6.71%\*\* |

---

\*The Blended Benchmark is computed using a combination of 45% Russell 3000 Index + 25% Bloomberg US Credit Index + 20% MSCI EAFE Index + 10% Bloomberg 1-3 Year US Government/Credit Index.

\*\* The benchmark lifetime return is as of the month end prior to the Portfolio's inception date.

Returns reflect the reinvestment of all distributions. Please see page 18 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.10%. The management fee was 0.19%. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderate – Managed Volatility

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period August 1, 2013 (inception date) through December 31, 2022*

![](mimdiaf4167581-ncsrsx20x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimdiaf4167581-ncsrsx6x2.jpg) | Russell 3000 Index | $10000 | $25778 |
| ![](mimdiaf4167581-ncsrsx6x3.jpg) | Current Blended Benchmark | $10000 | $18311 |
| ![](mimdiaf4167581-ncsrsx6x4.jpg) | Delaware Ivy VIP Pathfinder Moderate – Managed Volatility — Class II shares | $10000 | $15498 |
| ![](mimdiaf4167581-ncsrsx6x6.jpg) | MSCI EAFE Index (gross) | $10000 | $15241 |
| ![](mimdiaf4167581-ncsrsx6x5.jpg) | Bloomberg US Credit Index | $10000 | $12420 |
| ![](mimdiaf4167581-ncsrsx6x7.jpg) | Bloomberg 1-3 Year US Government/Credit Index | $10000 | $10891 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Pathfinder Moderate – Managed Volatility Class II shares for the period from August 1, 2013, through December 31, 2022.

The graph also shows a $10,000 investment in the current blended benchmark consisting of 45% Russell 3000 Index + 25% Bloomberg US Credit Index + 20% MSCI EAFE Index + 10% Bloomberg 1-3 Year US Government/Credit Index, as well as each of the individual indices, for the period from August 1, 2013, through December 31, 2022.

The Russell 3000 Index measures the performance of the largest 3,000 US companies, representing approximately 98% of the investable US equity market.

The Bloomberg US Credit Index measures the total return performance of nonconvertible, investment grade domestic corporate bonds and SEC-registered foreign issues. All bonds in the index have at least one year to maturity.

The MSCI EAFE (Europe, Australasia, Far East) Index represents large- and mid-cap stocks across 21 developed markets, excluding the United States and Canada. The index covers approximately 85% of the free float-adjusted market capitalization in each country.

The Bloomberg 1-3 Year US Government/Credit Index is a market value–weighted index of government fixed-rate debt securities and investment grade US and foreign fixed-rate debt securities with average maturities of one to three years.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company. <br>

[**Table of Contents**](#toc3)

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | Lifetime |
| Class II shares (commenced operations on August 1, 2013) | -14.00% | +2.83% | +4.32% | +5.36% |
| Current Blended Benchmark\* | -15.79% | +3.96% | +5.51% | +7.27%\*\* |

---

\*The Blended Benchmark is computed using a combination of 50% Russell 3000 Index + 25% MSCI EAFE Index + 20% Bloomberg US Credit Index + 5% Bloomberg 1-3 Year US Government/Credit Index.

\*\* The benchmark lifetime return is as of the month end prior to the Portfolio's inception date.

Returns reflect the reinvestment of all distributions. Please see page 21 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.17%. The management fee was 0.20%. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal, as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity, at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc3)

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period August 1, 2013 (inception date) through December 31, 2022*

![](mimdiaf4167581-ncsrsx23x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimdiaf4167581-ncsrsx6x2.jpg) | Russell 3000 Index | $10000 | $25778 |
| ![](mimdiaf4167581-ncsrsx6x3.jpg) | Current Blended Benchmark | $10000 | $19218 |
| ![](mimdiaf4167581-ncsrsx6x4.jpg) | Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility — Class II shares | $10000 | $16344 |
| ![](mimdiaf4167581-ncsrsx6x6.jpg) | MSCI EAFE Index (gross) | $10000 | $15241 |
| ![](mimdiaf4167581-ncsrsx6x5.jpg) | Bloomberg US Credit Index | $10000 | $12420 |
| ![](mimdiaf4167581-ncsrsx6x7.jpg) | Bloomberg 1-3 Year US Government/Credit Index | $10000 | $10891 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility Class II shares for the period from August 1, 2013, through December 31, 2022.

The graph also shows a $10,000 investment in the current blended benchmark consisting of 50% Russell 3000 Index + 25% MSCI EAFE Index + 20% Bloomberg US Credit Index + 5% Bloomberg 1-3 Year US Government/Credit Index, as well as each of the individual indices, for the period from August 1, 2013, through December 31, 2022.

The Russell 3000 Index measures the performance of the largest 3,000 US companies, representing approximately 98% of the investable US equity market.

The MSCI EAFE (Europe, Australasia, Far East) Index represents large- and mid-cap stocks across 21 developed markets, excluding the United States and Canada. The index covers approximately 85% of the free float-adjusted market capitalization in each country.

The Bloomberg US Credit Index measures the total return performance of nonconvertible, investment grade domestic corporate bonds and SEC-registered foreign issues. All bonds in the index have at least one year to maturity.

The Bloomberg 1-3 Year US Government/Credit Index is a market value–weighted index of government fixed-rate debt securities and investment grade US and foreign fixed-rate debt securities with average maturities of one to three years.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company. <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility

**The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.**

**Carefully consider the Portfolio's investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Portfolio's prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip/literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Portfolio and benchmark performance** | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* | *Average annual total returns through December 31, 2022* |
|  | 1 year | 3 year | 5 year | Lifetime |
| Class II shares (commenced operations on August 1, 2013) | -12.71% | +1.94% | +3.40% | +4.08% |
| Current Blended Benchmark\* | -14.40% | +1.84% | +4.20% | +5.81%\*\* |

---

\*The Blended Benchmark is computed using a combination of 40% Russell 3000 Index + 30% Bloomberg US Credit Index + 15% MSCI EAFE Index + 15% Bloomberg 1-3 Year US Government/Credit Index.

\*\* The benchmark lifetime return is as of the month end prior to the Portfolio's inception date.

Returns reflect the reinvestment of all distributions. Please see page 24 for a description of the index.

As described in the Portfolio's most recent prospectus, total operating expenses for Class II shares were 1.11%. The management fee was 0.20%. The expense ratio may differ from the expense ratios in the "Financial highlights" since they are based on different time periods and the expense ratio in the prospectus includes acquired fund fees and expenses, if any. See Note 2 in "Notes to financial statements" for additional details. Please see the "Financial highlights" section in this report for the most recent expense ratio.

Total returns may reflect waivers and/or expense reimbursements for some or all periods shown. If applicable, performance would have been lower without such waivers and reimbursements.

Ivy Variable Insurance Portfolios are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Earnings from a variable annuity or variable life investment compound tax-free until withdrawal, and as a result, no adjustments were made for income taxes.

Performance data do not reflect insurance fees related to a variable annuity or variable life investment or the deferred sales charge that would apply to certain withdrawals of investments held for fewer than eight years. Performance shown here would have been reduced if such fees were included and the expense limitation removed. For more information about fees, consult your variable annuity or variable life prospectus.

Investments in variable products involve risk.

Fixed income securities and bond funds can lose value, and investors can lose principal, as interest rates rise. They also may be affected by economic conditions that hinder an issuer's ability to make interest and principal payments on its debt. This includes prepayment risk, the risk that the principal of a bond that is held by a portfolio will be prepaid prior to maturity, at the time when interest rates are lower than what the bond was paying. A portfolio may then have to reinvest that money at a lower interest rate.

International investments entail risks including fluctuation in currency values, differences in accounting principles, or economic or political instability. Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility, lower trading volume, and higher risk of market closures. In many emerging markets, there is substantially less publicly available information and the available information may be incomplete or misleading. Legal claims are generally more difficult to pursue.

IBOR risk is the risk that changes related to the use of the London interbank offered rate (LIBOR) or similar rates (such as EONIA) could have adverse impacts on financial instruments that reference these rates. The abandonment of these rates and transition to alternative rates could affect the value and liquidity of instruments that reference them and could affect investment strategy performance. <br>

[**Table of Contents**](#toc3)

Performance summaries (Unaudited)

Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility

The disruptions caused by natural disasters, pandemics, or similar events could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio's ability to achieve its investment objective and the value of the Portfolio's investments.

Please read both the contract and underlying prospectus for specific details regarding the product's risk profile.

**Performance of a $10,000 investment**

*For the period August 1, 2013 (inception date) through December 31, 2022*

![](mimdiaf4167581-ncsrsx26x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| | | **Starting value** | **Ending value** |
| ![](mimdiaf4167581-ncsrsx6x2.jpg) | Russell 3000 Index | $10000 | $25778 |
| ![](mimdiaf4167581-ncsrsx6x3.jpg) | Current Blended Benchmark | $10000 | $16938 |
| ![](mimdiaf4167581-ncsrsx6x4.jpg) | MSCI EAFE Index (gross) | $10000 | $15241 |
| ![](mimdiaf4167581-ncsrsx6x6.jpg) | Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility — Class II shares | $10000 | $14578 |
| ![](mimdiaf4167581-ncsrsx6x5.jpg) | Bloomberg US Credit Index | $10000 | $12420 |
| ![](mimdiaf4167581-ncsrsx6x7.jpg) | Bloomberg 1-3 Year US Government/Credit Index | $10000 | $10891 |

---

The graph shows a $10,000 investment in Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility Class II shares for the period from August 1, 2013, through December 31, 2022.

The graph also shows a $10,000 investment in the current blended benchmark consisting of 40% Russell 3000 Index + 30% Bloomberg US Credit Index + 15% MSCI EAFE Index + 15% Bloomberg 1-3 Year US Government/Credit Index, as well as each of the individual indices, for the period from August 1, 2013, through December 31, 2022.

The Russell 3000 Index measures the performance of the largest 3,000 US companies, representing approximately 98% of the investable US equity market.

The Bloomberg US Credit Index measures the total return performance of nonconvertible, investment grade domestic corporate bonds and SEC-registered foreign issues. All bonds in the index have at least one year to maturity.

The MSCI EAFE (Europe, Australasia, Far East) Index represents large- and mid-cap stocks across 21 developed markets, excluding the United States and Canada. The index covers approximately 85% of the free float-adjusted market capitalization in each country.

The Bloomberg 1-3 Year US Government/Credit Index is a market value–weighted index of government fixed-rate debt securities and investment grade US and foreign fixed-rate debt securities with average maturities of one to three years.

Frank Russell Company is the source and owner of the trademarks, service marks, and copyrights related to the Russell Indexes. Russell<sup>®</sup> is a trademark of Frank Russell Company. <br>

[**Table of Contents**](#toc3)

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

**Past performance does not guarantee future results.** <br>

[**Table of Contents**](#toc3)

Disclosure of Portfolio expenses

For the six-month period from July 1, 2022 to December 31, 2022 (Unaudited)

As a shareholder of the Portfolio, you incur ongoing costs, which may include management fees; distribution and service (12b-1) fees; and other Portfolio expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Portfolio and to compare these costs with the ongoing costs of investing in other mutual funds.

The examples are based on an investment of $1,000 invested at the beginning of the period and held for the entire six-month period from July 1, 2022 to December 31, 2022.

**Actual expenses**

The first section of the tables shown, "Actual Portfolio return," provides information about actual account values and actual expenses. You may use the information in this section of the table, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first section under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period.

**Hypothetical example for comparison purposes**

The second section of the tables shown, "Hypothetical 5% return," provides information about hypothetical account values and hypothetical expenses based on a Portfolio's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Portfolio's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in each Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the tables are meant to highlight your ongoing costs only. As a shareholder of the Portfolio, you do not incur any transaction costs, such as sales charges (loads), redemption fees or exchange fees, but shareholders of other funds may incur such costs. Also, the fees related to the variable annuity investment or the deferred sales charge that could apply have not been included. Therefore, the second section of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. The Portfolios' expenses shown in the tables reflect fee waivers in effect and assume reinvestment of all dividends and distributions.

**Delaware Ivy VIP Pathfinder Aggressive<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1030.60 | 0.30% | $1.54 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1023.69 | 0.30% | $1.53 |

---

**Delaware Ivy VIP Pathfinder Conservative<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1011.60 | 0.22% | $1.12 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1024.10 | 0.22% | $1.12 |

---

**Delaware Ivy VIP Pathfinder Moderate<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1022.10 | 0.08% | $0.41 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1024.80 | 0.08% | $0.41 |

---

[**Table of Contents**](#toc3)

**Delaware Ivy VIP Pathfinder Moderately Aggressive<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1027.10 | 0.07% | $0.36 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1024.85 | 0.07% | $0.36 |

---

**Delaware Ivy VIP Pathfinder Moderately Conservative<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1015.90 | 0.27% | $1.37 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1023.84 | 0.27% | $1.38 |

---

**Delaware Ivy VIP Pathfinder Moderate – Managed Volatility<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1016.60 | 0.27% | $1.37 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1023.84 | 0.27% | $1.38 |

---

**Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1020.40 | 0.41% | $2.09 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1023.14 | 0.41% | $2.09 |

---

**Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility<br> Expense analysis of an investment of $1,000**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Beginning<br> Account<br> Value<br> 7/1/22 | Ending<br> Account<br> Value<br> 12/31/22 | Annualized<br> Expense<br> Ratio | Expenses<br> Paid<br> During<br> Period<br> 7/1/22 to<br> 12/31/22\* |
| **Actual Portfolio return<sup>†</sup>** |  |  |  |  |
| Class II | $1000.00 | $1009.60 | 0.66% | $3.34 |
| **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) | **Hypothetical 5% return** (5% return before expenses) |
| Class II | $1000.00 | $1021.88 | 0.66% | $3.36 |

---

\*"Expenses Paid During Period" are equal to the relevant Portfolio's annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period).

<sup>†</sup>Because actual returns reflect only the most recent six-month period, the returns shown may differ significantly from fiscal year returns.

In addition to the Portfolios' expenses reflected above and on the previous page, each Portfolio also indirectly bears its portion of the fees and expenses of any investment companies (Underlying Funds) in which it invests. The tables above and on the previous page do not reflect the expenses of any Underlying Funds. <br>

(continues) 27

[**Table of Contents**](#toc3)

Security type

As of December 31, 2022 (Unaudited)

**Delaware Ivy VIP Pathfinder Aggressive**

---

| | |
|:---|:---|
| Security type | Percentage<br> of net assets |
| **Affiliated Mutual Funds** | **99.86%** |
| **Short-Term Investments** | **0.26%** |
| **Total Value of Securities** | **100.12%** |
| **Liabilities Net of Receivables and Other Assets** | **(0.12)%** |
| **Total Net Assets** | **100.00%** |
| **Delaware Ivy VIP Pathfinder Conservative** |  |
| Security type | Percentage<br> of net assets |
| **Affiliated Mutual Funds** | **99.83%** |
| **Short-Term Investments** | **0.25%** |
| **Total Value of Securities** | **100.08%** |
| **Liabilities Net of Receivables and Other Assets** | **(0.08)%** |
| **Total Net Assets** | **100.00%** |
| **Delaware Ivy VIP Pathfinder Moderate** |  |
| Security type | Percentage<br> of net assets |
| **Affiliated Mutual Funds** | **99.79%** |
| **Short-Term Investments** | **0.25%** |
| **Total Value of Securities** | **100.04%** |
| **Liabilities Net of Receivables and Other Assets** | **(0.04)%** |
| **Total Net Assets** | **100.00%** |
| **Delaware Ivy VIP Pathfinder Moderately Aggressive** |  |
| Security type | Percentage<br> of net assets |
| **Affiliated Mutual Funds** | **99.79%** |
| **Short-Term Investments** | **0.25%** |
| **Total Value of Securities** | **100.04%** |
| **Liabilities Net of Receivables and Other Assets** | **(0.04)%** |
| **Total Net Assets** | **100.00%** |
| **Delaware Ivy VIP Pathfinder Moderately Conservative** |  |
| Security type | Percentage<br> of net assets |
| **Affiliated Mutual Funds** | **99.83%** |
| **Short-Term Investments** | **0.25%** |
| **Total Value of Securities** | **100.08%** |
| **Liabilities Net of Receivables and Other Assets** | **(0.08)%** |
| **Total Net Assets** | **100.00%** |
| **Delaware Ivy VIP Pathfinder Moderate – Managed Volatility** |  |
| Security type | Percentage<br> of net assets |
| **Affiliated Mutual Funds** | **97.73%** |
| **Short-Term Investments** | **2.00%** |
| **Total Value of Securities** | **99.73%** |
| **Receivables and Other Assets Net of Liabilities** | **0.27%** |
| **Total Net Assets** | **100.00%** |
| **Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility** |  |
| Security type | Percentage<br> of net assets |
| **Affiliated Mutual Funds** | **97.80%** |
| **Short-Term Investments** | **2.00%** |
| **Total Value of Securities** | **99.80%** |
| **Receivables and Other Assets Net of Liabilities** | **0.20%** |
| **Total Net Assets** | **100.00%** |
| **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** |  |
| Security type | Percentage<br> of net assets |
| **Affiliated Mutual Funds** | **97.84%** |
| **Short-Term Investments** | **2.00%** |
| **Total Value of Securities** | **99.84%** |
| **Receivables and Other Assets Net of Liabilities** | **0.16%** |
| **Total Net Assets** | **100.00%** |

---

[**Table of Contents**](#toc3)

Schedules of investments

Delaware Ivy VIP Pathfinder Aggressive

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Affiliated Mutual Funds — 99.86%<<** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Core Equity Class II | 722567 | $8309520 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Corporate Bond Class II | 1084115 | 4867678 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Growth Class II | 979628 | 7807635 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP High Income Class I | 48561 | 136941 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP International Core Equity Class II | 629170 | 8927923 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Limited-Term Bond Class II | 649679 | 2975531 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Mid Cap Growth Class I | 363450 | 3489119 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Small Cap Growth Class I | 92760 | 566767 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Smid Cap Core Class II | 75455 | 840566 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Value Class II | 1429202 | 7946363 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware VIP Global Value Equity Class II | 1748257 | 7709813 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Affiliated Mutual Funds**<br> (cost $70,374,146) |  | **53577856** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Short-Term Investments — 0.26%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money Market Mutual Funds — 0.26% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 4.03%) | 34330 | 34330 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.06%) | 34330 | 34330 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 4.23%) | 34330 | 34330 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.11%) | 34331 | 34331 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $137,321) |  | **137321** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—100.12%**<br> (cost $70,511,467) |  | $**53715177** |

---

<sup><<</sup> Affiliated company. See Note 2 in "Notes to financial statements."

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Schedules of investments

Delaware Ivy VIP Pathfinder Conservative

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Affiliated Mutual Funds — 99.83%<<** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Core Equity Class II | 734448 | $8446149 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Corporate Bond Class II | 5290298 | 23753438 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Growth Class II | 959401 | 7646428 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP High Income Class I | 381212 | 1075018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP International Core Equity Class II | 308789 | 4381713 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Limited-Term Bond Class II | 4723503 | 21633645 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Mid Cap Growth Class I | 363258 | 3487273 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Small Cap Growth Class I | 93008 | 568281 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Smid Cap Core Class II | 89088 | 992441 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Value Class II | 1399697 | 7782313 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware VIP Global Value Equity Class II | 980929 | 4325899 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Affiliated Mutual Funds**<br> (cost $106,252,043) |  | **84092598** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Short-Term Investments — 0.25%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money Market Mutual Funds — 0.25% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 4.03%) | 52055 | 52055 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.06%) | 52055 | 52055 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 4.23%) | 52055 | 52055 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.11%) | 52055 | 52055 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $208,220) |  | **208220** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—100.08%**<br> (cost $106,460,263) |  | $**84300818** |

---

<sup><<</sup> Affiliated company. See Note 2 in "Notes to financial statements."

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Delaware Ivy VIP Pathfinder Moderate

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Affiliated Mutual Funds — 99.79%<<** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Core Equity Class II | 5161069 | $59352293 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Corporate Bond Class II | 19316208 | 86729772 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Growth Class II | 6896819 | 54967647 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP High Income Class I | 1275463 | 3596805 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP International Core Equity Class II | 3579521 | 50793405 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Limited-Term Bond Class II | 15863733 | 72655898 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Mid Cap Growth Class I | 2577592 | 24744881 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Small Cap Growth Class I | 663123 | 4051684 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Smid Cap Core Class II | 576099 | 6417745 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Value Class II | 10061958 | 55944488 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware VIP Global Value Equity Class II | 10288223 | 45371063 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Affiliated Mutual Funds**<br> (cost $596,196,928) |  | **464625681** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Short-Term Investments — 0.25%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money Market Mutual Funds — 0.25% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 4.03%) | 290016 | 290016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.06%) | 290016 | 290016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 4.23%) | 290016 | 290016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.11%) | 290016 | 290016 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $1,160,064) |  | **1160064** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—100.04%**<br> (cost $597,356,992) |  | $**465785745** |

---

<sup><<</sup> Affiliated company. See Note 2 in "Notes to financial statements."

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Schedules of investments

Delaware Ivy VIP Pathfinder Moderately Aggressive

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Affiliated Mutual Funds — 99.79%<<** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Core Equity Class II | 6944733 | $79864427 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Corporate Bond Class II | 17453091 | 78364378 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Growth Class II | 9354411 | 74554657 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP High Income Class I | 1033554 | 2914623 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP International Core Equity Class II | 5491240 | 77920695 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Limited-Term Bond Class II | 13064191 | 59833995 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Mid Cap Growth Class I | 3483868 | 33445130 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Small Cap Growth Class I | 895185 | 5469580 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Smid Cap Core Class II | 749835 | 8353165 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Value Class II | 13647416 | 75879634 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware VIP Global Value Equity Class II | 15469419 | 68220136 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Affiliated Mutual Funds**<br> (cost $732,143,221) |  | **564820420** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Short-Term Investments — 0.25%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money Market Mutual Funds — 0.25% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 4.03%) | 351947 | 351947 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.06%) | 351947 | 351947 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 4.23%) | 351947 | 351947 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.11%) | 351948 | 351948 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $1,407,789) |  | **1407789** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—100.04%**<br> (cost $733,551,010) |  | $**566228209** |

---

<sup><<</sup> Affiliated company. See Note 2 in "Notes to financial statements."

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Delaware Ivy VIP Pathfinder Moderately Conservative

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Affiliated Mutual Funds — 99.83%<<** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Core Equity Class II | 1366695 | $15716991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Corporate Bond Class II | 7197629 | 32317356 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Growth Class II | 1808278 | 14411974 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP High Income Class I | 501021 | 1412879 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP International Core Equity Class II | 783446 | 11117098 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Limited-Term Bond Class II | 6220765 | 28491106 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Mid Cap Growth Class I | 679489 | 6523096 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Small Cap Growth Class I | 174107 | 1063792 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Smid Cap Core Class II | 158424 | 1764846 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Value Class II | 2638142 | 14668067 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware VIP Global Value Equity Class II | 2328223 | 10267465 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Affiliated Mutual Funds**<br> (cost $175,394,855) |  | **137754670** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Short-Term Investments — 0.25%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money Market Mutual Funds — 0.25% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 4.03%) | 86075 | 86075 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.06%) | 86074 | 86074 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 4.23%) | 86075 | 86075 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.11%) | 86075 | 86075 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $344,299) |  | **344299** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—100.08%**<br> (cost $175,739,154) |  | $**138098969** |

---

<sup><<</sup> Affiliated company. See Note 2 in "Notes to financial statements."

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Schedules of investments

Delaware Ivy VIP Pathfinder Moderate – Managed Volatility

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Affiliated Mutual Funds — 97.73%<<** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Core Equity Class II | 4730673 | $54402743 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Corporate Bond Class II | 17710084 | 79518275 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Growth Class II | 6322975 | 50394112 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP High Income Class I | 1161742 | 3276111 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP International Core Equity Class II | 3280956 | 46556770 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Limited-Term Bond Class II | 14523774 | 66518884 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Mid Cap Growth Class I | 2362058 | 22675757 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Small Cap Growth Class I | 598362 | 3655995 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Smid Cap Core Class II | 526654 | 5866926 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Value Class II | 9224769 | 51289718 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware VIP Global Value Equity Class II | 9422905 | 41555010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Affiliated Mutual Funds**<br> (cost $547,633,916) |  | **425710301** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Short-Term Investments — 2.00%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money Market Mutual Funds — 2.00% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 4.03%) | 2175227 | $2175227 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.06%) | 2175227 | 2175227 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 4.23%) | 2175227 | 2175227 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.11%) | 2175227 | 2175227 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $8,700,908) |  | **8700908** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—99.73%**<br> (cost $556,334,824) |  | $**434411209** |

---

<sup><<</sup> Affiliated company. See Note 2 in "Notes to financial statements."

The following futures contracts were outstanding at December 31, 2022:<sup>1</sup>

**Futures Contracts<br> Exchange-Traded**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Contracts to Buy (Sell) | Notional<br> Amount | Notional<br> Cost<br> (Proceeds) | Expiration<br> Date | Value/<br> Unrealized<br> Appreciation | Variation<br> Margin<br> Due from<br> (Due to)<br> Brokers |
| (10) | &nbsp;&nbsp;&nbsp;&nbsp;E-Mini Russell 2000 Index | $(885450) | $(916949) | 3/17/23 | $31499 | $3100 |
| (122) | &nbsp;&nbsp;&nbsp;&nbsp;E-Mini S&P 500 Index | (23552100) | (24383509) | 3/17/23 | 831409 | 65575 |
| Total Futures Contracts | Total Futures Contracts |  | $(25300458) |  | $862908 | $68675 |

---

The use of futures contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The notional amounts presented above represent the Portfolio's total exposure in such contracts, whereas only the variation margin is reflected in the Portfolio's net assets.

<sup>1</sup>See Note 8 in "Notes to financial statements."

**Summary of abbreviations:**

S&P – Standard & Poor's Financial Services LLC

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number of<br> shares** | **Value (US $)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Affiliated Mutual Funds — 97.80%<<** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Core Equity Class II | 930040 | $10695462 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Corporate Bond Class II | 2336820 | 10492320 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Growth Class II | 1252067 | 9978977 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP High Income Class I | 136942 | 386176 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP International Core Equity Class II | 735301 | 10433923 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Limited-Term Bond Class II | 1751432 | 8021556 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Mid Cap Growth Class I | 465077 | 4464741 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Small Cap Growth Class I | 118828 | 726038 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Smid Cap Core Class II | 99671 | 1110331 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Value Class II | 1826671 | 10156292 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware VIP Global Value Equity Class II | 2070345 | 9130221 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Affiliated Mutual Funds** <br> (cost $98,913,502) |  | **75596037** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Short-Term Investments — 2.00%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money Market Mutual Funds — 2.00% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 4.03%) | 386583 | $386583 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.06%) | 386583 | 386583 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 4.23%) | 386583 | 386583 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.11%) | 386583 | 386583 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments** <br> (cost $1,546,332) |  | **1546332** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—99.80%** <br> (cost $100,459,834) |  | $**77142369** |

---

<sup><<</sup> Affiliated company. See Note 2 in "Notes to financial statements."

The following futures contracts were outstanding at December 31, 2022:<sup>1</sup>

**Futures Contracts<br> Exchange-Traded**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Contracts to Buy (Sell) | Notional<br> Amount | Notional<br> Cost<br> (Proceeds) | Expiration<br> Date | Value/<br> Unrealized<br> Appreciation | Variation<br> Margin<br> Due from<br> (Due to)<br> Brokers |
| (1) | &nbsp;&nbsp;&nbsp;&nbsp;E-Mini Russell 2000 Index | $(88545) | $(91695) | 3/17/23 | $3150 | $310 |
| (21) | &nbsp;&nbsp;&nbsp;&nbsp;E-Mini S&P 500 Index | (4054050) | (4197161) | 3/17/23 | 143111 | 11288 |
| Total Futures Contracts | Total Futures Contracts |  | $(4288856) |  | $146261 | $11598 |

---

The use of futures contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The notional amounts presented above represent the Portfolio's total exposure in such contracts, whereas only the variation margin is reflected in the Portfolio's net assets.

<sup>1</sup>See Note 8 in "Notes to financial statements."

**Summary of abbreviations:**

S&P – Standard & Poor's Financial Services LLC

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Schedules of investments

Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility

December 31, 2022

---

| | | |
|:---|:---|:---|
|  | **Number <br> of shares** | **Value (US $)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Affiliated Mutual Funds — 97.84%<<** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Core Equity Class II | 293331 | $3373303 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Corporate Bond Class II | 1545312 | 6938449 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Growth Class II | 388182 | 3093813 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP High Income Class I | 106586 | 300573 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP International Core Equity Class II | 168098 | 2385312 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Limited-Term Bond Class II | 1336344 | 6120455 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Mid Cap Growth Class I | 145807 | 1399749 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Small Cap Growth Class I | 37415 | 228609 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Smid Cap Core Class II | 33892 | 377552 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware Ivy VIP Value Class II | 566332 | 3148804 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware VIP Global Value Equity Class II | 499614 | 2203298 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Affiliated Mutual Funds** <br> (cost $39,099,283) |  | **29569917** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Short-Term Investments — 2.00%** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money Market Mutual Funds — 2.00% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 4.03%) | 150881 | $150881 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.06%) | 150880 | 150880 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 4.23%) | 150880 | 150880 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.11%) | 150881 | 150881 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Short-Term Investments**<br> (cost $603,522) |  | **603522** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Value of Securities—99.84%** <br> (cost $39,702,805) |  | $**30173439** |

---

<sup><<</sup> Affiliated company. See Note 2 in "Notes to financial statements."

The following futures contracts were outstanding at December 31, 2022:<sup>1</sup>

**Futures Contracts Exchange-Traded**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Contracts to Buy (Sell) | Notional<br> Amount | Notional<br> Cost<br> (Proceeds) | Expiration<br> Date | Value/<br> Unrealized<br> Appreciation | Variation<br> Margin<br> Due from<br> (Due to)<br> Brokers |
| (1) | &nbsp;&nbsp;&nbsp;&nbsp;E-Mini Russell 2000 Index | $(88545) | $(91695) | 3/17/23 | $3150 | $310 |
| (9) | &nbsp;&nbsp;&nbsp;&nbsp;E-Mini S&P 500 Index | (1737450) | (1798783) | 3/17/23 | 61333 | 4838 |
| Total Futures Contracts | Total Futures Contracts |  | $(1890478) |  | $64483 | $5148 |

---

The use of futures contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The notional amounts presented above represent the Portfolio's total exposure in such contracts, whereas only the variation margin is reflected in the Portfolio's net assets.

<sup>1</sup>See Note 8 in "Notes to financial statements."

**Summary of abbreviations:**

S&P – Standard & Poor's Financial Services LLC

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Statements of assets and liabilities

Ivy Variable Insurance Portfolios

December 31, 2022

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP<br> Pathfinder<br> Aggressive | Delaware Ivy<br> VIP<br> Pathfinder<br> Conservative | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderate | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderately<br> Aggressive |
| **Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments, at value\* | $137321 | $208220 | $1160064 | $1407789 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments of affiliated issuers, at value\*\* | 53577856 | 84092598 | 464625681 | 564820420 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends receivable | 444 | 701 | 3869 | 4700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivable for portfolio shares sold | 377 | 1 | 129 | 38 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivable for securities sold |  | 84506 | 247743 | 83459 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets | 53715998 | 84386026 | 466037486 | 566316406 |
| **Liabilities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | 55527 | 58528 | 134227 | 168777 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administration expenses payable to affiliates | 5153 | 8490 | 55783 | 68131 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payable for portfolio shares redeemed | 2930 | 82737 | 252090 | 84924 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | 63610 | 149755 | 442100 | 321832 |
| **Total Net Assets** | $53652388 | $84236271 | $465595386 | $565994574 |
| **Net Assets Consist of:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | $58370174 | $94550188 | $511302636 | $617021503 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total distributable earnings (loss) | (4717786) | (10313917) | (45707250) | (51026929) |
| **Total Net Assets** | $53652388 | $84236271 | $465595386 | $565994574 |
| **Net Asset Value** |  |  |  |  |
| **Class II:** |  |  |  |  |
| Net assets | $53652388 | $84236271 | $465595386 | $565994574 |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 13188151 | 19981251 | 113605108 | 136498995 |
| Net asset value per share | $4.07 | $4.22 | $4.10 | $4.15 |
| \*Investments, at cost | $137321 | $208220 | $1160064 | $1407789 |
| \*\*Investments of affiliated issuers, at cost | 70374146 | 106252043 | 596196928 | 732143221 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Statements of assets and liabilities

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderately<br> Conservative | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderate –<br> Managed<br> Volatility | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderately<br> Aggressive –<br> Managed<br> Volatility | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderately<br> Conservative –<br> Managed<br> Volatility |
| **Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments, at value\* | $344299 | $8700908 | $1546332 | $603522 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments of affiliated issuers, at value\*\* | 137754670 | 425710301 | 75596037 | 29569917 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash collateral due from broker on futures contracts |  | 1351200 | 228400 | 101200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivable for portfolio shares sold | 15018 | 4140 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends receivable | 1143 | 28735 | 5127 | 2018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivable for securities sold |  |  | 46922 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Variation margin due from broker on futures contracts |  | 68675 | 11598 | 5148 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets | 138115130 | 435863959 | 77434416 | 30281805 |
| **Liabilities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | 103904 | 81237 | 48939 | 44430 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administration expenses payable to affiliates | 17901 | 59854 | 7385 | 5509 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payable for portfolio shares redeemed | 3238 | 67189 | 64682 | 2459 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payable for securities purchased |  |  |  | 2413 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment management fees payable to affiliates |  | 74249 | 13335 | 5277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | 125043 | 282529 | 134341 | 60088 |
| **Total Net Assets** | $137990087 | $435581430 | $77300075 | $30221717 |
| **Net Assets Consist of:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | $153031231 | $475330298 | $83209221 | $34442768 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total distributable earnings (loss) | (15041144) | (39748868) | (5909146) | (4221051) |
| **Total Net Assets** | $137990087 | $435581430 | $77300075 | $30221717 |
| **Net Asset Value** |  |  |  |  |
| **Class II:** |  |  |  |  |
| Net assets | $137990087 | $435581430 | $77300075 | $30221717 |
| Shares of beneficial interest outstanding, unlimited authorization, no par | 33031476 | 100665625 | 16283748 | 8915458 |
| Net asset value per share | $4.18 | $4.33 | $4.75 | $3.39 |
| \*Investments, at cost | $344299 | $8700908 | $1546332 | $603522 |
| \*\*Investments of affiliated issuers, at cost | 175394855 | 547633916 | 98913502 | 39099283 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Statements of operations

Ivy Variable Insurance Portfolios

Year ended December 31, 2022

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br>Pathfinder Aggressive | Delaware Ivy VIP<br>Pathfinder Conservative | Delaware Ivy VIP<br>Pathfinder Moderate | Delaware Ivy VIP<br>Pathfinder Moderately<br> Aggressive |
| **Investment Income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Dividends from affiliated funds | $847877 | $1469357 | $7819267 | $9290969 |
| &nbsp;&nbsp;&nbsp;Dividends | 8370 | 13455 | 73001 | 88549 |
|  | 856247 | 1482812 | 7892268 | 9379518 |
| **Expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Accounting and administration expenses | 41613 | 49199 | 143372 | 168389 |
| &nbsp;&nbsp;&nbsp;Audit and tax fees | 23679 | 25123 | 22175 | 25039 |
| &nbsp;&nbsp;&nbsp;Reports and statements to shareholders |  |  |  |  |
| &nbsp;&nbsp;&nbsp;servicing expenses | 13962 | 13212 | 11580 | 35022 |
| &nbsp;&nbsp;&nbsp;Trustees' fees and expenses | 13310 | 17826 | 42999 | 58038 |
| &nbsp;&nbsp;&nbsp;Custodian fees | 11681 | 7783 | 42345 | 9380 |
| &nbsp;&nbsp;&nbsp;Legal fees | 8600 | 8313 | 5169 | 14404 |
| &nbsp;&nbsp;&nbsp;Dividend disbursing and transfer agent |  |  |  |  |
| &nbsp;&nbsp;&nbsp;fees and expenses | 3233 | 4453 | 25073 | 31875 |
| &nbsp;&nbsp;&nbsp;Registration fees | 6 | 6 | 6 | 6 |
| &nbsp;&nbsp;&nbsp;Other | 9994 | 12328 | 34997 | 42032 |
| &nbsp;&nbsp;&nbsp;Total operating expenses | 126078 | 138243 | 327716 | 384185 |
| **Net Investment Income (Loss)** | 730169 | 1344569 | 7564552 | 8995333 |
| **Net Realized and Unrealized Gain (Loss):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliated investments | 950859 | 692008 | 5358601 | 7199308 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital gain received from investments in affiliated funds | 10446732 | 9912252 | 73298639 | 100464990 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) | 11397591 | 10604260 | 78657240 | 107664298 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliated investments | (24141867) | (27145808) | (180279220) | (236925647) |
| **Net Realized and Unrealized Gain (Loss)** | (12744276) | (16541548) | (101621980) | (129261349) |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | $(12014107) | $(15196979) | $(94057428) | $(120266016) |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Statements of operations

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br>Pathfinder Moderately<br> Conservative | Delaware Ivy VIP<br>Pathfinder Moderate –<br> Managed Volatility | Delaware Ivy VIP<br>Pathfinder Moderately<br>Aggressive –<br>Managed Volatility | Delaware Ivy VIP<br>Pathfinder Moderately<br>Conservative –<br>Managed Volatility |
| **Investment Income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Dividends from affiliated funds | $2378169 | $6685372 | $1204867 | $510051 |
| &nbsp;&nbsp;&nbsp;Dividends | 21798 | 237484 | 42735 | 17603 |
|  | 2399967 | 6922856 | 1247602 | 527654 |
| **Expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Investment advisory fees |  | 918235 | 169513 | 68200 |
| &nbsp;&nbsp;&nbsp;Accounting and administration expenses | 71705 | 141980 | 47627 | 40112 |
| &nbsp;&nbsp;&nbsp;Legal fees | 55826 | 2022 | 8332 | 7698 |
| &nbsp;&nbsp;&nbsp;Custodian fees | 45964 | 3808 | 11393 | 9468 |
| &nbsp;&nbsp;&nbsp;Reports and statements to shareholders servicing expenses | 40582 | 13494 | 11509 | 12213 |
| &nbsp;&nbsp;&nbsp;Audit and tax fees | 22678 | 23044 | 23829 | 24058 |
| &nbsp;&nbsp;&nbsp;Trustees' fees and expenses | 13408 | 52551 | 14836 | 8950 |
| &nbsp;&nbsp;&nbsp;Dividend disbursing and transfer agent fees and expenses | 5887 | 9277 | 4355 | 1028 |
| &nbsp;&nbsp;&nbsp;Registration fees | 6 | 6 | 6 | 6 |
| &nbsp;&nbsp;&nbsp;Other | 11418 | 44335 | 9164 | 8963 |
| &nbsp;&nbsp;&nbsp;Total operating expenses | 267474 | 1208752 | 300564 | 180696 |
| **Net Investment Income (Loss)** | 2132493 | 5714104 | 947038 | 346958 |
| **Net Realized and Unrealized Gain (Loss):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliated investments | 1403122 | 5898509 | 1902648 | 271242 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital gain received from investments in affiliated funds | 19145324 | 62272793 | 13122286 | 4066210 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Futures contracts |  | 7109716 | 1286551 | 556898 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) | 20548446 | 75281018 | 16311485 | 4894350 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliated investments | (49466726) | (151811119) | (31478309) | (10321916) |
| &nbsp;&nbsp;&nbsp;Futures contracts |  | 1338945 | 234164 | 103417 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (49466726) | (150472174) | (31244145) | (10218499) |
| **Net Realized and Unrealized Gain (Loss)** | (28918280) | (75191156) | (14932660) | (5324149) |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | $(26785787) | $(69477052) | $(13985622) | $(4977191) |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Statements of changes in net assets

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Pathfinder Aggressive | Delaware Ivy VIP<br> Pathfinder Aggressive | Delaware Ivy VIP<br> Pathfinder Conservative | Delaware Ivy VIP<br> Pathfinder Conservative |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income (loss) | $730169 | $1157545 | $1344569 | $2571374 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) | 11397591 | 4917252 | 10604260 | 7375060 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (24141867) | 6197406 | (27145808) | 793342 |
| &nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (12014107) | 12272203 | (15196979) | 10739776 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (6081792) | (4618734) | (9920864) | (6783293) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 1236646 | 1153807 | 2994346 | 7733715 |
| &nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 6081792 | 4618734 | 9920864 | 6783294 |
|  | 7318438 | 5772541 | 12915210 | 14517009 |
| &nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (9528375) | (7370711) | (13546107) | (20260961) |
| &nbsp;&nbsp;&nbsp;Decrease in net assets derived from capital share transactions | (2209937) | (1598170) | (630897) | (5743952) |
| **Net Increase (Decrease) in Net Assets** | (20305836) | 6055299 | (25748740) | (1787469) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of year | 73958224 | 67902925 | 109985011 | 111772480 |
| &nbsp;&nbsp;&nbsp;End of year | $53652388 | $73958224 | $84236271 | $109985011 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Statements of changes in net assets

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Pathfinder Moderate | Delaware Ivy VIP<br> Pathfinder Moderate | Delaware Ivy VIP<br> Pathfinder Moderately<br> Aggressive | Delaware Ivy VIP<br> Pathfinder Moderately<br> Aggressive |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income (loss) | $7564552 | $13338108 | $8995333 | $14987324 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) | 78657240 | 48889770 | 107664298 | 63712517 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (180279220) | 26962268 | (236925647) | 45803323 |
| &nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (94057428) | 89190146 | (120266016) | 124503164 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (62270198) | (42760246) | (78642243) | (53200274) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 1889732 | 1792123 | 3808521 | 4843743 |
| &nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and |  |  |  |  |
| &nbsp;&nbsp;&nbsp;distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 62270198 | 42760246 | 78642243 | 53200274 |
|  | 64159930 | 44552369 | 82450764 | 58044017 |
| &nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (77015239) | (112412891) | (94266630) | (151624005) |
| &nbsp;&nbsp;&nbsp;Decrease in net assets derived from capital share transactions | (12855309) | (67860522) | (11815866) | (93579988) |
| **Net Decrease in Net Assets** | (169182935) | (21430622) | (210724125) | (22277098) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of year | 634778321 | 656208943 | 776718699 | 798995797 |
| &nbsp;&nbsp;&nbsp;End of year | $465595386 | $634778321 | $565994574 | $776718699 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Pathfinder Moderately<br> Conservative | Delaware Ivy VIP<br> Pathfinder Moderately<br> Conservative | Delaware Ivy VIP<br> Pathfinder Moderate –<br> Managed Volatility | Delaware Ivy VIP<br> Pathfinder Moderate –<br> Managed Volatility |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income (loss) | $2132493 | $4175492 | $5714104 | $13678694 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) | 20548446 | 13216767 | 75281018 | 82280739 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (49466726) | 5064263 | (150472174) | (2411822) |
| &nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (26785787) | 22456522 | (69477052) | 93547611 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (17346896) | (12482859) | (95792163) | (21326753) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 355804 | 2783081 | 14043254 | 17825120 |
| &nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 17346896 | 12482859 | 95792163 | 21326753 |
|  | 17702700 | 15265940 | 109835417 | 39151873 |
| &nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (23039255) | (32902562) | (38808203) | (310117607) |
| &nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | (5336555) | (17636622) | 71027214 | (270965734) |
| **Net Decrease in Net Assets** | (49469238) | (7662959) | (94242001) | (198744876) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of year | 187459325 | 195122284 | 529823431 | 728568307 |
| &nbsp;&nbsp;&nbsp;End of year | $137990087 | $187459325 | $435581430 | $529823431 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Statements of changes in net assets

Ivy Variable Insurance Portfolios

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Pathfinder Moderately<br> Aggressive –<br> Managed Volatility | Delaware Ivy VIP<br> Pathfinder Moderately<br> Aggressive –<br> Managed Volatility | Delaware Ivy VIP<br> Pathfinder Moderately<br> Conservative –<br> Managed Volatility | Delaware Ivy VIP<br> Pathfinder Moderately<br> Conservative –<br> Managed Volatility |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| **Increase (Decrease) in Net Assets from Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income (loss) | $947038 | $1580586 | $346958 | $1709313 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) | 16311485 | 6480584 | 4894350 | 10233959 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) | (31244145) | 6022229 | (10218499) | (2703178) |
| &nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets resulting from operations | (13985622) | 14083399 | (4977191) | 9240094 |
| **Dividends and Distributions to Shareholders from:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributable earnings: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (8050737) | (2885945) | (11995385) | (3230225) |
| **Capital Share Transactions:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 2070590 | 3343305 | 2289664 | 6191666 |
| &nbsp;&nbsp;&nbsp;Net asset value of shares issued upon reinvestment of dividends and distributions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | 8050737 | 2885945 | 11995385 | 3230225 |
|  | 10121327 | 6229250 | 14285049 | 9421891 |
| &nbsp;&nbsp;&nbsp;Cost of shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class II | (12569340) | (11700491) | (7078676) | (61135361) |
| &nbsp;&nbsp;&nbsp;Increase (decrease) in net assets derived from capital share transactions | (2448013) | (5471241) | 7206373 | (51713470) |
| **Net Increase (Decrease) in Net Assets** | (24484372) | 5726213 | (9766203) | (45703601) |
| **Net Assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of year | 101784447 | 96058234 | 39987920 | 85691521 |
| &nbsp;&nbsp;&nbsp;End of year | $77300075 | $101784447 | $30221717 | $39987920 |

---

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Financial highlights

Delaware Ivy VIP Pathfinder Aggressive Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $5.47 | $4.92 | $5.00 | $4.60 | $5.16 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.05 | 0.08 | 0.09 | 0.07 | 0.13 |
| Net realized and unrealized gain (loss) | (0.97) | 0.82 | 0.52 | 0.92 | (0.32) |
| Total from investment operations | (0.92) | 0.90 | 0.61 | 0.99 | (0.19) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.09) | (0.09) | (0.07) | (0.14) | (0.09) |
| Net realized gain | (0.39) | (0.26) | (0.62) | (0.45) | (0.28) |
| Total dividends and distributions | (0.48) | (0.35) | (0.69) | (0.59) | (0.37) |
| **Net asset value, end of period** | $4.07 | $5.47 | $4.92 | $5.00 | $4.60 |
| **Total return**<sup>2</sup>** | (16.72%) | 18.93% | 15.70% | 23.24% | (4.27%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $53652 | $74<sup>3</sup> | $68<sup>3</sup> | $66<sup>3</sup> | $59<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.21% | 0.07% | 0.12% | 0.09% | 0.09% |
| Ratio of net investment income to average net assets | 1.24% | 1.62% | 1.91% | 1.41% | 2.49% |
| Portfolio turnover | 30% | 18% | 21% | 18% | 51% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Financial highlights

Delaware Ivy VIP Pathfinder Conservative Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $5.50 | $5.31 | $5.15 | $4.83 | $5.16 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.07 | 0.13 | 0.10 | 0.09 | 0.10 |
| Net realized and unrealized gain (loss) | (0.84) | 0.39 | 0.49 | 0.59 | (0.20) |
| Total from investment operations | (0.77) | 0.52 | 0.59 | 0.68 | (0.10) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.13) | (0.10) | (0.09) | (0.10) | (0.06) |
| Net realized gain | (0.38) | (0.23) | (0.34) | (0.26) | (0.17) |
| Total dividends and distributions | (0.51) | (0.33) | (0.43) | (0.36) | (0.23) |
| **Net asset value, end of period** | $4.22 | $5.50 | $5.31 | $5.15 | $4.83 |
| **Total return**<sup>2</sup>** | (14.09%) | 10.18% | 12.67% | 14.66% | (1.93%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $84236 | $110<sup>3</sup> | $112<sup>3</sup> | $99<sup>3</sup> | $94<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.15% | 0.06% | 0.08% | 0.07% | 0.07% |
| Ratio of net investment income to average net assets | 1.44% | 2.32% | 2.02% | 1.71% | 1.89% |
| Portfolio turnover | 29% | 27% | 41% | 31% | 39% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Delaware Ivy VIP Pathfinder Moderate Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $5.51 | $5.15 | $5.19 | $4.89 | $5.40 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.07 | 0.11 | 0.10 | 0.08 | 0.12 |
| Net realized and unrealized gain (loss) | (0.91) | 0.61 | 0.51 | 0.79 | (0.31) |
| Total from investment operations | (0.84) | 0.72 | 0.61 | 0.87 | (0.19) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.12) | (0.11) | (0.09) | (0.14) | (0.08) |
| Net realized gain | (0.45) | (0.25) | (0.56) | (0.43) | (0.24) |
| Total dividends and distributions | (0.57) | (0.36) | (0.65) | (0.57) | (0.32) |
| **Net asset value, end of period** | $4.10 | $5.51 | $5.15 | $5.19 | $4.89 |
| **Total return**<sup>2</sup>** | (15.26%) | 14.66% | 14.35% | 19.05% | (3.90%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $465595 | $635<sup>3</sup> | $656<sup>3</sup> | $680<sup>3</sup> | $703<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.06% | 0.03% | 0.04% | 0.04% | 0.03% |
| Ratio of net investment income to average net assets | 1.46% | 2.05% | 2.05% | 1.62% | 2.26% |
| Portfolio turnover | 28% | 18% | 21% | 17% | 36% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Financial highlights

Delaware Ivy VIP Pathfinder Moderately Aggressive Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $5.66 | $5.18 | $5.32 | $4.98 | $5.59 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.06 | 0.10 | 0.10 | 0.08 | 0.13 |
| Net realized and unrealized gain (loss) | (0.96) | 0.75 | 0.52 | 0.92 | (0.37) |
| Total from investment operations | (0.90) | 0.85 | 0.62 | 1.00 | (0.24) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.12) | (0.10) | (0.09) | (0.15) | (0.10) |
| Net realized gain | (0.49) | (0.27) | (0.67) | (0.51) | (0.27) |
| Total dividends and distributions | (0.61) | (0.37) | (0.76) | (0.66) | (0.37) |
| **Net asset value, end of period** | $4.15 | $5.66 | $5.18 | $5.32 | $4.98 |
| **Total return**<sup>2</sup>** | (15.90%) | 16.88% | 15.12% | 21.40% | (4.71%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $565995 | $777<sup>3</sup> | $799<sup>3</sup> | $829<sup>3</sup> | $838<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.06% | 0.03<sup>%</sup> | 0.04% | 0.03% | 0.03% |
| Ratio of net investment income to average net assets | 1.43% | 1.88% | 2.02% | 1.56% | 2.35% |
| Portfolio turnover | 28% | 17% | 20% | 19% | 39% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Delaware Ivy VIP Pathfinder Moderately Conservative Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $5.53 | $5.26 | $5.22 | $4.90 | $5.32 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.06 | 0.12 | 0.10 | 0.08 | 0.11 |
| Net realized and unrealized gain (loss) | (0.87) | 0.51 | 0.50 | 0.70 | (0.24) |
| Total from investment operations | (0.81) | 0.63 | 0.60 | 0.78 | (0.13) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.13) | (0.11) | (0.10) | (0.12) | (0.07) |
| Net realized gain | (0.41) | (0.25) | (0.46) | (0.34) | (0.22) |
| Total dividends and distributions | (0.54) | (0.36) | (0.56) | (0.46) | (0.29) |
| **Net asset value, end of period** | $4.18 | $5.53 | $5.26 | $5.22 | $4.90 |
| **Total return**<sup>2</sup>** | (14.71%) | 12.37% | 13.52% | 16.85% | (2.67%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $137990 | $187<sup>3</sup> | $195<sup>3</sup> | $202<sup>3</sup> | $205<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.17% | 0.04% | 0.06% | 0.05% | 0.05% |
| Ratio of net investment income to average net assets | 1.39% | 2.17% | 2.09% | 1.67% | 2.07% |
| Portfolio turnover | 31% | 20% | 25% | 18% | 34% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Financial highlights

Delaware Ivy VIP Pathfinder Moderate – Managed Volatility Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $6.33 | $5.77 | $5.84 | $5.33 | $5.78 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.06 | 0.11 | 0.10 | 0.08 | 0.11 |
| Net realized and unrealized gain (loss) | (0.89) | 0.62 | 0.34 | 0.82 | (0.33) |
| Total from investment operations | (0.83) | 0.73 | 0.44 | 0.90 | (0.22) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.17) | (0.10) | (0.08) | (0.11) | (0.06) |
| Net realized gain | (1.00) | (0.07) | (0.43) | (0.28) | (0.17) |
| Total dividends and distributions | (1.17) | (0.17) | (0.51) | (0.39) | (0.23) |
| **Net asset value, end of period** | $4.33 | $6.33 | $5.77 | $5.84 | $5.33 |
| **Total return**<sup>2</sup>** | (13.22%) | 12.99% | 9.07% | 17.32% | (4.00%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $435581 | $530<sup>3</sup> | $729<sup>3</sup> | $707<sup>3</sup> | $606<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.26% | 0.22% | 0.23% | 0.23% | 0.23% |
| Ratio of net investment income to average net assets | 1.24% | 1.87% | 1.78% | 1.39% | 2.00% |
| Portfolio turnover | 32% | 19% | 42% | 9% | 28% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $6.11 | $5.46 | $5.63 | $5.15 | $5.66 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.06 | 0.09 | 0.09 | 0.07 | 0.11 |
| Net realized and unrealized gain (loss) | (0.91) | 0.73 | 0.33 | 0.88 | (0.37) |
| Total from investment operations | (0.85) | 0.82 | 0.42 | 0.95 | (0.26) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.10) | (0.09) | (0.07) | (0.12) | (0.07) |
| Net realized gain | (0.41) | (0.08) | (0.52) | (0.35) | (0.18) |
| Total dividends and distributions | (0.51) | (0.17) | (0.59) | (0.47) | (0.25) |
| **Net asset value, end of period** | $4.75 | $6.11 | $5.46 | $5.63 | $5.15 |
| **Total return**<sup>2</sup>** | (14.00%) | 15.24% | 9.71% | 19.29% | (4.75%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $77300 | $102<sup>3</sup> | $96<sup>3</sup> | $93<sup>3</sup> | $84<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.35% | 0.26% | 0.29% | 0.27% | 0.27% |
| Ratio of net investment income to average net assets | 1.12% | 1.58% | 1.68% | 1.32% | 2.04% |
| Portfolio turnover | 44% | 18% | 41% | 16% | 37% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Financial highlights

Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility Class II

Selected data for the share of the Portfolio outstanding throughout each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Year ended** | **Year ended** | **Year ended** | **Year ended** | **Year ended** |
| | **12/31/22** | **12/31/21** | **12/31/20** | **12/31/19** | **12/31/18** |
| **Net asset value, beginning of period** | $6.02 | $5.64 | $5.58 | $5.19 | $5.55 |
| **Income (loss) from investment operations:** |  |  |  |  |  |
| Net investment income<sup>1</sup> | 0.04 | 0.12 | 0.09 | 0.08 | 0.10 |
| Net realized and unrealized gain (loss) | (0.79) | 0.47 | 0.39 | 0.66 | (0.24) |
| Total from investment operations | (0.75) | 0.59 | 0.48 | 0.74 | (0.14) |
| **Less dividends and distributions from:** |  |  |  |  |  |
| Net investment income | (0.27) | (0.09) | (0.08) | (0.10) | (0.05) |
| Net realized gain | (1.61) | (0.12) | (0.34) | (0.25) | (0.17) |
| Total dividends and distributions | (1.88) | (0.21) | (0.42) | (0.35) | (0.22) |
| **Net asset value, end of period** | $3.39 | $6.02 | $5.64 | $5.58 | $5.19 |
| **Total return**<sup>2</sup>** | (12.71%) | 10.72% | 9.61% | 14.89% | (2.90%) |
| **Ratios and supplemental data:** |  |  |  |  |  |
| Net assets, end of period (000 omitted) | $30222 | $40<sup>3</sup> | $86<sup>3</sup> | $80<sup>3</sup> | $73<sup>3</sup> |
| Ratio of expenses to average net assets<sup>4</sup> | 0.53% | 0.26% | 0.30% | 0.27% | 0.29% |
| Ratio of net investment income to average net assets | 1.02% | 2.06% | 1.77% | 1.45% | 1.79% |
| Portfolio turnover | 43% | 24% | 45% | 14% | 28% |

---

<sup>1</sup> Calculated using average shares outstanding.

<sup>2</sup> Total return is based on the change in net asset value of a share during the period and assumes reinvestment of dividends and distributions at net asset value. Total return does not include fees, charges, or expenses imposed by the variable annuity and life insurance contracts for which Ivy Variable Insurance Portfolios serves as an underlying investment vehicle.

<sup>3</sup> Net assets reported in millions.

<sup>4</sup> Expense ratios do not include expenses of any investment companies in which the Portfolio invests.

See accompanying notes, which are an integral part of the financial statements. <br>

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

December 31, 2022

Ivy Variable Insurance Portfolios (Trust) is organized as a Delaware statutory trust and offers 26 portfolios. These financial statements and the related notes pertain to 8 portfolios: Delaware Ivy VIP Pathfinder Aggressive, Delaware Ivy VIP Pathfinder Conservative, Delaware Ivy VIP Pathfinder Moderate, Delaware Ivy VIP Pathfinder Moderately Aggressive, and Delaware Ivy VIP Pathfinder Moderately Conservative (collectively, the "Pathfinder Portfolios"), Delaware Ivy VIP Pathfinder Moderate – Managed Volatility, Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility, and Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility (collectively, the "Managed Volatility Portfolios") (each, a Portfolio and collectively, the Portfolios). The Trust is an open-end investment company. Each of the Portfolios are diversified as defined in the Investment Company Act of 1940, as amended (1940 Act).

Each Portfolio offers Class II shares. The shares of the Portfolios are sold only to variable life insurance separate accounts and variable annuity separate accounts.

**1. Significant Accounting Policies**

Each Portfolio follows accounting and reporting guidance under Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946, Financial Services — Investment Companies. The following accounting policies are in accordance with US generally accepted accounting principles (US GAAP) and are consistently followed by the Portfolios.

**Security Valuation** — Open-end investment companies, other than exchange-traded funds are valued at their published net asset value (NAV). Futures contracts are valued at the daily quoted settlement prices. Generally, other securities and assets for which market quotations are not readily available are valued at fair value as determined in good faith by each Portfolio's valuation designee, Delaware Management Company (DMC). Subject to the oversight of each Portfolio's Board of Trustees (Board), DMC, as valuation designee, has adopted policies and procedures to fair value securities for which market quotations are not readily available consistent with the requirements of Rule 2a-5 under the 1940 Act. In determining whether market quotations are readily available or fair valuation will be used, various factors will be taken into consideration, such as market closures or suspension of trading in a security. Restricted securities and private placements are valued at fair value.

**Federal and Foreign Income Taxes** — No provision for federal income taxes has been made as each Portfolio intends to continue to qualify for federal income tax purposes as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended, and make the requisite distributions to shareholders. Each Portfolio evaluates tax positions taken or expected to be taken in the course of preparing each Portfolio's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the "more-likely-than-not" threshold are recorded as a tax benefit or expense in the current year. Management has analyzed each Portfolio's tax positions taken or expected to be taken on each Portfolio's federal income tax returns through the year ended December 31, 2022, and for all open tax years (years ended December 31, 2019-December 31, 2021), and has concluded that no provision for federal income tax is required in each Portfolio's financial statements. In regard to foreign taxes only, each Portfolio has open tax years in certain foreign countries in which it invests in that may date back to the inception of each Portfolio. If applicable, each Portfolio recognizes interest accrued on unrecognized tax benefits in interest expense and penalties in "Other" on the "Statements of operations." During the year ended December 31, 2022, the Portfolios did not incur any interest or tax penalties.

**Underlying Funds** — Each Portfolio may invest in other investment companies (Underlying Funds) to the extent permitted by the 1940 Act. The Underlying Funds in which each Portfolio may invest include exchange-traded funds (ETFs). Each Portfolio will indirectly bear the investment management fees and other expenses of the Underlying Funds.

**Derivative Financial Instruments —** Each Portfolio may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other assets without owning or taking physical custody of securities, commodities and/or other referenced assets or to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/ or other risks. Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction or illiquidity of the instrument. Pursuant to Rule 18f-4 under the 1940 Act, among other things, each Portfolio must either use derivative financial instruments with embedded leverage in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. Each Portfolio's successful use of a derivative financial instrument depends on the investment adviser's ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the <br>

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**1. Significant Accounting Policies (continued)** 

amount of appreciation the Portfolios can realize on an investment and/or may result in lower distributions paid to shareholders. Each Portfolio's investments in these instruments, if any, are discussed in detail in the Notes to Financial Statements.

**Segregation and Collateralizations** — In certain cases, based on requirements and agreements with certain exchanges and third-party broker-dealers, each Portfolio may deliver collateral in connection with certain investments (e.g., futures contracts, foreign currency exchange contracts, options written, securities with extended settlement periods, and swaps). Certain countries require that cash reserves be held while investing in companies incorporated in that country. These cash reserves and cash collateral that has been pledged/received to cover obligations of each Portfolio under derivative contracts, if any, will be reported separately on the "Statement of assets and liabilities" as cash collateral due to/from broker. Securities collateral pledged for the same purpose, if any, is noted on the "Schedule of investments."

**Use of Estimates** — The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the fair value of investments, the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and the differences could be material.

**Other** — Expenses directly attributable to a Portfolio are charged directly to that Portfolio. Other expenses common to various funds within the Delaware Funds by Macquarie<sup>®</sup> (Delaware Funds) are generally allocated among such funds on the basis of average net assets. Management fees and certain other expenses are paid monthly. Security transactions are recorded on the date the securities are purchased or sold (trade date) for financial reporting purposes. Costs used in calculating realized gains and losses on the sale of investment securities are those of the specific securities sold. Income and capital gain distributions from any Underlying Funds in which a Portfolio invests are recorded on the ex-dividend date. Each Portfolio declares net investment income and distributions from net realized gain on investments, if any, following the close of the fiscal year. Each Portfolio may distribute more frequently, if necessary for tax purposes. Dividends and distributions, if any, are recorded on the ex-dividend date.

**2. Investment Management, Administration Agreements, and Other Transactions with Affiliates**

In accordance with the terms of its respective investment management agreement, each Portfolio (other than the Pathfinder Portfolios) pays DMC, a series of Macquarie Investment Management Business Trust and the investment manager, an annual fee which is calculated daily and paid monthly, based on each Portfolio's average daily net assets as follows:

---

| | |
|:---|:---|
| Portfolio | Management Fee (annual rate as a percentage of average daily net assets) |
| Delaware Ivy VIP Pathfinder Moderate – |  |
| &nbsp;&nbsp;&nbsp;Managed Volatility | 0.20% of net assets up to $500 million; |
|  | 0.17% of net assets over $500 million and up to $1 billion; |
|  | 0.15% of net assets over $1 billion. |
| Delaware Ivy VIP Pathfinder Moderately |  |
| &nbsp;&nbsp;&nbsp;Aggressive – Managed Volatility | 0.20% of net assets up to $500 million; |
|  | 0.17% of net assets over $500 million and up to $1 billion; |
|  | 0.15% of net assets over $1 billion. |
| Delaware Ivy VIP Pathfinder Moderately |  |
| &nbsp;&nbsp;&nbsp;Conservative – Managed Volatility | 0.20% of net assets up to $500 million; |
|  | 0.17% of net assets over $500 million and up to $1 billion; |
|  | 0.15% of net assets over $1 billion. |

---

The Pathfinder Portfolios pay no management fees.

DMC uses all of the management fee it receives from the Managed Volatility Portfolios to pay Securian Asset Management Inc. ("Securian"). Accordingly, Securian receives a fee based on the average daily net assets of the Managed Volatility Portfolios.

DMC has entered into sub-advisory agreements with the following entities on behalf of the Portfolios: <br>

[**Table of Contents**](#toc3)

Macquarie Investment Management Austria Kapitalanlage AG (MIMAK) is a part of Macquarie Asset Management (MAM). MAM is the marketing name for certain companies comprising the asset management division of Macquarie Group Limited. With respect to the Portfolios for which MIMAK serves as a sub-advisor, DMC has principal responsibility for all investment advisory services and may seek investment advice and recommendations from MIMAK and DMC may also permit MIMAK to execute Portfolio security trades on behalf of DMC and exercise investment discretion for securities in certain markets where DMC believes it will be beneficial to utilize MIMAK's specialized market knowledge.

Securian serves as sub-advisor to the Managed Volatility Portfolios. The sub-advisor makes investment decisions in accordance with the Portfolio's investment objectives, policies and restrictions under the supervision of DMC and the Board. DMC pays all applicable costs of the sub-advisor.

Prior to February 28, 2022, the Portfolios had an Accounting Services Agreement with Waddell & Reed Services Company (WRSCO), doing business as WI Services Company (WISC). Under the agreement, WISC acted as the agent in providing bookkeeping and accounting services and assistance to each Portfolio, including maintenance of Portfolio records, pricing of Portfolio shares and preparation of certain shareholder reports. For these services, each Portfolio paid WISC a monthly fee of one-twelfth of the annual fee based on the average net asset levels shown in the following table:

---

| | |
|:---|:---|
| (M - Millions) | Annual Fee Rate |
| $0 to $10M | $0 |
| $10 to $25M | 5748 |
| $25 to $50M | 11550 |
| $50 to $100M | 17748 |
| $100 to $200M | 24198 |
| $200 to $350M | 31602 |
| $350 to $550M | 41250 |
| $550 to $750M | 48150 |
| $750 to $1,000M | 60798 |
| Over $1,000M | 74250 |

---

In addition, each Portfolio paid WISC a monthly administrative fee at the annual rate of 0.01%, or one basis point, for the first $1 billion of net assets with no fee charged for net assets in excess of $1 billion. This fee was voluntarily waived by WISC until each Portfolio's net assets were at least $10 million and is included in "Accounting and administration expenses" on the "Statements of operations."

Effective February 28, 2022, Delaware Investments Fund Services Company (DIFSC), an affiliate of DMC, provides fund accounting and financial administrative oversight services to each Portfolio. For these services, DIFSC's fees are calculated daily and paid monthly, based on the aggregate daily net assets of all funds within the Delaware Funds at the following annual rates: 0.00475% of the first $35 billion; 0.0040% of the next $10 billion; 0.0025% of the next $45 billion; and 0.0015% of aggregate average daily net assets in excess of $90 billion (Total Fee). Each fund in the Delaware Funds pays a minimum of $4,000, which, in aggregate, is subtracted from the Total Fee. Each fund then pays its portion of the remainder of the Total Fee on a relative NAV basis. These amounts are included on the "Statements of operations" under "Accounting and administration expenses." From February 28, 2022 to December 31, 2022, each Portfolio paid for these services as follows:

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Pathfinder Aggressive | $4082 |
| Delaware Ivy VIP Pathfinder Conservative | 3642 |
| Delaware Ivy VIP Pathfinder Moderate | 14822 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 15579 |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 6568 |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 10785 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | 4608 |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 4162 |

---

Prior to June 27, 2022, under a Transfer Agency Agreement between the Trust and WISC, each Portfolio reimbursed WISC for certain out-of-pocket costs. Effective June 27, 2022, DIFSC is also the transfer agent and dividend disbursing agent of the Portfolios. For these services, DIFSC's fees are calculated daily and paid monthly, at the annual rate of 0.0075% of the Portfolios' average daily net assets. This amount is <br>

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**2. Investment Management, Administration Agreements, and Other Transactions with Affiliates (continued)** included on the "Statements of operations" under "Dividend disbursing and transfer agent fees and expenses." From June 27, 2022 through December 31, 2022, each Portfolio paid for these services as follows:

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Pathfinder Aggressive | $1720 |
| Delaware Ivy VIP Pathfinder Conservative | 2774 |
| Delaware Ivy VIP Pathfinder Moderate | 18070 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 18306 |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 4508 |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 10915 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | 2499 |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 1026 |

---

Pursuant to a sub-transfer agency agreement between DIFSC and BNY Mellon Investment Servicing (US) Inc. (BNYMIS), effective June 27, 2022, BNYMIS provides certain sub-transfer agency services to each Portfolio. Sub-transfer agency fees are paid by each Portfolio and are also included on the "Statements of operations" under "Dividend disbursing and transfer agent fees and expenses." The fees that are calculated daily and paid as invoices are received on a monthly or quarterly basis.

As provided in the investment management agreement, each Portfolio bears a portion of the cost of certain resources shared with DMC, including the cost of internal personnel of DMC and/or its affiliates that provide legal and regulatory reporting services to each Portfolio. These amounts are included on the "Statements of operations" under "Legal fees." For the year ended December 31, 2022, each Portfolio paid for internal legal and regulatory reporting services provided by DMC and/or its affiliates' employees as follows:

---

| | |
|:---|:---|
| Portfolio | Fees |
| Delaware Ivy VIP Pathfinder Aggressive | $1791 |
| Delaware Ivy VIP Pathfinder Conservative | 2779 |
| Delaware Ivy VIP Pathfinder Moderate | 15355 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 18704 |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 4581 |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 13468 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | 2540 |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 981 |

---

Trustees' fees include expenses accrued by each Portfolio for each Trustee's retainer and meeting fees. Certain officers of DMC, DIFSC, and DDLP are officers and/or Trustees of the Trust. These officers and Trustees are paid no compensation by the Portfolios.

In addition to the management fees and other expenses of a Portfolio, a Portfolio indirectly bears the investment management fees and other expenses of any Underlying Funds in which it invests. The amount of these fees and expenses incurred indirectly by a Portfolio will vary based upon the expense and fee levels of any Underlying Funds and the number of shares that are owned of any Underlying Funds at different times.

A summary of the transactions in affiliated companies during the year ended December 31, 2022 was as follows: <br>

[**Table of Contents**](#toc3)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br> beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on<br> affiliated<br> fund | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br>on affiliated fund | Value,<br> end of<br> period | Shares | Income<br> distributions | Capital gain<br> distributions |
| **Delaware Ivy VIP Pathfinder Aggressive** | **Delaware Ivy VIP Pathfinder Aggressive** | **Delaware Ivy VIP Pathfinder Aggressive** | **Delaware Ivy VIP Pathfinder Aggressive** |  |  |  |  |  |  |
| **Affiliated Mutual Funds—99.86%** | **Affiliated Mutual Funds—99.86%** | **Affiliated Mutual Funds—99.86%** |  |  |  |  |  |  |  |
| Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II |  |  |  |  |  |  |
|  | $9178872 | $4571374 | $1989417 | $270896 | $(3722205) | $8309520 | 722567 | $19944 | $1778585 |
| Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II |  |  |  |  |  |  |
|  | 7186240 | 738600 | 1686369 | (106245) | (1264548) | 4867678 | 1084115 | 139996 | 159664 |
| Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II |  |  |  |  |  |  |
|  | 14498685 | 3031568 | 4061772 | 407542 | (6068388) | 7807635 | 979628 |  | 2258228 |
| Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I |  |  |  |  |  |  |
|  | 184761 | 17925 | 36441 | (1941) | (27363) | 136941 | 48561 | 10262 |  |
| Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II |  |  |  |  |  |
|  | 11908221 | 1667121 | 2022036 | (11681) | (2613702) | 8927923 | 629170 | 219402 | 755517 |
| Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II |  |  |  |  |  |  |
|  | 3671127 | 509701 | 995487 | (34578) | (175232) | 2975531 | 649679 | 41032 | 23081 |
| Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I |  |  |  |  |  |  |
|  | 7150999 | 1163089 | 1922141 | 340198 | (3243026) | 3489119 | 363450 |  | 922116 |
| Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I |  |  |  |  |  |  |
|  | 1702929 | 213010 | 846522 | (173622) | (329028) | 566767 | 92760 |  | 161405 |
| Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II |  |  |  |  |  |  |
|  | 444429 | 898801 | 249413 | 1821 | (255072) | 840566 | 75455 |  | 152347 |
| Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II |  |  |  |  |  |  |
|  | 7858869 | 4819677 | 1866107 | 117166 | (2983242) | 7946363 | 1429202 | 111594 | 2316641 |
| Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II |  |  |  |  |  |  |
|  | 9985397 | 2867470 | 1824296 | 141303 | (3460061) | 7709813 | 1748257 | 305647 | 1919148 |
| Total | $73770529 | $20498336 | $17500001 | $950859 | $(24141867) | $53577856 |  | $847877 | $10446732 |

---

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**2. Investment Management, Administration Agreements, and Other Transactions with Affiliates (continued)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br> beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on<br> affiliated<br> fund | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br>on affiliated fund | Value,<br> end of<br> period | Shares | Income<br> distributions | Capital gain<br> distributions |
| **Delaware Ivy VIP Pathfinder Conservative** | **Delaware Ivy VIP Pathfinder Conservative** | **Delaware Ivy VIP Pathfinder Conservative** | **Delaware Ivy VIP Pathfinder Conservative** |  |  |  |  |  |  |
| **Affiliated Mutual Funds—99.83%** | **Affiliated Mutual Funds—99.83%** | **Affiliated Mutual Funds—99.83%** | **Affiliated Mutual Funds—99.83%** |  |  |  |  |  |  |
| Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II |  |  |  |  |  |  |
|  | $8080468 | $5844564 | $2069383 | $212806 | $(3622306) | $8446149 | 734448 | $20655 | $1842002 |
| Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II |  |  |  |  |  |  |
|  | 31506244 | 3520637 | 5004701 | (142311) | (6126431) | 23753438 | 5290298 | 666824 | 760510 |
| Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II |  |  |  |  |  |  |
|  | 14240107 | 3751005 | 4733946 | 403606 | (6014344) | 7646428 | 959401 |  | 2297003 |
| Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I |  |  |  |  |  |  |
|  | 1373629 | 167041 | 242737 | (5877) | (217038) | 1075018 | 381212 | 78854 |  |
| Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II |  |  |  |  |  |
|  | 5899916 | 1122454 | 1307128 | (268) | (1333261) | 4381713 | 308789 | 115073 | 396257 |
| Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II |  |  |  |  |  |  |
|  | 27291863 | 2851498 | 6894599 | (217276) | (1397841) | 21633645 | 4723503 | 321087 | 180612 |
| Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I |  |  |  |  |  |  |
|  | 7444303 | 1489905 | 2567733 | 314705 | (3193907) | 3487273 | 363258 |  | 899946 |
| Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I |  |  |  |  |  |  |
|  | 1518356 | 246765 | 732267 | (155272) | (309301) | 568281 | 93008 |  | 155926 |
| Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II |  |  |  |  |  |  |
|  | 132117 | 1285078 | 207708 | 3684 | (220730) | 992441 | 89088 |  | 143482 |
| Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II |  |  |  |  |  |  |
|  | 7233782 | 5843241 | 2558638 | 214256 | (2950328) | 7782313 | 1399697 | 107791 | 2237702 |
| Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II |  |  |  |  |  |  |
|  | 4946484 | 2013209 | 937428 | 63955 | (1760321) | 4325899 | 980929 | 159073 | 998812 |
| Total | $109667269 | $28135397 | $27256268 | $692008 | $(27145808) | $84092598 |  | $1469357 | $9912252 |

---

[**Table of Contents**](#toc3)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br> beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on<br> affiliated<br> fund | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br> on affiliated fund | Value,<br> end of<br> period | Shares | Income<br> distributions | Capital gain<br> distributions |
| **Delaware Ivy VIP Pathfinder Moderate** | **Delaware Ivy VIP Pathfinder Moderate** | **Delaware Ivy VIP Pathfinder Moderate** | **Delaware Ivy VIP Pathfinder Moderate** | **Delaware Ivy VIP Pathfinder Moderate** | **Delaware Ivy VIP Pathfinder Moderate** | **Delaware Ivy VIP Pathfinder Moderate** | **Delaware Ivy VIP Pathfinder Moderate** | **Delaware Ivy VIP Pathfinder Moderate** | **Delaware Ivy VIP Pathfinder Moderate** |
| **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** |
| Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II |  |  |  |  |  |  |
|  | $62752681 | $35266504 | $14184772 | $1693127 | $(26175247) | $59352293 | 5161069 | $144661 | $12900362 |
| Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II |  |  |  |  |  |  |
|  | 121848884 | 9709594 | 21237729 | (962288) | (22628689) | 86729772 | 19316208 | 2446890 | 2790668 |
| Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II |  |  |  |  |  |  |
|  | 103399554 | 21814558 | 30038972 | 3300130 | (43507623) | 54967647 | 6896819 |  | 16165515 |
| Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I |  |  |  |  |  |  |
|  | 4760134 | 398389 | 799629 | (67847) | (694242) | 3596805 | 1275463 | 269103 |  |
| Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II |  |  |  |  |  |  |
|  | 68143283 | 8359999 | 10641959 | 110715 | (15178633) | 50793405 | 3579521 | 1272046 | 4380325 |
| Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II |  |  |  |  |  |  |
|  | 94578066 | 7149921 | 23581754 | (921468) | (4568867) | 72655898 | 15863733 | 1096172 | 616597 |
| Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I |  |  |  |  |  |  |
|  | 52183853 | 8389025 | 15210625 | 2046470 | (22663842) | 24744881 | 2577592 |  | 6473626 |
| Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I |  |  |  |  |  |  |
|  | 11687167 | 1475417 | 5643704 | (1238671) | (2228525) | 4051684 | 663123 |  | 1127513 |
| Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II |  |  |  |  |  |  |
|  | 2288653 | 7433102 | 1596351 | 24702 | (1732361) | 6417745 | 576099 |  | 1070293 |
| Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II |  |  |  |  |  |  |
|  | 54635744 | 36015009 | 14478959 | 1132615 | (21359921) | 55944488 | 10061958 | 794767 | 16499046 |
| Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II |  |  |  |  |  |  |
|  | 57145854 | 16618324 | 9092961 | 241116 | (19541270) | 45371063 | 10288223 | 1795628 | 11274694 |
| Total | $633423873 | $152629842 | $146507415 | $5358601 | $(180279220) | $464625681 |  | $7819267 | $73298639 |

---

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**2. Investment Management, Administration Agreements, and Other Transactions with Affiliates (continued)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br> beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on<br> affiliated fund | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br>on affiliated fund | Value,<br> end of<br> period | Shares | Income<br> distributions | Capital gain<br> distributions |
| **Delaware Ivy VIP Pathfinder Moderately Aggressive** | **Delaware Ivy VIP Pathfinder Moderately Aggressive** | **Delaware Ivy VIP Pathfinder Moderately Aggressive** | **Delaware Ivy VIP Pathfinder Moderately Aggressive** | **Delaware Ivy VIP Pathfinder Moderately Aggressive** | **Delaware Ivy VIP Pathfinder Moderately Aggressive** | **Delaware Ivy VIP Pathfinder Moderately Aggressive** | **Delaware Ivy VIP Pathfinder Moderately Aggressive** | **Delaware Ivy VIP Pathfinder Moderately Aggressive** | **Delaware Ivy VIP Pathfinder Moderately Aggressive** |
| **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** | **Affiliated Mutual Funds—99.79%** |
| Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II |  |  |  |  |  |  |
|  | $86663258 | $45217484 | $18741557 | $2213098 | $(35487856) | $79864427 | 6944733 | $194825 | $17373804 |
| Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II |  |  |  |  |  |  |
|  | 112350661 | 9805077 | 22127394 | (1267788) | (20396178) | 78364378 | 17453091 | 2238174 | 2552629 |
| Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II |  |  |  |  |  |  |
|  | 139532663 | 28550865 | 38928703 | 4197596 | (58797764) | 74554657 | 9354411 |  | 21964865 |
| Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I |  |  |  |  |  |  |
|  | 3884486 | 355420 | 701417 | (70458) | (553408) | 2914623 | 1033554 | 220081 |  |
| Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II |  |  |  |  |  |  |
|  | 104254774 | 12745021 | 15960288 | 102190 | (23221002) | 77920695 | 5491240 | 1947694 | 6706934 |
| Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II |  |  |  |  |  |  |
|  | 77180123 | 6858066 | 19756687 | (768509) | (3678998) | 59833995 | 13064191 | 881408 | 495792 |
| Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I |  |  |  |  |  |  |
|  | 69505260 | 11431311 | 19556394 | 2442245 | (30377292) | 33445130 | 3483868 |  | 8841727 |
| Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I |  |  |  |  |  |  |
|  | 16091801 | 1990852 | 7845522 | (1627090) | (3140461) | 5469580 | 895185 |  | 1542982 |
| Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II |  |  |  |  |  |  |
|  | 3734944 | 9245973 | 2250310 | 26441 | (2403883) | 8353165 | 749835 |  | 1458635 |
| Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II |  |  |  |  |  |  |
|  | 74739751 | 47540638 | 18905188 | 1559012 | (29054579) | 75879634 | 13647416 | 1078153 | 22382053 |
| Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II |  |  |  |  |  |  |
|  | 87433224 | 24490672 | 14282105 | 392571 | (29814226) | 68220136 | 15469419 | 2730634 | 17145569 |
| Total | $775370945 | $198231379 | $179055565 | $7199308 | $(236925647) | $564820420 |  | $9290969 | $100464990 |

---

[**Table of Contents**](#toc3)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br> beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on<br> affiliated<br> fund | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br>on affiliated fund | Value,<br> end of<br> period | Shares | Income<br> distributions | Capital gain<br> distributions |
| **Delaware Ivy VIP Pathfinder Moderately Conservative** | **Delaware Ivy VIP Pathfinder Moderately Conservative** | **Delaware Ivy VIP Pathfinder Moderately Conservative** | **Delaware Ivy VIP Pathfinder Moderately Conservative** | **Delaware Ivy VIP Pathfinder Moderately Conservative** |  |  |  |  |  |
| **Affiliated Mutual Funds—99.83%** | **Affiliated Mutual Funds—99.83%** | **Affiliated Mutual Funds—99.83%** | **Affiliated Mutual Funds—99.83%** | **Affiliated Mutual Funds—99.83%** |  |  |  |  |  |
| Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II |  |  |  |  |  |
|  | $16110082 | $10223878 | $4139100 | $508085 | $(6985954) | $15716991 | 1366695 | $38766 | $3457001 |
| Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II |  |  |  |  |  |
|  | 44726603 | 4476132 | 8125680 | (332286) | (8427413) | 32317356 | 7197629 | 921876 | 1051395 |
| Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II |  |  |  |  |  |
|  | 27330486 | 6123612 | 8312166 | 817195 | (11547153) | 14411974 | 1808278 |  | 4367341 |
| Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I |  |  |  |  |  |
|  | 1868743 | 203344 | 361744 | (26645) | (270819) | 1412879 | 501021 | 104692 |  |
| Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II |  |  |  |  |  |
|  | 15052572 | 2325122 | 2900919 | 23076 | (3382753) | 11117098 | 783446 | 288585 | 993750 |
| Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II |  |  |  |  |  |
|  | 37128370 | 3400054 | 9879605 | (335913) | (1821800) | 28491106 | 6220765 | 425665 | 239436 |
| Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I |  |  |  |  |  |
|  | 14014280 | 2619358 | 4607829 | 605837 | (6108550) | 6523096 | 679489 |  | 1736753 |
| Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I |  |  |  |  |  |
|  | 3012381 | 435867 | 1477344 | (313239) | (593873) | 1063792 | 174107 |  | 300692 |
| Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II |  |  |  |  |  |
|  | 449419 | 2190974 | 445928 | 7761 | (437380) | 1764846 | 158424 |  | 276189 |
| Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II |  |  |  |  |  |
|  | 14197909 | 10614293 | 4937315 | 440732 | (5647552) | 14668067 | 2638142 | 204705 | 4249606 |
| Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II |  |  |  |  |  |
|  | 12622418 | 4337380 | 2457373 | 8519 | (4243479) | 10267465 | 2328223 | 393880 | 2473161 |
| Total | $186513263 | $46950014 | $47645003 | $1403122 | $(49466726) | $137754670 |  | $2378169 | $19145324 |

---

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**2. Investment Management, Administration Agreements, and Other Transactions with Affiliates (continued)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br> beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on<br> affiliated<br> fund | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br> on affiliated fund | Value,<br> end of<br> period | Shares | Income<br> distributions | Capital gain<br> distributions |
| **Delaware Ivy VIP Pathfinder Moderate – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderate – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderate – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderate – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderate – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderate – Managed Volatility** |  |  |  |  |
| **Affiliated Mutual Funds—97.73%** | **Affiliated Mutual Funds—97.73%** | **Affiliated Mutual Funds—97.73%** | **Affiliated Mutual Funds—97.73%** | **Affiliated Mutual Funds—97.73%** |  |  |  |  |  |
| Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II |  |  |  |  |  |
|  | $50867788 | $37799489 | $14067362 | $1659253 | $(21856425) | $54402743 | 4730673 | $121348 | $10821363 |
| Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II |  |  |  |  |  |
|  | 98434004 | 20389850 | 19451539 | (204912) | (19649128) | 79518275 | 17710084 | 2094380 | 2388632 |
| Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II |  |  |  |  |  |
|  | 84004437 | 30898540 | 30676804 | 2444654 | (36276715) | 50394112 | 6322975 |  | 13927542 |
| Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I |  |  |  |  |  |
|  | 3844919 | 683982 | 618349 | (28574) | (605867) | 3276111 | 1161742 | 226369 |  |
| Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II |  |  |  |  |  |
|  | 55040198 | 16877128 | 12866246 | 563953 | (13058263) | 46556770 | 3280956 | 1099356 | 3785660 |
| Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II |  |  |  |  |  |
|  | 76306200 | 14619066 | 19777335 | (504516) | (4124531) | 66518884 | 14523774 | 945496 | 531841 |
| Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I |  |  |  |  |  |
|  | 42363309 | 12918254 | 15529921 | 1898597 | (18974482) | 22675757 | 2362058 |  | 5519604 |
| Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I |  |  |  |  |  |
|  | 9381799 | 1973830 | 4845670 | (1075587) | (1778377) | 3655995 | 598362 |  | 948697 |
| Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II |  |  |  |  |  |
|  | 1840875 | 6843156 | 1414642 | 34590 | (1437053) | 5866926 | 526654 |  | 885507 |
| Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II |  |  |  |  |  |
|  | 44236648 | 38233494 | 14387808 | 1108405 | (17901021) | 51289718 | 9224769 | 667105 | 13848845 |
| Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II |  |  |  |  |  |
|  | 45987441 | 20853262 | 9139082 | 2646 | (16149257) | 41555010 | 9422905 | 1531318 | 9615102 |
| Total | $512307618 | $202090051 | $142774758 | $5898509 | $(151811119) | $425710301 |  | $6685372 | $62272793 |

---

[**Table of Contents**](#toc3)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br> beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on affiliated fund | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br>on affiliated fund | Value,<br> end of<br> period | Shares | Income<br> distributions | Capital gain<br> distributions |
| **Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility** |  |  |  |
| **Affiliated Mutual Funds—97.80%** | **Affiliated Mutual Funds—97.80%** | **Affiliated Mutual Funds—97.80%** | **Affiliated Mutual Funds—97.80%** | **Affiliated Mutual Funds—97.80%** |  |  |  |  |  |
| Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II |  |  |  |  |  |
|  | $11007679 | $7729564 | $3763995 | $481641 | $(4759427) | $10695462 | 930040 | $25496 | $2273629 |
| Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II |  |  |  |  |  |
|  | 14266341 | 3408156 | 4370840 | (107430) | (2703907) | 10492320 | 2336820 | 293938 | 335235 |
| Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II |  |  |  |  |  |
|  | 17719222 | 6625742 | 7194018 | 550305 | (7722274) | 9978977 | 1252067 |  | 2979134 |
| Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I |  |  |  |  |  |
|  | 493316 | 103032 | 130419 | (2762) | (76991) | 386176 | 136942 | 28141 |  |
| Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II |  |  |  |  |  |
|  | 13249590 | 4146129 | 3996999 | 132979 | (3097776) | 10433923 | 735301 | 257351 | 886194 |
| Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II |  |  |  |  |  |
|  | 9800936 | 2649990 | 3851427 | (81010) | (496933) | 8021556 | 1751431 | 115175 | 64786 |
| Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I |  |  |  |  |  |
|  | 8832526 | 2839202 | 3613249 | 433096 | (4026834) | 4464741 | 465077 |  | 1178822 |
| Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I |  |  |  |  |  |
|  | 2046124 | 455049 | 1165673 | (250686) | (358776) | 726038 | 118828 |  | 202287 |
| Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II |  |  |  |  |  |
|  | 474748 | 1348660 | 414616 | 7299 | (305760) | 1110331 | 99671 |  | 185483 |
| Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II |  |  |  |  |  |
|  | 9496135 | 8373876 | 4257286 | 468362 | (3924795) | 10156292 | 1826671 | 136243 | 2828351 |
| Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II |  |  |  |  |  |
|  | 11110153 | 4964590 | 3210540 | 270854 | (4004836) | 9130221 | 2070345 | 348523 | 2188365 |
| Total | $98496770 | $42643990 | $35969062 | $1902648 | $(31478309) | $75596037 |  | $1204867 | $13122286 |

---

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**2. Investment Management, Administration Agreements, and Other Transactions with Affiliates (continued)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value,<br> beginning<br> of period | Gross<br> additions | Gross<br> reductions | Net<br> realized<br> gain (loss)<br> on affiliated fund | Net change in<br> unrealized<br> appreciation<br> (depreciation)<br>on affiliated fund | Value,<br> end of<br> period | Shares | Income<br> distributions | Capital gain<br> distributions |
| **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** | **Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility** |
| **Affiliated Mutual Funds—97.84%** | **Affiliated Mutual Funds—97.84%** | **Affiliated Mutual Funds—97.84%** | **Affiliated Mutual Funds—97.84%** | **Affiliated Mutual Funds—97.84%** | **Affiliated Mutual Funds—97.84%** | **Affiliated Mutual Funds—97.84%** | **Affiliated Mutual Funds—97.84%** | **Affiliated Mutual Funds—97.84%** | **Affiliated Mutual Funds—97.84%** |
| Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II | Delaware Ivy VIP Core Equity Class II |
|  | $3384033 | $2689241 | $1371968 | $161256 | $(1489259) | $3373303 | 293331 | $8101 | $722433 |
| Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II | Delaware Ivy VIP Corporate Bond Class II |
|  | 9326207 | 1974356 | 2507121 | (106468) | (1748525) | 6938449 | 1545312 | 195244 | 222674 |
| Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II | Delaware Ivy VIP Growth Class II |
|  | 5777567 | 2207632 | 2660801 | 136803 | (2367388) | 3093813 | 388182 |  | 922126 |
| Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I | Delaware Ivy VIP High Income Class I |
|  | 389266 | 69655 | 95198 | (3679) | (59471) | 300573 | 106586 | 22402 |  |
| Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II | Delaware Ivy VIP International Core Equity Class II |
|  | 3125553 | 1032578 | 1073390 | 19377 | (718806) | 2385312 | 168098 | 61316 | 211144 |
| Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II | Delaware Ivy VIP Limited-Term Bond Class II |
|  | 7713598 | 1423566 | 2555137 | (64479) | (397093) | 6120455 | 1336344 | 93360 | 52515 |
| Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I | Delaware Ivy VIP Mid Cap Growth Class I |
|  | 2946158 | 898001 | 1308415 | 142512 | (1278507) | 1399749 | 145807 |  | 363875 |
| Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I | Delaware Ivy VIP Small Cap Growth Class I |
|  | 613637 | 137035 | 337389 | (87076) | (97598) | 228609 | 37415 |  | 62608 |
| Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II | Delaware Ivy VIP Smid Cap Core Class II |
|  | 92226 | 496464 | 122003 | 3700 | (92835) | 377552 | 33892 |  | 58359 |
| Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II | Delaware Ivy VIP Value Class II |
|  | 2971031 | 2650143 | 1370461 | 84674 | (1186583) | 3148804 | 566332 | 43958 | 912557 |
| Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II | Delaware VIP Global Value Equity Class II |
|  | 2599111 | 1223926 | 718510 | (15378) | (885851) | 2203298 | 499614 | 85670 | 537919 |
| Total | $38938387 | $14802597 | $14120393 | $271242 | $(10321916) | $29569917 |  | $510051 | $4066210 |

---

**3. Investments**

For the year ended December 31, 2022, each Portfolio made purchases and sales of investment securities other than short-term investments as follows:

---

| | | |
|:---|:---|:---|
| Portfolio | Purchases<br> other than<br> US government<br> securities | Sales<br> other than<br> US government<br> securities |
| Delaware Ivy VIP Pathfinder Aggressive | $20498336 | $17500001 |
| Delaware Ivy VIP Pathfinder Conservative | 28135397 | 27256268 |
| Delaware Ivy VIP Pathfinder Moderate | 152629842 | 146507415 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 198231379 | 179055565 |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 46950014 | 47645003 |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 202090051 | 142774758 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | 42643990 | 35969062 |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 14802597 | 14120393 |

---

[**Table of Contents**](#toc3)

The tax cost of investments and derivatives includes adjustments to net unrealized appreciation (depreciation) which may not necessarily be the final tax cost basis adjustments but which approximate the tax basis unrealized gains and losses that may be realized and distributed to shareholders. At December 31, 2022, the cost and unrealized appreciation (depreciation) of investments and derivatives for federal income tax purposes for each Portfolio were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Portfolio | Cost of<br> investments<br> and derivatives | Aggregate<br> unrealized<br> appreciation<br> of investments<br> and derivatives | Aggregate<br> unrealized<br> depreciation<br> of investments<br> and derivatives | Net unrealized<br> appreciation<br> (depreciation)<br> of investments<br> and derivatives |
| Delaware Ivy VIP Pathfinder Aggressive | $70568628 | $16796291 | $(33649742) | $(16853451) |
| Delaware Ivy VIP Pathfinder Conservative | 106532230 |  | (22231412) | (22231412) |
| Delaware Ivy VIP Pathfinder Moderate | 597656556 | 131571247 | (263442058) | (131870811) |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 734045810 |  | (167817601) | (167817601) |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 175850723 | 344299 | (38096053) | (37751754) |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 557594227 |  | (122320110) | (122320110) |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | 100678809 | 23171204 | (46561383) | (23390179) |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 39795232 |  | (9557310) | (9557310) |

---

US GAAP defines fair value as the price that each Portfolio would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. A three-level hierarchy for fair value measurements has been established based upon the transparency of inputs to the valuation of an asset or liability. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the reporting entity's own assumptions about the assumptions that market participants would use in pricing the asset or liability based on the best information available under the circumstances. Each Portfolio's investment in its entirety is assigned a level based upon the observability of the inputs which are significant to the overall valuation. The three-level hierarchy of inputs is summarized as follows:

---

| | |
|:---|:---|
| Level 1 – | Inputs are quoted prices in active markets for identical investments. (Examples: equity securities, open-end investment companies, futures contracts, and exchange-traded options contracts) |
| Level 2 – | Other observable inputs, including, but not limited to: quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks, and default rates) or other market-corroborated inputs. (Examples: debt securities, government securities, swap contracts, foreign currency exchange contracts, foreign securities utilizing international fair value pricing, broker-quoted securities, and fair valued securities) |
| Level 3 – | Significant unobservable inputs, including each Portfolio's own assumptions used to determine the fair value of investments. (Examples: broker-quoted securities and fair valued securities) |

---

Level 3 investments are valued using significant unobservable inputs. Each Portfolio may also use an income-based valuation approach in which the anticipated future cash flows of the investment are discounted to calculate fair value. Discounts may also be applied due to the nature or duration of any restrictions on the disposition of the investments. Valuations may also be based upon current market prices of securities that are comparable in coupon, rating, maturity, and industry. The derived value of a Level 3 investment may not represent the value which is received upon disposition and this could impact the results of operations. <br>

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**3. Investments (continued)**

The following tables summarize the valuation of each Portfolio's investments by fair value hierarchy levels as of December 31, 2022:

---

| | |
|:---|:---|
|  | Delaware Ivy<br>VIP Pathfinder<br> Aggressive |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Affiliated Mutual Funds | $53577856 |
| Short-Term Investments | 137321 |
| Total Value of Securities | $53715177 |
|  | Delaware Ivy<br> VIP Pathfinder<br> Conservative |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Affiliated Mutual Funds | $84092598 |
| Short-Term Investments | 208220 |
| Total Value of Securities | $84300818 |
|  | Delaware Ivy<br> VIP Pathfinder<br> Moderate |
|  | Level 1 |
| <u>Securities</u> |  |
| Assets: |  |
| Affiliated Mutual Funds | $464625681 |
| Short-Term Investments | 1160064 |
| Total Value of Securities | $465785745 |
|  | Delaware Ivy<br> VIP Pathfinder<br> Moderately<br> Aggressive |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Affiliated Mutual Funds | $564820420 |
| Short-Term Investments | 1407789 |
| Total Value of Securities | $566228209 |

---

[**Table of Contents**](#toc3)

---

| | |
|:---|:---|
|  | Delaware Ivy<br>VIP Pathfinder<br> Moderately<br> Conservative |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Affiliated Mutual Funds | $137754670 |
| Short-Term Investments | 344299 |
| Total Value of Securities | $138098969 |
|  | Delaware Ivy<br> VIP Pathfinder<br> Moderate –<br> Managed<br> Volatility |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Affiliated Mutual Funds | $425710301 |
| Short-Term Investments | 8700908 |
| Total Value of Securities | $434411209 |
| <u>Derivatives</u><sup>1</sup> |  |
| <u>Assets:</u> |  |
| Futures Contracts | $862908 |

---

<sup>1</sup> Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

---

| | |
|:---|:---|
|  | Delaware Ivy<br> VIP Pathfinder<br> Moderately<br> Aggressive –<br> Managed<br> Volatility |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Affiliated Mutual Funds | $75596037 |
| Short-Term Investments | 1546332 |
| Total Value of Securities | $77142369 |
| Derivatives<sup>1</sup> |  |
| Assets: |  |
| Futures Contracts | $146261 |

---

<sup>1</sup> Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**3. Investments (continued)**

---

| | |
|:---|:---|
|  | Delaware Ivy<br>VIP Pathfinder<br> Moderately<br> Conservative –<br> Managed<br> Volatility |
|  | Level 1 |
| <u>Securities</u> |  |
| <u>Assets:</u> |  |
| Affiliated Mutual Funds | $29569917 |
| Short-Term Investments | 603522 |
| Total Value of Securities | $30173439 |
| <u>Derivatives</u><sup>1</sup> |  |
| <u>Assets:</u> |  |
| Futures Contracts | $64483 |

---

<sup>1</sup> Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument at the year end.

During the year ended December 31, 2022, there were no transfers into or out of Level 3 investments. Each Portfolio's policy is to recognize transfers into or out of Level 3 investments based on fair value at the beginning of the reporting period.

A reconciliation of Level 3 investments is presented when a Portfolio has a significant amount of Level 3 investments at the beginning or end of the year in relation to each Portfolio's net assets. During the year ended December 31, 2022, there were no Level 3 investments. <br>

[**Table of Contents**](#toc3)

**4. Dividend and Distribution Information**

Income and long-term capital gain distributions are determined in accordance with federal income tax regulations, which may differ from US GAAP. Additionally, distributions from net short-term gains on sales of investment securities are treated as ordinary income for federal income tax purposes. The tax character of dividends and distributions paid during the years ended December 31, 2022 and 2021 were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Ordinary<br> income | Long-term<br> capital<br> gains | Total |
| <u>Year ended December 31, 2022:</u> |  |  |  |
| Delaware Ivy VIP Pathfinder Aggressive | $1498412 | $4583380 | $6081792 |
| Delaware Ivy VIP Pathfinder Conservative | 3030303 | 6890561 | 9920864 |
| Delaware Ivy VIP Pathfinder Moderate | 14728256 | 47541942 | 62270198 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 16658209 | 61984034 | 78642243 |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 4480748 | 12866148 | 17346896 |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 15103477 | 80688686 | 95792163 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | 1613342 | 6437395 | 8050737 |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 2172241 | 9823144 | 11995385 |
| <u>Year ended December 31, 2021:</u> |  |  |  |
| Delaware Ivy VIP Pathfinder Aggressive | 1596762 | 3021972 | 4618734 |
| Delaware Ivy VIP Pathfinder Conservative | 3023122 | 3760172 | 6783294 |
| Delaware Ivy VIP Pathfinder Moderate | 16714721 | 26045525 | 42760246 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 20765959 | 32434315 | 53200274 |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 5195138 | 7287721 | 12482859 |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 12123096 | 9203657 | 21326753 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | 1487007 | 1398938 | 2885945 |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 1532015 | 1698210 | 3230225 |

---

**5. Components of Net Assets on a Tax Basis**

As of December 31, 2022, the components of net assets on a tax basis were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP<br> Pathfinder<br> Aggressive | Delaware Ivy<br> VIP<br> Pathfinder<br> Conservative | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderate | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderately<br> Aggressive |
| Shares of beneficial interest | $58370174 | $94550188 | $511302636 | $617021503 |
| Undistributed ordinary income | 3448289 | 3728937 | 26623290 | 35423677 |
| Undistributed long-term capital gains | 8692462 | 8194288 | 59580314 | 81414730 |
| Other temporary differences | (5086) | (5730) | (40043) | (47735) |
| Unrealized appreciation (depreciation) of investments and derivatives | (16853451) | (22231412) | (131870811) | (167817601) |
| Net assets | $53652388 | $84236271 | $465595386 | $565994574 |

---

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**5. Components of Net Assets on a Tax Basis (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderately<br> Conservative | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderate –<br> Managed<br> Volatility | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderately<br> Aggressive –<br> Managed<br> Volatility | Delaware Ivy<br> VIP<br> Pathfinder<br> Moderately<br> Conservative –<br> Managed<br> Volatility |
| Shares of beneficial interest | $153031231 | $475330298 | $83209221 | $34442768 |
| Undistributed ordinary income | 7053028 | 26680113 | 5221597 | 1775825 |
| Undistributed long-term capital gains | 15670388 | 55912692 | 12271395 | 3572113 |
| Other temporary differences | (12806) | (21563) | (11959) | (11679) |
| Unrealized appreciation (depreciation) of investments and derivatives | (37751754) | (122320110) | (23390179) | (9557310) |
| Net assets | $137990087 | $435581430 | $77300075 | $30221717 |

---

The differences between book basis and tax basis components of net assets are primarily attributable to tax deferral of losses on wash sales, deferred directors fees, unamortized organizational costs, and mark-to-market of futures contracts.

For financial reporting purposes, capital accounts are adjusted to reflect the tax character of permanent book/tax differences. Reclassifications are primarily due to capital gain distributions from underlying regulated investment companies. Results of operations and net assets were not affected by these reclassifications. For the year ended December 31, 2022, the Portfolios had no reclassifications.

**6. Capital Shares**

Transactions in capital shares were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Pathfinder Aggressive | Delaware Ivy VIP<br> Pathfinder Aggressive | Delaware Ivy VIP<br> Pathfinder Conservative | Delaware Ivy VIP<br> Pathfinder Conservative | Delaware Ivy VIP<br> Pathfinder Moderate | Delaware Ivy VIP<br> Pathfinder Moderate |
|  | Year ended | Year ended | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 278057 | 218691 | 668715 | 1422907 | 435677 | 334618 |
| Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 1497978 | 918548 | 2339827 | 1303477 | 15187853 | 8317981 |
|  | 1776035 | 1137239 | 3008542 | 2726384 | 15623530 | 8652599 |
| Shares redeemed: | Shares redeemed: | Shares redeemed: | Shares redeemed: | Shares redeemed: | Shares redeemed: | Shares redeemed: |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | (2118183) | (1420014) | (3018788) | (3765450) | (17135328) | (21048827) |
| Net decrease | (342148) | (282775) | (10246) | (1039066) | (1511798) | (12396228) |

---

[**Table of Contents**](#toc3)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Pathfinder Moderately<br> Aggressive | Delaware Ivy VIP<br> Pathfinder Moderately<br> Aggressive | Delaware Ivy VIP<br> Pathfinder Moderately<br> Conservative | Delaware Ivy VIP<br> Pathfinder Moderately<br> Conservative | Delaware Ivy VIP<br> Pathfinder Moderate –<br> Managed Volatility | Delaware Ivy VIP<br> Pathfinder Moderate –<br> Managed Volatility |
|  | Year ended | Year ended | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 896493 | 880297 | 78272 | 516151 | 2885467 | 2920413 |
| Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 18995711 | 10160868 | 4130213 | 2403138 | 22122901 | 3584931 |
|  | 19892204 | 11041165 | 4208485 | 2919289 | 25008368 | 6505344 |
| Shares redeemed: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | (20729425) | (27863242) | (5072321) | (6094096) | (8036060) | (49187824) |
| Net increase (decrease) | (837221) | (16822077) | (863836) | (3174807) | 16972308 | (42682480) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Delaware Ivy VIP<br> Pathfinder Moderately<br> Aggressive –<br> Managed Volatility | Delaware Ivy VIP<br> Pathfinder Moderately<br> Aggressive –<br> Managed Volatility | Delaware Ivy VIP<br> Pathfinder Moderately<br> Conservative –<br> Managed Volatility | Delaware Ivy VIP<br> Pathfinder Moderately<br> Conservative –<br> Managed Volatility |
|  | Year ended | Year ended | Year ended | Year ended |
|  | 12/31/22 | 12/31/21 | 12/31/22 | 12/31/21 |
| Shares sold: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 390290 | 571261 | 595866 | 1065285 |
| Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: | Shares issued upon reinvestment of dividends and distributions: |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | 1698468 | 506555 | 3517708 | 566786 |
|  | 2088758 | 1077816 | 4113574 | 1632071 |
| Shares redeemed: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class II | (2473446) | (2011409) | (1842890) | (10182770) |
| Net increase (decrease) | (384688) | (933593) | 2270684 | (8550699) |

---

**7. Interfund Lending Program**

Pursuant to an exemptive order issued by the SEC (Order), the Ivy Funds and Ivy Variable Insurance Portfolios (collectively, the Funds only for purposes of this Note 7) have the ability to lend money to, and borrow money from, each other pursuant to a master interfund lending agreement (Interfund Lending Program). Under the Interfund Lending Program, the Funds may lend or borrow money for temporary purposes directly to or from one another (each, an Interfund Loan), subject to meeting the conditions of the Order. The interest rate to be charged on an Interfund Loan is the average of the overnight repurchase agreement rate and the short-term bank loan rate. This program is in existence but is not currently in use. The Funds made no Interfund Loans under the Interfund Lending Program during the year ended December 31, 2022. <br>

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**8. Derivatives**

US GAAP requires disclosures that enable investors to understand: (1) how and why an entity uses derivatives; (2) how they are accounted for; and (3) how they affect an entity's results of operations and financial position.

**Futures Contracts** — A futures contract is an agreement in which the writer (or seller) of the contract agrees to deliver to the buyer an amount of cash or securities equal to a specific dollar amount times the difference between the value of a specific security or index at the close of the last trading day of the contract and the price at which the agreement is made. The Portfolios may use futures in the normal course of pursuing its investment objective. The Portfolios may invest in futures contracts to hedge its existing portfolio securities against fluctuations in fair value caused by changes in prevailing market interest rates. Upon entering into a futures contract, the Portfolios deposit cash or pledge US government securities to a broker, equal to the minimum "initial margin" requirements of the exchange on which the contract is traded. Subsequent payments are received from the broker or paid to the broker each day, based on the daily fluctuation in the market value of the contract. These receipts or payments are known as "variation margin" and are recorded daily by the Portfolios as unrealized gains or losses until the contracts are closed. When the contracts are closed, the Portfolios record a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Risks of entering into futures contracts include potential imperfect correlation between the futures contracts and the underlying securities and the possibility of an illiquid secondary market for these instruments. When investing in futures, there is reduced counterparty credit risk to the Portfolios because futures are exchange-traded and the exchange's clearinghouse, as counterparty to all exchange-traded futures, guarantees against default. The Managed Volatility Portfolios posted cash collateral as margin for open futures contracts, which is disclosed on the "Statements of assets and liabilities" under "Cash collateral due from broker on futures contracts." Open futures contracts, if any, are disclosed on the "Schedules of investments."

During the year ended December 31, 2022, the Managed Volatility Portfolios invested in futures contracts to hedge the Portfolios' existing portfolio securities against fluctuations in value caused by changes in interest rates or market conditions.

During the year ended December 31, 2022, the Managed Volatility Portfolios experienced net realized and unrealized gains or losses attributable to futures contracts, which are disclosed on the "Statements of operations."

The table below summarizes the average quarterly balance of derivative holdings by each Portfolio during the year ended December 31, 2022:

---

| | | | |
|:---|:---|:---|:---|
|  | Short Derivative Volume | Short Derivative Volume | Short Derivative Volume |
|  | Delaware Ivy VIP<br> Pathfinder Moderate –<br> Managed Volatility | Delaware Ivy VIP <br> Pathfinder Moderately<br> Aggressive –<br> Managed Volatility | Delaware Ivy VIP<br> Pathfinder Moderately<br> Conservative –<br> Managed Volatility |
| Futures contracts (average notional value) | $(44592727) | $(8036503) | $(3463545) |

---

**9. Securities Lending**

Each Portfolio, along with other funds in the Delaware Funds, may lend its securities pursuant to a security lending agreement (Lending Agreement) with The Bank of New York Mellon (BNY Mellon). At the time a security is loaned, the borrower must post collateral equal to the required percentage of the market value of the loaned security, including any accrued interest. The required percentage is: (1) 102% with respect to US securities and foreign securities that are denominated and payable in US dollars; and (2) 105% with respect to foreign securities. With respect to each loan, if on any business day the aggregate market value of securities collateral plus cash collateral held is less than the aggregate market value of the securities which are the subject of such loan, the borrower will be notified to provide additional collateral by the end of the following business day, which, together with the collateral already held, will be not less than the applicable initial collateral requirements for such security loan. If the aggregate market value of securities collateral and cash collateral held with respect to a security loan exceeds the applicable initial collateral requirement, upon the request of the borrower, BNY Mellon must return enough collateral to the borrower by the end of the following business day to reduce the value of the remaining collateral to the applicable initial collateral requirement for such security loan. As a result of the foregoing, the value of the collateral held with respect to a loaned security on any particular day, may be more or less than the value of the security on loan. The collateral percentage with respect to the market value of the loaned security is determined by the security lending agent. <br>

[**Table of Contents**](#toc3)

Cash collateral received by each Portfolio of the Trust is generally invested in a series of individual separate accounts, each corresponding to a Portfolio. The investment guidelines permit each separate account to hold certain securities that would be considered eligible securities for a money market fund. Cash collateral received is generally invested in government securities; certain obligations issued by government sponsored enterprises; repurchase agreements collateralized by US Treasury securities; obligations issued by the central government of any Organization for Economic Cooperation and Development (OECD) country or its agencies, instrumentalities, or establishments; obligations of supranational organizations; commercial paper, notes, bonds, and other debt obligations; certificates of deposit, time deposits, and other bank obligations; certain money market funds; and asset-backed securities. Each Portfolio can also accept US government securities and letters of credit (non-cash collateral) in connection with securities loans.

In the event of default or bankruptcy by the lending agent, realization and/or retention of the collateral may be subject to legal proceedings. In the event the borrower fails to return loaned securities and the collateral received is insufficient to cover the value of the loaned securities and provided such collateral shortfall is not the result of investment losses, the lending agent has agreed to pay the amount of the shortfall to each Portfolio or, at the discretion of the lending agent, replace the loaned securities. Each Portfolio continues to record dividends or interest, as applicable, on the securities loaned and is subject to changes in value of the securities loaned that may occur during the term of the loan. Each Portfolio has the right under the Lending Agreement to recover the securities from the borrower on demand. With respect to security loans collateralized by non-cash collateral, each Portfolio receives loan premiums paid by the borrower. With respect to security loans collateralized by cash collateral, the earnings from the collateral investments are shared among each Portfolio, the security lending agent, and the borrower. Each Portfolio records security lending income net of allocations to the security lending agent and the borrower.

Each Portfolio may incur investment losses as a result of investing securities lending collateral. This could occur if an investment in each collateral investment account defaulted or became impaired. Under those circumstances, the value of each Portfolio's cash collateral account may be less than the amount each Portfolio would be required to return to the borrowers of the securities and each Portfolio would be required to make up for this shortfall.

During the year ended December 31, 2022, the Portfolios had no securities out on loan.

**10. Credit and Market Risk**

An outbreak of infectious respiratory illness caused by a novel coronavirus known as COVID-19 was first detected in China in December 2019 and has now been detected globally. This coronavirus has resulted in travel restrictions, closed international borders, enhanced health screenings at ports of entry and elsewhere, disruption of and delays in healthcare service preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions, and lower consumer demand, as well as general concern and uncertainty. The impact of COVID-19, and other infectious illness outbreaks that may arise in the future, could adversely affect the economies of many nations or the entire global economy, individual issuers and capital markets in ways that cannot necessarily be foreseen. In addition, the impact of infectious illnesses in emerging market countries may be greater due to generally less established healthcare systems. Public health crises caused by the COVID-19 outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. The duration of the COVID-19 outbreak and its effects cannot be determined with certainty.

Because each Portfolio invests substantially all of its assets in Ivy Variable Insurance Portfolios mutual funds, the risks associated with investing in the Portfolios are closely related to the risks associated with the securities and other investments held by the Underlying Funds.

Certain Underlying Funds may hold high-yield or non-investment-grade bonds, that may be subject to a greater degree of credit risk. Credit risk relates to the ability of the issuer to meet interest or principal payments or both as they become due. The Underlying Funds may acquire securities in default and are not obligated to dispose of securities whose issuers subsequently default and are not obligated to dispose of securities whose issuers subsequently default.

In the normal course of business, the Underlying Funds may invest in securities and enter into transactions where risks exist due to fluctuations in the market (market risk) or failure of the issuer of a security to meet all its obligations (issuer credit risk). The value of securities held by the Underlying Funds may decline in response to certain events, including those directly involving the issuers whose securities are owned by the Underlying Funds; conditions affecting the general economy; overall market changes; local, regional or global political, social or economic instability; and currency and interest rate and price fluctuations. Similar to issuer credit risk, the Underlying Funds may be exposed to counterparty credit risk, or the risk that an entity with which the Underlying Funds have unsettled or open transactions may fail to or be unable to <br>

[**Table of Contents**](#toc3)

Notes to financial statements

Ivy Variable Insurance Portfolios

**10. Credit and Market Risk (continued)**

perform on its commitments. The Underlying Funds manage counterparty credit risk by entering into transactions only with counterparties that they believe have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Underlying Funds to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties.

Certain Underlying Funds may enter into financial instrument transactions (such as swaps, futures, options and other derivatives) that may have off-balance sheet market risk. Off-balance sheet market risk exists when the maximum potential loss on a particular financial instrument is greater than the value of such financial instrument.

If an Underlying Fund invests directly in foreign currencies or in securities that trade in, and receive revenues in, foreign currencies, or in financial derivatives that provide exposure to foreign currencies, it will be subject to the risk that those currencies will decline in value relative to the base currency of the Underlying Funds, or, in the case of hedging positions, that the Underlying Fund's base currency will decline in value relative to the currency being hedged. Currency rates in foreign countries may fluctuate significantly over short periods of time for a number of reasons, including changes in interest rates, intervention (or the failure to intervene) by U.S. or foreign governments, central banks or supranational entities such as the International Monetary Fund, or by the imposition of currency controls or other political developments in the United States or abroad.

IBOR is the risk that changes related to the use of the London interbank offered rate (LIBOR) and other interbank offered rate (collectively, IBORs) could have adverse impacts on financial instruments that reference LIBOR (or the corresponding IBOR). The abandonment of LIBOR could affect the value and liquidity of instruments that reference LIBOR. The use of alternative reference rate products may impact investment strategy performance. These risks may also apply with respect to changes in connection with other IBORs, such as the euro overnight index average (EONIA), which are also the subject of recent reform.

**11. Contractual Obligations**

Each Portfolio enters into contracts in the normal course of business that contain a variety of indemnifications. Each Portfolio's maximum exposure under these arrangements is unknown. However, each Portfolio has not had prior claims or losses pursuant to these contracts. Management has reviewed each Portfolio's existing contracts and expects the risk of loss to be remote.

**12. Subsequent Events**

Management has determined that no material events or transactions occurred subsequent to December 31, 2022, that would require recognition or disclosure in the Portfolios' financial statements. <br>

[**Table of Contents**](#toc3)

Report of independent registered public accounting firm

To the Board of Trustees of Ivy Variable Insurance Portfolios and Shareholders of Delaware Ivy VIP Pathfinder Aggressive, Delaware Ivy VIP Pathfinder Conservative, Delaware Ivy VIP Pathfinder Moderate, Delaware Ivy VIP Pathfinder Moderately Aggressive, Delaware Ivy VIP Pathfinder Moderately Conservative, Delaware Ivy VIP Pathfinder Moderate — Managed Volatility, Delaware Ivy VIP Pathfinder Moderately Aggressive — Managed Volatility and Delaware Ivy VIP Pathfinder Moderately Conservative — Managed Volatility

**Opinions on the Financial Statements**

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of Delaware Ivy VIP Pathfinder Aggressive, Delaware Ivy VIP Pathfinder Conservative, Delaware Ivy VIP Pathfinder Moderate, Delaware Ivy VIP Pathfinder Moderately Aggressive, Delaware Ivy VIP Pathfinder Moderately Conservative, Delaware Ivy VIP Pathfinder Moderate — Managed Volatility, Delaware Ivy VIP Pathfinder Moderately Aggressive — Managed Volatility and Delaware Ivy VIP Pathfinder Moderately Conservative — Managed Volatility (eight of the portfolios constituting Ivy Variable Insurance Portfolios, hereafter collectively referred to as the "Portfolios") as of December 31, 2022, the related statements of operations for the year ended December 31, 2022 and the statements of changes in net assets and the financial highlights for each of the two years in the period ended December 31, 2022, including the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Portfolios as of December 31, 2022, the results of each of their operations for the year ended December 31, 2022, and the changes in each of their net assets and each of the financial highlights for each of the two years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.

The financial statements of the Portfolios as of and for the year ended December 31, 2020 and the financial highlights for each of the periods ended on or prior to December 31, 2020 (not presented herein, other than the financial highlights) were audited by other auditors whose report dated February 12, 2021 expressed an unqualified opinion on those financial statements and financial highlights.

**Basis for Opinions**

These financial statements are the responsibility of the Portfolios' management. Our responsibility is to express an opinion on the Portfolios' financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Portfolios in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the transfer agents and brokers. We believe that our audits provide a reasonable basis for our opinions.

/s/PricewaterhouseCoopers LLP<br> Philadelphia, Pennsylvania<br> February 23, 2023

We have served as the auditor of one or more investment companies in Delaware Funds by Macquarie<sup>®</sup> since 2010. <br>

[**Table of Contents**](#toc3)

Other Portfolio information (Unaudited)

Ivy Variable Insurance Portfolios

**Tax Information**

All disclosures are based on financial information available as of the date of this annual report and, accordingly are subject to change. For any and all items requiring reporting, it is the intention of each Portfolio to report the maximum amount permitted under the Internal Revenue Code and the regulations thereunder.

For the fiscal year ended December 31, 2022, each Portfolio reports distributions paid during the year as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | (A)<br> Long-Term<br> Capital Gains<br> Distributions<br> (Tax Basis) | (B)<br> Ordinary<br> Income<br> Distributions<br> (Tax Basis) | Total<br> Distributions<br> (Tax Basis) | (C)<br> Qualifying<br> Dividends<sup>1</sup> |
| Delaware Ivy VIP Pathfinder Aggressive | 75.36% | 24.64% | 100.00% | 26.42% |
| Delaware Ivy VIP Pathfinder Conservative | 69.46% | 30.54% | 100.00% | 12.35% |
| Delaware Ivy VIP Pathfinder Moderate | 76.35% | 23.65% | 100.00% | 19.81% |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 78.82% | 21.18% | 100.00% | 24.89% |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 74.17% | 25.83% | 100.00% | 16.73% |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 84.23% | 15.77% | 100.00% | 21.94% |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | 79.96% | 20.04% | 100.00% | 29.90% |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 81.89% | 18.11% | 100.00% | 15.67% |

---

(A) and (B) are based on a percentage of each Portfolio's total distributions.

(C) is based on each Portfolio's ordinary income distributions.

<sup>1</sup>Qualified dividends represent dividends which qualify for the corporate dividends received deduction.

For the fiscal year ended December 31, 2022, certain dividends paid by each Portfolio, determined to be Qualified Short-Term Capital Gains, may be subject to relief from US withholding for foreign shareholders, as provided by the American Jobs Creation Act of 2004; the Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010; and as extended by the American Taxpayer Relief Act of 2012. For the fiscal year ended December 31, 2022, the Portfolios have reported maximum distributions of Qualified Short-Term Capital Gains as follows:

---

| | |
|:---|:---|
|  | Qualified<br> Short-Term <br> Capital Gains |
| Delaware Ivy VIP Pathfinder Aggressive | $111809 |
| Delaware Ivy VIP Pathfinder Conservative | 172174 |
| Delaware Ivy VIP Pathfinder Moderate | 1550727 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 1899519 |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 463006 |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 5996422 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | 1065362 |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 485171 |

---

Each Portfolio intends to pass through foreign tax credits in the maximum amount and the gross foreign source income earned during the fiscal year 2022 by each Portfolio was as follows:

---

| | | |
|:---|:---|:---|
|  | Foreign Tax Credits | Gross Foreign Source Income Earned |
| Delaware Ivy VIP Pathfinder Aggressive | $32552 | $340685 |
| Delaware Ivy VIP Pathfinder Conservative | 17010 | 178115 |
| Delaware Ivy VIP Pathfinder Moderate | 189932 | 1986075 |
| Delaware Ivy VIP Pathfinder Moderately Aggressive | 289858 | 3032337 |
| Delaware Ivy VIP Pathfinder Moderately Conservative | 42400 | 444355 |
| Delaware Ivy VIP Pathfinder Moderate – Managed Volatility | 163099 | 1706979 |

---

[**Table of Contents**](#toc3)

---

| | | |
|:---|:---|:---|
|  | Foreign Tax Credits | Gross Foreign Source Income Earned |
| Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility | $37672 | $395005 |
| Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility | 9110 | 95327 |

---

**Board Consideration of Investment Management Agreements and Sub-Advisory Agreements at a Meeting Held on August 9-11, 2022**

At a meeting held on August 9-11, 2022 (the "Annual Contract Renewal Meeting"), the Board of Trustees (the "Board"), including a majority of Trustees each of whom is not an "interested person" as defined under the Investment Company Act of 1940 (the "Independent Trustees"), approved the renewal of the Delaware Ivy VIP Pathfinder Aggressive, Delaware Ivy VIP Pathfinder Moderately Aggressive, Delaware Ivy VIP Pathfinder Moderate, Delaware Ivy VIP Pathfinder Moderately Conservative, Delaware Ivy VIP Pathfinder Conservative, Delaware Ivy VIP Pathfinder Moderate – Managed Volatility, Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility and Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility (each, a "Fund" and together, the "Funds") Investment Management Agreements with Delaware Management Company ("DMC"); and the Sub-Advisory Agreements with Macquarie Investment Management Austria Kapitalanlage AG ("MIMAK" or the "Affiliated Sub-Adviser") and with Securian Asset Management, Inc. ("Securian" and together with the Affiliated Sub-Adviser, the "Sub-Advisers"), as applicable.

Prior to the Meeting, including at a Board meeting held in May 2022, the Trustees conferred extensively among themselves and with representatives of DMC about these matters. Also, the Board was assisted by the applicable Investment Committee, with each Investment Committee assisting the full Board in the discharge of its duties in reviewing investment performance and other matters throughout the year. The Independent Trustees were assisted in their evaluation of the Investment Management Agreements and the Sub-Advisory Agreements by independent legal counsel, from whom they received separate legal advice and with whom they met separately.

In providing information to the Board, DMC was guided by a detailed set of requests for information submitted to them by independent legal counsel on behalf of the Independent Trustees at the start of the Board's annual contract renewal process earlier in 2022. In considering and approving the Investment Management Agreements and the Sub-Advisory Agreements, the Trustees considered the information they believed relevant, including but not limited to the information discussed below. The Board considered not only the specific information presented in connection with the Meeting, but also the knowledge gained over time through interaction with DMC about various topics. In this regard, the Board reviewed reports of DMC at each of its quarterly meetings, which included information about, among other things, Fund performance, investment strategies, and expenses. In addition, the Investment Committees confer with portfolio managers at various times throughout the year. In considering information relating to the approval of the Funds' Investment Management Agreements and the Sub-Advisory Agreements, the Independent Trustees also received information from an independent fund consultant, JDL Consultants, LLC ("JDL").

The Board did not identify any particular information or consideration that was all-important or controlling, and each individual Trustee may have attributed different weights to various factors.

After its deliberations, the Board unanimously approved the continuation of the Investment Management Agreements and the Sub-Advisory Agreements for a one-year term. The following summarizes a number of important, but not necessarily all, factors considered by the Board in support of its approval.

**Nature, extent, and quality of services.** The Board received and considered various information regarding the nature, extent, and quality of the advisory services provided to the Funds by DMC under its Investment Management Agreements and the experience of the officers and employees of DMC who provide these services, including each Fund's portfolio manager. The Board's review included consideration of DMC's investment process and oversight and research and analysis capabilities, and its ability to attract and retain qualified investment professionals. The Board considered information regarding DMC's programs for risk management, including investment, operational, liquidity, valuation, and compliance risks. The Board received information with respect to the cybersecurity program and business continuity plans of DMC and its affiliates. The Board also considered non-advisory services that DMC and its affiliates provide to the Delaware Funds, including third party oversight, transfer agent, internal audit, valuation, portfolio trading, and legal and compliance. The Board took into account the benefits to shareholders of investing in a Fund that is part of a family of funds managed by an affiliate of Macquarie Group Ltd. ("Macquarie"), the parent company of DMC, and the resources available to DMC as part of Macquarie's global asset management business. <br>

[**Table of Contents**](#toc3)

Other Portfolio information (Unaudited)

Ivy Variable Insurance Portfolios

**Board Consideration of Investment Management Agreements and Sub-Advisory Agreements at a Meeting Held on August 9-11, 2022 (continued)**

The Board received and considered various information with respect to the services provided by the Sub-Advisers under the Sub-Advisory Agreements and the credentials and experience of the officers and employees of the Sub-Advisers who provide these services, including each Fund's MIMAK portfolio managers. The Board considered the division of responsibilities between DMC and the Sub-Advisers and the oversight provided by DMC. The Board considered the expertise of the Sub-Advisers with respect to certain asset classes and/or investment styles. The Affiliated Sub-Adviser is part of Macquarie's global investment platform that has offices and personnel that are located around the world. As a result, the Board noted that DMC had stated that the Affiliated Sub-Adviser can provide research, investment and trading analysis on the markets and economies of various countries in which the Funds may invest, make recommendations regarding securities and assist with security trades, as applicable. The Board took into account that the Sub-Advisory Agreements may benefit the Funds and their shareholders by permitting DMC to use the resources and talents of the Sub-Advisers in managing the Funds.

The Board concluded that, overall, it was satisfied with the nature, extent and quality of services provided (and expected to be provided) to the Funds by DMC and the Sub-Advisers.

**Investment performance.** The Board received and considered information with respect to the investment performance of the Funds, including performance reports and discussions with portfolio managers at meetings of the Board's Investment Committees throughout the year as well as reports provided by Broadridge Financial Solutions, an independent investment company data provider ("Broadridge"), furnished for the Annual Contract Renewal Meeting. The Broadridge reports prepared for each Fund showed its investment performance in comparison to a group of similar funds (the "Performance Universe"). The Board received a description of the methodology used by Broadridge to select the funds in the Performance Universe. Comparative annualized performance for each Fund was shown for the past 1-, 3-, 5- and 10-year and since inception periods, as applicable, ended December 31, 2021. The Board considered that the Funds were managed by Ivy Investment Management Company prior to the acquisition of its parent company, Waddell & Reed Financial, Inc. and its subsidiaries (the "Transaction"), and that each Fund's performance prior to the closing of the Transaction on April 30, 2021 is that of its predecessor manager.

*Delaware Ivy VIP Pathfinder Aggressive* – The Performance Universe for the Fund consisted of the Fund and all mixed-asset target allocation growth funds underlying variable insurance products, regardless of asset size or primary channel of distribution The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was in the first quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1- and 5-year periods and underperformed its benchmark index for the 3- and 10-year periods. The Board, however, noted that one of the Fund's portfolio managers began managing the Fund in October 2016 and the Fund's other two portfolio managers only began managing the Fund in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe and benchmark during the periods under review.

*Delaware Ivy VIP Pathfinder Moderately Aggressive* – The Performance Universe for the Fund consisted of the Fund, the Expense Group, and all other mixed-asset target allocation moderate funds of funds underlying variable insurance products, excluding outliers. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was in the first quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-year period and underperformed its benchmark index for the 3-, 5- and 10-year periods. The Board, however, noted that one of the Fund's portfolio managers began managing the Fund in October 2016 and the Fund's other two portfolio managers only began managing the Fund in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review.

*Delaware Ivy VIP Pathfinder Moderate* – The Performance Universe for the Fund consisted of the Fund and all mixed-asset target allocation moderate funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3- and 5-year periods was in the first quartile and for the 10-year period was in the second quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-year period and underperformed its benchmark index for the 3-, 5- and 10-year periods. The Board, however, noted that one of <br>

[**Table of Contents**](#toc3)

the Fund's portfolio managers began managing the Fund in October 2016 and the Fund's other two portfolio managers only began managing the Fund in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review.

*Delaware Ivy VIP Pathfinder Moderately Conservative* – The Performance Universe for the Fund consisted of the Fund and all mixed-asset target allocation moderate funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1- and 3-year periods was in the second quartile and for the 5-year period was in the first quartile and for the 10-year period was in the third quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3- and 5-year periods was above the median and for the 10-year period was below the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-year period and underperformed its benchmark index for the 3-, 5- and 10-year periods. The Board, however, noted that one of the Fund's portfolio managers began managing the Fund in October 2016 and the Fund's other two portfolio managers only began managing the Fund in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review.

*Delaware Ivy VIP Pathfinder Conservative* – The Performance Universe for the Fund consisted of the Fund and all mixed-asset target allocation conservative funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was in the first quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3-, 5- and 10-year periods was above the median of its Performance Universe. The Board also noted that the Fund outperformed its benchmark index for the 1-year period and underperformed its benchmark index for the 3-, 5- and 10-year periods. The Board, however, noted that one of the Fund's portfolio managers began managing the Fund in October 2016 and the Fund's other two portfolio managers only began managing the Fund in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review.

*Delaware Ivy VIP Pathfinder Moderate* – Managed Volatility – The Performance Universe for the Fund consisted of the Fund and all mixed-asset target allocation moderate funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the first quartile, for the 3- and 5-year periods was in the second quartile and for the since inception period was in the third quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3- and 5-year periods was above the median and for the since inception period was below the median of its Performance Universe. The Board also noted that the Fund underperformed its benchmark index for the 1-, 3- and 5-year and since inception periods. The Board, however, noted that one of the Fund's portfolio managers began managing the Fund in October 2016 and the Fund's other two portfolio managers only began managing the Fund in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review.

*Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility* – The Performance Universe for the Fund consisted of the Fund and all mixed-asset target allocation moderate funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-, 3-, and 5-year periods was in the first quartile and for the since inception period in the second quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-, 3- and 5-year and since inception periods was above the median of its Performance Universe. The Board also noted that the Fund slightly outperformed it benchmark index for the 1-year period and underperformed its benchmark index for the 3- and 5-year and since inception periods. The Board, however, noted that one of the Fund's portfolio managers began managing the Fund in October 2016 and the Fund's other two portfolio managers only began managing the Fund in November 2021. The Board noted that the Fund was generally performing in line with its Performance Universe during the periods under review.

*Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility* – The Performance Universe for the Fund consisted of the Fund and all mixed-asset target allocation moderate funds underlying variable insurance products, regardless of asset size or primary channel of distribution. The Board noted that the Broadridge report comparison showed that the Fund's total return for the 1-year period was in the second quartile, for the 3- and 5-year periods was in the third quartile, and for the since inception period was in the fourth quartile of its Performance Universe. The Broadridge report comparison showed that the Fund's total return for the 1-year period was above the median and for the 3- and 5-year and since inception periods was below the median of its Performance Universe. The Board also noted that the Fund underperformed its benchmark index for the 1-, 3- and 5-year and since inception periods. The Board, however, noted that one of the Fund's portfolio managers began managing the Fund in October 2016 and the Fund's other two portfolio managers only began managing the Fund in November 2021. <br>

[**Table of Contents**](#toc3)

Other Portfolio information (Unaudited)

Ivy Variable Insurance Portfolios

**Board Consideration of Investment Management Agreements and Sub-Advisory Agreements at a Meeting Held on August 9-11, 2022 (continued)**

The Board noted the explanations from DMC and the Sub-Advisers concerning the reasons for the Fund's relative performance versus the Performance Universe and its benchmark for the various periods.

**Comparative expenses.** The Board received and considered expense data for the Funds. Management provided the Board with information on pricing levels and fee structures for each Fund as of its most recently completed fiscal year. The Board also considered on the comparative analysis of contractual management fees and actual total expense ratios of each Fund versus contractual management fees and actual total expense ratios of a group of similar funds as selected by Broadridge (the "Expense Group"). In reviewing comparative costs, each Fund's contractual management fee and the actual management fee incurred by each Fund were compared with the contractual management fees (assuming all funds were similar in size to each Fund) and actual management fees, taking into account any applicable breakpoints and fee waivers, with a Fund's expense universe, which is comprised of the Fund, its Expense Group and all other similar funds underlying variable insurance products with similar 12b-1/non-12b-1 structures, excluding outliers (the "Expense Universe"). Each Fund's total expenses were also compared with those of its Expense Universe.

*Delaware Ivy VIP Pathfinder Aggressive* – The expense comparisons for the Fund showed that its actual management fee was below the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Pathfinder Moderately Aggressive* – The expense comparisons for the Fund showed that its actual management fee was below the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Pathfinder Moderate* – The expense comparisons for the Fund showed that its actual management fee was below the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Pathfinder Moderately Conservative* – The expense comparisons for the Fund showed that its actual management fee was below the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Pathfinder Conservative* – The expense comparisons for the Fund showed that its actual management fee was below the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Pathfinder Moderate – Managed Volatility* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Pathfinder Moderately Aggressive – Managed Volatility* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

*Delaware Ivy VIP Pathfinder Moderately Conservative – Managed Volatility* – The expense comparisons for the Fund showed that its actual management fee was above the median of its Expense Universe and its actual total expenses were above its Expense Group average.

The Board also received and considered information about the nature and extent of services offered and fee rates charged by DMC to other types of clients with investment strategies similar to those of the Funds. In this regard, the Board received information about the significantly greater scope of services, and compliance, reporting and other legal burdens and risks of managing registered investment companies compared with those associated with managing assets of other types of clients, including third-party sub-advised fund clients, unregistered funds and separately managed accounts.

The Board noted that DMC, and not the Funds, pays the sub-advisory fees to the Sub-Advisers and, accordingly, that the retention of the Sub-Advisers does not increase the fees and expenses incurred by the Funds.

Based on its consideration of the factors and information it deemed relevant, including those described here, the Board determined that the compensation payable to DMC under the Investment Management Agreements and to the Sub-Advisers under the Sub-Advisory Agreements was reasonable.

**Economies of scale.** The Board received and considered information about the potential for DMC to realize economies of scale in the provision of management services to the Fund, the difficulties of calculating economies of scale at an individual Fund level, and the extent to which <br>

[**Table of Contents**](#toc3)

potential scale benefits are shared with shareholders, including the extent to which any economies of scale are reflected in the level of management fees charged. DMC discussed its advisory fee pricing and structure for the Delaware Funds complex, including the current breakpoints. The Board noted that, as of March 31, 2022, Delaware Ivy VIP Pathfinder Moderate—Managed Volatility's net assets exceeded its first breakpoint level and that breakpoints result in a lower advisory fee than would otherwise be the case in the absence of breakpoints, when the asset levels specified in the breakpoints schedule are exceeded. The Board noted that each Fund may also benefit from economies of scale through initial fee setting, fee waivers and expense reimbursements, as well as DMC's investment in its business, including investments in business infrastructure, technology and cybersecurity.

**Management profitability.** The Board received and considered the Investment Management Profitability Analysis that addressed the overall profitability of DMC's business in providing management and other services to each Fund and the Delaware Funds as a whole, including the methodology used by DMC in allocating costs for the purpose of determining profitability. The Board also reviewed a report prepared by JDL regarding DMC's profitability as compared to certain peer fund complexes and the Independent Trustees discussed DMC's profitability in such context with representatives from JDL. Based on its review, the Board determined that DMC's profitability was not excessive in light of the nature, extent and quality of the services provided to each Fund.

**Ancillary benefits.** The Board received and considered information regarding the extent to which DMC and its affiliates might derive ancillary benefits from fund operations, including the potential for procuring additional business as a result of the prestige and visibility associated with its role as investment manager to the Delaware Funds; the benefits from allocation of fund brokerage to improve trading efficiencies; and the fees that various affiliates received for serving as transfer agent and for overseeing fund accounting and financial administration services to the Delaware Funds. The Board received information from DMC regarding its view of the performance of its affiliates in providing transfer agent and fund accounting and financial administration oversight services and the organizational structure employed to provide these services pursuant to their contracts with the Funds.

Based on its consideration of the factors and information it deemed relevant, including the costs of providing investment management and other services to the Funds and the ongoing commitment of DMC and its affiliates to the Funds, the Board did not find that any ancillary benefits received by DMC and its affiliates were unreasonable.

**Conclusion.** Based on its review, consideration and evaluation of all factors it believed relevant, including the above-described factors and conclusions, the Board, including all of the Independent Trustees, approved the continuation of DMC's Investment Management Agreements and of the Sub-Advisers' Sub-Advisory Agreements for an additional one-year period. <br>

[**Table of Contents**](#toc3)

Board of trustees / directors and officers addendum

Delaware Funds by Macquarie<sup>®</sup>

A mutual fund is governed by a Board of Trustees/Directors ("Trustees"), which has oversight responsibility for the management of a fund's business affairs. Trustees establish procedures and oversee and review the performance of the investment manager, the distributor, and others who perform services for the fund. The independent fund trustees, in particular, are advocates for shareholder interests. Each trustee has served in that capacity since he or she was elected to or appointed to the Board of Trustees, and will continue to serve until his or her retirement or the election of a new trustee in his or her place. The following is a list of the Trustees and Officers with certain background and related information.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name,<br> Address,<br> and Birth Year** | **Position(s)<br> Held with<br> the Trust** | **Length of Time<br> Served<sup>1</sup>** | **Number of<br> Funds in Fund<br> Complex Overseen<br> by Trustee** | **Principal<br> Occupation(s)<br> During the<br> Past Five Years** | **Other<br> Directorships<br> Held by Trustee<br> During the<br> Past Five Years** |
| **Interested Trustee** | **Interested Trustee** | **Interested Trustee** | **Interested Trustee** | **Interested Trustee** | **Interested Trustee** |
| **Shawn K. Lytle**<sup>2</sup> 100 Independence <br> 610 Market Street <br> Philadelphia, PA<br> 19106-2354 <br> 1970 | President, Chief Executive Officer, and Trustee | President and Chief Executive Officer since August 2015 Trustee since September 2015 | 126 | Macquarie Asset Management<sup>3</sup> (2015–Present) - Global Head of Macquarie Asset Management Public Investments (2019–Present) - Head of Americas of Macquarie Group (2017–Present) |  |
| **Independent Trustees** | **Independent Trustees** | **Independent Trustees** | **Independent Trustees** | **Independent Trustees** | **Independent Trustees** |
| **Jerome D. Abernathy**<br> 100 Independence <br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1959 | Trustee | Since January 2019 | 126 | Stonebrook Capital Management, LLC (financial technology: macro factors and databases) - Managing Member (1993-Present) |  |
| **Ann D. Borowiec**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1958 | Trustee | Since March 2015 | 126 | J.P. Morgan Chase & Co. (1987-2013) - Chief Executive Officer, Private Wealth Management (2011– 2013) | Banco Santander International (2016–2019) Santander Bank, N.A. (2016-2019) |
| **Joseph W. Chow** <br> 100 Independence <br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354 <br> 1953 | Trustee | Since January 2013 | 126 | Private Investor (2011–Present) |  |
| **H. Jeffrey Dobbs**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA <br>19106-2354<br> 1955 | Trustee | Since April 2019<sup>4</sup> | 126 | KPMG LLP (2002-2015) - Global Sector Chairman, Industrial Manufacturing (2010-2015) | TechAccel LLC (2015–Present) PatientsVoices, Inc. (2018–Present) Valparaiso University Board (2012-Present) Ivy Funds Complex (2019- 2021) |

---

[**Table of Contents**](#toc3)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name,<br> Address,<br> and Birth Year** | **Position(s)<br> Held with<br> the Trust** | **Length of Time<br> Served<sup>1</sup>** | **Number of<br> Funds in Fund<br> Complex Overseen<br> by Trustee** | **Principal<br> Occupation(s)<br> During the<br> Past Five Years** | **Other<br> Directorships<br> Held by Trustee<br> During the<br> Past Five Years** |
| **John A. Fry** <br> 100 Independence <br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1960 | Trustee | Since January 2001 | 126 | Drexel University - President (2010–Present) | Federal Reserve Bank of Philadelphia (2020–Present) FS Credit Real Estate Income Trust, Inc. (2018–Present) vTv Therapeutics Inc. (2017–Present) Community Health Systems (2004–Present) Drexel Morgan & Co. (2015–2019) |
| **Joseph Harroz, Jr.**<br> 100 Independence <br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1967 | Trustee | Since November 1998<sup>4</sup> | 126 | University of Oklahoma - President (2020–Present) - Interim President (2019–2020) - Vice President and Dean, College of Law (2010–2019) Brookhaven Investments LLC (commercial enterprises) - Managing Member (2019–Present) St. Clair, LLC (commercial enterprises) - Managing Member (2019–Present) | OU Medicine, Inc. (2020–Present) Big 12 Athletic Conference (2019-Present) Valliance Bank (2007–Present) Ivy Funds Complex (1998-2021) |
| **Sandra A.J. Lawrence**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354 1957 | Trustee | Since April 2019<sup>4</sup> | 126 | Children's Mercy Hospitals and Clinics (2005–2019) - Chief Administrative Officer (2016–2019) | Brixmor Property Group Inc. (2021-Present) Sera Prognostics Inc. (biotechnology) (2021-Present) Recology (resource recovery) (2021-Present) Evergy, Inc., Kansas City Power & Light Company, KCP&L Greater Missouri Operations Company, Westar Energy, Inc. and Kansas Gas and Electric Company (related utility companies) (2018-Present) National Association of Corporate Directors (2017-Present) Ivy Funds Complex (2019-2021) American Shared Hospital Services (medical device) (2017-2021) Westar Energy (utility) (2004-2018) |

---

[**Table of Contents**](#toc3)

Board of trustees / directors and officers addendum

Delaware Funds by Macquarie<sup>®</sup>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name,<br> Address, <br> and Birth Year** | **Position(s)<br> Held with<br> the Trust** | **Length of Time<br> Served<sup>1</sup>** | **Number of <br> Funds in Fund<br> Complex Overseen<br> by Trustee** | **Principal<br> Occupation(s)<br> During the<br> Past Five Years** | **Other<br> Directorships<br> Held by Trustee<br> During the<br> Past Five Years** |
| **Frances A. Sevilla-Sacasa** <br> 100 Independence<br> 610 Market Street Philadelphia, PA<br> 19106-2354<br> 1956 | Trustee | Since September 2011 | 126 | Banco Itaú International - Chief Executive Officer (2012–2016) | Florida Chapter of National Association of Corporate Directors (2021-Present) Callon Petroleum Company (2019-Present) Camden Property Trust (2011-Present) New Senior Investment Group Inc. (2021) Carrizo Oil & Gas, Inc. (2018-2019) |
| **Thomas K. Whitford**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1956 | Chair and Trustee | Trustee since January 2013 Chair since January 2023 | 126 | PNC Financial Services Group (1983–2013) - Vice Chairman (2009- 2013) | HSBC USA Inc. (2014–2022) HSBC North America Holdings Inc. (2013–2022) HSBC Finance Corporation (2013–2018) |
| **Christianna Wood** <br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1959 | Trustee | Since January 2019 | 126 | Gore Creek Capital, Ltd. - Chief Executive Officer and President (2009– Present) | The Merger Fund (2013–2021), The Merger Fund VL (2013–2021), WCM Alternatives: Event- Driven Fund (2013–2021), and WCM Alternatives: Credit Event Fund (2017–2021) Grange Insurance (2013–Present) H&R Block Corporation (2008–Present) |
| **Janet L. Yeomans**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1948 | Trustee | Since April 1999 | 126 | 3M Company (1995-2012) - Vice President and Treasurer (2006–2012) | Okabena Company (2009–2017) |
| **Officers** | **Officers** | **Officers** | **Officers** | **Officers** | **Officers** |
| **David F. Connor** <br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1963 | Senior Vice President, General Counsel, and Secretary | Senior Vice President, since May 2013; General Counsel since May 2015; Secretary since October 2005 | 126 | David F. Connor has served in various capacities at different times at Macquarie Asset Management. | None<sup>5</sup> |
| **Daniel V. Geatens**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA<br> 19106-2354<br> 1972 | Senior Vice President and Treasurer | Senior Vice President and Treasurer since October 2007 | 126 | Daniel V. Geatens has served in various capacities at different times at Macquarie Asset Management. | None<sup>5</sup> |

---

[**Table of Contents**](#toc3)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name,<br> Address,<br> and Birth Year** | **Position(s)<br> Held with<br> the Trust** | **Length of Time<br> Served<sup>1</sup>** | **Number of<br> Funds in Fund<br> Complex Overseen<br> by Trustee** | **Principal<br> Occupation(s)<br> During the<br> Past Five Years** | **Other<br> Directorships<br> Held by Trustee<br> During the<br> Past Five Years** |
| **Richard Salus**<br> 100 Independence<br> 610 Market Street<br> Philadelphia, PA <br> 19106-2354<br> 1963 | Senior Vice President and Chief Financial Officer | Senior Vice President and Chief Financial Officer since November 2006 | 126 | Richard Salus has served in various capacities at different times at Macquarie Asset Management. |  |

---

<sup>1</sup> "Length of Time Served" refers to the time since the Trustee or officer began serving one or more of the Trusts in the Delaware Funds complex.

<sup>2</sup> Shawn K. Lytle is considered to be an "Interested Trustee" because he is an executive officer of the Portfolios' investment advisor.

<sup>3</sup> Macquarie Asset Management is the marketing name for certain companies comprising the asset management division of Macquarie Group, including the Portfolios' investment advisor, principal underwriter, and transfer agent.

<sup>4</sup> Includes time served on the Board of Ivy Funds prior to the date when Ivy Funds joined the Delaware Funds complex.

<sup>5</sup> David F. Connor and Daniel V. Geatens serve in similar capacities for the six portfolios of the Optimum Fund Trust, which have the same investment manager, principal underwriter, and transfer agent as the Funds. Mr. Geatens also serves as the Chief Financial Officer of the Optimum Fund Trust, and he is Chief Financial Officer and Treasurer for Macquarie Global Infrastructure Total Return Fund Inc., which has the same investment manager as the Funds.

The Statement of Additional Information for the Fund(s) includes additional information about the Trustees and Officers and is available, without charge, upon request by calling 800 523-1918. <br>

[**Table of Contents**](#toc3)

Each Portfolio files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year on Form N-PORT. Each Portfolio's Form N-PORT, as well as a description of the policies and procedures that each Portfolio uses to determine how to vote proxies (if any) relating to portfolio securities, is available without charge (i) upon request, by calling 800 523-1918; and (ii) on the SEC's website at sec.gov. In addition, a description of the policies and procedures that each Portfolio uses to determine how to vote proxies (if any) relating to portfolio securities and the Schedule of Investments included in each Portfolio's most recent Form N-PORT are available without charge on the Portfolios' website at delawarefunds.com/vip/literature.

Information (if any) regarding how each Portfolio voted proxies relating to portfolio securities during the most recently disclosed 12-month period ended June 30 is available without charge (i) through the Portfolios' website at delawarefunds.com/proxy; and (ii) on the SEC's website at sec.gov.

---

| | |
|:---|:---|
| (2718725)<br> **ANN-VIP-PF-0223** | ![](mimdiaf4167581-ncsrsx88x1.jpg) |

---

Item 2. Code of Ethics

The registrant has adopted a code of ethics that applies to the registrant's principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party. A copy of the registrant's Code of Business Ethics has been posted on the Delaware Funds by Macquarie<sup>®</sup> Internet Web site at <u>www.delawarefunds.com</u>. Any amendments to the Code of Business Ethics, and information on any waiver from its provisions granted by the registrant, will also be posted on this Web site within five business days of such amendment or waiver and will remain on the Web site for at least 12 months.

Item 3. Audit Committee Financial Expert

The registrant's Board of Trustees has determined that certain members of the registrant's Audit Committee are audit committee financial experts, as defined below. For purposes of this item, an "audit committee financial expert" is a person who has the following attributes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. An understanding of generally accepted accounting principles and financial statements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. The ability to assess the general application of such principles in connection with the accounting for estimates, accruals, and reserves;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Experience preparing, auditing, analyzing, or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the registrant's financial statements, or experience actively supervising one or more persons engaged in such activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. An understanding of internal controls and procedures for financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. An understanding of audit committee functions.

An "audit committee financial expert" shall have acquired such attributes through:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Education and experience as a principal financial officer, principal accounting officer, controller, public accountant, or auditor or experience in one or more positions that involve the performance of similar functions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Experience actively supervising a principal financial officer, principal accounting officer, controller, public accountant, auditor, or person performing similar functions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Experience overseeing or assessing the performance of companies or public accountants with respect to the preparation, auditing, or evaluation of financial statements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Other relevant experience.

The registrant's Board of Trustees has also determined that each member of the registrant's Audit Committee is independent. In order to be "independent" for purposes of this item, the Audit Committee member may not: (i) other than in his or her capacity as a member of the Board of Trustees or any committee thereof, accept directly or indirectly any consulting, <br>

advisory or other compensatory fee from the issuer; or (ii) be an "interested person" of the registrant as defined in Section 2(a)(19) of the Investment Company Act of 1940.

The names of the audit committee financial experts on the registrant's Audit Committee are set forth below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;H. Jeffrey Dobbs

Sandra A.J. Lawrence

Frances Sevilla-Sacasa, Chair

Item 4. Principal Accountant Fees and Services

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Audit fees</u>.

The aggregate fees billed for services provided to the registrant by its independent auditors for the audit of the registrant's annual financial statements and for services normally provided by the independent auditors in connection with statutory and regulatory filings or engagements were $734,485 for the fiscal year ended December 31, 2022.

The aggregate fees billed for services provided to the registrant by its independent auditors for the audit of the registrant's annual financial statements and for services normally provided by the independent auditors in connection with statutory and regulatory filings or engagements were $743,661 for the fiscal year ended December 31, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Audit-related fees</u>.

The aggregate fees billed by the registrant's independent auditors for services relating to the performance of the audit of the registrant's financial statements and not reported under paragraph (a) of this Item were $0 for the fiscal year ended December 31, 2022.

The aggregate fees billed by the registrant's independent auditors for services relating to the performance of the audit of the financial statements of the registrant's investment adviser and other service providers under common control with the adviser and that relate directly to the operations or financial reporting of the registrant were $2,050,189 for the registrant's fiscal year ended December 31, 2022. The percentage of these fees relating to services approved by the registrant's Audit Committee pursuant to the <u>de</u> <u>minimis</u> exception from the pre-approval requirement in Rule 2-01(c)(7)(i)(C) of Regulation S-X was 0%. These audit-related services were as follows: year-end audit procedures; group reporting and subsidiary statutory audits.

The aggregate fees billed by the registrant's independent auditors for services relating to the performance of the audit of the registrant's financial statements and not reported under paragraph (a) of this Item were $0 for the fiscal year ended December 31, 2021. These audit-related services were related to the review of Form N-1A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Tax fees</u>.

The aggregate fees billed by the registrant's independent auditors for tax-related services provided to the registrant were $155,942 for the fiscal year ended December 31, 2022. The percentage of these fees relating to services approved by the registrant's Audit Committee pursuant to the <u>de</u> <u>minimis</u> exception from the pre-approval requirement in Rule 2-01(c)(7)(i)(C) <br>

of Regulation S-X was 0%. These tax-related services were as follows: review of income tax returns and review of annual excise distribution calculations.

The aggregate fees billed by the registrant's independent auditors for tax-related services provided to the registrant's investment adviser and other service providers under common control with the adviser and that relate directly to the operations or financial reporting of the registrant were $0 for the registrant's fiscal year ended December 31, 2022. The percentage of these fees relating to services approved by the registrant's Audit Committee pursuant to the de minimis exception from the pre-approval requirement in Rule 2-01(c)(7)(i)(C) of Regulation S-X was 0%.

The aggregate fees billed by the registrant's independent auditors for tax-related services provided to the registrant were $0 for the fiscal year ended December 31, 2021. These tax-related services were related to the review of the registrant's tax returns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>All other fees</u>.

The aggregate fees billed for all services provided by the independent auditors to the registrant other than those set forth in paragraphs (a), (b) and (c) of this Item were $0 for the fiscal year ended December 31, 2022.

The aggregate fees billed for all services other than those set forth in paragraphs (b) and (c) of this Item provided by the registrant's independent auditors to the registrant's adviser and other service providers under common control with the adviser and that relate directly to the operations or financial reporting of the registrant were $0 for the registrant's fiscal year ended December 31, 2022. The percentage of these fees relating to services approved by the registrant's Audit Committee pursuant to the <u>de</u> <u>minimis</u> exception from the pre-approval requirement in Rule 2-01(c)(7)(i)(C) of Regulation S-X was 0%.

The aggregate fees billed for all services provided by the independent auditors to the registrant other than those set forth in paragraphs (a), (b) and (c) of this Item were $0 for the fiscal year ended December 31, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The registrant's Audit Committee has established pre-approval policies and procedures as permitted by Rule 2-01(c)(7)(i)(B) of Regulation S-X (the "Pre-Approval Policy") with respect to services provided by the registrant's independent auditors. Pursuant to the Pre-Approval Policy, the Audit Committee has pre-approved the services set forth in the table below with respect to the registrant up to the specified fee limits. Certain fee limits are based on aggregate fees to the registrant and other registrants within the Delaware Funds by Macquarie<sup>®</sup>.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Service** | &nbsp;&nbsp;**Range of Fees** |
| &nbsp;&nbsp;**Audit Services** |  |
| &nbsp;&nbsp;Statutory audits or financial audits for new Funds | &nbsp;&nbsp;up to $50,000 per Fund |
| &nbsp;&nbsp;Services associated with SEC registration statements (e.g., Form N-1A, Form N-14, etc.), periodic reports and other documents filed with the SEC or other documents issued in connection with securities offerings (e.g., comfort letters for closed-end Fund offerings, consents), and assistance in responding to SEC comment letters | &nbsp;&nbsp;up to $10,000 per Fund |
| &nbsp;&nbsp;Consultations by Fund management as to the accounting or disclosure treatment of transactions or events and/or the actual or potential impact of final or proposed rules, standards or interpretations by the SEC, FASB, or other regulatory or standard-setting bodies (Note: Under SEC rules, some | &nbsp;&nbsp;up to $25,000 in the aggregate |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;consultations may be considered "audit-related services" rather than "audit services") |  |
| &nbsp;&nbsp;**Audit-Related Services** |  |
| &nbsp;&nbsp;Consultations by Fund management as to the accounting or disclosure treatment of transactions or events and /or the actual or potential impact of final or proposed rules, standards or interpretations by the SEC, FASB, or other regulatory or standard-setting bodies (Note: Under SEC rules, some consultations may be considered "audit services" rather than "audit-related services") | &nbsp;&nbsp;up to $25,000 in the aggregate |
| &nbsp;&nbsp;**Tax Services** |  |
| &nbsp;&nbsp;U.S. federal, state and local and international tax planning and advice (e.g., consulting on statutory, regulatory or administrative developments, evaluation of Funds' tax compliance function, etc.) | &nbsp;&nbsp;up to $25,000 in the aggregate |
| &nbsp;&nbsp;U.S. federal, state and local tax compliance (e.g., excise distribution reviews, etc.) | &nbsp;&nbsp;up to $5,000 per Fund |
| &nbsp;&nbsp;Review of federal, state, local and international income, franchise and other tax returns | &nbsp;&nbsp;up to $5,000 per Fund |

---

Under the Pre-Approval Policy, the Audit Committee has also pre-approved the services set forth in the table below with respect to the registrant's investment adviser and other entities controlling, controlled by or under common control with the investment adviser that provide ongoing services to the registrant (the "Control Affiliates") up to the specified fee limit. This fee limit is based on aggregate fees to the investment adviser and its Control Affiliates.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Service** | &nbsp;&nbsp;**Range of Fees** |
| &nbsp;&nbsp;**Non-Audit Services** |  |
| &nbsp;&nbsp;Services associated with periodic reports and other documents filed with the SEC and assistance in responding to SEC comment letters | &nbsp;&nbsp;up to $10,000 in the aggregate |

---

The Pre-Approval Policy requires the registrant's independent auditors to report to the Audit Committee at each of its regular meetings regarding all services initiated since the last such report was rendered, including those services authorized by the Pre-Approval Policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) The aggregate non-audit fees billed by the registrant's independent auditors for services rendered to the registrant and to its investment adviser and other service providers under common control with the adviser were $9,044,000 and $58,131 for the registrant's fiscal years ended December 31, 2022 and December 31, 2021, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) In connection with its selection of the independent auditors, the registrant's Audit Committee has considered the independent auditors' provision of non-audit services to the registrant's investment adviser and other service providers under common control with the adviser that were not required to be pre-approved pursuant to Rule 2-01(c)(7)(ii) of Regulation S-X. The Audit Committee has determined that the independent auditors' provision of these services is compatible with maintaining the auditors' independence.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Not applicable. <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) Not applicable.

Item 5. Audit Committee of Listed Registrants

Not applicable.

Item 6. Investments

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Included as part of report to shareholders filed under Item 1 of this Form N-CSR.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Divestment of securities in accordance with Section 13(c) of the Investment Company Act of 1940.

Not applicable.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies

Not applicable.

Item 8. Portfolio Managers of Closed-End Management Investment Companies

Not applicable.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Companies and Affiliated Purchasers

Not applicable.

Item 10. Submission of Matters to a Vote of Security Holders

Not applicable.

Item 11. Controls and Procedures

The registrant's principal executive officer and principal financial officers, or persons performing similar functions, have concluded that the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (17 CFR 270.30a-3(c))) are effective, as of a date within 90 days of the filing of this report, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the Investment Company Act of 1940 (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)) and provide reasonable assurance that the information required to be disclosed by the registrant in its reports or statements filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission.

There were no significant changes in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940 (17 CFR 270.30a-3(d)) that occurred during the period covered by the report to stockholders included <br>

herein that have materially affected, or are reasonably likely to materially affect, the registrant's internal control over financial reporting.

Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies

Not applicable.

Item 13. Exhibits

&nbsp;&nbsp;&nbsp;&nbsp;(a) (1) Code of Ethics

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[(2) Certifications of Principal Executive Officer and Principal Financial Officer pursuant to Rule 30a-2 under the Investment Company Act of 1940 are attached hereto as Exhibit 99.CERT.](mimivip4167561-ex99cert.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Written solicitations to purchase securities pursuant to Rule 23c-1 under the Securities Exchange Act of 1934.

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;(b) [Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are furnished herewith as Exhibit 99.906CERT.](mimivip4167561-ex99906cert.htm)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized.

**IVY VARIABLE INSURANCE PORTFOLIOS**

---

| | |
|:---|:---|
| /s/SHAWN K. LYTLE | /s/SHAWN K. LYTLE |
| By: | Shawn K. Lytle |
| Title: | President and Chief Executive Officer |
| Date: | March 9, 2023 |

---

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | |
|:---|:---|
| /s/SHAWN K. LYTLE | /s/SHAWN K. LYTLE |
| By: | Shawn K. Lytle |
| Title: | President and Chief Executive Officer |
| Date: | March 9, 2023 |

---

---

| | |
|:---|:---|
| **/s/RICHARD SALUS** | **/s/RICHARD SALUS** |
| By: | Richard Salus |
| Title: | Chief Financial Officer |
| Date: | March 9, 2023 |

---

## Ex-99.Cert

**EXHIBIT 99.CERT**

**<u>CERTIFICATION</u>**

I, Shawn K. Lytle, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this report on Form N-CSR of Ivy Variable Insurance Portfolios;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and
cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the
periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting
(as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures
to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being
prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) designed such internal control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within
90 days prior to the filing date of this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) disclosed in this report any change in the registrant's internal control over financial
reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee
of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial
information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.

Date: March 9, 2023

---

| | |
|:---|:---|
| /s/SHAWN K. LYTLE | /s/SHAWN K. LYTLE |
| By: | Shawn K. Lytle |
| Title: | President and Chief Executive Officer |

---

**CERTIFICATION**

I, Richard Salus, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this report on Form N-CSR of Ivy Variable Insurance Portfolios;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements
are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting
(as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures
to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being
prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) designed such internal control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within
90 days prior to the filing date of this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) disclosed in this report any change in the registrant's internal control over financial
reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee
of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial
information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.

Date: March 9, 2023

---

| | |
|:---|:---|
| **/s/RICHARD SALUS** | **/s/RICHARD SALUS** |
| By: | Richard Salus |
| Title: | Chief Financial Officer |

---

## Exhibit 99.906

**EXHIBIT 99.906CERT**

**Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

In connection with the attached report of the registrant on Form N-CSR to be filed with the Securities and Exchange Commission (the "Report"), each of the undersigned officers of the registrant does hereby certify, to the best of such officer's knowledge, that:

&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements
of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly
represents, in all material respects, the financial condition and results of operations of the registrant as of, and for, the periods
presented in the Report.

Date: March 9, 2023

---

| | |
|:---|:---|
| /s/SHAWN K. LYTLE | /s/SHAWN K. LYTLE |
| By: | Shawn K. Lytle |
| Title: | President and Chief Executive Officer |
| **/s/RICHARD SALUS** | **/s/RICHARD SALUS** |
| **By:** | **Richard Salus** |
| **Title:** | **Chief Financial Officer** |

---

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to the registrant and will be retained by the registrant and furnished to the SEC or its staff upon request.